ç¥çµå¿çå¦ç 究室
人éã®å¿ããè³ã¨ããè¦ç¹ããã¨ãããããããç¥çµå¿çå¦ã®åç¹ã§ãã
æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§ã®ç¥çµå¿çå¦ç ç©¶å®¤ã®æåã®ãã¼ãã¯ãåé èæ©è½é害ã¨è¨æ¶é害ã§ããã1980å¹´é ã®ãã¨ã§ãã
彿ã®ç¥çµå¿çå¦ã®ä¸å¿ã§ãã£ãæ¹æ³è«ã¯ãè³æå·è
ã®è¨åºçç¶ã®ç²¾å¯ãªåæã§ãæã
ããããè¸è¥²ããçç¶ã客観çã«è©ä¾¡ããæ¹æ³ãéçºããããã«ãããæ´»ç¨ãããã¼ã¿ãåæãããã¨ã§ãè³æ©è½ã®ã¡ã«ããºã ãæ¢ç©¶ãã¦ãã¾ãããç¾å¨ãåé èæ©è½æ¤æ»ã¨ãã¦å
¨å½ã§åºãæ´»ç¨ããã¦ãããKWCST (æ
¶æå¼ã¦ã£ã¹ã³ã³ã·ã³ã«ã¼ãå顿¤æ»)ãã¯ã彿æã
ãéçºãããã¼ã«ã®ä¸ã¤ã§ãã
1990年代ã«å
¥ããfunctional Neuroimagingçã®å°å
¥ã«ãããç¥çµå¿çå¦ã®æ¹æ³è«ã¯æ¥å±éãã対象ãããããç²¾ç¥çç¶ã«ãããã«ã¯å¥å¸¸è
ã®è³æ©è½ã«ã¾ã§æ¡å¤§ãã¾ãããããã¦æã
ããã®ãã¯ããã¸ã¼ãæå¤§éã«æ´»ç¨ãã¤ã¤ããã¤ãç²¾å¯ãªè¨åºçç¶åæã軽è¦ãããã¨ãªããç ç©¶ãç¶ãã¦ãã¾ãã
ç ç©¶ä¼ã¯ãåå第äºãç¬¬åæææ¥ã®å¤ã«éå¬ãã¦ãã¾ãã
以ä¸ãæã ã®ç ç©¶å 容ããç´¹ä»ãã¦ããã¾ãã(é æ¬¡æ´æ°ãã¾ã)
åè»æèã«é¢é£ããè³ãããã¯ã¼ã¯åæ
ã®å¤å
ââ èªç¥è¡åçæ³ã¨è¬ç©çæ³ã®æ¯è¼ç ç©¶ ââ
çå±±å¥çåã(æ
¶æç¾©å¡¾å¤§å¦ãä¿å¥ç®¡çã»ã³ã¿ã¼ãå°ä»»è¬å¸«ã»å»å¦é¨ãç²¾ç¥ã»ç¥çµç§å¦æå®¤å
¼æ
è¬å¸«)
Katayama N, Shinagawa K, Hirano J, et al.
Dynamic neural network modulation associated with rumination in major depressive disorder: a prospective observational comparative analysis of cognitive behavioral therapy and pharmacotherapy.
Translational Psychiatry, 2025; 15:267.
DOI: 10.1038/s41398-025-03489-y
â èæ¯
ãã¤ç
ã®ä¸»è¦ãªèªç¥çç¹å¾´ã§ããåè»æèï¼ruminationï¼ã¯ãå¦å®çãªæèå
容ãå復çã«æ³èµ·ãç¶ããå¾åãæããçç¶ã®æ
¢æ§åãåçºã®éè¦ãªè¦å ã¨ããããè¿å¹´ã®ç¥çµç»åç ç©¶ã«ãããåè»ã¯èªå·±åç
§çæèã«é¢ä¸ããããã©ã«ãã»ã¢ã¼ãã»ãããã¯ã¼ã¯ï¼Default Mode Network: DMNï¼ã®éæ´»åã¨å¯æ¥ã«é¢é£ãããã¨ãæããã«ãªã£ã¦ããããããã主è¦ãªæ²»çæ³ã§ããèªç¥è¡åçæ³ï¼Cognitive Behavioral Therapy: CBTï¼ããã³è¬ç©çæ³ããåè»é¢é£ã®è³ãããã¯ã¼ã¯åæ
ã«ã©ã®ããã«ä½ç¨ããã®ãã¯ååã«è§£æããã¦ããªãã£ãã
â æ¹æ³
æ¬ç ç©¶ã§ã¯ããã¤ç
æ£è
79åããã³å¥å¸¸å¯¾ç
§è
56åã対象ã«ãæ²»çåå¾ï¼16é±éï¼ã®å®éææ©è½çMRIï¼resting-state fMRIï¼ãåå¾ããè³æ´»åã®æéçå¤åãé ããã«ã³ãã¢ãã«ï¼Hidden Markov Model: HMMï¼ã«ããè§£æããããã¤ç
群ã¯ãããã¯ã®ããã¥ã¢ã«ã«åºã¥ã16åã®å人CBTãåãã群ã¨ãæ¨æºçãªæãã¤è¬ã«ããè¬ç©çæ³ç¾¤ã«åé¡ãããåè»ã®éç度ã¯åè»åå¿å°ºåº¦ï¼Rumination Response Scale: RRSï¼ãæãã¤çç¶ã¯GRID-HAMDãç¨ãã¦è©ä¾¡ãããHMMã«ããæ½åºããã12ã®è³ç¶æ
ã«ã¤ãã¦ãåç¶æ
ã®åºç¾é »åº¦ãæç¶æéãé·ç§»ç¢ºçãç®åºããæ²»çæ³ããã³æéã®è¦å ã«ããå¤åãæ¤è¨ããã
â çµæ
ãã¤ç
群ã§ã¯ãDMNã®åºç¾é »åº¦ããã³æç¶æéã®å¢å ãéè¡æ©è½ãããã¯ã¼ã¯ï¼Central Executive Network: CENï¼ã®æ´»åä½ä¸ãèªãããããDMNã®åºç¾é »åº¦ã¯RRSã¹ã³ã¢ã¨æ£ã®ç¸é¢ã示ããåè»å¾åãå¼·ãã»ã©DMNåªä½ã®è³ç¶æ
ã®çºçé »åº¦ãé«ããã¨ã示ãããã
æ²»çå¹æã®æ¯è¼ã§ã¯ãCBT群ã«ããã¦DMNã®åºç¾é »åº¦ã®ææãªä½ä¸ã¨DMNããCENã¸ã®é·ç§»ç¢ºçã®ä¸æã観å¯ãããè³å
ãããã¯ã¼ã¯ã®åçæè»æ§ã®å復ã示åãããã䏿¹ãè¬ç©çæ³ç¾¤ã§ã¯ãDMNæ´»åãå¾é¨å¸¯ç¶åãä¸å¿ã¨ãã徿¹é åã¸åæ§æãããå¤åãã¿ãããCBTã¨ã¯ç°ãªãç¥çµé©å¿æ§å¼ã確èªãããã
â èå¯
æ¬ç ç©¶ã¯ãåè»æèã«é¢é£ããè³ãããã¯ã¼ã¯ã®æéçåæ
ï¼network dynamicsï¼ãå®éçã«æ¤è¨¼ããåã®å ±åã§ãããCBTã¨è¬ç©çæ³ãç°ãªãç¥çµæ©æ§ãä»ãã¦ãã¤ç
ãæ¹åããå¯è½æ§ã示ããã
CBTã¯ãèªç¥åæ§æãè¡åæ´»æ§åãéãã¦DMNã®éæ´»åãæå¶ããå®è¡ç³»ãããã¯ã¼ã¯ã¸ã®é©å¿çåãæ¿ããä¿é²ãããã¨ã«ãããåè»å¾åã軽æ¸ããã¨èãããããããã«å¯¾ããè¬ç©çæ³ã¯ç¥çµä¼éç©è³ªã¬ãã«ã®èª¿ç¯ãéãã¦ãè³å
æ´»åã®å±æçåç·¨æãå¼ãèµ·ããã¨æ¨å®ãããã
両治çã®å¹æã¯è¨åºçæ¹åã¨ãã¦ã¯é¡ä¼¼ãã¦ãã¦ããè³ãããã¯ã¼ã¯ã¬ãã«ã§ã¯ç°ãªãçµè·¯ã«ãã£ã¦éæããããã¨ã示åããããã®ç¥è¦ã¯ãä»å¾ã®åå¥åæ²»çæ¦ç¥ããã³ç¥çµææ¨ã«åºã¥ãæ²»ç鏿ã®çºå±ã«è³ãããã®ã§ããã¨èããã
(çå±±å¥çåã2025.11.1.)
çä½PETããã³æ»å¾è³ãµã³ãã«ã«ããæããã«ãããèå¹´ææ°åé害ã«ãããã¿ã¦ç
ç
é»ç¬å¿ (å½ç«ç²¾ç¥ã»ç¥çµå»çç ç©¶ã»ã³ã¿ã¼ç
é¢ãè¨åºæ¤æ»é¨ãç¥çµç
çåéãä¸ç´å°é修練å»)
Kurose, S., Moriguchi, S., Kubota, M., Tagai, K., Momota, Y., Ichihashi, M., Sano, Y., Endo, H., Hirata, K., Kataoka, Y., Goto, R., Mashima, Y., Yamamoto, Y., Suzuki, H., Nakajima, S., Mizutani, M., Sano, T., Kawamura, K., Zhang, MR., Tatebe, H., Tokuda, T., Onaya, M., Mimura, M., Sahara, N., Takahashi, H., Uchida, H., Takao, M., Meyer, J., Higuchi, M., Takahata, K. Diverse tau pathologies in late-life mood disorders revealed by PET and autopsy assays. Alzheimer's & Dementia: The Journal of the Alzheimer's Association. 21(6), e70915, 2025.
èå¹´ææ°åé害ã¯ãèªç¥çã®åé§ç¶æ
ã¨ãã¦çºçããå¯è½æ§ãææããã¦ãã¾ãããããã忥µæ§é害ããã¤ç
ã¨ãã£ãèå¹´ææ°åé害ã®ç¥çµç
çå¦çåºç¤ã¯ã¾ã ååã«æããã«ãªã£ã¦ãã¾ããã
ããããã¯ãèå¹´ææ°åé害ãã¢ã«ããã¤ãã¼ç
ï¼ADï¼ãéADã¿ã¦ãªããã¼ã®åé§æ®µéã¨ãã¦ç¾ãããã©ããããçä½è³ããã³æ»å¾è³ãç¨ãã¦æ¤è¨¼ãã¾ãããå
·ä½çã«ã¯ã2019å¹´ãã2023å¹´ã«ããã¦ã52ä¾ã®èå¹´ææ°åé害æ£è
ã¨47ä¾ã®å¹´é½¢ã»æ§å¥ãä¸è´ãããå¥å¸¸å¯¾ç
§è
ã対象ã«ãã¿ã¦PETï¼18F-florzolotauï¼ããã³ã¢ããã¤ãPETï¼11C-PiBï¼ã宿½ãã¾ãããããã«ã208ä¾ã®åæ¤çä¾ã対象ã«ãè¨åºç
çå¦çé¢é£è§£æãè¡ãã¾ããã
è§£æã®çµæãèå¹´ææ°åé害æ£è
ã¯å¥å¸¸å¯¾ç
§ã¨æ¯ã¹ã¦ææã«ã¿ã¦PETããã³ã¢ããã¤ãPET齿§çãé«ããã¿ã¦ã®éç©ãã¿ã¼ã³ããã¯å
¸åçããã³éå
¸åçADã«å ãã夿§ãªéADã¿ã¦ãªããã¼ã®åå¨ã示ããã¾ãããç¹ã«ã¢ããã¤ãPETé°æ§ç¾¤ã«ããã¦ã¯ãç²¾ç¥ç
çç¶ãä¼´ãæ£è
ã§åé ç®è³ªãç·æ¡ä½ã®ã¿ã¦éç©ãææã«é«ãèªãããã¾ããããããã®æè¦ã¯ãæ»å¾è³è§£æã«ããã¦ãè£ä»ããããèå¹´æã«èºç
ããã¤ç
ãåããçä¾ã§ã¯ã夿§ãªã¿ã¦ãªããã¼ãæããé »åº¦ãé«ããã¨ãæããã«ãªãã¾ããã
æ¬ç ç©¶ã¯ãçä½PETã§ä¸çã«å
é§ãã¦èå¹´ææ°åé害æ£è
ã®çä½è³ã§å¤æ§ãªã¿ã¦ç
çãå¯è¦åããããã«ãå¤§è¦æ¨¡ãªæ»å¾è³ãµã³ãã«ã§ãèå¹´ææ°åé害ã¨ã¿ã¦ç
çã¨ã®é¢é£ã示ããç¹ã§éè¦ãªæç¾©ãæãã¾ãã

(é»ç¬å¿ã2025.10.4.)
èå
å´åé åéæå·å¾ã®éæçãªå¥ä¸éå§å°é£
è¹å±±ééï¼è¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§ï¼
Voluntary Swallowing Initiation Difficulty After Dorsomedial Prefrontal Cortex Damage: A Case Report.
Cogn Behav Neurol. 2025 Mar 1;38(1):9-15.
https://doi.org/10.1097/WNN.0000000000000383.
Motojima N, Funayama M, Nakajima A, Nakamura T, Baba M, Kobayashi S.
ãèæ¯ãèå å´åé åéãéåã®éå§ã«éè¦ãªå½¹å²ãæããã¦ãããã¨ã¯ã黿°ççå¦ã®ç ç©¶ããæããã«ãªã£ã¦ããããã®é åã両å´ã«ããã£ã¦æå·ãããã¨ãç¡åç¡è¨çï¼akinetic mutismï¼ãåããéæçãªéåãè¦ãããªããªããã¨ããããããããã®çä¾ã§ã¯é度ã®ã¢ãã·ã¼ãä¼´ãã䏿¹ãéåéå§ã®ã¿ã«éå±ããçç¶ã¯ãçå´ã®èå å´åé åéã®æå·å¾ã«ä¸è¢ã®éåéå§å°é£ãçºè©±éå§å°é£ãåããçä¾ãæ°ä¾å ±åããã¦ãããã®ã®ãç¥è¦ã¯ååã«èç©ããã¦ããªããæ¬å ±åã§ã¯ãåé¨ä½ã®æå·å¾ã«éæçãªå¥ä¸ã®éå§å°é£ãèªããçä¾ãæç¤ºããã
ãçä¾ã å³èå
å´åé åéã®ç¥çµè è½è
«ãå¤ç§çã«æåºããç´å¾ãããæ¶²ä½ã®éæçãªå¥ä¸éå§ãå°é£ã¨ãªã£ãï¼ï¼ä»£å¥³æ§ã§ãããé é¨MRIã§ã¯å³èå
å´åé åéã«è
«çã®æåºé¨ä½ãèªããããæåºåã«ã¯ midline shift ãä¼´ããå·¦èå
å´åé åéã«ãåºããæµ®è
«ãã¿ããããå·¦ä¸è¢ãä¸å¿ã¨ããä¸å
¨éº»çºãèªããããå¾ã
ã«è»½æ¸ãããå¸å¼åå°ãå·¦æã®ææ¡åå°ãæ¬è½æ§ææ¡åå¿ãèªãããããããã2é±éå¾ã6é±éå¾ã«æ¶å¤±ããã䏿¹ãæ¶²ä½ã®å¥ä¸éå§å°é£ã¯2ãæå¾ã¾ã§æ®åããã
æ¬çä¾ã§ã¯å¥ä¸åå°ã¯æ£å¸¸ã§ãããåå¼ã¨ãã£ãå¥ä¸ã«å¯¾ããå¤çãªéåèªçºè¦å ãé¢ä¸ããåºå½¢ç©ã®å¥ä¸ã«ã¯åé¡ããªãã£ãã䏿¹ãåå¼ãä¼´ããªãæ¶²ä½ã®å¥ä¸ã§ã¯å¥ä¸ã®éå§ãå°é£ã§ãå
¨ãéå§ã§ããªãããå£è
å
ã«æ¶²ä½ãçã¾ããå¸å¼ãè¦ãããå
æè¬ã®å¥ä¸ãå°é£ã§ãããçµé¼»è管ã®çç½®ãå¿
è¦ã¨ãªã£ããæ¶²ä½å¥ä¸ã®éå§å°é£ã¯ãç²åº¦ãå³ã温度ãæç¤ºã®æç¡ãéæå¥ä¸ãå¦ããä½å¹¹ã®è§åº¦èª¿æ´ã«ããéåã®è£å©ã¨ãã£ãæ¡ä»¶ã®å¤åã«é¢ä¿ãªãåºç¾ããã䏿¹ã§ãæ¶²ä½ã®éãå¢å ããã¨çç¶ãæªåããå¥ä¸éå§å°é£ãå¼·ãæèãããã¨ããå
æãä¼´ããã¨ãããã«å¤§ããªè¬å¤ã®å
æã§ã¯ä¸å±¤é¡èã¨ãªã£ãããããã®æè¦ã®å¤ãã¯å¥ä¸é å½±æ¤æ»ã§ã確èªããããæ¬çä¾ã«ã¯ãå¥ä¸å¤±è¡ã¨é¢é£ãããã¨ãå¤ãå£é¡é¢å¤±è¡ãçºè©±å¤±è¡ã¯èªããããªãã£ãã
ãèå¯ãæ¬çä¾ã¯ãèå å´åé é éã®æå·å¾ã«æ¶²ä½ã®å¥ä¸éå§ãå°é£ã¨ãªã£ãçä¾ã§ãããããããã¯ãå¤çãªéåèªçºã®æç¡ãéåéå§ã«é¢ããå é度ã®ç¨åº¦ãèªç¥æ©è½ãããã¯æ åã«ããå½±é¿ããæ¶²ä½ã«éå®ããå¥ä¸éå§å°é£ã®èæ¯ã«é¢ä¸ãã¦ããã¨èãã¦ãããåå¼éåãä¼´ãåºä½ã§ã¯å¥ä¸éå§å°é£ã¯èªããããªãã£ããã¨ãããå¤çãªéåèªçºãå¥ä¸éå§ãä¿é²ãã¦ããã¨èãããããã¾ããæ¶²ä½å¥ä¸ã¯åºä½å¥ä¸ã¨æ¯è¼ãã¦ãã大ããªå é度ãå¿ è¦ã¨ãããã¨ã示åããã¦ãããæ¶²ä½ã®éãå¤ããªãã¨å¥ä¸éå§å°é£ãæªåãããã¨ããå¥ä¸ã«å¿ è¦ãªåã®å½±é¿ã示åãã¦ãããããã«ãå¥ä¸éå§å°é£ãæèãããã¨ãæªåãæããã®ã¯ãæ åãè¡åã®å¶å¾¡ã«é«åº¦ãªãªã½ã¼ã¹ãè¦æ±ããããã®çµæãèå å´åé åéã®æ©è½ã®ä½ä¸ãå¼ãèµ·ãããå¯è½æ§ããããèå å´åé åéã¨éåéå§ã¨ã®é¢ä¿ãããæããã«ããã«ã¯, ä»å¾ãé¡ä¼¼ããçä¾ã®èç©ãå¿ è¦ã§ããï¼
(è¹å±±ééã2025.9.1.)
èªéã¹ãã¯ãã©ã çã®èå¤å´åé åéã«ãããé·ééç®è³ªå
æå¶ -ä¿¡å·æºæ¨å®æ³ãç¨ããæ¤è¨-
䏿æ (æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ ç²¾ç¥ã»ç¥çµç§)
Yu Mimura, Shinichiro Nakajima, Mayuko Takano, Masataka Wada, Keita Taniguchi, Shiori Honda, Hiroyuki Uchida, Masaru Mimura, Yoshihiro Noda. Long-interval intracortical inhibition in individuals with autism spectrum disorders: A TMS-EEG study with source estimation analyses. Clinical Neurophysiology., 178, 2110936, 2025.
èæ¯ï¼
çµé èç£æ°åºæ¿ï¼Transcranial magnetic stimulation: TMSï¼ã¯ã³ã¤ã«ãå©ç¨ãã黿°åºæ¿ã«ããããã®è³ç®è³ªãç´æ¥åºæ¿ãããã®åºåã¨ãã¦å¾ãããèªçºé»ä½ããè³ç®è³ªã®ç¥çµççæ©è½ãè©ä¾¡ãããã¨ãã§ãããTMSã«ããåºæ¿ã«ã¯åçºåºæ¿ã¨äºé£çºåºæ¿ããããè³ç®è³ªã«ç£æ°åºæ¿ãäºé£çºã§ä¸ããäºçºç®ã®ç£æ°åºæ¿ã§å¾ãããèªçºé»ä½ã測å®ããç³»ãèããããã®æãåºæ¿ééã100msã«è¨å®ããã¨åçºåºæ¿æã«æ¯ãã¦èªçºé»ä½ãæå¶ãããç¾è±¡ã観å¯ãããããã¯long interval intracortical inhibition (LICI)ã¨å¼ã°ãããLICIã¯ããã¾ã§ã®å ±åããGABA-Bå容ä½ãä»ããæå¶æ©è½ãåæ ãã¦ããã¨èãããã¦ãããèªéã¹ãã¯ãã©ã ç(Autism spectrum disorder: ASD)è
ã®è³ç®è³ªã¯è奮/æå¶ãã©ã³ã¹ã®ä¸åè¡¡ãç
æ
ã¨ãã¦èãããã¦ãããGABA-Bå容ä½ä½åè¬ãè¨åºçç¶ãæ¹åããããªã©ã®å ±åãããLICIã®æå¶å¹æãæ¸å¼±ãã¦ããã¨æ¨å®ãããã
ç®çï¼
æ¬ç ç©¶ã®ç®çã¯ãçµé èç£æ°åºæ¿-è³æ³¢åææ¸¬å®æ³ï¼TMS-EEGæ³ï¼ãç¨ãã¦ãASDè
ã®èå¤å´åé åéï¼Dorsolateral prefrontal cortex: DLPFCï¼ã«ãããLICIã®æå¶å¹æãè©ä¾¡ãããã¨ã§ãããå
è¡ç ç©¶ã«ããã¦ã¯ASDã®LICIã«ããæå¶å¹æã¯å¥å¸¸è
ã¨åç¨åº¦ã«ä¿ããã¦ããã¨å ±åããã¦ãããã¨ãããæ¬ç ç©¶ã«ããã¦ã¯è§£ææ¹æ³ã工夫ãã¦å®æ½ããã
æ¹æ³ï¼
ASD32åããã³å¥å¸¸å¯¾ç
§è
34åã対象ã«ãå·¦DLPFCã«åçºã®ç£æ°åºæ¿åã³100msã®ééã§äºé£çºåºæ¿ãä¸ããèªçºè³æ³¢ãå¾ããã¾ãããã¹ã¦ã®åå è
ã®TMSèªçºé»ä½ããLocal mean field potentialï¼LMFPï¼ãç®åºããLICIå¹æãæ¤è¨ãããæ¬¡ã«ãä½ç©ä¼å°ã®å½±é¿ãæå°éã«æããããã«ãè³æ³¢ãã¼ã¿ã«å¯¾ãã¦ä¿¡å·æºæ¨å®æ³ãé©ç¨ãDLPFCã®é»ä½ãæ¨å®ãããæå¾ã«ä¿¡å·æºæ¨å®æ³ã§å¾ããããã¼ã¿ã«å¯¾ãã¦æé卿³¢æ°è§£æãè¡ããLICI广ã卿³¢æ°å¸¯åãã¨ã«æ¤è¨ããã
çµæï¼
ASDã¨å¥å¸¸å¯¾è±¡è
ãçµ±åããLMFPè§£æã§ã¯ãåºæ¿å¾165ã234msã®éã®ç®è³ªæ´»åãLICIã«ãã£ã¦æå¶ããããã¨ã示ãããï¼p = 0.024ï¼ãä¿¡å·æºæ¨å®æ³ãç¨ãã¦ããåãæé帯åã«ããã¦LICIã®æå¶å¹æã確èªããããããã«ãæé卿³¢æ°è§£æã§ã¯ãθããα帯åã«ããã¦åºæ¿å¾30ã300msã®éã«LICIæå¶å¹æã示ããããããããåLICI广ã«ããã¦ASD群ã¨å¥å¸¸å¯¾ç
§ç¾¤éã§ç¾¤éæ¯è¼ãè¡ã£ãããããããææãªç¾¤éå·®ã¯ã¿ãããªãã£ãã
çµè«ï¼
TMS-EEGæ³ã¨LICIãçµã¿åãããæ¹æ³ã®ã¿ã§ã¯ãASDã«ãããGABA(B)å容使©è½ä¸å
¨ãæ¤åºããã«ã¯ä¸ååã§ããå¯è½æ§ããããããã¯ASDã®ç°è³ªæ§ãåç²¾ç¥è¬å
æãªã©ãå½±é¿ãã¦ããã¨èããããã
æç¾©ï¼
æ¬ç ç©¶ã¯ãASDã«ãããLICI广ãä¿¡å·æºæ¨å®ææ³ã«ããæ¤è¨ããåãã¦ã®ç ç©¶ã§ãããã¨ã«æç¾©ããããä»å¾ã¯ä»ã®ã¢ããªãã£ãåºæ¿æ¹æ³ãçµã¿åãããè§£æãæã¾ããã
(䏿æ ã2025.8.6.)
ã¡ã¢ãªã¼ã¯ãªãã¯ã«ãããèªç¥çé¡ä¼¼ã®æ²»çå¯è½æ§ã®ããç²¾ç¥ç¾æ£ã®åé¡
è¹å±±ééï¼è¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§ï¼
Identifying reversible psychiatric dementia mimics in new memory clinic outpatients.
Funayama M, Kurose S, Takata T, Sato H, Izawa N, Isozumi K, Abe Y.
J Alzheimers Dis Rep. 2025 Mar 21; 9: 25424823251329804.
https://doi.org/10.1177/25424823251329804.
[èæ¯]ä»®æ§èªç¥çã®ããã«èªç¥çã«é¡ä¼¼ããæ²»çå¯è½æ§ã®ããç¾æ£ã診æãããã¨ã¯ãã¡ã¢ãªã¼ã¯ãªããã¯ã®è¨ºçã«ããã¦æ¥µãã¦éè¦ã§ãããããããèªç¥çã«é¡ä¼¼ããç¥çµç¾æ£ã®åé¡ã¯ååã«ç ç©¶ããã¦ãã䏿¹ã§ãç²¾ç¥ç¾æ£ã®åé¡ã«ã¤ãã¦ã¯ååã«ç ç©¶ããã¦ãããããã®å®éã®å¯éæ§ã«é¢ãã詳細ãªãã¼ã¿ãéããã¦ãããæ¬ç ç©¶ã§ã¯ããã®ç¹ãæããã«ãããã¨ãç®çã¨ããã
[æ¹æ³]è¶³å©èµ¤ååç é¢ã®ã¡ã¢ãªã¼ã¯ãªããã¯ãå診ã§å診ãã夿¥æ£è 749åã徿¹è¦çã«èª¿æ»ãããç å ãé²è¡é度ãMini-Mental State Examinationï¼MMSEï¼ã«ããç¥çµå¿çå¦çè©ä¾¡ãèªç¥æ©è½ãæ£å¸¸ç¯å²ããMild Cognitive Impairmentï¼MCIï¼ããèªç¥çã®ã¬ãã«ã«ãããã¨ãã£ãèªç¥æ©è½ã®ã¬ãã«ãæ²»çå¯è½æ§ã«ã¤ãã¦ãç²¾ç¥ç¾æ£ããã³ç¥çµç¾æ£ã«åé¡ãã¦æ¤è¨ãããããã«ãæ²»çã«ããèªç¥æ©è½ãå®éã«å復ããçä¾ï¼MCIã¾ãã¯èªç¥çã®ã¬ãã«ããæ£å¸¸ç¯å²ã«å復ããä¾ãã¾ãã¯èªç¥çã®ã¬ãã«ããMCIã«å復ããä¾ï¼ãç¹å®ããã
[çµæ]749åã®ãã¡121åï¼16.2%ï¼ãæ²»çå¯è½æ§ã®ããç¾æ£ãæãããã®å 訳ã¯ç²¾ç¥ç¾æ£75åãç¥çµç¾æ£46åã§ãã£ããç²¾ç¥ç¾æ£ã«ã¯ããã¤ç ãªã©ã®æ°åé害ãçµ±å失調çã»å¦æ³æ§é害ãADHDãã¢ã«ã³ã¼ã«ä½¿ç¨é害ãè§£é¢æ§é害ãä¸å®é害ãå«ã¾ãã¦ãããæ²»çå¯è½æ§ã®ãªãç¾¤ã¨æ¯è¼ããã¨ããããã®ç²¾ç¥ç¾æ£ç¾¤ã¯å¹´é½¢ãè¥ããé²è¡é度ãéããMMSEã¹ã³ã¢ãé«ãã£ããåæ§ã«ãæ°´é çãæ ¢æ§ç¡¬èä¸è¡è «ãªã©ã®æ²»çå¯è½æ§ã®ããç¥çµç¾æ£ç¾¤ã«ã¤ãã¦ããæ²»çå¯è½æ§ã®ãªãç¾¤ã¨æ¯è¼ããã¨å¹´é½¢ãè¥ããé²è¡é度ãéãã£ããMCIã¾ãã¯èªç¥çã®ã¬ãã«ã§ãã£ãçä¾ã®ãã¡6åï¼0.9%ï¼ãå®å ¨ãªæ¹åï¼3ä¾ï¼ã¾ãã¯é¨åçãªæ¹åï¼3ä¾ï¼ã示ãããã®ä¸ã«ã¯ç²¾ç¥ç çç¶ãåããç²¾ç¥ç¾æ£ã®2ä¾ï¼å¦æ³ãä¼´ãéè¡æãã¤ç ããã³æ¥æ§ä¸éæ§ç²¾ç¥ç ï¼ãå«ã¾ãã¦ãããã¾ããæ²»çå¯è½æ§ã®ããç¾æ£ãæãã¦MCIãªããã¯èªç¥çã®ã¬ãã«ã§ãã£ã73ä¾ã®ãã¡14ä¾ï¼19%ï¼ã¯ããã§ã«ã¢ã«ããã¤ãã¼ç ãä¸å¿ã¨ããèªç¥çãåä½µãã¦ããã
[çµè«]æ²»çå¯è½æ§ã®ããèªç¥çé¡ä¼¼ç¾æ£ã¯ç¨ã§ã¯ãããã®ã®ãéå¥ã«ã¯æ³¨æãå¿ è¦ã§ãããç¹ã«æ¯è¼çå¹´é½¢ãé«ããªãã æ¥éãªèªç¥æ©è½ä½ä¸ã示ãçä¾ã§ã¯æ éãªè©ä¾¡ãæã¾ãããå®éã«æ¹åããä¾ã®å²åã®ä½ãã¯ããããã®ç¾æ£ãèªç¥çã®ãªã¹ã¯å åã¨å¼·ãé¢é£ãã¦ããå¯è½æ§ããèªç¥çã®åé§ç¶æ ã§ãã£ãå¯è½æ§ãåæ ãã¦ããã¨èããããã
(è¹å±±ééã2025.6.1.)
ä¸å¹´æã«ãããç·è¶ããã³ã³ã¼ãã¼ã®æåç¿æ
£ã¯ãå°æ¥çãªèªç¥çäºé²ã«å¯ä¸ãããï¼é·æç¸¦æã³ãã¼ãç ç©¶
æ¯æ¨æå® (æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ã»ç¥çµç§å¦æå®¤ãç¹ä»»è¬å¸«)Koreki A, Nozaki S, Shikimoto R, Tsugane S, Mimura M, Sawada N. A longitudinal cohort study demonstrating the beneficial effect of moderate consumption of green tea and coffee on the prevention of dementia: The JPHC Saku Mental Health Study. J Alzheimers Dis. 2025 Jan;103(2):519-527. doi: 10.1177/13872877241303709.
æ¬ç ç©¶ã¯ãå½ç«ããã»ã³ã¿ã¼ã¨ã®å
±åç ç©¶ã§ãå¤ç®çã³ãã¼ãç ç©¶ã®ä¸ç°ã¨ãã¦è¡ããã¾ããã詳細ã¯å½ç«ããã»ã³ã¿ã¼ã®æ¬ç ç©¶ã®ææå ±åã«é¢ããHPããåç
§ãã ããã
https://epi.ncc.go.jp/jphc/outcome/9527.html
ä»ã¾ã§ã«ãç·è¶ãã³ã¼ãã¼ã®æåãèªç¥æ©è½ä½ä¸ãäºé²ãã广ãããå¯è½æ§ãææããã¦ãã¾ããããç ç©¶æéãæ¯è¼ççããé·æéã®å¹æã«ã¤ãã¦ã¯ããããã£ã¦ãã¾ããã§ãããè¿å¹´ã®ç ç©¶ãããèªç¥çãå¼ãèµ·ããè³å
ã®ç°å¸¸ã¿ã³ãã¯ã®èç©ãè³è¡ç®¡ã®èåã¯ä¸å¹´æããå§ã¾ããã¨ãæããã«ãªã£ã¦ãããã¨ãããä¸å¹´æããã®çæ´»ç¿æ
£ã®èç©ãå¾ã®èªç¥æ©è½ä½ä¸ã«å½±é¿ãä¸ããå¯è½æ§ãèãããã¾ãããæ¬ç ç©¶ã§ã¯ãä¸å¹´æã®ç·è¶ãã³ã¼ãã¼æåã®ç¿æ
£ã¨ãç´20å¹´å¾ã®èªç¥æ©è½é害ã¨ã®é¢é£ãæ¤è¨ããç¹ãç¹å¾´ã§ãã
æ¬ç ç©¶ããã¯ãç·è¶ã®ç¿æ
£ã1æ¥1æ¯ä»¥ä¸ã ã£ã群ãåºæºã¨ããå ´åãç·è¶ã2ï½3æ¯é£²ãã§ãã群ã§ã¯ãèªç¥æ©è½é害ã®ãªã¹ã¯ã44%ä½ä¸ãã¦ãããã¨ã示ããã¾ãããç¹ã«ç·æ§ã«ããã¦ãã®å¾åãé¡èã§ãç·è¶ã2ï½3æ¯é£²ãã§ããã°ã«ã¼ãã§ã¯62%ã®ãªã¹ã¯ä½ä¸ãç·è¶ã4ï½6æ¯é£²ãã§ããã°ã«ã¼ãã§ã¯61%ã®ãªã¹ã¯ä½ä¸ã示ããã¾ããã䏿¹ã§ã³ã¼ãã¼ã®å½±é¿ã¯ãããå¹´é½¢ã®é«ã群ã§ã¯ãã³ã¼ãã¼æåã1æ¥1æ¯æªæºã®æ¹ãåºæºã¨ããå ´åãã³ã¼ãã¼ã1æ¯ä»¥ä¸é£²ã群ã§ã¯46%ã®ãªã¹ã¯ä½ä¸ã示ããã¾ããã
ä»åã®çµæãå¾ãããå¯è½æ§ã¨ãã¦ãç·è¶ã®æé
¸åä½ç¨ãæççä½ç¨ãè¡ç®¡ä¿è·ä½ç¨ãç°å¸¸ã¿ã³ãã¯è³ªã®èç©é»å®³ãªã©ã®ç¥çµä¿è·ä½ç¨ãã¾ãã³ã¼ãã¼ã§ã¯ãã®æé
¸åä½ç¨ãæççä½ç¨ãè¡ç®¡ä¿è·ä½ç¨ãªã©ã«å ããã³ã¼ãã¼ã®èªç¥æ©è½ã¸ã®åºæ¿ä½ç¨ãéè¦ãªå½¹å²ãæããã¦ããå¯è½æ§ãèãããã¾ããæ¬ç ç©¶ã®éçã¯ããããããããªãç ç©¶ãå¿
è¦ã§ãã
(æ¯æ¨æå®ã2025.6.1.)
ãã¬ãã¢ã ç²¾ç¥å»å¦è¾å ¸ãã䏿å°ãææ¾å¤ªé ç·¨é

ãåºæ(å
¨æè»¢è¨)ã
ã¹ããã§ç°¡åã«ãä½ã§ããããã«ãç¥èãå¾ããã¨ãã§ããæä»£ã«ãç´ã®è¾å
¸ã®åå¨æç¾©ã¯ä½ããæ¬è¾å
¸ã®çºåã«ããã£ã¦ãããã¸ã§ã¯ãéå§æç¹ãããã¼ã å
ã§å¸¸ã«èªåèªçãè°è«ãéãã¦ããã®ã¯ãã®åãã§ãããç²¾ç¥å»å¦ã®æªæ¥ã¨éå»ãåçã«å°éããç¾ä»£ãè¨è¿°ããããããæã
ãå°éããåçã§ãã£ããåè¼èªã®é¸æã説ææã®è¨è¿°ãããã¦ããã¬ãã¢ã ç²¾ç¥å»å¦è¾å
¸ãã¨ããæ¸åãããããã¹ã¦ã®ä¸ã«ãã®ç念ãåéããã¦ããã
ç°¡åã«ãä½ã§ããããã«ãããã¯äººéã®éçãè¶
ããå©ä¾¿æ§ã§ãããæ£èª¤ä¸è©³ã®æ
å ±ã®æ°¾æ¿«ãå éããã¦ããããããªç©ºéã§éè¦ãããã®ã¯æ£ããã誤ããã§ã¯ãªããæ£ãããã«è¦ããããç´å¾ããããããããã«ã¯ç¹å®ã®ãããã¯å¤ãã®äººã
ã«ã¨ã£ã¦é½åãè¯ãæ
å ±ãããããããã®ãæ¡æ£ã®æ¨é²åã«ãªããçå®ã¯ãã®æ¡æ£ã®ä¸ã«é²æ£é§æ¶ããã20ä¸ç´åé ã®å²å¦è
ã¦ã£ãã²ã³ã·ã¥ã¿ã¤ã³ã¯ãæ°èãçå®ãå ±éãã¦ãããã©ããã確ããããã¨ãã¦ãã®æ°èãä½é¨ãè²·ãã¨ããè¡åã®æãéãææãã1)ãã³ãã¼ãè¨å¤§ã«éãã¦ãç宿§ãå¢ããã¨ã¯ä¸åãªãã®ã ã21ä¸ç´åé ã®ç¾ä»£ã§ãã¦ã¯ããããã¢ã¯ã»ã¹æ°ãåçæ°ã¯ããããè¨å¤§ã§ãã£ã¦ããçå®ã¨ã¯ç¡é¢ä¿ã§ãããã¨ã¯è¨ãã¾ã§ããªãã
ã§ã¯ç²¾ç¥å»å¦ã«ãããæ£ããæ
å ±ã¨ã¯ä½ããæ£ããç¥èã¨ã¯ä½ããç²¾ç¥å»å¦ã®çå®ã¨ã¯ä½ããICDãDSMã«å»ã¾ãã診æåºæºãä¸ã¤ã®çå®ã§ãããææ°ã®ãã¥ã¼ããµã¤ã¨ã³ã¹ã®ã¨ããã³ã¹ã«è£æã¡ãããç¾ç
çè§£ãä¸ã¤ã®çå®ã§ãããããã¦ä¼çµ±çãªç²¾ç¥å»å¦ãæ¶µé¤ãã¦ãã塿ºãä¸ã¤ã®çå®ã§ããããããã¯æã«ç¸çç¾ããä¸ååé³ãå¥ã§ãªããããããäºå®èª¿åã¨ãã¦ã®çå®ãç®æãã¦åé²ãç¶ãã¦ãããæ¬è¾å
¸ã¯ãããªéã®éä¸ã§ç«ã¡æ¢ã¾ã£ã¦ã¿ãã¹ã¯ãªã¼ã³ã·ã§ããã§ãããäºå®èª¿åãç¾å®ã«ãªãã®ã¯ç¾å¹´å¾ãããããã¯åå¹´å¾ãããããªãããã¬ãã¢ã (åå¹´ç´)ã®ãã¼ãã³ã°ã«ã¯ããããæå³ãããããã¦ããã
æ¬è¾å
¸ãå½¢ã«ãããã¨ãã§ããã®ã¯ãå·çè
ã®å
çæ¹ãããã¦ç²¾å¯ãã®ãããªãç·¨é使¥ããã¦ããã ãã弿å ã®ä¸å¤å®ãããå°æç¿ããã®ãå°½åã®ãé°ã§ãããæ·±ãæè¬ãã¦ãã¾ãªããããã«ãæ¬è¾å
¸ã®å身ã§ãããç²¾ç¥ç§ãã±ããè¾å
¸ãã®å·çè
ã»ç·¨éè
ã®æ¹ã
ã«ãæ·±ãæè¬ããããåè¾å
¸ã¯1981å¹´ã«åçãçºè¡ããã1989å¹´ã«è£æ£çã1997å¹´ã«æ°çã2006å¹´ã«æ°è¨çãçºè¡ãããã¨ããæ´å²ãããããã®å
容ã®ä¸é¨ã¯ãæ¬è¾å
¸ã«ã彿ã®ã¾ã¾ã®å½¢ã§ããããã¯ç¾ä»£ã®ç¥è¦ãå çããå½¢ã§ãåãç¶ãã§ãããéå»ã®å·çè
ã®ä¸ã«ã¯ãã§ã«é¬¼ç±ã«å
¥ãããå
çãããã£ããããããããã大å
è¼©ãæ¬è¾å
¸ãã©ãè©ä¾¡ããã¦ããããæ¯ããæ°æã¡ãæã
ã«ã¯ãããã¨ãåç½ããªããã°ãªããªãã
ãã¬ãã¢ã ã¯éå»ã ãã§ãªããã¡ããæªæ¥ã«ãç®ãåãããã¼ãã³ã°ã§ãããä¸åå¹´å¾ã®äººã
ã®ç®ã«ã¯ãæ¬è¾å
¸ã«æ ãåºãããç¾ä»£ã®ç²¾ç¥å»å¦ã¯ã©ã®ããã«è¦ããã®ããããããèªå¤§çãªãã®ãããªå¤¢ãæã£ã¦ãããã¬ãã¢ã ç²¾ç¥å»å¦è¾å
¸ããããã«ä¸æ¢ããã
2025å¹´3æãæ¡ã®éè±ãç®åã«ããæ¥ã«
ç·¨è
ã代表ãã¦
ææ¾å¤ªé
JDCå
çªçºã¡ã³ã¿ã«ã¯ãªããã¯
æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ ç²¾ç¥ã»ç¥çµç§
1) Wittgenstein L: Philosophische Untersuchungen. Basil Blackwell, 1953. (é¦è¨³. ã¦ã£ãã²ã³ã·ã¥ã¿ã¤ã³å ¨é8. å²å¦æ¢ç©¶. è¤æ¬éå¿è¨³ã大修館æ¸åº æ±äº¬ã1976.ã第265ç¯ )
ã解説ã
弿å ãããä¼çµ±ããç²¾ç¥å»å¦è¾å
¸æ¹è¨ããã¸ã§ã¯ãã®ã話ããã£ãã®ã¯2018å¹´ã§ãã£ããããã¦ä¸æå°ææå®¤(彿)ã§ã䏿å°å
çã弿å 社é·ã弿å ãæ
å½è
(ä¸å¤å®ãã)ãææ¾ã®ãã¼ãã£ã³ã°ãè¡ããããããã§ã¯ãä»ã¨ããæä»£ã«è¾å
¸ãçºåãããã¨ã®æå³ã¯ä½ãã¨ãããã¨ãä¸å¿ã¨ããè°è«ãå±éãããããã®åçãæ¬è¾å
¸ã§ãããã¨ãã»ã³ã¹ã¯åºæã«è¨ãããéãã§ããã
ãã®å¾ãã³ããç¦ããããã¾ããICD-11診æåã®æ£å¼ãªè¨³èªã®æ±ºå®ãå¾
ã£ããã¨ãªã©ããã£ã¦ãæãçµéãããããã®ã»ã©ãããããçºåãããã¨ãã§ãããç·¨éååè
ãå·çè
ã®å
çæ¹ã«ã¯ããã«ããããã¦æè¬ç³ãä¸ãã¾ãã
(ææ¾å¤ªéã2025.5.27.)
ãé éè¨æ¶æ¤æ»ãæ´æ°çã®éçº
å±±æ¬å°ç·é(åèçåèãªãããªãã¼ã·ã§ã³ã»ã³ã¿ã¼ãªãããªãã¼ã·ã§ã³æ²»çé¨)
æ±å£æ´å(æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ã»ç¥çµç§å¦æå®¤)
2010年以éã®æ¬é¦ã®ç¤¾ä¼çåºæ¥äºã«é¢ãããé éè¨æ¶æ¤æ»ãæ´æ°çã®éçº. 髿¬¡è³æ©è½ç ç©¶ 44(3): 199-209, 2024
"Remote Memory Test updated version" for social events in Japan since 2010 using famous people photographs
å±±æ¬å°ç·é1)ãå°è¥¿æµ·é¦2)ãæ±å£æ´å2) ãç°ä¸æ¥å¥3)ãä½ç«¹ç¥äºº4) ãæ± 䏿£æ5) ãè西æä»£6)ãèå°å°ä¹
1)ã䏿æ 2)ã穴水幸å2, 7, 8)
1)åèçåèãªãããªãã¼ã·ã§ã³ã»ã³ã¿ã¼ãªãããªãã¼ã·ã§ã³æ²»çé¨
2)æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ã»ç¥çµç§å¦æå®¤
3)æ±äº¬é½å¥åº·é·å¯¿å»çã»ã³ã¿ã¼ãªãããªãã¼ã·ã§ã³ç§
4)大éªå¤§å¦å¤§å¦é¢å»å¦ç³»ç ç©¶ç§ç²¾ç¥å»å¦æå®¤
5)ä¼é£ä¸å¤®ç
é¢ãªãããªãã¼ã·ã§ã³æè¡ç§
6)ç·åãªãããªç¾ä¿éç
é¢ãªãããªãã¼ã·ã§ã³ç§
7)åèçåèãªãããªãã¼ã·ã§ã³ã»ã³ã¿ã¼ãªãããªãã¼ã·ã§ã³ç§
8)å½ç«ç
颿©æ§æ æ¨å»çã»ã³ã¿ã¼ç²¾ç¥ç§
9)æ±äº¬é½ç«å¤§å¦äººæç¤¾ä¼å¦é¨
ãæ¦è¦ã
ãé éè¨æ¶æ¤æ»ãã¯ï¼1970年代ï½2010å¹´ã«æ´»èºããæå人ãåã社ä¼çåºæ¥äºã®åçãç¨ãã¦ï¼äººåã®æ³èµ·ã¾ãã¯åèªï¼åºæ¥äºã«é¢ãããã¼ã¯ã¼ãã®æ³èµ·ãæ±ãï¼å¾ç¹åãããã¨ã«ããå¥å¿çæ£è
ã®é éè¨æ¶ãè©ä¾¡ã§ããæ¤æ»ã§ãããæã
ã¯2010年代ã®åçãç¨ãã¦ãé éè¨æ¶æ¤æ»ãã®æ¤æ»ææ³ãè¸è¥²ãããæ´æ°çãã使ãï¼ä¿¡é ¼æ§ã¨å¦¥å½æ§ãæ¤è¨ããã2020å¹´æç¹ã§20æ³ä»¥ä¸ã®å¥å¸¸è
183åã«ãæ´æ°çãã宿½ãï¼ä¸ä»£ãã¨ã®å¹³åå¾ç¹ã¨æ¨æºåå·®ãæ±ãããåæ¤æ»æ³ãç¨ãã¦ç´å
ç¸é¢ä¿æ°ãæ±ããçµæå¼·ãç¸é¢ã示ããï¼æ¬æ¤æ»ã®é«ãä¿¡é ¼æ§ã示ããããã¾ãï¼å¥å¿çã¨è¨ºæããã15çä¾ã«ãé éè¨æ¶æ¤æ»ãã¨ãæ´æ°çãã宿½ãï¼åçä¾ã®åå·®å¤ãæ±ããã縦軸ãåå·®å¤ï¼æ¨ªè»¸ãåºæ¥äºã®å¹´ä»£ã¨ããã°ã©ãã§ç¤ºããçµæï¼çä¾ã®éåæ§å¥å¿ã®ç
æ
ãæ¤æ»çµæã§èª¬æãããã¨ãã§ãï¼å¦¥å½æ§ã示ããããä¾ãã°èªå·±å
ç«æ§è³çå¾ã«éå»10ï½15å¹´ã®èªä¼çè¨æ¶ï¼Autobiographical Memoryï¼ã®éåæ§å¥å¿ãåããçä¾ã¯ï¼ã°ã©ãä¸ã§åæéã®æéå¾é
ãèªãããããæ¬æ¤æ»ã¯ãé éè¨æ¶æ¤æ»ãã¨åæ§ã«ï¼éåæ§å¥å¿ã®å®¢è¦³çææ¨ã¨ãã¦æç¨ã§ãããã¨ã示åããããè¨åºã«ãããéåæ§å¥å¿ã®è¨ºæããªãããªç«æ¡ã¸ã®æ´»ç¨ãæå¾
ã§ããã
(å±±æ¬å°ç·éã2025.4.1.)
解説ããç ç©¶ãç¹ã
éåæ§å¥å¿ã®æ§æ ãæããã«ããã«ã¯ãæ¬äººã®é éè¨æ¶ãæ¬ æãã¦ããæéãå 容ãæããã«ããå¿ è¦ãããã¾ãããããæããã«ããã«ã¯ãè¨æ¶ãæ¬ æãã以åã«ç¢ºãã«ãè¨æ¶ããã¦ããããã¨ã®è¨¼æãé常ã«é£ããããã«æ¹æ³è«çãªå°é£ãä¼´ãã¾ãããã®ãããªæ¡ä»¶ä¸ã«ããã¦ãã1980年代å¾åãã1990年代ã«ããã¦åµæå·¥å¤«ãããé éè¨æ¶æ¤æ»ãå¤ãçºè¡¨ããã¾ãããå½ç¥çµå¿çå¦ç 究室ãããèªåä¼çè¨æ¶æ¤æ»ï¼åçããèªåä¼çè¨æ¶ã¨æ°ããæ¤æ»æ³ã«ã¤ãã¦ï¼è³ã¨ç²¾ç¥ã®å»å¦ã1993ï¼ããç©åä¾¡æ ¼ãè§£çãã¦ããããã©ã¤ã¹ãã¹ãã®æç¨æ§ï¼åçãããã©ã¤ã¹ãã¹ãã®æç¨æ§ã«ã¤ãã¦ï¼ç°¡ä¾¿ãªéåæ§å¥å¿æ¤æ»ã®ã³ã«ãµã³ãçå群ã¸ã®å¿ç¨ï¼ç²¾ç¥å»å¦ã1997ï¼ãå ±åããã¾ããã社ä¼çãªåºæ¥äºã«é¢ããé éè¨æ¶æ¤æ»ã«é¢ãã¦ã¯ãæ¤æ»é ç®ãå¤ããªããã¨ã¨ãæ°ããæ¤æ»é ç®ã追å ããªããã°ãªããªãã¨ããæ§é çãªèª²é¡ãããã1996å¹´ãæ¬¡ã«2016å¹´ã«å ±åãã¾ããï¼æ±å£ããè¦è¦æ§é éè¨æ¶æ¤æ»ã®ä½è£½ã¨ãã®å¦¥å½æ§ã®æ¤è¨ï¼ç¥çµå¿çå¦ã1996ï¼æ±å£ããæå人ã®é¡ãå«ã¾ãã社ä¼çåºæ¥äºåçãç¨ããé éè¨æ¶æ¤æ»ä½æã®è©¦ã¿ï¼èªç¥ãªãããªãã¼ã·ã§ã³ã2016ï¼ãåçã¯è¥¿ã®å¤§éªå¤§å¦å¤§å¦é¢å»å¦ç³»ç ç©¶ç§ç²¾ç¥å»å¦æå®¤ç¥çµå¿çç ç©¶å®¤ãæ¬¡ã«æ±ã®å½ç¥çµå¿çå¦ç 究室ãããã«ä»åã¯æ±ã»è¥¿ã®ç ç©¶å®¤ã¨æ°ãã«å¥ã®ç é¢ã«æå±ããå çæ¹ã¨ååããæ¤æ»å å®¹ãæ´æ°ãã¾ãããè¨åºã§æ´»ç¨ãããæ¤æ»ã¯æä»£ãçµã¦ãåæã®ç ç©¶è ãç¹ããªããçãæ®ã£ã¦ãããã¨ãç¥ã£ã¦ããã ãããã¨æãã¾ãã
(æ±å£æ´åã2025.4.5.)
æéãï¼ï¼ï¼åé
ãé²ãï¼æNMDAå容ä½è³çã®è¨ºæã®éµã¨ãªãæéã®å¤å®¹
å¹³ç°ãã, åç°å¤®, è¹å±±éé, ã»ãï¼è¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§ï¼Time moving 100-fold slower: time distortion as a diagnostic clue in anti-NMDA receptor encephalitis. BMC Neurol. 2025 Feb 24;25(1):75.
https://doi.org/10.1186/s12883-025-04078-8.
Hirata R, Wada H, Yamamoto K, Sogi Y, Muzuta H, Isaka Y, Funayama M.
ãèæ¯ãæNMDAå容ä½è³çã¯é篤ã§çå½ãè
ããç¾æ£ã§ãããç´30%ã®æ£è
ãICUã«å
¥å®¤ãã5ï½11%ãæ»äº¡ããã¨å ±åããã¦ãããæ©æã®å
ç«çæ³ã«ãããæ£è
ã®70ï½80%ã大å¹
ã«å復ãããã¨ã示ããã¦ãããè¿
éãªè¨ºæã¨æ²»çã®éå§ãäºå¾ãå·¦å³ãããæ¬ç¾æ£ã§ã¯ãåæã«æ£è
ã®87%ãæ¥æ§ã®è¡åå¤åã示ãã59%ãåçºçç¶ã¨ãã¦ç²¾ç¥çç¶ãåãããã¨ãããçµ±å失調çãªã©ã®ç²¾ç¥ç¾æ£ã¨ã®éå¥ãé£ãããããããéå¥ã«é¢ããå ±åã¯å°ãªããéå®åç²¾ç¥ç
ã«æãç
åãé¡ä¼¼ããã¨ããè¦è§£ããç¥è¦ã®å¤å®¹ãç¹å¾´ã§ããå¯è½æ§ã示åããã¦ãããã®ã®ãååãªç¥è¦ã«ã¯è³ã£ã¦ããªãã
ã¨ããã§ãã±ã¿ãã³ããã§ã³ãµã¤ã¯ãªã¸ã³ãªã©ã®NMDAå容ä½é»å®³è¬ã«ãã£ã¦çãã主ããç¾è±¡ã¯æéã®å¤å®¹ã§ãããNMDAå容使©è½ã¨å¯æ¥ã«é¢é£ãã¦ãããã¨ãæããã«ãªã£ã¦ãããæ¬å ±åã§ã¯ãæNMDAå容ä½è³çã®åæã«é¡èãªæéã®å¤å®¹ãåããçä¾ãæç¤ºãããã®æè¦ãæ¬ç¾æ£ã®æ©æè¨ºæã¨æ²»çã®æãããã¨ãªãå¯è½æ§ã«ã¤ãã¦èå¯ããã
ãçä¾ãç
åæã«é¡èãªæéã®å¤å®¹ãåããå
ç«çæ³ã«ããã»ã¼å®å
¨ã«å復ããæNMDAå容ä½è³çã®2ä¾ã§ããããããã®çä¾ããç²¾ç¥çç¶ã®ä¸ã§æéã®æªã¿ã主è¦ãªçç¶ã§ãã£ãã
çä¾1ï¼ ä¸å¹´ç·æ§ãçºçåæã«ãæéã100åé
ãé²ããã¨æããå¼·ãæéã®å¤å®¹ãçµé¨ããé¢äººæãè´è¦ç°å¸¸ãä¼´ã£ããä»ã®çç¶ãå®å
¨ã«å復ããå¾ãããã®æéã®å¤å®¹ã¯1年以䏿ç¶ãããããªãã¡ãæèé害ãå¼·ãæ¥µæä»¥åã ãã§ãªããæ¥µæä»¥å¾ã®å復æã«ãæéã®å¤å®¹ã主çç¶ã§ãã£ããæéã®å¤å®¹ãæèé害ã¨ã¯ç¡é¢ä¿ã§ãã£ããã¨ãç¹å¾´çã§ãã£ãã
çä¾2ï¼ è¥å¹´å¥³æ§ãçºçåæã«ãæéã2ï½3åé
ãé²ããã¨æãããå½åã¯èªãæéã®å¤å®¹ã訴ããªãã£ãããæ¥µæãè±ããå¾ãæ²»çè
ãå°ããéã«ç¢ºèªããããæ¬çä¾ã¯çºçåæã«ç²¾ç¥ç§ç
é¢ã«å
¥é¢ããæ¹åãä¹ããã£ããã黿°çæ£çæ³ã®ããã«ç´¹ä»ãããã徿¹è¦çã«ã¿ãã¨ãæéã®å¤å®¹ãéå¥ã«å½¹ç«ã£ãå¯è½æ§ãããã
ãèå¯ãæ¬å ±åã¯æéã®å¤å®¹ãç¹ã«æéãé ãé²ãç¥è¦ãæNMDAå容ä½è³çã®åæã«ç¹å¾´çã§ããå¯è½æ§ã示åããããã®ç¬ç¹ãªæè¦ã¯ãä»ã®ç¾æ£ã§ã¯ä¸»è¦ãªå¤ç«çç¶ã¨ãã¦ç¾ãããã¨ãç¨ã§ãããç²¾ç¥ç¾æ£ã«ãããæéã®å¤å®¹ã¨åºå¥ããä¸ã§æç¨ã§ãããæ¬ç¾æ£ã¯çµ±å失調çã¨ã®éå¥ãå°é£ã ããæéã®å¤å®¹ãç åæããé¡èã«åºç¾ãã¦ãããã¨ãããéå¥ã«å½¹ç«ã¤å¯è½æ§ãé«ããããã«ãä¸é¨ã®æ£è ã¯æéã®å¤å®¹ãèªçºçã«è¨´ããªããããåæè©ä¾¡æã«ãã®çç¶ãç©æ¥µçã«è©ä¾¡ãããã¨ã診æç²¾åº¦ã®åä¸ã«å¯ä¸ããã¨èããããããã®ç¹ãæç¢ºã«ããã«ã¯ãä»å¾å¤æ°ä¾ã§ã®ç ç©¶ãå¿ è¦ã§ããã
(è¹å±±ééã2025.3.6.)
91æ³ã¾ã§ç¶æECTããããªããã®ç¶ç¶ã»çµçµã®å¤æã«è¦æ
®ããå£è
å
ã»ãã¹ãããã¼ã®1ä¾
森山泰1), é«å®®å½°ç´2), 横山ç
§å¤«3), å¢ç°ä¸éäº1), 森山æ½4)1)é§æ¨éç
é¢ç²¾ç¥ç§
2)Neuropsychiatry, Department of Neurosciences, Leuven Brain Institute, KU Leuven, Belgium.
3)é§æ¨éç
é¢ç¥çµå
ç§
4)ææå¤§å¦å»å¦é¨éº»é
ç§å¦æå®¤
ç²¾ç¥ç§æ²»çå¦ 39: 1395-1402,2024
黿°ããããçæ³(electroconvulsive therapy: ECT)ã¯è¬ç©æ²»çæµææ§ã»ä¸èæ§ã示ãçµ±å失調çã»æ°åé害æ£è ã«å¯¾ãã¦é«ãæå¹æ§ã¨å³å¹æ§ãæå¾ ãããæ²»çæ³ã§ãããæ¥æ§æECTå¾ã«åçã»åçºãäºé²ããä¸ã¤ã®æ¹çã¨ãã¦ãå æè¬ã®èª¿æ´ã«å ãã¦ç¶æECT (maintenance ECT) ãããããã®æ½è¡ééããã³æ½è¡æéã«ã¤ãã¦æ¥æ¬ç²¾ç¥ç¥çµå¦ä¼ç·¨éã®ECTã°ãããã©ã¯ãã£ã¹ã§ã¯ããã¤ç ããã³çµ±åå¤±èª¿çæ£è ã«ããã¦é±1ã®ééãã2鱿¯ã1ã«æãã¨ã®ééã«ç§»è¡ãã¦ãã以å¾ãå¾ã ã«ééãããã¦ããï¼ãæåçºããªããã°ä¸æ¢ãæ¤è¨ãã¨ãªã£ã¦ããã
ã¨ããã§ç²¾ç¥çç¶ãæ´»çºãªå ´åã®ç¶æECTã®çµçµéç¨ã«ã¤ãã¦ã¯ãã¾ãæ¤è¨ããã¦ããªããä»åæã
ã¯è¶
é«é½¢çä¾ã«ç¶æECTããããªããã®ç¶ç¶ã»çµçµã®å¤æã«è¦æ
®ããå£è
å
ã»ãã¹ãããã¼ã®1ä¾ãçµé¨ããã
çä¾ã¯ä¸æ©å«ãæçµ¶ã飿ä¸è¯ããå£è
å
ã»ãã¹ãããã¼ãä¸é£ãªã©ã«é篤åããç²¾ç¥çç¶ã®ããã«ã5-6é±ééã§ECTãç¶ç¶ãã¦ãããä»å91æ³æã«:1)ECTå¾ã®è¡ä¸é
¸ç´ 飽å度ã®ä½ä¸ãçºä½éããå¦ã¨ãã£ãECTã®åä½µç;2)å¾®ç±ãèªç¥çã¨ãã£ã身ä½ä½µåç;3)æ¬äººã®ECTæ²»çã¸ã®æå¦:ãèªããããECTã䏿¢ããã¨ããç²¾ç¥çç¶ã®æãããªåçºãèªãããECTãåéãç²¾ç¥çç¶ãæ¹åããæç¹ã§ã¢ããã³ã¹ããã£ã¬ã¯ãã£ã1)ããããªã£ãã
ãã®å¾ãé »èçºä½ãä¸è
骨骨æã¨ãã£ããã¾ãã¾ãªèº«ä½ä½µçºçãèªããªãããECTãç¶ããã代æ¿çæ³ã¨ãã¦ç£æ°åºæ¿çæ³ãèæ
®ãå°é夿¥ãå診ãããé©å¿ã§ã¯ãªãã¨ã®ãã¨ã§ãã£ããæçµçã«ä½ã¢ã«ããã³è¡çã«ä¼´ãè¸æ°´è²¯çã®ãã麻é
ç§å»å¤æã§ECTã¯91æ³ã§çµçµã¨ãªã£ããããã®å¾ã¯èªç¥çãé²è¡ãã䏿¹ã§ãç²¾ç¥çç¶ã®åçã¯èªãã¦ããªãã
æ¬çä¾ã®ãããªè¶
é«é½¢çä¾ã®ECTç¶ç¶ã»çµçµã«é¢ãã¦ã¯ç²¾ç¥çç¶ã身ä½ä½µåç¾æ£ãECTã®åä½µçãæ¬äººã»å®¶æã®æ²»çã¸ã®åæ©ã¥ããå
ç§ã»éº»é
ç§ã¨ã®é£æºãªã©å¤é¢çã«å¤æãããã¨ãéè¦ã§ãããã
1)ããæ£è
ãããã¯å¥å¸¸äººããå°æ¥èªãã夿è½åã失ã£ãéã«èªåã«ãããªãããå»çè¡çºã«å¯¾ããæåãåãã£ã¦ææè¡¨ç¤ºãããã¨ãã¨å®ç¾©ããããããã«ã¯ä»£ç人表示ã¨å
容çæç¤ºãããã代ç人表示ã¨ã¯äºåæç¤ºããããªããã®ãææã表示ã§ããªããªã£ãå ´åã«æ±ºå®ããããªã代ç人ãæåãã¦ããäºåæç¤ºã§ããã
å
容çæç¤ºã¯æ²»çã«ã¤ãã¦ã®æ£è
ã®æã¿ãè¨é²ããäºåæç¤ºã§ãå½äººãæãã ãæå¦ãããããæ²»çããªãã代諾è
ãå»çã®å
å®¹ãæ±ºå®ããéã«æéã¨ãªãåºæºãæå®ãã¦ãããã®ã§ãã
(森山泰ã2025.1.6.)
èªç¥çã®åé§ç¶æ
ã«ãããéçãã¤ç
ã®äººã®è¨åºçç¹å¾´
è¥¿ç°æ´èï¼æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ã»ç¥çµç§å¦æå®¤ 大å¦é¢å士課ç¨ï¼Hana Nishida, Akihiro Takamiya, Shun Kudo, Takahito Uchida, Bun Yamagata, Shogyoku Bun, Hiroyuki Uchida, Frank Jessen, Masaru Mimura, Jinichi Hirano. Characteristics of Severe Late-Life Depression in the Prodromal Phase of Neurodegenerative Dementia, The American Journal of Geriatric Psychiatry: OSEP, 2024, doi: 10.1016/j.osep.2024.10.003.
ãèæ¯ã
èå¹´æãã¤ç
ã®ä¸é¨ã¯ç¥çµå¤æ§ç¾æ£ã¨é¢é£ãã¦ããã¨ããã¦ããããèªç¥çã軽度èªç¥é害ã¸ç§»è¡ãã人ã®è¨åºçç¹å¾´ã¯ååã«èª¿æ»ããã¦ããªããã¾ãããã¤ç
ã®éç度ãç¥çµå¤æ§ç¾æ£ã¸ã®ç§»è¡ã«å½±é¿ããå¯è½æ§ã示åããã¦ãã䏿¹ã§ã黿°ããããçæ³ (electroconvulsive therapy: ECT)ãå¿
è¦ãªéçã®ãã¤ç
ã®äººã®ãã¡ãç¥çµå¤æ§ç¾æ£ã«ç§»è¡ãã人ã®è¨åºçç¹å¾´ã¯æããã§ã¯ãªãã
ãæ¹æ³ã
2012å¹´4æãã2022å¹´9æã®éã«ãå½é¢ã«ã¦ECTã§æ²»çãããèå¹´æãã¤ç
ã®äººã®ãã¡ãä¸å¹´ä»¥ä¸å½é¢ã§çµéã追跡ãã人ã«ã¤ãã¦å¾æ¹è¦çã«ã«ã«ã調æ»ãè¡ã£ããããã¦è¿½è·¡ä¸ã«èå¹´æãã¤ç
ããç¥çµå¤æ§ç¾æ£ã«ç§»è¡ãã人ã¨ãç§»è¡ããªãã£ã人ã®è¨åºçæ
å ±ãæ¯è¼ããã
ãçµæã
94åã®ãã¡12å(11%)ã¯ECTæ½è¡å¾å¹³å20ã¶æå¾ã«ç¥çµå¤æ§ç¾æ£ã¸è¨ºæãç§»è¡ãããç¥çµå¤æ§ç¾æ£ã¸ç§»è¡ãã人ã¯ãç§»è¡ããªãã£ãäººã¨æ¯è¼ãã¦ãããã¤ç
ã®çºçå¹´é½¢ãé«é½¢(p = 0.01)ã§ãã¡ã©ã³ã³ãªã¼ã®ç¹å¾´ãåãã人ãå°ãªã(p = 0.03)ãç²¾ç¥ç¾æ£ã®å®¶ææ´ã®æ¢å¾ãæã¤äººãå°ãªãã£ã(p = 0.01)ãæ²»çåå¿æ§ã«é¢ãã¦ã¯ä¸¡ç¾¤ã§å·®ã¯èªããªãã£ãã
ãçµè«ã
ä¸è¨ç¹å¾´ãåããéçã®èå¹´æãã¤ç
ã®äººã«å¯¾ãã¦ã¯ãç¥çµå¤æ§ç¾æ£ã¸ã®ç§»è¡ããªããç¹ã«æ³¨æãã¦çµéã追ããã¨ãéè¦ã§ããã
(è¥¿ç°æ´èã2024.12.19.)
黿°ããããçæ³ã¨èªç¥æ©è½
é«å®®ãå½°ç´ (FWO special research associate (postdoctoral) KU Leuven, Leuven Brain
Institute, Department of Neurosciences, Neuropsychiatry, Leuven, Belgium)Electroconvulsive therapy and cognitive
performance from the Global ECT MRI Research Collaboration
Kiebs M, Farrar DC, Yrondi A, Cardoner N, Tuovinen N, Redlich R, Dannlowski U, Soriano-Mas C, Dols A, Takamiya A,
Tendolkar I, Narr KL, Espinoza R, Laroy M, van Eijndhoven P, Verwijk E, van Waarde J, Verdijk J, Maier HB,
Nordanskog P, van Wingen G, van Diermen L, Emsell L, Bouckaert F, Repple J, Camprodon JA, Wade BSC, Donaldson KT,
Oltedal L, Kessler U, Hammar Ã
, Sienaert P, Hebbrecht K, Urretavizcaya M, Belge JB, Argyelan M, Baradits M, Obbels
J, Draganski B, Philipsen A, Sartorius A, Rhebergen D, Ousdal OT, Hurlemann R, McClintock S, Erhardt EB, Abbott CC.
J Psychiatr Res, 2024 10.1016/j.jpsychires.2024.09.013.
è¿å¹´ãå¤ãã®ç ç©¶é åã«ããã¦å ±åãããè«ææ°ãå¢å ã®ä¸éã辿ã£ã¦ããããåç¾ãããªãæ£çºçãªå ±åãå°ãªããªãã䏿¹ãå¤ãã®é åã«ããã¦å¤æ½è¨å
±åç ç©¶ãçãã«è¡ãããããã«ãªããå¤§è¦æ¨¡ã³ãã¼ãã«ããä¿¡é ¼æ§ã®é«ãé å¼·ãªçµæã®å ±åããè¤æ°ã³ãã¼ãã«ããåç¾å¯è½æ§ã®å ±åãå¢ãã¦ãã¦ãããECTã¨ããé åã«ããã¦ã夿½è¨å
±åç ç©¶ãã¼ã ã§ããThe
Global ECT MRI Research Collaboration
(GEMRIC)ãçµç¹ããã¦ãããGEMRICã¯å
ã
ECTè³ç»åç ç©¶ã®å½éå
±åç ç©¶ã°ã«ã¼ãã¨ãã¦éå§ãããããæè¿ã§ã¯å種ã¯ã¼ãã³ã°ã°ã«ã¼ãã®çºè¶³ãåç»æ©é¢ã«ããæ°ããã³ã©ãã¬ã¼ã·ã§ã³ã®ä¿é²ãã¸ã£ã¼ãã«ã¯ã©ãã®éå¬ãªã©ãã®æ´»åå
容ã¯å¤å²ã«ããã£ã¦ãã¦ããã
æ¬è«æã¯GEMRIC Clinical and Cognitive Working Groupã«ããECTã®ç¸¦æç ç©¶ãè¡ãéã®èªç¥æ©è½æ¸¬å®ã«é¢ããæ¨å¥¨äºé
ãå ±åãã¦ãããå
容ã¯ä»¥ä¸ã®ãªã³ã¯ãã確èªå¯è½ã§ããã
https://www.sciencedirect.com/science/article/pii/S0022395624005351?via%3Dihub
è«æã®å
容ããWorking Groupã§è©±ãåããããã¨ãã¾ã¨ããã¨ãèªæµæ¢æ§èª²é¡ (verbal fluency test: VFT)
ã¯ECTã«é¢ããæ¥æ§ã®èªç¥æ©è½å¤åãéæã«æããããå¯è½æ§ããããå
¨è¬çèªç¥æ©è½æ¸¬å®ã«ã¯MMSEã§ã¯ãªãMoCAã使ããã¨ãæã¾ãããèªä¼çè¨æ¶ã®æ¸¬å®ã«é¢ãã¦ã¯3ã¤ã®åè£ããããã®ã®ããããå©ç¹ã¨æ¬ ç¹ããã1ã¤ã«çµãæ¨å¥¨ãããã¨ã¯é£ãããä»å¾è¡ãååãç ç©¶ã§ã¯åæ½è¨ã§ãã¼ã¿ãåå¾ãããã¨ãæã¾ãããã¨ãããã¨ã§ããã
ãã®ãããªå½¢ã§ä»å¾ã®ç ç©¶ã«å½¹ç«ã¤æè¨ãã¾ã¨ããªãããå種ã¯ã¼ã¯ã·ã§ããã®éå¬ãªã©ãéãã¦å½é交æµãæ·±ããECTã«é¢ããç ç©¶å ±åãè¡ããªãããã®é åã®çºå±ã«å¯ä¸ãã¦ãããã¨ãæã
ã®ç®æ¨ã§ããã
(é«å®®å½°ç´ã2024.11.20.)
çµ±å失調çã«ãããSense of Agencyã®é層çè§£æï¼éåå¶å¾¡ãå¶å¾¡æ¤åºãèªå·±å¸°å±
大äºåè²´ï¼æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ã»ç¥çµç§å¦æå®¤ã大å¦é¢å士課ç¨ï¼Oi H, Wen W, Chang AY, Uchida H, Maeda T.: Hierarchical analysis of the sense of agency in schizophrenia: motor control, control detection, and self-attribution. Schizophrenia. 2024;10(1): 79-79. doi: 10.1038/s41537-024-00512-x.
https://www.nature.com/articles/s41537-024-00512-x
çµ±å失調çã«ãããèªæé害ã¯ã主観çä½é¨ã§ãããããããã¾ã§èªç¶ç§å¦ã®å¯¾è±¡ã¨ãããã¨ã¯ã§ããªãã£ãããè¿å¹´èªæé害ã«ã¤ãã¦ç¥çµç§å¦ç観ç¹ããæããSense of Agencyï¼SoAï¼ã¨ãããã©ãã¤ã ãæ³¨ç®ããã¦ãããSoAã¨ã¯ãèªå·±ã®è¡çºã¨ãããã«ä¼´ã£ã¦çããå¤çã®å¤åãèªå·±ã®æå¿ã®éãã«å¶å¾¡ã§ããã¨ããæè¦ã®ãã¨ã§ãããæ¥æ¬èªã§ã¯ä¸»ä½æãªã©ã¨è¨³ãããããã®ãè¡çºã«ä¼´ãèªå·±æèãã«ã¤ãã¦ã¯å®è¨¼çã«è©ä¾¡ã§ãããããçµ±åå¤±èª¿çæ£è
ã対象ã¨ããè¡åå®é¨ãè¡ãããSoAç°å¸¸ãå ±åããã¦ãããè³å
ã§SoAç°å¸¸ãçããã¡ã«ããºã ã«ã¤ãã¦ã¯ããã¤ãºæ¨è«ãä¸å¿ã¨ããè¨ç®è«çç²¾ç¥å»å¦ã®è¦³ç¹ãããèå¯ããã¦ãããããããå
è¡ç ç©¶ã§ã¯ãèªä»å¸°å±èª²é¡çã«ãã£ã¦éå°ãªèªå·±å¸°å±ï¼SoAã®å¢å¤§ï¼ã示ããã䏿¹ã§ãèªå·±ã®å¶å¾¡ã«å¯¾ããæ¤åºè½åã®ä½ä¸ï¼SoAã®æ¸å¼±ï¼ã示åããã¦ãããçµ±å失調çã«ãããSoAç°å¸¸ã®å
¨ä½åã¯ãã¾ã 䏿ã§ããããã®ããã«çµ±å失調çã®SoAç ç©¶ã«ããã¦ä¸è²«ããçµæãå¾ããã¦ããªãåå ã¨ãã¦ãåã
ã®å®é¨ç³»ã§æ±ãé層æ§ãç°ãªã£ã¦ããå¯è½æ§ãèãããããSoAã®çæéç¨ã«ããã¦ã¯ã使¬¡ãªæè¦éåã¬ãã«ãã髿¬¡ãªèªç¥ã¬ãã«ã¸ã¨è³ãæ§ã
ãªé層ã«ãããè¤æ°ã®è¦ç´ ãé¢ãã£ã¦ããããããããå
æ¬çã«è©ä¾¡ããç ç©¶ã¯ã¾ã è¡ããã¦ããªããããã§æ¬ç ç©¶ã§ã¯ãåä¸ã®å®é¨ãã¶ã¤ã³ã®3種é¡ã®éåå¶å¾¡èª²é¡ãç¨ãã¦ãSoAã®çæã«é¢ããæ§ã
ãªé層ã®è¤æ°ã®è¦ç´ ãå
æ¬çã«è©ä¾¡ããã
å
·ä½çã«ã¯ãçµ±åå¤±èª¿çæ£è
26åãå¥å¸¸è
27åã対象ã¨ãã¦ãreaching taskãcontrol detection taskãcontrol judgment taskã®3種é¡ã®èª²é¡ã宿½ããã3ã¤ã®èª²é¡ãã¹ã¦ã«ããã¦ã被é¨è
ã¯æå
ã®ãã¦ã¹ãåããã¦ç»é¢ä¸ã®ããããæä½ãããããã¦ã¹ã®åãã¨ãããã®åãã¨ã®éã«ã©ã³ãã ãªç©ºéãã¤ã¢ã¹ï¼äºåã«è¨é²ãããä»äººã®æã®åãã¨ã0度ãããã¯90度ã®è§åº¦ãã¤ã¢ã¹ãçµã¿åããããã®ï¼ãå ãããããReaching taskã§ã¯ãå¶éæéå
ã«ããããç»é¢ä¸ã®ã¿ã¼ã²ããã«ã§ããã ãå¤ãã¿ãããããã¨ã§ã使¬¡ãªæè¦éåã¬ãã«ã«ãããéåå¶å¾¡è½åãè©ä¾¡ãããControl detection taskã§ã¯ã3ã¤ã®ãããã®ä¸ãã被é¨è
ã®ãã¦ã¹ã®åããä¸é¨åæ ãã¦ããããããæ£ãã鏿ãããã¨ã§ãèªå·±ã®å¶å¾¡ã«å¯¾ããæ¤åºè½åãè©ä¾¡ãããControl judgment taskã§ã¯ã被é¨è
ã¯ç»é¢ä¸ã®ããããèªåã§å¶å¾¡ã§ãã¦ããã¨æãããå¦ãã«ã¤ãã¦åçãããã¨ã§ã髿¬¡ãªèªç¥ã¬ãã«ã«ããã主観çãªèªå·±å¸°å±å¤æãè©ä¾¡ããã
ãã¦ã¹ã®ç§»åé度ãå
±å¤éã¨ãã¦æ··åãã¶ã¤ã³ANCOVAã宿½ããã¨ãããreaching taskããã³control detection taskã«ããã¦ãæ£è
ç¾¤ã®æç¸¾ãææã«ä½ãã£ãï¼ããããF(1, 47)â=â39.46, pâ<â0.001, partial η2â=â0.456; F(1, 47)â=â6.92, pâ=â0.011, partial η2â=â0.128ï¼ããcontrol judgment taskã§ã¯ä¸¡ç¾¤éã«ææå·®ãèªããªãã£ãï¼F(1, 47)â=â0.02, pâ=â0.884, partial η2â<â0.001ï¼ãã¤ã¾ãçµ±åå¤±èª¿çæ£è
ã§ã¯ãéåå¶å¾¡è½åã¨ãèªå·±ã®å¶å¾¡ãæ¤åºããè½åãææã«ä½ããã¨ã示ãããããèªå·±å¸°å±å¤æã¯ä¿ããã¦ãããã¾ãã3ã¤ã®èª²é¡ã®æç¸¾ãç¨ãã¦é層çã¯ã©ã¹ã¿ã¼åæã宿½ããã¨ãããçµ±åå¤±èª¿çæ£è
ã¨å¥å¸¸è
ã86%ã¨ããé«ã精度ã§åé¡å¯è½ã§ãã£ãã
æ¬ç ç©¶ã«ãããçµ±å失調çã«ãããSoAç°å¸¸ã«ããã¦ã¯ãæè¦éåã¬ãã«ã«ãããSoAã®æåº¦ã®ä½ä¸ãããæ¬è³ªçã§ããããããèªç¥ã¬ãã«ã«ãããèªå·±å¸°å±ãã¤ã¢ã¹ã«ãã£ã¦ä»£åãã¦ããå¯è½æ§ã示åããããã¾ãã3ã¤ã®å®é¨èª²é¡ã®çµæã«ãã£ã¦ãçµ±åå¤±èª¿çæ£è
ã¨å¥å¸¸è
ãé常ã«é«ã精度ã§åé¡ã§ãããã¨ãããä»å¾ããã«ç²¾åº¦ãé«ãã¦ãããã¨ã§ãå°æ¥çã«SoA課é¡ã診æè£å©ãã¼ã«ã¨ãã¦æç¨ã¨ãªãå¯è½æ§ãããããã®ãããªSoAç ç©¶ããè¨ç®è«çç²¾ç¥å»å¦ãç¥çµççå¦çæ¤æ»ã¨çµã¿åããããã¨ã§ãããå
æ¬çãªç
æ
è§£æã«ç¹ããå¯è½æ§ããããããããæ°ããªæ²»çæ³ãèªç¥ãªãããªãã¼ã·ã§ã³æ¹æ³ã®éçºã¸ã¨çºå±ãã¦ãããã¨ãæå¾
ãã¦ããã
(大äºåè²´ã2024.10.16)
身ä½åé害ã¨ã®éå¥ãè¦ããPainful legs and moving toes syndromeã®ä¸ä¾Mimura, Y., Komatsu, K., Yasushi, Y., Seki, M., Nakajima, S., Uchida, H. and Mimura, M. (2024), A case of painful legs and moving toes syndrome mimicking somatic symptom disorder. Psychogeriatrics, 24: 1023-1029. https://doi.org/10.1111/psyg.13155
ãæ¦è¦ã
Painful legs and moving toes syndrome (PLMT)ã¯ä¸å¹´æä»¥éã®å¥³æ§ã«å¤ããä¸éæéååã³âããããâãâã¡ãã¡ãâã¨ãããã¤ããçã¿ãè¶³ããã¤ã¾å
ã«ããã¦è¨´ãããã¨ãç¹å¾´ã®ç¾æ£ã§ãã.䏿¢æ§ã®ç¼çå¦ççµè·¯é害åã³æ«æ¢¢ç¥çµé害ããã®ç
æ
ã¨ãã¦æ¨å®ããã¦ãããã診æã«æç¨ãªæ¤æ»ããªããã誤診ããããããç¹ã«çã¿ã®è¨´ããå¼·ãããã®å
容ãç¬ç¹ã§ãããããã«ç²¾ç¥ç¾æ£ã«ééããããå¯è½æ§ãããã
ãçä¾ã
çä¾ã¯70æ³ä»£å¥³æ§ï¼X-6å¹´ã«å¸¯ç¶ç±ç¹å¾ã«é°é¨ã®ç¼çãèªãè¤æ°ã®ç
é¢ãå診ï¼é®çè¬ã¸ã®åå¿æ§ãä¸è¯ã§ãããã¤ç¶æ
ãçããã¹ã«ããªããéå§ããããæ¯æ¦ã®ããããã«ä¸æ¢ã¨ãªã£ãï¼ç¿å¹´ã«ã¯å¤ç¨è¬ã§ç¼çã¯æ¹åï¼X-1å¹´ã«ä½å¹¹ãããããç¾è±¡ãèµ·ããããã«ãªãï¼ã¯ããã¼ãã éå§ï¼çç¶ã¯æ¹åãããè¶³ã®å
å´ããå¼ã£å¼µããããããªçããèªããï¼Xå¹´3æã«ä»é¢è³ç¥çµå
ç§ãåè¨ºãæ¤æ»ã®çµæãã¼ãã³ã½ã³ç
é¢é£ç¾æ£ãçãããï¼åå¹´5æã«å½é¢ã«ç²¾æ»å çã®ããä»»æå
¥é¢ã¨ãªã£ãï¼å
¥é¢æï¼å·¦è¶³è¶¾ãã大è
¿ã®ç¼çï¼ä¸éæéåã¨è
°ã®éãã訴ããï¼ä¸æ¹ã§ãä¸é£ãåããªèº«ä½çç¶ã¸ã®ãã ãããææãä¸å®ã¯è´åããããäºæ¬¡çãªæãã¤çç¶ãåå®ã§ããªãã£ããã¨ãã身ä½åé害ãããã«æ¬ ããã¨æããããã®çåããç¥çµå
ç§å»ããpainful legs and moving toesã®å¯è½æ§ã«ã¤ãã¦ç¤ºåãããã ã,ããã¬ããªã³ãéå§ï¼ç¼çã¯å¾ã
ã«æ¹åãç¾ç
æè²ããã¦éé¢ã¨ãªã£ãï¼å種精æ»ã®çµæããã¼ãã³ã½ã³ç
ã¨è
°é¨èæ±ç®¡ççªçãè¤éã«é¢ä¸ãPLMTãçºçããã¨æ¨å®ããã. ä»ã¾ã§ã®ç
æ´ããæç¤ºã«å½±é¿ãããããï¼ç¼çãææã«æãã身ä½åé害ãããèæ¯ããã£ããï¼æ£ç¢ºã«è¨´ããè´åã»è¨ºå¯ãããã¨ã§éå¥ã§ãã1ä¾ã§ãã£ãï¼
ãæ¬çä¾ããå¾ãããæè¨ã
ï¼ãåå ã®ç¹å®ã§ããªãçã¿ã宿ã«ç²¾ç¥ç¾æ£ã¨ããªããã¨
ï¼ãPLMTã¯ããã¬ããªã³ãªã©ãä¸å¿ã«è¬ç©çæ³ã§ããç¨åº¦ã³ã³ããã¼ã«ã§ãããã¨
ï¼ãPLMTã®ç
æ
ãè¤éã§ããããããçä¾ãã¨ã«ã±ã¢ãã©ã³ãèæ
®ããã¹ã. æ¬çä¾ã§è¨ãã°ãã¼ãã³ã½ã³ç
ãè
°é¨èæ±ç®¡ççªçåæ¹ã«å¯¾ãã¦ã®å çãå¥åããå¯è½æ§ããã.
(䏿æ ã2024.9.1.)
è³åä¸å¾ã®å°¿å¤±ç¦ã¯è¡åã³ã³ããã¼ã«ã®é害ã¨éæ´»åèè±ã«é¢é£ãã
è¹å±±éé(è¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§é¨é·)Post-stroke urinary incontinence is associated with behavior control deficits and overactive bladder. Neuropsychologia 2024. 201, 108942. https://doi.org/10.1016/j.neuropsychologia.2024.108942.
Michitaka Funayama, Akihiro Koreki, Taketo Takata, Yoshitaka Nakagawa, Masaru Mimura
ãèæ¯ãè³åä¸å¾ã«ã¯ï¼å²ä»¥ä¸ã®æ£è ã«å°¿å¤±ç¦ãåºç¾ããï¼å°¿å¤±ç¦ã¯æ£è ã®çæ´»ã®è³ªãä½ä¸ãããã ãã§ã¯ãªã, ä»è·è ã®è² æ ãå¢ããããã«æ£è ã®ä»è·æ½è¨ã¸ã®å ¥æãä½åãªãããããªã©, æ£è ã®çæ´»ä¸ã§ã®å¤§ããªæ¯éã¨ãªãï¼è³åä¸å¾ã®å°¿å¤±ç¦ã®æ©åºã¯,ãè³æå·å¾ã«åå°ã®è±æå¶ã¨ãã¦çããBabinskiåå°ã¨é¡ä¼¼ããæ©åºã§ããéæ´»åèè±ï¼æå°¿åå°ã®éå°ãªè±æå¶ï¼ã§èª¬æããã¦ããï¼ä¸æ¹ã§, çä¾å ±åããã¯åé èãä¸å¿ã¨ãã大è³åçã®æå·å¾ã«å°¿æã«ç¡é¢å¿ã¨ãªã£ã¦å°¿å¤±ç¦ã«è³ãä¾ãè¨è¼ããã¦ããï¼è³æ©è½ç»åããã, åé èãä¸å¿ã¨ãã大è³ç®è³ªã«ãã£ã¦æå°¿ã®ã³ã³ããã¼ã«ãè¡ããã¦ãããã¨ãæããã«ãªã£ã¦ããï¼ãããä»ã¾ã§, è³åä¸å¾ã®å°¿å¤±ç¦ã®èæ¯ã«ããç¥çµå¿çå¦çã¡ã«ããºã ã¨ãã®ç¥çµåºç¤ã«ã¤ãã¦, å æ¬çãªç ç©¶ã¯è¡ããã¦ããªãã£ãï¼ä»åããããã¯,ãè³åä¸å¾ã®æ£è 群ã対象ã¨ãã¦, ãã®ç¹ãæããã«ããï¼
ãæ¹æ³ãè³åä¸å¾å年以ä¸çµéãã71ä¾ã«å¯¾ãã¦,ã尿失ç¦ã®é »åº¦,ãéæ´»åèè±ï¼å°¿ã®åæ°ã¨å°¿æåè¿«æï¼, ç§»åè½å, 尿失ç¦ã«é¢é£ãã身ä½ç¾æ£ãè¬ç©çæ³ã®æç¡, ç¥çµå¿çå¦çæè¦ï¼å ¨è¬çèªç¥æ©è½,ãè¦å½è,ãè¨æ¶, æ³¨ææ©è½, éè¡æ©è½, æ´å¯åãè¡åæ§ãå¶å¾¡ããè½åãªã©ã¨ãã£ãè¡åã³ã³ããã¼ã«ã®ç¨åº¦ï¼ãè©ä¾¡ããï¼çµ±è¨ææ³ã¨ãã¦ã¯, 尿失ç¦ã®é »åº¦ã被説æå¤æ°ã¨ãã¦, ãã®ä»ã®å åã説æå¤æ°ã¨ãã¦, 尿失ç¦ã¨åå åã¨ã®é¢ä¿ãåå帰åæã«ã¦èª¿ã¹ãï¼ãã®å¾, åå帰åæã«ã¦på¤ã0.1æªæºã§ãã£ã説æå¤æ°ãç¨ãã¦å¤éç·å½¢å帰åæãè¡ã, 交絡å åãã³ã³ããã¼ã«ããï¼ããã«, 尿失ç¦ã®ç¥çµè§£åå¦çåºç¤ã詳細ã«èª¿ã¹ãããã«,ãMRIcronã½ããã¦ã§ã¢ã使ç¨ãã¦Boxel-Based Lesion-Behavior Mappingã宿½ããï¼
ãçµæãå¤éç·å½¢å帰ã¢ãã«ã®çµæãã, 尿失ç¦ã®é »åº¦ã¯è¡åã³ã³ããã¼ã«ã®é害ã¨éæ´»åèè±ã®éçåº¦ã«ææã«é¢é£ãã¦ãããæ³¨æé害ã¨å°¿å¤±ç¦ã®é »åº¦ã¨ã®é¢ä¿ã¯, ãããã«ææãªæ°´æºã«ã¯éããªãã£ãï¼Boxel-Based Lesion-Behavior Mapping ããã¯, å³å´ãä¸å¿ã¨ããåé èè ¹å å´é¨ã®ç å¤ã尿失ç¦ã®é »åº¦ã¨é¢é£ããå¯è½æ§ã示åãããã, çµ±è¨å¦çã«ææãªæ°´æºã«ã¯ãããã«éããªãã£ãï¼ å®éã®æ£è ãå®¶æããã¯, å°¿æãæããããç¶æ³ã¨ãªã£ã¦ãâã¤ããâã¨æãã, ãã¬ããè¦ã¦ããéã«, æ°ã¥ããã失ç¦ãã¦ãããªã©ã®ã¨ãã½ã¼ããèãããï¼
ãçµè«ãè³åä¸å¾ã®å°¿å¤±ç¦ã¯, éæ´»åèè±ã¨è¡åã³ã³ããã¼ã«ã®é害ã¨ãã£ã2ã¤ã®è¦å ã¨å¯æ¥ã«é¢é£ãã¦ãããã¨ãæããã«ãªã£ãï¼ã¾ã, åé èè ¹å å´é¨ãç¥çµåºç¤ã§ããå¯è½æ§ã示åãããï¼ãããã®çµæãã, è³æå·å¾ã®å°¿å¤±ç¦ã¯åé èè ¹å å´é¨æå·å¾ã®è±æå¶è¡åã¨é¡ä¼¼ããåé èçç¶ã¨ãã¦æããããå¯è½æ§ã示åãããï¼
(è¹å±±ééã2024.8.1.)
é©å¿é害ã®èæ¯ã«ãã髿¬¡è³æ©è½éå®³ãææ¡ããå¿
è¦æ§ï¼å³é é -å´é -å¾é èã®å¿åæ§è³æ¢å¡ã®ï¼ä¾
第120忥æ¬ç²¾ç¥ç¥çµå¦ä¼å¦è¡ç·ä¼ (æå¹ã2024.6.22.)䏿 ¹å¼é£1)ãæ»ä¸ç´ä¹1)ãäºå®®æ1)ãåç°è²´è¨1)ãå
ç°è£ä¹1)ãè¹å±±éé1)2)ã
1) æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ã»ç¥çµç§å¦æå®¤ 2)è¶³å©èµ¤ååç
é¢ãç²¾ç¥ç¥çµç§
ãç®çã髿¬¡è³æ©è½é害ã¯ç²¾ç¥ç§ãå«ããå»çç¾å ´ã§è¦éãããã¡ã§ããï¼ç¹ã«ï¼å³åçæå·ã¯å¤±èªããªãããã«ï¼çç¶ãåããã¥ããï¼ä»åããããã¯ï¼é·æã«æ¸¡ã社ä¼çä¸é©å¿ãèµ·ããã¦ããèæ¯ã«è³æ¢å¡ã«ãã髿¬¡è³æ©è½é害ãå¼·ãåå¨ããï¼ä¾ãå ±åããï¼
ãçä¾ã68æ³ç·æ§ï¼çºéã®é ãã®ææã¯ãªãï¼X-6å¹´ã«ç©å¿ããèªè¦ãä»é¢ãå診ããã¨ããï¼å³é é èï½å´é èï½å¾é èã«å¿åæ§è³æ¢å¡ãçºè¦ããããï¼ç¡çåæ§ã¨è¨ºæããã¦ããï¼ç¥çµå¦çç°å¸¸æè¦ã¯ã¿ãããªãã£ããï¼ãã®é ããææ¬²ä½ä¸ãæãã¤æ°åãããï¼å®¶æããã話ã®ã¾ã¨ã¾ããªããææãããããã«ãªã£ãï¼æ°åå¤èª¿çã¨è¨ºæããï¼æä¸å®è¬ãæä¸ããã¦ããï¼X-3å¹´ï¼è·å ´ã§ã®ç°åãæ©ã«æãã¤çç¶ãåºç¾ãï¼é©å¿é害ã¨è¨ºæãããï¼ä¼è·ãéè·ãå§ãããããæ±ºæã§ããï¼æ¹é決å®ã¨ä¼é¤ç®çã«Xå¹´ããå ¥é¢ããï¼å ¥é¢æï¼è©±ãåé·ã§ã¾ã¨ã¾ãã«æ¬ ããï¼ä»è ã®åå¿ã«å¿ããè¨åã®é¸æãã§ããªãï¼æãé¡ã«æã£ã¦ãã¥ãããªã©èªç¨è«ã®é害ã身ä½ç©ºéã®é害ã示åããçç¶ãèãããï¼WAIS-â £ã§ã¯ç¥è¦æ¨çï¼PRIï¼ã¨å¦çé度ï¼PSIï¼ã®ä½ä¸ãç®ç«ã¡ï¼ç¥çµå¿çæ¤æ»ã§ã¯é¸ææ§æ³¨æã®ä½ä¸ãï¼å½¢ã®å¼å¥ãæªç¥ç¸è²ã®ç°åå¼å¥ã®é å»¶ï¼å·¦åå´ç©ºéç¡è¦ï¼å¤å½¢è¦ãè¦ãããï¼ãããã®æ©è½ã®ä½ä¸ãè·å ´ã§ã®é©å¿éå®³ãæ°åå¤èª¿çã®èæ¯ã«ãããã¨ãæããã¨ãªã£ãï¼é«æ¬¡è³æ©è½é害ã¨è¨ºæãï¼è¨ªåçè·å°å ¥ãªã©ç¤¾ä¼èª¿æ´ãããã®ã¡ã«éé¢ã¨ãªã£ãï¼
ãèå¯ãå³åçã®è³æ¢å¡å¾ã«è«¸æ©è½ä½ä¸ãçãï¼é©å¿é害ãèµ·ãããä¸ä¾ãå ±åããï¼æ¬çä¾ã§ã¯ç¹ã«è©±ã®è¿é ããä»äººã®ææ ãå¯ããè½åã®ä½ä¸ãæè¦ã¨ãã¦è¦ãããï¼ããã¯å³åçãå·¦åçã¨æ¯è¼ãã¦åªä½ã«è©±ã®æ§é ãä¸è²«æ§ï¼å æé¢ä¿ãªã©è©±ã®å ¨ä½åã«é¢ããè¨èªå¦çãè¡ã£ã¦ãããï¼æ åèªç¥ã®æ£ç¢ºæ§ã«é¢ä¿ãã¦ããããããï¼ãããé害ãããçµæãåæ ãã¦ããï¼ã¾ãï¼WAISã¨è³ç å¤ã®é¨ä½ã®ç¸é¢ã示ããéå»ã®ç ç©¶ã§ã¯ï¼ç¥è¦æ¨çï¼PRIï¼ã¯å³åçã«ï¼è¨èªçè§£ï¼VMIï¼ã»ã¯ã¼ãã³ã°ã¡ã¢ãªï¼WMIï¼ã¯å·¦åçï¼å¦çé度(PSI)ã¯ä¸¡æ¹ã«é¢ä¿ãã¦ãããã¨ãããã£ã¦ããï¼æ¬çä¾ã¯ç¥è¦æ¨çï¼PRIï¼ã¨å¦çé度ï¼PSIï¼ã®ä½ä¸ãè¦ããï¼å³åçã®é害ãåæ ãããã®ã¨ãªã£ã¦ãã.ããããã®ææ¨ã®ä½ä¸ãæ¬äººã®è·å ´ã§ã®ä¸é©å¿ã®ä¸é¨ã«å½±é¿ãã¦ããå¯è½æ§ãé«ãï¼å³åçãå·¦åçã¨æ¯è¼ãã¦åªä½ã«æ ãæ©è½ã¯ç©ºéèªç¥ï¼é¡ã®èªèï¼æ åã®çè§£ã表ç¾ï¼æ³¨æçï¼æ§ã ãããï¼ãããã®æ©è½ä½ä¸ããã®åå ã¨ãã¦å³åçæå·ããããã¨ã«æ°ã¥ããã«ããï¼è³æ¢å¡ã®é¨ä½ã«ä¼´ãçç¶ãææ¡ãï¼æ¢å¾æ´ãçç¶åºç¾ã®æç³»åï¼ç»åæè¦ãªã©ã«æ³¨æãã¦è¨ºå¯ãããã¨ã診æä¸éè¦ã«ãªãã¨æ°ä»ããããçä¾ã§ãã£ãï¼
(䏿 ¹å¼é£ã2024.7.11.)
軽度èªç¥é害ã®èå¤å´åé åéã«ãããçæ½ææ±å¿æ§æå¶ãç¨ããç¥çµççæ©è½è©ä¾¡ï¼TMS-EEGç ç©¶
䏿æ (æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨å»å¦ç ç©¶ç§ / æ±äº¬é½ç«æ¾æ²¢ç
é¢ ç²¾ç¥ç§ å»å¡)Mimura Y, Tobari Y, Nakajima S, Takano M, Wada M, Honda S, Bun S, Tabuchi H, Ito D, Matsui M, Uchida H, Mimura M, Noda Y. Decreased short-latency afferent inhibition in individuals with mild cognitive impairment: A TMS-EEG study. Prog Neuropsychopharmacol Biol Psychiatry. 2024 Feb 12:132:110967. doi: 10.1016/j.pnpbp.2024.110967.
ãèæ¯ã大è³ç®è³ªã®ç¥çµççæ©è½ã®è©ä¾¡æ³ã¨ãã¦çµé èç£æ°åºæ¿(TMS)ã¨é«ç²¾åº¦è³æ³¢è¨(EEG)ãçµã¿åãããTMS-EEGæ³ãç¥ããã¦ãããTMSåºæ¿æ³ã®ä¸ã¤ã§ããæ«æ¢¢æè¦åºæ¿ã¨TMSã«ãã䏿¢åºæ¿ãçµã¿åãããçæ½ææ±å¿æ§æå¶(SAI)ã¯ä¸»ã«ã³ãªã³ä½åæ§ç¥çµãä»ããæå¶æ©è½ãåæ ãããããã¾ã§å¥å¿å軽度èªç¥é害(aMCI)ã«å¯¾ãã¦TMS-EEGæ³ã¨SAIãçµã¿åããã¦è©ä¾¡ããç ç©¶ã¯ãªãã
ãç®çãTMS-EEGæ³ãç¨ãã¦aMCIã®å·¦èå¤å´åé åé(DLPFC)ã«ãããç¥çµççæ©è½ãSAIæ³ã§è©ä¾¡ãããã¨ãç®çã¨ããã
ãæ¹æ³ãæ¬ç ç©¶ã¯æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨å«çå§å¡ä¼ã®æ¿èªãå¾ã¦å®æ½ãã (æ¿èªçªå·: 20170152)ãaMCI30ä¾(å¹´é½¢68.3±8.0æ³, 女æ§11ä¾)ã対ç
§å¥å¸¸(HC)30ä¾(å¹´é½¢67.4±6.9æ³, 女æ§10ä¾)ã対象ã«å·¦DLPFCã«å¯¾ãã¦å®éæéåé¾å¤ã®120%強度ã§åçºåºæ¿80çºã¨SAIåºæ¿ï¼åºæ¿éé=N20ï¼4msecï¼80çºãã©ã³ãã ã«ä¸ããååºæ¿å¾ã®èªçºè³æ³¢ã®å
¨é»æ¥µå¹³åé»å ´(GMFP)ãåºæ¿é¨ä½å±æå¹³åé»å ´(LMFP)ãå卿³¢æ°æåã®Total powerãç¾¤éæ¯è¼ããããçµæãGMFPè§£æã§ã¯åºæ¿å¾100msecã«ããã¦aMCI群ã§HCç¾¤ã«æ¯ãã¦æå¶å¹æãä½ãã£ã(p=0.034)ããã®æå¶å¹æã¨MMSEå¾ç¹ã«è² ã®ç¸é¢ãèªããããï¼r=-0.41, p=0.023ï¼ã䏿¹LMFPè§£æã§ã¯ææãªç¾¤éå·®ãã¿ãããªãã£ãããã¼ã¿ã«ãã¯ã¼è§£æã«ããã¦MCI群ã§ã¯HCç¾¤ã«æ¯ãã¦åºæ¿å¾200msecã«ãããβ帯åã®æå¶å¹æãææã«æ¸å¼±ãã¦ããã
ãèå¯ãaMCI群ã§ã¯å·¦DLPFCã«ãããSAIã«ããæå¶å¹æãä½ããããã¯èªç¥æ©è½åã³Î²æ¯åã¨é¢ä¸ãã¦ããå¯è½æ§ã示åããããããã¾ã§Î²æ¯åã¯ã³ãªã³ä½åæ§ç¥çµã®æ´»ååã³èªç¥æ©è½ã¨é¢ãããã¨ãå ±åããã¦ããæ¬ç ç©¶ããSAIãMCIã®æ©æã³ãªã³ä½åæ§ç¥çµä½ä¸ãåæ ããç¥çµççå¦çãã¼ã«ã¼ã«ãªããã¨ãæå¾
ãããã
(䏿æ ã2024.6.1.)
å¾å¤©æ§è³æå·ã«ããã主観çãªå¥¥è¡ç¥è¦ã®é害ã¨å®¢è¦³çãªç«ä½è¦ã®é害ãã¤ãªã
è¹å±±éé(è¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§é¨é·)Investigating the Link Between Subjective Depth Perception Deficits and Objective Stereoscopic Vision Deficits in Individuals with Acquired Brain Injury. Cogn Behav Neurol 2024. DOI: 10.1097/WNN.0000000000000369. Michitaka Funayama, Tomohito Hojo, Yoshitaka Nakagawa, Shin Kurose, Akihiro Koreki.
ãèæ¯ãè³è¡ç®¡é害ãå¤å·æ§è³æå·ã¨ãã£ãå¾å¤©æ§è³æå·å¾ã«ããã¦ã主観çãªå¥¥è¡ç¥è¦ã®é害ãåããå ±åã¯ä»¥åããè¨è¼ããã¦ããããããããããã®ä¾ã§ã¯å®¢è¦³çãªç«ä½è¦ã®æ¤æ»ãã»ã¨ãã©è¡ããã¦ããªããä¸é¨ã®å ±åã§ã¯ç«ä½è¦ã®æ¤æ»ãè¡ããã¦ãããããã®å ´åã¯ä¸»è¦³çãªå¥¥è¡ç¥è¦ã®è¨´ãããªãä¾ã§ããããç å·£ãæããã«ãªã£ã¦ããªãä¾ã§ãã£ãããããã£ã¦ãæç¢ºã«ç¹å®åãããç å¤ãæã¤å¾å¤©æ§è³æå·ã®æ£è ã«ããã¦ã主観çãªå¥¥è¡ç¥è¦ã®æå·ã¨å®¢è¦³çãªç«ä½è¦ã®æå·ã®é¢ä¿ãæç¢ºã«ç¤ºããå ±åã¯ãªãã£ããããããã¯ãã®ã®ã£ãããåããã¹ããæç¢ºãªç å·£ãèªãããªãã§ä¸»è¦³çãªå¥¥è¡ç¥è¦ã®é害ã®è¨´ããããå¾å¤©æ§è³æå·3ä¾ï¼è³è¡ç®¡é害2ä¾ãå¤å·æ§è³æå·1ä¾ï¼ã«ã¦ã客観çãªç«ä½è¦ã®æ¤æ»ãè¡ã£ãã
ãæ¹æ³ããä¸çãçµµã®ããã«å¹³é¢ã«è¦ãããã3æ¬ã®ç©å¹²ãããã®ã©ã¡ããè¿ããé ããåãããªãããªã©å¥¥è¡ç¥è¦ã®é害ã訴ããå¾å¤©æ§è³æå·3ä¾å¯¾ãã¦ãç¥çµå¦çãç¼ç§çãç¥çµå¿çå¦çæ¤æ»ã詳細ã«è¡ã£ããæ¬¡ãã§ã2種é¡ã®ç«ä½è¦ã®æ¤æ»ãè¡ã£ããå³åçæå·ã¨å¥å¸¸è ã®2ã¤ã®å¯¾ç §ç¾¤ãç¨ãã¦ããããã®çµæãæ¯è¼ããã
ãçµæã奥è¡ç¥è¦ãé害ããã¦ããå¾å¤©æ§è³æå·3ä¾ã¯ãè¨èªæ§IQã«ããã¦ã¯å³åçæå·ç¾¤ã¨éããèªããªãã£ãããè¦ç©ºéæ©è½ã¨é¢é£ããå使§IQã§ã¯å³åçæå·ç¾¤ãããæç¸¾ã¯ä½ä¸ãã¦ãããï¼ç¨®é¡ã®ç«ä½è¦ã®æ¤æ»ã«ããã¦ã¯ããã®3ä¾ã®æç¸¾ã¯2ã¤ã®å¯¾ç §ç¾¤ã¨æ¯è¼ãã¦å¤§ããä½ä¸ãã¦ããããã®3ä¾ã«ããã主ããç å·£ã¯å³åçãä¸å¿ã¨ããå¾é èã®æ¥é¨ï¼cuneusï¼ããä¸é é å°èã®å¾é¨ã§ãã£ãã
ãèå¯ãæ¬3ä¾ã®çµæã¯ä»ã¾ã§ã®åç©å®é¨ã§ã®ç¥è¦ãè£å¼·ãããã®ã§ãããå¾é èããé é èãçµã¦åé èã«ã¤ãªããè¦è¦èªç¥ã®èå´çµè·¯ï¼ç©ã¸ã®ãªã¼ãã³ã°ãææ¡ãç¹å®ã®éå ·ã«å¯¾ããæã®å½¢ãªã©ã¨é¢é£ï¼ãããã®çµè·¯ã®åææ®µéã§å¥¥è¡ç¥è¦ãç«ä½è¦ã«æ·±ãé¢ä¿ãããã¨ã示ããã®ã§ããã
(è¹å±±ééã2024.5.8.)
ãã¼ããã³é¢é£ã¿ã³ãã¯åå¸ã¨mRNAåå¸ã¨ã®é¢é£
å±±æ¬ä¿å¤© (æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ ç²¾ç¥ã»ç¥çµç§ãç¹ä»»å©æ)Yamamoto Y, Takahata K, Kubota M, Takeuchi H, Moriguchi S, Sasaki T, Seki C, Endo H, Matsuoka K, Tagai K, Kimura Y, Kurose S, Mimura M, Kawamura K, Zhang MR, Higuchi M.: Association of protein distribution and gene expression revealed by positron emission tomography and postmortem gene expression in the dopaminergic system of the human brain. Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):3928-3936. doi: 10.1007/s00259-023-06390-2.
ãã¼ããã³å容ä½ããã¼ããã³ãã©ã³ã¹ãã¼ã¿ã¼ãcatechol-O-methyl transferase (COMT)ãªã©ã®ãã¼ããã³é¢é£ã¿ã³ãã¯ã®ãããã¸ã«ã«ãªè³å å±å¨ã¯ããã¼ããã³ç¥çµä¼éã®æå¸¸æ§ã ãã§ãªãããã¼ããã³ã«é¢é£ããèªç¥éç¨ã«ããã¦ãéè¦ã§ãããä¸è¬ã«ãè³å ã¿ã³ãã¯åå¸ã¯ãéºä¼åã®è»¢åã¨ãã®å¾ã®RNAããã»ã·ã³ã°ãã¿ã³ãã¯ã®ç¿»è¨³å¾ä¿®é£¾ãã¿ã³ãã¯è¼¸éãã¿ã³ãã¯åè§£ãªã©æ§ã ãªæ®µéã§å¶å¾¡ããã¦ãããçä½è³PETã¨æ»å¾è³mRNAã¢ãã©ã¹(Allen human brain atlas)ãçµã¿åããããã¨ã§ã転åå¾ã®å¶å¾¡éç¨ãã¿ã³ãã¯åå¸ã«åã¼ãå½±é¿ãæããã«ãªãã¤ã¤ãããããã¾ã§ã«ãã¼ããã³é¢é£ã¿ã³ãã¯ã«ã¤ãã¦ã®ç ç©¶ã¯ä¹ãããã»ãããã³é¢é£ã¿ã³ãã¯ã«ã¤ãã¦ã®ç ç©¶ãè¤æ°å ±åããã¦ããããããã«ããã¨ãmRNAã®çºç¾ã¬ãã«ã¯ã»ãããã³å容ä½å¯åº¦ã¨ç©ºéçã«ç¸é¢ããããã»ãããã³ãã©ã³ã¹ãã¼ã¿ã¼å¯åº¦ã¨ã¯ç¸é¢ããªããã¨ãå ±åãããããã®ã»ãããã³å容ä½ã¨ãã©ã³ã¹ãã¼ã¿ã¼ã¨ã®å·®ç°ã¯ãã·ããã¹åã¿ã³ãã¯ã¨ã·ããã¹å¾ã¿ã³ãã¯ã®è»¢åå¾ã®å¶å¾¡éç¨ãç°ãªãå¯è½æ§ã示åãããããã§ãæ¬ç ç©¶ã§ã¯ããã¼ããã³D1ãD2/D3å容ä½ã¨ãã¼ããã³ãã©ã³ã¹ãã¼ã¿ã¼ã«ç¦ç¹ãå½ã¦ãmRNAçºç¾ã¨ã¿ã³ãã¯åå¸ã®é¢ä¿ãæ¢ç´¢ããã
æ¬ç ç©¶ã§ã¯ã60åã®è¥å¹´å¥å¸¸è ã®PETãã¼ã¿ãåéããã60人ã®è¢«é¨è ã®ãã¡ã29人ï¼å¥³æ§4人ãå¹´é½¢32.3 ± 7.6æ³ï¼ã11C- SCH-23390 PETã23人ï¼å¥³æ§4人ãå¹´é½¢29.7 ± 8.9æ³ï¼ã11C-FLB457 PETãå¥å¸¸ç·æ§14人ï¼å¹´é½¢27.2 ± 6.1æ³ï¼ã18F-FE-PE2I PETãæ®åãããããã¼ããã³D1ãD2ãD3å容ä½ãããã³ãã¼ããã³ãã©ã³ã¹ãã¼ã¿ã¼ã®mRNAçºç¾ãããã¯ãwww.meduniwien.ac.at/neuroimaging/mRNA. htmlããå ¥æããã11C-SCH-23390 PETã®BPNDå¤ã¨ãã¼ããã³D1å容ä½mRNAçºç¾éã¨ã®é¢å¿é åãã¨ã®ç¸é¢ï¼ 11C-FLB-457 PETã®BPNDå¤ã¨ãã¼ããã³D2/D3å容ä½mRNAçºç¾éã¨ã®é¢å¿é åãã¨ã®ç¸é¢; 18F-FE-PE2Iã®VTå¤ã¨ãã¼ããã³ãã©ã³ã¹ãã¼ã¿ã¼mRNAçºç¾éã¨ã®é¢å¿é åãã¨ã®ç¸é¢ãã¹ãã¢ãã³ã®é ä½ç¸é¢ãç¨ãã¦æ¤è¨ããã
11C-SCH-23390 PETã®BPNDå¤ã¨ãã¼ããã³D1å容ä½mRNAçºç¾éã¨ã®éã«ææãªæ£ã®ç¸é¢ãèªããããï¼r = 0.769, p = 0.0021ï¼ããã¼ããã³D1å容ä½ã¨åæ§ã«ã11C-FLB-457 PETã®BPNDå¤ã¯ãã¼ããã³D2å容ä½mRNAçºç¾ã¬ãã«ã¨æ£ã«ç¸é¢ãã¦ãããï¼r = 0.809ãp = 0.0151ï¼ããã¼ããã³D3å容ä½mRNAçºç¾ã¬ãã«ã¨ã¯ç¸é¢ãã¦ããªãã£ãï¼r = 0.413ãp = 0.3095ï¼ããã¼ããã³D1å容ä½ã¨D2å容ä½ã¨ã¯å¯¾ç §çã«ã18F-FE-PE2I PETã®VTå¤ã¨ãã¼ããã³ãã©ã³ã¹ãã¼ã¿ã¼mRNAçºç¾ã¬ãã«ã¨ã®éã«ã¯ææãªç¸é¢ã¯èªããããªãã£ãï¼r = -0.5934, p = 0.140ï¼ã
以ä¸ããããã¼ããã³D1å容ä½ããã³D2å容ä½ã®mRNAçºç¾éã¨ãããããã®ã¿ã³ãã¯åå¸ã¨ã®éã«ã¯é åãã¨ã®ç¸é¢ããããã¨ãããã£ãããããããã¼ããã³ãã©ã³ã¹ãã¼ã¿ã¼ã®mRNAçºç¾éã¨ãã®ã¿ã³ãã¯åå¸ã®éã«ã¯é åãã¨ã®ç¸é¢ã¯è¦ããããã·ããã¹åã¨ã·ããã¹å¾ã¿ã³ãã¯ã®å±å¨ã«ã¯ç°ãªãå¶å¾¡ã¡ã«ããºã ããããã¨ã示ããããå ·ä½çã«ã¯ãã·ããã¹å¾ã¿ã³ãã¯ã¯è»¢åå ´æã¨ã¿ã³ãã¯åæ(ç´°èä½è¿å)ãåå¸é¨ä½ãã»ã¼è¿æ¥ãã¦ããããã·ããã¹åã¿ã³ãã¯ã¯ç´°èä½è¿åã§è»¢åãªãã³ã«ã¿ã³ãã¯åæããªãããå¾ã«è»¸ç´¢è¼¸éãä»ãã¦ç´°èä½ããé¢ãã軸索æ«ç«¯ã«åå¸ãã¦ããå¯è½æ§ã示åãããããããã®çµæã¯ããã©ã³ã¹ã¯ãªããã¼ã ã¢ãã©ã¹ããã¼ããã³ä½åæ§ç¥çµç³»ã®ãã¥ã¼ãã¤ã¡ã¼ã¸ã³ã°ç ç©¶ã«å¿ç¨ããããã®ãããåºãçè§£ãæä¾ãããã®ã§ããã
(å±±æ¬ä¿å¤©ã2024.4.22.)
çµé èç£æ°åºæ¿æ³ãç¨ããéã¢ã«ããã¤ãã¼åèªç¥çåã³è»½åº¦èªç¥é害ã®ç¥çµççå¦çãã¤ãªãã¼ã«ã¼ï¼ã¬ãã¥ã¼ã¨ã¡ã¿è§£æ
䏿æ (æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨å¤§å¦é¢å士課ç¨)Mimura Y, Tobari Y, Nakahara K, Nakajima S, Yoshida K, Mimura M, Noda Y. Transcranial magnetic stimulation neurophysiology in patients with non-Alzheimer's neurodegenerative diseases: a systematic review and meta-analysis. Neuroscience and biobehavioral reviews. 155; 10545: 2023.
大è³ç®è³ªã®ç¥çµççæ©è½ã®è©ä¾¡æ³ã¨ãã¦çµé èç£æ°åºæ¿(TMS)ã¨çé»å³(EMG)ãçµã¿åãããTMS-EMGæ³ã¯ãéåç®è³ªã®ç¥çµççæ©è½è©ä¾¡æ³ã¨ãã¦ç¢ºç«ãã¦ããã大ã¾ãã«è¨ãã°TMSã®åºæ¿ã«å¯¾ããå¿çãEMGã§è©ä¾¡ããè³ç®è³ªæ©è½ãæ¨å®ããæ¹æ³ã§ãããç¹ã«Paired pulse paradigm(è¤æ°ååºæ¿)ã§ã¯äºåã®åºæ¿ã®çµã¿åããã§å¾ãããèªçºé»ä½ãè©ä¾¡ãããã¨ã§GABA-Aãåæ ããç®è³ªã®æå¶æ©è½ Short interval intracortical inhibition (SICI)ãGlutamateãåæ ããè奮æ©è½ intra cortical facilitation(ICF)ãã³ãªã³ãåæ ããæå¶æ©è½Short latency afferent inhibition(SAI)ãããããè¨æ¸¬ã§ããã以åãæã ã¯ã¢ã«ããã¤ãã¼åèªç¥ç(AD)åã³è»½åº¦èªç¥é害(MCI)ã«å¯¾ãã¦ãTMS-EMGç¥çµæ´çè©ä¾¡ãæç¨ã§ãããã¨ãå ±åããã
ä»åãæã ã¯ç¥çµå¤æ§ç¾æ£å ¨ä½ã®30ï¼ ãå ããåãªãè¨æ¶é害ã«ã¨ã©ã¾ããªãèªç¥æ©è½ä½ä¸ãç¹å¾´ã¨ããéADã®ç¥çµå¤æ§ç¾æ£ã«ã¤ãã¦ãåæ§ã«èª¿ã¹ããçµæã¨ãã¦71æ¬ã®è«æãã¡ã¿è§£æã«å«ã¾ãããTMSç¥çµççå¦çæ¤æ»ã«ãããåé å´é åèªç¥çï¼FTDï¼æ£è ã§ã¯ã°ã«ã¿ãã³é ¸ä½åæ§æ©è½ã®ä½ä¸åã³GABA-Bä½åæ§ç¥çµæ©è½ã®ä½ä¸ããFTDãã¬ãã¼å°ä½åèªç¥ç(DLB)ãé²è¡æ§æ ¸ä¸æ§éº»çºããã³ãã³ãã³ç ãç®è³ªåºåºçå群ãå¤ç³»çµ±è縮ç-ãã¼ãã³ã½ã³åæ£è ã§ã¯GABA-Aä½åæ§æ©è½ã®ä½ä¸ãæããã«ãªã£ããããã«ãDLBãè¡ç®¡æ§èªç¥çã§ã¯ã³ãªã³ä½åæ§æ©è½ã®ä½ä¸ãèªããããããããã®çµæã¯ãNADãéå¥ããæ°ããªè¨ºæææ®µã¨ãã¦ã®TMSã®å¯è½æ§ã示åãã¦ããã
(䏿æ ã2024.3.1.)
黿°ããããçæ³ (ECT) ã¨ã±ã¿ãã³ã®æå¹æ§ã¯åçãªã®ãï¼
é«å®® å½°ç´ (FWO special research associate (postdoctoral), KU Leuven, Leuven Brain Institute, Department of Neurosciences, Neuropsychiatry, Leuven, Belgium.)Ketamine or ECT? What have we learned from the KetECT and ELEKT-D trials?
Joakim Ekstrand, Akihiro Takamiya (co-first), Axel Nordenskjold, George Kirov, Pascal Sienaert, Charles Kellner, Pouya Movahed Rad
Int J Neuropsychopharmacol, 2023 doi: 10.1093/ijnp/pyad065.
黿°ããããçæ³ (electroconvulsive therapy: ECT) ã¯éçãã¤ç
ã«å¯¾ãã¦æãæå¹ãã¤å³å¹æ§ã®ããæ²»çã§ãããããããé »åãªå
¨èº«éº»é
ãè¦ããä¸éæ§ã®èªç¥æ©è½é害ã®ãªã¹ã¯ãæããããã®ãããECTã¨æ¯è¼ãã¦ç°¡ä¾¿ã«æ½è¡å¯è½ã§ãå¯ä½ç¨ã¯å°ãªããé«ãæå¹æ§ã¨å³å¹æ§ããã¤æãã¤æ²»çãæ±ãããã¦ããããã®ãããªèæ¯ãããã±ã¿ãã³ã®ç¹æ»´æä¸ã¨ECTã®æ²»çå¹æãæ¯è¼ããé壿§è©¦é¨ãããã¾ã§ã«2ã¤è¡ããã¦ãããã¹ã¦ã§ã¼ãã³ã§è¡ãããKetECT試é¨ã¯ãã±ã¿ãã³ã®æå¹æ§ã¯ECTã«å£ãã¨2022å¹´ã«å ±åããã䏿¹ãç±³å½ã§è¡ãããELEKT-D試é¨ã¯ãã±ã¿ãã³ã®æå¹æ§ã¯ECTã¨åçã ã¨å ±åããã
ã©ã¡ãã®çµæãæ£ããã®ã ãããï¼ã¤ãããåããããªã£ã¦ãã¾ããããããªãããããããææç¾©ãªåãã¯ãã©ã¡ãã®çµæãï¼èªåã®ããï¼è¨åºç¾å ´ã«é©ç¨ã§ããã®ãï¼ãã ã¨æããããæ£ãããã©ããã¨ããç¹ã§ã¯ãã©ã¡ãã®ç ç©¶ãé©åãªæç¶ãã§è¡ããã¦ããã2ã¤ã®ç¸åããçµè«ã¯ããããã®å ´ã¨æ¡ä»¶*1ã«ããã¦ã¯æ£ããã®ã§ã¯ãªããã¨æãã
ãã®2ã¤ã®è¨åºç ç©¶ã§æãæ³¨ç®ãã¹ãç¹ã¯ãECTã®æå¹æ§ã®éãã§ãããã¹ã¦ã§ã¼ãã³ã®è¨åºç ç©¶ã§ã¯ECTã®å¯è§£çã63%ã§ãã䏿¹ãç±³å½ã§ã¯22%ã ã£ã ï¼ã±ã¿ãã³ã®å¯è§£çã¯ãããã46%ã38%ã ã£ã*2ï¼ããã®ãããã±ã¿ãã³ã¨ã®æ¯è¼äºã
ã®åã«ãããªãECTã®æå¹æ§ã2ã¤ã®è¨åºç ç©¶ã§ããã¾ã§éãã®ãï¼ãã¨ããæ°ããªçåãåºã¦ãã¦ãã¾ããECTã¯æ¨æºçãªæ²»çã¨ãã¦2ã¤ã®é壿§è©¦é¨ã«ããã¦åºæºã¨ããã¦ããããã®åºæºãããã¾ã§éãã¨ããã®çµæã®è§£éã«ã¯æ
éã«ãªããããå¾ãªãã
ãã®2ã¤ã®è¨åºç ç©¶ã®çµæããå¾ãããæè¨ã¯ããECTã«é¢ãã¦ãéå»90å¹´è¿ãæ´å²ã®ä¸ã§èç©ããã¦ããè¨åºç¥ã¨ç ç©¶ææããã¨ã«ãé©åãªçä¾ã«é©åãªæ¹æ³ã§æ½è¡ãããã¨ããã®æ²»ç广ãæå¤§éå¼ãåºãä¸ã§å¤§åã ãã¨ãããã¨ã§ãããECTã§æãæ¹åãè¦è¾¼ã¾ããæ£è
åã¨ãã¦ã¡ã¿è§£æã§å ±åããã¦ããç¹å¾´ã¯ãé«é½¢ãç²¾ç¥ç
çç¶ãã¨ãã½ã¼ãã®çãã§ãããè¨åºçã«ã¯ä¸å®çãPTSDãªã©ã®ä½µåããªããã¨ãã½ã¼ãéã«å¯è§£æããã£ããã¨ãããçç©å¦çãªè¦å ãå¼·ãã¨èããããçä¾ã®æ¹ãããæ¹åããããã¨èãããã¦ãããã¹ã¦ã§ã¼ãã³ã§ã¯å
¥é¢ç°å¢ã§ECTãè¡ãããç±³å½ã§ã¯9å²è¿ãã®æ£è
ã¯å¤æ¥éé¢ã§è¡ãããã¨ããéãããããECTã®æ½è¡æ¹æ³ã«é¢ãã¦ã¯ãå³çå´ (right unilateral: RUL) ã®é»æ¥µé
ç½®ãã¤è¶
çãã«ã¹æ³¢ (ultrabrief pulse: UBP) ã®åºæ¿ãç¨ããECTã¯å¯è§£ã¾ã§ã®ã»ãã·ã§ã³æ°ãçãã«ã¹æ³¢ã®ECTã¨æ¯è¼ãã¦å¤ãå¿
è¦ã§ãããã¨ãææããã¦ãããç±³å½ã®ELEKT-D試é¨ã«ããã6ã9ã»ãã·ã§ã³ã§ã¯ååãªæ²»ç广ãå¾ãã«ã¯ååã§ãªãã£ãã¨èãããã*3ã
2024å¹´1æç¾å¨ãã»ã¼å
¨ã¦ã®çä¾ãå
¥é¢æ£è
ãã¤90%以ä¸ã両å´åºæ¿ã¨ããæ¥æ¬ã®ECTè¨åºã«ãã©ã¡ãã®è¨åºç ç©¶ã«åºã¥ãã¨ããã³ã¹ãé©ç¨ã§ãããããã¨ããåãã«å¯¾ããçãã¯èªãã¨åºã¦ããã®ã§ã¯ãªãã ãããã䏿¹ãã±ã¿ãã³ã®æ²»ç广ãæå¤§éå¼ãåºãæ¹æ³è«ãé©åãªæ£è
åã®æ¢ç©¶ãä»å¾å¿
è¦ãªã®ã§ã¯ãªããã¨æãã
*1 ECTã®å¯¾è±¡æ£è
ãæ½è¡æ¹æ³ã¯ãå½ãå°åã«ããç°ãªããã¨ãç¥ããã¦ãããçè
ãå°æ»å»ãªãã·ã§ã³æéã«ç±³å½ã«ã¦ECTè¨åºãå¦ãã éã«ã¯ãç²¾ç¥ç§å»ãé©åã§ãªãã¨ããã£ã¦ãã¦ãæ£è
ã®ä¿éºã®å¶ç´ã«ããECTãæ½è¡ããªãã¨ãããªãã¨ããå ´é¢ãç®ã®å½ããã«ãè¡æãåãããéã«ã夿¥ã§ã®æ½è¡ãçå´ECTãæ®åãã¦ããããçµ±åå¤±èª¿çæ£è
ã¸ã®æ½è¡ãå¤ãæ¥æ¬ã®ç¾ç¶ã«é¢ãã¦ã¯ãããªãï¼ãã¨åããè¿çã«çª®ãããã¨ããã°ãã°ã§ããã
*2 ç±³å½ã®è¨åºç ç©¶ (ELEKT-D試é¨) ã®ä¸»è¦ã¢ã¦ãã«ã ã¯å¯è§£çã§ã¯ãªãããæ¯è¼ã®ããMADRSã§è©ä¾¡ããå¯è§£çã示ãã¦ããã
*3 æ¬è«æã®å
±èè
ã§ãããKellnerå
çã主å°ããç±³å½ã®PRIDE試é¨ã«ããã¦ãUBPãRUL ECTãæ¡ç¨ããã¦ããããå¯è§£çã¯62%ã ã£ããPRIDE試é¨ã¯60æ³ä»¥ä¸ã®é«é½¢è
ã®ã¿ãçµã¿å
¥ãã¦ããã¨ãã対象è
ã®å¤§ããªéãã¯ãããããããã«ãã¦ãUBP RUL ECTèªä½ã«åé¡ãããããã¯ãªããããããUBPã¯é壿§è©¦é¨ã§åºæºã¨ãããæ¨æºçECTã¨è¨ãããã¯çåã§ããã
(é«å®®å½°ç´ã2024.2.1.)
è³ç»åç ç©¶ã®åºç¤æ´å
é«éæ´æ (å½ç«ç ç©¶éçºæ³äººãå½ç«ç²¾ç¥ã»ç¥çµå»çç ç©¶ã»ã³ã¿ã¼ National Center of Neurology and Psychiatry; NCNP è³ç
æ
çµ±åã¤ã¡ã¼ã¸ã³ã°ã»ã³ã¿ã¼ Integrative Brain Imaging Center; IBIC è¨åºè³ç»åç ç©¶é¨)
ã¯ããã«
å½ç«ç²¾ç¥ã»ç¥çµå»çç ç©¶ã»ã³ã¿ã¼ã»è³ç
æ
çµ±åã¤ã¡ã¼ã¸ã³ã°ã»ã³ã¿ã¼ï¼IBICï¼ã§ã¯ãã£ã³ãã¹å
ã®ç
é¢ãç ç©¶æã¨ã®æ©æ¸¡ãããã¤ã¤ç»åç ç©¶ã®æ¨é²ãå³ã£ã¦ããããIBICã®éè¦ãªä½¿å½ã®ä¸ã¤ã¨ãã¦ãããå½ã®å¤æ½è¨å
±åç»åç ç©¶ã®æ¨é²ããã³ç ç©¶ç°å¢ã®åºç¤æ´åãæ²ãããã¦ããã
è¿å¹´ã®ç»å診ææè¡ããã³ã³ã³ãã¥ã¼ã¿ã¼æè¡ãæ
å ±éä¿¡æè¡ã®çºå±ã«ãããç»åç ç©¶ã¯é·è¶³ã®é²æ©ãéãã¦ãããMRIã§ã¯è¨åºã§ã¯T1強調ç»åãT2強調ç»åãæ¡æ£å¼·èª¿ç»åçã«ããæ§é ã»å½¢æ
診æãè¡ãããããæ©è½çMRI ã§ã¯å®éæè³è¡æµã課é¡è² è·æã®è³è¡æµå¤åãã¿ããã¨ãã§ããè³æ©è½ç ç©¶ããã³ç²¾ç¥ç¥çµç¾æ£ã®ç
æ
ç ç©¶ã«ç¨ãããã¦ãããPETãSPECCTãªã©ã®æ ¸å»å¦ã§ã¯è³è¡æµã»ä»£è¬ããã¢ããã¤ãçã®èç©ãç¥çµä¼éæ©è½ãã¿ããã¨ãã§ãããç¾å¨ã®ç»åã¯ãããããã¸ã¿ã«ãã¼ã¿ã§ä¿åãããè§£æã¯ã³ã³ãã¥ã¼ã¿ã¼ä¸ã§å°ç¨ã®ã½ããã¦ã§ã¢ãç¨ãããçµæã¨ãã¦ç»åç ç©¶ã§ã¯å¤§éã®ãã¸ã¿ã«ãã¼ã¿ãæ±ããã¨ã«ãªãã
夿½è¨å
±åç»åç ç©¶
æ½è¨ã®å£æ ¹ãè¶ãã¦åºãçä¾ãåéãã夿½è¨å
±åç ç©¶ã¨ããææ³ã¯ç²¾ç¥ç¾æ£ã«éãããã¾ãå½å
å¤ã§ãè¨åºç ç©¶ã®æ¨æºã¨ãªã£ã¦ããã夿½è¨å
±åç»åç ç©¶ãæ¨é²ããããã«ã¯åæ½è¨ããç»åãã¼ã¿ãå¹çããéç©ãã管çãããã¨ãä¸å¯æ¬ ã§ãããIBICã§ã¯2010年代ååããè³ç
æ
çµ±åã¤ã¡ã¼ã¸ã³ã°ãµãã¼ãã·ã¹ãã ï¼Integrative Brain Imaging Support System; IBISSï¼ã管çã»éå¶ãã¦ãããIBISSã§ã¯åç ç©¶åå æ½è¨ããå½éæ¨æºè¦æ ¼ã§ããDICOM (Digital Imaging and Communications in Medicine) å½¢å¼ã®ç»åãã¼ã¿ãæ°åçã®å人æ
å ±ãåãé¤ãã¦ãã¤ã³ã¿ã¼ããããä»ãã¦ã¢ãããã¼ãããã¯ã©ã¦ããµã¼ãã«ä¿ç®¡ã»ç®¡çãããIBISSã§ã¯ä½¿ç¨è
ã®IDã¨ãã¹ã¯ã¼ãã®ä»ã«ããããããåç ç©¶æ½è¨ã®ã°ãã¼ãã«IPã¢ãã¬ã¹ãã¢ã¯ã»ã¹å¯è½ãªæ½è¨ã¨ãã¦ç»é²ãã¦ããããã以å¤ã®IPã¢ãã¬ã¹ããã¯ã¢ã¯ã»ã¹ã§ããªããã¨ã§å®å
¨æ§ãä¿ã£ã¦ãããIBISSã¯ããã¾ã§10以ä¸ã®å½å
ã®å¤æ½è¨å
±åç»åç ç©¶ããã¸ã§ã¯ãã§ä½¿ç¨ãããMRIãPETãSPECTãCTã®ãã¼ã¿ãåéãã¦ããã
ç¹ã«æè¿ã®AMEDã®å½éè³ããã¸ã§ã¯ãã¯å¤æ©ç¨®èª¿åMRIæ®åãããã³ã«ã¨å¼ã¶é«å質ã»é«åè§£è½ã§æ¨æºåããããããã³ã«ãç¨ãã¦ããããã®åããã¼ã¿ã®ç¨®é¡ãå¢ããã¤ãã¼ã¿éã大éåããããã®ããIBISSã¯2022å¹´ã«ã¬ãã¡ã³ãã¯ã©ã¦ãã®ä¸ã¤ã§ããææ°ã®ã¯ã©ã¦ãã«ç§»è¡ãã大å¹
ãªæ©è½æ¹ä¿®ãè¡ã£ãã仿¥ã®ã¯ã©ã¦ãã§ã¯ãã¼ã¿ãä¿ç®¡ããã®ã¿ãªãã使¥ã»æ©è½ããé åãæã¤ãã¨ãã§ããããæ¡å¼µæ§ãé«ãããã®ãããã§å©ç¨è
ã®è¦æã«å¿ãã¦ããã¸ã§ã¯ããã¨ã«å¤§å¹
ãªã«ã¹ã¿ãã¤ãºãå¯è½ã«ãªã£ãã
ç»åãã¼ã¿ã®å質管ç
ä¸ã¤ã®ããã¸ã§ã¯ãã§ã¯NCNPå
ã®ç ç©¶é¨ã¨å
±åã§å¤§è¦æ¨¡MRIãã¼ã¿ã®å質ãã§ãã¯ãè¡ã£ã¦ãããã¾ãã¯DICOMã¿ã°ï¼ãããã¼ï¼ã®èªåãã§ãã¯ã·ã¹ãã ãéçºãããã©ã¼ããããææ°ãæ®åã·ã¼ã¯ã¨ã³ã¹ã®ä¸åãæ¤åºããããã®éç¨ã§T1, T2強調ç»åãªã©ãèªåæ½åºããé éèªå½±ã®ãµã¼ãã«è»¢éãæ¾å°ç·ç§å°éå»ã«ç ç©¶ç¨ã®æ¨æºåãããåºæºã»æé ã«åã£ã¦èªå½±ãã¦ãããããã¨ãã°ãéå¸¸ã®æ¾å°ç·ç§èªå½±ã§ã¯æ£å¸¸å¤ç°ã¨ã¿ãªããããã®ã§ãã£ã¦ãã大è³ç®è³ªã®å®¹ç©æ¸¬å®ã«å½±é¿ããã¨èããã¨é¤å¤ãã¹ãã§ãããããã«ãããããã¢ã¼ããã¡ã¯ãã®ç¢ºèªãè¡ããç ç©¶å©ç¨ã®è¦³ç¹ããè§£æã«ä½¿ç¨ã§ãããã®çµ±åçãªå¤æãè¤æ°äººã§è¡ãããã®è³ªã®æ
ä¿ã¨ãã¦æ¯é±ãã¼ãã£ã³ã°ãè¡ããè©ä¾¡ã®å
±éåã®ãã¬ã¼ãã³ã°ãè¡ã£ã¦ããããã®æ¹æ³ã§ç¾å¨ãæ°åã®ç»åã®å質ãã§ãã¯ãè¡ã£ã¦ãããå質管çãã·ã¹ãã åãããã¨ã«ããå¹ççã«ãªã£ããã人ã®ç®ã»å¤æãå¿
è¦ã§ãããç¹ã«ç²¾ç¥ç¾æ£ã®ç ç©¶ã§ã¯å¾®å¦ãªå·®ãæ¤åºããå¿
è¦ããããããç ç©¶ç¨ç»åã®å³å¯ãªå質管çãè¡ããã¨ãä¸å¯æ¬ ã§ããã¨èãã¦ããã
æç¶å¯è½ãªãã¼ã¿ç®¡ç
仿¥ã§ã¯åäººã®æ¥å¸¸çæ´»ã§ãã¯ã©ã¦ãã使ç¨ããæèããã¨ãã¯ã©ã¦ãã¨ãã¼ã«ã«ã®ãã½ã³ã³ãã·ã¼ã ã¬ã¹ã«ä½¿ç¨ãã¦ãããã¨ãå¤ãã¨æããããã¾ããã»ã¨ãã©ã®ç ç©¶ã§ä½ããã®å½¢ã§ã¯ã©ã¦ãã«ããã¼ã¿ãç½®ãã¦ãããå½å
å¤ã§ãã¯ã©ã¦ãã«å¤§éã®ãã¼ã¿ãä¿æããããã«ããã«OSãã¢ããªã±ã¼ã·ã§ã³ãç«ã¡ä¸ããã¯ã©ã¦ãå
ã§è§£æãè¡ãç ç©¶ãæ£è¦ããããã¨ãã«æ©æ¢°å¦ç¿ã人工ç¥è½ãå©ç¨ããè§£æã«æã¡è¾¼ãããã«ã¯å¤§éã®ãã¼ã¿ãæ¬ ãããªããã¾ããè¿å¹´ã¯ãã¼ã¿ã·ã§ã¢ãªã³ã°ãéè¦è¦ãããã¯ã©ã¦ãä¸ã§ãã¼ã¿ãå
¬éããã¦ãããããããªãããç ç©¶ç¨ã¯ã©ã¦ããç¶æãã¦ãããã¨ã¯ç°¡åã§ã¯ãªããå¤é¨å
¬çç ç©¶è²»ã¯é常ææã®ãã®ã§ãããããã ãã§ã¯ã©ã¦ããç¶æãã¦ããã®ã¯é£ããããªã³ãã¬ãã¹ï¼ãã¼ã«ã«ï¼ã®ãµã¼ããä½µç¨ãã¤ã¤ãIBICã®ä½¿å½ã¨ãã¦ç¶ç¶çãªéç¨ã¨åºç¤æ´åããã¦ããããã¨èãã¦ããã
(é«éæ´æã2024.1.5.)
çµ±å失調çã«ãããèªå·±ä¸»ä½æã®å¤èª¿ã¯ãäºæ¸¬ã·ã°ãã«ã®é
å»¶ããçããï¼è¨ç®è«çã¢ãã«ã«ããã·ãã¥ã¬ã¼ã·ã§ã³ç ç©¶
æ²æå®°ã(æå大å¦çºéé害å»çç ç©¶æãè¬å¸«)Aberrant sense of agency induced by delayed prediction signals in schizophrenia: a computational modeling study
NPJ Schizophrenia 2023. DOI: 10.1038/s41537-023-00403-7.
Tsukasa Okimura, Takaki Maeda, Masaru Mimura, Yuichi Yamashita
ãæ¦è¦ã
çµ±å失調çã®ç
æ
ã¯æªã æããã«ããã¦ããªãããèªæé害ã䏿 ¸çç¶ã§ããã¨èãããã¦ãããè¿å¹´ãèªæé害ã¯èªå·±ä¸»ä½æï¼sense of agencyï¼SoAï¼ã®è¦³ç¹ããå®è¨¼çç ç©¶ã§èª¿æ»ããã¦ããããSoAã¨ã¯ãèªåèªèº«ãèªåã®è¡åããã®ä¸çã¸ã®å½±é¿ãå¼ãèµ·ããã¦ããã¨ããæè¦ã§ãããçµ±å失調çã§ã®SoAã®å¤èª¿ã¯ãããã¤ãã®è¡åå®é¨ç ç©¶ã§ç¤ºããã¦ãã¦ããã®ä¸ã®ï¼ã¤ã«ãåç°ãã«ãã£ã¦éçºãããKeio methodã«ããç ç©¶ï¼Maeda et al., 2012, 2013ï¼ããããåç°ãã¯ã齿§çç¶åªä½ã®çµ±å失調çã§ã¯SoAéå°ï¼ããªãã¡ãç©äºã®çµæãèªåã®æå³ã«çµã³ä»ãããããã¨ï¼ãé°æ§çç¶åªä½ã®çµ±å失調çã§ã¯SoAéå°ãããã¨ã示ãããã¤ã¾ããçµ±å失調çã§ã®SoAã®å¤èª¿ã¨SoAã®å¤èª¿ã®ï¼ã¤ã®ã¿ã¤ãã齿§çç¶ã¨é°æ§çç¶ã«å¯¾å¿ããå½¢ã§ç¤ºãããã¨ã«ãªããçµ±å失調çã§ã®SoAã®å¤èª¿ã®æ©åºã¯æªè§£æã§ãããããè³ãæ
å ±å¦çã·ã¹ãã ã¨ããã¨ãã«ãçµ±å失調çã§ã¯äºæ¸¬æ©è½ã®ç°å¸¸ããããã¨ãã仮説ãå
è¡ç ç©¶ã§ãªããã¦ãããããã§æ¬ç ç©¶ã§ã¯ããçµ±å失調çã§ã¯äºæ¸¬æ©è½éã§ã®ä¼éé
å»¶ããããã¨ç¦ç¹ãçµã£ã仮説ãç«ã¦ãããã®çç±ã¯ãçµ±å失調çã«ãããSoAã®å¤èª¿ã®è³åºç¤ãæªè§£æã§ããããWhitfordãã®ç ç©¶ï¼2011, 2012, 2015, 2018ï¼ãã¯ããã¨ãã¦frontoparietal networkã®ç½è³ªç°å¸¸ã®ç¥è¦ããããã¦ããããã§ããã
ä¸è¨ä»®èª¬ãçµ±åå¤±èª¿çæ£è
ã対象ã¨ãã¦å®è¨¼ããã®ã¯å°é£ã§ããããã«ãæã
ã¯ãè¨ç®è«çã¢ããã¼ãã®ï¼ã¤ã§ããå帰ãã¥ã¼ã©ã«ãããã¯ã¼ã¯ã¢ãã«ï¼RNNã¢ãã«ï¼ã§ã®ã·ãã¥ã¬ã¼ã·ã§ã³ã§ä»®èª¬æ¤è¨¼ããããæ¬ç ç©¶ã®RNNã¢ãã«ã¯ãç¾æç¹ã§ã®è¦è¦ã»è´è¦ã»åºæå容æè¦ããããå
¥åå±¤ãæ¬¡ã®æç¹ã§ã®ãããã®æè¦ãSoAã®å¤æãåºåããåºå層ãç¾æç¹ã®å
¥åã¨ããã¾ã§ã®å
¥åã®å±¥æ´ããæ¬¡ã®æç¹ã®äºæ¸¬ã®ä¸å¿ãæ
ãæè層ãããªãã
ãã®RNNã¢ãã«ã使ã£ã¦ãã¾ããKeio methodã®å¥å¸¸è
ã®çµæãå¦ç¿ããããããªãã¡ãKeio methodã®ã¿ã¹ã¯ã«éã£ã¦ã¯å¥å¸¸è
ã¨åããããªSoAã®å¤æãã§ããããã«ãªã£ãã¢ãã«ã使ããããã®å¾ããäºæ¸¬æ©è½éã§ã®ä¼éé
å»¶ãã®ä»®èª¬æ¤è¨¼ãããããã«ãæè層å
ã®ä¼éé
å»¶ãããã¨ãããåç°ãã®è¡åå®é¨ï¼2013ï¼ã®ããã«ãçµ±å失調çãã¿ã¼ã³ã§ããï¼ã¤ã®ã¿ã¤ãã®SoAã®å¤èª¿ãåç¾ããããæ¬ç ç©¶ã®ä»®èª¬æ¤è¨¼ã¯ã·ãã¥ã¬ã¼ã·ã§ã³ã§ããããä»ã®RNNã¢ãã«é害å®é¨ã§ãçµ±å失調çãã¿ã¼ã³ãåç¾ãããå¯è½æ§ãããã®ã§ãæ¯è¼å®é¨ã¨ãã¦ãæè層å
ã¸ã®ã©ã³ãã ãã¤ãºã®è¿½å ãæè層ããåºå層ã¸ã®ä¼éé
å»¶ãå
¥å層ããæè層ã¸ã®ä¼éé
å»¶ã®RNNã¢ãã«é害å®é¨ãããã¨ãããçµ±å失調çãã¿ã¼ã³ã®SoAã¯è¦³å¯ãããªãã£ãããããã®çµæã¯ããäºæ¸¬ä¿¡å·ã®ä¼éé
å»¶ã仮説ãçè«çã«æ¯æããçµ±å失調çã«ãããSoAã®å¤èª¿ã®ç
æ
ãçè§£ããææããã¨ãªãã¨èãããããã
(æ²æå®°ã2023.12.10.)
Steroid therapy and rehabilitation in the treatment in a patient with delayed
neurological sequelae due to carbon monoxide poisoningï¼A case report.
ä¸é
¸åçç´ ä¸æ¯ã«ããé
çºæ§è³çã«å¯¾ãã¦ã¹ããã¤ããã«ã¹ããã³å¾çæ³ã¨ãªãããªãã¼ã·ã§ã³ãè¡ã£ã1ä¾
ä¸æãæ 1ï¼2ï¼ï¼å¤§äºãåè²´1ï¼2ï¼ï¼é«ç°ãæ¦äºº1ï¼2ï¼ï¼ä¸æãå°2ï¼ï¼è¹å±±ãéé1ï¼2ï¼
1ï¼è¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§
2ï¼æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ã»ç¥çµç§å¦æå®¤
䏿¯ç ç©¶ã36ï¼32ï¼37ï¼2023
ãæ¦è¦ã
ä¸é
¸åçç´ (CO)䏿¯ã«ããé
çºæ§è³ç(DNS)ã¯ãCOæé²ã«ããæ¥æ§æçç¶ãæ¹åãã4-6é±éã®ç¡çåæéãçµã¦æèé害ã失è¦å½èãè¨éåé害ã失ç¦ã失è¡ãäººæ ¼å¤åãªã©ã®å¤å½©ãªçç¶ãåããè³çã§ããããã®äºå¾ã¯æ±ºãã¦è¯å¥½ãªãã®ã§ã¯ãªããæ²»çæ³ã確ç«ããããã®ã¯ãªããä»åæã
ã¯CO䏿¯ã«ããDNSãçºçããã3 åã®ã¹ããã¤ããã«ã¹ããã³ã¹ããã¤ãå¾çæ³ã¨ãªãããªãã¼ã·ã§ã³ã«åå¿ãéé¢ã¸ã¤ãªãããã¨ãã§ããçä¾ãçµé¨ããã®ã§å ±åããã
ãçä¾ã
æ£è
ã¯30 ä»£ç·æ§ãCOæé²å¾ç¬¬29 ç
æ¥ã®æã«æèéå®³ãæªåãï¼MRIæè¦ããããã¦CO䏿¯ã«ããDNSã¨è¨ºæããã忥ãã髿¶²ä¸ã®ãã¨ãªã³å¡©åºæ§èç½ï¼MBPï¼ã®æ¨ç§»ãã¿ãªããã¹ããã¤ããã«ã¹çæ³ãè¡ãªã£ããåå¿ã¯é¨åçã§ã第47ç
æ¥ããç¡åç¶æ
ã¨ãªãçå¼·åã墿ªãããADLã®èªç«åº¦ã®ææ¨ã§ããFunctional independence measure (FIMãéåæ©è½91ç¹æºç¹ï¼ã¯ç¬¬53ç
æ¥ã«ããã¦æä½ç¹ã§ãã13ç¹ã¾ã§ä¸ãã£ããããã髿¶²MBPã¯å çã«ããæ¸å°ãã¦ãããã¹ããã¤ãå¾çæ³ã«åãæ¿ãç¶ç¶çã«ä»å
¥ããã¨ãã第75ç
æ¥é ããå¾ã
ã«æèã¬ãã«ãADLãèªç¥æ©è½ãæ¹åããã第108 ç
æ¥ã«ã¯MBP ã¯æ¤åºæåº¦ä»¥ä¸ã¨ãªãï¼ç·©å¾ã§ã¯ãã£ããæèã¬ãã«ã¨ADL ã¯æ¹åããããã®å¾ãç©æ¥µçã«ãªãããªãã¼ã·ã§ã³ãè¡ã第154 ç
æ¥ã«ã¯èªçºèªãèªãï¼ç¬¬190 ç
æ¥ã«ã¯ADL ã¯èªç«ã¬ãã«ã¸æ¹åãããèªç¥æ©è½ã¯DNSçºçåã®WAIS-III: VIQ53 PIQ52 FIQ48 VC56 PO55 WM50æªæº PS52âDNSçºçç´å¾ï¼è©ä¾¡å°é£âDNSçºçå¾åå¹´ã®WAIS-IIIï¼VIQ 65 PIQ 69 FIQ 64 VC 73 PO 68 WM 58 PS 72ã¨æ¹åãéé¢ã¨ãªã£ããããããªãããé颿ã¾ã§ãé£äºã®éã«é¤æ²¹ã®è¢ããã¾ãéããããä½åãéãããã¨ãç¶ãããããé¨å±ã«éããããã¿ãªã«ã®ç³¸å±ãéãç¶ããããªã©ã¢ãã·ã¼ãå¸¸åæ§ã¯æ®åããã
ãèå¯ã
å
¸åçãªé
çºæ§è³çã®é·æçµéã追ããã¨ãã§ãããç¶ç¶çãªã¹ããã¤ãå çããã³ãªãããªãã¼ã·ã§ã³ã¯è±é«ã®æå¶ã«å¯ä¸ãï¼é«æ¶²ä¸ã®MBP ã«åæ ããï¼æèã¬ãã«ã®æ¹åã«ã¤ãªãã£ãã¨èãããããæ¬çä¾ã§ã¿ãããããã«ã¢ãã·ã¼ã¯é度ã§ãã¤é·å»¶ããå¯è½æ§ãé«ãã社ä¼å¾©å¸°ã®å¤§ããªéå£ã¨ãªããè¬ç©çæ³ã«å ããé·æçã«ãªãããªãã¼ã·ã§ã³ã«ããããã¨ãéè¦ã§ããã
(䏿æ ã2023.11.1.)
åæã«è¡åç°å¸¸ååé å´é åèªç¥çã¨èª¤è¨ºãããç¥çµæ¢
æ¯ï¼äººçã大ããå¤ããéå¥è¨ºæ
è¹å±±éé(è¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§é¨é·)Neurosyphilis Initially Misdiagnosed as Behavioral Variant Frontotemporal Dementia: Life-Changing Differential Diagnosis.
Funayama M, Kuramochi S, Kudo S.
J Alzheimers Dis Rep. 2023 Sep 26;7(1):1077-1083. doi: 10.3233/ADR-230107. eCollection 2023.
ãã¯ããã«ã
è¡åç°å¸¸ååé å´é åèªç¥çï¼bvFTDï¼ã¯å¤æ§ç¾æ£ã®ä¸ã§ã誤診ãããããç¾æ£ã§ãããåæã«ä»ã®ç²¾ç¥ç¾æ£ãç¥çµç¾æ£ã¨èª¤è¨ºããã¦ãããã¿ã¼ã³ã¯bvFTDã¨æçµè¨ºæã¨ãªã£ãä¾ã®ç´50ï¼
ã«è³ããéã«åæã«bvFTDã¨è¨ºæãããç´50%ã¯æçµçã«ä»ã®ç²¾ç¥ç¾æ£ãç¥çµç¾æ£ã®è¨ºæã«è³ããã¨ããããå¾è
ã®ä¸ã§ãæ²»çã§æ¹åãè¦è¾¼ã¾ããæ²»çå¯è½ãªèªç¥çï¼treatable dementiaï¼ã¨ã®éå¥ã誤ããªããã¨ã¯æ¥µãã¦éè¦ã§ãããä»åããããã¯ãåæã«bvFTDã¨è¨ºæããã¦ããããå¾ã«ç¥çµæ¢
æ¯ã§ãããã¨ã夿ããæ²»çã§ã»ã¼å®å
¨ã«æ¹åããä¾ãå ±åããã
ãçä¾ã
çä¾ã¯47æ³ã®ä¸äººæ®ããã®ç·æ§ã§ãããä»äºã§å¤§äºãªè·ç©ãè½ã¨ããªã©ã®å¤±æããå§ã¾ããå¾ã
ã«å¤å¹¸çã¨ãªããã®ã®æ°ã«é£ããªããã¨ã«å¯¾ãã¦ã¯ææçã«ãªããªã©æ§æ ¼å¤åãèªãããææ¬²ãä½ä¸ããèªå®
ã§å°¿ã便ã«ã¾ã¿ãããªã©ã®è¡ç観念ã®ä½ä¸ãèªãããçºçãã6ã«æå¾ã«ç²¾æ»ã®ããã«Aãç
é¢ã«å
¥é¢ããããå»å¸«ã«ãã¿ã¤ããã¨ãããã仿£ã®é£äºãçã¿é£ãããããããªã©ã®è±æå¶ãç®ç«ã£ããã¾ãã常ã«å¨å²ã®æ£è
ã®è¡åã«æ°ãåããããªã©ç°å¢ä¾åçãªè¡åãç®ç«ã£ããMRIã§ã¯ä¸¡å´åé èã«è縮ãèªãã99mTc-ECT SPECTã«ããã¦ã両å´åé èã¨å´é èã®åæ¹é¨ã«ç¸å¯¾çè¡æµéã®ä½ä¸ãèªãããç¥çµå¿çæè¦ã«ããã¦ãWAISã§æ¸¬å®ããç¥è½ã¯æ£å¸¸ç¯å²å
ã§ãã£ãããWisconsin Card Sorting Testã®æç¸¾ã®ä½ä¸ãèªãããClinical Dementia Ratingã¯2ã§ãã£ããbvFTDã¨ãã¦çºçãã7ã«æå¾ã«å½é¢ã«è»¢é¢ã¨ãªã£ãããè¡æ¸
ã¨é«æ¶²ã«ããã¦æ¢
æ¯ã«é¢ããSTSã TPHAãFTA-Absã®å
¨ã¦ãé«å¤ã§ãããã髿¶²ã®ç´°èæ°ã3.3/mm3, ã¿ã³ãã¯47mg/dl, IgG 164mg/Lã¨æ£å¸¸ä¸éããé«å¤ã示ãããæãããªç®èçç¶ãç¥çµæè¦ã¯èªãããHIVãé°æ§ã§ãã£ãã2400ä¸åä½ã®ããã·ãªã³ã10æ¥éããã®å¾ã¢ã¢ãã·ã·ãªã³1000mgã6ã«æéæä¸ãããæ²»çéå§ãã1ã«æå¾ã«ã¯èªå®
ã§ã®èªç«ããçæ´»ãå¯è½ã¨ãªããæ²»çéå§ãã6ã«æå¾ã«ã¯å
ã®å°±å´ã«æ»ã£ãããã®å¾10å¹´éãåçºã¯èªããªãã£ãã
ãèå¯ã
ç¥çµæ¢
æ¯ãbvFTDã¨èª¤è¨ºããã¨ããè¨åºã§ã¯å½ãåã®ãããªçä¾ã§ããããç»åæè¦ãæ¤æ»ãçåããã¹ã¦ä¸å¯§ã«è¨è¿°ããå ±åä¾ã¯ãæå¤ãªãã¨ã«ä»ã¾ã§ã«åå¨ããªãã£ããé¡ä¼¼çä¾ã¯2ä¾ã»ã©åå¨ããããããããè¡æ¶²ã§ã¯æ¢
æ¯æ¤æ»ã齿§ã§ãã£ããã髿¶²ã§ã¯æ¢
æ¯æ¤æ»ã¯é°æ§ã§ãã£ãçä¾ã§ãããæ¬çä¾ã¯æ¨ªæçãªçç¶ã¨ç»åæè¦ããã¯bvFTDãçããããã縦æçã«ã¿ãã¨å¤æ§ç¾æ£ã¨ãã¦ã¯æ©ãããé²è¡ã§ããã40代ã¨ããè¥ãããå¹´é½¢ã¨ã¨ãã«ãå
¸åçãªçµéã¨ã¯ç°ãªã£ããç¥çµæ¢
æ¯ãã¯ããã¨ããtreatable dementiaã¯ãæ£è
ã®å¾ã®äººçãæ±ºå®çã«å¤ãã¦ãã¾ããããæ±ºãã¦è¦éãã¦ã¯ãªããªãç¾æ£ã§ãããå
¸åçãªå¤æ§ç¾æ£ã¨ã®çåã®éããèªããããå ´åã¯ãé©åã«éå¥ãããã¨ãå¿
è¦ã§ããã
(è¹å±±ééã2023.10.23)
æ¥éé²è¡æ§èªç¥çãããããçæ§é«èçã®ä¸ä¾
䏿æ (æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨å¤§å¦é¢å士課ç¨)Crucial differential diagnosis of rapidly progressive dementia: A case of leptomeningeal metastasis.
Mimura Y, Oi H, Takata T, Mimura M, Funayama M.
Psychiatry Clin Neurosci Rep. 2023;2:e137.ããhttps://doi.org/10.1002/pcn5.137
ãèæ¯ã
ç¥çµçç¶ãä¼´ããªãæ¥éé²è¡æ§èªç¥ç(Rapidly progressive dementia: RPD)ã¯ãã°ãã°ç²¾ç¥ç¾æ£ã¨èª¤è¨ºããããã¨ããããçæ§é«èç(Leptomeningeal metastasis: LM)ã¯é«ãæåº¦ã¨ç¹ç°åº¦ãæããæ¤æ»ã«ä¹ããã診æãã®ãã®ãå°é£ãªãã¨ã§ç¥ããã¦ãããä»åæã
ã¯ç²¾ç¥çç¶ã主ä½ã¨ããRPDãåããLMã®è¨ºæã«è³ã£ãä¸ä¾ãçµé¨ããã®ã§å ±åããã
ãçä¾ã
çä¾ã¯70代ã®ç·æ§ãX-1å¹´ãèçã¨è¨ºæããåå¦çæ³ä¸ã§ãã£ããXå¹´ã2é±éã®çµéã§æææ§ã失è¦å½ãè±è¡£ãªã©ã®é¸è±è¡çºãèªãããçç¶ã¯æªåããååãè¨ãããæ··ä¹±ãã空ä¸ã«ä½ããããããªä»èãç¹°ãè¿ãçºå¿é
ããå®¶æã«é£ãããå½é¢å¤ç§ãå診ãããã忥ã®é é¨MRIã§ã¯ç¹è¨ãã¹ãç°å¸¸æè¦èªãããç²¾ç¥é¢ã®é¢ä¸ã«ã¤ãã¦å½ç§ã¸ç´¹ä»ã¨ãªããç²¾æ»ç®çã«å»çä¿è·å
¥é¢ã¨ããã
ãå
¥é¢å¾çµéã
å
¥é¢æãJCSI-3ã¨æèé害ãèªããä½ããã¤ãããã¨æã伸ã°ãæ§åãç®ç«ã£ãããã以å¤ã«ãæãããªç¥çµå¦çå·£çç¶ãèªããªãã£ãã忥è
°æ¤ç©¿åºæ½è¡ããã¨ãããç´°èæ°/èç½ã®ä¸æãèªããããã¹ããã¤ããã¢ã·ã¯ããã«ãæçå¤ã«ã¦å çéå§ããã第4ç
æ¥ã«ã¯èæãªæ¹åãã¿ããçºèªãè¦ãããããã«ãªãæ©è¡ãæé£ãèªåã§å¯è½ã§ãã£ããHDS-R/MMSEã¯å
¥é¢æè©ä¾¡ä¸è½ã§ãã£ãããããã4ç¹/9ç¹ã¨è»½åº¦æ¹åããã忥ã髿¶²ç´°è診ããClass Vã®å ±åãåããçæ§é«èçã®è¨ºæã¨ãããå®¶æã¨ç¸è«ã®ä¸ãæããå¤é«æ³¨çæ³ã¯è¦éããã¨ã¨ããã第5ç
æ¥ãã广ãèªããã¹ããã¤ãããã¼ããã«ã¹ã§ç¶ç¶ã¨ããã第12ç
æ¥ã«é é¨MRIã忤ããã¨ããé«èè¥åãèªãçæ§é«èçã¨ãã¦çç¾ããªãæè¦ã§ãã£ãããã®å¾å¾ã
ã«å
¨èº«ç¶æ
æªåããçµå£æé£ã¯å°é£ã¨ãªã£ããBest supportive careã«ããã£ããã第73ç
æ¥ã«æ°¸ç ãããã
ãèå¯ã
ç²¾ç¥çç¶ãç®ç«ã£ãLMã®ä¸ä¾ãå ±åãããããã¾ã§ãç²¾ç¥çç¶ãããããLMã®å ±åã¯æ£è¦ãããããè³ç¥çµæè¦ã®ç°å¸¸ã麻çºãåæã«èªãã¦ãããæ¬çä¾ã¯ç²¾ç¥çç¶ã主ä½ã¨ãã¦ããç¹ã§ç°ãªã£ã¦ããã
LMã®è¨ºæã´ã¼ã«ãã³ã¹ã¿ã³ãã¼ãã¯é å½±MRIã ããæ¬çä¾ã¯1åç®ã®MRIæ¤æ»ã§é°æ§ã§ãããå¹»è¦ãç®ç«ã£ãããç²¾ç¥ç¾æ£ãçããããç¹ã«ã¢ã«ã³ã¼ã«é¢è±ãèå¹´æç²¾ç¥ç
ãããå¦ãéå¥ç¾æ£ã¨ãã¦ããã£ã¦ãããMRIæ¤æ»ã¯æåº¦ãä½ãã¨ããåé¡ããããLMãçã£ãå ´åã¯ç©æ¥µçã«é«æ¶²æ¤æ»ãè¡ãå¿
è¦ããããã¾ãMRIæ¤æ»ã髿¶²æ¤æ»ãååã®æ¤æ»ã§ã¯è¦è½ã¨ãå¯è½æ§ãææããã¦ãããã©ã¡ãã®æ¤æ»ãçµã¿åããã¦ãçãããå ´åã¯è¤æ°åã®æ½è¡ãæ¤è¨ããã¹ãã§ããã
æ¬çä¾ã¯RPDãåãã¦ãããå¹»è¦ã®æ§è³ªã«ã¤ãã¦æ¬äººã®è¨´ãã¯è´åã§ããªãã£ãããç²¾ç¥ç¾æ£ã«ä¼´ãå¹»è¦ã¯è¤éå¹»è¦ã§ãã¤æ¬äººã«ã¨ã£ã¦ãã¬ãã£ããªãã®ãå¤ãããããã£ãæ§è³ªã確èªã§ããªãéãå¹»è¦ãç²¾ç¥ç¾æ£ç±æ¥ã¨å¤æãããã¨ã«ã¯å±éºæ§ãä¼´ãã
LMã¯ãã¾ã ã«æ²»çæ³ã確ç«ãã¦ããªããããã®äºå¾ãæ¨å®ãããã¨ã¯å®¶æãæ¬äººã«ã¨ã£ã¦æç¾©æ·±ããçãèæ¯ã¨ããæ£è
ãRPDãåããã¨ãã«å®æã«ããå¦ã¨å¤æãããæ£ç¢ºãªè¨ºæããããã¨ã¯æ¥µãã¦éè¦ã§ããã
(䏿æ ã2023.10.1.)
ã·ã£ãã¼ã¤ã³ã°è¡åã¯å¤çãèªèã§ããªããã¨ã¨é¢é£ãã¦ãããããããªãï¼ posterior cortical atrophy (PCA)æ£è
ã«ãããã·ã£ãã¼ã¤ã³ã°ã®çä¾å ±å
å·¥è¤ é§¿(æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ã»ç¥çµç§å¦æå®¤ã大å¦é¢å士課ç¨)Shadowing Behavior may be Associated with an Inability to Recognize the External World: A Case Report of Shadowing in a Patient with Posterior Cortical Atrophy
Shun Kudo, Michitaka Funayama, Shin Kurose, Yusuke Shimizu, Taketo Takata, Masaru Mimura
J Alzheimers Dis. 2023. doi: 10.3233/JAD-230257.
ãèæ¯ã
èªç¥çãªã©ã®å¤æ§ç¾æ£ã«ããã¦ãä»è·è
ãå»å¸«ãªã©ãå¾è¿½ãããä¾ã¯ç¨ã«çµé¨ããããããã®èæ¯ãæ©åºã¯ä»ã¾ã§ã®ã¨ããæããã§ã¯ãªããä»åããããã¯ã誰ãã®å¾ããã²ãããã«ã¤ãã¦æ©ããã·ã£ãã¼ã¤ã³ã°ããé¡èã§ãã£ãposterior cortical atrophyã®1ä¾ãå ±åãããã®èæ¯ãæ©åºãæ¤è¨ããã
ãçä¾ã
çºçæå¹´é½¢59æ³ã
59æ³ã®å¤é ããé »ç¹ã«éã«è¿·ããèªåè»äºæ
ãèµ·ããããã«ãªã£ãããã¨ãã½ã¼ãè¨æ¶éå®³ã¯æããã§ã¯ãªãã£ãã61æ³æã«ã¯40å¹´å¤ãã¦ããä¼ç¤¾ã®ãã¬ã¹æ©ãä¸æãæ±ããªããªãè¿å»ãå診ãããé é¨MRIã»SPECTã§ã¯å³é é -å¾é èãä¸å¿ã¨ããè縮/ç¸å¯¾çè¡æµéä½ä¸ãèªããããã63æ³æã«ã¯é»å製åã使ããªããªãã64æ³æã«ã¯èªåã®ååãæ¸ãã¦ãæåãæãè½ã¡ããéä¸ã§åãããã¨ããã£ããä¸å®ãå¼·ãä»è·è
ã§ãã妻ã®å¾ããé¢ãããã¨ããªããã¨ããã£ãã66æ³æã«ã¯ãå®¶æã®é¡ãè¦ã¦ã誰ã ãå¤å¥ãããã¨ãã§ããªããªã£ããã¾ããé²è¡æ§ã®æµæ¢æ§å¤±èªãç®ç«ã¡ãæ¥å¸¸ç©åã使ããªããªã£ã¦ãã£ãã妻ãä½èª¿ãå´©ãèªå®
ã§ã®çæ´»ãå°é£ã¨ãªãä½å®
åè人ãã¼ã ã«å
¥æããããç¹å®ã®è·å¡ãå
¥æè
ã®å¾ãã常ã«ä»ãã¦æ©ããã·ã£ãã¼ã¤ã³ã°ããç®ç«ã¡ãå
¥æè
éã§æãããã¨ãå¤ã
çãããæ½è¨å´ã対å¿ã«é£æ¸ã67æ³æã«ç²¾ç¥ç§ç
é¢ã¸å
¥é¢ã¨ãªã£ãã
å
¥é¢å¾ã®è¨ºå¯ã§ã¯ããã¼ãã³ã½ã³çç¶ãå«ãç¥çµå¦çã«ã¯æãããªç°å¸¸ãèªããªãã£ãããæ¤
åã«ã¯èªåã®ä½ãåããã¦åº§ãããç©åãæ´ãã®ã«æéãããããç
æ£å
ã§è¦æ¸¡ããçãç¯å²ã§ãèªå®¤ã®ä½ç½®ãææ¡ã§ããªããªã©é¡èãªè¦ç©ºéé害ãèªãããããç
æ£å
ã§ãå診ã«ç¡è¨ã§ä»ãã¦ãããã¨ãé »ç¹ã«è¦ããã䏿¹ãåå§åå°ãç°å¢ä¾åçãªè¡åã¯è¦ãããªãã£ããMMSEã¯3/30(峿æ³èµ·ã®ã¿å¯)ã§ãã£ãã
ãèå¯ãæ¬çä¾ã«ããããå¾è¿½ããã«ã¤ãã¦ã¯ãé¡èãªè¦ç©ºéé害ã失è¡ã失èªã®ããå¤çã®ç¶æ³çè§£ãå°é£ã§ãããã¨ãèæ¯ã«ããã誰ãã®å¾ããæ©ããã¨ã§èªèº«ãå®ããã¨ãã代åçãªæ©åºãèããããããã®æ£è ã®é害ã®éç度ï¼MMSE 3/30ï¼ãèããã¨ããã®1çä¾ããæ±ºå®çãªçµè«ãå°ãåºããã¨ã¯å°é£ã§ããããå¨å²ã®ç°å¢ãèªèãããã¨ã®æ·±å»ãªå°é£ã¯ãã·ã£ãã¼ã¤ã³ã°è¡åã®çºç¾ã«å¯ä¸ãã¦ããå¯è½æ§ãããã
(å·¥è¤é§¿ã2023.9.18.)
çä¾! 失èªçã®ãªãããªãã¼ã·ã§ã³
ä¸å·è¯å°ãä½éæ´åãè¹å±±ééèããããæ°èå»å¦åºç社ãã2023
è¹å±±éé (è¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§é¨é·)
æ¬æ¸ã®ç¹å¾´ã¯ãè¨åºç¾å ´ã§å¤±èªçè ã®ãªãããªãã¼ã·ã§ã³ãè¡ãè¨èªè´è¦å£«ã®ã¿ãªããã失èªã«ããããå»å¸«ã«ã¨ã£ã¦ãã失èªçã¨ãã®ãªãããªãã¼ã·ã§ã³ãçè§£ããä¸ã§æ¥µãã¦åªããå 容ãè¨è¼ããã¦ãããã¨ã§ãããæ±æ¸å·ç é¢ãªãããªãã¼ã·ã§ã³ç§ã®è¨èªå®¤ã¯ãããå½ã«ããã失èªçã®ãªãããªãã¼ã·ã§ã³ã«ããã¦æãæ£çµ±ãªæµããæã¡ãã¾ãããªãããªãã¼ã·ã§ã³ã®è³ªã®é«ãã®ã¿ãªãããªãããªãã¼ã·ã§ã³ãæ½ãã¦ãã失èªçè ã®æ°ã«ããã¦ããããå½ã§ã¯æé«æ°´æºã§ããããã®æ±æ¸å·ç é¢ã§é·å¹´å¹ããã¦ããè²´éãªç¥è¦ããã¨ã«ã失èªçã®ãªãããªãã¼ã·ã§ã³ã®ç¾å ´ã§ãã®ã¾ã¾å½¹ç«ã¤å®è·µçãªå 容ãè¨è¼ããã¦ãããããã«è¦éãã¦ãªããªããã¨ã¯ã失èªçè ã¨ãã®å®¶æãå¿ççã«ãããã«ã¯ç¤¾ä¼çã«æ¯ããå§¿å¢ãæ¬æ¸ã«çµã¿è¾¼ã¾ãã¦ãããã¨ã§ãããããå½ã§å¤±èªçã«ããããå»çå¾äºè ã«ã¯ããã²æ¬æ¸ãã失èªçã¨ãã®ãªãããªãã¼ã·ã§ã³ãå¦ãã§ããã ãããã
(è¹å±±ééã2023.8.1.)
解説ããå®è·µ!ãããã¦ãçä¾!ã
æ¬æ¸ã®ãåºæã«ä»£ãã¦ãã®åé ã«ã¯æ¬¡ã®ããã«è¨ããã¦ãã:
çè ãã2022å¹´3æã«åè¡ãããå§å¦¹æ¸ãå®è·µ!ã失èªçã®ãªãããªãã¼ã·ã§ã³ãã¨æ¬æ¸ã¯ãéå»ç´40å¹´ã«ãããæ±æ¸å·ç é¢ã§è¡ã£ã¦ãã失èªçè¨èªè¨ç·´ã®è¨åºã§å¦ãã ç¥è¦ãæ¸ãã¨ãããã®ã§ãããæ¬¡ä¸ä»£ã®å¤±èªçã®è¨èªè¨ç·´çºå±ã«ãä½ããããå½¹ã«ç«ã¤ãã¨ãé¡ã£ããã®ã§ãã
ãã®ä¸æã¨ä¸è¨è¹å±±ééé¨é·ã®ç´¹ä»æãããããã°ãæ¬æ¸ã®è§£èª¬ã¨ãã¦ã¯å®ç§ã§ããããä¸ã¤ã ãã©ããã¦ã追è¨ããªããã°ãªããªãã®ã¯ããçä¾!ãã¨ããã¿ã¤ãã«ã®éããæ¬æ¸ã«ã¯å®éã®è±å¯ãªè¨ç·´æ åã®DVDãä»ãããã¦ããã¨ãã大ããªç¹é·ã§ããã失èªçã¨ããæ§è³ªä¸ããã®çç¶ãè¨ç·´ããæåæ å ±ã ãããå¾ããããã®ã«ã¯ç¸å½ãªéçãããããDVDãè¦è´ãããã¨ã§æ ¼æ®µã«çè§£ãæ·±ã¾ããã¨ã¯è¨ãã¾ã§ããªãããããã£ã¦ãã®ãããªè¦è´è¦è³æãä»ããã¦ãããã¨ã¯å¤±èªçã®æ¸ç±ã«ããã¦ã¯å¿ é æ¡ä»¶ã¨ãè¨ããããç¾å®ã«ã¯å人æ å ±çã®ãã¼ãã«ãããããå¿ é æ¡ä»¶ã ããéæå°é£ãªçæ³ãã§ãã£ãã¨ãããæ¬æ¸ã«ããã¦ã¯ãæ¬æ¸ã«åçä¾ã®è©³ç´°ãªå人æ å ±ãããã¦è¨èªè¨ç·´ã®è©³ç´°ãªçµéãæ¸ããã¨ãDVDã«ããè¨ç·´æ åã®æä¾ã«ãããã対象ã¨ãªã失èªçè ã¨ãå®¶æã®ãã¹ã¦ã®æ¹ããåãã§å諾ãã¦ããã ããã¨ãã§ãã¾ãããã¨ãããã¨ããåºæã«ããã¦ãã«è¨ããã¦ããã失èªçè ã®ããã®ãèè ãã®40å¹´ã«ããã並ã ãªãã¬åªåããå½äºè ã®æ¹ã ããã®æ·±ãä¿¡é ¼ãå¾ããã¨ã§ãæ¬æ¸ã®çºåãå®ç¾ãããã¨ãããããããèªã¿åããã¨ãã§ããã
1968å¹´ã失èªçãä¸å¿ã¨ãã髿¬¡è³æ©è½ããã¼ãã«ä¼è±é®å±±æ¸©æ³ç é¢ã§éå¬ãããç ç©¶ä¼ãé®å±±ã«ã³ãã¡ã¬ã³ã¹ããæ¯ä½ã¨ãã¦çºè¶³ãããæ¥æ¬å¤±èªçç ç©¶ä¼ãã¯ã1983å¹´ã«ãæ¥æ¬å¤±èªçå¦ä¼ãã¨åç§°ã夿´ããæ´»çºãªæ´»åãç¶ãããã2003å¹´ã«ã¯ãã®åç§°ããæ¥æ¬é«æ¬¡è³æ©è½é害å¦ä¼ (æ§ å¤±èªçå¦ä¼)ãã«å¤æ´ãããããã«2013å¹´ã«ã¯ãæ¥æ¬é«æ¬¡è³æ©è½é害å¦ä¼ãã¨ãªã£ã¦ã失èªçããå¦ä¼åããæ¶å¤±ããã(è¿ãå°æ¥ã«ã¯ãé害ããåé¤ããã髿¬¡è³æ©è½å¦ä¼ãã¸ã®å¤æ´ãäºå®ããã¦ãã)ã髿¬¡è³æ©è½ã«é¢ããè¨åºã»ç ç©¶ã®ç¯å²ã®çºå±ã¯å¤§å¤åã°ãããã¨ã§ã社ä¼ã«å¯¾ããè²¢ç®ã大ããæ¡å¤§ãã¦ãããã失èªçã®å°éå®¶ã®ç¸å¯¾çãªæ¸å°ãæãããã¦ããã¨ããç¾å®ãããã失èªçã¯ãè¨åºã«ããã¦ã¯å¯¾è±¡è ãè¨å¤§ã«åå¨ããç ç©¶ã«ããã¦ã¯ã人éã®æèãè¨èªãé¢ãã¦è«ãããã¨ãä¸å¯è½ã§ãã以ä¸ãè³æ©è½ã®ã¿ãªãã人éãã®ãã®ã®çè§£ã«åããæ·±ãåºããã¼ããå å¨ãã¦ããããç§ãã¡ãçæ¶¯ãããã¦ã失èªçã®æ¹ã®ããã«é å¼µã£ã¦ã¾ããããã¨æãã¾ãã(æ¬æ¸ãåºæã«ããã¦ãã®çµã³)ã¨ããæ±ºæããçã¾ããæ¬æ¸ãã失èªçã®è¨åºã«ãç ç©¶ã«ãã大ããè²¢ç®ãããã¨ã¯çããªãã
(ææ¾å¤ªéã2023.8.29.)
èªç¥çã«ä¼´ãæ¥å¸¸çæ´»ä¸ã®å°é£ããèºçã®å±éºæ§ãå¢å ãããï¼å£è
å
ä¸è¡çã¨å¥ä¸é害ããã®è¦å
è¹å±±éé(è¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§é¨é·)PneumoniaãRiskãIncreasedãbyãDementia-RelatedãDailyãLivingãDifficulties:ãPoorãOralãHygieneãandãDysphagiaãasãContributingãFactors.
Am J Geriatric Psychiatry 2023. doi: 10.1016/j.jagp.2023.05.007.
Michitaka Funayama, Akihiro Koreki, Taketo Takata, Tetsuya Hisamatsu, Jin Mizushima, Satoyuki Ogino, Shin Kurose, Hiroki Oi, Yu Mimura, Yusuke Shimizu, Shun Kudo, Akira Nishi, Hiroo Mukai, Riko Wakisaka, Masaaki Nakano
ãèæ¯ã èºçã¯èªç¥çæ£è ã®ä¸»è¦ãªæ»å ã§ãããããã®å ·ä½çãªèæ¯ã¯ååã«ã¯æããã«ãªã£ã¦ããªããæå¤ã«ããä»ã¾ã§ã«èªç¥çã«çããèºçã®å±éºå åã«ã¤ãã¦ã®ç·æ¬çãªç ç©¶ã¯è¡ããã¦ããããé«é½¢è ã«çããèºçããã®ç¥è¦ãèªç¥çã®è¨åºã§å¿ç¨ãã¦ããã ãã§ãã£ãããããã£ã¦ãèªç¥çã«é¢é£ããè¦å ãã©ã®ããã«èºçã«å½±é¿ãããã«ã¤ãã¦ã¯æããã«ãªã£ã¦ããªãã£ããç¹ã«ãå£è å è¡çãç§»åè½åã®ä½ä¸ãªã©ã®èªç¥çã«é¢é£ããæ¥å¸¸çæ´»ä¸ã®å°é£ããããã«ã¯èªç¥çã®æ²»çã®éã«ç¨ããèº«ä½ææã¨èºçã®é¢é£æ§ã«ã¤ãã¦ã¯ãã»ã¨ãã©ã«ç ç©¶ããã¦ããªãã
ãæ¹æ³ã2011å¹´ãã2022å¹´ã®12å¹´éã«èªç¥çã®è¡åã»å¿ççç¶ã«ããè¶³å©èµ¤ååç é¢ç¥çµç²¾ç¥ç§ç æ£ã«å ¥é¢ãã454ä¾ã®èªç¥çã®å ¥é¢ä¾ï¼è¤æ°åå ¥é¢ãå«ãããã336人ã®èªç¥çãæã¤æ£è ï¼ã対象ã¨ãããå ¥é¢æ£è ããå ¥é¢ä¸ã«èºçãçºçãã群ï¼n=62ï¼ã¨çºçããªãã£ã群ï¼n=392ï¼ã®2群ã«åãããæåã«ãèºçã®çºçã¨é¢é£ããå¯è½æ§ã®ããåè¨24é ç®ãããªãã¡ãèªç¥çã®ç å ï¼ã¢ã«ããã¤ãã¼ç ãªã©ï¼ãèªç¥çã®éç度ï¼Clinical Dementia Ratingï¼ã身ä½ç¶æ³ï¼å¥ä¸é害ãæèé害ã使 é¤ãè±æ°´ãªã©ï¼ã身ä½åä½µçï¼ç³å°¿ç ãCOPDãªã©ï¼ãè¬ç©çæ³ï¼æç²¾ç¥ç è¬ãªã©ï¼ãèªç¥çã«é¢é£ããæ¥å¸¸çæ´»ä¸ã®å°é£ï¼å£è å ä¸è¡çã¨ç§»åè½åã®ä½ä¸ï¼ãèº«ä½ææã®æ½è¡ã«ã¤ãã¦ã2群éã®éãã調ã¹ããæ¬¡ã«ãæ½å¨çãªäº¤çµ¡å åã¨ç¹°ãè¿ãã®å ¥é¢ãã³ã³ããã¼ã«ãããããmixed effects logistic regression analysisãç¨ãã¦ãèºçã®å±éºå åãæããã«ããã
ãçµæãèªç¥çæ£è ã«ãããèºçã®çºçã¯ãå£è å ä¸è¡çãçé ã¨ãã¦ãå¥ä¸é害ãæèé害ã¨é¢é£ãã¦ãããã¨ãæããã¨ãªã£ãï¼p<0.01ï¼ãèº«ä½ææã¨ç§»åè½åã®ä½ä¸ã¯ãèºçã®çºçã¨é¢é£ããå¾åã示ããï¼p<0.10ï¼ã
ãèå¯ã èªç¥çã®èºçã®çºçã«å½±é¿ããå åã¨ãã¦ãå£è
å
ã®ä¸è¡çã«ããå£è
å
ã®ç
åæ§å¾®çç©ã®å¢å ã¨ãå¥ä¸é害ãæèé害ã«ããæ°éã¸ã®å¥ä¸ç©ã®é¤å»ã®å°é£ãã®2ã¤ã®è¦å ãèãããããèº«ä½ææããã³ç§»åè½åã®ä½ä¸ã¨èºçã¨ã®é¢ä¿ãæããã«ããããã«ã¯ããããªãç ç©¶ãå¿
è¦ã§ããããããèªç¥çã¨é¢é£ããè¦å ããä¸è¬çã«å¤ãå ±åããã¦ãã身ä½åä½µçãèªç¥çã®éç度ã¨èºçã®çºçã®é¢é£ããã坿¥ãªé¢é£ããããã¨ã¯ã注ç®ã«å¤ããã¨æããããããªãã¡ãããããã®çµæã¯ãä»å
¥ã«ãã£ã¦èªç¥çã«ä¼´ãèºçã®çºçãããç¨åº¦æå¶ã§ããå¯è½æ§ã示åããã
å£è
å
ã®ä¸è¡çã«å¯¾ãã¦ã¯ãå£è
ã±ã¢ã®æå°ãæ´å©ãèªç¥çã«ä¼´ãèºçã«å¯¾ããäºé²ã«ããã¦æå¹ã§ããå¯è½æ§ããããããã«ã¯ãå¥ä¸ãæ©è¡ã«é¢ãããªãããªãã¼ã·ã§ã³ãèº«ä½ææãæ¸å°ããããã¨ãèªç¥çã®èºçãäºé²ããå¯è½æ§ãããã
(è¹å±±ééã2023.7.1.)
ãã¤ç
ã®æªæ¥æ§æèã«å¯¾ããèªç¥è¡åçæ³ã®è³æ©è½ã¢ããã¼ãã«ããæ²»çæ©åºã®è§£æï¼ã©ã³ãã 忝è¼è©¦é¨ (IMAGING study)
çå±±å¥çå (æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§ 婿)1)ãKatayama N, Nakagawa A, Umeda S, Terasawa Y, Kurata C, Tabuchi H, Kikuchi T, Mimura M. Frontopolar cortex activation associated with pessimistic future-thinking in adults with major depressive disorder. Neuroimage Clin. 23: 101877. 2019.
2)ãKatayama N, Nakagawa A, Abe T, Kurata C, Sasaki Y, Mitsuda D, Nakao S, Mizuno S, Ozawa M, Nakagawa Y, Ishikawa N, Umeda S, Terasawa Y, Tabuchi H, Kikuchi T, Mimura M. Neural and clinical changes of cognitive behavioural therapy versus talking control in patients with major depression: a study protocol for a randomised clinical trial. BMJ Open. 10(2): e029735. 2020.
3)ãKatayama N, Nakagawa A, Umeda S, Terasawa Y, Abe T, Kurata C, Sasaki Y, Mitsuda D, Kikuchi T, Tabuchi H, Mimura M. Cognitive behavioral therapy effects on frontopolar cortex function during future thinking in major depressive disorder: A randomized clinical trial. J Affect Disord. 1;298(Pt A):644-655. 2022.
4)ãAmano M, Katayama N, Umeda S, Terasawa Y, Kikuchi T, Tabuchi H, Abe T, Mimura M, Nakagawa A. The Effect of Cognitive Behavioral Therapy on Future Thinking in Patients with Major Depressive Disorder: A Randomized Controlled Trial. Front. Psychiatry. doi: 10.3389/fpsyt.2023.997154.
5)ãKatayama N, Nakagawa A, Umeda S, Terasawa Y, Shinagawa K, Kikuchi T, Tabuchi H, Abe T, Mimura M. Functional connectivity changes between frontopolar cortex and nucleus accumbens following cognitive behavioral therapy in major depression: A randomized clinical trial. Psychiatry Res Neuroimaging. 2023 Apr 11;332:111643. doi: 10.1016/j.pscychresns.2023.111643.
ãã¤ç
ã¯æªæ¥ã«å¯¾ããèªç¥ãå¦å®çã¨ãªããã¨ã¯Aron T. Beckã®ãã¤ç
ã«ãããå¦å®çãªèªç¥ã®ï¼å¾´ã¨ãã¦ãç¥ããã¦ããããã®æªæ¥æ§æèã«é¢é£ããBA10ã®æ´»åãå¥å¸¸è
ããããã¤ç
ã§ã¯éæ´»åã«ãªã£ã¦ãããã¨ã2019å¹´ã«å ±åãæ¬ç¥çµå¿çå¦ç ç©¶ã®HPã«ãæ²è¼ãã¦ããã ããï¼ï¼ï¼ã
ãã®å¾ããã¤ç
群ã¯é±ï¼åç´45åéã®èªç¥è¡åçæ³ã16åè¡ãèªç¥è¡åçæ³ç¾¤(CBT群)ã¨èªç¥ã®å¤å®¹ãä¿ããªãããããã«ã¦ã³ã»ãªã³ã°ãè¡ãtalking control群ï¼TC群ï¼ã«ã©ã³ãã åããæ¯è¼è©¦é¨ãè¡ã£ãï¼ãããã³ã«è«æ:(ï¼)ï¼ããã®çµæãæªæ¥ãæ³åãã¦ããæã®BA10ã®æ´»åãCBT群ã§ã¯ä½ä¸ï¼æ£å¸¸åï¼ããTC群ã§ã¯å¤åããªãã£ãï¼ï¼ï¼ãå°æ¥ã«ã¤ãã¦æ³åãã¦åçããã¾ã§ã®æéãæ¸¬ã£ãåå¿æéãCBT群ã§ã¯ç縮ããããTC群ã§ã¯å¤åããªãã£ãï¼ï¼ï¼ãå®éæã®è³æ©è½çµåã¯BA10ã¨å´åæ ¸ã¨çµåæ§ã®å¤åã両群ã§å·®ãèªãããã®å¤åã¯æ²»ççµçµ1å¹´å¾ã®è¨åºçç¶ã¨ç¸é¢ããã£ãï¼ï¼ï¼ã
2019å¹´ã«æ¨ªæç ç©¶ãçºè¡¨ããæã¯ãã¤ç ã¯å°æ¥ãæ³åããã¨ãã«åªåãå¿ è¦ãªã®ã ãªã¨ãããããã«ããèãã¦ããªãã£ããæªæ¥ã«å¯¾ããèªç¥ã®å¤å®¹ãä¿ãCBTã¨èªç¥ã®å¤å®¹ãä¿ããªãTCã§ã¯ãæªæ¥æ§æèä¸ã®è³æ´»åå¤åã«å·®ã¯ããã®ãã«èå³ãæã¡RCTãè¡ã£ãããã®çµæãCBT群ã§ã¯æªæ¥æ§æèãè¡ããã¨ã«å°é£ããæ¸ããã¨ãè³æ©è½ç»åãããè¡åææ¨ãããæããã«ãªãããã®å¤åã¯æ²»ççµçµå¾ã®è¨åºçç¶ã¨ãç¸é¢ãã¦ãããã¨ãããCBTã®æã¤é·æçãªå¹æã«ãé¢é£æ§ãããã®ã§ã¯ãªããã¨èãã¦ãããèªç¥è¡åçæ³ã§ã¯ããã¤ç ã®æ£è ãããæ±ãã¦ããç¾å®çãªåé¡ãæ´çããçæçåã³é·æçãªç®æ¨ããã¦ããããå®ç¾ããããã«å¿ è¦ãªãã¨ãã¹ã¢ã¼ã«ã¹ãããã§èãã¦ããæ²»çæ³ã§ãããç§ãã¡ã2020å¹´4æã®ã³ããç¦åæã¯1ã¶æå¾ãåå¹´å¾ã1å¹´å¾ã®æªæ¥æ§æèãå ¨ãã§ããªããªã£ããããããã³ããã¦ã¤ã«ã¹ã®ææçµè·¯ãçç¶ãäºé²çãæ²»çæ¹æ³ãªã©ç¾å®ã®åé¡ãæ´çããããã¨ã«ãããå¾ã ã«èªåéã®ãã¸ãã£ããªæªæ¥ãæ³åãããã¨ãå¯è½ã¨ãªã£ããç§ã¯CBTã»ã©ãã¼ãåãã¦ãããã¤ç æ£è ããã«ã¯ã¾ãã«åããããªãã¨ãèµ·ãã¦ããã®ã§ã¯ãªããã¨èãã¦ãããèªåã®ãã¸ãã£ããªæªæ¥ãæ³åããè½åã¯äººéã«ã¨ã£ã¦é常ã«éè¦ãªèªç¥ã§ããããããéæ©è½çã§ãããã¤ç ã«å¹æãããèªç¥è¡åçæ³ã®ä¸ã¤ã®æ²»çæ©åºã®è§£æã«ãªã£ãã®ã§ããã°å¹¸ãã§ãããåå ãã¦ãã ãã£ã被é¨è ã®æ¹ã ãããã¦é·ãã«æ¸¡ããæå°ãã¦ãã ãã£ãå¤ãã®ç¥çµå¿çå¦ç 究室ã®å çæ¹ã«å¿ããæè¬ç³ãä¸ãã¾ãã
(çå±±å¥çåã2023.6.1.)
å¾é¨ç®è³ªè縮çããã³ç®è³ªåºåºæ ¸çåç¾¤ã®æ£è
ã«çããéå
·ã®æã¡æ¹ã«éå®ãã失è¡
大森æºè£ãè¹å±±ééã穴水幸åãä»äºç°ãã¡ãç°æ¸èOmori T, Funayama M, Anamizu S, Niida R, Tabuchi H. A selective hand posture apraxia in an individual with posterior cortical atrophy and probable corticobasal syndrome. Cogn Behav Neurol. 2023 Mar 27. doi: 10.1097/WNN.0000000000000339
èæ¯
è¿å¹´ã®å¤±è¡ç ç©¶ã§ã¯ãéå
·ã®æä½æ¹æ³ã¨æã¡æ¹ãåºå¥ãã¦è©ä¾¡ãããã¨ã主æµã«ãªã£ã¦ãã¦ãããããããéå
·ã®æã¡æ¹ã«éå®ããå ±åä¾ã¯ãè³è¡ç®¡é害ã§ï¼ä¾ãä½é
¸ç´ è³çã«ã¦ï¼ä¾ã§ãããä¸çã§ã極ãã¦ã¾ãã«ããå ±åããã¦ããªããã¨ããã§ã夿§ç¾æ£ã®ä¸ã§ãå¾é¨ç®è³ªè縮çãç®è³ªåºåºæ ¸çå群ã§ã¯ãããã失è¡ãé »ç¹ã«åºç¾ããç
æ
ã§ããããããã夿§ç¾æ£ã«ããã¦ã¯éå
·ã®æã¡æ¹ã«éå®ãã失è¡ä¾ã®å ±åä¾ã¯çç¡ã§ãããä»åããããã¯ãå¾é¨ç®è³ªè縮çããã³ç®è³ªåºåºæ ¸çåç¾¤ã®æ£è
ã«çããéå
·ã®æã¡æ¹ã«éå®ãã失è¡çãè©³ç´°ã«æ¤è¨ããã
ã¾ãããã®çç¶ã説æããçè«çèæ¯ã«ã¤ãã¦ãèå¯ããã
çä¾
çä¾ã¯66æ³æã«èªå®¶ç¨è»ã§é§è»ãããéã®å°é£ãã¨çè¡£ã®é害ãåããå¾ã
ã«éå
·ã®æã¡æ¹ãåãããªããªã£ã女æ§ã§ãããä»é¢ã§ã¯è¨ºæãã¤ããã68æ³ã«å½é¢ã«å診ã¨ãªã£ãããã®éã«ã¯é»è»ãä¹ãç¶ãã§ã²ã¨ãã§é½å¿ã¸åºããããªã©ãçè¡£ã¨éå
·ä½¿ç¨ä»¥å¤ã®IADLãADLã¯ä¿ããã¦ãããç¥çµå¦çæè¦ã§ã¯ãå·¦ä¸è¢ã«çå¼·åãç¡åãç®è³ªæ§æè¦é害ãèªãããç¥çµå¿çæè¦ã¨ãã¦ã¯èå´ååæå¤±èªãç®ç«ã£ã¦ãããé é¨MRIã§ã¯å³å´åªä½ã®ä¸¡å´é é èã®è縮ãã99mTc-ECD SPECTã§ãåé¨ä½ã®ç¸å¯¾çè¡æµéã®ä½ä¸ãèªãããã¾ããéå
·ã®æã¡æ¹ã«é¢é£ããã¨å ±åããã¦ããå·¦é é éæºã®åæ¹é¨ãç¸å¯¾çè¡æµéã®ä½ä¸ãèªããããããã³ãã©ã³ã¹ãã¼ã¿ã¼ã¤ã¡ã¼ã¸ã³ã°ã«ããã¦ãå³å´åªä½ã§ç·æ¡ä½ã§ã®éç©ä½ä¸ãèªããããããã®çµæãããå¾é¨ç®è³ªè縮çããã³ç®è³ªåºåºæ ¸çå群ã®è¨åºè¨ºæã«è³ã£ãã
éå
·ä½¿ç¨ã«ã¤ãã¦ã¯æã¡æ¹ã«éå®ããé害ãç®ç«ã£ããä¾ãã°ãèªçºçã«ã¯ãã¿ã使ãã¨ãæã§ã¯ãªãåã®æ¹ãæã¡ã試è¡é¯èª¤ãã¦ãæ£ããæã¡æ¹ã«ã¯è³ããªãã£ããããããã¯ãã¿ãæ£ããæãããå¾ã¯ãä½¿ç¨æ¹æ³ã¯æ£ããã£ããã¯ãã¿ã«éããããããæ¯ãã©ã·ãã¹ãã¼ã³ãªã©ã®éå
·ãåæ§ã«ãæ£è
ã®éå
·ã®æã¡æ¹ã¯å°é£ã§ãã䏿¹ã§ãæ£ããæã¡æ¹ãããå¾ã®ä½¿ç¨æ¹æ³ã¯å¸¸ã«æ£ç¢ºã§ãã£ããéå
·ã®æ©è½ã«é¢ããç¥èã¯ä¿ããã¦ãããæ£è
ã¯éå
·ã®æ©è½ãæ£ããå£è¿°ããããã«ã¯ã³ããã¨ã¹ãã¼ã³ããããã¨ãããããªã©ã10åã®éå
·ã2ã¤ãã¤çµã¿åããã«ãã課é¡ãå
¨ã¦æ£çãããããã«ãã³ã¤ã³ã10000åæãªã©ã®ç©åãã¤ãããã¨èªä½ã«ã¯åé¡ã¯ãªãããããã®ç©åã«å¯¾å¿ãã親æã¨äººå·®ãæã®éã®å¹
ãæ£ããã£ããããªãã¡ãæ¬çä¾ã¯ãããããã®éå
·ã«ç¹æãªæã¡æ¹ã«é¸æçãªé害ãåå¨ããã¨èããããã
ãã®é害ãããã«æããã«ããããã«ãæ¬çä¾ã«å ãã¦å¹´é½¢ã¨èªç¥çã®éç度ããããããã夿§ç¾æ£6ä¾ã対ç
§ç¾¤ã¨ããããããã¯ä»¥ä¸ã®ï¼ã¤ã®èª²é¡ãè¡ã£ãã5ã¤ã®éå
·ã«é¢ãã¦æã¡æ¹ï¼æã¤ä½ç½®ãæã¡æ¹ï¼ããã³æä½æ¹æ³ï¼ã¿ã¤ãã³ã°ãä¸è¢ã®ä½ç½®ãæ¯ãå¹
ï¼ãæ£ããè¡ã課é¡ãç®¸ã®æã被æ¤è
ã®å³å´ããã³å·¦å´ã«ç½®ãã¦æ£ããæã¡æ¹ãã¿ã課é¡ãæä½æ¹æ³ã®ç¥èãåã課é¡ï¼ã®ããããã¢ã¤ãã³ãã¸ã§ã¦ãã®3ã¤ã®éå
·ã®ä¸ããç°ãªãæä½æ¹æ³ãé¸ã¶ãªã©ï¼ã®3課é¡ãè¡ã£ããæ¬çä¾ã¯æåã®2ã¤ã®èª²é¡ã®æã¡æ¹ã®èª²é¡ã«ã¦å¯¾ç
§ç¾¤ã¨æ¯è¼ãã¦æç¸¾ãä½ä¸ãã¦ããããæä½æ¹æ³ã¨æä½æ¹æ³ã®ç¥èãåã課é¡ã§ã¯å·®ãèªããªãã£ããããªãã¡æ¬çä¾ã¯ãéå
·ã«é¢ããæä½æ¹æ³ãæä½æ¹æ³ã®ç¥èãæ©è½ã®ç¥èã®ããããè¯å¥½ã«ä¿ããã¦ããä¸ã§ãéå
·ã®æã¡æ¹ã«é¢ãã¦é¸æçãªé害ãèªããã
æ¬çä¾ã示åãããã¨
æ¬çä¾ã¯å³å´åªä½ã®é é èã®è縮/æ©è½ä½ä¸ãèªãããããã®ã®ãéå
·ã®æã¡æ¹ã«é¢é£ããã¨å ±åããã¦ããå·¦é é éæºã®åæ¹é¨ãç¸å¯¾çè¡æµéã®ä½ä¸ãèªããããã®è³ç»åæè¦ã¯ãæ¬çä¾ã«åºç¾ãã鏿çãªéå
·ã®æã¡æ¹ã®å¤±è¡ã®åå¨ãæ¯æãããããã«æ¬çä¾ã§ã¯ãè©³ç´°ãªæ¤æ»ãåºã«ãã¦ãéå
·ã«é¢ããæä½æ¹æ³ãæä½æ¹æ³ã®ç¥èãæ©è½ã®ç¥èã®ããããè¯å¥½ã«ä¿ããã¦ããä¸ã§ãéå
·ã®æã¡æ¹ã«é¢ãã¦é¸æçãªé害ãèªãããã¨ãæããã«ããããã®ä¸¡æ¹ã®ç¹ãã²ã¨ã¤ã®çä¾ã§ç¤ºããå ±åã¯ãæ¬çä¾ãä¸çã§åãã¦ã§ããã
æ¬çä¾ã«èªãããã鏿çãªéå
·ã®æã¡æ¹ã®å¤±è¡ã¯ãOsiurakã®æå±ããreasoning-based hypothesisãæ¯æããããã®çè«ã§ã¯éå
·ã®æã¡æ¹ãéå
·ã®æä½ãéå
·ã®ç¥èã¨ãã£ãæ©è½ãããããç¬ç«ãã¦è³ã«åå¨ããã¨ããã¦ããããããã£ã¦ãããããã®çä¾ãåãã鏿çãªéå
·ã®æã¡æ¹ã®å¤±è¡ã®çç¶ã¯ããã®çè«ã¨åè´ããã䏿¹ã§Buxbaumã®æå±ããmanipulation-based hypothesisã¯ãæä½æ¹æ³ã®ç¥èã®ä½ä¸ã失è¡å
¨ä½ã®åºæ¬ã§ããã¨ããããæ¬çä¾ã§ã¯æä½æ¹æ³ã®ç¥èã¯ä¿ããã¦ããä¸ã§ã鏿çãªéå
·ã®æã¡æ¹ã®å¤±è¡ãçããããããã®çè«ã¨ã¯çç¾ããã
ãªãããªãã¼ã·ã§ã³ã®è¦³ç¹ããã¯ãç®å°ãªã©ã®å·¥å¤«ã«ãããæ£ããéå
·ã®æã¡æ¹ã«è³ããéå
·ã®ä½¿ç¨ãæ£ããè¡ãããå¯è½æ§ãé«ãããããã£ã¦ãæ¬çä¾ã®ããã«è©³ç´°ãªå¤±è¡çã®ææ¡ããªãããªãã¼ã·ã§ã³ã«ããã¦ãå¿
è¦ã§ããã¨èããããã
(è¹å±±ééã2023.5.1.)
çä¾å ±åï¼ãã´ãããã¯ååçºæ§é²è¡æ§å¤±èªãåããã¢ããã¤ãPETããã³ã¿ã¦ PETãç¨ãã¦éã¢ã«ããã¤ãã¼ç
æ§ã¿ã¦ãªãã·ã¼ã¨èããããä¸ä¾
ç¾ç°åç´ãæ
¶æç¾©å¡¾å¤§å¦å¤§å¦é¢å»å¦ç ç©¶ç§å士課ç¨ï¼ç²¾ç¥ã»ç¥çµç§å¦æå®¤ï¼Momota, Y., Konishi, M., Takahata, K., Kishimoto, T., Tezuka, T., Bun, S., Tabuchi, H., Ito, D., Mimura, M., 2022. Case report: Non-Alzheimerâs disease tauopathy with logopenic variant primary progressive aphasia diagnosed using amyloid and tau PET. Front. Neurol. 13. https://doi.org/10.3389/FNEUR.2022.1049113
ãæ¦è¦ã
èªç¥çï¼èªç¥æ©è½ã®é害ï¼ãåããç¾æ£ç¾¤ã§ã¯ãçåã®é¡ä¼¼æ§ãéå
¸åæ§ã«ããè¨åºè¨ºæãå°é£ãªå ´åãããããã®ãããªç¾æ£ç¾¤ã®ä¸ã¤ã«ãä»ã®èªç¥æ©è½ã®é害ãç®ç«ããè¨èªçç¶ã®ã¿ãé²è¡ããé²è¡æ§å¤±èªãæããããèæ¯ç
çã«æ¦ã対å¿ãã3ã¤ã®åï¼»éæµæ¢ï¼å¤±ææ³åãæå³åããã´ãããã¯ï¼èªæ¸å°ï¼åï¼½ã«åé¡ããããè¿å¹´ã®èªç¥ç診çã§ã¯ãã¢ããã¤ããã¿ã¦ãªã©ã®ãã¤ãªãã¼ã«ã¼ãéè¦ããã¤ã¤ãããä¸ã§ããæ°ããªã¿ã¦ãã¬ã¼ãµã¼ãç¨ããé½é»åæ¾åºæå±¤æ®å½± (PET) ãè¡æ¶²ãã¤ãªãã¼ã«ã¼ãæ©æè¨ºæããã³ç
çå¦çæ ¹æ ã®æ¨å®ã«æç¨ã¨ãããã
Eisai-Keio Innovation Laboratory for Dementia (EKID) ã®è¨åºç ç©¶ãèªç¥çã®ç
æ
ã¡ã«ããºã è§£æã¨åµè¬æ¨çåµåºã®ããã®è¨åºç ç©¶ãã§ãã徿¥ããè¡ãããã¢ããã¤ãPETã«å ããæ°ãã«éçºããã18F-Florzolotau (18F-PM-PBB3) ããã¬ã¼ãµã¼ã¨ããã¿ã¦PETãè¡æ¶²æ¤æ»ãã²ãã è§£æãªã©ã宿½ããççå¦ãéºä¼å¦ãæ¾å°ç·ç§ãç¥çµå
ç§ãç²¾ç¥ç¥çµç§ãªã©ã®é 忍ªæçãªç ç©¶ãé²ãããã¦ãããèè
ã¯è¨èªè´è¦å£«ã¨ãã¦å¤§å¦é¢å¨ç±ä¸ãæ¬è¨åºç ç©¶ã®ãªã¯ã«ã¼ãéå§åã®æºå段éããé¢ãã£ããæ¬ç¨¿ã§ç´¹ä»ããã®ã¯ããã´ãããã¯ååçºæ§é²è¡æ§å¤±èª (logopenic variant primary progressive aphasia: lv-PPA) ãåããå½åã®è¨åºæè¦ã¯ã¢ã«ããã¤ãã¼åèªç¥ç (AD) ã«çç¾ããªãã£ãããEKIDã«ãããè«¸æ¤æ»ã®çµæãADã¨ã¯ç°ãªãã¿ã¦ãªãã·ã¼ï¼ã¿ã¦èç½ã®ç°å¸¸èç©ãåããç¾æ£ï¼ã示åãããçä¾ã§ããã
ã失èªçã¯è¨èªè´è¦å£«ã主ãªå°éé åã¨ããçåã§ãããã夿§ç¾æ£ã«ä¼´ãé²è¡æ§å¤±èªããã¨ã«æ¬çä¾ãåããããã´ãããã¯ååçºæ§é²è¡æ§å¤±èªãã¯æ¯è¼çå°ãªããé常è¨åºã§ã¯ãã¾ãçµé¨ããªããæ¬çä¾å ±åã«ã¯ãå
񆊊
ã®åé åã«ãããæ°æ§ã®ç¥è¦ãç¹ãè¾¼ã¾ãã¦ãããæ£è
ããã夫妻ããã³æ¬çä¾å ±åã«é¢ãã£ãçæ§ã«æè¬ããé¢é£ç¾æ£ã®ç
æ
è§£æã«ã¤ãªãããã¨ãæå¾
ãããã
ãçä¾ã
æ£è
ã¯60代女æ§ã§ãï¼å¹´åã«ã¢ã«ããã¤ãã¼åèªç¥çã¨è¨ºæãããããæç¢ºãªèªè¦çç¶ã¯ãªãã£ãããã®å¾ãå¾ã
ã«è¨èã®åºã¥ãããèªè¦ããç²¾æ»ã®ããå½é¢ãç´¹ä»å診ã¨ãªã£ãã診å¯ã§ã¯æãããªéåçç¶ãéä½è·¯ï¼éä½å¤è·¯çç¶ãããã³å¤±è¡ã¯èªããªãã£ããæ¥å¸¸çæ´»ã«æ¯éããããæãããªè¨æ¶é害ã¯èªããªãã£ãããè¨èªæ§è¨æ¶ã®ä½ä¸ã示åããããçºè©±ã¯æ¦ãæµæ¢ã§ãã£ãããå¼ç§°ãèªåæãæã®å¾©å±ã«ããã¦åèªå°é£ããã³é³é»ç誤ãï¼»é³é»ã®ç½®æï¼ä¾ï¼ãã¤ããããâãããã¤ããï¼ãé³é»ã®æ¬ è½ï¼ä¾ï¼ããããã³ãâãããã³ãï¼ï¼½ãèªããããããããã®æè¦ã¯ãä¸è¬ã«èæ¯ç
çãADã§ãããã¨ã®å¤ãlv-PPAã®ç¹å¾´ã«åè´ãããåå»ã§å®æ½ãããPittsburgh Compound-Bããã¬ã¼ãµã¼ã¨ãã ã¢ããã¤ãPETã®çµæã¯ã齿§çããã§ãã£ããç£æ°å
±é³´ç»åæ³ããã³åä¸å
åæ¾å°åã³ã³ãã¥ã¼ã¿ã¼æå±¤æ®å½±æ³ã§ã¯ãADãçãæè¦ãèªããããããããã18F-Florbetabenããã¬ã¼ãµã¼ã¨ããã¢ããã¤ãPETã¯é°æ§ã18F-Florzolotauããã¬ã¼ãµã¼ã¨ããã¿ã¦PETã¯é½æ§ã§ãADã¯å¦å®çã¨èãããããã¿ã¦ãã¬ã¼ãµã¼ã®éç©ã¯ã主ã«å·¦åçã®ä¸å´é åãä¸å´é åãç¸ä¸åãããã³åé èå¼èé¨ã«èªããããããããã®çµæãããæ¬çä¾ã¯åé å´é è夿§çãä¸ã§ãç
çå¦çã«ã¿ã¦ãªãã·ã¼ã«åé¡ãããåé å´é è夿§ç [fronto-temporal lobar degeneration (FTLD)]-ã¿ã¦ã®å¯è½æ§ãé«ãã¨èããããã
æ¬çä¾ã§ã¯ãã¢ããã¤ãPETãã¿ã¦PETãå«ãå
端çãªæ¤æ»ã®çµæãå½åã«æ³å®ãããADã®è¨åºè¨ºæã¨ã¯ç°ãªãç
çèæ¯ãæ¨å®ãããããã®ä¸æ¹ã§ããã¹ã¦ã®æ¤æ»çµæãå¿
ãããä¸è²«ããç
çèæ¯ãæ¯æããªãã£ãç¹ã¯ãé²è¡æ§å¤±èªãåããç¾æ£ã®å¤æ§æ§ãããããã¦ç¤ºããã®ã¨èããããã
(ç¾ç°åç´ã2023.4.19.)
ç²¾ç¥å»å¦ç ç©¶ã®æ¹æ³è«
åç°è²´è¨ (æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§ å°ä»»è¬å¸«)
âãããâãæ±ãé£ãã
âãããâã¨ãããã®ã¯ãå®ä½ã¨ãã¦ã¨ããããã¨ã¯ã§ããªãããã®ãããªâãããâã«çç¶ãç¾ãã¦ããç¾æ£ã«ã¤ãã¦ãããã«ç ç©¶ããã°ããã®ã§ããããï¼èº«ä½å»å¦ã«ããã¦ã¯ã身ä½ã¨ããå®ä½ã客観çã«æ±ããã¨ãã§ããããã身ä½ã®ç çæ§ã«ã¤ãã¦ã¯ãèªç¶ç§å¦ã«ä¾æ ãã¦ãã¾ãç§å¦æè¡ãé§ä½¿ãã¦è¨ºæããç ç©¶ãããã¨ãå¯è½ã§ãããè³ç§å¦ã¯ããã®æ¹æ³è«ã§è¡ããã¨ãå¯è½ã§ããã䏿¹ãç²¾ç¥å»å¦ã«ããã¦ã¯ãâãããâã®ç çæ§ã«ã¤ãã¦ã¯èªç¶ç§å¦ã§ã¯æ±ããã¨ãã§ããªããããåºæã®æ¹æ³è«ãå¿ è¦ã§ããããã®æ¹æ³è«ãç²¾ç¥ç çå¦ã§ãããç¥çµå¿çå¦ã«ã¤ãã¦ã¯ãè³ã¨ã®é¢é£ã§âãããâã«ã¤ãã¦èããç²¾ç¥ç çå¦ã®ä¸ã®ä¸é åã§ããããâãããâã®ããã¿ãçè§£ããããã«è³ãåç §ããã®ã§ãã£ã¦ãè³ã®ç ç©¶ãç®çãªã®ã§ã¯ãªãã
ç²¾ç¥å»å¦ã«åºæã®æ¹æ³è«
ç²¾ç¥å»å¦ãå»å¦ã®ä¸ç«¯ãæ ã£ã¦ãã以ä¸ãå½ç¶ãªãããäºå®ã«åºã¥ããå®è¨¼çãªæ¹æ³è«ã§ãªããã°ãªããªãããç²¾ç¥ç çå¦ãåºã¥ãäºå®ã¨ã¯ãæ£è ããã®âãããâã®è¡¨ç¾ï¼Ausdruckï¼ã¨ãã¦ã®ãèªãããããã¨ã°ãã¨ãè¡åãã¨ããäºå®ã§ããï¼1ï¼ãæ£è ããã®èªãããã¨ã°ãã大åã«æ±ãå§¿å¢ã大åæã§ãããèªãããããã¨ã°ããæ¼ããããéèªã§ãããã®ã¾ã¾ã«è¨è¿°ãããã¨ãããã¦æ£è ããã®ãè¡åãããå®éçã«ã宿§çã«ãä¸å¯§ã«è¨è¿°ãããã¨ãåºæ¬ã§ããããã®ä¸ã§ã精緻ãªçç¶åæãè¡ããâãããâã®ããã¿ã®çè§£ãããã¦ç²¾ç¥ç¾æ£ã®ç æ 仮説ã«ã¤ãã¦èããã®ãç²¾ç¥ç§å»ã®ããã¹ãä»äºã§ããã
âãããâã¨è³ã®é¢ä¿
ç²¾ç¥å»å¦ã«ããã¦ï¼ç²¾ç¥ç çå¦ã¨è³ç§å¦ã¨ãé£ç¹ãã¦ç ç©¶ãé²ãããã¨ãã§ããã°ï¼å¤§ããªææãå¾ããããã¨ã§ããããé£ç¹ã®ããã«ãâãããâã¨è³ã¨ãæ¶æ©ããæ¹æ³è«ãæ±ãããã¦ããããããããå¿èº«åé¡ï¼å¿è³åé¡ï¼ããããããã¯é£åã§ããã

æ
¶æã®ç¥çµå¿çå¦ç 究室ãåµå§ãã鹿島æ´éå
çã¯ãâãããâã¨è³ã®é¢ä¿ã«ã¤ãã¦ãâãããâã¨è³ã¨ã¯éãæãã®é¢ä¿ã§ããã¨ãããè¦æ¹ãããã¯æ¹æ³è«ã®éãã§ãã£ã¦ãã©ã¡ããæ£ããã¨ãããã¨ã§ã¯ãªããã¾ãã©ã¡ãã䏿¹ã«éå
ããããã®ã§ã¯ãªããæ¬æ¥ãæ¹æ³è«ã®ç¯çãç°ãªãã®ã§ããããã両è
ã®é£ç¹ã¯æ²»ççã§ããéãã«ããã¦æå³ãããããããããã¯éãæãã®é¢ä¿ã§ãããããåãã対å¿ããããã¨ã§ãã£ã¦ã両è
ãçµ±åãããã¨ã§ã¯ãªããã¾ãããã¯è«ççã«ããããªããã¨ã§ãããï¼2ï¼ã¨è¿°ã¹ã¦ããããã®ä¸ã§ãâãããâã®ç¾è±¡ãçç¶ãè³ã«ç¹ãå¾ãè¨èã§ï¼è³ã®æ©è½é害ãâãããâã«ç¹ãå¾ãè¨èã§è¡¨ç¾ãããã¨ã大åã§ããããã®ãããªè¨èãå
±æãããã¨ã®éè¦æ§ãè¿°ã¹ã¦ããã
ãããã«ã仿¥ï¼è³ç§å¦ã®éçã«ãã£ã¦ï¼ç²¾ç¥å»å¦ã«ããã¦ç²¾ç¥ç
çå¦ã¨è³ç§å¦ã¨ã®æçµ¶ãæ·±å»ã«ãªãã¤ã¤ãããããã«ç²¾ç¥å»å¦ãè³ä¸å
è«çãªææ³ã«ãªã£ã¦ãã¦ãããã¨ãåé¡ã¨ãªã£ã¦ãããè³ç§å¦ã«ã¤ãã¦ã¯ãè½åã®ããç¥çµç§å¦è
ã«å¤§ãã«é²ãã¦ããããããæã
ç²¾ç¥ç§å»ãé¼èãã¦ããã ããããç¥çµç§å¦è
ãç²¾ç¥ç§å»ã¨ã®é£ç¹ã«ããã¦æ±ãã¦ããã®ã¯ãè¨åºã«ããã精緻ãªçç¶åæã§ãã£ã¦ï¼ç¹ã«å
å æ§ç²¾ç¥ç
ã®çç¶ï¼ãè³ã®ç ç©¶ã§ã¯ãªããç²¾ç¥å»å¦ã®æ¹ãããâãããâã®ç¾è±¡ãçç¶ãè³ã«ç¹ãå¾ãè¨èã§é©åã«è¡¨ç¾ããã¦ãç¥çµç§å¦è
ã«ä¼ãããã¨ãæ±ãããã¦ããã®ã§ãããããã¦ãå
å¼åã®å è¤å
ä¸éå
çã¯ãç¥çµç§å¦ã¨ã®é£ç¹ã«ããã¦ã¯ãç
åï¼ç¾æ£ã«ãã´ãªã¼ï¼ã§ã¯ãªããâsymptom orientedâã§é£ç¹ããããã«ã¨å¸¸ã
ä»°ããã¦ããããç®´è¨ã§ãããç²¾ç¥å»å¦ã«ãããç
åã¯ããã¾ã ã«ã«ãã´ãªã¼è¨ºæããã£ã¡ã³ã¸ã§ã³è¨ºæãã¨å§ã
諤ã
ã§æ··è¿·ãã¦ããï¼3ï¼ãã«ãã´ãªã¼è¨ºæããããã¾ã§ãæä½ç診æã§ãããå®ç¾©ãå¢çã®å¤è»¢ãæ¿ãããããç
åã®ã¿ã§ã®ã¤ã³ã¯ã«ã¼ã¸ã§ã³ã§ã¯ãã¨ã¦ãç¥çµç§å¦ã®å俵ã«ä¹ããããæ°´æºã«ã¯ãªããã¨ãããã®ç¯ç¼ã§è¦æãã¦ãããããç²¾ç·»ãæ¥µããç¥çµç§å¦ã®ç¥è¦ã«ç¹ããããã®ãããã«è¦åã£ã精緻ãªçç¶åæãã¤ã¾ãç²¾ç¥ç
çå¦ã®å®åãå¿
è¦ã¨ãããã¨ã§ãããäºå®ãå è¤å
ä¸éå
çã«ããçç¶ã®æ½åºã¨ãã®åæã¯é®®ããã§ãã£ãã
ç²¾ç¥ç§å»èªãããå®ç´ã«ãè³ç§å¦ä¸è¾ºåã«ãªã£ã¦ãã¾ããç²¾ç¥å»å¦ãèæ¨ãçãã¬ç¼ãéåï¼ããªãã¡ãâããããæ±ãã¬ç²¾ç¥å»å¦âã¨ãã¦ãã¾ããªãããã«ããªããã°ãªããªããç²¾ç¥ç§å»ããå
å æ§ç²¾ç¥ç
ã«ã¤ãã¦ããåãããªãããã£ããã¨è¨ºã¦é¢ãã£ããã¨ããªãã¨ãããæªãåè«ã®ãããªäºæ
ã«ãªããã¨ã屿§ãã¦ããã䏿¯ã«ãªãã¤ã¤ããæ£®ã«ãè¥æ¨ãæ¤ãã¦ã¯ãæ°´é£ããç¶ãã¦ãããããªå¿å¢ã§ããããåã³å·¨æ¨¹ã®è³ãç«ã¤æ£®ã¸ã¨åçãããã«ã¯ãé·ãæéãè¦ããã®ã§ããã
ãããã¹ãæ²»çè«
ç²¾ç¥å»å¦ã«ã¯ã大ããåãã¦äºã¤ã®æ²»çæ¹ç¥ããããä¸ã¤ã¯ãâãããâ ï¼ä½é¨ï¼ã«ä»å
¥ãã¦è³ã調ããã¨ããã¢ããã¼ãã§ããï¼ç¥çµç³»ã®âåç·¨æâï¼ãããä¸ã¤ã¯ãè³ã«ä»å
¥ãã¦âãããâã調ããã¨ããã¢ããã¼ãï¼ããããçç©å¦çæ²»çï¼ã§ãããå
å æ§ç²¾ç¥ç
ã«ããã¦ã¯ã主ã¨ãã¦å¾è
ã®æ²»çæ¹ç¥ãã¨ããã¦ããããå
å æ§ç²¾ç¥ç
ã«ããã¦ããâãããâã«ä»å
¥ããã¦è³ã調ããã¨ããæ²»çæ¹ç¥ããã£ã¦ç¶ãã¹ãã§ãããçç©å¦çæ²»çï¼è¬ç©çæ³ãªã©ï¼ã¨ç¸è£çã«é²ãããã¨ã§ãæ²»çãããé«ãæ°´æºã§å®ç¾ã§ãããã®ã¨èãããããç²¾ç¥ç¾æ£ã¯ãè¬ç©çæ³ãªã©ã®çç©å¦çæ²»çã ãã§ã¯éçãããã¨ããè¨åºçäºå®ããããä»å¾ãã¾ãã¾ããâãããâã«ä»å
¥ããæ²»çã®å·¥å¤«ãå¿
è¦ã«ãªã£ã¦ãããã®ã¨äºæ¸¬ãããã¨ããããããç²¾ç¥å»å¦ã¯ããããã¹ãã§ãããããããç²¾ç¥å»å¦ã«ããã§ããªããã¨ã§ãããã¨ããèã«éãã¦ç ç©¶ã«è¨ãã¹ãã§ããã
ï¼æç®ï¼
1ï¼ åç°è²´è¨ï¼âèªæâä½é¨ã®ç°å¸¸ã®ã¨ããæ¹. ç²¾ç¥ç§æ²»çå¦ï¼in pressï¼
2ï¼ é¹¿å³¶æ´éï¼âãããâã¨âè³âï¼éãæãï¼. ç²¾ç¥ç¥çµå¦éèª 116 ; 316-322, 2014.
3ï¼ åç°è²´è¨, æ²æå®°, éååï¼çµ±å失調çã«ãããã¹ãã¯ãã©ã ã¨ããã¡ã¿ãã¡ã¼ã®å°å
¥ã®æç¾©ã¨åé¡ç¹ï¼ãç²¾ç¥å»å¦ã®åºç¤3ï¼ç²¾ç¥å»å¦ã«ãããã¹ãã¯ãã©ã ã®ææ³ã, 妿¨¹æ¸é¢, 104-112, 2016.
(åç°è²´è¨ã2023.3.21.)
髿¬¡è³æ©è½é害ã®ä¸çãããã¾ã¿ã
å
å´ç« (æ±äº¬ç¦ç¥å¤§å¦ç¤¾ä¼ç¦ç¥å¦é¨ææ / å¼ççç·åãªãããªãã¼ã·ã§ã³ã»ã³ã¿ã¼ç¥çµç§)髿¬¡è³æ©è½é害ã®ä¸çãããã¾ã¿ããååä¸ç´è¨ºã¦ããå¤å·æ§è³æå·è
4åããå¦ãã ãã¨ã10å¹´åã¨ãã®10å¹´.ã髿¬¡è³æ©è½ç ç©¶42: 251-257, 2022
https://www.jstage.jst.go.jp/article/hbfr/42/3/42_251/_article/-char/ja/
æ¬ç¨¿ã¯ãä¸¡è¦ªã®æ
é·ã§ããç¦å³¶çé¡å±±å¸ã«ã¦éå¬ãããã髿¬¡è³æ©è½é害å¦ä¼ã§ã®æè²è¬æ¼ã®å
容ãã¾ã¨ãããã®ã§ãããããã«ï¼ä¾ãã¨ãããæãåºæ·±ãçä¾ãæç¤ºããããæ¬äººããå°å·ç©ã¨ãã¦ã¯æ²è¼ã®åæãå¾ãããã4ä¾ã§ã®æ§æã¨ãªã£ã¦ãããæ¬æã«è¨ããããã«ã診ã¦ããæ£è
ããããæ°ãã«æãããããã¨ã°ããã§ãããé·ãããã®æ£è
ããã¨è©±ãã¨ããããããªææ
ãããã¦ãããåãã¦å¯¾é¢ããæããã®èªåã®æ©ã¿ããµããããã鿦ããããéå»ã®ãã¹ã¦ã®ãã¨ãæããããæãããæãåºãããã
å°çã¯20代åã°ã®ããåºãã®ãããæ±äº¬é½ä¸ã®ããç
é¢ã«å¤å¤ã§åºã¦ãããããã«ã¯æ±å¤§ãã¤ãã¹ãã¿ã«ãåµãããå®®å
åå
çãã2é±ã«ä¸æ¥ã ãå°æ¨è²åå
çããããã¦ãè¥ãæãããã£ã¨æ
å½ãã¦ããæ£è
ãããå
¥é¢ã夿¥ã§è¨ºã¦ããã20å¹´åããããã£ã¨åããã®æ£è
ãããã¡ã§ããã彿ããããã¯ãã®æå³ããã¨ãããããããªãã£ãããã®å¾ãå°æ¨å
çã®èªä¼æ¬ã«ãç»å ´ããæä¸å»é¢ã®æä¸å
çï¼å
代ï¼ã®ã¨ããã§ãæã
ãæä¼ãããããã¡ã³ã¿ã«ã¯ãªããã¯ã®é»ææãä¸çºã®å»é¢ã§20å¹´æ¥ã®æ£è
ãããã¡ã大å¢ã¿ã¦ããã
ãã®æä¸å
çãããæã診çæã®ä¼å ±ã«èªåã®è¿æ³ãè¼ããããã®çãï¼é ã®æç« ãä»ã§ãå¿ããããªããããã¯ãèªåã¯è¥ãããåºãã®ããã¯ç
æ°ããã¿ããªãã£ãããã ãã ãçæ´»ãã¿ãã¦ãã¦ã次第ã«çæ´»ã ãããã¿ããªãç¿ã«ãªã£ã¦ãã¾ã£ããã¨ãã£ãå
容ã§ãã£ãï¼æ£ç¢ºã«ã¯éã£ã¦ããããããã¾ãããããè¦ãã§ãã¿ã¾ããï¼ãä»ãªããããããå®¶æããæ¬äººã®è¾ãæ¥ã
ãããããªãæ¥ã
ããããã¯å¸æããã£ãæ¥ã
ãããã¦äººçãã®ãã®ã«å¯¾å³ãã¦ããå
çã®è¨¼ã ã£ãã®ã ã
å°çã¯ãã®å¾30å¹´åã«ã身ä½ãªãããªãã¼ã·ã§ã³ç
é¢ã«è»¢å¤ã«ãªã£ããç¥çµå¿çããããªãã¦ã¯ãªããªããªã£ããä»ã¯ãªãå¥é¤¨ä¸éã®çé
ã§ã®ç ç©¶ä¼ãå è¤å
ä¸éå
çã¯ãã諸å
çæ¹ããè³æå·è
ã®è¨åºãå¦åãä¸ããæãã£ããããã¦ä»ããããã¨ãããã¾ã§ã®æç« ã§ç»å ´ãã人ãã¡ãèªåã¨çä¾ã®æ¹ã
以å¤ãã¿ãªé¬¼ç±ã«å
¥ããã¦ãã¾ã£ããç ç©¶ä¼ã®20代ã®è¥ã大å¦é¢çãã®çºè¡¨ãèãã¦ã¯ããã®ææ°ãã¨ã¹ãã¼ããã«ç¾¨æãæãã仿¥ãã®é ãããã«è¥ãé è³ãåãè¾¼ã¿ãç ç©¶ä¼ãã¾ãã¾ãçºå±ããããã¨ãé¡ã£ã¦ãã¿ã¾ããã
(å å´ç« ã2023.2.27.)
å
å容æè¦ã¨èªå·±ä¸»ä½æã®é¢ä¿æ§ããã³å¿æã«ãããã®èª¿æ´ï¼æ¢ç´¢çç ç©¶
æ¯æ¨æå®ï¼ä¸ç·ç²¾ç¥å»çã»ã³ã¿ã¼ãç²¾ç¥ç§å»é·ï¼Koreki A, et al. The relationship between interoception and agency and its modulation by heartbeats: an exploratory study. Sci Rep. 2022 Aug 10;12(1):13624.
ãç ç©¶æ¦è¦ã
æ¬ç ç©¶ã¯å¥å¸¸è
ã®ã¿ã対象ã¨ãã¦ãããããã®ç ç©¶èæ¯ã«ã¯è¨åºããããæ¬ç ç©¶ã®ãã¼ãã®ä¸ã¤ã§ããèªå·±ä¸»ä½æ(Sense of agency)ã¨ã¯ãä½ãåºæ¥äºï¼èº«ä½éåãå«ãï¼ãèµ·ããæã«ãããèµ·ããã¦ããã®ã¯ãèªåãã§ããã¨ããæè¦ã§ãããçµ±å失調çã§ã¯ãã®èªå·±ä¸»ä½æã®éå®³ãæ³å®ããã¦ãããã¾ãæ¬ç ç©¶ã®ããä¸ã¤ã®ãã¼ãã§ããå
å容æè¦(Interoception)ã¨ã¯ã身ä½å
é¨ã®æè¦ãæå³ããããã«ã¯å¼å¸ãèæãªã©ãå«ã¾ããããã®å
å容æè¦ãç²¾ç¥ç¾æ£å
¨è¬ã§ç°å¸¸ãããå ±åããã¦ããããããï¼ã¤ã®é åãé¢é£ããããã¨ã示ããã®ãæ¬ç ç©¶ã®å¦è¡ç価å¤ã§ãããããã¯ç²¾ç¥ç¾æ£ã«ãããå¤å½©ãªçç¶ã®ç
æ
ççãããå¤è§çã«èª¬æãããå¯è½æ§ãçã¿åºãã
å
·ä½çãªç ç©¶æ¹æ³ã¯ä»¥ä¸ã§ããã被é¨è
ã®èªå·±ä¸»ä½æãIntentional binding課é¡ã§è©ä¾¡ãå
å容æè¦ãå¿æåºå¥èª²é¡ã§è©ä¾¡ããããããã代表çãªç¥çµå¿çå¦ç課é¡ã§ãããçµæã¯ã両è
ã¯æ£ã®ç¸é¢ã示ãããã¤ã¾ãå
å容æè¦ãè¯ã被é¨è
ã¯èªå·±ä¸»ä½æãé«ããéã«å
å容æè¦ãæªã被é¨è
ã¯èªå·±ä¸»ä½æãä½ãã£ãã
ããã«è峿·±ãã®ã¯èæã¨ã®é¢ä¿ã§ãããããã§ã¯å¿æã¨ããå
å容æè¦ã®ã·ã°ãã«ãå§å容ä½ãéãã¦è³ã«ä¿¡å·ãéããã¨ã§è³æ©è½ï¼æ¬ç ç©¶ã§ã¯èªå·±ä¸»ä½æï¼ãå¤åãããã¨ããç¹ãè©ä¾¡ãã¦ãããçµæã¯ãå
å容æè¦ãè¯ã被é¨è
ã§ã¯å縮æã§èªå·±ä¸»ä½æã¯é«ããéã«å
å容æè¦ãæªã被é¨è
ã§ã¯å縮æã§èªå·±ä¸»ä½æã¯ä½ãã£ãã
ãã£ã¦æ¬ç ç©¶ã§ã¯å¥å¸¸è
ã®ç¯å²ã§ã¯ããããæªãå
å容æè¦ã¯å
¨ä½çã«ã¿ã¦ãèæã¨ã®é¢ä¿æ§ã§è¦ã¦ãä½ãèªå·±ä¸»ä½æã¨é¢ä¿ãã¦ãããã¨ã示ããããä»å¾ã¯ãã®å æé¢ä¿ãæ£è
群ã§ã®è¨åºçæå³ãæ¤è¨ãã¦ãããã¨ã§ãç²¾ç¥ç¾æ£ã®ç
æ
ççã¸ã®æ·±ãçè§£ãæ°ããªæ²»çæ³ã®éçºã«ã¤ãªããå¯è½æ§ãèããããã
ãå°æ¥ç屿ã
æ¬ç ç©¶ã®ãããªå¿è³é£é¢ããã®ç ç©¶ã¢ããã¼ãã¯è³ã®ã¿ã®ç ç©¶ã§ã¯æªè§£æã ã£ãé åã«ã¡ã¹ãå
¥ããããå¯è½æ§ããããè¿å¹´ãè³æ©è½ã¯å縮æã¨æ¡å¼µæã§ç°ãªãå¯è½æ§ã示ããã¦ãã¦ããã大ã¾ãã«ã¯éåæ©è½ã¯å¿èã®å縮æã§å¼·ã¾ããæè¦æ©è½ã¯æ¡å¼µæã§å¼·ã¾ãã¨ããããããã«ã¯èº«ä½ã®å
å¤ããã®æè¦ãã¤ã¾ãå
å容æè¦ï¼ããã§ã¯å¿æï¼ã¨å¤å容æè¦ï¼è¦è¦ãè´è¦ãªã©ï¼ã¨ãè³ãããã«é©åã«ååããæé©ãªè³æ©è½ãä½ãåºãã¦ããããåæ ããã¦ããããã®ãããªè³æ©è½ã®å´é¢ãé©åãªèªæå½¢æã«ãé¢ä¸ãã¦ãããã¨ãæ¬ç ç©¶ããã¯ç¤ºåãããéã«ãã®è³æ©è½ã®å¤èª¿ã¯æ§ã
ãªæªè§£æã®çç¶ã説æã§ããå¯è½æ§ããããä»å¾ã®ç ç©¶ã«ç²¾é²ãã¦ã¾ããã¾ãã
(æ¯æ¨æå®ã2023.1.20.)
第1åã大å¦é¢ç Research Day
䏿æ (æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ 大å¦é¢å士課ç¨)
å»ã2022å¹´8æ31æ¥ãæ ¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ã»ç¥çµç§å¦æå®¤ä¸»å¬ã§ã第ä¸åãResearch dayããéå¬ããããçºæ¡è ã¯åæå®¤åææã®å ç°è£ä¹å çã§ãå çãçå¦ããã¦ããããã³ã大å¦ã§æ¯å¹´è¡ããã¦ããå¦å ã®ãã¹ãã¯ãé¢çãä¸åã«ä»ãã¦çºè¡¨ããååç§°ã®ããã°ã©ã ããçæ³ãå¾ã¦ããã®åº¦ãææ¡ããã ãããæå®¤å ã®ææä»¥ä¸å©æã®å çæ¹ã¾ã§åéããã ããç·å¢16åã®å¤§å¦é¢çãåã ã®ç ç©¶å 容ãç´¹ä»ããã³ã¡ã³ããããã ããã座é·ãå¸ä¼ã大å¦é¢çãæ å½ããæ©æãã©ãã«ãªã©ããã£ãããªãã¨ãä¹ãåããã¨ãã§ããå ¨ä½ã¨ãã¦é常ã«å®ãã®ãã1æ¥ã¨ãªã£ãã
ã³ããç¦ã§å¤§å¦é¢çå士ã®äº¤æµãæ¥µç«¯ã«æ¸ã£ãç¾å¨ã«ããã¦ãä»é¢çã®ç ç©¶å 容ãç¥ããã¨ãçºè¡¨ãèããã¨ã¯é常ã«éè¦ãªæ©ä¼ã¨ãªãåç£ç¢ç£¨ãããã¨ãã§ãããç¥çµå¿çæå®¤ããã¯3åã®é¢çãçºè¡¨ãããããä¸è¨ç´¹ä»ããã
(䏿æ ã2022.12.4.)
æ¼é¡5 è æ³¢ ç¾ç©ãå士課ç¨3å¹´
ãä»è
ã®ç½ªã«å¯¾ããç½°ã®è©å®èª²é¡ãç¨ããè³æå·ã«ãããéå¾³å¤æã®æ¤è¨ã
å士課ç¨3å¹´ã®è
æ³¢ã¯æ¨å¹´åº¦ãç²¾ç¥ç¥çµç§å¤æ¥ã®æ£è
æ§ã®ååãå¾ã¦è¡¨é¡èª²é¡ã«é¢ãããã¼ã¿ãåéããã®äºåè§£æã®å
容ã«ã¤ãã¦çºè¡¨ããã
è³æå·ã«ãã社ä¼è¡åé害ã¯è³æå·è
ã®ç¤¾ä¼å¾©å¸°ã妨ãã大ããªè¦å ã®ä¸ã¤ã¨ãªã£ã¦ããã社ä¼è¡åé害ã®è¦å ã®ä¸ã¤ã¯é徳観ã§ããã¨èãããã¦ãããé徳観ã®å¤åã«ããããã¦ã¯ãããªããã¨ããããããã¹ããã¨ãããªãã許ãããã¹ãã§ãªãè¡åã許容ãã¦ãã¾ãã責ããè² ãããå¿
è¦ããªãè¡åã«ã¤ãã¦å¿
è¦ä»¥ä¸ã«è²¬ããè² ãããããªã©ãã¾ãã¾ãªè¡åãçãããå¾è
2ã¤ã¯èªåã«ã¯ç´æ¥å½±é¿ã®ãªã第ä¸è
ã®è¡åã«ã¤ãã¦ã®éå¾³ç夿ãããã¨ããç¤¾ä¼æ©è½ãç¶æããå©ä»çä»ç½°ã«ãããããã®ã§ãããããã«æ¬ç ç©¶ã§ã¯æ³¨ç®ããã
æ¬ç ç©¶ã§ã¯ã第ä¸è
ã«å¯¾ããé徳夿ãè³æå·ã«ã©ã®ããã«å½±é¿ãåããã®ããæ¤è¨ãããããçãã·ããªãªãèªã¿ç»å ´äººç©ãã©ã®ç¨åº¦æªãã¨æããã夿ããéå¾³å¤æèª²é¡ã使ããè³æå·ç¾¤35åã¨å¹´é½¢ã»æ§å¥ã»å¦æ´ããããããå¥å¸¸å¯¾ç
§ç¾¤30åãããã¼ã¿ãåéããããã®çµæãè³æå·ç¾¤ã¯å¥å¸¸ç¾¤å¹³åããææã«ä¹é¢ããè©ä¾¡ãããçä¾ãå¤ããã¨ãåãã£ããã¾ããè¡çºè
ãæå³ãæã¡ä¸éå¾³ãªè¡çºãããã·ããªãªã§ã¯å¥å¸¸å¯¾ç
§ç¾¤ã«æ¯ãããæªããªãã¨å¤æããè¡çºè
ãè¡åããçµææå³ãã¦ããªãã£ãä»è
ã¸ã®å®³ãæãã¦ãã¾ã£ãã·ããªãªã§ã¯å¥å¸¸å¯¾ç
§ç¾¤ã«æ¯ãããæªãã¨å¤æããå¾åãã¿ããããã¾ããææ
é¢ã§ã¯ã©ã®ãããªã·ããªãªãèªãã§ã常ã«å¼·ãææ
ãè¦ãã群ã¨ã»ã¨ãã©ã«ææ
ãåããªã群ã«è³æå·è
ãå¤ãå«ã¾ãã¦ããã
ä»å¾ã¯ãã¼ã¿ãããã«è©³ããè§£æãè³æå·è
ã®ç¬¬ä¸è
ã«å¯¾ããé徳夿ã®ç¹å¾´ãæããã«ãã¦ããäºå®ã§ããã
æ¬ç ç©¶ã¯ä¸è¬ç¤¾å£æ³äººæ¥æ¬æå®³ä¿éºåä¼2021年度交éäºæ
å»çä¸è¬ç ç©¶å©æãããã³2021年度å
¬çè²¡å£æ³äººäºä¹é ç
é¢ç ç©¶å©æéã®ãµãã¼ããåãã¦å®æ½ããã
(è æ³¢ç¾ç©ã2022.12.4.)
æ¼é¡6 䏿 æ ãå士課ç¨3å¹´
ãå¥å¿å軽度èªç¥é害ã«ãããã³ãªã³æ©è½ã®è©ä¾¡ï¼TMS-EEG-MRIç ç©¶ã
å士課ç¨3å¹´ã®ä¸æã¯ãç¾å¨ç´æ¥æå°ãåãã¦ããç²¾ç¥ç
æ
ççå¦ç 究室ã§ã®ç ç©¶å
容ããã表é¡ã®å
容ãçºè¡¨ããã
大è³ç®è³ªã®ç¥çµççæ©è½ã®è©ä¾¡æ³ã¨ãã¦çµé èç£æ°åºæ¿(TMS)ã¨é«ç²¾åº¦è³æ³¢è¨(EEG)ãçµã¿åãããTMS-EEGæ³ãç¥ããã¦ãããTMSã«ããå
¥åã«å¯¾ããåå¿ãè³æ³¢ã§è©ä¾¡ãã試ã¿ã§ãããTMSã«ããå
¥åæã«ã¯åçºåºæ¿ã®ã¿ãªãã種ã
ã®ãããã³ã«ããããä»åã¯æ«æ¢¢æè¦åºæ¿ã¨TMSã«ãã䏿¢åºæ¿ãçµã¿åãããçæ½ææ±å¿æ§æå¶(SAI)ãç¨ãããSAIãããã³ã«ã«ããåºåã¯å¤§è³ç®è³ªã®ã³ãªã³ä½åæ§ç¥çµççæ©è½ãåæ ãã¦ããã¨èãããã¦ãããããã«è¿å¹´ãè³å
ã®ãã«ã¨ããããªã³æ©è½ãé侵襲çã«è¨æ¸¬ããææ³ã¨ãã¦neuromelanin(NM) -sensitive MRIãæ³¨ç®ããã¦ãããNMã¯ä»£è¬ç£ç©ã§ãããéææ ¸ã«ããããã«ã¨ããããªã³æ©è½ææ¨ã¨èãããã¦ãããéææ ¸ã¯ã¢ã«ããã¤ãã¼ç
ã§ãç
åæã«å¤æ§ãèµ·ãããã¨ãç¥ããã¦ããããã®å¤æ§ã¯ãã¤ãã«ãåºåºæ ¸ã®ã³ãªã³ä½åç¥çµã¸å½±é¿ãä¸ããã¨èãããã¦ããã
ä»åãå¥å¿å軽度èªç¥é害(aMCI)21åã¨å¹´é½¢ã»æ§å¥ããããããé«é½¢å¥å¸¸è
(HC)23åã«å¯¾ãã¦SAIæ³ãçµã¿åãããTMS-EEGæ³ã«ããè©ä¾¡åã³NMæ¿åº¦ã®è©ä¾¡ãè¡ã£ããçµæã¨ãã¦ãHCã®å·¦DLPFCã«ããã¦ãSAIæ³ã«ããå¹³åé»å ´ã®æå¶å¹æã確èªããã䏿¹ã§ãaMCIã®å·¦DLPFCã«ããã¦ã¯åæ§ã®æå¶å¹æã確èªããããaMCIã®DLPFCã«ãããã³ãªã³ä½åæ§ç¥çµåè·¯ã®é害ãTMS-EEGæ³ãéãã¦ç¢ºèªããããTMS-EEGã¯é侵襲çã«ã³ãªã³ä½åæ§ç¥çµåè·¯ã®è©ä¾¡ãå¯è½ã§ãããã¨ã示åãããã䏿¹ã§NMæ¿åº¦ã«ã¤ãã¦ã¯ææå·®ãå¾ããããã¾ãSAIã®æå¶å¹æã¨ã®ç¸é¢é¢ä¿ãã¿ãããªãã£ããNMæ¿åº¦ã«ã¤ãã¦ã¯ããã«ãµã³ãã«æ°ãå¢ããã¦æ¤è¨ãã¦ããäºå®ã§ããã
åå
容ã¯è§£æçµæãããã«æ´çãã¦ãä»å¾æç¨¿äºå®ã§ããã
(䏿æ ã2022.12.4.)
æ¼é¡7 å æ¿é¦ãããã¤ç ã®æ¯ããæªçºçã®å¨ã¸ã®è³æ§é ã®ä¸ä»£éä¼éã
å士課ç¨3å¹´ã®åã¯ãPsychiatry and Clinical Neurosciencesã«å
æ¥acceptãããå¦ä½è«æã®ç ç©¶å
容ãçºè¡¨ããã
Minami F et al: Intergenerational concordance of brain structure between depressed mothers and their never-depressed daughters. Psychiatry and Clinical Neurosciences 76: 579-586, 2022.
親ã¯åã®èªç¥ãè¡åãè³ã«å¤§ããªéºä¼çãç°å¢çå½±é¿ãä¸ãããããä¸ä»£é广ã¨ãããä¸ä»£éå¹æã¯æ°åé害æ£è
ã«ããã¦ã観å¯ãããç¹ã«æ¯è¦ªã¨å¨ã¨ã®éã§ãã¤ç
ã®å¼·ãé¢é£ããããã¨ãç¥ããã¦ãããæ¬ç ç©¶ã®ä¸»ãªç®çã¯ããã¤ç
æ£è
ã¨ãã®ãã¤ç
ã§ãªãåå«ã®éã§ãããã®è³ã«ããã女æ§ç¹æã®ä¸ä»£éä¼éãã¿ã¼ã³ã調æ»ãããã¨ã§ãã£ãã
ãã¤ç
ã®æ¢å¾ãæã¤å¯è§£æã®è¦ªã¨ãã®ãã¤ç
ã®æ¢å¾ã®ãªãå®åãå«ã34å®¶æãã78åãåéãããMRIç»åãã¼ã¿ã®source-based morphometryè§£æããã³surface-based morphometryè§£æãç¨ãã¦ã4種é¡ã®è¦ªåéï¼ããªãã¡ãæ¯-å¨ãæ¯-æ¯åãç¶-å¨ãç¶-æ¯åï¼ã®è³æ§é ã®é¡ä¼¼æ§ã®ç¨åº¦ãæ¤è¨ããã
ç¬ç«æååæã«ãããçµæä¸¡å´ã®å帯ç¶ç®è³ªãå¾å¸¯ç¶ç®è³ªãæ¥åé¨ãä¸åé åãä¸å´é åãä¸é é èãå·¦è§åãªã©ã®ããã©ã«ãã¢ã¼ããããã¯ã¼ã¯(DMN)ããã³ä¸å¤®å®è¡ãããã¯ã¼ã¯(CEN)ã«ä½ç½®ããè³é åã«ããã¦ãæ¯-å¨ãã¢ã§ã®ã¿ç°ç½è³ªæ§é ã®ææãªæ£ã®ç¸é¢ãã¿ã¨ãããåæ§ã®æè¦ã¯ãä»ã®3çµã®è¦ªåãã¢ã§ã¯ã¿ã¨ããªãã£ããFreeSurferã«ããè§£æã§ã¯åROIã®ç®è³ªä½ç©ãç®è³ªè¡¨é¢æ§ãç®è³ªåã®ç¸é¢ä¿æ°ããã¢ã§ç®åºããã¨ãããå³å°¾å´ä¸åé åã®ç®è³ªä½ç©ããã³å·¦å°¾å´ä¸åé åã®ç®è³ªè¡¨é¢ç©ã«ããã¦æ¯-å¨ã§ææã«æ£ã®ç¸é¢ãèªãããåé¨ä½ã«ãããç¸é¢ä¿æ°ãä»ã®ãã¢ã¨æ¯è¼ããçµæãæ¯-å¨éã«ææã«ç¸é¢ä¿æ°ãé«ããã¨ã示ãããã
æ¬ç ç©¶ããDMNãCENã¨ãã£ããã¤ç
ã«é¢ä¸ããè³ãããã¯ã¼ã¯ã«ããã¦ãå¯è§£æã®è¦ªã¨ãã®é«ãªã¹ã¯ã®å®åã¨ã®éã«å¥³æ§ææãªä¸ä»£éä¼éãã¿ã¼ã³ãæãããã¨ã示ããããæ¬ç ç©¶ã®çµæã¯ããã¤ç
çºçãªã¹ã¯ã®é«ãè
ã¸ã®æ©æä»å
¥ã®è¦ç¹ã«ã¤ãªãããã¨ãæå¾
ããã
ä»å¾ã¯ãå¨ç£æã®æ¯è¦ªã®è³æ©è½ã®å¤åãç²¾ç¥çç¶ã¸ã®å½±é¿ãããã«çã¾ãã¦ããåä¾ã®ç¥çµçºéã¸ã®å½±é¿ããé«ãªã¹ã¯è
ã¸ã®äºé²ãªã©ã«é¢ãã調æ»ããã¦ããããã¨èãã¦ããã
(åæ¿é¦ã2022.12.4.)
æ°åé害ã«ãããå¯è§£ã¨å復ã«é¢é£ããç¥çµåè·¯åºç¤ã®è§£æã«è³ãã縦æMRIç ç©¶ï¼éç§°å½éè³ç ç©¶ï¼
å¹³éä»ä¸ (æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§ãå°ä»»è¬å¸«)
è¿å¹´å¤§è¦æ¨¡è³ç»åãã¼ã¿ãç¨ãã¦ãè³ã®çºéé害ãèåã®å¶å¾¡ãç²¾ç¥ã»ç¥çµç¾æ£ã®ç
å è§£æã»è¨ºæã»æ²»çæ³çã«è¿«ããã¨ããå½å®¶ããã¸ã§ã¯ããä¸ççã«å¤ãå
·ä½åããã¤ã¤ãããæ¬é¦ã«ããã¦ãå½ç«ç ç©¶éçºæ³äººæ¥æ¬å»çç ç©¶éçºæ©æ§ï¼AMEDï¼ããæ¦ç¥çå½éè³ç§å¦ç ç©¶æ¨é²ããã°ã©ã ãï¼ä»¥ä¸ãå½éè³ï¼ãæ¨é²ãã¦ãã¾ãã
å½éè³ã¯ãæ¬é¦ã®å¤ãã®å¤§å¦ã»ç ç©¶æ©é¢ãåç»ããå¥å¸¸ããç¾æ£ã«è³ãè³ç»åçã®ç·åçè§£æãAIã«ããè³ç§å¦æè¡éçºãããã¨éããéé·é¡åç©ã¨ã®ç¥çµåè·¯æ¯è¼ç ç©¶çãç®æãããã¯ããã¸ã§ã¯ãã§ããæ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§ã¯ãå½éè³ã®ä¸ã§ãã¤ç
ã®ç¸¦æè³ç»åãã¼ã¿ãåå¾ãããã®ç¥çµåè·¯åºç¤ã®è§£æãç®çã¨ãããæ°åé害ã«ãããå¯è§£ã¨å復ã«é¢é£ããç¥çµåè·¯åºç¤ã®è§£æã«è³ãã縦æMRIç ç©¶ããå½ç«ç²¾ç¥ã»ç¥çµã»ã³ã¿ã¼ã京é½å¤§å¦ã¨ã®å
±åç ç©¶ã¨ãã¦æ
å½ãã¦ãã¾ãã
å
·ä½çã«ã¯æäººæããé«é½¢æã®ãã¤ç
ã«å¯¾ããé常治çï¼è¬ç©çæ³ã»èªç¥è¡åçæ³ã»é»æ°ããããçæ³ã»çµé èç£æ°åºæ¿ï¼ãåçãããã¤ç
çä¾350ä¾ã¨å¥å¸¸å¯¾ç
§ä¾150ä¾ã対象ã¨ãã¦ãMRIè³ç»åï¼æ§é ç»åãå®éæè³æ©è½ç»åçï¼ãè¨åºãã¼ã¿ãåå¾ããæ©æ¢°å¦ç¿ãå¿ç¨ããã¤ç
ã«ãããâ å¯è§£ã»å復ã«é¢é£ããç¥çµåè·¯åºç¤ã®è§£æãâ¡çç¶ãã¡ã¤ã³ã¨é¢é£ããç¥çµåè·¯åºç¤å¤åã®è§£æãâ¢åæ²»çã®å¯è§£ã»å復ã®äºæ¸¬å åã¨ãªãç¥çµåè·¯åºç¤ã®è§£æãã¨ããï¼ã¤ã®ç 究課é¡ã«ã¤ãã¦æ¤è¨¼ãã¦ããã¾ãã
ãã¤ç
ã¯QOLã社ä¼çæ´»ã«ä¸ããå½±é¿ã大ããã¨ããããã®ç°è³ªæ§ã®é«ããææããã¦ãã¾ããæ¬ç ç©¶ã§ç¥çµåè·¯åºç¤ãè§£æãããåæ²»çæ³ã«å¯¾ããæ²»çå¹æäºæ¸¬ã¢ãã«ããã¤ç
ã®å±¤å¥åãå®ç¾ã§ããã°ããã¤ç
ã®ç²¾å¯å»çã«ç¹ãããæ°åé害ã®å®è¨åºã«ãè³ããçµæãå¾ãããã®ã§ã¯ãªããã¨èãã¦ãã¾ãã
(å¹³éä»ä¸ã2022.11.26.)
ãªãã¯ã¹ãã©ã¼ã便ã
åæ°£å¤§æ (ãªãã¯ã¹ãã©ã¼ãã»ã¦ã¨ããï¼ã»ã³ãã¯ãã¹ãæ´¾é£ç ç©¶å¡. ãªãã¯ã¹ãã©ã¼ã大å¦å²å¦ç§ã¦ã¨ããå¿ç¨å«çã»ã³ã¿ã¼)WAKE, Taisei. Oxford Uehiro/St Cross Scholar. The Oxford Uehiro Centre for Practical Ethics
BEEEEEP! HONK! HONK!
ã¤ã®ãªã¹ã§è»ãé転ãã¦æ°ãã¤ãããã¨ããããããã«ã¯ã©ã¯ã·ã§ã³ãå¤ãèããã¨ã ã10åãèµ°ãã°2ã3åã¯é³´ããèªåã«åãããããã®ã§ãªãã¦ããããæ°ã¯ããªããæ¥æ¬ã§ã¯ãã¾ãé³´ãããããã¨ããªãã®ã§ãæåãããã¯ãã¯ãã¦ãããããã©ãã®ãã¡ãããã¯ä½ãæ»æçãªã¡ãã»ã¼ã¸ã§ã¯ãªããã以å¿ä¼å¿ãããè¨èã§ä¼ãããã¨ã大åã«ããæåããªã®ãã¨ã²ã¨ãåç¹ãã¦ãå¿ãè½ã¡çããã
ã人ã¨ãã¦ã©ãããã¹ããããè¨èã§æ ¹æ ãæã£ã¦èª¬æããã®ãå²å¦ã®ä¸åéã¨ãã¦ã®å«çå¦ã§ãããå°è±¡è«ã«éããªãããæ¥æ¬ã§ã¯ãã¾ãå«çã«ã¤ãã¦ç©æ¥µçã«è©±ãåããã¨ã好ã¾ããªããæºã«åãã°è§ãç«ã¤1)ã100å¹´ã¨å°ãåã«å«æ¦ã«æ»å¨ããå°èª¬å®¶ãããåç ´ãã¦ãããéãããå»çè³æºã誰ã«å²ãå½ã¦ããã¨ãããå«ççã«ã¯éè¦ãªè°è«ããè°è«èªä½ãå«ççã§ãªãã¨å«æªæãæã¤äººãããã
è¨ããªããã°ä¼ãããªãããè¨ããã¨ã許ãããæåãè¨ããªãã¦ãä¼ããããè¨ããã¨ã許ãããªãæåã
ããããããªãã¯ã¹ãã©ã¼ã大å¦ã® Faculty of Philosophy ã¯50å以ä¸ã®ãã«ã¿ã¤ã å°ä»»æå¡ã®ä»ã150å以ä¸ã®æå¡ãè¦ããä¸çã§ãé¡ãè¦ãªãå²å¦ã®å°ã 2)ãããã¦å²å¦ã¯ãå½å¤§å¦ã®å¦å£«éç¨ã§æã人æ°ãé«ãããã 3)ã
ãã®å²å¦ç§ã«ãçè
ãæå±ããThe Oxford Uehiro Centre for Practical Ethics4)ã¯è¨ç½®ããã¦ãããAI (Artificial Intelligence) ããã³ãããã¯ãå»çå«çãå«ããææ°ãã¤ä¼çµ±çãªå¿ç¨å«çå¦ã®è°è«ããå»å¦ãå
¬è¡è¡çã人æç§å¦ã®å°éå®¶ã¨ã¨ãã«ãæã«ã¯çµ±è¨å¦ãå®é¨å¿çå¦ã®ã¢ããã¼ãã¨ãæ¥ç¶ããªããããã¤ãããã¯ãªäººç交æµã®ä¸ã§è¡ããã¦ããã
è³å¦ã¯å¥ã®æ©ä¼ã«è²ãã¨ãã¦ãç§ã®èå³ãå¼ããè°è«ã®ä¸ä¾ãæãããªããï¼å½ã»ã³ã¿ã¼ã®ãµã³ããªã³ã°ãã¤ã¢ã¹ã«ãªããªããã¨ãç¥ãï¼ãéå¾³æ§ã®bio enhancement 5)ããå»çã«ãããAIã¨è²¬ä»»ã®å¸°å±6)ãªã©ã§ããã
ãã®ãããªç°å¢ã«èº«ãç½®ããã¡ã以åããæ¶åä¸è¯ã ã£ãè¨èãã¾ãã¾ãæ°ã«ãªã£ã¦ãããããã¯å»çã«ããããä¸ç«ãã¨ããè¨èã§ãããæç®ã«ç»å ´ããé »åº¦ã2000年代ã«å
¥ã£ã¦ããæ¥æ¿ã«å¢å ãã¦ããã使ãããæèã®ä¸ã¤ã«ããæææ±ºå®æ¯æ´ããããã
æææ±ºå®æ¯æ´ã®èæ¯ã«ããèãã¯ãå»çå«çãçå½å«çã®ä¸æ ¸ã¨ãªãååã®ä¸ã¤ã§ãããèªå¾ï¼autonomyï¼ãã®å°éã§ããããã®å«æã¯èªå·±æ±ºå®ã«ã¨ã©ã¾ããªãåºãããããã«ãããä¸äººä¸äººã®ä¾¡å¤è¦³ãéè¦ããå»çãç®æããã¨ãããã¯ã¨ã¦ãéè¦ãªèãã ã
ãããå½äºè
ã®ä¾¡å¤è¦³ããå¤ãã®äººããè¦ã¦ãã®äººã®ãæåï¼best interestï¼ããæãªãå¯è½æ§ãé«ãå ´åããèªå¾ãã¨ãæåããã©ã®ããã«èª¿æ´ãããã«ã¤ãã¦ã¯å¤ãã®ç«å ´ãããè°è«ã¯ç¶ãã¦ããã
ãããããããå»çã«é¢ãããã®ãèªåã®ä¾¡å¤è¦³ãæ¼ãä»ããªããã¨ããæä½éã®çæã¨ãã¦ãä¸ç«ãã¨ããæ
度ãåãããã®ãããããªãããããããã¾ã§ããä¸ç«ãã¨ããæ¦å¿µãå·¡ã£ã¦ã¯ãå¤ãã®æ³¨æãåèµ·ããã¦ãããä¾ãã°æ¢åã®æ¨©åé¢ä¿ã®å¾é
ãè³æºé
åã®ä¸åè¡¡ãæ¯èªããã ãã«ãªããããããªãã
ãããã¯ç¥ã¯æ»ãã 7)ã¨è¨ããã¦ä¹
ããç¾å¨ããã¨ããã³ã¹ãããç§å¦çã ã¨ãããthe view from nowhereãã®âæ£ããâè¦ç¹ã欲ãã¦ããã®ãããããªãã¨éªæ¨ãããã¦ãã¾ããç¾å¨ä½¿ããããããªæå³ã§ã®ã客観æ§ãæ¦å¿µã§ãã19ä¸ç´ã«ãèªçãããæ´å²ççµç·¯ãææããç ç©¶ãããã8)ãã¨ãããããç®ã®åã®äººã«ã¨ã£ã¦æãåã鏿è¢ãé¸ã¶æ¯æ´ãããéãã人éããå®å
¨ã«é¢ãããâæ£ããâè¦ç¹ã¨ãããã®ãã©ãã»ã©æå¹ãªã®ããç§ã«ã¯ã¾ã ããããªãã
è¨åºã®ç¾å ´ã¯ã²ã¨å¼å¸ãæ´ããæãªã©ãªããã®ããã«æ¬¡ããæ¬¡ã«å¯¾å¿ã«è¿½ãããããæ£è
ä¸å¿ããå°å³ããªã©ãã以䏿¤è¨ãã«ããè¨èã®ä¸ãããããã¨é²ããæ©ã¿ã®å
ãééã£ãæ¹åã«åãããªãããã«ãæ·±ãåå³ãããâåãâç®çå°ãå¿
è¦ã§ã¯ãªãã ããããç¾å ´ã¨çè«ã®ã®ã£ãããå°ãã§ãåããæãããããã®ãªãã¯ã¹ãã©ã¼ãã§å¾ããããã¨é¡ãã
ã¨ãããããªãã¨ãèããªããã¯ã©ã¤ã¹ãã»ãã£ã¼ãã»ã«ã¬ãã¸ã«å
¥ãã¨ãæ ç»ãããªã¼ã»ããã¿ã¼ãã§æåãªé£å ã«ãµã¨è¿·ãè¾¼ããç´
ãé»è²ã®èãç©ããç§ã®æ°å¦æãå§ã¾ãã

1) å¤ç®, 1906, èæ; 2) Faculty of Philosophy, University of Oxford website; 3) ãªãã¯ã¹ãã©ã¼ã大妿¥æ¬äºåæä»£è¡¨ã¢ãªã½ã³ã»ãã¼ã«æ°ã¤ã³ã¿ãã¥ã¼; 4) www.practicalethics.ox.ac.uk; 5) Savulescu, 2001, Bioethics; 6) Kiener, 2021, AI & SOCIETY; 7) Nietzsche, 1882, The Gay Science ; 8) ãã¹ãã³ãã2021, 客観æ§
(åæ°£å¤§æã2022.10.20.)
解説ãä¸ç«ã¯ä½è²ã
å®ã¯ã¤ã®ãªã¹ããéããã¦ããä¸ã®åçãè¦ãã¨ãç§ã¯ãããªã¼ã»ããã¿ã¼ã«åºã¦ããè¬å ã ã¨æã£ããããæã£ãæ¹ã¯ã»ãã«ãããã£ãããã®ã§ã¯ãªããã¨æ¨å®ãã¦ãããçãã ãããããã¡ããHPã®å稿ã«å氣大æç ç©¶å¡ https://www.practicalethics.ox.ac.uk/people/dr-taisei-wakeãæ ç»ã®åçãæ·»ä»ããã¯ãã¯ãªããå½¼ãè¨è¼ãã¦ããã¨ãããããã¯åæ°£ç ç©¶å¡ãçå¦ä¸ã®ãªãã¯ã¹ãã©ã¼ã大å¦å ã«ããcollege ã®https://www.chch.ox.ac.uk/é£å ã§ãããåçã§è¦ãã¨ããã«ããã°ã¯ã¼ããã®ãã®ã«ã¿ããããã¤ã®ãªã¹ã«ã¯ããããããªã¼ã»ããã¿ã¼ãããã®æ®å½±å ´æããã¡ãã¡ã«ããããããæ¥æ¬ã§ããã°åã¨åå°ã®ç¥é ãã®éå ·å±ã®ãããªãã®ã«ãããã®ã§ãããã
åæ°£ç ç©¶å¡ã®The Oxford Uehiro Centre for Practical Ethicsã¸ã®çå¦ã決å®ããã®ã¯2020å¹´7æãå®éã«æ¸¡è±ããã®ã¯2022å¹´4æã§ããããã¡ãããã®æéå·®ã¯ã³ããç¦ã®å½±é¿ã§ãããããªãã¯ã¹ãã©ã¼ã便ããã¯ã2022å¹´9æ12æ¥ã®å½å¦ã®ç ç©¶ä¼ã§åæ°£ç ç©¶å¡ã®ããä¸ç«ãã§ãããã¨ã®å²å¦ãã¨é¡ãããã¤ã³ãã¯ãããWebè¬æ¼å 容ã«é¢é£ãã¦ããããªã¢ã¼ãä¼è°ãæ¥éã«æ®åããå°çã®ã©ãã«ãã¦ãç ç©¶ä¼ã«åå ã§ããããã«ãªã£ãã®ã¯ãè¨ãã¾ã§ããªãã³ããç¦ã®ããããã大ããªå¤åã®ã²ã¨ã¤ã§ãããã¨ã³ãããæªããã¨ã°ããã§ã¯ãªãã£ãã¨ããè¨èãé ããããããæ¬¡ã®ç¬éãã³ããã«è¦ããã è¨å¤§ãªæ°ã®æ¹ã ãããã£ãããã¨ããäºå®ã«æ°ã¥ããæ±ºãã¦ãããªè¨èã¯å£ã«ããæ²é»ãããããããã¨ãã¯ãä¸ç«ãä¿ã¤ã®ãæãå®å ¨ãªæ 度ã§ããã
åæ°£ç ç©¶å¡ã®è¬æ¼ãã¼ãã§ããä¸ç«ã¯ãããããæ¶æ¥µçãªä¸ç«ã§ã¯ãªããä¸ç«ã ããæè¦ã表æããªãã¨ãããã¨ã§ã¯ãªããä¸ç«ãªç«å ´ããæè¦ã表æããã¨ããç©æ¥µçãªä¸ç«ãæå³ãã¦ãããæè¦ã¨ã¯ããããä¸ç«ãªç«å ´ãã表æãããã¨ãã«ã¯æ®éçãªä¾¡å¤ããããå¸¸ã«æ£ããããå°ãªãã¨ãéã«èª¤ã£ã¦ãããã¨ã¯ãªãã¨ããæ¼ ç¶ã¨ããã¤ã¡ã¼ã¸ãããããã§ã¯æ¬¡ã®ãããªå ´åã«ã¯ã©ãèããã®ãã¨åæ°£ç ç©¶å¡ã¯åããããã
ã»èå¾
ãçºçãã¦ããã¨ããèå¾
è
ã¨è¢«èå¾
è
ã«å¯¾ãã¦ã第ä¸è
ãä¸ç«ã®ç«å ´ãåãã¨ã¯ã©ããããã¨ã?ãèå¾
ã容èªãããã¨ã«ãªããªãã?
ã»å
å¼å§å©ãçºçãã¦ããã¨ããç¶è¦ªãä¸ç«ã®ç«å ´ãåãã¨ã¯ã©ããããã¨ã? å¹´é·ã®å
ãåã¤ãã¨ã容èªãããã¨ã«ãªããªãã?
ããä¸ã®ãä¸ç«ããæ£ããæ åº¦ã§ãªãã¨ããããã§ã¯æ£ããæ åº¦ã¨ã¯ã©ã®ãããªãã®ã«ãªãã®ã? ä¸ã®ãä¸ç«ãã¨ã¯å¥ã®ç¨®é¡ã®ãä¸ç«ããããã®ã?ããããããä¸ç«ãã¨ã¯ä½ã?
åæ°£ç ç©¶å¡ã®è§£èª¬æã®ä¸ã«ãããã以䏿¤è¨ãä¸å¯è½ãªè¨èãã¸ã®è¨åãããããæ£è ä¸å¿ãããå°å³ãããã®ä¾ã¨ãã¦æãããã¦ãããããããè¨èã¯ãããã°çµ¶å¯¾ã«æ£ãããåè«ã許ããªãã¨ããæ§è³ªãæã£ã¦ãããããä¸ç«ãããã®ä¸ã¤ãããããªããããã¦ãçµ¶å¯¾ã«æ£ãããåè«ã許ããªããã¨ã¯ããªãã¡ãåã«ãã®è¨èã¯ãæ£ãããã¨ãããã¨ä»¥å¤ã«ã¯ä½ãå ·ä½çãªæå³ãæãã¦ããªãããã¤ã¦ããæææ±ºå®æ¯æ´ãã«ããã¦æã¾ããæ åº¦ã¨ãã¦ãä¸ç«ããææ¡ããæ¡ç¨ãããæç¹ã§ã¯ããä¸ç«ãã¯ããããæ¯ã¥ãã¦ãããã®ãããªçã ããè¨èã ã£ãã®ã§ãããããããæ¥éã«è²è¤ªããä»ã§ã¯ãã ãæ£ãããã¨ããç½ããã³ããå ¨é¢ã«å¡ãããåãªãè¨å·ã¨åãã¦ããã®ã§ã¯ãªããã
ãæ£ãããã¨ã¹ãã¬ã¼ãã«è¨ãã¨éã«è¡æ£èã空æ°ãæ¼ããããããå¥ã®è¨èã«è¨ãæããã¨ç©ºæ°ã¯å¼·å¶æ£å¸¸åããããããããè¨èã¯ä¾¿å©ã§å®å ¨ãªã®ã§å¤ã人ãå£çä¼¼ã常å¥å¥ã«ãªãããå¯ãæ·»ããããã®ä»£è¡¨çãªä¸ä¾ã§ãããããã¨ããã³ã¹ããã社ä¼å®è£ ããåé¡ã§ãããããããè¨èãå£ã«ããèªåã¯ãã®è¨èã«ãã£ãè¡åããã¦ããã¨è¨ãã°ãããã¯ãèªåã¯æ£ãããã¨å®£è¨ãã¦ãããã¨ã¨åå¤ã§ãããã ãããå¯ãæ·»ãããã¨ããã³ã¹ãã社ä¼å®è£ ããªã©ã®è¨èã人ãçºããã®ãèãã¨ãå®ã«è»½èã§ãããã«ã¯éãã¨ç§ãªã©ã¯æãã®ã ããã¾ãããã¾ã§ã¯ããã¨ããããéããæ¬å½ã«é²ãã«ãªãã®ã¯ãããããè¨èã®å¦å®å½¢ã使ãããå ´åã§ããããå¯ãæ·»ã£ã¦ããªããã¨è¨ãã°ãããã¯å¼·ãæ¹å¤ã®è¨èã«ãªãããæ£ããããç½ã ã¨ããã°ããå¯ãæ·»ã£ã¦ããªããã¯é»ãªã®ã§ããããã¯ããå¯ãæ·»ãããä½ãæå³ãã¦ãããã¯å¸èåãããããªãã¯å¯ãæ·»ã£ã¦ããªããã¨ã¯ããããªãã¯æ£ãããªããã¨æ¹å¤ãã¦ãããã¨ã«çãããåè«ã許ããªãæ¹å¤ã»ã©å±éºãªãã®ã¯ãªãããå·®å¥ãã¨ããæ¹å¤ãç¹ã«å±éºãªãã®ã®ä¸ã¤ã§ããããã¯å·®å¥ã ãã¨æ±ºãã¤ããã°ãç¸æã¯ãã以ä¸çºè¨ãããã¨ãäºå®ä¸ç¦ãããããã®å対ã®ãå·®å¥ã§ãªããã¨ãããçºè¨ãå¸¸ã«æ£ããã¨ãããã¨ã«ãªãããå¯ãæ·»ããããå·®å¥ãããå®ã«éãè¨èã§ããããä¸ç«ããããããè¨èã«ãªãå±éºãç¸å½ã«åãã è¨èã§ãããã¨ããåæ°£ç ç©¶å¡ã®è¬æ¼ãè´ãã¦çè§£ãããã¨ãã§ããããä¸ç«ããªã©ã¨ãããã¨ãããããããã®ããã客観æ§ãã¨åæ§ããã çæ³çãªãç½ããæå³ãã¦ããã ãã§ãå®ä½ã¯ã©ãã«ããªãã®ã§ã¯ãªããã
ãä¸ç«ããã客観æ§ãããé常ã«å¤ãã®ç¥çæ´»åã®ãã¼ã¹ã«ããæ¦å¿µã§ããããã®è¨èãåºãããã¨äººã¯ãã以ä¸èãããã¨ãªãããã¯æ£ããã¨ç´å¾ããã®ã常ã§ãããã ããã®æ£ããã¨ä¿¡ãã¦ãããã¨ã¯æ£ããã®ããæ£ãããªãã®ããããæ£ãããªãã¨ããã°ããããã¯ãæ£ãããªãé¨åãããã°ãå»çæ´»åãç§å¦ããã®åå°ã失ããããã¦èå¼±ãªãã®ã«ãªããããããåé¡ã追究ã§ããå¦åã¯å²å¦ä»¥å¤ã«ã¯ãªããå²å¦ã®çåããªãã¯ã¹ãã©ã¼ã大å¦å²å¦ç§ã¦ã¨ããå¿ç¨å«çã»ã³ã¿ã¼ã§æåéãå²å¦ã«æµ¸ãæ¥ã ãéã£ã¦ããåæ°£ç ç©¶å¡ã®æ¬¡ã®ã¬ã¯ãã£ã¼ã«å¤§ãã«æå¾ ãããã
(ææ¾å¤ªéã2022.10.31.)
æé£ã¿ã¤ãã¨ææçã®åä½µãæé£é害ã®ãªãã£ã¼ãã£ã³ã°æã®è¡çæåã®æä½å¤ãäºæ¸¬ãã
è¹å±±éé(è¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§é¨é·)Funayama M, Koreki A, Mimura Y, Takata T, Ogino S, Kurose S, Shimizu Y, Kudo S. : Restrictive type and infectious complications might predict nadir hematological values
among individuals with anorexia nervosa during the refeeding period: a retrospective study. Journal of Eating Disorders (2022) 10:64 https://doi.org/10.1186/s40337-022-00586-x
ãã¯ããã«ãæé£é害ã«ããã¦è¡çæåãä½ä¸ãããã¨ã¯å ±åããã¦ãããããã®æ©åºã¯æããã§ã¯ãªããç¹ã«å ¥é¢å¾ã®ãªãã£ã¼ãã£ã³ã°æã«ã¯è¡çæåãæ´ã«ä½ä¸ããï¼ï½ï¼é±éå¾ã«æ¹åãããã¨ãå¤ãããããã£ã¦ããã®ææã®è¡çæåã®æä½å¤ã«é¢ä¿ããå åãæããã«ãããã¨ã¯è¨åºä¸éè¦ã§ãããä»åããããã¯ãæé£é害ã®ãªãã£ã¼ãã£ã³ã°æã®è¡çæåã®å¤ã«å½±é¿ãåã¼ãå åãæ±ããã
ãæ¹æ³ã1999å¹´ãã2018å¹´ã¾ã§ã«è¶³å©èµ¤ååç é¢ç¥çµç²¾ç¥ç§ç æ£ã«å ¥é¢ããæé£é害ã®101å ¥é¢ä¾ï¼è¤æ°åã®å ¥é¢ä¾ãå«ã55åï¼ã対象ã¨ããããã¢ã°ããã³ãç½è¡çãè¡å°æ¿ã¨ãã£ãï¼ã¤ã®è¡çæåã«ã¤ãã¦ãå ¥é¢æããªãã£ã¼ãã£ã³ã°æã®æä½å¤ããã®2æç¹ã§ã®æ¸å°å²åã¨ãã£ãï¼ã¤ã®å¤ãæ±ããããããã®å¤ã¸ã®èª¬æå åã¨ãã¦ç½¹ç æéãæ§å¥ãæé£/éé£ååã¿ã¤ããbody mass indexãBUN/Cræ¯ãææçã®æç¡ãã«ããªã¼æåéãæ ¢æ§è èç ï¼ãã¢ã°ããã³ã®ã¿ï¼ãALTï¼è¡å°æ¿ã®ã¿ï¼ãç¨ããä¸è¬åç·å½¢æ··åã¢ãã«ã«ã¦çµ±è¨è§£æãè¡ããå¤éæ¯è¼è£æ£ãè¡ã£ãã
ãçµæãå ¥é¢æã®ãã¢ã°ããã³ã¯12.1 ± 2.7 g/dlãã22.3% æ¸å°ãã¦9.4 ± 2.5 g/dlã«ä½ä¸ããã赤è¡çã®è¼¸è¡ãå¿ è¦ã¨ãã12å ¥é¢ä¾ã®ãã¡5å ¥é¢ä¾ï¼41.7%ï¼ã«ããã¦ã¯ãå ¥é¢æã®ãã¢ã°ããã³å¤ã¯æ£å¸¸ç¯å²å ã§ãã£ããç½è¡çã¯5387 ± 3474/μlãã33.6%æ¸ã3576 ± 1440/μlã«ãè¡å°æ¿ã¯226 ± 101 Ã103/μlãã24.3%ã®æ¸å°ãèªãã¦171 ± 80 Ã103/μlã¨ä½ä¸ããããããã®è¡çæåã®æä½å¤ã¯å ¥é¢5ï½10æ¥å¾ã«åºç¾ããããã¢ã°ããã³ã®æä½å¤ã¨ç½è¡çã®æä½å¤ãªã©ã3ã¤ã®è¡çæåã®éã§ã¯æä½å¤ãæ¸å°å²åãä¸å¿ã«ææãªç¸é¢ã示ãããä¸è¬åç·å½¢æ··åã¢ãã«ããã¯ãæé£ã¿ã¤ãã¯ç½è¡çã®æä½å¤ã«é¢é£ããææçã®åä½µï¼ä¸»ã«èª¤å¥æ§èºçã¨ã«ãã¼ãã«é¢é£ã®å°¿è·¯ææçãæè¡çï¼ã¯ãã¢ã°ããã³ã®æä½å¤ã¨ä½ä¸å²åãããã«ã¯èµ¤è¡çã®è¼¸è¡ã®å¿ è¦æ§ã¨é¢é£ãã¦ããã
ãèå¯ãæé£éå®³å ¥é¢ä¾ã®ãªãã£ã¼ãã£ã³ã°æã®è¡çæåã®ä½ä¸ã¯ãæé£ã¿ã¤ãã¨ææçã®åä½µã¨ãã£ãå åã«ãã£ã¦äºæ¸¬ã§ããå¯è½æ§ããããç¹ã«ãææçã®ã³ã³ããã¼ã«ã¯éè¦ã§ããããèª¤å¥æ§èºçãã«ãã¼ãã«é¢é£ã®ææçã¯ãå¯ããããé²ãã ãä¸å¿ è¦ãªã«ãã¼ãã«ãæå»ããããããã¨ã§ããç¨åº¦äºé²ã§ãããã¨ãã§ãããã¾ããå ¥é¢æã«ãã¢ã°ããã³å¤ãæ£å¸¸ç¯å²å ã§ãã£ã¦ã赤è¡çã®è¼¸è¡ãå¿ è¦ã¨ããä¾ãå°ãªããªããããæé£ã¿ã¤ããææçã®åä½µãæããä¾ãä¸å¿ã¨ãã¦ãæé£é害ã®å ¥é¢å¾ï¼ï½ï¼é±éã®éã¯å ¥é¢æã®ã¿ãªããå ¥é¢å¾ã«è¿½å ã®è¡æ¶²æ¤æ»ãå¿ è¦ã§ãããã
(è¹å±±ééã2022.9.1.)
åæã®Posterior cortical atrophyã«ãããè¦ç©ºéã¯ã¼ãã³ã°ã¡ã¢ãªã®ä½ä¸ã¯ã¿ããã³ã°ã¹ãã³èª²é¡ã§æãããã
è¹å±±éé(è¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§é¨é·)Michitaka Funayama, Taketo Takata, Yoshitaka Nakagawa, Kosaku Sunagawa, Asuka Nakajima, Hiroaki Kawashima, Masaru Mimura.
Visuospatial working memory dysfunction from tapping span test as a diagnostic tool for patients with mild posterior cortical atrophy
Scientific Reports. 11, 10580. https://doi.org/10.1038/s41598-021-90159-w, 2021
ãèæ¯ãPosterior cortical atrophy (PCA) ã¯50~65æ³ã¨ãã£ãæ¯è¼çè¥å¹´ã«çºçãã夿§ç¾æ£ã®ã²ã¨ã¤ã®å½¢ã§ãããããããåææ®µéã®PCAã診æãããã¨ã¯ãã°ãã°å°é£ã§ããã診æã¾ã§ã«æéãããã£ãã誤診ãããããã£ãããããã¨ãç¥ããã¦ããããã®çç±ã¯ãçç¶é¢ã«ããã¦è¦ç©ºéé害ãå ¸åçã§ãããããã®ä»ã®è¨èªãè¨æ¶ãè¡åã®ãããã®å´é¢ãã»ã¼æ£å¸¸ã«ä¿ããããã¨ãæã大ããªè¦å ã§ãããããã«ãç¥çµå¿çæ¤æ»ã«ããã¦ãMini Mental State Examination (MMSE)ã®å³å½¢æ¨¡å課é¡ãé¤ãã¦ãè¨åºç¾å ´ã§ç°¡ä¾¿ã«ã§ããæ¤æ»æ³ãç¥ããã¦ããªããã¨ãä¸å ã§ãããå®éã«åæã®PCAã«ããã¦ã¯ãMMSEãHasegawa Dementia Scale-Revisedï¼HDS-Rï¼ã¨ãã£ãç°¡æãªèªç¥æ©è½æ¤æ»ã§ã¯æ£å¸¸å¤ã«ãªããã¨ãã»ã¨ãã©ã§ãããããããå¤ãã®PCAä¾ã§è¥å¹´çºçã«ããããããçºçããæ°å¹´ã®ãã¡ã«å°±å´ãå°é£ã¨ãªããå®¶åºçæ´»ã§ãè»ã®é転ãé»å製åã®ä½¿ç¨ãæçãé£å¨ã®çä»ããééã®æ¯æããçè¡£ãå ¥æµ´ãªã©æ¥å¸¸çæ´»ã«æ¬ ãããªãè½åã®ä½ä¸ãç®ç«ã¤ããã«ãªããå ¸åçãªã¢ã«ããã¤ãã¼ç ãããæ¥å¸¸çæ´»ã§ã®åé¡ãå¤ãã¨ãããããããPCAã®æ£è ãæ¯æ´ããéã«ãã¾ãã¯é©åãªè¨ºæã¨çç¶ã®ã¡ã«ããºã ã®ææ¡ãå¿ é ã§ãããä»åããããã¯è¨åºç¾å ´ã§æ¥µãã¦æè»½ãªã¿ããã³ã°ã¹ãã³èª²é¡ãåæã®PCAã®è¨ºæã®è£å©ã«ãªãå¾ãããã¾ããã¿ããã³ã°ã¹ãã³èª²é¡ã®æç¸¾ãPCAã§è¦ç©ºéã¯ã¼ãã³ã°ã¡ã¢ãªã®æç¸¾ã表ãã¦ããã®ãã©ããã«ã¤ãã¦èª¿ã¹ãã
ãæ¹æ³ã対象ã¯Clinical Dementia Rating (CDR) 0.5ã®æ®µéã®PCA 8ä¾ï¼61.5±5.6æ³ï¼ã¨å¹´é½¢ãåãããCDR 0.5ã®å¥å¿åã¢ã«ããã¤ãã¼ç ï¼ADï¼9ä¾ï¼61.4±6.3æ³ï¼ã両群ã«MMSEã¨HDS-Rã«å ãã¦ãæ¨æºæ³¨ææ¤æ»æ³ã®ã¿ããã³ã°ã¹ãã³èª²é¡ã¨æ°å±èª²é¡ãåé ã¨éé ã§è¡ã£ããè¦ç©ºéã¯ã¼ãã³ã°ã¡ã¢ãªã«é¢ãã¦é å»¶ãããã³ã°èª²é¡ã¨ç§»åãããããã§çµã°ããå³å½¢çµã¿ç«ã¦èª²é¡ãè¡ã£ãããããã®æ¤æ»ã®åæã¨ãã¦ã2ã¤ã®ç©ï¼2ã¤æ¡ä»¶ï¼ã¨3ã¤ã®ç©ï¼3ã¤æ¡ä»¶ï¼ã®éã®ä½ç½®é¢ä¿ãåãä½ç½®é¢ä¿èª²é¡ãè¡ã£ãã
ãçµæãPCA 8ä¾ã¨ããç®çã®ãã®ã«è¦ç·ãåãããã¨ãã§ããªãç²¾ç¥æ§æ³¨è¦éº»çºã¨è¦è¦ã®ãã¨ã§ãã®ãã¤ãããªãè¦è¦å¤±èª¿ã¯èªãããåæã«è¤æ°ã®ãã®ã«è¦è¦ã§æ³¨æãåãããã¨ãå°é£ã§ããèå´ååæå¤±èªï¼è¦è¦æ§æ³¨æé害ï¼ãè¦ç©ºéé害ã®ä¸æ ¸çç¶ã§ãã£ããä½ç½®é¢ä¿èª²é¡ã¯2ã¤æ¡ä»¶ã§PCA8ä¾ã¨ãå ¨åæ£çãããã3ã¤æ¡ä»¶ã§ã¯PCA8ä¾ä¸2ä¾ã«ããã¦èª¤çãèªããã両群éã§MMSE, HDS-Rãæ°å±èª²é¡ã®æç¸¾ã§ã¯å·®ãèªããªãã£ãããã¿ããã³ã°ã¹ãã³ã®æç¸¾ã¯åé ï¼PCA 2.1±1.1, AD 4.2±0.7, p<0.01ï¼ãéé ï¼PCA 0.9±1.2, AD 3.1±0.8, p<0.01ï¼ã¨ãã«PCA群ãä½ãã£ããæ°å±ã®ã¹ãã³ããã¿ããã³ã°ã¹ãã³ã®ã¹ãã³ãå¼ããå·®åã¯åé ï¼PCA 3.5±0.9, AD 0.7±1.1, p<0.01ï¼ãéé ï¼PCA 2.0±1.1, AD -0.1±0.6, p<0.01ï¼ã¨ãã«PCA群ã§å¤§ãããæ°å±ã¨æ¯ã¹ã¦ã¿ããã³ã°ã¹ãã³ã®æç¸¾ã®ä½ä¸ãPCA群ã«ããã¦ç®ç«ã£ããPCA群ã«ãããã¿ããã³ã°ã¹ãã³èª²é¡ã®æç¸¾ã¯ãè¦ç©ºéã¯ã¼ãã³ã°ã¡ã¢ãªèª²é¡ã¨å¼·ãç¸é¢ã示ãã(r=0.64~0.93)ã
ãèå¯ãPCA群ã§ã¯æ°å±èª²é¡ã¯å¥å¿åã¢ã«ããã¤ãã¼ç ã¨åç¨åº¦ã®æç¸¾ã§ãã£ãããã¿ããã³ã°ã¹ãã³èª²é¡ã®æç¸¾ã¯æ¥µãã¦æªããåé ã§2æ¡ç¨åº¦ãéé ã§ã¯ã»ã¨ãã©ã§ããªãã¬ãã«ã§ãã£ããå®éãPCAã®è¦ç©ºéé害ã¯Bálint syndromeã®ä¸ã§ãç²¾ç¥æ§æ³¨è¦éº»çºãè¦è¦å¤±èª¿ã¨ãã£ãçç¶ã¯æé度ã«ãªãã¾ã§åºç¾ãããåæãã䏿ã¾ã§ã¯åæã«èå´ååæå¤±èªã主çç¶ã§ããããããã£ã¦ãåæã®PCAã§ã¯ãç²¾ç¥æ§æ³¨è¦éº»çºããªãã®ã§æ¤æ»èªä½ã¯å®æ½ãå¯è½ã§ãããããã«è¦è¦å¤±èª¿ããªãã®ã§æã使ãã¿ããã³ã°ã¹ãã³èª²é¡ã§ãã£ã¦ãè¦ç©ºéã¯ã¼ãã³ã°ã¡ã¢ãªã®ä½ä¸ãåæ ã§ããã¨èããããããããã£ã¦ãè¦ç©ºéé害ã䏿 ¸çç¶ã¨ããPCAã«ããã¦ã¿ããã³ã°ã¹ãã³èª²é¡ã¯è¨ºæã®è£å©ã¨ãªãå¯è½æ§ã示ãã¦ããã æ¬ç ç©¶ããã¯ã¿ããã³ã°ã¹ãã³èª²é¡ã®æç¸¾ãè¦ç©ºéã¯ã¼ãã³ã°ã¡ã¢ãªã®è½åãåæ ãã¦ãããã¨ãæããã«ãªã£ãã以åããPCAã§ã¯ãã®ä¸»çç¶ã§ããè¦ç©ºéé害ã®ãã¼ã¹ã¨ãªãè¦ç©ºéã¯ã¼ãã³ã°ã¡ã¢ãªãä½ä¸ãã¦ããã¨ããå ±åãæ°ä¾ã®ç ç©¶ã§è¨ããã¦ããããæ¬çºè¡¨ã§ã¯ä»ã¾ã§ãããå¤ã便°ã§ãããæããã«ããã
(è¹å±±ééã2022.8.1.)
ååã¨ãã½ã¼ãç²¾ç¥ç
ã®ä¸ã§ã®èªå·±å
ç«æ§è³çã¨çµ±å失調çã¹ãã¯ãã©ã é害ã¨ã®éå¥
è¹å±±éé(è¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§é¨é·)Michitaka Funayama, Akihiro Koreki, Taketo Takata, Shin Kurose, Tetsuya Hisamatsu, Atsushi Ono, Tatsuhiko Yagihashi, Jin Mizushima, Yoshikazu Yagi, Satoyuki Ogino, Hiroki Oi, Yu Mimura, Yusuke Shimizu, Shun Kudo, Akira Nishi, Hiroo Mukai.
Differentiating autoimmune encephalitis from schizophrenia spectrum disorders among patients with first-episode psychosis. Journal of Psychiatric Research151, 419-426, 2022
https://doi.org/10.1016/j.jpsychires.2022.05.008
ãã¯ããã«ãååã¨ãã½ã¼ãç²¾ç¥ç ã®åå ã®å¤ãã¯çµ±å失調çãä¸å¿ã¨ããç²¾ç¥ç¾æ£ã§ããããã¾ãã§ã¯ãããã®ã®èªå·±å ç«æ§è³çã®çä¾ãååã¨ãã½ã¼ãç²¾ç¥ç ã®ä¸ã«ç´ãã¦ãããã¨ããããèªå·±å ç«æ§è³çã¯ç²¾ç¥ç¾æ£ã¨ã¯æ²»çæ³ãæ ¹æ¬çã«ç°ãªããããã«æ©æã®æ²»çä»å ¥ã«ãã£ã¦è¯å¥½ãªäºå¾ãå¾ãããããã両è ã®éå¥ã¯è¨åºä¸æ¥µãã¦éè¦ã§ãããã¨ãããããã®ï¼ã¤ã®ç¾æ£ã®ç²¾ç¥çç¶ã«é¢ããç¸éç¹ã¯ä»ã¾ã§æããã«ãªã£ã¦ããªããä¾ãã°ãæNMDAå容ä½è³çãä¸å¿ã¨ããèªå·±å ç«æ§è³çã®ç²¾ç¥çç¶ã¯ãçµ±åå¤±èª¿çæ§ã®çç¶ãå¹»è¦ã»å¦æ³ãé¡å¾ªç°ç²¾ç¥ç ï¼éå®åç²¾ç¥ç ï¼ãªã©ã¨è¨è¼ããã¦ããã®ã¿ã§ãããä»åããããã¯ãã®ä¸¡è ãæ¯è¼ããcase control studyãä¸çã§åãã¦è¡ã£ãã対象ãååã¨ãã½ã¼ãç²¾ç¥ç ã®çä¾ã¨ãã¦ã徿¹è¦çã«ãã®ï¼ã¤ã®ç¾æ£ã®ç²¾ç¥çç¶ã®éãã調ã¹ãã
ãæ¹æ³ãè¶³å©èµ¤ååç é¢ç¥çµç²¾ç¥ç§ç æ£ã«2001å¹´ãã2021å¹´ã®æéã«ååã¨ãã½ã¼ãç²¾ç¥ç ã®ããã«å ¥é¢ããçä¾ã®ä¸ã®ãèªå·±å ç«æ§è³ç10ä¾ã¨çµ±å失調çã¹ãã¯ãã©ã é害177ä¾ã対象ã¨ãããç²¾ç¥çç¶ãä¸å¿ã«ãç¥çµçç¶ãç¥çµå¿çå¦çæè¦ãæ¢å¾æ´ãç æ£çæ´»ã®èªç«åº¦ï¼çè·å¿ è¦åº¦ï¼ã«ã¤ãã¦ãã«ã«ã調æ»ãè¡ããä¸¡ç¾¤ã§æ¯è¼ãè¡ã£ããç²¾ç¥çç¶ã¨ãã¦ã¯å¹»è¦å ¨è¬ãå¹»è¦ãå¹»è´ãã·ã¥ãã¤ãã¼ä¸ç´çç¶ã®ä¸ã®è¨èªå¹»è´ï¼èªå·±ã®è¡çºã«éä¼´ãå£åºãããå½¢ã®å¹»è´ãªã©ï¼ãç¥è¦å¤å®¹ã妿³å ¨è¬ãã·ã¥ãã¤ãã¼ä¸ç´çç¶ã®ä¸ã®å¦æ³æ§èªå·±ä½é¨ï¼ããããä½é¨ãªã©ï¼ãã·ã¥ãã¤ãã¼ä¸ç´çç¶å ¨è¬ã妿³æ§èª¤èªçå群ãç·å¼µç çå群ãé£åå¼ç·©ãåãä¸ãããçµ±è¨å¦çææ³ã¨ãã¦ã¯ãã£ãã·ã£ã¼æ£ç¢ºç¢ºçæ¤å®ãç¨ããç²¾ç¥çç¶ã«é¢ãã¦ã¯ãã³ãã§ãã¼ãå¤éæ¯è¼æ¤å®ãç¨ããã
ãçµæãèªå·±å ç«æ§è³çã®ç²¾ç¥çç¶ã«ã¯ç¥è¦å¤å®¹ãï¼p=0.019ï¼å¤ãã䏿¹ã§çµ±å失調çã¹ãã¯ãã©ã é害ã«å¤ãç²¾ç¥çç¶ã«ã¯ã·ã¥ãã¤ãã¼ä¸ç´çç¶å ¨è¬ï¼p=0.017ï¼ã 妿³å ¨è¬ï¼p=0.014ï¼ãé£åå¼ç·©ï¼p=0.003ï¼ãæãããããç¹ã«ãã·ã¥ãã¤ãã¼ä¸ç´çç¶ã¨é£åå¼ç·©ã¯çµ±å失調çã¹ãã¯ãã©ã é害ã®ã¿ã«åºç¾ãããã¾ãããããããè¨èªçç¶ã¯èªå·±å ç«æ§è³çã®ã¿ã«ãARMSï¼ç²¾ç¥ç çºçå±éºç¶æ ï¼ã®æ¢å¾ã¯çµ±å失調çã¹ãã¯ãã©ã é害ã®ã¿ã«åºç¾ãããç æ£çæ´»ã®èªç«åº¦ã¯çµ±å失調çã¹ãã¯ãã©ã éå®³ã®æ¹ãé«ãã£ãã
ãèå¯ãèªå·±å ç«æ§è³çã®åæã«ããã¦ã¯ããããããä¸éæéåãªã©ã®ç¥çµçç¶ãåºç¾ããåã«ç²¾ç¥çç¶ã忝ã«ç«ã¤ãã¨ãå¤ããã¾ããMRIã髿¶²æ¤æ»ã¨ãã£ãæ¤æ»ããã®å ´ã§è¡ããã¨ãã§ããªãæ²»çç°å¢ã§ãããã¨ãå°ãªããªããããªãã¡ãç²¾ç¥çç¶ãå ã«èªå·±å ç«æ§è³çã¨çµ±å失調çã¹ãã¯ãã©ã é害ã®éå¥ãè¦æ±ãããå ´é¢ããããæ¬ç ç©¶ã§æããã«ãªã£ãç¥è¦ããéå¥ã®ä¸å©ãMRIã髿¶²æ¤æ»ãªã©ã®è©³ç´°ãªæ¤æ»ã®å¿ è¦æ§ã®æç¡ã®ç®å®ã«ãªããããããªãã
(è¹å±±ééã2022.7.1.)
ã¢ãã·ã¼ãè±æå¶ãç²¾ç¥ç¾æ£ã®ä½µåãå¤å·æ§è³æå·å¾ã®å°±å´ç¶æ³ã«é¢ä¿ãã
è¹å±±éé (è¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§é¨é·)Funayama M, Nakagawa Y, Nakajima A, Kawashima H, Matsukawa I, Takata T, Kurose S.
Apathy level, disinhibition, and psychiatric conditions are related to the employment status of people with traumatic brain injury.
Am J Occup Ther 2022 Mar 1;76(2):7602205060. doi: 10.5014/ajot.2022.047456.
ãèæ¯ã
髿¬¡è³æ©è½é害ãèµ·ããç¾æ£ã®ä¸ã§ãå¤å·æ§è³æå·ã¯è³åä¸ã¨æ¯è¼ããã¨è¥å¹´ã«åºç¾ããå²åãå¤ãããããã£ã¦ãå¤å·æ§è³æå·å¾ã«å°±å´ã«ã¤ãªãããã¨ã¯ãªãããªãã¼ã·ã§ã³ã«ããã¦æ¥µãã¦éè¦ãªãã¼ãã§ãããéå»ã®ç ç©¶ããã¯ãå¤å·ã®éç度ãæå·åã®å°±å´ç¶æ³ãå°±å´ãç®çã¨ãããªãããªãã¼ã·ã§ã³ã¸ã®åå ãèº«ä½æ©è½ãèªç¥æ©è½ãæ
åé¢ã®å®å®æ§ãªã©ãå°±å´ã¸ã®äºæ¸¬å åã¨ãã¦æãããã¦ãããããããå¤å·æ§è³æå·å¾ã«ãã°ãã°åºç¾ããã¢ãã·ã¼ãè±æå¶ãç²¾ç¥ç¾æ£ã®æç¡ã¨ãã£ãè¦ç´ ã¯ãéå»ã®ç ç©¶ã«ããã¦å
æ¬ãã¦åãä¸ãããããã¨ã¯ãªãã£ããä»åããããã¯ï¼Funayama et al 2022ï¼ãããã®å åãèæ
®ãã¦å¤å·æ§è³æå·å¾ã®å°±å´ç¶æ³ã調ã¹ãã
ãæ¹æ³ã
ããããã対象ã¨ããä¾ã¯ã2015å¹´ãã2020å¹´ã¾ã§ã«è¶³å©èµ¤ååç
é¢ã¨æ±æ¸å·ç
é¢ã®é«æ¬¡è³æ©è½å¤æ¥ãå診ãã18æ³ãã65æ³ã¾ã§ã®å¤å·æ§è³æå·ä¾110åã§ãããå°±å´ç¶æ³ã¯3段éï¼ä¸è¬å°±å´ãç¦ç¥çå°±å´ãå°±å´ãªãï¼ã«åé¡ãããå°±å´ç¶æ³ã説æããå åã¨ãã¦ãæ£è
èæ¯ï¼å¹´é½¢ãæ§å¥ãæè²æ´ãæå·ããã®çµéå¹´æ°ãæå·åã®å°±å´ç¶æ³ãå¤å·ã®éç度ãã¦ãããã®æç¡ãç²¾ç¥ç¾æ£ã®æç¡ï¼ãéåæ©è½ï¼FIMã®æ©è¡ã»è»ããè©ä¾¡é
ç®ï¼ãèªç¥ã»ç²¾ç¥æ©è½ï¼ç¥è½ãWAIS-â
¢ã®è¨èªæ§ããã³å使§IQãã¨ãã½ã¼ãè¨æ¶ããªãã¼ãã¼ãè¡åè¨æ¶æ¤æ»ã®æç¸¾ãéè¡æ©è½ãã¦ã¤ã¹ã³ã³ã·ã³ã»ã«ã¼ãã»ã½ã¼ãã£ã³ã°ã»ãã¹ãã®éæã«ãã´ãªã¼æ°ãã¢ãã·ã¼ãæ¨æºææ¬²æ¤æ»æ³ã®é¢æ¥ã«ããææ¬²è©ä¾¡ã¹ã±ã¼ã«ãè±æå¶ãBADS質åç´ã®è±æå¶ã«é¢ä¿ãã5é
ç®ãç¨ãã¦è©ä¾¡ï¼ãç¨ãããçµ±è¨ææ³ã«ã¯ç·å½¢å¤å¥åæãç¨ããæææ°´æºãp<0.05ã¨è¨å®ããã
ãçµæã
è¯å¥½ãªå°±å´ã¸ã®é¢é£å åã¨ãã¦ãç²¾ç¥ç¾æ£ãèªããªããã¨ï¼p<0.01ï¼ãã¢ãã·ã¼ï¼p<0.01ï¼ãè±æå¶ã®ç¨åº¦ï¼p<0.05ï¼ã軽ããã¨ãè¥å¹´ã§ãããã¨ï¼p<0.05ï¼ãæãããããæ¬ç ç©¶ã®åé¡ç¹ã¯ç
èãæ§æ ¼å¾åãå°±å´ãç®çã¨ãããªãããªãã¼ã·ã§ã³ã¸ã®åå ãçµæ¸ç¶æ³ãèæ
®ã«å
¥ãã¦ããªããã¨ã§ããããããã®åé¡ç¹ã¯ãããã®ã®ãå¤å·æ§è³æå·å¾ã®å°±å´ç¶æ³ã«ã¯ãç²¾ç¥ç¾æ£ã®ä½µåãã¢ãã·ã¼ãè±æå¶ã¨ãã£ãç²¾ç¥çç¶ã大ããé¢é£ããå¯è½æ§ã示ãããã
ãæ¬ç ç©¶ã示åãããã¨ã
ãã®çµæããªãããªãã¼ã·ã§ã³ã®ç¾å ´ã¸ç¤ºåããç¹ã¯ä»¥ä¸ã®ããã§ããããå¤å·æ§è³æå·å¾ã®å人ã«åºç¾ãããããã®çç¶ã軽æ¸ããããããªãããªãã¼ã·ã§ã³ã«é¢ããããããã¯ããã®äººãã®äººã«ãã£ããã¤ã©ã¼ã¡ã¤ãçãªå¯¾å¿ãããå¿
è¦ãããããã¡ãããã®ç¹ã¯ãä¸è¨ã«æãã並åããç²¾ç¥ç¾æ£ã®ã¿ã対象ã¨ãã¦ããããã§ã¯ãªããä¾ãã°ãã¢ãã·ã¼ãå¼·ãç¶æ³ã§ãã£ã¦ããæ¬äººã®ããæ°ãã§ããããªå°±å´å
容ãå°±å´è¨ç·´å
容ãæä¾ãããã¨ã§å°±å´ãå°±å´è¨ç·´ã«ã¤ãªããå ´åãå°ãªããªããè±æå¶ã«é¢ãã¦ã¯ãç²¾ç¥ç§ãå¿çç³»ããã®ã¢ããã¤ã¹ãæå¹ã§ãããä¾ãã°ãç¦ç¥çå°±å´ã«é¢ããç¦ç¥åéã®è·å¡ã¯ãå©ç¨è
ã«åªãããããã¨ã ããéè¦ã§ããã¨èãã¦ãããã¨ãå¤ããããããè±æå¶ãé¡èãªå©ç¨è
ã«é¢ãã¦ã¯ããããã®è·å¡ã®é¢ããæ¹ã«ãã£ã¦ãããå©ç¨è
ã®è±æå¶ãæªåããããã¨ãå°ãªããªãããã¡ããåªããæ¥ãããã¨ã¯åºæ¬ä¸ã®åºæ¬ãªã®ã§ã¯ãããããã®ä¸æ¹ã§é©åãªéçè¨å®ãå®ãããã¨ãéè¦ã§ããããã®æ¹æ³ã«ãã£ã¦å©ç¨è
ã®è±æå¶ã®è»½æ¸ã«ã¤ãªãããã¨ãå¤ãããããã¯ãéå£ã®ãªãããªãã¼ã·ã§ã³ã®å ´ãå©ç¨ãã¦è±æå¶ã®å¼·ãå人ãå¨å²ãããã£ã¼ãããã¯ãããããã¨ãã²ã¨ã¤ã®æ¹æ³ã§ãããã
æ¬ç ç©¶ã®çµæãã²ã¨ã¤ã®è¸ã¿å°ã¨ãã¦ãå¤å·æ§è³æå·å¾ã®å°±å´ã«å¯¾ãã¦ããããã¢ããã¼ããæ¬¡ã
ã«éçºããããã¨ãå¼·ãåæããã
(è¹å±±ééã2022.6.1.)
MRI-SPECT-EEGã§åæã«èªããç°å¸¸æè¦ãèè¡ã¸ã®èå¼±æ§ã示åããä¸éæ§å
¨å¥å¿çã®ä¸ä¾
䏿æ (æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ã»ç¥çµç§å¦æå®¤ã大å¦é¢å士課ç¨)Yu Mimura, M.D. 1)2), Michitaka Funayama, M.D., Ph.D. 2), Masaru Mimura, M.D., Ph.D. 1).
Combined abnormal findings of MRI-SPECT-EEG suggest vulnerability to ischemia in transient global amnesia.
Journal of the Neurological SciencesããVolume 438, 15 July 2022, 120273.
https://doi.org/10.1016/j.jns.2022.120273
ãæ¦è¦ã
è¶³å©èµ¤ååç
é¢ã§çµé¨ããä¸éæ§å
¨å¥å¿ç(Transient global amnesia: TGA)ã®çä¾å ±åã§ãããTGAã¯ãã®æ´¾æãªè¨åºåã«æ¯ãã¦ä¸è¬ã«æ¤æ»æè¦ãç®ç«ããªããã¨ãç¹å¾´ã¨ãããããããè¿å¹´MRIãSPECTãä¸å¿ã«ç°å¸¸æè¦ã®å ±åãéã¾ã£ã¦ãããã¨ã¯ãããã¾ã ç
æ
è§£æã¯ååã§ã¯ãªããä»åæã
ã¯è¤æ°ã®ç°å¸¸æè¦ãåæã«ã¿ãããä¸ã¤ã®ç
æ
ã示åããçä¾ãçµé¨ããããå ±åããã
ãçä¾ã40代女æ§ã
ï¼»ç¾ç
æ´ï¼½ææ¥æï¼çºçå8æéï¼ã¯æ®æ®µéãã«éããã¦ãããå¹³æã¨åæ§ã«ä»äºãããªããå¤ãã©ãã³ã¹ã¹ã¯ã¼ã«ã¸ãã£ãããã³ã¹ã®ç·´ç¿ä¸ã«çªç¶âåã質åãç¹°ãè¿ãâãããå人ã夫ã¸é£çµ¡ãè¿ãã«ãã¦ããã£ããè¿ãã«æ¥ã夫ã«å¯¾ãã¦ãã誰ã«è¨ããã¦è¿ãã«æ¥ãã®ãããªãã§è¿ãã«ããã®ãã¨ç¹°ãè¿ãã夫ã¯ç¹°ãè¿ãåãå
容ãè¿çãããä¾ç¶ã¨ãã¦åæ§ã®è³ªåãç¹°ãè¿ããã夫ã«é£ãããã¦ææ¥å¤æ¥ãå診ããã
ï¼»å
¥é¢å¾çµéï¼½
å
¥å®¤æï¼çºçå¾3æéç¨åº¦ï¼ãèº«ä½æè¦ã»ç¥çµæè¦ã«ã¯ç¹è¨ãã¹ãç°å¸¸æè¦ãèªããªãã£ããæ¥ä»ã2æ¥ééãã¦ãã軽度ã®è¦å½èé害ã¯ç¶ãã¦ããããåã質åãç¹°ãè¿ããªã©æ··ä¹±ããã¦ããæ§åã¯ãªãã£ããå
¥é¢æç¹ã§ç°¡æçã«èªç¥æ©è½æ¤æ»ãè¡ã£ãã¨ãã3åèªã®å³æåçã¯å¯è½ã ã£ãããé
å»¶åçã§ã¯1åèªã«ãã´ãªã¼ã«é¢ãããã³ããè¦ããï¼ä¹ãç©ã§ãâé»è»ã¨æ£çï¼ãSerial7ã¯å診æ
å½å»ãæ½è¡ããéã«ã¯ã97ããã3ãå¼ããã§ãããï¼ãã¨æ··ä¹±ããããã ããçè
ãå°ç徿½è¡ããéã«ã¯åé¡ãªãã§ãã¦ããã髿¶²æ¤æ»ãé é¨CT/é é¨MRIæ¤æ»ãä¸è¬æ¡è¡æ¤æ»ã§ç°å¸¸ã¯ãªãã£ãããæ¬äººã¨ç¸è«ã®ä¸çµé観å¯ç®çã®å
¥é¢ã¨ãããå
¥é¢å¾å¥å¿çç¶ã¯æ¹åããããTGAã¨è¨ºæããã第2ç
æ¥Wechsler memory scale-revisedãè©ä¾¡ããã¨ããé
å»¶åçã¯84ã¨æãããªä½ä¸ã¯èªããªãã£ãã忥ãã¡ããã©çºçå¾48æéé çµéããã¿ã¤ãã³ã°ã§é é¨MRIç»åã忤ããã¨ãã左海馬CA1é åã«æ¡æ£å¼·èª¿åã§é«ä¿¡å·ã確èªããããè³è¡æµECD-SPECTæ¤æ»ã§ã¯æ¥åé¨ããå¾é¨å¸¯ç¶åã«ããã¦è¡æµä½ä¸ãèªãããé ¸åèããã³é ¸éèã¨ã³ã¼æ¤æ»ã§ã¯ç°å¸¸ãèªãããå
é ¸éèéæµæè¦ãèªããªãã£ããå
¥é¢ä¸ã®è³æ³¢ã§å®ééç¼æã«Subclinical rhythmic electroencephalographic discharge of adults (SREDA)ãèªããããã«éææ°æ¡ä»¶ã§èæ¯è³æ³¢ã®å¾æ³¢åã¨æ¯å¹
ã®å¢å¤§ãèªããéææ°çµäºå¾1åç¨åº¦ã¾ã§æç¶ãããçºçå¾9æ¥ç®ã®æç¹ã§é é¨MRIã®æµ·é¦¬ã«ãããé«ä¿¡å·ã¯æ¶å¤±ããã
ãèå¯ã
çä¾ã¯å
¸åçãªTGAã®çµéã示ãããããã®çµéã®ä¸ã§MRI/SPECTæè¦ã«å ãã¦è³æ³¢ã§SREDAãèªããã¨ããç¹ã§è²´éãªçä¾ã§ãããç¾å¨ã®ã¨ãããããã3ã¤ã®æè¦ãåæã«èªããã¨ããå ±åã¯ãªãã
海馬ã§ã¯é£åéã§å¦çãããæ
å ±ãå
å
ç®è³ªãä»ãã¦æ¯ç¶åâCA3âCA1ã¨ã·ããã¹ãå½¢æãä¼éããï¼ããããä¸ã·ããã¹åè·¯ï¼ãããã«CA1ããå
å
ç®è³ªã¸ã¨åºåããè¨æ¶ãå½¢æãããã¨èãããã¦ããããã®åè·¯ã®æ§æè¦ç´ ã§ããCA1ã®ä¸éæ§ã®é害ã«ããTGAã®å¥å¿ãçãããã¨ãæ³å®ããMRIæè¦ã¯ãããæ¯æããããªãCA1ãªã®ãã¯çµè«ãåºã¦ããªãããMRIã®æ¤è¨ããTGAã®æç³»åã«ä¼´ãæ¡æ£å¼·èª¿åã®ä¿¡å·å¤åã¯èè¡ã¢ãã«ã¨ä¸è´ãã¦ãããã¨ãããè¡è¡åå¦çãªæ©åºãæ³å®ããã¦ãããCA1ã¯ç¹ã«ä½é
¸ç´ ç¶æ
ã«ãã代è¬ã¹ãã¬ã¹ã«é常ã«å¼±ãé¨ä½ã§ãããããTGAã®ç
å·£ã¨ãã¦ç»åæè¦ãå¾ãããããã¨å ±åããã¦ããã
æ¬çä¾ã§ã¯CA1ç
å¤ã«å ãã¦SPECTã«ã¦æ¥åé¨ã®è¡æµä½ä¸ã示ããããããã¾ã§ã22ä¾ã®TGAçä¾ã§å·¦æ¥åé¨ã®è¡æµä½ä¸ãææã§ãããã¨ãããã«6ã¶æã®ãã©ãã¼ã¢ããã§åé¨ä½ã®è¡æµãæ¹åãããã¨ãå ±åããã¦ãããæ¥åé¨ã¨å¾é¨å¸¯ç¶åã¯Default mode networkã®ä¸é¨ã®Posterior medial episodic network (PM network)ã®æ§æè¦ç´ ã¨ãã¦æµ·é¦¬ã¨ã¨ãã«è¨æ¶ãæ¯ãããå
·ä½çã«ã¯æ¥åé¨ã¨å¾é¨å¸¯ç¶åã¯æµ·é¦¬ã«å
¥åããè´è¦çã»è¦è¦çã«å¦çãããèªå·±ãå¨å²ã®ç©ºéã«é¢ããè¨æ¶ãããã«ç²¾ç·»ãªè¨æ¶ã«å¼·ããåãããã£ã¦ããã¨èãããã¦ãããæµ·é¦¬ã¯PM networkã®æéè¦ãªhubã§ãããæ¥åé¨ã¨ã®é£æºã§èªå·±ã«é¢é£ã¥ããè¨æ¶ãæ´çãããå¾é¨å¸¯ç¶åã¨ã®é£æºã§èªèº«ã®ç¥èãã¹ãã¼ãã¨ã®çµ±åãã¯ããããããã®ãããªé¢ä¿ãããæµ·é¦¬ã®æ©è½ç°å¸¸ã¯TGAã®ç
æ
ã®æ¬æ
ã§ããããããæ©è½çã«é£åãã¦ããå¾é¨å¸¯ç¶åãæ¥åé¨ã®è¡æµä½ä¸ãå¼ãèµ·ããããã¨èå¯ãããã
SREDAã¯4-7Hzã®é«æ¯å¹
徿³¢ã卿³¢æ°ãå¤ããªããå¾åçã«ããããããã¿ã¼ã³ã§ãããä¸è¬äººå£ã®0.06%ç¨åº¦ã«ã¿ããããããªãç¨ã ããç
çæç¾©ã«ã¤ãã¦ã¯ä¸æã§ããæ£å¸¸äºåã¨èãããã¦ãããTGAã¨ã®é¢é£ã«ã¤ãã¦ã¯ãªãã¨ããå ±åã¨ãé¢ä¿ã示åããå ±åããããé¢ä¿ã示åããå ±åã«ããã¦ãæç¢ºãªé¢é£æ§ã¯ææããã¦ããªãããããSREDAã¯éææ°ä¸ã«ç¾ãããã¨ãå¤ããè¡ç®¡æ£ç¸®åã³ããã«ä¼´ãèè¡ã»ä½é
¸ç´ ã¨é¢é£ããã¨ããå ±åããããå®éã«æ¬çä¾ãèæ¯è³æ³¢ã§SREDAãèªããããã«éææ°æ¡ä»¶ã§ã®å¾æ³¢åãã¿ããéææ°æã®èå¼±æ§ã示åãããããã©ãã³ã¹ã¨ããå¼å¸æ°ã䏿ãããã¨ããã£ããã«çºçããã®ãé¢ä¿ãæ·±ãããã«è¦ãããããã¾ã§ã®è°è«ãç·åããã°ãSREDAã®åºç¾ã¯éææ°æã«ãããç¥çµã®è¡è¡åå¦çãªèè¡ã¸ã®èå¼±æ§ã示ããå®éã«ã¹ãã¬ã¹ãããã£ãã¨ãã«èè¡ã®å½±é¿ãåããããCA1é åã®æ©è½ãä¸éæ§ã«ä½ä¸ããæµ·é¦¬ãä¸å¿ã¨ããPM networkå
¨ä½ã®æ©è½ãé害ããããã¨ã§ç¹ã«èªèº«ã«é¢é£ããã¨ãã½ã¼ãè¨æ¶ã®è¨éã»ä¿æãèããé害ããããããã®ã¹ãã¬ã¹ãè§£é¤ãããã¨èªç¶ã«æ¹åãã¦ãããã¨ããTGAã®ç
æ
ä»®èª¬ãæµ®ãã³ä¸ãã£ã¦ãããããã¦æ¬çä¾ã¯ãã®ä»®èª¬ãæ¯æããæè¦ã示ãã¦ãããè²´éãªä¸ä¾ã¨ãããã
(䏿æ ã2022.5.13.)
è§£èª¬ãæµ·é¦¬ã®æãéã
çªç¶çºçãããç®ç«ã¤çç¶ã¯å½æã§ãããä½åº¦ãåã質åãç¹°ãè¿ãããã¾èªåããããã¦ããç¶æ³ãèªèã§ãã¦ããªãæ§åã§ããããããç¥çµå¦çæè¦ãå«ããä»ã«ã¯çç¶ã¯å
¨ããªããããã¦24æéã¨ãããªããã¡ã«ããããã«æ£å¸¸ã«æ»ãããã ãã¨ãã½ã¼ãä¸ã®è¨æ¶ã¯å¤±ããã¦ããããããTGA (Transient Global Amnesia)ã§ããã
TGAã®æåã®å ±åã¯1956å¹´ãBenderã®âepisode of confusion with amnesiaâ ã§ããã¨ããã®ãä¸è¬çã ãã1882å¹´ãRibotã®Disease of Memoryã«ãTGAã¨æãããçä¾ã®è¨è¼ãããã以å¾ããã®ç¹ç°ãã¤æ´¾æãªçç¶ã¯ç²¾ç¥ç§å»ãç¥çµå
ç§å»ã®æ³¨ç®ãéãç¶ãã¦ããããã¡ã«ããºã ã¯ãªããªãè§£æãããªãã£ããæµ·é¦¬é åã®ä½ããã®ç°å¸¸ã§ãããã¨ãããã¨ã¾ã§ã¯èª°ã«ã§ãæ¨æ¸¬ã§ãããã¤ããããããã«ãç´å¾ã§ãã説æã§ãã£ããããä½ããã®ç°å¸¸ãã§ã¯ä½ã®èª¬æã«ããªã£ã¦ãããããã¤ããç´å¾ã§ãã説æãã§ãããã¨ã¯ãæ£ãã説æãã§ãããã¨ãæå³ããªãã
ãããªç¶æ³ã®ä¸ãå®éã«æµ·é¦¬é åã®ç°å¸¸ãå¯è¦åãããç ç©¶ã¯å¾ã
ã«èç©ããã¦ãããã ãããã¯æåéããå¾ã
ã«ãã§ãã£ããæåã®å ±åããå°ãªãè¦ç©ãã£ã¦ãããã«50å¹´ãéãã¦ããã«ãããããããä»ãªãæ©åºãè§£æããã¦ããªããã¨ã®èæ¯ã«ã¯ãTGAãä¸éæ§ã®çç¶ã§ããã¨ããç¹æ§ããããããããã¤çºçãããã¯äºæ¸¬ã§ããªãããããã¤åºä¼ããã¯ããããªããTGAã«ã¤ãã¦ç ç©¶ãããã¨èãã¦ãããã®å
·ä½çè¨ç»ãç«ã¦ããã¨ã¯äºå®ä¸ä¸å¯è½ãªã®ã§ããã
ãã®ãããªç¶æ³ã®ä¸ãTGAã®ä¸çä¾ããMRIãSPECTãEEGã¨ããä¸ã¤ã®æ¤æ»ã§çµæãå¾ã䏿æ 大å¦é¢çã®ä»äºã¯é常ã«è²´éã§ããããããå¯è½ã«ããã®ã¯ã䏿é¢çã®è¨åºã¸ã®ç±æã¨ãè¿
éã«æ¬¡ã
ã«æ¤æ»ãæ½è¡ããè¡ååã«å°½ããã䏿é¢çã®ç´¹ä»æã®çµã³ã«è¨ããã¦ããéããæ¬çä¾ã¯TGAã®ç
æ
ä»®èª¬ãæ¯æããæè¦ã示ããè²´éãªä¸ä¾ã§ãããã ãæ¬ç ç©¶ã®ç価ã¯ããã«ãã®å
ã«ãããããã¯æµ·é¦¬ã«ã¤ãã¦ã®ç ç©¶ã¸ã®æ°ããªæãéããããã¨ã¸ã®æå¾
ã§ããã
ç¥çµå¿çå¦ã§ã¯ãæåéãéå±ãããè³é åã®å±å¨æå·ä¾ã«ã¤ãã¦ã®ç¶¿å¯ãªç ç©¶ãã大ãã«çºå±ã«è²¢ç®ãã¦ãããè¨æ¶ã«é¢ãã¦ããã°ãScovilleã1957å¹´ã«å ±åãã両å´é èåé¤ã®çä¾HMãTeuberã1968å¹´ã«å ±åãããã§ã³ã·ã³ã°ã®äºæ
ã«ããè¦åºæå·ã®çä¾NAã«ã¤ãã¦ã®ç²¾å¯ãªæ¤æ»ãã¼ã¿ã¯ãç¾ä»£ããªãç ç©¶å²ä¸ã«ç¦ç¶ã¨è¼ãå°ä½ãå ãã¦ãããããããä¾ã¯ããããé常ã«ç¨ãªçä¾ã§ãããå¾ãããæè¦ãä¸è¬åãããã¨ã«ã¯éçãããã
ããã«å¯¾ãTGAã¯ã夿°ä¾ãç 究対象ã«ã§ãããããå¯éæ§ã§ãããããåãä¸ä¾ã«ã¤ãã¦ãè¨æ¶é害ããã®ææã¨ãªãã®ææã®æ¤æ»æè¦ã®æ¯è¼ãå¯è½ã§ãããããã¦ãã®äºã¤ã®æ¤æ»æè¦ã®éããæµ·é¦¬ã®æ©è½é害ãåæ ãã¦ãããã¨ãå®è¨¼ããã®ããã®ä¸æé¢çã®ä»äºã§ãããããªãã¡æ¬ç ç©¶ã¯ãTGAã«ã¤ãã¦ã®è²´éãªä¸ä¾å ±åã¨ãããã¨ã«ã¨ã©ã¾ãããTGAãæµ·é¦¬ã®æ©è½ãæ¢ç©¶ããããã®å
¥ãå£ã®ä¸ã¤ã§ãããã¨ã確å®ã«ç¤ºããã¨ããæå³ã§ã海馬ã¨è¨æ¶ã«ã¤ãã¦ã®ç ç©¶ã«æ°ããªå°å¹³ãéãå¯è½æ§ãç§ãã¦ããã
(ææ¾å¤ªéã2022.5.30.)
èªéçã¹ãã¯ãã©ã è
åãã®ãã¼ãã£ã«ãããããç¨ããéå£åãªã³ã©ã¤ã³å°±è·é¢æ¥ãã¬ã¼ãã³ã°ããã°ã©ã
çï¨åä¸ (é·å´å¤§å¦å»æ¯è¬å¦ç·åç ç©¶ç§æªæ¥ã¡ã³ã¿ã«ãã«ã¹å¦åé ææ)Group-Based Online Job Interview Training Program Using Virtual Robot for Individuals With Autism Spectrum Disorders
Hirokazu Kumazaki H, Yuichiro Yoshikawa Y, Taro Muramatsu, Hideyuki Haraguchi, Hiroko Fujisato, Kazuki Sakai, Yoshio Matsumoto Y, Hiroshi Ishiguro, Tomiki Sumiyoshi, Masaru Mimura. Group-Based Online Job Interview Training Program Using Virtual Robot for Individuals With Autism Spectrum Disorders. Front Psychiatry. 2022.12:704564. doi: 10.3389/fpsyt.2021.704564.
COVID-19ã®æµè¡ã«ä¼´ãæ¥å¢ãããªã³ã©ã¤ã³å°±è·é¢æ¥ã¯ãæµè¡ãåã¾ã£ãå¾ã社ä¼ã«æ®ããã¨ãäºæ³ããã¦ããããªã³ã©ã¤ã³å°±è·é¢æ¥ã¯ãASDè ã«ã¨ã£ã¦å¤§ããªéå£ã¨ãªã£ã¦ãããASDè åãã®ãªã³ã©ã¤ã³å°±è·é¢æ¥ã®ã¨ããã³ã¹ã«åºã¥ãããã¬ã¼ãã³ã°ã¯ç¾å¨ã¾ã§ã»ã¨ãã©ãªããæ°ããªãã¬ã¼ãã³ã°ã®éçºãæå¾ ããã¦ãããASDè å人ã®ãªã³ã©ã¤ã³å°±è·é¢æ¥ã«ãããã¹ãã«ç¿å¾ãä¿é²ããããã«ãæã ã¯ãã¼ãã£ã«ãããããç¨ããéå£åãªã³ã©ã¤ã³é¢æ¥ãã¬ã¼ãã³ã°ããã°ã©ã ï¼GOTï¼ãéçºãããGOTã§ã¯ã颿¥å®ã¨é¢æ¥åé¨è ããããããã¼ãã£ã«ããããã¨ãã¦ç»é¢ä¸ã«æ ãåºããã¦ããã5人ã®åå è ãã°ã«ã¼ãã¨ãªãã颿¥åé¨è ã颿¥å®ãè©ä¾¡è ã®å½¹å²ãæ¼ãããåå è ã¯ãã¹ã¦ã®å½¹å²ãç¡ä½çºã®é åºã§è¡ã£ããåã»ãã·ã§ã³ã¯ã䏿¬¡é¢æ¥ã»ãã·ã§ã³ããã£ã¼ãããã¯ã»ãã·ã§ã³ãäºæ¬¡é¢æ¥ã»ãã·ã§ã³ã§æ§æããããåå è ã¯è¨25åã®ã»ãã·ã§ã³ãçµé¨ãããGOTã®åå¾ã«ã¯ãGOTã®å¹æãæ¤è¨¼ããããã«ã人éã®ããã®é¢æ¥å®ã¨ã®ãªã³ã©ã¤ã³æ¨¡æ¬å°±è·é¢æ¥ï¼MOHï¼ã宿½ãããè¨15人ã®ASDè ãæ¬ç ç©¶ã«åå ãããGOTã®åå¾ã§ãèªä¿¡ãææ¬²ãä»è è¦ç¹ã®çè§£ãè¨èªè½åãéè¨èªè½åã颿¥ã®ããã©ã¼ãã³ã¹ã¹ã³ã¢ã®æ¹åãèªãããã¾ãã颿¥å®ãè©ä¾¡è ã®è¦ç¹ã®éè¦æ§ã«ã¤ãã¦ã®èªèãã1åç®ã®MOHå¾ã«æ¯ã¹ã2åç®ã®MOHå¾ã«ææã«å¢å ããããã¼ãã£ã«ããããã使ç¨ãã颿¥å®ãè©ä¾¡è ã®è¦ç¹ã¨ããä»è è¦ç¹ãä½é¨ãããã¨ã§ã颿¥ã¹ãã«åå¾ã®éè¦æ§ãå¦ã³ãã¢ããã¼ã·ã§ã³ã®æç¶ã¨é¢æ¥ã¸ã®èªä¿¡åä¸ã«ã¤ãªãã£ãã¨èãããããä»å¾ããå¤§è¦æ¨¡ã§å¤æ§ãªãµã³ãã«ã§ã縦æçãªãã¶ã¤ã³ã«ãããããªãç ç©¶ãé²ãã¦ããå¿ è¦ãããã
(çå´åä¸ã2022.4.1.)
æ±è²
2022å¹´4æ1æ¥,é·å´å¤§å¦å»çç§å¦å°æ»ã«ãæªæ¥ã¡ã³ã¿ã«ãã«ã¹å¦è¬åº§ããè¨ç½®ããè¬åº§ãæ
å½ããã¦ããã ããã¨ã«ãªãã¾ããã
ã¡ã³ã¿ã«ãã«ã¹ã®éè¦å¢å ã«ä¼´ã,å診ã¾ã§ã®å¾
æ©æéãé·ããªã,å»çè³æºã¾ã§ã®ã¢ã¯ã»ã¹ãé£ãããªã£ã¦ããç¾å®ãããã¾ããããã«å°åã«ãã£ã¦ã¯å»å¸«ä¸è¶³ã«ããå»çå´©å£ãé²ã¿ï¼å»çè³æºã®ä¸è¶³ã¯æ·±å»ãªç¤¾ä¼åé¡ã¨ãªã£ã¦ããã¾ãã
æè¿ã®ç§å¦æè¡ã®é²æ©ã«ã¯ç®è¦ã¾ãããã®ãããã¾ããç²¾ç¥é害ã®è¨ºæã¯ï¼å®¢è¦³çè©ä¾¡ã®æ
ä¿ãé£ãããã¨ãä¸å ã§,å»å¸«ã«ãã診æãç°ãªãã¨ããåé¡ãããã¾ããããã®åé¡ã解決ããããã«æ£è
æ§ã®è¨ºçæ
å ±ãè¡åãã診æï¼æ²»çæ¹éã®æ±ºå®ãè¡ã人工ç¥è½ã®æ´»ç¨ãèãããã¾ããã¾ãããåããããã®æè¡é²æ©ã«ãç®è¦ã¾ãããã®ãããã¾ããããããã¯äºãããã°ã©ã ãããã¨ã§äººéåæ§ã®åä½ãè¡ããã¨ãå¯è½ã§ããï¼äººéã¨æ¯è¼ãã¦å¸¸ã«åä¸ã®åä½ãå¯è½ãªæ£ç¢ºæ§ãããã¾ãããã®å©ç¹ãå©ç¨ãã¦ï¼ç²¾ç¥ç§è¨ºçã®ã¨ãã¹ãã¼ãã®é¢è«æè¡ãããããã®ããã°ã©ã ã«çµã¿è¾¼ããã¨ã§ï¼ãã®é¢è«ãå¥ã®ããããã§åç¾ã§ããå¯è½æ§ãããã¾ããããã«ãã®ãããããæ£è
æ§ã®é¢æ¥ãå¦çã®æè²ã«å°å
¥ãããã¨ã§ï¼å
¨å½åå°ã§çµ±ä¸åããæå
端ã®é¢æ¥ã®æä¾ï¼ããã³é¢æ¥æ³ã®æè²ãå¯è½ã¨ãªãã¾ããã¾ãã¢ã´ã¡ã¿ã¼æè¡ã®é²æ©ã«ãç®è¦ã¾ãããã®ãããã¾ããã¢ã´ã¡ã¿ã¼ãé©åã«ç¨ãããã¨ã§é éå»çã®è³ªã®åä¸ãæå¾
ããã¾ããç²¾ç¥ç§å»çã«ã¯,ç
é¢,診çæ,å¾
å室,é¢å³¶å»çã ãã§ãªã,ãã¤ã±ã¢,訪åçè·,ã°ã«ã¼ããã¼ã ,使¥æ,妿 ¡,ç¹å¥æ¯æ´æè²ãã¯ããã¨ãã夿§ãªãã£ã¼ã«ãã§ã®å±éãæå¾
ã§ãã¾ãããã®ããã«äººå·¥ç¥è½,ããããã»ã¢ã´ã¡ã¿ã¼æè¡ã¯å»çè³æºã®ä¸è¶³ãè£ãã ãã§ãªããé«åº¦ã§æ¨æºçãªå»çã¸ã®è²¢ç®ãæå¾
ããã¾ããåå°åã®å¤æ§ãªé åã§ã人工ç¥è½,ããããã»ã¢ã´ã¡ã¿ã¼æè¡ãé©åã«ç¨ãããã¨ã§,é«åº¦ãªå»çãå
¨å½åå°ã«ãããããã¨ã«ã¤ãªãã,å°åã«ãããå»çã®æ ¼å·®æ¯æ£ã®å¹æãæå¾
ã§ãã¾ãã
ææ°ã®ç§å¦æè¡ã¨ã®å
±çã課é¡ã¨ãªã£ã¦ãã䏿¹ã§ã徿¥å
人ãã¡ãç¯ãä¸ãã¦ããä¼çµ±çç²¾ç¥ç§å»çã®å績ã大ãããå
人ãã¡ã«æ¬æãå¿ãã,å¦ã³ãç¶ãã¦ãããã°ãªããªãã¨æã£ã¦ããã¾ããä»å,é·å´å¤§å¦ã§æ°ãã«è¨ç½®ãããæªæ¥ã¡ã³ã¿ã«ãã«ã¹è¬åº§ã§ã¯ï¼æ¢åã®ä¼çµ±çç²¾ç¥ç§å»çã¨äººå·¥ç¥è½ãããããã¨ãã£ãææ°ã®ç§å¦æè¡ã®å
±çã«ã¤ãã¦ç ç©¶ãé²ãã¦ããã¾ããç²¾ç¥ç§å»çã®çºå±ã«å¯ä¸ããã¨ã¨ãã«ï¼å¢å ããã¡ã³ã¿ã«ãã«ã¹åéã®éè¦ã«ã対å¿ã§ããæ¬¡ä¸ä»£åã®äººæè²æãç®æãã¦ããã¾ããæ¬è¬åº§ãçºå±ããããã¨ã§ãããããä¸è©±ã«ãªãé·å´å¤§å¦ãããã¾ã§ãä¸è©±ã«ãªã£ãæ
¶æç¾©å¡¾å¤§å¦ã«æ©è¿ããããã¨æã£ã¦ããã¾ãã
(çå´åä¸ã2022.4.9.)
COVID-19 ãã³ãããã¯ä¸ã§ã®ãæ¢åã®ç²¾ç¥ç¾æ£ãæã¤æ£è
ã®çç¶å¤åï½å¥³æ§ã¨æ°åé害æ£è
ã¯ç²¾ç¥çç¶ãæªåããããï½
é»ç¬å¿ã(æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨å»å¦ç ç©¶ç§ãç²¾ç¥ç¥çµç§å士課ç¨/è¶³å©èµ¤ååç
é¢ãç¥çµç²¾ç¥ç§ãé常å¤å»å¸«)Kurose S, Funayama M, Takata T, Shimizu Y, Mimura Y, Kudo S, Ogino S, Mimura M. Symptom changes in patients with pre-existing psychiatric disorders in the initial phase of the COVID-19 pandemic: Vulnerability of female patients and patients with mood disorders. Asian Journal of Psychiatry, 2022. 68, 102966
https://doi.org/10.1016/j.ajp.2021.102966
COVID-19 ãã³ãããã¯ã¯æªç¥ã®ææçã¨ããã ãã§ãªããããã¯ãã¦ã³ãªã©ã¨ãã£ãé颿ªç½®ãçµæ¸çãªåé¡ãªã©æ§ã ãªçç±ã§ã¡ã³ã¿ã«ãã«ã¹ã«æªå½±é¿ãä¸ãããç²¾ç¥ç¾æ£ãæããªãå¥å¸¸è ã対象ã¨ãããã¡ã³ã¿ã«ãã«ã¹ã«é¢ããç ç©¶ã¯æ°å¤ããããã®ã®ãæ¢åã®ç²¾ç¥ç¾æ£ãæã¤æ£è ãCOVID-19 ãã³ãããã¯ä¸ã§ã©ã®ãããªçç¶å¤åããããã«ã¤ãã¦ã®å æ¬çãªç ç©¶ã¯ååã«è¡ããã¦ããªãã£ããããã§ãï¼1ï¼COVID-19ãã³ãããã¯ã®åæã«ã©ã®ç²¾ç¥ç¾æ£ã§çç¶ã墿ªããããããï¼2ï¼ãã®äº¤çµ¡å åããæããã«ãããããæ¥æ¬ã§ã®ååã®ç·æ¥äºæ 宣è¨åã¨ç·æ¥äºæ 宣è¨ä¸ã®2ã«æéï¼èª¿æ»æéï¼2020å¹´4æ8æ¥ï½6æ7æ¥ï¼ã«ãè¶³å©èµ¤ååç é¢ã®ç¥çµç²¾ç¥ç§å¤æ¥æ£è 1592人ã®ç²¾ç¥çç¶ã«ã¤ãã¦Global Assessment of Functioning (GAF) ãç¨ãã¦ååãã«è©ä¾¡ããã診æã«ãã´ãªã¼ï¼ICD-10ã§ã®F0ã9ï¼ã¨å¢æªã®é¢ä¿ã«ã¤ãã¦ãã«ã¤äºä¹æ¤å®ãè¡ã£ããããã«ãæ§å¥ãå¹´é½¢ã診æã«ãã´ãªã¼ãpandemicåã®GAFã¹ã³ã¢ãç¬ç«å¤æ°ã¨ãããã¸ã¹ãã£ãã¯å帰åæãè¡ã£ããæ°åé害ï¼F3ï¼ããã³ç¥çµçæ§é害ï¼F4ï¼æ£è ã®å¢æªçã¯ãããã4.32ï¼ ããã³5.37ï¼ ã§ããï¼å¨è³ªæ§é害ï¼F0ï¼ããã³çµ±å失調çï¼F2ï¼æ£è ã®ãããããææã«é«ãã£ãï¼X2 (9, N = 1592) = 27.8, p < 0.01ï¼ããã¸ã¹ãã£ãã¯å帰åæã®çµæï¼æ°åé害æ£è ããã³å¥³æ§æ£è ã¯ãä»ã®é害æ£è ãç·æ§æ£è ãããããããææã«é«ããã¨ãæããã«ãªã£ãï¼ãªããºæ¯ï¼95ï¼ ä¿¡é ¼åºéï¼ï¼2.4ï¼1.2-4.6ï¼ï¼pï¼.01ï¼F3ï¼3.1ï¼1.5-6.6ï¼ï¼å¥³æ§ï¼pï¼.01ï¼ããããã®ç¥è¦ãããç²¾ç¥ç§å»ã¯ãã³ãããã¯ä¸ã«ããã¦ãæ°åé害æ£è ããã³å¥³æ§æ£è ã®ç®¡çã«ç¹ã«æ³¨æãå¿ è¦ã§ãããã¨ã示åãããã
(é»ç¬å¿ã2022.3.11.)
解説ãæããMental Healthã®æãå½±
ææµã«ä¹ã£ã¦ãããã¨ã身è¿ã§ãããã¨ããµã¤ãã®äººã¨é¢ä¿ãæ·±ããã¨ãããããæ¡ä»¶ãéµå®ããã°ãã¡ã³ã¿ã«ãã«ã¹ã¯æããèªããã¨ãã§ããæ³¨ç®åº¦ã®é«ã話é¡ã«ãªããCOVID-19ä¸ã§ãåæ§ã§ãããã³ããã§çæ´»ãæ¿å¤ãã¦ãã¾ãããããªã¨ãããã¡ã³ã¿ã«ãã«ã¹ã«æ°ãé ãã¾ãããã人ã¨ã³ãã¥ãã±ã¼ã·ã§ã³ãåãã¾ããããè¦åæ£ããçæ´»ããã¾ãããããã©ã³ã¹ã®åããé£äºããã¾ããããã¢ã«ã³ã¼ã«ã¯æ§ããã«ãã¾ããããåè«ã®ä½å°ã¯ãªããæãããæ¯æ¥ã®ææè æ°ã®æ°åã人ãã¨ã®ããã«æ¨ªç®ã§è¦ã¤ã¤ãã«ãã«ãã¨ç¬ã£ã¦éããããã§ããã
COVID-19ã¯ãã¯ãä¸ã¤ã®ç½å®³ã§ããããç½å®³æã®Mental Healthã¨ã¯æ¬æ¥ãããªæ°æ¥½ãªãã®ã§ã¯ãªããããããæ¥æ¬èªã®ã¡ã³ã¿ã«ãã«ã¹ã¯ãMental Healthããæ·±å»ãªé¨åãåãåã£ãç¹ç°ãªè¨èã§ããããã¨ãã°ç±³å½ã®NIMH = National Institute of Mental Healthãããããé篤ãªç²¾ç¥é害è ã対象ã¨ããç²¾ç¥å»å¦ã®ç ç©¶æã§ãããã¨ãããæãããªéããMental Healthã¯ã¡ã³ã¿ã«ãã«ã¹ã¨ã¯ããªããã¥ã¢ã³ã¹ãç°ãªããæ±ºãã¦ãµã¤ãã®äººã ã ããè¦éã«å ¥ãããã®ã§ã¯ãªããæ¥æ¬èªã®ã¡ã³ã¿ã«ãã«ã¹ã¯Mental Healthã®æããä¸åéã«ãããªãããã®å½±ã«ã¯çã«å»çãå¿ è¦ã¨ãã人ã ãè¨å¤§ã«åå¨ãããç¶ç¶çãªç²¾ç¥å»çãå¿ è¦ã¨ãã人ã ãæ¥æ¬ã®ããããå ´æã«åå¨ãããæ±æ¥æ¬å¤§éç½ã®ã¨ããæ¥æ¬ç²¾ç¥ç¥çµå¦ä¼ã被ç½å°ã®Mental Healthã®å«ç·ã®èª²é¡ã¨ãã¦åãä¸ãå®è¡ããã®ããç²¾ç¥ç§æ²»çè¬ã®å®å®ä¾çµ¦ã§ãã£ããç½å®³æã«çã«å¿ è¦ã¨ãããã®ã¯ããããæ´»åãªã®ã§ãã£ã¦ãææµã«ä¹ã£ãã身è¿ãªããµã¤ãã®äººã ã«é¢ä¿ãæ·±ãã¡ã³ã¿ã«ãã«ã¹ãæããå·é ·ãã§ç¤¾ä¼ãæºããã°ããã®å½±ã«ããMental Healthã¯æ·±å»ããå¢ãã¦ããã
é»ç¬å¿é¢çã¯ããã«çç®ãããæ¢åã®ç²¾ç¥ç¾æ£ãæã¤æ£è ã®çç¶å¤åãæããã«ããæ¬ç ç©¶ã¯ãCOVID-19ä¸ã§ã®çã®Mental Healthç ç©¶ã¨å¼ã¶ã«ãµãããããããã¯ææµã«ä¹ã£ã¦ããã¨ã¯è¨ãããå¤ãã®äººã«ã¨ã£ã¦èº«è¿ã§ã¯ãªããããããªãããç²¾ç¥ç¾æ£ãæã¤ãµã¤ãã®äººã ã«é¢ä¿ãæ·±ããè²´éãªãã¼ã¿ã示ãããã®ã§ããã
(ææ¾å¤ªéã2022.3.23.)
å
å æ§ã«ã³ãããã¤ãç³»ã®ä»£è¬é
µç´ ã§ããã¢ãã¢ã·ã«ã°ãªã»ãã¼ã«ãªãã¼ã¼(MAGL)ãããã®çä½å
ã§åãã¦å¯è¦åãããã¨ã«æå
é«çåè¼ (å½ç«ç ç©¶éçºæ³äºº éåç§å¦æè¡ç ç©¶éçºæ©æ§ éåçå½ã»å»å¦é¨é éåå»ç§å¦ç ç©¶æ è³æ©è½ã¤ã¡ã¼ã¸ã³ã°ç ç©¶é¨ ç ç©¶å¡)Takahata K, et al: First-in-human in vivo undefined imaging and quantification of monoacylglycerol lipase in the brain: a PET study with 18F-T-401.
Eur J Nucl Med Mol Imaging 2022. https://doi.org/10.1007/s00259-021-05671-y
ç ç©¶ã®æ¦è¦
欧米諸å½ã§ã¯ã大麻ãå»çç¨ã ãã§ãªã娯楽ç¨ã«ãéæ¾ããã巨大ãªå¸å ´ãå½¢æãã¤ã¤ãããã¨ãè¿å¹´ç¹°ãè¿ãå ±éããã¦ãããæãå½ã§ã¯ãå¤§éº»ã®ææãæ ½å¹ã¯å¤§éº»åç· æ³ã«ãã£ã¦å³ããå¦ç½°ã®å¯¾è±¡ã¨ãªã£ã¦ãããå»çç¨å¤§éº»ã®åæ³åã«åããè°è«ãæ¤è¨ãããããå§ã¾ã£ã段éã§ããã大麻ã«å«ã¾ããççæ´»æ§ç©è³ªã¯ã«ã³ãããã¤ãã¨å¼ã°ãã¦ãããå®ã¯ããããå«ãåç©ã®ä½å
ã«ã¯ã«ã³ãããã¤ãã«é¡ä¼¼ããä½ç¨ãæã¤ç©è³ªãè¤æ°åå¨ãã¦ãããå
å æ§ã«ã³ãããã¤ãã¨ç·ç§°ãããã主ãªå
å æ§ã«ã³ãããã¤ãã«ã¯ã2-ã¢ã©ãããã¤ã«ã°ãªã»ãã¼ã«(2-AG)ã¨ã¢ãã³ããã¤ãããããç¥çµä¼éç³»ã®å¶å¾¡ãççãç¼çãæé£ãè¨æ¶ãå¦ç¿ãªã©ã®éè¦ãªççç¾è±¡ã«é¢é£ãã¦ãããï¼-AGã¨ã¢ãã³ããã¤ãã¯1990年代å¾åã«ç¸æ¬¡ãã§åå®ãããããé·ããããã©ã¡ããçã®å
å æ§ã«ã³ãããã¤ãããã¨ããè°è«ããªããã¦ããã夿°ã®æ¤è¨¼ãè¡ãããçµæã2-AGãã¢ãã³ããã¤ãã®800åã®æ¿åº¦ãæãããã¨ã2-AGãè¨æ¶ãå¦ç¿ã«éè¦ãªå½¹å²ãæã¤éè¡æ§ã·ã°ãã«ä¼éã¨ã®åªä»ç©è³ªã§ãããã¨ããã2-AGãããçã®å
å æ§ã«ã³ãããã¤ãã§ããã¨ã¿ãªããã¦ãããããã¦ããã®2-AGã®ä»£è¬ãæ
ãä¸å¿çãªé
µç´ ãã¢ãã¢ã·ã«ã°ãªã»ãã¼ã«ãªãã¼ã¼(MAGL)ã§ãããMAGLã®é»å®³ã¯ã2-AGã®æ¿åº¦ã䏿ããããã¨ã«ããæççä½ç¨ãç¼çæå¶ä½ç¨ãç¥çµä¿è·ä½ç¨ãªã©ããããããã¨ãå ±åããã¦ãããã¾ããMAGLé»å®³å¤ã¯ããã¤ç
ãä¸å®é害ãç¥çµå¤æ§ç¾æ£ãççæ§ç¾æ£ãªã©ã®ç
æ
修飾ä½ç¨ãæã¤ãã¨ãããç²¾ç¥ç¥çµç¾æ£é åã«ãããæ¬¡ä¸ä»£ã®åµè¬æ¨çã¨ãªã£ã¦ãããããããªãããããã¾ã§ããã®çä½å
ã§MAGLãé侵襲çã«æããããä¾ã¯ãªããMAGLã®çä½ã¤ã¡ã¼ã¸ã³ã°æè¡ã®éçºãæã¾ãã¦ããã
æ¬è«æã®èè
ãæå±ããéç æ©æ§ã§ã¯ãMAGLãæ¨çã¨ããPETè¬ã®åè£ååç©ç¾¤ãæ¦ç°è¬åå·¥æ¥æ ªå¼ä¼ç¤¾ããæä¾ãåããåç©å®é¨ã§ã®æ¤è¨¼ãéãã¦ãããããã¦ãåè£ååç©ç¾¤ã®ä¸ããT-401ã¨ããç©è³ªãPETè¬ã¨ãã¦æãè¯å¥½ãªæ§è³ªãæãããã¨ãè¦åºããä¸ã§ã18Fã«ãã£ã¦æ¨èãããã¨ã«ããæ°è¦PETè¬ã§ãã18F-T-401ãéçºãããæ¬ç ç©¶ã¯ã18F-T-401ã«ããPETæ¤æ»ãããã§åãã¦è¡ã£ãç ç©¶ã§ãããã18F-T-401ãè¯å¥½ãªè³ç§»è¡æ§ã¨ä»£è¬çå®å®æ§ãæãããã¨ãã¾ãMAGLã«å¯¾ãã¦å¯éçãªçµåãæãããã¨ã示ãã18F-T-401ãPETè¬ã¨ãã¦çæ³çãªæ§è³ªãæãããã¨ãæããã«ãããããã«ãgenomic plotã¨å¼ã°ããæ°ããææ³ãç¨ãããã¨ã«ããã18F-T-401ã§æ¸¬å®ããè³å
MAGLå¯åº¦ãMAGLã®mRNAçºç¾éã®è³å
åå¸ã¨ãæ£ç¢ºã«ä¸è´ãã¦ãããã¨ã示ããã以ä¸ã®æ¤è¨çµæããã18F-T-401ã«ããPETãè³å
ã®MAGLãå¯è¦åã§ãããã¨ã証æãããæ¬ç ç©¶ã¯ãããã®MAGLãçä½å
ã§åãã¦å¯è¦åããç ç©¶ã§ãããå
å æ§ã«ã³ãããã¤ãããã³MAGLãæ¨çã¨ããåµè¬ããç²¾ç¥ç¥çµç¾æ£ã®ç
æ
ç ç©¶ãªã©ã«æ´»ç¨ããããææã§ããã¨èããããã
ä½è«
æãå½ã§ã¯å¤§éº»åç· æ³ã«ããæ ½å¹ãå³ããå¶éããã¦ãã大麻è(麻)ã§ããããåæ³çã«æ ½å¹ãããã±ã¼ã¹ãåå¨ãããç§ã®çå°ã§ãã徳島çã«ã¯ãåå½å±±å°ã®å±±ä¸ã«æ¨å±å¹³ (æ§æ¨å±å¹³æãç¾å¨ã¯å»æ)ã¨ããå°åããããå¤ä»£ãã天çå®¶ã®ç¥ç¥ã«ä½¿ç¨ããéº»ãæ ½å¹ãã¦ããæ´å²ãæã¤ã天çå³ä½ã®éã«è¡ããã大åç¥ã§ã¯ãéºæï¼ããããï¼ã¨ãã麻ã®ç¹ç©ãä¸å¯æ¬ ã§ããããããã«ã¯æ¨å±å¹³æã§æ ½å¹ããã麻ã使ç¨ããã¦ããã®ãããããã§ããã2019å¹´ã®å¤©çå³ä½ã«éãã¦è¡ããã大åç¥ã§ããæ¨å±å¹³ã§æ ½å¹ããã麻ããç¹ãããéºæï¼ããããï¼ãä¾ããããããã¾ãã¾ãç§ã®æ¯ãæ¨å±å¹³æã®åºèº«ã§ãã£ããã¨ãããç§ãå便代ã«ã¯ãã®å±±æ·±ãèªç¶è±ããªæ¨å±å¹³æã§å¤ä¼ã¿ãéããã¦ãããããã¦ããã®å°ã§å¤ãããè¡ããã¦ããã¨ããéºæï¼ããããï¼ã®ä½æãéº»æ ½å¹ã®è¦å´ã«ã¤ãã¦ãç¥ç¶ããããèãããã¦ãããåç©«åã®ææã«ãªãã¨ãè¥ãææ°ã24æéä½å¶ã§è¦å¼µãçªãè¡ã£ã¦ãéºæï¼ããããï¼ã¨ãªã麻ãå³éã«è¦åãã¦ããããã ãæåããå¹³æã«æ¹å
ããã1989å¹´ã«ãããã®å°ã§éº»æ ½å¹ãè¡ããããã¨ãè¨æ¶ãã¦ããã
å®ã¯ã徳島çã«ã¯å¤§éº»æ¯å¤ç¥ç¤¾ã大麻çºã麻æ¤é¡ã¨ãã£ãã麻ãã«ç±æ¥ããå°åã夿°æ®ããã¦ãããããã¯ãå¤ä»£ãé¿æ³¢å½ã«å
¥æ¤ããå¿é¨æ°ãæããå°éçæè½ã§ãã£ããéº»æ ½å¹ãã«é¢é£ãã¦ããã¨ããããé¿æ³¢å½ä¸ä¹å®®ã§ãã大麻æ¯å¤ç¥ç¤¾ã§ç¥ããã¦ãã大麻æ¯å¤å¤§ç¥ã¯ãå¤ä»£ã«é¿æ³¢å½ãéæããå¿é¨æ°ï¼ããã¹ãï¼ã®ç¥å
ã¨ãããç¥æ¦å¤©çã®æä»£ã«å¿é¨æ°ã®åå«ãé¿æ³¢å½ã«å
¥ãå½åãéæãã¦éº»ã®ç¨®ãæãã¦éº»å¸ãä½ããé·åã®ç£æ¥ã®åºãéãããã¨ããã®åã®ç±æ¥ã¨ããã¦ãããã¾ãããå¤èªæ¾éºãã§ã¯ãé¡åã麻æ¤ãã¯é¿æ³¢å¿é¨ãéº»ãæ¤ãããã¨ã«ç±æ¥ããã¨è¨è¿°ããã¦ãããå¿é¨æ°ã¯ãå
ã
å¤ä»£æå»·ã«ãããç¥ç¥ãæ
ã£ãæ°æã§ããããå¥è¯æä»£ã«å¢åãå¢ããä¸è£æ°ã«å°ä½ãæ¼ãããã¿ã¨ãªããåã°è¿«å®³ããããããªå½¢ã§æå»·ãéãããã®å¾ã¯æ¥æ¬ã®åå°ã«æ£ãã°ããå°æ¹æ°æã¨ãªã£ã¦ãã£ãããã§ãããé¿æ³¢å¿é¨æ°ããæ¥æ¬åå°ã«æ£ãã°ã£ãå¿é¨æ°ã®æ«è£ã®ä¸ã¤ã§ãæçµçã«åå½å±±å°ã®å¥¥æ·±ãã§ããæ¨å±å¹³ã«å
¥æ¤ããã¨ããããæå»·ããé ãé¢ããæ¨å±å¹³ã®å°ã«ãã£ã¦ãéº»ã®æ ½å¹ãç¶ãã天çå³ä½ã®ç¥ç¥ã«ä¸å¯æ¬ ã§ããéºæï¼ããããï¼ãç®ä¸ããå½¹å²ã仿¥ã¾ã§æ®ãã¦ããã¨ããç¹ã¯å¤§å¤è峿·±ãããªããéºæï¼ããããï¼ã®éº»ãæ ½å¹ãããæ¨å±å¹³ã¨ããå°åã¯ããã®å°ã«ããæ£®é (ããã¨ã)ã¨å¼ã°ããå ´æããçã¾ããã¨ããããæ¨å±å¹³æã§ã¯ãå®å¾³å¤©çã®å°å±ã®å
è£ããæ£®é ã®ä½ç½®ã«åå¨ãããã¨ãå¹³ã¯å°å±å¹³æ°ã平家ã§ãããå°å±ã«ç¶ãã¦å¹³ãå ãããã®ã§ããã¨ä¼æ¿ããã¦ãã(æ¨å±å¹³ææå²ãæå46å¹´)ãæ£®é ã¯éºããåå½å±±å°ã®ä¸ã§ããç·©ãããªå¾æå°ã窪å°ãåºããå ´æã§çµ¶å¥½ã®æ¥ç
§æ¡ä»¶ããã¡ãæ°ã¶æããæ¸
æ°´ããããå°å·ãæµãã¦ãããã¨ãããå
¥æ¤è
ãªãçã£å
ã«å±
ä½ãã好æ¡ä»¶ã®å ´æã§ããã¨ããããç§ãä½åº¦ã森é ã訪ãããã¨ããããä»è¿ä¸å¸¯ã®å±±ã¯å¤§å¤æ·±ãããæ£®é ã¯è¦äºãªæ£ç°ã«å²ã¾ããå¹³å¦å°ã§ãããããããè¦æ¸¡ãåå½å±±å°ã®é¢¨æ¯ã¯å¤§å¤ç¾ãããæ¥æ¬ã§ä¸çªå¥½ããªå ´æã¯ã©ããã¨å°ããããããç§ã¯ã森é ãã¨çãã¦ãããé¿æ³¢å¿é¨æ°ã¯è¿«å®³ããéããããã«ãã®ãããªå±±ä¸ã®å°ãé¸ãã ã®ã§ã¯ãªããå½¼ãã®ã¢ã¤ãã³ãã£ãã£ã§ããã£ãéº»æ ½å¹ã«æé©ãªåå°ã§ãã£ããã¨ãããã®å°ãé¸ãã ã®ã§ã¯ãªããã¨ãæ³åãã¦ããã
天çå³ä½ã¨ããæä»£ã®ç¯ç®ã«åããã¦è¡ãããéº»æ ½å¹ããå½ç¶ãªãã大麻åç· æ³ã«ã®ã£ã¨ã£ã¦è¡ããã¦ãããæ¨å±å¹³ã§ã¯ããèã£ã±ã®ä¸æããã¨ãå¤ã«åºããªããã¨ããåè¨èã®ãã¨ãå³éãªç®¡çã§è¡ããã¦ããã¨ãããæãå½ã§ãã大麻ãå»çç®çã§ä½¿ç¨ãããæ¥ãé ããªããã¡ã«ãã£ã¦ããã¨æãããããå
å æ§ã«ã³ãããã¤ããæ¨çã¨ããè¬å¤ã«ãã£ã¦ã大麻æ§ã®å¹æããã鏿çã§ãå¯ä½ç¨ã®å°ãªãå½¢ã§ãããããã¨ãå¯è½ã«ãªããããããªããæ¬ç ç©¶ã§ã¯ãããã®çä½å
ã«åå¨ããå
å æ§ã«ã³ãããã¤ãã®ä»£è¬é
µç´ ãæ¨çã¨ããã¤ã¡ã¼ã¸ã³ã°æè¡ã®ç¢ºç«ã«æåããããæãå½ã®æåã ãã§ãªãã幼尿ã®è¨æ¶ã¨çµã³ã¤ãã麻ãã«é¢é£ããç ç©¶ãæ
ãæ©ä¼ãå¾ããã¨ã§ãèªåã«ã¨ã£ã¦ãéå¸¸ã«ææ
¨æ·±ãææã¨ãªã£ãã
(é«çåè¼ã2022.2.1.)
徳島çç¾é¦¬å¸æ¨å±å¹³å°åºã®éº»æ ½å¹ã®æ§å(2019å¹´5æãçè æ®å½±)
é«é½¢è
ã®åæè½åãâèªç¥çé«é½¢è
ã®å»çåæã«ãããè½åè©ä¾¡ã¨æ¯æ´ã®è©¦ã¿â
æ±å£æ´å (æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ã»ç¥çµç§å¦æå®¤ã訪åç ç©¶å¡)ãè¨åºç²¾ç¥å»å¦ 51:49-56, 2022.
æææ±ºå®æ¯æ´çã«ä¿ãåçå´åçããåºãããå種ã¬ã¤ãã©ã¤ã³ï¼ãé害ç¦ç¥ãµã¼ãã¹çã®æä¾ã«ä¿ãæææ±ºå®æ¯æ´ã¬ã¤ãã©ã¤ã³ãï¼2017å¹´3æçå®ï¼ããèªç¥çã®äººã®æ¥å¸¸çæ´»ã»ç¤¾ä¼çæ´»ã«ãããæææ±ºå®æ¯æ´ã¬ã¤ãã©ã¤ã³ã(2018å¹´6æçå®)ãã人çã®æçµæ®µéã«ãããå»çã»ã±ã¢ã®æ±ºå®ããã»ã¹ã«é¢ããã¬ã¤ãã©ã¤ã³ãï¼2018å¹´3ææ¹è¨ï¼ãã身å¯ãããªã人ã®å
¥é¢åã³å»çã«ä¿ãæææ±ºå®ãå°é£ãªäººã¸ã®æ¯æ´ã«é¢ããã¬ã¤ãã©ã¤ã³ãï¼2019å¹´5æçå®ï¼ããæææ±ºå®æ¯æ´ãè¸ã¾ããå¾è¦äºåã®ã¬ã¤ãã©ã¤ã³ãï¼2020å¹´10æçå®ï¼ãããï¼ã¯ãé«é½¢è
ãããã¯èªç¥æ©è½ãä½ä¸ããè
ã«å¯¾ããæææ±ºå®æ¯æ´ã«ã¤ãã¦èª¬æããã¦ãããå®ãããã¦ããæææ±ºå®ãæ±ããããå ´é¢ã¯ç°ãªããã®ã®ããããã対象è
ã®ææãå°éããããã«ç¹°ãè¿ããæ¬äººã®æããèãããæ±²ã¿åã£ãããããã¨ã®éè¦æ§ã強調ããã¦ããã
è¨åºç¾å ´ã§ã¯ãåäººã®ææãå°å³ãå°éãããã¨ããæããå¼·ããã䏿¹ã§ãå»çè
ãæåã¨èããæ²»çãæ£è
ã鏿ããªãã£ãå ´åãã¨ãããæ£è
ã®æææ±ºå®è½åãååã§ãªãã¨æããå ´åã«ã¯é£ãã対å¿ã«è¿«ããããã¨ãå°ãªããªããæ¬é¦ã«ãããé«é½¢åã«ããé«é½¢æ£è
ã®å¢å ãããã«å»çæè¡ã®é²æ©ã«ããæ²»çã®é©ç¨ãé«é½¢åããããç¾å¨ã§ã¯ãçã
èªç¥çé«é½¢è
ã®å»çåæã«é¢ããç¥è¦ã®éç©ãè°è«ãå¾
ãããã¨ããã§ããã
æ¬è«æã§ã¯ãå»çåæè½åè©ä¾¡æ¹æ³ã«é¢ããè«æãã¬ãã¥ã¼ããAppelbaumã¨Grissoãæå±ãããæ²»çã«å¯¾ããæææ±ºå®ï¼å»çåæï¼è½åã¯ãçè§£ãèªèãè«ççæèã鏿ã®è¡¨æã®æ©è½çè½åã䏿 ¸ãæãã¨ããã4ã¤ã®è½åã¢ãã«ãã«åºã¥ã使ãããMacArthur Competence Assessment Tools for Treatmentï¼MacCAT-Tï¼ãç´¹ä»ãããä»ã«ãã4ã¤ã®è½åãã¹ã¦ãè©ä¾¡ãããã®ã§ã¯ãªãããAid to Capacity Evaluation (ACE)ãã«ã¤ãã¦èª¬æããã
ããã«4ã¤ã®è½åã¢ãã«ã®åè½åã¨èªç¥æ©è½ã¨ã®é¢é£ã«ã¤ãã¦ãæ¦è¦³ããã軽度èªç¥é害ï¼MCIï¼ãèªç¥ççºçåæã®é«é½¢è
ã対象ã¨ããç ç©¶ã§ã¯ä¸è²«ããçµæã¯å¾ããã¦ããªãããæ¦ãMCIãèªç¥çã軽度ã®å ´åã§ãå»çåæè½åã®ä½ä¸ã¯çãããããå¿
ãä½ä¸ãã¦ããã¨ã¯ãããªãç¹ã§ç¥è¦ã¯ä¸è´ããã¨ããã§ãããããããã£ã¦ãæ£è
ã«èªç¥æ©è½ä½ä¸ããã£ãã¨ãã¦ãåæè½åã¯ä½ä¸ãã¦ããªãã¨ã®åæã§ãæ£è
æ¬äººã®ææãååã«å°éãããããã«ãæ§ã
ãªå ´é¢ã§çºããããæ¬äººã®è¨åãæ
度ãªã©å»çåæè½åè©ä¾¡ã¨æ¯æ´ã®è³æã¨ãªãæ
å ±åéãå¿ãããªããã°ãªããªãã
æå¾ã«ãæ¬å¦ã®ç²¾ç¥ã»ç¥çµç§é«é½¢è
èªç¥é害ãµãã¼ããã¼ã ï¼Dementia Support Team: DSTï¼ã循ç°å¨å
ç§ã®ã°ã«ã¼ãã¨ååããé«é½¢è
æææ±ºå®æ¯æ´ã«é¢ããåãçµã¿ãç´¹ä»ãããèªç¥çé«é½¢è
ã®å»çåæè©ä¾¡ãæ¯æ´ã«é¢ãã¦ãèªç¥çãããç¥ãç²¾ç¥ç§ã®ãã¼ã ãæãããå½¹å²ã¯å¤§ãããä»å¾ã¯å»çåæã®æ¯æ´ã¯å°éå®¶ã ãã§ãªã,åè·ç¨®ãæ
å ±ãå
±æãããã¨ã«ããã診çç§ã横æãã¦ããã¤å¤è·ç¨®ã§åãçµããã¨ãæå¾
ãããããããå®ç¾ããã°ãèªç¥æ©è½ã®ä½ä¸ããã£ã¦ããæ¬äººã®ææãæå¤§éå°éããæ²»çãè¿
éã«å¯è½ã«ãªãã
(æ±å£æ´åã2022.1.16.)
é«é½¢è
ã®åäºè²¬ä»»è½å --- è³ç»åã®å½¹å²ãå«ã㦠---
ææ¾å¤ªé (æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§åææ)è¨åºç²¾ç¥å»å¦ 51:49-56, 2022.
æ³å¾ã¯é«é½¢è
ã®ç¯ç½ªã«è¿½ãã¤ãã¦ããªããç¾è¡ã®åæ³ãå¶å®ãããã®ã¯ææ²»æä»£ã1907å¹´ã§ãããå½æã®æ¥æ¬äººã®å¹³å寿å½ã¯ç·å¥³ã¨ãã«40æ³ä»£ã§ãã£ãããããã£ã¦é«é½¢è
ã®ç¯ç½ªã¯æ³å®å¤ããæ³å®å
ã§ãã£ãã¨ãã¦ããããã¦ä¾å¤çãªãã®ã¨è¦ããã¦ããã¯ãã§ãããã¾ããã¢ãã¤ã¹ã»ã¢ã«ããã¤ãã¼ãã¢ã«ããã¤ãã¼ç
ã®æåã®çä¾ãå ±åããã®ã1906å¹´ã ãããèªç¥çã¨ããæ¦å¿µãã彿ã¯åå¨ãã¦ããªãã£ãã®ã§ããããããªæä»£ã«ä½ãããæ³å¾ããé«é½¢è
ã®ç¯ç½ªãæ¿å¢ãã¦ããç¾ä»£ã«é©ç¨ãããã¨ã®æªã¿ãä»ãé²ãã«ãªã£ã¦ãã¦ããã
ããã§åäºè£å¤ã®æ³å»·ã¯ãã¥ã¼ããµã¤ã¨ã³ã¹ã®ç¥è¦ã«æå¾
ããã®ã§ããããç¾ä»£ã®ãã¥ã¼ããµã¤ã¨ã³ã¹ã¯é«é½¢è
ã®ç¯ç½ªã追ãæãã¦ãããã追ãæãã¦ãããã¨ããã®ã¯ãè¯ãæå³ã§è¨ã£ã¦ããã®ã§ã¯ãªããä¼´èµ°ãã¹ãç«å ´ã«ããã®ã«ããããããããã®å½¹å²ãæ¾æ£ãã¦ã¯ããå
ã¾ã§èµ°ãå»ã£ã¦ãã¾ã£ã¦ããã¨ãã£ãæå³ã§ãããæ³å¾ã¸ã®å¿ç¨ãåæã¨ããªãã§é²æ©ãããã¥ã¼ããµã¤ã¨ã³ã¹ããæ³ã®ä¸çã«æã¡è¾¼ããã¨ã®æªã¿ãä»ãé²ãã«ãªã£ã¦ãã¦ãããããã¯ãè³ç»åæ¤æ»æè¦ãç¥çµå¿çå¦çæ¤æ»æè¦ãããã®é©ç¨ç¯å²ã大ããé¸è±ãã¦é©ç¨ããã¨ããBrain Overclaim Syndrome (è³éå°éè¦çå群)ã¨å¼ã°ããäºæ
ã¨ãã¦æ³å»·ã«å
·ç¾ãã¦ããããã®é¡èãªä¾ããé«é½¢è
ã®åäºè²¬ä»»è½å夿ã§ããã責任è½åã¯ç²¾ç¥é害ã¨å¯çããæ¦å¿µã§ãããç²¾ç¥éå®³ã®æ¦å¿µã¯ç²¾ç¥å»å¦ã®èªç以æ¥å¤é·ãéãã¦ãã¦ãããããã¥ã¼ããµã¤ã¨ã³ã¹ã®é²æ©ã«ãã£ã¦ãè³æ©è½é害ã¨ããè¦ç¹ãé¢ããç²¾ç¥é害ã¨ãããã®ã¯ãã¯ãèããããªãæä»£ã«ãªããããã«ä¼´ãå¿
ç¶çã«ã責任è½åã«ã¤ãã¦ãè³æ©è½é害ã¨ããè¦ç¹ã§è«ãããã¨ãå¿
é ã«ãªã£ããå é½¢ãããããã¯èªç¥çã¨ããç¾æ£ã«ããè³æ©è½é害ã®çµæã¨ãã¦ç¯ç½ªãè¡ãããã¨ãã被å人ãéé£ãããã¨ãã§ããã®ããã§ããã¨ããã°ãã®æ ¹æ ã¯ä½ããéã«ã§ããªãã¨ããã°ãã®æ ¹æ ã¯ä½ããããã¦éé£ã§ããªãã®ã§ããã°ãã§ã¯ã©ãããã°ããã®ãã
è³æ©è½ã®è§£æã¯äººé観ãå¤ããã«ã¯ããããªããå«çéå¾³æ©è½ãããã¦å¿ã¨å¼ã°ãããã®ããè³æ©è½ã®ç¾ãã§ãã£ã¦ããããã£ã¦è³ã®ç ã§ããããå´©å£ãããã¨ãããå¾ãã¨ããç¾å®ãã人ã ã®å¸¸èã«ã¾ã§åºã¾ã£ããã責任éé£ã¨ããæ¦å¿µã¯æ°ããªè¡£ãçºã£ã¦ç¤¾ä¼ã«è¿«ã£ã¦ããã§ããããé«é½¢è ãèªç¥çã®è²¬ä»»è½åãåãåäºè£å¤ã¯ããã®æåç·ã«ããã
(ææ¾å¤ªéã2022.1.20.)
解説ãå¿ã¨è³ã¨å¸æ³ç²¾ç¥å»å¦
æ±å£è«æãææ¾è«æã¯ãããããè¨åºç²¾ç¥å»å¦51å·»1å·(2022å¹´1æ)ã®ç¹éãé«é½¢ç¤¾ä¼ã¨å¸æ³ç²¾ç¥å»å¦ãã«åè¼ããããã®ã§ããã叿³ç²¾ç¥å»å¦ã¨ã¯ãåºç¾©ã«ã¯ãæ³ã¨ç²¾ç¥å»å¦ã®æ¥ç¹ã«ãããã®ãã¹ã¦ãæããæ³ã¯ã人éãèªç±ææãæã¡ãçæ§çã«è¡åãããã¨ãåæã¨ããããã§ã社ä¼ãç¶æããããã«ä½ããã壮大ãã¤ç·»å¯ãªã·ã¹ãã ã§ããããã®ã·ã¹ãã ã«ããã¦ã¯ãå¿=ç²¾ç¥æ©è½ã«ä¸å®ç¯å²ããã®é¸è±ããã対象è ãåã«ããã¨ããæ³ã確ç«ãã¦ããç²¾å¯ããæ¥ã«éç¨ããªããªãã人ã ã¯ãä½ãæ£ããä½ãæªãã®ããä½ã鵿³ã§ä½ãéæ³ãã®å¤æã«å°æãããé«é½¢è ã¨èªç¥çã®æ°ãè¨å¤§ã«ãªã£ãæãå½ã§ã¯ããã®åé¡ã®çºçä»¶æ°ã¯å¢å ãã䏿¹ã§ããããã®ä»£è¡¨ããæ±å£è«æã®èªç¥çé«é½¢è ã®å»çåæã§ãããææ¾è«æã®é«é½¢è ã®åäºè²¬ä»»è½åã§ãããããããã社ä¼å ã«çãã人éã®ç²¾ç¥æ©è½=å¿ã®è©ä¾¡ãè¦æ±ãããé åã§ããããã®è©ä¾¡ã¯è³æ©è½ã®è©ä¾¡ã«ç´çµãã¦ããã人éã®å¿ããè³ã¨ããè¦ç¹ããã¨ããããæ¬HPåé ä¸è¡ç®ã«è¨ããç¥çµå¿çå¦ã®åç¹ãç¾å®ç¤¾ä¼ã«ããããã¨å±éãããã®ããæ¬ç¹éãé«é½¢ç¤¾ä¼ã¨å¸æ³ç²¾ç¥å»å¦ãã®ä¸çã§ããã
æå¾ã«ãã®ç¹éã®å ¨ä½åã示ãã
é«é½¢è
ç¯ç½ªã®ç¾ç¶ã¨èª²é¡ã(äºååµç¦äººã»åè大å¦)
é«é½¢ç¤¾ä¼ã¨æ³ã(è¥¿å±±å¥æ²»éã»äºçªçºæ³å¾äºåæ)
é«é½¢è
ã®åäºè²¬ä»»è½å â è³ç»åã®å½¹å²ãå«ã㦠--ã(ææ¾å¤ªéã»æ
¶æç¾©å¡¾å¤§å¦)
é«é½¢è
ã®åäºè¨´è¨è½åã(ä¸å³¶ç´ã»å¤æ©ããã°ç
é¢)
é«é½¢è
ã®åæè½å â- èªç¥çé«é½¢è
ã®å»çåæã«ãããè½åè©ä¾¡ã¨æ¯æ´ã®è©¦ã¿ --ã(æ±å£æ´åã»æ
¶æç¾©å¡¾å¤§å¦)
ååè
ã®é«é½¢å â è¶
é«é½¢ç¤¾ä¼ã«ãããé«é½¢ååè
ã®ç¾ç¶ â (å°å±±ç°éæã»ä»ã»ãããã¾å¸ä¿å¥ç¦ç¥å±ä¿å¥é¨å¥åº·å¢é²èª²)
é«é½¢è
ã®èªåè»é転 â è¿å¹´ã®éè·¯äº¤éæ³ã®æ¹æ£ã«ã¤ã㦠â (髿©ä¿¡è¡ã»åå¸é¢å¤§å¦)
é«é½¢è
ã«ããä»è·æ®ºäººã®ç¹å¾´ã(ç°å£å¯¿åã»ç¥å¥å·çç«ç²¾ç¥å»çã»ã³ã¿ã¼)
(ææ¾å¤ªéã2022.1.21.)
ã¢ã«ã³ã¼ã«æ§èªç¥çã¨èª¤è¨ºããã¦ããå³å´é èååé å´é åèªç¥ç
è¹å±±ééï¼è¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§é¨é·ï¼Michitaka Funayama, Asuka Nakajima, Shin Kurose, and Taketo Takata.
Putative Alcohol-Related Dementia as an Early Manifestation of Right Temporal Variant of Frontotemporal Dementia. Journal of Alzheimerâs Disease 83 (2021) 531â537.
DOI 10.3233/JAD-210501
ãèæ¯ãåé å´é åèªç¥çã®åææ®µéã§ã®è¨ºæã«ã¯ã誤診ã®å¯è½æ§ã常ã«ã¤ãã¾ã¨ããåé å´é åèªç¥çã®åæè¨ºæã¯ç´åæ°ã®ä¾ã§å¾ã«å¤æ´ããã主ã«ç²¾ç¥ç¾æ£ãã¢ã«ããã¤ãã¼ç ãªã©ã®ä»ã®å¤æ§ç¾æ£ã®è¨ºæã«è³ããã¨ãå¤ããå対ã«ãæçµè¨ºæãåé å´é åèªç¥çã§ãã£ãä¾ã®ä¸ã§ç´åæ°ã¯åæã«ã¯ç²¾ç¥ç¾æ£ã®è¨ºæãåãã¦ããã¨ããå ±åãããããã®åé å´é åèªç¥çã®ãªãã§ããå³å´é 極ã«å¤æ§ã®ä¸å¿ãæã¤å ´åã¯ç¹ç°çãªçç¶ã«æ¬ ãããã¨ãããã¨ããã診æãå°é£ã§ããã¨è¨ããã¦ãããä»åããããã¯ãåæçç¶ã¨ãã¦ã¢ã«ã³ã¼ã«ä¾åçã¨ãªãã¢ã«ã³ã¼ã«æ§èªç¥çã¨èª¤è¨ºããã¦ããå³å´é èååé å´é åèªç¥çã®1ä¾ãå ±åããã
ãçä¾ã
ã¢ã«ã³ã¼ã«æ§èªç¥çã®è¨ºæ
çä¾ã¯ãæè²æ´16å¹´ãå®¶æã§çµå¶ããææ¨åºã®ç¤¾é·ã¨ãã¦é·å¹´åãã¦ãããä»äºç±å¿ãªçé¢ç®ãªç·æ§ã§ããã60æ³é ãããã£ãããªãã¢ã«ã³ã¼ã«ä¾åçã¨ãªããä¼ç¤¾ã¯åç£ã«è³ã£ããåææããä»ã®äººã話ãããã¨ã«æ³¨æãåããªããªã£ããä»äºä¸ã®ãã¹ãå¤ããªã£ãããã¦ãå®¶åºå
ã§ã妻ã¨ã®å£è«ãçµ¶ããé¢ä¿ãæªåãã¦ãã£ããçºçãã4å¹´å¾ï¼64æ³ï¼ã«ã¯ãã£è¡æ§å¿ä¸å
¨ï¼ã¢ã«ã³ã¼ã«æ§å¿ççï¼ã«ããå
¥é¢å çã¨ãªã£ãããç
室ã§å«ç
ãããããã«å¼·å¶éé¢ã¨ãªã£ããçºçãã5å¹´å¾ï¼65æ³ï¼ã«ãã£è¡æ§å¿ä¸å
¨ã§åå
¥é¢ãããã仿£è
ã®é¨å±ã«å
¥ã£ã¦å·èµåº«ã®ä¸ã®ç©ãé£ã¹ããï¼éé£å¾åãä¼´ãï¼ã仿£è
ã®éèæ³¨å°ç¨ã®ã·ãªã³ã¸ãã³ãã®é»æºãåã£ãããããããã¢ã«ã³ã¼ã«æ§èªç¥çã®è¨ºæã§ç¥çµç²¾ç¥ç§ã«è»¢åºã¨ãªã£ããç¥çµç²¾ç¥ç§ç
æ£ã«å
¥é¢ä¸ã¯ãã¾ãã¾ãªè¨åãè¡åã®åé¡ãç®ç«ã£ãã人ã®è©±ãèããã«ç«ã¡å»ã£ã¦ãã¾ã䏿¹ã§ãèªåã®è©±ã¯ä¸æ¹çã«å¤å¼ã«æµæ¢ã«è©±ãããã°ãã°è©±ãè±ç·ãã¦ãããèºççèã«ããèºçã«ç½¹æ£ããããèªå®¤ã«çã¾ãç´æãå®ããã«åæã«ä»æ£è
ã®é¨å±ã«å
¥ãè¾¼ã¿ã仿£è
ï¼äººã«ãèºççèã«ããèºçããã¤ãã¦ãã¾ã£ãããåæã«å·èµåº«ããé£ã¹ç©ãæã£ã¦ãã¦é£ã¹ãããç
æ£å
±æã§ããæ°èãéèªã«è½æ¸ããããããã¦ããã妻ã¨ã¯é¢å©ã«è³ããæ½è¨ã«å
¥æã¨ãªã£ããé é¨CTã§ã¯å³å´é 極ã«è縮ãèªããããå½æã¯æ³¨ç®ããã¦ããªãã£ãã
åé å´é åèªç¥çã®è¨ºæ
æ½è¨å
¥æã¨ãªã65æ³ä»¥éã¯ã¢ã«ã³ã¼ã«ãçµ¶ã£ãããæ½è¨å
ã®å
±æã®éèªã¸è½æ¸ããããããä»äººã®é¨å±ã«ä¸ããè¾¼ã¿äººã®é£ã¹ç©ãé£ã¹ã¦ãã¾ã£ããããç°å¸¸è¡åãç¶ãããå½ç§ã§å¤æ¥éé¢ãç¶ç¶ãã¦ãããã診å¯å®¤ã§ã¯å»å¸«ãåãããã¦ãããã«ç«ã¡å»ã£ã¦ãã¾ãç«ã¡å»ãè¡åãç®ç«ã£ãã67æ³ããã¯æ¯ååã話ããããªã«ã´ã¼ã«æè¨çç¶ãã68æ³ããã¯æ±ºã¾ã£ãæéã«é£å ã«å
¥ããæ±ºã¾ã£ãæéã«å¤åºãããæå»è¡¨çè¡åãèªãããæãããªæå³è¨æ¶é害ãåºç¾ãã67æ³æã«ã¯æ½è¨ã®åºã®ãã¹ãåã£ã¦ãã®ã¾ã¾çã§é£ã¹ã68æ³æã«ã¯æ½è¨å
ã®åå±
è
ãèªèã§ããªããªã£ãã69æ³ããã¯è¡¨å±¤å¤±èªãå«ãæãããªèªç¾©å¤±èªãåºç¾ããããã®æç¹ã§æ®åããé é¨MRIã¨Tc-99mECD SPECTã§ã¯ä¸¡å´å´é 極ã«è縮/ç¸å¯¾çè¡æµéã®ä½ä¸ãèªããããã®æç¹ã§ãããããã¢ã«ã³ã¼ã«æ§èªç¥çã§ã¯ãªããåé å´é åèªç¥çã®è¨ºæã«è³ã£ããã¢ã«ã³ã¼ã«ä¾åçãåé å´é åèªç¥çã®åæçç¶ã¨ãã¦æã«åºç¾ããçç¶ã®ã²ã¨ã¤ã§ãããã¨ããããã¹ã¦ã®ç
æ
ãä¸å
çã«æãããã¨ãã§ããã
ãèå¯ã
誤診ã®èæ¯
çç¶ã詳細ã«è¨ºã¦ããªãã£ãã®ããã¡ããåå ã§ããããä¸åº¦ã¢ã«ã³ã¼ã«æ§èªç¥çã¨è¨ºæãã¦ãã¾ã£ããã¨ã§ãç°å¸¸è¡åãã¢ã«ã³ã¼ã«æ§èªç¥çã«å½ã¦ã¯ãã¦ãã¾ã£ãç¹ãæããããããããã徿¹è¦çã«ã¿ãã¨è¨ºæã¸ã®ãã³ãã¯å¤ããç«ã¡å»ãè¡åãä»äººã®é¨å±ã¸ã®æ¼ãå
¥ãã¨åæã«äººã®é£ã¹ç©ãé£ã¹ããªã©ã®å
±æä¸å
¨ãé¡èãªè±æå¶ã¯ã¢ã«ã³ã¼ã«æ§èªç¥çã§ã¯å
¸åçã§ã¯ãªããéé£å¾åãã¢ã«ã³ã¼ã«ä¾åçèªä½ãåé å´é åèªç¥çã®é£ç¿æ
£ã®å¤åã¨æãããã¨ãã§ããã
ã¢ã«ã³ã¼ã«æ¶è²»éã®å¢å ã¨åé å´é åèªç¥ç
é£ç¿æ
£ã®å¤åãã¢ã«ã³ã¼ã«æ¶è²»éã®å¢å ã¯åé å´é åèªç¥çã®åæçç¶ã®ãã¡ã®ï¼ã¤ã§ããã¨èããããå·¦å´é èã®è縮ã主ä½ã§ããæå³æ§èªç¥çãããå³å´é èååé å´é åèªç¥çã«å¤ããã¨ãç¥ããã¦ãããã¢ã«ã³ã¼ã«æ¶è²»éã®å¢å ã®åå ã¨ãã¦å ±é
¬ç³»ã®ç°å¸¸ãææãããã ãã§ã¯ãªããå³å´é 極ã®è縮ã«ããå³è¦ã®æå³è¨æ¶é害ãåå ã®1ã¤ã¨æ¨æ¸¬ããã¦ãããããããå®éã«ã¢ã«ã³ã¼ã«ä¾åçã¨ãªããããã«ã¯ã¢ã«ã³ã¼ã«æ§èªç¥çã¨ã¾ã§èª¤è¨ºããã¦ããã¨ããã²ã¨ã¤ã®å
¸åä¾ã®å ±åã¯ä»ã¾ã§ãªãã£ããæ¬å ±åã§ã¯ãåé å´é åèªç¥çã®åæçç¶ã¨ãã¦ã¢ã«ã³ã¼ã«ä¾åçããããããã¨ãæç¢ºã«ç¤ºããã®ã§ããã
ãªããå³å´é ååé å´é åèªç¥çã®çåã¯æè¿æ³¨ç®ãéãã¦ãã¦ãããåé å´é åèªç¥çã®ç°å¸¸è¡åã«æå³è¨æ¶ãã©ã®ããã«çµ¡ãã®ãããããè§£ãéµãç§ãããã¦ããå¯è½æ§ãããã
(è¹å±±ééã2021.12.1.)
ã¢ã«ã³ã¼ã«é¢è±æã®æ¿ããçºæ±ã¨çºç±ã«ãã循ç°è¡æ¶²éæ¸å°æ§ã·ã§ã㯠~çä¾å ±å~
è¹å±±ééï¼è¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§é¨é·ï¼Michitaka Funayama, Ryotaro Okochi, Shintaro Asada, Yusuke Shimizu, Shin Kurose and Taketo Takata.
Severe diaphoresis and fever during alcohol withdrawal cause hypovolemic shock: case report. BMC Psychiatry (2021) 21:387. https://doi.org/10.1186/s12888-021-03393-x
ãèæ¯ãç«å¦ç ç©¶ããã¯ã¢ã«ã³ã¼ã«ä½¿ç¨é害ã«ããå ¥é¢ãçµé¨ããæ£è ã¯ãä¸è¬äººå£ãããå¹³åä½å½ã24ï½28æ³çããªããã¨ãæããã«ãªã£ã¦ãã¦ããããã®åå ã«ã¯ä¸»ã«é·æã«ãããã¢ã«ã³ã¼ã«ä½¿ç¨ã«ããèå¨é害ï¼èèãªã©ã®æ¶åå¨ã循ç°å¨ãªã©ï¼ãæããããããã¢ã«ã³ã¼ã«é¢è±æã«ãããããã䏿´èãããã¤ã¼å¿ççãªã©æ»ã«è³ãå¯è½æ§ã®ãã身ä½åä½µçãåºç¾ãããã¨ãããããããã®èº«ä½ç¾æ£ã«ã¯é¢è±ã«ä¼´ã䏿¢ç¥çµç³»ã®éæ´»åãã¢ãã¬ããªã³ä½ç¨ã®å¢å¼·ãé¢é£ãã¦ãããã¢ã«ã³ã¼ã«é¢è±æã«ã¯ä»ã«ããçºæ±ãçºç±ãæ¯æ¦ãå¹»è¦ãé¯è¦ãç²¾ç¥éåè奮ãä¸ç ãä¸å®ãªã©ã®çç¶ãåºç¾ããããé度ã®çºæ±ã¨çºç±ã¯å¾ªç°è¡æµéã®ä½ä¸ãå¼ãèµ·ããå¯è½æ§ããããããããä»ã¾ã§ã«ã¢ã«ã³ã¼ã«é¢è±æã«å¾ªç°è¡æµéã®ä½ä¸ã¨ããã«é¢é£ãã身ä½åä½µçã®å ±åã¯ãªããä»åããããã¯ãé£äºã¯ã»ã¼å ¨éæåãã¦ãããã®ã®ãã¢ã«ã³ã¼ã«é¢è±æã«çããæ¿ããçºæ±ã¨çºç±ã«ãã£ã¦å¾ªç°è¡æ¶²éæ¸å°æ§ã·ã§ãã¯ã¨ããã«ä¼´ãè åæ§è ä¸å ¨ãåããçä¾ãå ±åããã
ãçä¾ãçä¾ã¯20å¹´æ¥ã®ã¢ã«ã³ã¼ã«ä¾åçãä¼´ã52æ³ç·æ§ã§ãããã¢ã«ã³ã¼ã«æ§èé害ããChild-Pugh Bã®è硬å¤ã¨é£ééèç¤ãä½µçºãã¦ããããé£ééèç¤ããã®åè¡ã«ã¦å ¥é¢å çãè¡ã£ã¦ãããç·æ¥ã®å è¦é¡çéèç¤çµç´®è¡ã¨è¼¸è¡ã«ãã£ã¦èº«ä½çã«ã¯æ¹åå¾åã§ãã£ããã第4ç æ¥ç®ããä¸ç ã第5ç æ¥ç®ã«ã¯æ¯æ¦ãé »èãæèå¤å®¹ãå¹»è¦ãé¯è¦ã«å ããæ¿ããçºæ±ãä¼´ãã¢ã«ã³ã¼ã«é¢è±çç¶ãåºç¾ããã第6ç æ¥ç®ã«ãæ¿ããçºæ±ã¯ç¶ããããã«38âå°ã®çºç±ãå ãã£ããé¢è±ããå¦ãç¶ãã¦ããæéãæ£è ã¯é£äºãã»ã¼å ¨éãæåãã¦ãããã第ï¼ç æ¥ç®ã«ã¯è¡å§ã75/48mmHgã¾ã§ä¸éãã循ç°è¡æ¶²éæ¸å°æ§ã·ã§ãã¯ã¨ããã«é¢é£ããè åæ§è ä¸å ¨ï¼è¡æ¸ ã¯ã¬ã¢ããã³æ¿åº¦3.4mg/dlï¼ãåãããç´°è夿¶²ã«ããå¤éã®è¼¸æ¶²çæ³ã«ãã£ã¦ãããã®ç æ ã¯æ¹åããã
ãèå¯ãæ¬ä¾ã¯ãã¢ã«ã³ã¼ã«é¢è±æã®ä¸æ¢ç¥çµç³»ã®éæ´»åãã¢ãã¬ããªã³ä½ç¨ã®å¢å¼·ã«ãã£ã¦çããæ¿ããçºæ±ã¨çºç±ãæ£è ã®å¿ è¦æ°´åéãå¢å ããã循ç°è¡æ¶²éæ¸å°æ§ã·ã§ãã¯ã«è³ã£ããã®ã§ãããç²¾ç¥ç§é åã«ããã¦é¨åçã«é¡ä¼¼ããç æ ã¯ç·å¼µç ï¼ãªããã¯æªæ§çå群ï¼ã§èªãããããã¢ã«ã³ã¼ã«é¢è±ãç·å¼µç ã¯ãã®ç²¾ç¥ç¶æ ã®ã³ã³ããã¼ã«èªä½ã§ååã«å¤§å¤ãªã®ã§ããããåæã«ããã«ä¼´ã身ä½é¢ã®ç æ ææ¡ãéè¦ã¨ãªããããããç²¾ç¥ç§å»ã«ã¯ãç²¾ç¥é¢ããã³èº«ä½é¢ã®ä¸¡è ã«å¯¾ããç´°ãã管çãæ±ããããã
(è¹å±±ééã2021.12.11.)
解説ãçã«æç¾©ããå»å¦è«æã¨ã¯
å»å¦è«æãæ¸ãç®çã¯ä½ããå°æ¥ã®çä¾ã®è¨ºæã»æ²»çã»å¦éã«å½¹ç«ã¦ãããã§ãããå°æ¥ã®çä¾ã¨ã¯ãè¨åºå»ã®ç®ã®åã«ç¾ããåå¥ã®çä¾ã§ãããããã¨çä¾å ±åããã¯å»å¦è«æã®åç¹ã¨ãããã¨ã«ãªãããåä¸ã®çä¾ã¯æ±ºãã¦åå¨ããªãããããããæ¬è³ªãå ±æããè¤æ°ã®çä¾ã対象ã¨ãã¦ä¸è¬åãããã°ã«ã¼ããã¼ã¿ã®æ¹ããçµå±ã¯åå¥ã®çä¾ã®è¨åºã«è³ãããã¨ã«ãªããããããªããããã«çºçããæ·±å»ãªåé¡ã¯ããæ¬è³ªãå ±æãããã¨ããç¹ã«ãããç²¾ç¥ç§ã§æ±ãå¤ãã®ç¾æ£ã§ã¯ãä½ãæ¬è³ªã§ãããã¯ã¾ã ã¾ã 䏿ã®ãã®ã大é¨åã ãã ãã観å¯å¯è½ãªçç¶ã«åºã¥ããæä½ç診æåºæºãå ¬å¼ã®ãã®ã¨ãã¦æ±ç¨ããã¦ããããããã¨è¨ºæåãåãã§ãæ¬è³ªãå ±æãã¦ããã¨ããä¿è¨¼ã¯å ¨ããªããããã°ã«ã¼ããã¼ã¿ã«ã©ãã¾ã§æå³ããããã«ã¤ãã¦ã¯çå符ãã¤ããåãè²ããã¨ãã°èµ¤ãè²ã®è±ã ããéãã¦ç ç©¶ãã¦ããå¾ãããã®ã¯èµ¤ãè²ç´ ã«ã¤ãã¦ã®ãã¼ã¿ã®ã¿ã§ãããããã¯ç§å¦çã«æ£ããç¥è¦ã§ãã£ã¦ããç ç©¶ã§æ±ããã´ã¼ã«ããã¯ããé¢ãããã®ã§ãããªãã
ãããã¦ç²¾ç¥å»å¦ã¯åªããçä¾å ±åã®èç©ãåæãããæ®µéã«ããããä»ã®å»å¦åéã¨ååã®è©ä¾¡åºæºãç®æãããã¨ããäºæ ããã£ã¦ãã°ã«ã¼ããã¼ã¿ã®æ¹ãé«ãå°ä½ã«ããã¨ããã®ãç¾å®ã§ããããããªé風ã®ä¸ãè¹å±±ééé¨é·ã¯ãåä¸è»¢ã³ååèµ·ã(æ¬HP2020å¹´4æåç §)ã®ä¸å±ã®ã¨ãã«ã®ã¼ã§ãæ´ç·´ãããçä¾å ±åãçºåãç¶ãã¦ãããåé å´é åèªç¥çã®åæçç¶ã¨ãã¦ã¢ã«ã³ã¼ã«ä¾åçãç¾ããã¨ããçä¾ã¯(J Alzheimer dis 2021)ãå ¨çµéããæ¯ãè¿ã£ã¦ã¿ãã°çµéã®åæã«è¨ºæå¯è½ã§ãã£ãã¨ææã§ãã¦ãããªã¢ã«ã¿ã¤ã ã§ã®è¨ºæã¯é常ã«å°é£ã§ãããã¨ã¯ééããªããã¢ã«ã³ã¼ã«é¢è±çç¶ããäºæ¬¡çã«è±æ°´ã¨ãªãã·ã§ãã¯ã«é¥ãã¨ããçä¾ã¯(BMC Psychiat 2021)ãã¢ã«ã³ã¼ã«ä¾åçã®æ¥å¸¸è¨åºã§å®ã¯å¤æ°ééãã¦ããã¨æãããããææãããªããã°æ°ã¥ããã¨ã¯ãããã¦å°é£ã§ãããã©ã¡ããå°æ¥ã®åå¥çä¾ã®è¨ºæã»æ²»çã»å¦éã«å¤§ãã«æç¨ã§ããããã°ã«ã¼ããã¼ã¿ã¨ãã¦ã®è«æã¨ãã¦æç«ãããã¨ã¯ã¾ãèããããªããé 風ã«ä¹ãã°èª°ã§ãæ¯è¼ç楽ã«åé²ã§ãããé風ã®ä¸ã§ã®åé²ãããçã®åé²ã§ãããçã«æç¾©ããå»å¦è«æã§ãããè¹å±±é¨é·ãåºçãç¶ãã¦ããä¸é£ã®çä¾å ±åãã¾ãã«ããã§ããã¨è¨ãããã
(ææ¾å¤ªéã2021.12.29.)
ç·æ¡ä½ã«ããããããã³D2å容ä½ããã³ãããã³ãã©ã³ã¹ãã¼ã¿ã¼ã®çµåæ§ã¨å±æç°ç½è³ªè³å®¹ç©ã¨ã®é¢é£æ§
é»ç¬ãå¿æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨å»å¦ç ç©¶ç§ãç²¾ç¥ç¥çµç§åå£«èª²ç¨ / éåå»ç§å¦ç ç©¶æãè³æ©è½ã¤ã¡ã¼ã¸ã³ã°ç ç©¶é¨ãè³ç¾æ£ãã©ã³ã¹ã¬ã¼ã·ã§ãã«ç ç©¶ã°ã«ã¼ããå®ç¿ç
Kurose S, Kubota M, Takahata K, Yamamoto Y, Fujiwara H, Kimura Y, Ito H, Takeuchi H, Mimura M, Suhara T, Higuchi M. Relationship between Regional Gray Matter Volumes and Dopamine D2 Receptor and Transporter in Living Human Brains. Human Brain Mapp, 2021. 42(12), 4048-4058 https://doi.org/10.1002/hbm.25538
ç·æ¡ä½ã§ã®ãããã³ç¥çµä¼éã¯ãç®è³ªç·æ¡ä½ãããã¯ã¼ã¯ã®å¼·åº¦ãçµåæ§ãã·ããã¹å¯å¡æ§ã«ãç¸äºçãæ©è½çã«é¢é£ãã¦ããã¨èãããã¦ãããçµ±å失調çãªã©ã®ç²¾ç¥ç¥çµç¾æ£ã§ã¯ããããã³ç¥çµä¼éããã³ç®è³ªç·æ¡ä½ãããã¯ã¼ã¯ã®ç°å¸¸ãè³æ§é ã®å¤åããããããç¹°ãè¿ãå ±åããã¦ãããããããããã対象ã¨ãã¦çä½ã§ãããã³ç¥çµä¼éã¨è³æ§é ã¨ã®é¢é£ã調ã¹ããã®ã¯å ±åãå°ãªãã£ããããã§æã ã¯ãéå»ã«éç æ©æ§ã§æ®åãããPETãã¼ã¿ãç¨ãã¦ãå¥å¸¸äººã®è³ã«ããã¦ãããã³ãã©ã³ã¹ãã¼ã¿ã¼ããããã³D2å容ä½ã屿è³å®¹ç©ã®é¢é£ã«ã¤ãã¦èª¿ã¹ã.
34人ã®ç·æ§å¥å¸¸è
ï¼å¹³åå¹´é½¢23æ³ï¼ã«å¯¾ãã¦ãé é¨MRIã»T1強調ç»å, [11C]racloprideï¼ãããã³D2å容ä½ï¼ã»[18F]FE-PE2Iï¼ãããã³ãã©ã³ã¹ãã¼ã¿ã¼ï¼ãç¨ããPETæ¤æ»ãè¡ã£ãããããã®ãªã¬ã³ãã® binding potentials (BPND) ãå®éåããç·æ¡ä½ã®3ã¤ã®æ©è½çãªé åï¼limbic, executive, sensorimotorï¼ã«åãã¦ããããã®ãªã¬ã³ãã®BPNDã®ç¸é¢è§£æãè¡ã£ããããã«, voxel-based morphometry (VBM)æ³ãç¨ãã¦ã屿ç°ç½è³ªå®¹ç©ã¨ããããã®ç·æ¡ä½é åã«ãããBPNDã¨ã®ç¸é¢ããå¹´é½¢ãMRIæ®åããã³ã«ãå
¨è³å®¹ç©ãå
±å¤éã¨ãã¦è§£æãè¡ã£ãã
[11C]raclopride ã®ãlimbic subregionã«ãããBPNDã¯æµ·é¦¬é¤ããã³æµ·é¦¬ååã¨ãã®é£æ¥ããå´é èã®è³å®¹ç©ãexecutive subregionã«ãããBPNDã¯åé åéã¨ãã®é£æ¥ããé åã®è³å®¹ç©ã sensorimotor subregionã«ãããBPNDã¯ä¸æ¬¡ä½æ§æè¦éããã³è£è¶³éåéã«ãããè³å®¹ç©ãã¨ã«ããããææãªæ£ã®ç¸é¢ãèªããã ãããã¯ãç®è³ªç·æ¡ä½ãããã¯ã¼ã¯ã®æ©è½çã»è§£åå¦çãªç¹ããã«åºã¥ãããã®ã§ãã£ãã䏿¹ã§ã[18F]FE-PE2Iã§ã¯ææãªç¸é¢ã¯ã¿ãããªãã£ãã
ãããã®çµæããããããã³D2å容ä½ã®å¯åº¦ãç®è³ªç·æ¡ä½ã®æ©è½çã»æ§é çãªé¢é£ã«é¢ä¸ãã¦ãããã¨ã示ããã䏿¹ã§ããããã®é¢é£ã¯ãããã³ãã©ã³ã¹ãã¼ã¿ã¼å¯åº¦ãåæ ãã¦ããã¨èããããé»è³ªç·æ¡ä½çµè·¯ã¨ã¯ç¬ç«ãã¦ããã¨èãããããä»å¾ãçµ±å失調çããã¼ãã³ã½ã³ç
ã®æ£è
ã対象ã¨ãã¦åæ§ã®ç ç©¶ãè¡ããã¨ãããããã³ã¨è³æ§é ã®è¦³ç¹ã«ãããç
æ
è§£æã«ã¤ãªããã¨èããããã
(é»ç¬å¿ã2021.11.18.)
解説ã360度ã®è¦ç¹ããç²¾ç¥ãã¿ã
æ¬HP2020å¹´6æã䏿¢æ§èªå¾ç¥çµãããã¯ã¼ã¯ãå«ããè³å ¨ä½ã§ã®è³è¡æµã®äº¢é²ãèªããæªæ§ç·å¼µç ã®1ä¾ã(Schizophrenia Research 2019) ã®1st authorã§ããé»ç¬å¿å»å¸«ããã®å¾å¤§å¦é¢ã«é²å¦ããéåå»ç§å¦ç ç©¶æã§è¡ã£ãä»äºã§ããã
20ä¸ç´åã°ã«çµ±å失調çã®ãããã³ä»®èª¬ãæå±ããã¦ä»¥æ¥ããããã³ã¯ç²¾ç¥å»å¦ç ç©¶ã«ããã主役ã¨ããè¨ããç©è³ªã§ããããããã«ããããã®å½¹å²ã«ã¤ãã¦ã¯æªè§£æã®é¨åã大éã«æ®ã£ã¦ããããããªç¶æ³ã®ä¸ãé»ç¬é¢çã®æ¬ç ç©¶ã¯ãããã®ç·æ¡ä½ã«ããããããã³D2å容ä½ã¨ãããã³ãã©ã³ã¹ãã¼ã¿ã¼ ã®é¢ä¿ã«ã¤ãã¦ã®è²´éãªãã¼ã¿ãå ±åãããã®ã§ããã
å»å¸«7å¹´ç®ã®é»ç¬é¢çã¯ãæ ¶æç²¾ç¥ç¥çµç§å ¥å±å¾ãè¶³å©èµ¤ååç é¢ãä¸å¿ã«ãæ ¶æç¾©å¡¾å¤§å¦ç é¢ãä¸ç·ç²¾ç¥å»çã»ã³ã¿ã¼ã§å¹ åºãè¨åºãç ç©¶ãè¡ã£ã¦ãããç¹ã«é¢å¿ãæã£ã¦åãçµãã§ããã®ã¯ãè³æå·å¾ãç¥çµå¤æ§ç¾æ£ã®é«æ¬¡è³æ©è½é害ãç²¾ç¥çç¶ãããã¦å å æ§ç²¾ç¥ç¾æ£ã®ä¸ã§ç¹ã«å¨è³ªå ãæ³å®ããã¦ããç æ ã§ãä¸è¨æ¬HP2020å¹´6æã«ç´¹ä»ããè«æã¯ãããå½¢ã«ãªã£ããã®ã®ä¸ã¤ã§ãããåè«æã«ä»£è¡¨ãããéããããã¾ã§ã®å½¼ã®æ¹æ³è«ã¯ãç¥çµå¿ç妿è¦ãè©³ç´°ã«æ¤è¨ããã±ã¼ã¹ã¹ã¿ãã£çã§ãã£ãããæ¬ç ç©¶ã¯ãè¨åºã®ç¬¬ä¸ç·ããç ç©¶æã«èå°ãç§»ãã¦ã®ãææ°ã®ã¤ã¡ã¼ã¸ã³ã°æè¡ãé§ä½¿ãã¦ã®ä»äºã§ãããããã¯æ±ºãã¦è»¢èº«ãä¼å³ãã¦ã®ãã¨ã§ã¯ãªããç²¾ç¥ç§å»ã¨ãã¦è¨åºãè¡ãªã£ã¦ãããã¨ãæå¤§éã«çãããç ç©¶ãå½¼ã®ç®æãã¨ããã§ãæè¿ã§ã¯ç¥çµç çå¦ã«ãæãåºããç²¾ç¥çåå¦ãç¥çµå¿çå¦ããã¥ã¼ãã¤ã¡ã¼ã¸ã³ã°ãç¥çµç çå¦ããã¤ãããã¯ã«ç¹ãããç²¾ç¥ãã360度ã®ãããã観ç¹ããã¿ãã¨ããç®æ¨ã«åãã¦æ©ã¿ç¶ãã¦ããã
(ææ¾å¤ªéã2021.11.29.)
失èªçè
ã®åäºè£å¤? --- 失èªçè
ã«è£å¤ãåãããã¨ãå¯è½ãªã®ã?
æè¤ææµ (æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§ç¹ä»»å©æãè¨èªè´è¦å£«)失èªçæ£è
ã«ããåäºäºä»¶ã®è£å¤
ææ¾å¤ªéãæè¤ææµ
èªç¥ãªãããªãã¼ã·ã§ã³2021å¹´26å·»1å· p.1-14
https://doi.org/10.50970/cogrehab.2021.001
ãäºä»¶ã®æ¦è¦ã
70æ³ä»£ç·æ§Aæ°ã¯ãè³æ¢å¡ã«ãã失èªçãæ£ã£ãå¾ã被害è
ã§ãã妻ã¨ã®éã«æ§ã
ãªè¡ãéããçããèªãé¢å©èª¿åãèµ·ãããããå¼è·å£«ã¨ã®çéãä¸è¯ã§èª¿åã®å
容ãçµç·¯ãè¦éããååçè§£ã§ãããåã¤ã¤ããã§å§ãã調åã§è² ãã¦ãã¾ã£ãã¨èªèããä¸å¯è§£ãã¨æããã§æ··ä¹±ãã¦ãããä½ã¨ãæ°æã¡ãæãã¦ãããã®ã®ãèããããã«èªãã®æã§å¦»ã殺害ããèªé¦ããã
ã起訴ãã夿±ºç¢ºå®ã¾ã§ã
Aæ°ã¯æ®ºäººç½ªã§èµ·è¨´ãããããè£å¤æã«ãã訴è¨è½åéå®ä¾é ¼ãåããæã
ãè¨èªã»èªç¥æ©è½æ¤æ»ããã³è¨´è¨è½åå¤å®ã«ç¹åããæ¤æ»ãªã©ãè¡ã£ãããã®çµæã訴è¨è½åãããä½ãé©åãªæ´å©ãè¦ãããã¨ããæ¡ä»¶ã¤ãã®å¤å®ã¨ãªã£ãã
è£å¤æã¯é宿¸ã«åºã¥ããè¨èªè´è¦å£«ã§ããæè¤ããé訳人ãã¨æåãå
¬å¤ã§ã®åå¸ãèªãããããã«å
¨æçè¨æ¥è
ãå°å
¥ããå
¬å¤ä¸ã®å
¨ã¦ã®å£é ã§ã®ããåããã¢ãã¿ã¼ä¸ã§ç¢ºèªã§ããããé
æ
®ããã
å
¬å¤ãå§ã¾ãåã«è£å¤æã«ããã¦8åã®ãå
¬å¤åæ´çæç¶ããããããæè¤ã¯é訳人ã¨ãã¦Aæ°ã«åå¸ãããã¾ãAæ°ã¨å¼è·äººã¨ã®è³ªåç·´ç¿ã«ãåå¸ãããããã«é±1åã®éé¢ãªããè¨å®ãè¨èªè¨ç·´ããã³è³ªåç·´ç¿ã®äºç¿ã»å¾©ç¿ãéãããå
¬å¤ã¾ã§ã®æºåæéã¯1年以ä¸ã«åãã ããããã¯Aæ°ã«ã¨ã£ã¦æå¹ãªãªãããªãã¼ã·ã§ã³ã®æ©ä¼ã¨ãªããã³ãã¥ãã±ã¼ã·ã§ã³è½åã«ã¯æ¹åãã¿ãã
å
¬å¤ã«ããã¦Aæ°ã¯ãã¢ãã¿ã¼ä¸ã«ç¤ºãããæã«ãã£ã¦è£å¤æå
ã§ã®ä»è
ã®çºè¨ãããããçè§£ãã¦ããã¨æ¨æ¸¬ãããããããã被å人質åãã«ããã¦ãã¨ãã«æ¤å¯å®ã®è³ªåã«å¯¾ãã¦Aæ°æ¬äººãçããéã«ã¯ã質åã®çè§£ã¯ååã§ãªããåçãé©åã§ãªãå ´é¢ããã£ããããªãã¡ãæ¥å¸¸çãªã³ãã¥ãã±ã¼ã·ã§ã³è½åã¯é«ãã¦ããè£å¤ã¨ããå³å¯ã«ããã¨ã°ãã§ããåããããå ´é¢ã«ååãªã ãã®è¨èªè½åã¯æãã¦ããªãã£ãã
ä¸å¯©å¤æ±ºã¯ãæ²å½¹10å¹´ãã§ãããå¼è·å´ã¯æ§è¨´ããã
äºå¯©ã¯ãæ§è¨´æ£å´ãã§ãããä¸åããã«å¤æ±ºã¯ç¢ºå®ãããAæ°ã¯ç¾å¨æå½¹ä¸ã§ããã
失èªçè Aæ°ã«è¨´è¨è½åã¯ãã£ãã®ããé訳人ã¨ãã¦ã®æ¯æ´ã¯ååã ã£ãããå ¬å¤ã§ã®è³ªåã¯å¤±èªçè ã«å¯¾ãã¦é©åã§ãã£ãããããããä»åã®äºä»¶ã¯ãªãèµ·ãã£ã¦ãã¾ã£ãã®ããæ¬ç¨¿ã§ã¯ãããå ¨éç¨ãè¨ãæ¤è¨¼ãããæ å½å¼è·å£«ã®æ¹ãããã³ã¡ã³ããããã ããã
(æè¤ææµã2021.10.12.)
解説ãåç½°ã¨ããäºå®èª¿å
人ã¯å復ãç®æããè³æå·è ã¯å復ãç®æããå»çè ã¯åå¾©ã®æ¯æ´ã«å°½åãããã ããå復ã¨ã¯ä½ã? 端çã«ã¯æ©è½ã®å復ã§ããããããæ©è½ãå®å ¨ã«å復ãããã¨ã¯ãªããããã§ã人ã¯å復ãç®æããä½ã®ããã«? ããè¯ãçãããã? ãããããè¯ãçããã¨ã¯ã©ãçãããã¨ã? ããããçãæ¹ã«è¯ãæªããããã®ã? ãããªåããæããããããã人ã¯ç«ã¡å°½ãã以å¤ã«ãªããããã§ã人ã¯å復ãç®æããããã¨å復ãç®æããã¨èªä½ãã´ã¼ã«ãªã®ã? ããã§ãªãã¨ããã°ãå復ã®å ã«ã¯ããè¯ãçããããä¸çãããã¨ä¿¡ããããããã人ã¯å復ãç®æãã®ã§ãããã
ä¾å¤ã¨ãããã®ããããå復ã®å ã®ã´ã¼ã«ã誰ã®ç®ã«ãæç¢ºãªå ´åã¨ããä¾å¤ãããããã¾ãã¾ããã¯æ®ºäººäºä»¶ã§ãã£ãã夫ãå¦»ãæ®ºå®³ãããæ®ºäººäºä»¶ã¨ãã¦ã¯ããå¹³å¡ãªä¸ä¾ã§ããããã 夫Aæ°ã失èªçã§ããã¨ããç¹ã ããéã£ã¦ããã失èªçæ£è ã«ããæ®ºäººãããã«ã失èªçã®æ®ºäººç¯ã®èªç¥ãªãããªãã¼ã·ã§ã³ã¨ããç¹æ®ãªäºæ ãçºçãããè£å¤ãåããæ©è½ã ãã®å復ãã´ã¼ã«ã¨ããããããã¦ä¾å¤çãªèªç¥ãªãããªãã¼ã·ã§ã³ããæã ã¯éå§ãããã¨ã«ãªã£ãã
ãªãããªãã¼ã·ã§ã³éå§åã«ã¯ãè©ä¾¡ãå¿ é ã§ãããæ¬äºä¾ã§ã¯ããã¯è¨´è¨è½åã®éå®ã§ãã£ãã訴è¨è½åããªãã¡è£å¤ãåããè½åã®å¤å®ã§ãããããã¯è£å¤æããã®å½ä»¤ãåããææ¾ãè¡ãªã£ããããã¦è¨´è¨è½åããã¨çµè«ããããã ãæ¯æ´ãå¿ è¦ã¨ããæ¡ä»¶ãã¤ãããè£å¤æã¯ãããåãã¦å ¬å¤ã«åãã¦ã®æºåãéå§ãããä¸å¿ã¨ãªã£ãã®ã¯è¨èªè¨ç·´ã§ãã£ããæ å½ããã®ã¯æè¤ææµè¨èªè´è¦å£«ã§ããã1年以ä¸ãç·è¨120æéã«åã¶è¨ç·´ãçµã¦ãè£å¤å¡è£å¤ã®æ³å»·ã§å ¬å¤ãéå§ããããæ³å»·ã§ã¯æè¤è¨èªè´è¦å£«ããåäºè¨´è¨æ³175æ¡ã®ãé訳人ãã¨ãã¦ã常ã«Aæ°ã®æ¨ªã«åº§ããAæ°ã®ã³ãã¥ãã±ã¼ã·ã§ã³å ¨è¬ã«ã¤ãã¦ã®æ¯æ´ãè¡ãªã£ããAæ°é®æãã夿±ºã¾ã§ä¸è²«ãã¦ãã®äºä»¶ãæ å½ããã岡æ ä¸å¼è·å£«ã¯ãæ¬è«æã«ãå¯ãããã ããæ å½å¼è·äººã³ã¡ã³ãã®ä¸ã§ãããããããæ¯æ´ãã¯ãæãå½ã§æåã®ãã®ã ã£ãã¨èãããã¾ãã»ã»ã»ä»åã®æ¹æ³ã¯ãç¾æç¹ã§èããããæå¤§éã®æ¯æ´ã ã£ãã¨èãããã¾ãããã¨è¿°ã¹ã¦ãããããæ¯ãè¿ã£ã¦è¦ãã°åçãã¹ãç¹ã»æ¹åãã¹ãç¹ã¯å¤ã ãã£ããã®ã®ããªãããªãã¼ã·ã§ã³æå¦ã®ææ¨ãã´ã¼ã«ã®éæåº¦ã¨ããã®ã§ããã°ãæ¬äºä¾ã®èªç¥ãªãããªãã¼ã·ã§ã³ã¯100%æåããã¨è¨ããã§ãããã
ãã®ã´ã¼ã«ã¯ãæ²å½¹10å¹´ã®å¤æ±ºã§ãã£ãã70代ã®å¤±èªçæ£è ããããã10å¹´ã®æ³æãååæã§éããããããã®èªç¥ãªãããªãã¼ã·ã§ã³ã§å°éããã´ã¼ã«ã§ãã£ãã
ããææ¾ã訴è¨è½åãªãã¨å¤å®ããã°ãå½¼ã¯ååæã«å
¥ããã¨ã¯ãªãã£ãã
ããæè¤è¨èªè´è¦å£«ãè¨èªè¨ç·´ãããªããã°ãå½¼ã¯ååæã«å
¥ããã¨ã¯ãªãã£ãã
ããæè¤è¨èªè´è¦å£«ãæ³å»·ã§æ¯æ´ããªããã°ãå½¼ã¯ååæã«å
¥ããã¨ã¯ãªãã£ãã
ã´ã¼ã«ãæ²å½¹10å¹´ã§ãããã¨ãããã£ã¦ããããæã
ã®è¡åã¯å¤ãã£ã¦ããã ããããã©ããã®æç¹ã§ç«ã¡ãããã§ããã ãããã
è¥å·é¾ä¹ä»ã®æããæ²³ç«¥ã¯ããã®ä¸ã«çã¾ãã¦ãããã©ãããæ¬äººãæ±ºå®ãããæ²³ç«¥ã¯ãªãããçã¾ããåã«æªæ¥ãç¥ã£ã¦ãããæææ±ºå®ãããã®ã§ãããçãããã¨ãã¤ããã¦èãé£ãã¨ä¿¡ããã°ãçã¾ãã¦ããªããã¨ã鏿ãããã®é¸æã¯å°éããã¦ç´ã¡ã«å¦åãããã
äººã¯æ²³ç«¥ã§ã¯ãªããããå¼·å¶çã«ãã®ä¸ã«åå¨ãããã¨ãå¼·ãããããããã¦çãããã¨ãå¼·ããããããã®å
ã«ã¯è¯ãæªæ¥ãããã¨ä¿¡ãããã¨ãå¼·ãããã¦çãããå復ããã°ããè¯ãçãããã¨ãã§ããã¨ãæ¬äººãå»çè
ãä¿¡ãããã¨ãå¼·ãããã¦ä»ãçãããæªæ¥ãç¥ããªãããããã人ã¯çãç¶ããããã®ã§ãããã
(ææ¾å¤ªéã2021.10.28.)
嫿ªææ
ã«ä¼´ãå¿æèªçºç£å ´ã®å¤åã«ã¤ãã¦
å³¶ã®æ´»åãä¸å¿ã¨ããè³ç£å³ç ç©¶
å è¤éã(ã¤ã¤ãã¡ã³ã¿ã«ãã¹ãã¿ã«èªç¥çç¾æ£å»çã»ã³ã¿ã¼é·)Kato, Y, Takei, Y, Umeda, S, Mimura, M, Fukuda, M. Alterations of Heartbeat Evoked Magnetic Fields Induced by Sounds of Disgust.
Front Psychiatry 2020;11(0):683. https://doi.org/10.3389/fpsyt.2020.00683
ãèæ¯ã
JamesãLangeã«é¡ãæ
åã®æ«æ¢¢èµ·æºèª¬ã¯ãå¤çããã®åºæ¿ã«å¿ãã¦èµ·ãã身ä½å¤åãè³ã®æ
åèªç¥ããã»ã¹ãæãåããèªè¦çãªæ
åä½é¨ãæ§æããããã¨ãããã®ã§ãããæ
åã¯ããã¾ã§ä¸æ¢ã§åèµ·ããã身ä½ç¶æ³ã®å¤åã¯ãããã®çµæã«éããªãã¨ãã䏿¢èµ·æºèª¬ã¨ã®è°è«ãçµã¦ãæªã çµè«ã«ã¯è³ããªããã®ã®ãå°ãªãã¨ã身ä½ã¨ãããã®åæ¹åæ§ã®å½±é¿ï¼Body-Mind Interactionï¼ãåå¨ãããã¨ã«ã¯ééããç¡ãããããã¯é害ãªã©ã®ç²¾ç¥ç¾æ£ã§ã¿ãããããã«ã身ä½ç¶æ³ã®å¤åã¯ä¸æ¢ã«ãããæ
åå¦çã«å½±é¿ãåã¼ãããããæ´ãªã身ä½ç¶æ³ã®å¤åãçããã¨ã¯ãæ¥å¸¸ã®è¨ºçå ´é¢ã§ãè¯ãç®ã«ããç¾è±¡ã§ãããæéåè§£è½ã®é«ãMEGç ç©¶ã«ãã£ã¦ããã®æ§ãªæ¯è¼çé·ãæ½æã§è¦ãããæ
åå¤åãæãããã¨ã¯ããã¾ã§å°é£ã§ãã£ãããä»åæã
ã¯å¿æã«åæããHeartbeat Evoked Magnetic Fields (HEFs)ã¨ããæ°ããææãç¨ãã¦ãå¿ã¼è³ç¸é¢ã«é¢é£ããè³ç£å ´å¿çãæ¤è¨ããã®ã§å ±åããã
ãæ¹æ³ã
対象ã¯å¥å¸¸è¢«é¨è
39ä¾ã§ãIADS-2 (International Affective Digital Sounds) ããæç²ãã嫿ªé³å£°ãã対ç
§é³å£°ã¨ã®æ¯è¼ã§è´è¦åºæ¿ã¨ãã¦ä¸ããã嫿ªåºæ¿ã¯åä¾ã®èå¾
ãDVãååé³ãªã©æ
æ¯ãããããã¨æµ®ãã¶ç°å¢é³ã§ããã対ç
§é³ã®éçå ´ã®å声ãã¤ãã·ã·ã®é³´ã声ãªã©é³éã6ç§éã®æ§æãä¸è´ãããã®ã鏿ãããåºæ¿ã¯ãããã2åãã¤15種é¡è¡ãã対ç
§ã¼å«æªã¼å¯¾ç
§ã¼å«æªã®é çªã«1ãããã¯ã§3åãåè¨12åã®æ¤æ»ã¨ããï¼https://www.frontiersin.org/files/Articles/562066/fpsyt-11-00683-HTML/image_m/fpsyt-11-00683-g001.jpgï¼ããã®éå
¨é å¼ã®è³ç£å³è¨ã§å¿çãè¨é²ããããããã®æ¡ä»¶ã«ããã¦å¿é»å³ã®Rãã¼ã¯ãæ½æ0ã¨ããå ç®å¹³åãè¡ã£ãããããå¿é»å³ã«åæããå ç®å¹³å波形ããè³è¡¨ã«ãããã½ã¼ã¹æ¨å®ãè¡ãã卿³¢æ°å¸¯åãã¨ã®å¿çå¼·åº¦ãæ¡ä»¶éã§æ¯è¼æ¤è¨ããã
ãçµæã å¿é»å³ã¨åæããè³æ´»åã¨ãã¦ã嫿ªæ¡ä»¶ä¸ã§æ½æ300msä»è¿ã«ä¸¡å´æ§å³åªä½ã®å³¶ç®è³ªã®æ´»åãèªããï¼https://www.frontiersin.org/files/Articles/562066/fpsyt-11-00683-HTML/image_m/fpsyt-11-00683-g002.jpgï¼ãä»ã®è³é åã¨ã®ç¸é¢é¢ä¿ã卿³¢æ°å¸¯åãã¨ã®æ´»åãè¦ãããã«å³¶ç®è³ªãå¾é¨ã»è ¹å´åé¨ã»èå´åé¨ã®3é åã«åãæ¡ä»¶éã®æ´»åãè¦ãã¨ããã嫿ªæ¡ä»¶ã§å³å³¶é åã®è ¹å´åé¨ã«ããã¦ã®ã¿19ããã³23Hzã®Î²å¸¯åã«ãããææãªæ¯å¹ å¢å¤§ãèªããï¼https://www.frontiersin.org/files/Articles/562066/fpsyt-11-00683-HTML/image_m/fpsyt-11-00683-g003.jpgï¼ããããã®æ¯å¹ å¢å¤§ã¯ä¸»ã«æ½æ500msä»è¿ã§è¦ãããããå è¡ããæ½æ300msä»è¿ã§14Hzã®æ¯å¹ æå¶ãææã§ãã£ãï¼https://www.frontiersin.org/files/Articles/562066/fpsyt-11-00683-HTML/image_m/fpsyt-11-00683-g004.jpgï¼ãã¾ããã®å³è ¹å´åé¨é åã¨åè³ã®ç¸é¢ãè¦ãã¨ããβ帯åã§ã®å·¦å´åé åéè ¹å å´é¨ã¨ã®ææãªç¸é¢ãèªããï¼https://www.frontiersin.org/files/Articles/562066/fpsyt-11-00683-HTML/image_m/fpsyt-11-00683-g005.jpgï¼ã
ãèå¯ã
å
è¡ç ç©¶ããã¯å«æªææ
ã¨å³¶ç®è³ªã®æ´»åã®ç¸é¢ã示åããã¦ããããè³ç£å³ãç¨ãã¦å¿ã¼è³ç¸é¢ãã¿ãæã
ã®èª²é¡ã§ããå³¶ç®è³ªã¨ãããå³è
¹å´åé¨é åã嫿ªææ
ã«ããβ帯åã«ã¦è³¦æ´»ããããã¨ã示ãããããããã®æ´»åã¯å·¦åé åéè
¹å
å´é¨ã¨ã®ç¸äºä½ç¨ã«ããçºç¾ããã¦ããã嫿ªææ
ã«ãã賦活ãããèº«ä½æè¦æ
å ±ãå³è
¹å´åé¨å³¶ç®è³ªãä»ãã¦å·¦åé åéè
¹å
å´é¨ã«è³ãçµè·¯ã§å¦çããã¦ããå¯è½æ§ã示åãã¦ãããåé åéè
¹å
å´é¨ã¯èº«ä½æè¦ãéããèªç¥å¦çã«ã坿¥ã«é¢é£ãã¦ãããèº«ä½æè¦ã®æ±å¿æ§æ
å ±ã®ã¨ã³ããã¤ã³ãã§ããã®ã¿ãªãããéã«èº«ä½æè¦ãå¤åãããèµ·ç¹ã¨ãã¦ãæ©è½ãããä»åã®æã
ã®å ±åã¯ãæ
åè² è·ãå¿ã¼è³ç¸é¢ã«ããããå¤åã主ã«å³¶ããã³åé åéè
¹å
å´é¨ã«ãããβ帯åã®æ´»åã¨é¢é£ãã¦ãããã¨ã示ãã¦ããã
(å è¤éã2021.9.1.)
解説ã0.001ç§ã®å æ
ç·å¼µããã¨å¿èãããããããã誰ã«ã§ãããããå¹³å¡ãªä½é¨ã ãã19ä¸ç´ã®å²å¦è ã»å¿çå¦è William Jamesã«ãã£ã¦ãã®å¹³å¡ãªä½é¨ã¯æå³æ·±é·ãªä½é¨ã«çã¾ãå¤ãã£ãããããJames-Langeã®ææ ã®æ«æ¢¢èµ·æºèª¬ã§ããããç·å¼µããã¨å¿èããããããããã¨ããæç« ã¯ãæç³»åçã«ã¯ãã¾ãç·å¼µã¨ããææ ãçºçãããã®å¾ã«åæ¸ã¨ãã身ä½å¤åãçºçãããã¨ãæå³ãã¦ãããããã¯äººã®èªç¶ãªä¸»è¦³çæè¦ã«ä¸è´ãã¦ããããçå®ã¯é åºãéã§ã身ä½å¤åãå ã§ãç·å¼µã¨ããææ ã¯ããã«åå¿ãã¦çºçããã¨ããã®ãJamesã®èª¬ã§ããããäººã¯æ²ããããæ³£ãã®ã§ã¯ãªããæ³£ãããæ²ããã®ã ãã¨ãããå½¼ãè¨ã£ãã¨ãããæåãªè¨èã«ããã象徴ããã¦ãããããã«çã£åããå対ããã®ãCannon-Bardã®ææ ã®ä¸æ¢èµ·æºèª¬ã§ã両説ã®äºãã¯æ¬HPã«2020å¹´10æã«ç´¹ä»ããæ¢ ç°è¡ææç£è¨³ã®ãææ ãã«è©³ç´°ã«è§£èª¬ããã¦ããã
ç§ã«ã¯å®ä½é¨ããããè¬å ã§100人ã»ã©ã®å¦çãåã«ãã¦å®ç¿ã®èª¬æããã¦ããæã®ãã¨ã ãå¦çã®ä¸é¨ããå§ã¾ã£ãç§èªããç§ãç»å£ããæç¹ã§ãã§ã«é¨å±ä¸ã«åºããã大é¨ãã¨ãã£ãæ§ç¸ã«ãªã£ã¦ãããã¾ããããããã¨ã§ã¯ãããããã®æã®ç§ã¯ãããã大ç®ã«è¦ã¦ããç«å ´ã«ã¯ãªãã£ããã¾ããªãå§ã¾ããã®å®ç¿ã¯å¤ãã®å»çæ½è¨ã®ãåæã»ãååã«ãã£ã¦æãç«ã£ã¦ãããã®ã§ãå¦çã«ã¯ç·å¼µæãæã£ã¦çå£ã«åãçµããã¨ãæ±ãããã¦ãããç§ã®å½¹å²ã¯ããã確å®ã«å¦çã«ä¼ãããã¨ã§ãã£ãã
ããã§ç§ã¯ãå®ããããäºåçãªè©±ãå§ãã¤ã¤ããã®ç¶æ
ã§ç§ã¯ã©ããã¹ããã¨å·éã«èããåãå
¥ããªããã°ãªããªãã¨ããçµè«ã«éããããã®æãå¦çã®é¨ãã¯ç¸å½ãªé³éã«éãã¦ãããåãå
¥ããã¨ã¯ããªãã¡æé³´ã以å¤ã«ãªãã£ãã
ã¾ãããã¾ã§ã¯å¤§å¦ã®å¡åº¸ãªæå¡ãèããããªãã¨ã§ãããè峿·±ãã®ã¯ããããã ã
ç§ã¯ãã®ããã«å·éãã¤è«ççã«èããæ«ã«æé³´ããã¨ã鏿ããã®ã§ããããæé³´ã£ãé端ã«äºæ
ã¯æ¥å¤ãããå¦çã¯é©ãã¦éã¾ãããã£ããããã¯å¥ã«ããã®ã ããæ¥å¤ã¯ç§ã®èº«ä½ã«çºçãããæ¿ãã忏ã¨çºæ±ã§ããã
ããã¾ã§ã¯éç©ã§ãã£ãç§ã®èº«ä½ããæé³´ã£ãç¬éãã交æç¥çµåªä½ã«ãªã£ããããã«ã¯ææ
ã®æããæããã忏ã¨çºæ±ã®çªç¶ã®çºçã¨ããäºæãã¬äºæ
ã«ç¼ç½ããã®ã ããããããèªåã®è¨èã»å£°ã«èªåãè奮ãããã¨ãããã¿ã¼ã³ã§ããã
ãªã¢ã«ã¿ã¤ã ã§èªåèªèº«ã®åå¿ãããåæãããã¨ã¾ã§ç§ã¯ã§ãã¦ããã®ã ããããã§ãèªåã®ææ
ã®æããæå¶ãããã¨ã¯ããªãå°é£ã ã£ãããã¾èªåã¯ã辺ç¸ç³»ããçºçãã¦ããè奮ãåé èã§æå¶ãããã¨ãã¦ãããã ããã£ããæ´ãå§ããreptile brainã大人ãããããã®ã¯å®¹æã§ãªãããã ããããªfolk neuroscienceçãªãã¨ã¾ã§ãã®ã¨ãèãã¦ãããã¨ãããè¨æ¶ãã¦ããã
客観çã«ã¯ãã®ã¨ãã®ç§ã¯ããã¬ã¦æé³´ã£ããã¨è¦ããã§ããããã ã宿
ã¯ãæé³´ã£ããããã¬ããã®ã§ãããã¾ãã«James-Langeã®ææ
ã®æ«æ¢¢èµ·æºèª¬ã®å
·ç¾ãã®ãã®ã®è峿·±ãä½é¨ã§ãã£ãã
ããããããªä½é¨ã§ã¯æ±ºãã¦James-Lange説ã証æãããã¨ã«ã¯ãªããªãã
ãæé³´ã£ããããã¬ããã¨ããã®ã¯ãããã¾ã§ãç§ã®ä¸»è¦³ã§ãã£ã¦ããã®ä¸»è¦³ã¯ä¸»è¦³ã¨ãã¦ã¯ã©ãã¾ã§ãæ£ãããããããããæé³´ããã¨ããæææ±ºå®ã®ç´åã«ãå®éã«ã¯å¾®ç´°ãªããããææãªãææ
ã®æãããã£ãã®ãããããªããã¤ã¾ãææ
ã®æããç§ã«æææ±ºå®ããããã®ã§ãã£ã¦ãå·éã«æææ±ºå®ããã¨ããã®ã¯ã¿ããã®ãã¨ã«ãããªãã®ãããããªããç§ã®ææ
ãæã£ãã®ã¯ç§ãã忏ã¨çºæ±ã®çªç¶ã®çºçã¨ããäºæãã¬äºæ
ã«ç¼ç½ãããããã ã¨å
ã»ã©è¨ã£ããç§ã¯ç¢ºãã«ããæãããæç³»åã¨ãã¦ã¯åæ¸ã»çºæ±ãå
ã§ãææ
ã®æããå¾ã ã£ããããããã®éã®ãç·å¼µãå
ã§åæ¸ãå¾ãã¨ãã主観çä½é¨ã¯äºå®ãåæ ãã¦ããªãã¨ããã®ãJames-Lange説ãªã®ã§ãããããåã主観çä½é¨ã§ããã忏ãå
ã§ææ
ã®æããå¾ããã常èã¨ã¯é åºãéã§James-Lange説ã«ä¸è´ãã¦ããã¨ããã ãã®çç±ã§æ£ããã¨èããæ ¹æ ã¯ãªãããç·å¼µããããå¿èããããããããã¨ããã®ãè§£éã§ããã®ã¨å
¨ãåæ§ã«ãã忏ã»çºæ±ãçºçããããææ
ãæã£ãããã¾ãè§£éã«ãããªããã©ã¡ãã®è§£éãæ£ããããæ±ºçãã¤ããã«ã¯ææ
ã¨èº«ä½å¤åã®æéçé åºã測å®ããªããã°ãªããªãããã®æéã¨ã¯ããªã»ã³ã³ã=0.001ç§ã®ãªã¼ãã¼ã§ããã
ããã¾ã§ã®æéåè§£è½ãæã¤è³æ©è½æ¸¬å®æ©å¨ã¯ãç¾ä»£ã§ã¯MEGãããªããMEGã¯James-Lange vs Cannon-Bard以æ¥ç¶ãã¦ããæ´å²çäºãã«æ±ºçãã¤ããå¯è½æ§ãç§ããæ¦å¨ã§ãããåªããæéåè§£è½ã«å ãã¦ããããã¦å¾®ç´°ãªç£æ°æ´»åãè¦éããªãã¨ããæ¸¬å®æåº¦ãMEGã®æã¤å大ãªåã§ããããã®æåº¦ã®ããMEGã¯ãè¿æãå°ä¸éãèµ°ã£ãã ãã§ãã¤ãºãå ¥ãæ¸¬å®å¤ãä¹±ãããã ããMEGã§è³ãç©¶ããã¨ããå è¤éåå£«ã¯æ±äº¬ãé¢ãã群馬ã®å°ã§ç ç©¶ãç¶ãã¦ããã
ãã£ã¨ããä»®ã«æéçé¢ä¿ã証æãããã¨ãã¦ãã¾ã å
ãããã
ãã¨ãã°æ¼ã¯å¤ã«å
è¡ããããæ¼ã¯å¤ã®åå ã§ã¯ãªãã稲å
ã¯é·é³´ã«å
è¡ãããã稲å
ã¯é·é³´ã®åå ã§ã¯ãªããæéçé åºã¯ãå æé¢ä¿è¨¼æã®ãããã°å¿
è¦æ¡ä»¶ã«ãããªããAãæéçã«Bã«å
è¡ãããã¨ã証æããããã¦Aã¨Bã®æéå·®ã®éã«ä½ãèµ·ãã¦ãããã証æããã¨ãåãã¦ãåå ãAã§çµæãBã§ããã¨çµè«ãããã¨ãã§ããã®ã§ããã
æ¬ç ç©¶ã¯ãæç³»åã®è¨¼æã¾ã§ã«ã¯è³ã£ã¦ããªããã®ã®ãããªã»ã³ã³ãã®ã¿ã¤ã ã¹ãã³ã«ãããææ ã¨èº«ä½å¤åã®è³å ã«ã¼ãããããªãã¡è³å ã§ä½ãèµ·ãã¦ããããè¦äºã«ç¤ºããã¦ãããããã¯ãã¡ããMEGã®ååãé§ä½¿ãããã®ã ããå®ã¯æéåè§£è½ããã¾ãã«é«ãããã«ãæ½æã®é·ãæ åå¤åãæãããã¨ã¯MEGã§ã¯ä¸å¯è½ã§ã¯ãªããã¨å¾æ¥ã¯èãããã¦ããã¨ãããå¿æã«åæããHEFsã¨ããç»æçãªæ¹æ³ãç¨ãã¦ãã®ä¸å¯è½ãå¯è½ã«ããã®ãå è¤åå£«ã®æ¬ç ç©¶ã§ããã
ããã¦MEGããããã¦å¾®ç´°ãªç£å ´å¤åãæãããã¨ãã§ãããã¨ã®è£ã«ã¯ãæ´»åãç¹°ãè¿ãå ç®å¹³åããã¨ãã仿ãããããã¨ãããã¨ã¯ã¤ã¾ããè¬å ã§ã®ç§ã®ä½é¨ã®éãä»®ã«ä½ããã®æ¹æ³ã§ç§ã®è³æ´»åãMEGã§æ¸¬å®ã§ããã¨ãã¦ãããã®ä¸åã®ä½é¨ãææã«ãã¦ãææ ã®æãã¨åæ¸ã»çºæ±ã®æéçé åºã証æããã®ã¯ä¸å¯è½ã ã¨ãããã¨ã§ãããããã¨MEGã§James-Langeã¨Cannon-Bardã®è«äºã«æ±ºçãã¤ãããã¨ã¯ä¸å¯è½ãªã®ãã
ããããããããã«ãä¸å¯è½ãå¯è½ã«ããæ¹æ³ã¯ããã¯ãã§ãããä¸å·ã®MEG使ãã»å è¤éå士ã®å¡æºã«æå¾ ãããã
(ææ¾å¤ªéã2021.9.29.)
Logocloniaã¯logopenicåé²è¡æ§å¤±èªã®æ«æã«åºç¾ããå¯è½æ§
è¹å±±éé (è¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§é¨é·)Yoshitaka Nakagawa, Michitaka Funayama, Masahiro Kato. Logoclonia might be a Characteristic of Logopenic Variant Primary Progressive Aphasia at an Advanced Stage: Potential Mechanisms Underlying Logoclonia. J Alzheimers Dis. 2019; 70(2): 515-524. doi: 10.3233/JAD-190184.
ãLogocloniaã¨ã¯ã
Logocloniaã¨ã¯ãããªããããããããããã¾ãã¨ã¨ã¨ã¨ã¨ã¨ã¨ã¨ããªã©ã¨èªã®éä¸ãæå¾ã®é³ç¯ãæå³ããªãæµæ¢ã«ç¹°ãè¿ãç¾è±¡ã§ãããåãèªå
¨ä½ãç¹°ãè¿ãåèªå復palilaliaãåèªã®æåã®åé³ã®ç¹°ãè¿ããç¹å¾´ã¨ãã¦ç·å¼µã¨åªåãä¼´ãçºå£°ã§ããåé³stutteringã¨ã¯çç¶ãç°ãªããLogocloniaã¯1910å¹´ã«Kraepelinã«ãã£ã¦æå±ãããã¾ãã«ã¢ã«ããã¤ãã¼ç
ãä¸å¿ã¨ãã夿§ç¾æ£ã§å ±åããã¦ãããããã®æ©åºã¯æããã§ã¯ãªãã£ããä»åããããã¯logocloniaãåããæ£è
ãå
¨ä½ã®å¤±èªçè
ããåãåºãããã®è¨èªé¢ã®ç¹å¾´ã¨è³æ©è½ç»åããlogocloniaã®æ©åºã«è¿«ã£ãã
ãLogocloniaã¯logopenicåé²è¡æ§å¤±èªã®æ«æã«åºç¾ããå¯è½æ§ã
2008å¹´1æãã2017å¹´12æã¾ã§ã«æ±æ¸å·ç
é¢ãªãããªãã¼ã·ã§ã³ç§ã¨è¶³å©èµ¤ååç
é¢é«æ¬¡è³å¤æ¥ã«éé¢ãã914åã®å¤±èªçæ£è
ï¼è³è¡ç®¡é害ãé é¨å¤å·ã¨ãã£ã髿¬¡è³æ©è½éå®³ã®æ£è
ã¨å¤æ§ç¾æ£ã«ããé²è¡æ§å¤±èªãå«ããlogopenicåé²è¡æ§å¤±èªã¯16åï¼ã®ä¸ã§5åãlogocloniaãåããããããã®5ä¾ãåæã«ã¯logopenicåé²è¡æ§å¤±èªãåããè¨åºçã«ã¯ã¢ã«ããã¤ãã¼åèªç¥çã¨è¨ºæããä¾ã§ãããLogocloniaãåããæç¹ã§ã¯ãããã®ä¾ãé度ã®èªç¥çã«è³ã£ã¦ããã
Logocloniaãåããæç¹ã®5ä¾ã®è¨èªé¢ã¯ãæµæ¢æ§ã¯ä¿ããã¦ãããã®ã®å¼ç§°è½åã¨é³é»æ³èµ·è½åãèããä½ä¸ãã¦ãããè³æ©è½ç»åããã¯ããã¼ã«é åãæ¯è¼çä¿ããã¦ãã䏿¹ã§å·¦å´é èããé é èã®è¨èªéã®ç¸å¯¾çè¡æµéã大ããä½ä¸ãã¦ããæè¦ã§ãããè¨èªæè¦ãæ¯æãããã®ã§ãã£ããããªãã¡ãlogocloniaã¯æµæ¢æ§ãä¿ããã¦ããä¸ã§èªãé³é»ã®æ³èµ·ãèããä½ä¸ãã¦ããä¸ã§ãé³é»ã®ããªã¨ã¼ã·ã§ã³ãå°ãªããªããåãé³ã®ç¹°ãè¿ãã«è³ã£ããã®ã§ã¯ãªããã¨èãããããã¨ããã§ãlogopenicåé²è¡æ§å¤±èªã¯ããã¨ãã¨é³é»æ§é²è¡æ§å¤±èªã¨å¼ã°ãã¦ããããã«ãæ§é³ã¨ãã£ãéåé¢ã®æµæ¢æ§ã¯ä¿ããã¦ããããåæããåèªå°é£ãé³é»ã®æ³èµ·ã®åé¡ãåºç¾ãããã¨ãç¹å¾´ã§ãããLogocloniaã¨logopenicåé²è¡æ§å¤±èªã®èæ¯ã«ã¯ãé¡ä¼¼ããæ©åºããããããããªãã
(è¹å±±ééã2021.8.1.)
æ
¢æ§æã®å¤å·æ§è³æå·ã«ãããåºç¯ãªç½è³ªæ§é ç°å¸¸ã¨èªé é³ã®æµæ¢æ§é害ã¨ã®é¢é£
山縣 æ (æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§å°ä»»è¬å¸«)Yamagata B, Ueda R, Tasato K, Aoki Y, Hotta S, Hirano J, Takamiya A, Nakaaki S, Tabuchi H, Mimura M. Widespread white matter aberrations are associated with phonemic verbal fluency impairment in chronic traumatic brain injury. J Neurotrauma. 2020, 37(7):975-981. doi: 10.1089/neu.2019.6751.
åå·ç´å¾ããããè»½åº¦ã®æèé害ã§ãããããããç¶æ ããçæéã ãç¶ãããã¤MRIä¸ãè³æå·ã®æè¦ããªãã±ã¼ã¹ã§ããã®å¾ã«èªç¥æ©è½é害ãåããå ±åãç¸æ¬¡ãã§ããã軽度å¤å·æ§è³æå·ï¼mild traumatic brain injury; mTBIï¼ã®ã軽度ãã¨ã¯ãæèé害ã軽度ã§ãããã¨ããä»ããããåç§°ã§ããããå®éã®è¨åºçç¶ã¯è»½åº¦ã¨ã¯éããªããDiffusion Tensor Imagingï¼DTIï¼ãç¨ããæè¿ã®è³ç»åç ç©¶ã«ããã¨ãé é¨å¤å·å¾ã®æèæ¶å¤±ã0~20åãå¤å·å¾ã®å¥å¿ã24 æé以å ãã°ã©ã¹ã´ã¼ã³ã¼ãã¹ã±ã¼ã«ã¹ã³ã¢ã13~15ã§å®ç¾©ãããï½TBIã«ããã¦ãããè³æ¢ãå å ãªã©ã®ç½è³ªç·ç¶ã«ããã¦å¾®ç´°ãªç½è³ªæ§é ç°å¸¸ãçãããã¨ããçµæãå ±åããã¦ããï¼Aoki et al., 2012; 2016ï¼ãã¤ã¾ããMRIã§ã¯è³æå·ã確èªãããã¨ã¯ã§ããªãããç½è³ªã«ãããå¾®ç´°ãªæ§é ç°å¸¸ã¨ããã«ããæ§é ççµåã®æå·ãTBIã«ãããæ½å¨çãªç¥çµç çã¨æ³å®ããã¦ãããå¤å·å¾ã®é«æ¬¡è³æ©è½é害ãã³ã¾ãæ§è»¸ç´¢æå·ã®çºçæ©åºãè¨ºææ¦å¿µã®æ ¹å¹¹ãè¦ãå¯è½æ§ããããæ¬ç ç©¶ã§ã¯ãTBIã«ãããèªç¥æ©è½é害ã«é¢ããæ½å¨çãªã¡ã«ããºã ã調ã¹ãããã«ãæ ¢æ§æã®TBIæ£è ã«ã¿ãããç½è³ªç·ç¶ã®æå·ã¨èªç¥æ©è½é害ã¨ã®é¢é£æ§ã«ã¤ãã¦èª¿æ»ããã
æ ¢æ§æã®è»½åº¦ããä¸ç度/é度ã®TBI群18åã¨å¹´é½¢ã®ä¸è´ããå¥åº·å¯¾ç §ç¾¤17åã対象ã¨ãããDTIè§£æã«ããã¦åºã使ããã¦ããTract-Based Spatial Statisticsï¼TBSSï¼ã¨ããè§£æã½ãããç¨ãã¦ãTBIã®ç½è³ªæ§é ç°å¸¸ã®ãã¿ã¼ã³ãç¹å®ãããå ·ä½çã«ã¯ãæ¡æ£ç°æ¹æ§ã®ææ¨ã¨ãã¦fractional anisotropy ï¼FAï¼å¤ã¨axial diffusivity ï¼ADï¼å¤ãradial diffusivityï¼RDï¼å¤ã®ï¼ã¤ãç®åºãç¾¤éæ¯è¼ãè¡ã£ããããã«TBSSã®threshold-free cluster enhancement correctionã使ç¨ãã¦ãç½è³ªç·ç¶æã®æå·ã¨èªç¥æ©è½é害ã¨ã®é¢ä¿æ§ã調ã¹ãã
TBSSè§£æã«ãããTBI群ã¯å¥åº·å¯¾ç §ç¾¤ã¨æ¯è¼ãåºç¯ãªè³é åã§FAå¤ãä½ä¸ãã¦ãããç½è³ªæ§é ç°å¸¸ãæãã¦ãããã¨ã示åããããè峿·±ããã¨ã«ããããã®é åã®å¤§é¨åã§ãFAå¤ãæ¸å°ãã¦ããé åã¨RDå¤ãå¢å ãã¦ããé åãéãªã£ã¦ããã䏿¹ã§ãADå¤ã§ã¯ç¾¤éå·®ã¯ã¿ã¨ããªãã£ãããããã®DTIãã©ã¡ã¼ã¿ã®çµã¿åãããããç¥çµç çæè¦ã¨ãã¦è±é«ãã¿ã¦ããå¯è½æ§ã示åããããæ¬¡ã«éç度ãmTBI群ã®ã¿ã«éå®ãããµãã°ã«ã¼ãè§£æãè¡ã£ãããããã§ãå¥åº·å¯¾ç §ç¾¤ã¨æ¯è¼ããå¤ãã®ç½è³ªç·ç¶ã§FAå¤ãææã«ä½ä¸ãã¦ãããèªæµæ¢æ§èª²é¡ï¼verbal fluency task: VFTï¼ã«ããã¦ãèªé é³VFTã¯TBIç¾¤ã§ææã«æç¸¾ãä½ä¸ãã¦ããããæå³æ§VFTã§ã¯å·®ãèªããªãã£ããFAå¤ã¨èªé é³VFTã®æç¸¾ãåºç¯å²ãªç½è³ªç·ç¶ã«ããã¦æ£ã®ç¸é¢ã示ãããããã¯ãç½è³ªæ§é ã«ç°å¸¸ãããã»ã©ãèªé é³VFTã®æç¸¾ãä½ããã¨ã示åãã¦ããã䏿¹ã§ãFAå¤ã¨æå³æ§VFTã§ã¯ç¸é¢ãã¿ã¨ããªãã£ãã
æ¬ç ç©¶ã§ã¯ãæ§ã ãªéç度ã®TBIã対象ã¨ãã¦ãããåã ã®çä¾ã§è³æå·ã®å¤§ãããä½ç½®ãç¨åº¦ã«ã°ãã¤ããããã«ãé¢ããããæ ¢æ§æTBIæ£è ã¯åºç¯ãªé åã§ç½è³ªæ§é ç°å¸¸ã示ãããããã¯ããã¹ã¦ã®éç度ãéãã¦TBIã§ã¯å¥åº·å¯¾ç §ç¾¤ã¨æ¯è¼ããç½è³ªç·ç¶ã®çµ±åæ§ãä½ä¸ãã¦ããã¨ããéå»ã®ç ç©¶å ±åã確èªãããã®ã¨ãªã£ããã¾ããå´é èã§ã¯ãªãã主ã«åé èã«æå°ãããåçå ããã³åçéãã¤ãªãåè¦åºæ¾ç·ãå°éåãè³æ¢ã®FAå¤ã¨èªé é³VFTã®æç¸¾ã«ç¸é¢ãã¿ã¨ãããåè¦åºæ¾ç·ã¯ãå å ã®åèãéãåé åéï¼ä¸»ã«èå¤å´åé åéï¼ã¨è¦åºãã¤ãªãç½è³ªç·ç¶ã§ãããå®è¡æ©è½ã¨è¤éãªè¡åè¨ç»ã«é¢ä¸ãã¦ãããã¾ãå°éåï¼è³æ¢ã®åæ¹æå°ç·ç¶ï¼ã¨è³æ¢ã¯ãåé é åã®åçéã®æ¥ç¶ãæã¡ããããã®é åã®æå·ã¯åé èæ©è½ã®é害ã«é¢ä¸ãã¦ããï¼Paul et al., 2007; Edwards et al., 2017ï¼ã以ä¸ãããèªé é³VFTã¯ãæå³æ§VFTã¨æ¯è¼ãã¦ãTBIã«ããã¦ãåé èãä¸å¿ã¨ããç½è³ªæ§é ç°å¸¸ã«ããå®è¡æ©è½é害ãããéæã«åæ ããèªç¥æ©è½æ¤æ»ã§ããå¯è½æ§ã示åãããã
(山縣æã2021.8.3.)
解説ãå¿ã®é è½èª¬ãå®è¨¼ãã
人ã¯çºèªããåã«ãèªåãä½ãçºèªããããç¥ã£ã¦ãããç¥ã£ã¦ãããä¸èªä¸å¥ã¾ã§æèãã¦ããããã§ã¯ãªããããã§ãæå³ããéãã«æ£ç¢ºã«çºèªãããã¨ãã§ããã
ããã§ãç¥ã£ã¦ãããã¨ããè¨èã«ãã ããã¨ãè¿·è·¯ã«è¿·ãè¾¼ããã¨ã«ãªããæèãã¦ããªãã®ã«ç¥ã£ã¦ããã¨ããã®ã¯ä¸ä½ã©ããããã¨ãªã®ããã¨ããåãããã®ç¬¬ä¸æ©ã«ãªããå²å¦è
ã®ä¸é¨ã¯ãã®åãã追究ã(ãã®è¿½ç©¶èªä½ã¯è峿·±ã使¥ã§ã¯ãã)ããããããå¿ã®é è½èª¬ãå¦å®ã¨ããçµè«ã«éãã¦ããããå¿ã®é è½èª¬ãã¨ã¯ããå¿ã¯ãã®äººã®å
é¨ã«é ããã¦ãããã¨ãããããã°å¸¸èã«åè´ããèãæ¹ã§ãè³ç§å¦çãªè¨èã«è¨ãæããã°ãã人éã®ç²¾ç¥æ©è½ã¯å¿
ãããã«å¯¾å¿ããè³å
ã®æ´»åããããã¨ãããã¨ã«ãªããããã®è³å
ã®æ´»åããããããã£ã¦ä»ã®ã¨ããã¯ãããªãæ¤æ»æ©å¨ãç¨ãã¦ãå
¨è²ã¾ã§ã¯è¦ããã¨ãã§ããªãããããã¨ãã°çºèªãããã¾ã§ã¯ããã®äººãä½ãæå³ãã¦ãããã¯ä»äººã«ã¯ããããªããã ãæ¬äººã ãã¯çºèªããåã«èªåãä½ãæå³ãã¦ãããããç¥ã£ã¦ããããã¤ã¾ãæå³ã¯ãçºèªãããã¾ã§ã¯æ¬äººã®ä¸ã«é è½ããã¦ãã=è³å
ã®æ´»åã¨ãã¦é è½ããã¦ããã¨ããã®ããå¿ã®é è½èª¬ãã§ããã
ãã®ã¨ãæ¬äººã¯ãããããçºèªãããã¨ããä¸èªä¸å¥ã¾ã§æèãã¦ããªããããç¥ã£ã¦ãããã®ã¯ãã©ããã¯ã¹ã§ããã¨ããã®ãããå¿ã®é è½èª¬ããå¦å®ããå²å¦è
ã®è«èã®åºçºç¹ã§ãããããã¦ããå¿ã®é è½èª¬å¦å®ãã¯ãè«ççã«ã¯ãã人éã®ç²¾ç¥æ©è½ã¯å¿
ãããã«å¯¾å¿ããè³å
ã®æ´»åãããããã¨ã®å¦å®ã«ç´çµããã
è¹å±±ééé¨é·ã«ããlogocloniaã®ç²¾å¯ãªè§£æã«åºã¥ãæ¨å®ãæ£ãããã°ããå¿ã®é è½èª¬å¦å®ãã¯æè²ãæªããªãããlogocloniaã¯ãæµæ¢æ§ãä¿ããã¦ãã䏿¹ã§èªãé³é»ã®æ³èµ·ãèããä½ä¸ãã¦ãããé³é»ã®ããªã¨ã¼ã·ã§ã³ãå°ãªããªã£ãçµæãåãé³ã®ç¹°ãè¿ãã«è³ã£ããã®ã§ãããã¨ããè¹å±±é¨é·ã®æ¨å®ã¯ãèªãé³é»ã¨ãã¦è³å
ã«åå¨ãããã®(ããããåå¨ãããã¨ãæ¬äººã¯ãæèãã¦ããªããããç¥ã£ã¦ããã)ãåãåºããæ³èµ·ãã¨ããæ©è½ã®é害ãããæµæ¢æ§ãã¨ããæ©è½ã®ç¶æã«ãã£ã¦çºçããã¨è¨ãæãããã¨ãã§ããããã¾ãæ¨å®ãã¨è¨ã£ããããã®æ¨å®ä»¥å¤ã«ã¯ãããªããããããããããã¾ãã¨ã¨ã¨ã¨ã¨ã¨ã¨ã¨ããªã©ã¨èªã®éä¸ãæå¾ã®é³ç¯ãæå³ããªãæµæ¢ã«ç¹°ãè¿ãlogocloniaã¨ããç¾è±¡ã説æãããã¨ã¯ã»ã¼ä¸å¯è½ã§ãããã¨ã«å ããããã¼ã«é åãæ¯è¼çä¿ããã¦ãã(æµæ¢æ§ã®ä¿æã«å¯¾å¿)䏿¹ã§å·¦å´é èããé é èã®è¨èªéã®ç¸å¯¾çè¡æµéã大ããä½ä¸ãã¦ãã(èªãé³é»æ³èµ·ã®é害ã«å¯¾å¿)ã¨ããè³æ©è½ç»åæè¦ããã®æ¨å®ã®èª¬å¾åãé常ã«å¤§ãããã¦ããã
è³å
ã«åå¨ããèªãåãåºãæ©è½ã«çç®ããè¨åºæè¦ã¨è³ç»åæè¦ã«åºã¥ã説å¾åããè«ãå±éãã¦ããã¨ããæå³ã§ã¯ã山縣æè¬å¸«ã®è«æãåæ§ã§ãããããã¦å±±ç¸£è¬å¸«ã¯ããã®ç ç©¶çµæã«åºã¥ããèªé é³VFTã¨æå³æ§VFTã¨ããããããã·ã³ãã«ãªæ¤æ»ã®æã¤æ·±ãæå³ãææãã¦ããããã®ææã¯è³æ©è½é害ã®é©åãªè©ä¾¡ãéãã¦ãå½äºè
ã«ã¨ã£ã¦ã®å¤§ããªæ©æµã«ç¹ãããã®ã§ããã
è¨èªæ©è½ã«ããããç ç©¶ã¯ãã®ããã«ãè³ã¨å¿ã®æ ¹æ¬çãªé¢ä¿ã«ããããéè¦ãªãã¼ã¿ããã°ãã°æä¾ãã¦ãããã仿¹ãå²å¦çæå¼ã¯ãéå¾¹ããè«çã®è¿½ç©¶ã¨ããæå³ã§ã¯é常ã«è峿·±ããã®ã§ããããã©ããä¸ç®æã§äºå®ããå¤ããã¨ãå¥å¦ãªçµè«ã«ãã©ãçãããå¿ã®é è½èª¬å¦å®ãã¯ã人ãçºèªããéã«ããä¸èªä¸å¥ã¾ã§æèãã¦ããªããããç¥ã£ã¦ãããã®ã¯ãã©ããã¯ã¹ã§ããã¨ããæ®µéã«æ·±å»ãªççµããããæ¬äººãèªåã®çºèªå 容ãçºèªããåã«ãã§ã«ãç¥ã£ã¦ãããã®ã¯ããããè³å ã«åå¨ãã¦ãããã¨ãæãã¦ããã®ã§ãã£ã¦ãæèã¨ã¯ç¡é¢ä¿ã§ãããããã¦çºèªã¨ããè¡çºããè³å ã«åå¨ãããã®ãåãåºã使¥ã§ãããã¨ã¯ãä»åã®è¹å±±é¨é·ã山縣è¬å¸«ã®ç ç©¶ãéå¼ã«ç¤ºãã¦ããããã¯ãå²å¦ã¯è³æ©è½ã«ã¤ãã¦ã®äºå®ãé¢ããæå¼ã¨ãã¦æç«ããå¦åã§ã¯ãªããä»ã®ã¨ããNeurophilosophyã¨å¼ã°ãã¦ããåéããããå²å¦ã®æ¬æµã«ãªã£ã¦ãããã¨ã¯å¦å®ã§ãã¾ãã
(ææ¾å¤ªéã2021.8.28.)
ä¸å¹´æã«ãããéé£ã»å¤ä¾¡ä¸é£½åèèªé
¸æåéã¨èå¹´æã®èªç¥çã®é¢é£
éå´æå (ä¸ç·ç²¾ç¥å»çã»ã³ã¿ã¼å»é·)Shoko Nozaki, Norie Sawada, Yutaka J. Matsuoka, Ryo Shikimoto, Masaru Mimura, Shoichiro Tsugane :
Association Between Dietary Fish and PUFA Intake in Midlife and Dementia in Later Life: the JPHC Saku Mental Health Study
J Alzheimerâs Dis. 2021;79(3):1091-1104. doi: 10.3233/JAD-191313.
ãèæ¯ã
é«é½¢åã®ä¸ãèªç¥çã®äºé²ãé²è¡ã®æå¶ã¯å½æ°çãªé¢å¿äºã¨ãªã£ã¦ãããç¹ã«é£äºå
容ãçæ´»ç¿æ
£(å«ç
ã飲é
ãéåãªã©)ãªã©ãèªãã®åãçµã¿ã§æ¹åå¯è½ãªå±éºå åãæããã«ãããã¨ã¯éå¸¸ã«æå³ãããã¨èãããããé£äºã«ã¤ãã¦ã¯ãå°ä¸æµ·é£(éèãæç©ãå
¨ç²ç²ãéããªãªã¼ããªã¤ã«ããããé¡ãå¤ãæåããé£ç¿æ
£)ãéé£ã«ã¤ãã¦æ¤è¨ããªããã¦ãããéé£ãå¤ãã¨èªç¥çã®ãªã¹ã¯ãä¸ããã¨ã®å ±åãå¤ããã®ã®ãå°åå·®ããããªã©ä¸å®ãã¦ããªãã£ããä¸å®ããªãçç±ã¨ãã¦ã¯ãéå»ã®ç ç©¶ã¯éé£éããã¨ãã¨å°ãªãæååã§è¡ããã¦ãããå·®ãåºã«ããã¨ãã£ãå¯è½æ§ãèãããããã¾ããè³ã®ç¥çµç´°èã®å¤åã¯èªç¥ççºçã®ä½å¹´ãåããèµ·ãã£ã¦ãããã¨ãåãã£ã¦ãããéé£éãæ¸¬å®ããææã¨èªç¥çã観å¯ããææãè¿ãããã¨å·®ãåºã«ããã¨ãã£ããã¨ãèãããããæ¥æ¬ã¯ä¸ççã«ãéé£éãå¤ããã¨ã§ç¥ããã¦ãããæ¬ç ç©¶ã§ã¯æ¥æ¬ã«ãããèå¹´æã®èªç¥çãªã¹ã¯ã¨ä¸å¹´æã®éé£éã®é¢é£ãæ¤è¨ããã
ãæ¹æ³ã
1990å¹´ã«é·éçä½ä¹
ä¿å¥æç®¡å
ã®åä½ä¹
é¡8çºæï¼1990å¹´æç¹ï¼ã«å±
ä½ãã¦ãã40ï½59æ³ã®ç´1ä¸2å人ã®ãã¡ã1995ï¼96å¹´ã®å¥è¨ºãã¼ã¿ãããããã¤2014-15å¹´ã«è¡ã£ãããããã®æ¤è¨ºãã«åå ãã1127人ã®ãã¼ã¿ã«ãã¨ã¥ãã¦ãéé£éãéã«å¤ãå«ã¾ããä¸é£½åèèªé
¸æåéã¨ãã®å¾ã®è»½åº¦èªç¥é害ã»èªç¥çã¨ã®é¢é£ãæ¤è¨ãããé£äºã«ã¤ãã¦ã¯ã147åç®ã®é£å(éä»é¡ã¨éå å·¥é£åã¯19åç®)ã®éå»1å¹´éã®æåç¶æ³ãå°ããé£ç©æåé »åº¦èª¿æ»ç¥¨ã1995å¹´ã2000å¹´ã«è¡ããå¹³åå¤ãç¨ãã¦éé£éã¨å¤ä¾¡ä¸é£½åèèªé
¸ã®æåéãæ¨å®ããã軽度èªç¥æ©è½é害ã»èªç¥çã«ã¤ãã¦ã¯ã2014-2015å¹´ã«ç¥çµå¿çæ¤æ»ãæãã¤çç¶ã®è³ªå票ãç¨ããæ¤è¨ºãè¡ããç²¾ç¥ç§å»ãåç ç©¶åå è
ã診å¯ãã¦ãèªç¥çã軽度èªç¥æ©è½é害ããã¤ç
ã®è¨ºæãè¡ã£ããèªç¥çã«é¢é£ããä»ã®å åã調æ´ããããã1995å¹´ã«å¾ãå«ç
ã飲é
ãèº«ä½æ´»åéãæè²æ´ã®ãã¼ã¿ãã2014-2015å¹´ã«å¾ãç³å°¿ç
ããããå¿çæ¢å¡ããã¤ç
æ¢å¾ã«é¢ãããã¼ã¿ãç¨ããã
ãã®ããã«å¾ããããã¼ã¿ãç¨ããéé£éã»ä¸é£½åèèªé
¸ã®æåéã¨èªç¥çã軽度èªç¥æ©è½é害ã®é¢é£ã«ã¤ãã¦ããã¸ã¹ãã£ãã¯å帰åæãè¡ã£ããéé£éãããããã®å¤ä¾¡ä¸é£½åèèªé
¸æåéã«ã¤ãã¦ã¯ãä½ãæ¹ãã4åä½ã®ã°ã«ã¼ãã«åãã¦è§£æãããModel1ã¨ãã¦æ§ãå¹´é½¢ãæè²æ´ã調æ´ãModel2ã¨ãã¦æ§ãå¹´é½¢ãæè²æ´ãå«ç
æ´ã飲é
æ´ãèº«ä½æ´»åéãæ¢å¾æ´ï¼ãããå¿çæ¢å¡ãç³å°¿ç
ããã¤ç
ï¼ã調æ´ããModel2ãæçµã¢ãã«ã¨ããã
ãçµæã
ãããã®æ¤è¨ºåå æã®å¯¾è±¡è
ã®å¹³åå¹´é½¢ã¯73æ³ã6å²ã女æ§ã§ãã£ããç ç©¶åå è
1,127人ã®ãã¡ã380人ã軽度èªç¥é害ã54人ãèªç¥çã¨è¨ºæããããèªç¥çã«ã¤ãã¦ã¯ãéé£éãä¸çªä½ãã°ã«ã¼ã(Q1)ãåºæºã¨ããå ´åãQ4ã§ã¯ãªã¹ã¯ã0.39åã¨61ï¼
ã®ä½ä¸ãèªãããããã¾ããããããéé£éãå°ãªãQ2ãQ3ã§ããªã¹ã¯ã¯ãããã0.43åã0.22åã¨ãªããéé£éãä¸çªä½ãQ1ã¨æ¯ã¹ãã¨ãªã¹ã¯ã¯ä½ãã£ããéã«å¤ãå«ã¾ããå¤ä¾¡ä¸é£½åèèªé
¸ã§ãããã³ãµãããµã¨ã³é
¸(DHA)ã«ã¤ãã¦ããä¸çªæåéã®å°ãªãQ1ãåºæºã¨ããå ´åãQ4ã®èªç¥çã®ãªã¹ã¯ã¯0.28åã¨ãªãã72%ã®ãªã¹ã¯ã®ä½ä¸ãèªãããããã¾ããéé£éã¨åæ§ã«Q2ãQ3ã§ããªã¹ã¯ã¯ãããã0.39åã0.30åã¨ä½ãã£ããåããå¤ä¾¡ä¸é£½åèèªé
¸ã§ããã¨ã¤ã³ãµãã³ã¿ã¨ã³é
¸(EPA)ããã³ãµãã³ã¿ã¨ã³é
¸(DPA)ã«ã¤ãã¦ãQ1ã¨æ¯è¼ããå ´åãQ4ã®ãªã¹ã¯ã¯ãããã0.44ã0.22ã¨ãªãä½ä¸ãèªããããããä½ä¸ãèªããããã®ã¯Q3ããã§ãã£ãã軽度èªç¥æ©è½é害ã«ã¤ãã¦ãåæ§ã®æ¤è¨ãè¡ã£ãããéé£éãå¤ä¾¡ä¸é£½åèèªé
¸æåéã¨ããèªç¥çã®ãªã¹ã¯ä½ä¸ã®ãããªå¼·ãé¢é£ã¯èªããããªãã£ãã
ãèå¯ã
éé£éãDHAã«ã¤ãã¦ã¯ãéå»ã®å ±åã§ãèªç¥çäºé²ã«å¹æãããå¯è½æ§ã示åããã¦ããããéé£éã調ã¹ãææã¨èªç¥æ©è½ã調ã¹ãææã®ééãçããã¨ãå¤ããç ç©¶ã®éçã®ä¸ã¤ã¨ãã¦ææããã¦ãããä»åã®ç ç©¶ã§ã¯ä¸å¹´æã®éé£éãç´20å¹´å¾ã®èªç¥çãªã¹ã¯ã¨é¢é£ããããã¨ã示ãããéã«å¤ãå«ã¾ããå¤ä¾¡ä¸é£½åèèªé
¸ã§ããDHAãããã«EPAãDPAã®æåéã§ãåæ§ã®å¹æã観å¯ããã¦ãããã¨ãããä¸å¹´æããé·æã«éãå¤ãé£ã¹ãããå¿ããããã¨ã§ãèªç¥çãäºé²ãã广ãããå¯è½æ§ã示ããããéé£ãå¤ä¾¡ä¸é£½åèèªé
¸ã®æåã¯èªç¥çã¨é¢é£ãæ·±ãè³åä¸ãå¿è¡ç®¡ç¾æ£ã®ãªã¹ã¯ä½ä¸ã«ãé¢é£ãã¦ããã¨ãããä»åã®ç ç©¶ã§ã¯ãããã®è¦å ã調æ´ããä¸ã§ãèªç¥çã®ãªã¹ã¯ä½ä¸ã«é¢é£ãã¦ãããã¨ã示ããããä¸ççã«éé£éãå¤ãæ¥æ¬ã§ããéé£éã®ã天äºå¹æ(ä¸å®ä»¥ä¸éé£éãããå ´åã¯å¹æã観å¯ãããªããªããã¨)ãã§ã¯ãªãéé£éãå¤ãã¨èªç¥çãªã¹ã¯ãä½ããã¨ã観å¯ã§ãããã¨ã¯ã大ããªææã¨è¨ãããä»åã®ç ç©¶ã§ã¯ãä¸å¹´æã«èªç¥æ©è½ãè©ä¾¡ãã¦ãããããã¨ãã¨èªç¥æ©è½ãè¯å¥½ãªäººããã¾ãã¾éé£éãå¤ãã¨ããå¯è½æ§ã¯å¦å®ã§ããªããããéé£ãå¤ä¾¡ä¸é£½åèèªé
¸ã®å¹æãçµè«ä»ããããã«ã¯ããããªãç ç©¶ãå¿
è¦ã§ãããã¾ãã軽度èªç¥æ©è½é害ã§ã¯éé£ãé«ä¾¡ä¸é£½åèèªé
¸ã®æåã®æç¢ºãªå¹æã観å¯ã§ããªãã£ãããããã®ç¹ã«é¢ãã¦ãä»å¾ã®ç ç©¶ãå¿
è¦ã§ããã
(éå´æåã2021.7.20.)
解説ãäºé²ã®ç§å¦ã¨å²å¦
äºé²ãã¸ãã¹ã«ã¯å¸¸ã«æå¤§éã®è¦æãå¿
è¦ã§ããã
第ä¸ã¯çå½ã®åé¡ã§ãããããªãã¡ããããã§äºé²ã§ãããã¨ç¤ºãããããã«ãæ¬å½ã«äºé²å¹æãããã®ãã¯çã£ã¦ããããªããã°ãªããªããäºé²ãã¸ãã¹ã¯ãããããäºé²ãããã¨äººã¯å¼·ãé¡ã£ã¦ããããä»ã®ã¨ããæå¹ãªäºé²æ³ã¯ãªããã¨ããç¶æ³ã«ããã¦èªç¶ã«çºçããèããæ´ãæ°æã¡ãå©ç¨ãããã®ã§ãã¤ã¾ããããã§äºé²ã§ãããã¨ããæ
å ±ã«æ¥ããã¨ãã人ã«ã¯çãããå
ã«ä¿¡ããã¨ããå¿ççæ§ããå½¢æããã¦ããã®ã常ã§ãããè©æ¬ºå¸«ã«ã¨ã£ã¦ã¯ããã»ã©é¨ããããã«ã¢ã¯ããªãã
æ²»çãã¸ãã¹ãããã¯åãã ããæ²»çã®å ´åã¯å¹æã®æç¡ãæ¯è¼ççæéã«æããã«ãªãã®ã«å¯¾ããäºé²ã§ã¯å¹æã®æç¡ã®å¤å®ã«ã¯é·ãæéãè¦ãããããã©ãããé·ãæéãçµã¦ãå¹æãæ¬å½ã«ãã£ãããªãã£ããã¯ããããªããã¨ã®æ¹ããããå¤ããèªç¥çã¯ãã®æãããã®ã®ä¸ã¤ã§ãããã
ããããäºæ
ã«ä¹ãã¦æè±¡ç¡è±¡ã®ãã§ã¤ã¯ãä¸ã®ä¸ã«åºåã£ã¦ãããä½ã®ç§å¦çæ ¹æ ããªãã«ãããããããèªç¥çãäºé²ã§ããã¨å§ä¼ããããããã¦äººã¯é·æéã«ããã£ã¦ãããæåãç¶ãããããã¯ãµããªã§ãã£ããé£ã¹ç©ã§ãã£ãããããããããæãèå»¶ãã¦ããã¨ã»äºé²ãã¸ãã¹ã¯ãã®ãã¿ã¼ã³ã§ããã¨æããããããã¨ãç§å¦çæ ¹æ ããã£ã¦ããäºé²ã§ããã¨ãã話ã«ã¯ãªãè¦æãå¿
è¦ã§ããã
ããã第äºããã¼ã¿ã¬ãã«ã®åé¡ã§ããã
ãã¼ã¿ã¬ãã«ã¨ããã¨ãå°éå®¶ã®éã§ã¯ã¨ããã³ã¹ã¬ãã«ã¨ããæ¦å¿µãããã«æµ®ãã¶ããå®ç¤¾ä¼ã§ã¯ãã以åã«ãåºç¤ç ç©¶ã§å¾ããããã¼ã¿ããã®ã¾ã¾è¨åºã¬ãã«ã®å¹æã®è¨¼æã«ãªããã®ããã«èª¤è§£ããã¦ããã¨ããåé¡ã®æ¹ãããã大ãããç´°èã¬ãã«ãåç©ã¬ãã«ã®ãã¼ã¿ã¯ãããããããã«ä¿¡é ¼ã§ãããã®ã§ãã£ã¦ããè¨åºå¿ç¨ã¾ã§ã«ã¯ã¾ã ã¾ã é·ãéã®ããããã¨ããäºå®ãç¡è¦ãããã®ã§ããã
ãããã¯ãªã¢ãããã¨ãã¦ãã第ä¸ã¨ãã¦ãéã®åé¡ãããã
èªç¥çã®äºé²ã«æå¹ã§ãããã¨ãç§å¦çã«è¨¼æãããç©è³ªã¯ããã¤ããããããã¨ãããåãã¦(ããã«ãä¹ãã¦ãã¨è¨ãã¹ããããããªã)ããã®ç©è³ªãå«ã¾ãã¦ããé£ç©ãç´¹ä»ãããããèªç¥çäºé²ã«æå¹ãªãã¨ãç§å¦çã«è¨¼æãããæåãå«ã¾ãã¦ããé£ç©ãã¯ãé常ã¨ã¯ç°ãªãæå³ã§ã®é£æ¬²ãããããã¨ã«ãªãã
ã ããèªç¥çäºé²ã«æå¹ãªãã¨ãç§å¦çã«è¨¼æãããæåãå«ã¾ãã¦ããé£ç©ããé£ã¹ãããã«å¿ããã¦ããèªç¥çäºé²ã«ã¯æ±ºãã¦ç¹ãããªãã
ãã¨ãã°ãã¼ãºã®æåã®ä¸ã«ã¯èªç¥çäºé²å¹æãããç©è³ªãå«ã¾ãã¦ããããäºé²ã®æå¹éãæåããããã«ã¯ãã¼ãºãä½ååãé£ã¹ããã¨ãå¿
è¦ã§ãããããããéè¦ãªæ
å ±ãã¹ããããã¦ããèªç¥çäºé²ã®ããã«ãã¼ãºãé£ã¹ãããã¨è¦ããã®ã§ããã°ãããã¾ãè©æ¬ºã§ããã
éã«ã¤ãã¦ã¯éã®åé¡ããããããã¾ã§ã«èªç¥çäºé²å¹æããããã¨ã示ãããç©è³ªã®å¤ãã«ã¯ãè³é©ãªéã®ç¯å²ã¨ãããã®ãããããã®ç¯å²ãè¶
ãã¦æåãéããã¨éã«å¹æãè½ã¡ãã¨ãããã¿ã¼ã³ã«ãªã£ã¦ãããã¨ã大é¨åã§ããããããã£ã¦éå°æåã«ãããã¡ãªããã¨å¸¸ã«èä¸åããã§ããããââã«ã¯äºé²å¹æãããããââã¯ä½ã«è¯ãããªã©ã¨ãã£ãã¨ããããã¯ãââãæåããã°ããã»ã©è¯ããã¨ãããã¨ã«ã¯æ±ºãã¦ãªããªãã®ã§ããã
æå¾ã«ã第åã¨ãã¦ãå²å¦ã®åé¡ãããã
ããé£ã¹ç©ãäºé²ã«æå¹ãªãã¨ãç§å¦çã«è¨¼æãããã¨ãããããããã®æå¹éã¯æ¥å¸¸çã«æåã§ãã常èçãªéã ã£ãã¨ããã
ã ããããå«ããªé£ã¹ç©ã ã£ããã©ãããããæ®éã¯ãã¾ãé£ã¹ãªãç©ã ã£ããã©ãããããããã§ãé£ã¹ç¶ãããããããããããªããããã¯é£äºãèªç¥çäºé²ã«ç¹åããç®çã¨ãããã¨ã«ã»ããªããªãããã§ã¯æ¯æ¥ã®é£åãäºé²å°ç¨ã®å ´ã«ãããã¨ããã®ãã
èªç¥çã¯äºé²ããããã ãèªç¥çã®äºé²ã¯äººçã®ç®æ¨ã§ã¯ãªãã
ããã«è¨ãã°ãå¥åº·ã®ç¶æã人çã®ç®æ¨ã§ã¯ãªãã
æ¯æ¥æ±ºã¾ã£ãç©ãé£ã¹ã決ã¾ã£ãçæ´»ãããææ
¢ã®æ¥ã
ãéãããã®çµæãå¥åº·ãç¶æããããèªç¥çã«ã¯ãªããã«äººçãçµããããããªäººçãã人ã¯è¯ãã£ãã¨æããã®ããè¥èªåèã¯ãã®å¾ã®ä½ããã®é«ãç®çã®ããã«è¡ããã®ã§ãã£ã¦ãè¥èªåèãã®ãã®ã¯ç®çã«ã¯ãªãã¾ããããããªã人ãããã®ãããããªãããããã¯å人ã®å²å¦ã®åé¡ã«ãªããä½ã«å¤å°æªããã¨ãããã¨ãã¦ãããã®æ¹ã人çãæ¥½ããã®ã§ããã°ãã¡ããåãã¨ããå²å¦ããããããããã¨ãããããã®æ¹ããããæ®éãããããªããããã«ã¯ãã®æ¹ãå¥åº·ãªèãæ¹ã¨ããè¨ãããããããªãã
èªç¥çã®äºé²ã«æå¹ã¨ããã¦ãããã®ã¯ããããããããããçã«æå¹ã¨ããããã«ã¯ã以ä¸ã®ãããªåé¡ãã¯ãªã¢ãããªããã°å®ç¨ã«ã¯ãªããªãã
ãããã¦ãéå´æååå£«ã®æ¬è«æã®å大ãªä¾¡å¤ãè¦ãã¦ããããã¼ãã¯éãé£ã¹ããã¨ã§ãããéãèªç¥çäºé²ã«å½¹ç«ã¤ã®ã§ã¯ãªããã¨ããã®ã¯ãæããè¨ããã¦ãããã¨ã§ã¯ãããç§å¦çãã¼ã¿ããã£ãããããéå´å士ãè«æå
ã§ææãã¦ãããããªæ§ã
ãªãã¼ã¿è§£éä¸ã®åé¡ããããæ¬å½ã«æå¹ãã©ããã«ã¯çå符ãä»ãããç¶ãã¦ããã
ãããªç¶æ³ã«ãã£ã¦ãJPHCã³ãã¼ãã®æ´»ç¨ãéãã¦éå´å士ãã¾ã¨ããæ¬ç ç©¶ã¯ãç»æçãªæå³ãæã£ã¦ãããJPHCã³ãã¼ããhttps://epi.ncc.go.jp/jphc/ã¯ã10é½åºçç·å¢14ä¸äººã®å°å使°ããæ§æãããæ§ã
ãªç
æ°ã®çºçã¨çæ´»ç¿æ
£ã®é¢ãããæããã«ãããã¨ãç®çã«ããé·æè¿½è·¡ããã¸ã§ã¯ãã§ãããæ¬ç ç©¶ã¯ãã®ä¸ã®ä½ä¹
ã³ãã¼ã(é·éç)ããçã¾ãããã®ã§ã1990å¹´ãã20å¹´é追跡ãã¦å¾ããããã¼ã¿ã«ãç²¾å¯ãªçµ±è¨è§£æãè¡ã£ãææã§ããã
ãããã£ã¦å
ã«æãã第ä¸ã¨ç¬¬äºã®åé¡ã¯ç¢ºå®ã«ã¯ãªã¢ããã¦ãããããªãã¡ããã¼ã¿ã«ã¯ååãªç§å¦çæ ¹æ ããããå®è¨åºã«é©ç¨ã§ããã¨ããã³ã¹ã¨ãªã£ã¦ããã
ããã¦å¾ãããçµæã¯äººã
ãååã«å®æ½å¯è½ãªäºé²æ³ã§ãã£ããæ¬è«æããã®ã¡ãã»ã¼ã¸ã¯ã䏿¥ã«é80ã°ã©ã ãé£ã¹ããã¨ãèªç¥çäºé²ã«å¹æããããã¨ããåç´æå¿«ãªãã®ã§ããããã¤ã³ãã¯80ã°ã©ã ã¨ããæ°åã§ãããé80ã°ã©ã ã¨ã¯ã»ã¼éã®åã身ä¸åãã«ããããæ¥æ¬äººã®å¹³åçãªé£çæ´»ãèããã¨ããããæ¯æ¥é£ã¹ãã¨ããã®ã¯å¤æ°æ´¾ã¨ã¯è¨ããªããããããã¨æãã°ååã«å®è¡å¯è½ãªç¯å²ã§ãããããã¦ãéã«ãã®éãè¶
ãã¦é£ã¹ãç¿æ
£ã¨ããã®ã¯ãªããªãå¾ããã«ããããããã£ã¦éå°æåã«ãããã¡ãªãããæ°ã«ããå¿
è¦ã¯ã»ã¼ãªããã¨ãããã¨ã¯ãç¾å®çã«ã¯ãéã¯é£ã¹ãã°é£ã¹ãã»ã©è¯ãã¨ããåç´ãªé£ç¿æ
£ãæ¨å¥¨ãããã¨ãããã¨ã«ãªããããã¯ããªãç»æçãªã¡ãã»ã¼ã¸ã§ããããã¾ãããäºé²æ³ã¨ããã¦ãããã®ã®ä¸ã§ããã®éå´è«æã示åããã䏿¥ã«é80ã°ã©ã ãé£ã¹ããã¨ããäºé²æ³ã¯ãç§å¦çæ ¹æ ããã¼ã¿ã¬ãã«ãããã¦éçã«å®è¡å¯è½ã¨ããæå³ã§ãæ¯é¡ãªãå®ç¨æ§ãæã£ãæ¹æ³ã ã¨è¨ããã
ã§ã¯æå¾ã®ç¬¬åãå²å¦ã«ã¤ãã¦ã¯ã©ãããéãå«ããªäººã«ã¯ããã®äºé²æ³ã¯å½¹ã«ç«ããªãã¨ãããã¨ã«ãªãããã§ãããã ãéããã»ã©å¥½ãã§ã¯ãªããå«ãã¨ããç¨ã§ã¯ãªãã¨ããã¬ãã«ã®äººã«ã¤ãã¦ã¯ã工夫ããã°è¡åå¤å®¹ã®ä½å°ã¯ããã工夫ã¨ã¯ãã¨ãã°ãéã好ããªäººãå¢ããããã«ãéæçãçºå±ã»æ´ç·´ããã¦ãããã¨ãæããããããèªç¥çäºé²ã®ããã«ãããããã¨ãæ¨é²ãããã¨ã®é©ä¸é©ãã¾ãå²å¦ã®åé¡ãã¨å¼ã¶ã®ã¯å°ã 大è¢è£ã§ãã£ã¦ãç¾å³ããéæçãé£ã¹ã¦èªç¥çãäºé²ã§ããã®ã§ããã°ãå¥åº·ã¨ç活謳æã®ä¸¡æ¹ã«è³ããåæ¡ã§ã¯ãªããã¨æããå¦ä½ã§ããããã
(ææ¾å¤ªéã2021.7.30.)
Parkinsonç
ã«å¯¾ãã黿°ããããçæ³ï¼ã·ã¹ãããã£ãã¯ã¬ãã¥ã¼ã¨ã¡ã¿è§£æ
é«å®®ãå½°ç´ï¼æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ã»ç¥çµç§å¦æå®¤ãç¹ä»»å©æï¼Takamiya A, Seki M, Kudo S, Yoshizaki T, Nakahara J, Mimura M, Kishimoto T.
Electroconvulsive Therapy for Parkinsonâs Disease: A Systematic Review and Meta-Analysis. Mov Disord 2021 Jan; 36 (1): 50â58.
黿°ããããçæ³ (electroconvulsive therapy: ECT) ã¯ç²¾ç¥ç¾æ£ã«å¯¾ãã¦å¹æã確ç«ãããæ²»çã§ãããParkinsonç
ã¯éåçç¶ã®ã¿ãªããç²¾ç¥çç¶ãåºç¾ãããããããParkinsonç
ã«ãããç²¾ç¥çç¶ã®æ²»çã«ããã¦ãæç²¾ç¥ç
è¬ã®ä½¿ç¨ã«ä¼´ãéåçç¶ã®æªåãªã©å¯ä½ç¨ãããååé使ç¨ã§ããªãã¨ããã¸ã¬ã³ããçããããECTã¯Parkinsonç
ã®éåçç¶ã¨ç²¾ç¥çç¶ã®ä¸¡è
ã«å¹æãè¦è¾¼ããå¯è½æ§ã示åããã¦ããããã®ãããªèæ¯ããã¨ã«ãç²¾ç¥ã»ç¥çµç§ã¨ç¥çµå
ç§ã®ä¸¡è
ã§ãéå»ã«è¡ãããParkinsonç
ã«å¯¾ããECTã®æå¹æ§ã調ã¹ãç ç©¶ã®ã¬ãã¥ã¼ãè¡ã£ãã
14ã®ç ç©¶ï¼129åï¼ã®ãã¼ã¿ãè§£æããæ²»çåå¾ã®å種çç¶è©ä¾¡å°ºåº¦ã®å¤åéãç®åºãããECTã¯éåçç¶ããã¤çç¶ãç²¾ç¥ç
çç¶ãWearing-offç¾è±¡ã«å¯¾ãã¦ææã¯æ¹å广ãæå¾
ã§ããèªç¥æ©è½ã¯æªåãããªãã¨ããçµæã§ãåºçãã¤ã¢ã¹ã®å½±é¿ãèæ
®ãã¦ããããã®çµæã¯å¤ãããªãã£ããECTã®éåçç¶ã«å¯¾ããæ¹å广ã¯ãç²¾ç¥çç¶ããªãParkinsonç
ã®æ£è
ã®ã¿ã対象ã¨ããç ç©¶ã®ãµãã°ã«ã¼ãè§£æã«ããã¦ãææã§ãã£ãã
ECTã¯ãã¤ç
ãçµ±å失調çã«ããããã¤çç¶ãç²¾ç¥ç
çç¶ã«å¯¾ãã广ã®ã¿ãªãããParkinsonç
ã«ããããã¤çç¶ãç²¾ç¥ç
çç¶ã«å¯¾ãã¦ãæå¹ã§ããå¯è½æ§ã示åããããParkinsonç
ã«ä¼´ãç²¾ç¥çç¶ã«å¯¾ãã¦æå¹æ§ã示ãããè¬ç©çæ³ã®é¸æè¢ã¯å°ãªããéåçç¶ãæªåãããæ¸å¿µãããæ²»çã«é£æ¸ããã±ã¼ã¹ãå°ãªããªããECTã¯èªç¥æ©è½ã¸ã®æªå½±é¿ã®æ¸å¿µããããè¿å¹´ã®æ¹æ³è«ã®æ¹åï¼é»æ¥µé
ç½®ããã«ã¹å¹
ã®èª¿æ´ãªã©ï¼ã«ããèªç¥æ©è½ã¸ã®å½±é¿ãæå°éã«æãããã¨ãå¯è½ã§ãããECTã®éåçç¶ã¸ã®æ¹å广ã¯ç²¾ç¥çç¶ã®æ¹åã¨ã¯ç¬ç«ãã¦ããå¯è½æ§ããããããã®æ©åºã¯ä¸æã§ããä»å¾ã®ç ç©¶ãå¿
è¦ã§ãããããã¾ã§ã«Parkinsonç
ã«å¯¾ããECTã®ã©ã³ãã 忝è¼è©¦é¨ã¯1ã¤ããè¡ããã¦ããªãã£ãããæ¬ç ç©¶ã§ã¯ä¸»ã«è¦³å¯ç ç©¶ã®çµæããã¨ã«ãã¦ããçµæã®è§£éã«ã¯æ³¨æãå¿
è¦ã§ãããä»å¾ã®è³ªã®é«ãã©ã³ãã 忝è¼è©¦é¨ãæã¾ããã
ããã¾ã§ãå¦è¡è«æã¨ãã¦ã®ã使³ã«åã£ã¦æ·¡ã
ã¨è¨è¼ããå
容ã§ãããããã¯ãã®ã¬ãã¥ã¼ãããéã®å人çãªææ³ã§ãããè«æãç¶²ç¾
çã«æ¤ç´¢ããã¨ãã¨ããã³ã¹è³ä¸ä¸»ç¾©ã«ããã¦æä¸å±¤ã¨ä½ç½®ä»ããããçä¾å ±åãå¤ãç®ã«æ¢ã¾ã£ãããã«ã¼ã«ã¯ã«ã¼ã«ã¨ãã¦å
¨ã¦é¤å¤ããã¦ããã ãããããããæ²»çæ´ãé·ããç¾æ£ã®é²è¡ã¨è¬ç©çæ³ã®å¯ä½ç¨ã®å½±é¿ãè¤éã«çµ¡ã¿åããè³å¤ç§æ²»çå«ãä»ã®æ²»çæ³ã§ã¯ã©ããããããªã飿²»ä¾ã«ããã¦ããECTã§éåçç¶ã¨ç²¾ç¥çç¶ã®ä¸¡è
ãæ¹åããã¨ããå ±åã¯ç¢ºãã«ããã¦ãã¦ãããããã§ãç¥çµå
ç§é åã§ã¯ããã¾ã§ECTã«ã¹ãããã©ã¤ããå½ãããã¨ããªãã£ãã¨ãããã¨ã¯é©ãã§ããã両ç§ã®é¢¨éããè¯ããããã¨ã®å¿
è¦æ§ãæãããã£ããã«ããªã£ããã¾ãããªãECTã¯Parkinsonç
ã®éåçç¶çç¶ã«æå¹ãªã®ãããªãECTã¯æç²¾ç¥ç
è¬ã¨ç°ãªãéåçç¶ãæªåãããã«ç²¾ç¥ç
çç¶ãæ¹åããããã¨ãã§ããã®ãã¨æ§ã
ãªçåãå´åºãããã³ãã©ã®ç®±ãéãã¦ãã¾ã£ããããªå¦ãªæè¦ã«ããªã£ãããããã«å¸æãããã¨ä¿¡ãä»å¾ã®ç ç©¶ã«ã¤ãªãããã¨æãã
(é«å®®å½°ç´ã2021.6.1.)
解説ãå°å°ããã叿
æ
¶æç²¾ç¥ç¥çµç§ã®å»å±ã®å
輩ã«ãæåã®æä»£ãããçè縮æ§å´ç´¢ç¡¬åçALSã«å¯¾ãã黿°ããããçæ³(ECT)ã®æå¹æ§ãå¼·ã主張ãã¦ããããå
çãããã£ããããé¿é¨æ£å
ç(æå22å¹´æ
¶æå»å¦é¨å26åçãå¹³æ8å¹´ä»ç)ã§ããã
ãç¥æ
æéä¸ç
ãã¨é¡ãããé¿é¨å
çã®ãèæ¸ã«ã¯ãECTã§æ¹åããALSã®å®ä¾ãããã¤ãç´¹ä»ããã¦ããã忏ã®ã¯ãããã«ã¯ããç¥(観念)ã«éä¸ããããåè£ç
ãææ
ã«éä¸ããããèºãã¤ç
ãè¡åã«éä¸ããããã¦ããããããã¦ããã®éä¸ã®æ£å対ã®è² éä¸ç
ã¨ããã®ããã£ã¦ã観念ã®è² éä¸ç
ãç´åçãææ
ã¸ã®è² éä¸ç
ã失ææ
çãè¡åã¸ã®è² éä¸ç
ããã«ã³ã¬ãã·ã¼ãã«ã¿ãã¬ãã·ã¼ã¨èã¸ã¦ãããã¨è¨è¼ããã¦ãããé¿é¨å
çã¯ãã®ä»ã«ã表æ
ç
ãã¨ããæ¬ãåºçãã¦ãããããããã¯ã表æ
ã®ç
æ°ãã¨ããæå³ã§ã¯ãªãããemotion-expression diseaseãã¨ããæå³ã§ããã忏ã®åºæã«ã¯ãç§ã¯ææ
ãã®ãã®ã®æ¬è³ªã¯ä½ããã¨ããã«ä¼´ãèº«ä½æè¦ã調ã¹ãææ
ã«ã¯å¿
ã対å¿ããèº«ä½æè¦ããããææ
ã¨èº«ä½æè¦ã®éã«ã¯å¯æ¥ãªé¢ä¿ã®ãããã¨ã«æ°ã¥ãããããã¦ããã®èº«ä½æè¦ã«æ³¨æãéä¸ããç°å¸¸ã«é«ã¾ã£ãæã«ç
æ°ã¨ããç¶æ
ã«ãªãã¯ããªããã¨ã仿¥èº«ä½çã«ã¯åå 䏿ã§ãç²¾ç¥çã«ã¯åæä¸è½ã¨ããã¦ããããé£ç
ããããã«è©²å½ãããã¨ãçªãã¨ããæ²»çã®ç®å®ãã¤ãããã¨ãåºæ¥ããã¨è¨è¼ããã¦ãããããã«ã¯ãçè縮æ§å´ç´¢ç¡¬åçãçãè³è
«çãç½è¡ç
ããã®é¢ããè§£æãããã¨ãã§ãããã¨ã¾ã§è¨ããã¦ããã
ç§ã¯ç ä¿®å»ã®ãããé¿é¨å çãå»å±ã訪ããå ´é¢ã«ééãããã¨ããããããã«å± åããããªã¼ãã³ã®å çæ¹ã¯é¿é¨å çããèåç¡ç¨½ãªçè«ã主張ãã人ã¨ãã¦æ¬é ãã¦ãããã¨ãããè¦ãã¦ãããç´ ç´ãªç ä¿®å»ã§ãã£ãç§ã¯ãªã¼ãã³ã®å çæ¹ã®å§¿å¢ã«ç´ ç´ã«ç´å¾ããé¿é¨å çã®ç¬ç¹ã®çè«ã«ç´ ç´ã«å¦å®ã®æ°æã¡ãæã£ã¦ããã®ã§ããããæ¯ãè¿ã£ã¦ã¿ãã°ã彿ã®ç²¾ç¥å»å¦ã®çè«ã¯(ç¾ä»£ã®çè«ã?)ããã¨ãåªå¢ã®ãã®ã§ãã£ã¦ãã©ããæ ¹æ èå¼±ã§ãã£ãã¨ããæä»£èæ¯ã«éã¿ãã°ãé¿é¨å çã®çè«ã¯å¾è´ãã¹ãè²´éãªãã®ã§ãã£ãã¨è¨ããããå¾ã®Damasioã®somatic marker theoryã¨ã®ç¹ãããè¦åºããã¨ãã§ããã
Parkinsonç ã«å¯¾ããECTç ç©¶ã1950年代ããä¸çã§ç´°ã ã¨ããããçå®ã«é²ãããã¦ãããã¨ããç§ã¯é«å®®å½°ç´ç¹ä»»å©æã®è«æãèªãã¾ã§ã¯ä¸è¦ã«ãå ¨ãç¥ããªãã£ãããã®ç ç©¶ã«çç®ããé«å®®ç¹ä»»å©æãé¿é¨å çã¨å¯¾æ¯ããã®ã¯å¤±ç¤¼ãªãã¨ããããã¨ãç§°è³ãã¦ãããã¨ã«ãªãã®ãããããã¯ãã®ä¸¡æ¹ããç§ã«ã¯å¤æã§ããªããããäºäººã®ã©ã¡ãã®ç®ã«ãECTã¨ãECTãæå¹ãªç¾æ£ã«ã¤ãã¦ã®ç»æçãªæªæ¥ãæãå¯è½æ§ãè¦ãã¦ãããã¨ã¯ç¢ºãã§ãããã
é«å®®ç¹ä»»å©æã¯ECTã¨Parkinsonç ã«ã¤ãã¦ã®ç ç©¶è«æãæ¸çããã«ã¤ãã¦ããã³ãã©ã®ç®±ãããã¦ãã¾ã£ããããªå¦ãªæè¦ã«ãªã£ããã¨è¨ãã¦ãããããããã³ãã©ã®ç®±ããçæç®±ããå®ç³ç®±ããç§ã«ã¯å¤æã§ããªãããç®±ãéããã¾ã¾ã§ã¯ä½ãå¾ãããªããã¨ã¯ç¢ºãã§ããããããã¦ç®±ãéããã¦åºã¦ãããã®ããç®ããããã¦ãã¦ã¯ãå¸æã«æ°ã¥ããã¨ã¯ã§ããªãã
(ææ¾å¤ªéã2021.6.28.)
é度ã®ä½æ é¤ãä¼´ãæé£é害ã®ãªãã£ã¼ãã£ã³ã°çå群ã«ããè¡æ¸
ãªã³å¤ã®ä½ä¸ã¯Body Mass Indexã¨BUN/Cræ¯ã«ãã£ã¦äºæ¸¬ã§ãã
è¹å±±éé(è¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§é¨é·)Funayama M, Mimura Y, Takata T, Koreki A, Ogino S, Kurose S: Body mass index and blood urea nitrogen to creatinine ratio predicts refeeding hypophosphatemia of anorexia nervosa. Journal of Eating Disorders (2021) 9:1ãhttps://doi.org/10.1186/s40337-020-00356-7
ãèæ¯ã
身ä½çã«éåº¦ãªæé£éå®³ã®æ¥æ§ææ²»çã«ããã¦ããªãã£ã¼ãã£ã³ã°çå群ã«ä¼´ãä½ãªã³è¡çã®éç度ãäºæ¸¬ãããã¨ã¯è¨åºä¸éè¦ã§ãããéå»ã®ç ç©¶ããã¯å
¥é¢æã®Body Mass Index (BMI)ãBUN/Cræ¯ããªãã£ã¼ãã£ã³ã°ã«ããä½ãªã³è¡çã®çºçã¨é¢é£ãããã¨ãæããã¨ãªã£ã¦ããããããããããã®éå»ã®ç ç©¶ã¯ä½ãªã³è¡ççºçã®æç¡ã調ã¹ãç ç©¶ã§ãããå®éã®è¨åºã§éè¦ãªè¡æ¸
ãªã³å¤ãã©ãã ãä½ä¸ããããäºæ¸¬ããç ç©¶ã§ã¯ãªããã¾ããéå»ã®ç ç©¶ã®å¯¾è±¡è
ã®ä½æ é¤ã®ç¨åº¦ã¯BMI12.7~16.2ã¨ãå¿
ãããé度ã§ã¯ãªããããã«ãéå»ã®ç ç©¶ã«ããã¦ã¯ãªãã£ã¼ãã£ã³ã°æã®å®éã®æåéããªã³ã®è£å
éãèæ
®ãã¦ããªããä»åããããã¯ãé度ã®ä½æ é¤ãä¼´ãæé£é害ã®ãªãã£ã¼ãã£ã³ã°ã«èµ·ããè¡æ¸
ãªã³å¤ã®ä½ä¸ã®ç¨åº¦ã«å½±é¿ããè¦å ã«ã¤ãã¦ã徿¹è¦çç ç©¶ã§ã¯ãããã®ã®ãå¯è½ãªéãã®è¦å ãåãè¾¼ãã ä¸ã§èª¿ã¹ãã
ãæ¹æ³ã
対象ã¯ã1999å¹´4æãã2018å¹´3æã¾ã§è¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§ç
æ£ã«å
¥é¢ããBMIã16æªæºã®æé£é害68ä¾ã®ãã¡ãæ²»çãæ¤æ»ã«ååã§ãã63ä¾ï¼å¥³æ§61ä¾ãå¹´é½¢37.2 ± 10.4æ³ãBMI 11.5±1.6ãæ²»çéå§å¾1é±éã®å¹³åã«ããªã¼æåé1233 ± 590 kcal/dayï¼ã§ãããè¡æ¸
ãªã³å¤ã®ä½ä¸ã®ç¨åº¦ã«ã¯å¤å¤éç·å½¢å帰åæãç¨ããä½ãªã³è¡çã®çºçã®æç¡ (P<2.5mg/dl) ã«ã¯å¤å¥åæã使ã£ãã説æå åã«ã¯å¹´é½¢ãæ§å¥ãå
¥é¢æãã¼ã¿ï¼è¡æ¸
ãªã³å¤ãBMIãBUN/Cræ¯ãã¢ã«ããã³å¤ãæé£ã»éé£ã¿ã¤ãï¼ãæ²»çã«é¢ãããã¼ã¿ï¼ã«ããªã¼æåéããªã³æä¸éãä½éå¢å çï¼ãç¨ããã
ãçµæã
è¡æ¸
ãªã³å¤ã¯å
¥é¢æ3.9±1.4mg/dlãæä½å¤2.6±0.8mg/dlã§ãããæä½å¤ã¯å
¥é¢3.9±4.0æ¥å¾ã«åºç¾ãããè¡æ¸
ãªã³å¤ã®ä½ä¸ã®ç¨åº¦ããã³ä½ãªã³è¡çã®çºçã¯ãããããBMIã¨BUN/Cræ¯ãé¢é£ãããããªãã¡ãBMIãä½ãã»ã©ãã¾ããBUN/Cræ¯ãé«ãã»ã©ããªãã£ã¼ãã£ã³ã°ã«ããè¡æ¸
ãªã³ã®ä½ä¸ã®ç¨åº¦ã¯å¤§ãããä½ãªã³è¡çã®çºçã®å±éºæ§ãé«ã¾ããã¨ãæããã¨ãªã£ãã䏿¹ã§ãæ 餿ä¸éã¯éå»ã®ç ç©¶ã¨åæ§ã«è¡æ¸
ãªã³å¤ã®ä½ä¸ã®ç¨åº¦ã«ãä½ãªã³è¡çã®çºçã«ãå½±é¿ããªãã£ãã
ãèå¯ã
ããããã®ç ç©¶ã®å¯¾è±¡ã¯ãä»ã¾ã§ã®å種ã®ç ç©¶ã®ä¸ã§ã¯æãé度ã®ä½æ é¤ãä¼´ãæé£é害ã§ãã£ãããªãã£ã¼ãã£ã³ã°ã«ããè¡æ¸
ãªã³å¤ã®ä½ä¸ã®ç¨åº¦ã¯ãBMIã¨BUN/Cræ¯ã«ãã£ã¦äºæ¸¬ã§ãããã¨ãæããã¨ãªã£ããã¾ããä½ãªã³è¡çã®çºçã«ã¤ãã¦ããéå»ã®ç ç©¶ã¨åæ§ã«ãBMIã¨BUN/Cræ¯ã¨é¢é£ããã
ãªãã£ã¼ãã£ã³ã°æã®æ 餿ä¸éã«ã¤ãã¦ã¯ã以åã¯ä½ãªã³è¡çãä¸å¿ã¨ããé»è§£è³ªã®ç°å¸¸ãæ¸å¿µãã¦ãå°éããå¾ã
ã«å¢ãããã¨ãä¸è¬çãªè¦è§£ã§ãã£ããã2010年代ããã¯ãããè¦ãç ç©¶ãç¸æ¬¡ãã§ãããæ¬ç ç©¶ããå¾ãããç¥è¦ãããã®è¦è§£ã«ã¯çç¾ããªãçµæã§ãã£ãã
極度ã®ä½æ é¤ãä¼´ãæé£é害ã«å¯¾ãã¦ã¯ãBMIã¨BUN/Cræ¯ããè¡æ¸
ãªã³å¤ã®ä½ä¸ãäºæ¸¬ããä¸ã§é©åãªãªã³ã®è£å
ã忥ããè¡ããªããã使 é¤ã«ä¼´ããããªã身ä½åä½µçãé²ãä¸ã§ã第1ç
æ¥ç®ããããç¨åº¦ã®æ 餿ä¸ãè¡ããã¨ãé©åã§ãããããããªãããã ããã®ç¹ã¯ä»å¾ã®ãããªãç ç©¶ãå¿
è¦ã§ããã
(è¹å±±ééã2021.5.1.)
éçã®Anorexia Nervosaã§ã¯è±æ°´ã¨åè硬åã«é¢é£ããè³æ¢å¡ãçºçããå¯è½æ§ããã
䏿æ (æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ã»ç¥çµç§å¦æå®¤ã大å¦é¢å士課ç¨)Yu Mimura, M.D., Yusuke Shimizu, M.D.1)2), Hiroki Oi, M.D., Shin Kurose, M.D., Shun Kudo, M.D., Taketo Takata, M.D., Masaru Mimura, M.D., Ph.D., and Michitaka Funayama, M.D., Ph.D. : âCase Series: Ischemic stroke associated with dehydration and arteriosclerosis in individuals with severe anorexia nervosaâ Journal of Eating Disorders. (2021) 9:39. https://doi.org/10.1186/s40337-021-00393-w
ç¾å¨è¶³å©èµ¤ååç
é¢ãããæé£é害ã«é¢ããç
æ
ãæ²»çã«ã¤ãã¦ç²¾åçã«ãã¼ã¿åéã¨è«æå·çãé²ãã¦ãããè¹å±±é¨é·ãå·çãããããä½ãªã³è¡çã®äºæ¸¬ã«ã¤ãã¦BMIã¨BUN/Creæ¯ãæç¨ã§ãããã¨ããè«æãåèªã«åºçãããã°ããã§ããã
ç§èªèº«ã¯ãæ é¤çæ³ä¸ã«ã©ã®ããã«ã¤ã³ã¹ãªã³åæ
ãå¤åãããããã¡ã¤ã³ãã¼ãã«ãã¼ã¿åéãè§£æãé²ãã¦ããã
ä»åã®ã±ã¼ã¹ã·ãªã¼ãºã¯ãã®éç¨ã§æ£è
ãããã¡ã¨è§¦ãåã£ã¦ãããã¡ã«ãµã¨ãè³æ¢å¡ãæå¤ã¨é ãã¦ããã®ã§ã¯ãªããï¼ãã¨ããç¾å ´æè¦ããçæ³ãå¾ã¦å·çããã
ãæ¦è¦ã
ããã¾ã§Anorexia nervosa(AN)æ£è
ã§ã¯å¿è¡ç®¡ã¤ãã³ããéèè¡æ çã®ãªã¹ã¯ãé«ãã¨ããå ±åã¯ããã¦ãããããã䏿¹ã§è³æ¢å¡ã«ã¤ãã¦ã®å ±åã¯æå¤ã«ãå°ãªããæ¬ã±ã¼ã¹ã·ãªã¼ãºã§ã¯ANæ£è
ã¨è³æ¢å¡çºçã«ã¤ãã¦æ¤è¨ããã
ãã±ã¼ã¹ã
2018å¹´4æãã2020å¹´12æã¾ã§å½é¢ã«å
¥é¢ããå
¨ANçä¾ã対象ã¨ããã29å
¥é¢ä¾(19人)ã®ãã¡ã2åãå
¥é¢ä¸ã«è³æ¢å¡ã®è¨ºæã«è³ã£ãã1ä¾ç®ã¯30代åå女æ§ã第10ç
æ¥ã«å·¦è©ã®éåæã¨10åç¨åº¦æç¶ããå·¦ä¸å
¨éº»çºã§çºçããè¨åºçã«ã¯ä¸éæ§è³èè¡çºä½ã¨èããããçä¾ã ã£ãããç»åä¸ã¯å¤çºè³æ¢å¡ãææãããã2ä¾ç®ã¯50代åå女æ§ãå
¥é¢æãã軽度ã®ä¼å°å¤±èªãæèªå°é£ãèªããç»åä¸ã¯å·¦ç¸ä¸åãä¸å¿ã¨ããè³æ¢å¡ãææããããã©ã¡ãã®çä¾ãè¥å¹´ã®è³æ¢å¡ã§ããããå¾¹åºçã«å
¨èº«æ¢ç´¢ãè¡ãªã£ããã軽度ã®è±æ°´ã¨åè硬åã®ã¿ãææãããã
ãèå¯ã
ã©ã¡ãã®çä¾ãæ¡è¡ã§ååºè½äº¢é²ãèªãããçä¾1/2ã¨ãã«BUN/Creæ¯ãé«å¤ã§ããè±æ°´ã示åããããçä¾1ã§ã¯æãããªãçä¾2ã§ã¯è»½åº¦ã®åè硬åãææãããã
ã¾ããã®ã±ã¼ã¹ã·ãªã¼ãºãããä¸è¬çãªè³æ¢å¡çºççããèãã¦éçANã§ã¯è³æ¢å¡çºççãé«ããã¨ã示åãããã
ç
æ
ã¯ããã¾ã§æ¨æ¸¬ã®åãåºãªãããè±æ°´ã¯ééããªãé¢ä¿ããã¨èãããããã«è±æ°´ã«å ãã¦ANæ£è
ã¯ä½è¡å§ã§ãããä½éæµã«ãªããã¨ã墿ªå åã§ããã¨äºæ¸¬ããããæç¤ºçä¾ã§ãè³æ¢å¡ã®äºå¾äºæ¸¬å åã§ç¨ããããBUN/Creæ¯ãé«ããè±æ°´ã®é¢ä¸ã示åãããããããCreãä½ãANã§ã¯é大è©ä¾¡ããå¯è½æ§ããããä»ã®ç
æ
ãèæ
®ã«å
¥ããå¿
è¦ããã£ããã¾ãè±æ°´ãç
æ
ã¨ãã¦ã輸液ã«ã¤ãã¦ã¯Refeedingçå群ã«ä¼´ãå¿ä¸å
¨ã®ãªã¹ã¯ãèããã¨ANã«ããã¦ã¯1ml/kgç¨åº¦ã®ç¹æ»´ã妥å½ã§ããã¨èå¯ããã
æç¤ºçä¾ã§ã¯æ¡è¡ããéååºç¶æ
ã§ãããã¨ãããã£ãããã®æç¹ã§ã©ã¯ãæ¢å¡ã¯å¦å®çã¨èããã䏿¹ã§å
¨èº«æ¢ç´¢ããéèè¡æ ã®å¡æ æºåå®ã«ã¯è³ããªãã£ããABI/CAVIã®çµæããã¯åè硬åã®é¢ä¸ã示åããããã¨ããç²¥ç¶ç¡¬åã«ã¯è³ããªãã¬ãã«ã§ã®åè硬åãè±æ°´ã«å ãã¦èæ¯ç
æ
ã®ä¸ç«¯ãæ
ãã¨èãããããæé£é害ã§ã¯è¡å°æ¿æ°ã®ä½ä¸ãè¡å°æ¿æ©è½ã®ä½ä¸ãè¡å°æ¿å®¹ç©ã®å¢å¤§ãªã©ãèµ·ãããã¨ããããã¦ãããããããåè硬åã«é¢ãã£ã¦ããã¨èå¯ããã
è±æ°´ã¨åè硬åèªä½ã絡ã¿ãããã®ã§ããããã«ãã®é¢ä¿ã¯è¤éã§ããã使 é¤âè±æ°´âä½éæµã使 é¤âè¡å°æ¿æ©è½ä½ä¸âåè硬åãã¨ããããããã®é¢ä¿ã«å ãã¦ãè±æ°´âè¡ç®¡å
è±æ°´âã¢ã«ãã¹ããã³åæ³äº¢é²âåè硬åãã¨ãã£ãé¢ä¿ããè±æ°´âè¡ç®¡å
ç®æ©è½ä½ä¸âåè硬åã¨ãã£ãé¢ä¿ãããé常ã«è¤éã§ããã
å䏿½è¨ã§ãããã¨ãå
¨å¡ã«MRIãã¨ã£ã¦ããªããã¨ãçµé£éå¿ã¨ã³ã¼ãè¡ãªã£ã¦ããªã©ã®åé¡ã¯ããããæ¬ã±ã¼ã¹ã·ãªã¼ãºã§ã¯ANã¨è³æ¢å¡ã®é¢ä¿ã«ã¤ãã¦ã¯ããã¦è¨åã§ããè²´éãªå ±åã¨èãã¦ããã
ãçµè«ã
ANã®æ¥æ§ææ é¤ç®¡çã«ããã¦ãè³æ¢å¡çºçã®å¯è½æ§ã«çæããå¿
è¦ããããç¹ã«è»½å¾®ãªç¥çµæè¦ã診æã®å¥æ©ã¨ãªããããç
æ
ã¨ãã¦ã¯åè硬åã¨è±æ°´ã«èµ·å ããéååºç¶æ
ãèãããããã©ã¡ããæ é¤ãæ´ãããã¨ãåçºäºé²ã«éè¦ã§ããããè±æ°´ã«å¯¾ãã¦ã¯Refeedingçå群ã«ããæº¢æ°´ã«æ³¨æããå¿
è¦ããããä»å¾ãããªãçä¾ã®èç©ãæã¾ããã
ãè«æã§è§¦ããããªãã£ãç¹ã
è«æå
ã§ã¯è°è«ãè¤éã«ãªãé¢ä¿ããåæ°ã®é¢ä¿ã§è§¦ããããªãã£ãç¹ã2ç¹ããã
ã¾ãã2çä¾ã¨ãã«ç¥çµæè¦ã¯å¾®ç´°ãªãã®ã§ããã1çä¾ç®ã¯MRIãæ®ããªãã£ããTIAã¨ãã¦ããå¯è½æ§ã2çä¾ç®ã¯è§£é¢æ§é害ã®åä½µããã診æã«è³ããªãã£ãå¯è½æ§ããã£ããANã®å
¨èº«ç¶æ
ãæªãã¨ãã«ã¯å°æ´ç¥çµå·£çç¶ãè¦è½ã¨ãããããã¨ããããéå¸¸ã«æè²çãªçä¾ã§ãã£ãã¨èãã¦ããã
ããã«ãããã¯èªåã®å¦æ³ã«è¿ããã以åå·çãããæé£é害ã®ç¥çµå¿çæè¦ãã§ãè¿°ã¹ãããã«ãANæ£è
ã§ã¯ã»ããã·ããè½åãå¼±ããã ãããå¼·ããªããã¨ããããããã¯è³è¡ç®¡æ§èªç¥çæ£è
ã®æ§æ ¼å¤åï¼ãªããå
éåï¼ã«é¡ä¼¼ãã¦ããã¨æãããã¨ãããããããã£ãèè¡ãä½éæµãANæ£è
ã®ç¥çµå¿çæè¦ã®åãã説æã§ããå¯è½æ§ãããã¨èãã¦ãããããã«ã¤ãã¦ã¯åæ°ã®åé¡ããè°è«ãå®å
¨ã«è¦éããã¨ã¨ãããä»å¾æ¤è¨ãã¦ããããã
ã¾ãæ¬é¡ã®ã¤ã³ã¹ãªã³åæ
ã«ã¤ãã¦ããã¼ã¿åéãç¶ãã¦ããããã²ä¸çã«çºä¿¡ãæ²»çæ³ã«æ°ããªç¤ºåãä¸ãããã¨èãã¦ããã
(䏿æ ã2021.5.10.)
解説ãæé£é害è¨åºã®èºé²ã¸
ååã¨èåã®å¤è»¢ãç¹°ãè¿ãã®ã¯ããããã人é社ä¼ã®æ³åãªã®ã§ããããæ¿æ²»ã§ããç§å¦ã§ããããã¦å»çã§ããé«åº¦ãªä»äºã®è¿½ç©¶ã¯å°éååãä¿é²ããããã¯ãã¡ããããªãã®ææãä¸ãããã®ã®ãååãä¸å®ã®ã¬ãã«ãè¶
ããã¨éã«ã¿ãå²ãã®å¼å®³ã®æ¹ã大ãããªã£ã¦éã«èåã®æ¹åã«è»¢ãããããã¦ã¾ãã©ããã®æç¹ã§å°éååã«åããããã®å¤è»¢ãé·ãã¹ãã³ã§ç¹°ãè¿ãããã®ã人é社ä¼ã®æ´å²ã§ããã
ã ãå®è¨åºã«ããã¦ã¯ããã®å¤è»¢ã¯è¿
éã«ç¹°ãè¿ããããã¨ãå¿
è¦ã§ãããçç¶ã®ä¸é¨ã ããåãåã£ã¦ãããç²¾å¯ã«æ²»çãã¦ããããã§ã¯æ£è
ã¨ãã人éã®æ²»çã«ã¯ãªããªããã¨ã¯ãã°ãã°ããããã®åé¡ãå¦å®ã«ç¾ããã®ã¯ãç²¾ç¥çç¶ã¨èº«ä½çç¶ã®ä¸¡æ¹ãåé¡ã¨ãªãç
æ
ã§ãæé£é害ã¯ãã®ä»£è¡¨çç¾æ£ã§ãããä»ãæé£é害ã¯common diseaseã¨ãããã»ã©æ£è
æ°ãå¤ãç¾æ£ã¨ãªã£ã¦ããã«ãããããããç²¾ç¥ç§çæ²»çã¨èº«ä½ç§çæ²»çã®é©æ£ãªå°éååã¨èåã«åºã¥ããå»çãæ¨æºã«ãªã£ã¦ããã¨ã¯è¨ãé£ãã®ãæãå½ã®ç¾ç¶ã§ããã
ãããªç¶æ³ã®ä¸ã身ä½çã«éçãªæé£é害ã§ãã£ã¦ãç²¾ç¥ç§å»ãä¸å¿ã¨ãªãé«åº¦ãªç²¾ç¥çã»èº«ä½çæ²»çãè¡ã£ã¦ããæ°å°ãªãç
é¢ã®ä¸ã¤ãè¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§ã§ãããæ é¤ç¶æ
ã®æ¹åéç¨ã«ããããªãã£ã¼ãã£ã³ã°çå群ãããã¦é©åãªé£è¡åãé»å®³ããèªç¥ã®æªã¿ã¯ãã©ã¡ããæé£é害治çã«ãããéè¦ãªãã¼ãã§ããããä¸ã«ç´¹ä»ããäºã¤ã®è«æã¯ããããã«ã¤ãã¦åé¢ç¥çµç²¾ç¥ç§ã®è¹å±±ééé¨é·ã¨ä¸ææ å»å¸«(æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ã»ç¥çµç§å¦æå®¤å¤§å¦é¢å士課ç¨)ããæ¥å¸¸ã®è¨åºã®å®è·µãçºå±ãããè²´éãªå ±åã§ããã
è¹å±±è«æã«ã¯æé£é害ã®èº«ä½çæ²»çã«æåéã仿¥ããå½¹ç«ã¤ç¥è¦ãæå¿«ã«ç¤ºããã¦ãããä¸æè«æã«ã¯ããã«å ããæé£é害ã«ã¤ãã¦ããç¥ããã¦ããè¡åç¹æ§ã«è³ã®å¨è³ªæå·ãé¢ä¸ãã¦ããã¨ããé©ãã¹ãå¯è½æ§ã示åããã¦ããã䏿é¢çã¯è§£èª¬æã®ä¸ã§ãèªåã®å¦æ³ã«è¿ããã¨æ§ããã«è¿°ã¹ã¦ããããæ ¹æ ãã妿³ããã(ããã¯å¦æ³ã®å®ç¾©ã¨çç¾ããã)ãæ²»çæ¹æ³ã®åçãªå¤é©ã«ç¹ãããã¨ã¯å»å¦ã®æ´å²ã®ä¸ã«å»ã¾ããäºå®ã§ãããæ¬è«æã®ãã¼ã¿ã¯ã¾ãã«ãã®ãæ ¹æ ãã«ãªãããç»æçãªãã®ã§ããã
(ææ¾å¤ªéã2021.5.24.)
èªéçã¹ãã¯ãã©ã çè
ã®ä»å
¥ã«æé©ãªãããã
å½ç«ç²¾ç¥ã»ç¥çµå»çç ç©¶ã»ã³ã¿ã¼ãå
ç«¥ã»éå¹´æç²¾ç¥ä¿å¥ç 究室ã室é·ãçï¨åä¸Hirokazu Kumazaki, Taro Muramatsu, Yuichiro Yoshikawa, Yoshio Matsumoto, Hiroshi Ishiguro, Mitsuru Kikuchi, Tomiki Sumiyoshi, Masaru Mimura. Optimal robot for intervention for individuals with autism spectrum disorders. Psychiatry and Clinical Neuroscience. 74 , 581-586. doi: 10.1111/pcn.13132. 2020.
æè¿ã®æ¥éãªç§å¦æè¡ã®é²æ©ã«ãããããåããããã¯æ§ã ãªåéã«ããã¦æ´»èºãã¦ããç¾ç¶ããããæè¿ã®ã¨ããã³ã¹ã¯ï¼ãããããèªéçã¹ãã¯ãã©ã ç(ASD)è ã¸ã®æ¯æ´ã«ãå½¹ç«ã¤å¯è½æ§ã示åãã¦ãããASDè ã«ããã¦ã人éã®è¨ç·´å£«ããããããããã®æ¹ãã¿ã¹ã¯ã¸ã®éä¸ãé«ããã¨ãããè¦ããããASDè ã«ä½¿ç¨ããããããã®ç¨®é¡ãå½¢æ ã«ã¤ãã¦ã¯ãç¾å¨ã¾ã§æ§ã ãªæ¹æ³ã§æ¤è¨ããã¦ãããå¤è¦ãã·ã³ãã«ãªãããããåç©åããããã¯ããã®ã·ã³ãã«ãã¨ãæçãä¿ããã¨ããããåãå ¥ãããã¦ãããã¢ã³ããã¤ãããããã«ã¯ãããããã§è¨ç·´ããææãæ¥å¸¸çæ´»ã«æ±åããããå¯è½æ§ãããã¨ããå©ç¹ããããããããã¨ã¦ã¼ã¶ã¼ã®è¦ªåæ§ãèãããã¨ã¯ãããããä»å ¥ã®æ½å¨è½åãæå¤§éã«å¼ãåºãããã«éè¦ã§ãããããããå´ã®è¦å ã¨ãã¦ãå¤è¦ãéåãæè£ ã髪åãé ç½®ã¯éè¦ãªè¦å ã§ãããã¾ããå¹´é½¢ãæ§å¥ãç¥è½ææ°ãªã©ã®å©ç¨è å´ã®å åã¯ãã¦ã¼ã¶ã¼ã¨ããããã¨ã®è¦ªåæ§ã«ä¸ããå¯è½æ§ããããASDè ã®æ¯æ´è ã¯ãASDä»å ¥ã«ãããããããã®æ½å¨çãªå½¹å²ãç¥ããªãã£ãããæ°ãä»ãã¦ããªãã£ãããããæ¯æ´è ãããããã®ä½¿ç¨çµé¨ãè±å¯ã§ããã°ããã®çµé¨ã«åºã¥ãã¦ããããã®æ½å¨çãªå½¹å²ã®å¤ããç¹å®ãããã¨ãã§ãããããã¾ã§ã®ã¨ãããASDè ã¸ã®æ¯æ´ãç®çã¨ããããããã®ç ç©¶ã¯å°ãªãããã®ããã®æé©ãªãããããå®ç¾ããããã«ã¯ãä»å¾ãããªãç ç©¶ãå¿ è¦ã§ããã
(çï¨åä¸ã2021.4.1.)
解説ã䏿°å³ã®è°·ãè¶ãã¦
ASDè ãããããã«è¦ªåæ§ãæãããã¨ã¯ããç¥ããã¦ãããè¨å¤§ãªç ç©¶è«æããã§ã«åå¨ããããããããããã¨ã²ã¨ãã¨ã§è¨ã£ã¦ãå¤ç¨®å¤æ§ã§ãããã©ã®ãããªãããããASDè ä»å ¥ã«æé©ã§ãããã«ã¤ãã¦ã®ç ç©¶ã¯ã¾ã ã¾ã å°ãªããããããã«ããä»å ¥ã¯ã人éã¨ã®äº¤æµã®ããã®è¨ç·´ã«ä½ç½®ã¥ããããããã人éã«ä¼¼ãã¢ã³ããã¤ããããããæé©ã§ããã¨ããã¨ããã¾ã§ã¯æ³åã§ããããã¢ã³ããã¤ãããããã¨ãã£ã¦ããããã¾ãå¤ç¨®å¤æ§ã§ããã人éã«ä¼¼ã¦ããã°ä¼¼ã¦ããã»ã©ãããã¨ããã¨ãããåç´ã«ã¯ãããªããã䏿°å³ã®è°·ãã¨å¼ã°ããã䏿°å³ãªæ¦å¿µãããã䏿°å³ã®è°·ã¨ã¯ã人ãããããã«æããè¦ªåæ§ã®ç¨åº¦ã«ã¤ãã¦ã®çµé¨åã§ããã人éã«å ¨ãä¼¼ã¦ããªããããã«ãæ©æ¢°ã¨ããå¤è¦ã®ãããããããã人éã«ä¼¼ã¦ããããããã®æ¹ã«äººã¯è¦ªåæ§ãæã¤å¾åããããããã¾ã人éã«ä¼¼ããã¦ããã¨ããã£ã¦ä¸æ°å³ã«æãããã¦å¿é¿ãããããããçªãæãã¦å®å ¨ã«äººéãã®ãã®ã§ããã°è¦ªåæ§ã¯æé«åº¦ã«ãªããã¤ã¾ããæ¨ªè»¸ã«äººéã¨ã®é¡ä¼¼æ§ã縦軸ã«ãã®ããããã«æããããè¦ªåæ§ãã¨ãã¨ãã°ã©ãã¯å³ä¸ããã«ãªãããããå°ç¹ã§æ¥è½ãããããè¶ ããã¨æ¥ä¸æããããã®æ¥è½ããé¨åã䏿°å³ã®è°·ã§ãããASDè ã§ã¯ãã®ä¸æ°å³ã®è°·ãå³ã«ã·ãããããã®ã¾ã¾å䏿ããªããã¤ã¾ãã¢ã³ããã¤ãããããã«å¯¾ããè¦ªåæ§ã䏿°å³ãã®æè¦ãå®åçºéè ã¨ã¯ä¸ç¨®ç°ãªã£ã¦ãããããã«è峿·±ããã¨ã«ãASDè ã®è¦ªã«ãåæ§ã®å¾åãããããããã¾ãçï¨åä¸å®¤é·ãè«æã«è¨ãã¦ãã(Kumazaki et al: Impressions of humanness for android robot may represent an endophenotype for Autism Spectrum Disorders. J Autism Dev Disord 2017. DOI 10.1007/s10803-017-3365-0)ã
ãã®ããã«ASDã¨ããããã«ã¤ãã¦ãåºæ±ãã¤æ·±ãç ç©¶ãç¶ãã¦ããçï¨å®¤é·ããç¾å¨å©ç¨å¯è½ãªããããã«ã¤ãã¦ãASDè ã¸ã®ä»å ¥ã¸ã®é©æ§ã¨ãã観ç¹ããå ·ä½çã«è«èãå ããã®ãPCNã®æ¬è«æã§ãããããå®ç©ã®åçãã«ã¿ãã°çã«åè¼ããã¦ãããããããã仿¥ããå½¹ç«ã¤ããããå ¥éãã¨ã§ãè¨ãã¹ãèªã¿ããããã®ã¨ãªã£ã¦ãããããããã«ã¤ãã¦ã®è±å¯ãªè¨åºçµé¨ã«æ¯ããããåºç¤çã»çè«çä»äºããããã®ããã«é常ã«å®æ¦çãªä»äºã¾ã§å¹ åºãè«æãpublishãã¦ããçï¨å®¤é·ã¯ç¾å¨ãæ ¶æç¾©å¡¾å¤§å¦ç é¢ã§ã®ãããã夿¥ã®éè¨æºåãçã ã¨é²ãã¦ããã
(ææ¾å¤ªéã2021.4.28.)
çµ±å失調çå½äºè ã®çç¶è« ææ¾å¤ªé ç·¨èã2021å¹´2æ5æ¥çºè¡ãä¸å¤å»å¦ç¤¾
æ¬æ¸ã¯ãçµ±å失調çã¨ã¯ä½ããã¨ããåãã«çãããã¨ãããããããéå¿çãªæ¬ã§ããã
ç²¾ç¥çç¶ã¯å½äºè ã®èªãã®ä¸ã«ããã
ãããæ¬æ¸åºæã®ç¬¬ä¸æã§ããã
ç²¾ç¥ç¾æ£ã¯å®¢è¦³çãªææ¨ã«ä¹ãããç¾ä»£ã®ç²¾ç¥å»å¦ã«ããã診æãå½äºè
ã®èªãå
容ã主ããæ ¹æ ã«ãã¦ãã以ä¸ãçç¶ã¯å½äºè
ã®èªãã®ä¸ããè¦åºã以å¤ã«ãªããæ¬æ¸ã«åããããå®ä¾ã®å¤§é¨åã¯ãå½äºè
ã®èªçºçãªããã®èªãã§ããã
è¨åºã«ããã診å¯ã§ã¯ããããå½äºè
ã®èªç±ãªèªããéè¦ããå½¢ã§é²ãããã¨ãã¦ãã診å¯ãå»å¸«ã¨å½äºè
ã®å¯¾è©±ã«ãã£ã¦é²ãããããã®ã§ãã以ä¸ãããã«ã¯å»å¸«ããã®èªå°ã¨ããå´é¢ããããã¨ã¯å¦ããªãããã®èªå°ãããã¨ãå½äºè
ã®èªãã¯ç¾ä»£ã®ç²¾ç¥å»å¦ã®æ ã«è¦å®ããããã®ã«ã©ããã¦ãå¾ãã¦ãããç¾ä»£ã®ç²¾ç¥å»å¦ã確åºããæ£ç¢ºãªä½ç³»ã§ããã°ããã§ãããããã¾ã ã¾ã çºå±éä¸ã®ç²¾ç¥å»å¦ã®ä¸ã§ãçµ±å失調çã®çç¶è«ã¯ç¹ã«æªçãªã®ã§ããããããã®æ å
ã«è¦å®ãã¦ãã¾ããã¨ã¯è´å½çãªåé¡ã§ããã
æ¬æ¸ã®å®ä¾ã§ã¯èªå°ã¯æåéãçç¡ã§ããããã®ãããªèªãã®èéã¯ãã¤ã³ã¿ã¼ããããçºéããç¾ä»£ã«ããã¦åãã¦å¯è½ã«ãªã£ãæ¹æ³ã§ãããã¨ãç¹çãã¹ãã§ããããæ¬æ¸ã®æ°ããç¹ã¯ããã ããããããªãããããã ãã§ãçç¶è«ã¨ãã¦ã®æç¾©ã¯ãããã¦å¤§ããã¨èè ã¨ãã¦ã¯èãã¦ããã
ããã¯ãã¨ããããã®å¼ç¨ã§ãæ¬ã®ãªãã«ãè¨ããããæ¬æ¸ã®å¤§ããªç¹é·ã§ããã
æ¬ã®ãªãã«ã¯ãåºç社ã使ãã¦ãã ãã£ããã£ããã³ãã¼ã¨ãã¦ã®æç« ãè¨ããã¦ãããæ¬¡ã®éãã§ããã
å½äºè ããèªçºçã«å¯ããããè¨å¤§ãªçºè¨ãèéã»åé¡ããç²¾ç¥çç¶è«ã®åæ§ç¯ãå³ãå¯ä¸ç¡äºã®æ¸
åæ»ããçµ±å失調çã®è¨ºæå¦ã«æ¥ãæã¡è¾¼ãææ¬²ä½
ãå¯ä¸ç¡äºã®æ¸ããã©ããããæ¥ãæã¡è¾¼ãããã©ãããããã¯èªè
ãå¤å®ãããã¨ã§ããããå°ãªãã¨ããããç®æãã¦èããæ¸ã§ããã¨ã¾ã§ã¯èè
ã¨ãã¦ã¯ã£ããã¨è¨ããã¨ãã§ããã
ããã¦ãã®å¤§ããªã´ã¼ã«ã«åããæ¬æ¸ã®æ§æã¯ããããã¦ã·ã³ãã«ã§ãããç®æ¬¡ã¯ãã£ãããã ãã§ããã
1ç« ãå¹»è´è«
2ç« ãå¹»è¦è«
3ç« ã妿³è«
4ç« ãä»å¾è«
5ç« ã診æè«
ããã¦1ç« ã®åé ã¯ãã®èªãããå§ã¾ãã
æ©ãã¦ããã¨ã¿ããªç§ã®ãã¨ãè¦ã¦ãããã¤ã¯æ°æã¡æªãããæ»ããã¨ãè¨ã£ã¦ç¬ãã®ã§ããé»è»ã®ä¸ã§ãã¿ããªã®ç®ç·ããã£ã¡ãåãã¦ãã¦ãã½ãã½è©±ãã¦ãã¾ãã
ç²¾ç¥ç§è¨åºã§å½äºè
ããããèãããèªãã§ãããå¹³å¡ãªãã®ã¨ãã£ã¦ãããã§ããããããããã§ã¯ããã®ä½é¨ã¯å¹»è´ãªã®ããããã¨ãåãªãèªæèéå°ãªã®ããããã«ãã£ã¦ãã®ã±ã¼ã¹ã®è©ä¾¡ã¯å¤§ããç°ãªããDSM-5ã«ããã°å¹»è´ã¯ããå¹»è¦ã¯é®®æã§ãæ£å¸¸ãªç¥è¦ã¨åçã®å¼·ãã§ä½é¨ãããã¨å®ç¾©ããã¦ããããããã®å½äºè
ãããã話ãèããçµæã声ãã¯ã£ããã¨èãããããã§ã¯ãªãã¨è¨ãããã°ããã®ä½é¨ã¯å¹»è´ã§ã¯ãªããã¨ã«ãªããããã¨èªæèéå°ã«ãããªãã®ãããããã¯é¢ä¿å¿µæ
®ã¨ããç¨èªããã¦ãã¹ããã
ã¨ãããµãã«ãç¾ä»£ã®ç²¾ç¥å»å¦ç¨èªã«ãã ãããã¨ã§ãæ¬è³ªããé¸è±ããç¡ç¨ã«é¯ç¶ããè°è«ã«é¥ããçµ±å失調çã®çç¶ãè¦ããªããªã£ã¦ããã¨ããèãã®ãã¨ã«ãå¥ã®è¦ç¹ããã®çç¶è«ãææ¡ããã®ãæ¬æ¸ã§ããããã®å
·ä½çå
容ã¯ãã²æ¬æ¸ãæã«åã£ã¦ãèªã¿ããã ãããã1ç« ã®ãã¼ã¯ã¼ãã¯ãå¹»è´ç³»ãã¨ããé èªã§ãããçµ±å失調çã§ã¯è»½è¦ããã¦ããå¹»è¦ãããã¦ä¸ã¤ã®ç« ã¨ãã2ç« ãããã«ã¯å¹»è¦ã¨å¦æ³ã®å
±éã®åºç¤ã示ããã¨ãã3ç« ãçµã¦ãçµ±å失調çã®å
¨çç¶ã®çµ±ä¸ççè§£ãç®æããä»å¾ã¨ããæ¦å¿µã®4ç« ã«ç§»è¡ãã¦ãããæ¬æ¸ã§ããä»å¾ã¨ã¯ãæåã®ååã«å³¶å´ææ¨¹ãæå±ããã®ã¾ã¾åçµããã¦ããç¨èªãè§£åããç¥çµå¿çå¦ãã¯ããã¨ããç¾ä»£ã®ãã¥ã¼ããµã¤ã¨ã³ã¹ã¨ã®æ¥ç¹ã示ããæ¦å¿µã§ããã
ããã¦è¨ºæè«ã¨é¡ããæçµè«ã§å±éããã®ã¯ãå½äºè
ã®ããã¨ããè¦ç¹ããã®è¨ºæè«ã§ããã
å»å¦ã®å¾æ¥ã®è¨ºæè«ã«ã¯ãå½äºè
ã¸ã®ç´æ¥ã®æ
å ±æä¾ã¨ããè¦ç¹ãæ¬ å¦ãã¦ãããå»å¦ã¯å¸¸ã«çºå±éä¸ã®å¦åã§ããããã診æè«ãå½ç¶ã«å¸¸ã«çºå±éä¸ã§ãããç¾ä»£ã®è¨ºæåºæºããã¨ãã°DSMã¯ãé ãæªæ¥ã®ããæ´ç·´ããã診æä½ç³»ãè¦éã«å
¥ãããä»®ã®ä½ç³»ã«ãããªããã ãç¾ä»£ã®å½äºè
ã«ã¨ã£ã¦ã¯ãéè¦ãªã®ã¯é ãæªæ¥ã§ã¯ãªãç¾å¨ã§ããã診æåºæºã«éããç¾ä»£ã«ããã¦ã¯ãç ç©¶éä¸ã»çºå±éä¸ã®å»å¦çç¥è¦ããã¤ã³ã¿ã¼ãããã«ãã£ã¦ãªã¢ã«ã¿ã¤ã ã§å½äºè
ã«ä¼ããããããããã£ã¦è¨ºæè«ã¯ãå½äºè
ã¸ã®ç´æ¥ã®æ
å ±æä¾ãåæã¨ãã¦ã®è¨ºæè«ã§ãªããã°ãªããªãã
æ¬æ¸ã¿ã¤ãã«ã«ãå½äºè
ãã¨ããèªãå
¥ããæå³ã¯ãã²ã¨ã¤ã«ã¯ãç²¾ç¥çç¶ã¨ã¯å½äºè
ã®èªãã®ä¸ã«ãããã¨ã強調ããããã§ããããããä¸ã¤ã¯ãå½äºè
ã¸ã®æ
å ±ã¨ãã¦æå¹ãªçç¶è«ã§ãããã¨ãæå³ãã¦ããã
æ¬æ¸æ¬æã¯ããçµãã ã
å½äºè ã®çç¶è«ã¨ã¯ãéå»ã®ç¥è¦ãå°éããããã§ã®ãç¾å¨ã¨æªæ¥ã®å½äºè ã®ããã®è¨ºæè«ã«åºã¥ãçç¶è«ãæãã
(ææ¾å¤ªéã2021.3.26.)
人ã¸ã®å¼·å¶çãªå¾è¿½ãï¼æ°ããç°å¢ä¾åæ§ã®è¡å
è¹å±±éé (è¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§é¨é·)Michitaka Funayama, Taketo Takata.
Forced person-following: a new type of stimulus-bound behavior.
Neurocase 25, 2019 doi.org/10.1080/13554794.2019.1638944
ãä»ã¾ã§ã«å ±åããã¦ããç°å¢ä¾åçãªè¡åã
éå»ã«ãã¾ãã¾ãªå½¢ã®ç°å¢ä¾åçãªè¡çº/è¡åãããªãã¡ãæ¬è½æ§ææ¡åå¿ãéå
·ã®å¼·è¿«ç使ç¨/å©ç¨è¡åãæ¨¡å£è¡åãç°å¢ä¾åçå群ãåé¿è¨èªãå¼·å¶çãªå¼ç§°ãé³èªãªã©ãå ±åããã¦ããããããã®è¡çº/è¡åã¯åé èå
å´ãä¸å¿ã¨ããæå·ã«ãã£ã¦ãå¤é¨ç°å¢ããã®åºæ¿ã«ãããããªããã®ã¾ã¾åå¿ãã¦ãã¾ãåé èæ§ã®è§£æ¾ç¾è±¡ã¨ãã¦èª¬æããã¦ãããä»åããããã¯ä»ã¾ã§ã®å ±åã«ãªããå¼·å¶çã«äººãå¾è¿½ãããçåãå ±åããã
ã人ã¸å¼·å¶çã«å¾è¿½ããç¶ããçä¾ã
çä¾ã¯38æ³æã«ç·´çãç¨ããèªæ®ºã«ãã£ã¦ä¸é
¸åçç´ ä¸æ¯ããã®ä½é
¸ç´ è³çãèµ·ãããæ£è
ã§ãããè³ã®æå·é¨ä½ã¯ä¸¡å´åé èã両å´é é èã両å´å´é èãããã³ãããã®ç®è³ªä¸ãããã«ä¸¡å´ã®æ·¡è¼çã¨ä¸¡å´ã®å°¾ç¶æ ¸ã«åãã ãå¸å¼åå°ãªã©ã®åå§åå°ãç®ç«ã£ããã麻çºã¯ä¸è¢ã«è»½åº¦èªããã®ã¿ã§ããä¸è¢ã«ã¯éº»çºã¯èªãããçºç2ã¶æåå¾ã«ã¯æ©è¡ã¯èªç«ã§ããããã«ãªã£ããããããããã¨åæã«æ£è
ã¯è¦çã«å
¥ã£ã人ã«å¼·å¶çã«å¾è¿½ããããããã«ãªã£ããè¦çããé¢ããã¾ã§å¼·å¶çãªå¾è¿½ãã¯ç¶ããé·ãã¨ãã¯1æéã«ãåã¶ãã¨ããã£ããæ£è
ã¯åæã«ç°¡åãªåèªã®çè§£ãå°é£ãªé度ã®å¤±èªçãé度ã®è¦ç©ºéé害ï¼ã²ã¨ãã§èªå®¤ã«ã¯æ»ãããããã«æ¤
åã«èº«ä½ãæ£ããåããããã¨ãå°é£ï¼ãæå³è¨æ¶éå®³ï¼æ¥å¸¸ç©åãå®¶æãããèªèã§ããªãï¼ãåãã¦ãããçºç9ã¶æå¾ã«åå§åå°ã®è»½æ¸ã¨è¦ç©ºéé害ã®è»½æ¸ï¼èªå®¤ã«ã²ã¨ãã§æ»ããããã«ãªã£ãï¼ã¨ä¸¦è¡ãã¦ãå¼·å¶çãªäººã¸ã®å¾è¿½ãã¯æ¶å¤±ããã
ãé¡ä¼¼ããçåã¨æ³å®ãããæ©åºã
ãã®çåã¯ãã¬ãã§ã¦ã®çã¾ããã¦ã®ãããæåã«è¦ãçãç©ãå¾è¿½ãããããè¾¼ã¿ç¾è±¡ãä¹³å
ã®æ¯è¦ªã¸ã®å¾è¿½ãã«é¡ä¼¼ãããæ¬çä¾ã§ã¯åé èãåºåºæ ¸ã®ã¿ãªããå¾é¨è³ã大ããæå·ãããå¾é¨è³ã®æå·ãåæ ããé度ã®å¤±èªçãè¦ç©ºéé害ãæå³è¨æ¶é害ãä¼´ã£ã¦ããããããã£ã¦ãæ¬çä¾ã®å¼·å¶çãªå¾è¿½ã®æ©åºã¯åé èæå·ã«ããè§£æ¾ç¾è±¡ã§ã¯ãããã®ã®ãèªåã®å±
å ´æãå¨å²ã®ãã®ã®æå³ãå
¨ãåãããªãã¨ããç¶æ³ä¸ã§ãã£ããã¨ãå½±é¿ãã¦ãããã®ã¨èãããããããªãã¡ãããè¾¼ã¿ç¾è±¡ãä¹³å
ã®æ¯è¦ªã¸ã®å¾è¿½ãã¨åæ§ã«ãå¨å²ã®ç¶æ³ãåããããããã«åé èæ©è½ãä½ä¸ãã¦ããããã«äººã®å§¿ã®åºæ¿ã«å¯¾ãã¦ããããããªã追å¾ããç°å¢ä¾åçãªè¡åãæ¹èµ·ããããã®ã§ã¯ãªããã¨èãããããæ¬çä¾ã«è¦ããã人ã¸ã®å¼·å¶çãªå¾è¿½ãã¯ã人éã®æ¬è½çãªè¡åã®æ©åºã«ãã³ããä¸ããå¯è½æ§ãããã
(è¹å±±ééã2021.2.1.)
ã³ã¾ãæ§è»¸ç´¢æå·ä¾ã«èªããããaction slip
ï½ã飯ãã°ã©ã¹ã«ããããæºå¸¯é»è©±ãå·èµåº«ã«å
¥ããï½Scooping rice into a glass and putting a cell phone in the refrigerator: Action slips in an individual with a diffuse axonal injury
Cognitive Behavioral Neurology 2020; 33: 259â265ä¸å³¶ææ¥ä½³ãè¹å±±ééã䏿æºä¹
ãèæ¯ãå¥å¸¸è ã«ããã¦ããç ç³ã®ä»£ããã«å¡©ãã³ã¼ãã¼ã«å ¥ãã¦ãã¾ã£ãããæçã®å¾ã«ã¬ã¹ãæ¶ãå¿ãããããã¨ãã£ãç¡æèã«è¡ã£ã¦ããè¡çºã«åºç¾ãããã¹ãèªãããã¨ãããããããã®ãã¹ã¯æ³¨æé害ã¨ãã¦æãããããã¨ãå¤ãããè¡çºã®å´é¢ããã¯action slipã¨æããç«å ´ããããå¤å·æ§è³æå·ãã¯ããã¨ããå¾å¤©æ§è³æå·ã«ããã¦ã¯action slipãå¥å¸¸è ãããå¤çºãããã¨ãäºæ³ãããããä»ã¾ã§ã«å ±åã¯ãªããã¦ããªããããããéè¡æ©è½éå®³ãæ³¨æé害ãè¡çº/è¡åé¢ããæããaction disorganization syndromeã¨ããæ¦å¿µã«ãã£ã¦å¾å¤©æ§è³æå·ã®çç¶ã説æããå ±åããªããã¦ãããããããaction disorganization syndromeã¯ç°å¢ä¾åçãªè¡åãä¿ç¶ã注æé害ãªã©ããåºç¾ããè¡çº/è¡åã®é害ã®ç·ç§°ã§ãããç¹å®ã®çç¶ãæããçåã§ã¯ãªããä»åããããã¯ãã³ã¾ãæ§è»¸ç´¢æå·å¾ã«action slipã®ã¿ãå¤çºãã社ä¼çæ´»ãæ¥å¸¸çæ´»ã«åé¡ãçãã¦ããä¾ãæç¤ºãããªãããªãã¼ã·ã§ã³ã®æ¹æ³ã«ã¤ãã¦ãå ±åãããæ³¨æé害ã§ã¯ãªãaction slipã®æ¦å¿µãç¨ãããã¨ã§ãã³ã¾ãæ§è»¸ç´¢æå·å¾ã®çç¶ãããæç¢ºã«ãªãããªãããªãã¼ã·ã§ã³ã«ãã¤ãªããå¯è½æ§ã«ã¤ãã¦èå¯ããã
ãçä¾ã39æ³ã®ç·æ§ã交éäºæ ã«ã¦ã³ã¾ãæ§è»¸ç´¢æå·ãç½¹æ£ãä¿åçæ²»çãè¡ã£ããå ¥é¢æã®Glasgow Coma Scaleã¯10ã¨ä¸çåº¦ã®æèé害ãèªããããéåæ©è½ãæè¦ç³»ã«é害ã¯èªãããæèéå®³ãæ°æ¥ä»¥å ã«æ¹åããçºçï¼é±å¾ã«èªå® ã«éé¢ã¨ãªã£ãã復è·ããããã®ã®ãè·å ´ã§ã¯æ¸é¡ãç´å¤±ããããããã¹ãä»äºãå¿ããããæ©æ¢°ã®æä½ã§éè¦ãªã¹ããããçç¥ãã¦ãã¾ã£ããã¨ããã¹ãç¶çºããããã«è¾è·ãä½åãªãããããæ¥å¸¸çæ´»ã«ããã¦ãã飯ãããã£ã¦ããéã«æ¯åã«ã°ã©ã¹ãåã£ã¦ã¨è¨ãããã¨ãã«ã飯ãã°ã©ã¹ã«å ¥ãã¦ãã¾ã£ãããå·èµåº«ã«è²·ã£ã¦ãããã®ãå ¥ããéã«æºå¸¯é»è©±ãå·èµåº«ã«å ¥ãã¦ãã¾ã£ãããã¦ããï¼ç½®æã¨ã©ã¼ï¼ãã¾ããã³ã¼ãã¼ã«ãã«ã¯ãå ¥ããéã«ãã«ã¯ã®ãã±ãããéãã¦å®éã«ãã«ã¯ãå ¥ããåã«ãã±ãããã´ãç®±ã«æ¨ã¦ã¦ãã¾ã£ããããã³ã«ã©ãããããã¾ã¾ãã¼ã¹ã¿ã¼ã«å ¥ãã¦ãã¾ã£ãããå¤åºæã«æºå¸¯é»è©±ã財å¸ãå¿ãããç´å¤±ããããã¦ããï¼çç¥ã¨ã©ã¼ï¼ãç¥çµå¿çå¦çæ¤æ»ã§ã¯ãç¥è½ãè¡çºãã¨ãã½ã¼ãè¨æ¶ãã¯ã¼ãã³ã°ã¡ã¢ãªã注æ/éè¡æ©è½ã¯ãã¹ã¦æ£å¸¸ç¯å²ã§ãã£ãã䏿¹ã§ãaction slipãå«ãæ¥å¸¸çæ´»ä¸ã®è¡çº/è¡åã®å¤±æãè©ä¾¡ããã¹ã±ã¼ã«ã§ããCognitive Failures Questionnaireã§ã¯ãå¥å¸¸è ã¨æ¯è¼ãã¦å¤§ããªæç¸¾ã®ä½ä¸(å¥å¸¸è å¹³åãã-4.9 æ¨æºåå·®)ãèªããã
ããªãããªãã¼ã·ã§ã³ãç½®æã¨ã©ã¼ã«é¢ãã¦ã¯ãæ£è ãè¡ãè¡çºã使ç¨ããç©åãè¨èªåãããæå·®ã確èªãããããããã¨ã§ç¡æèã®è¡çºãæèåãã¦ã¨ã©ã¼æ°ãæ¸ãããã¨ã試ã¿ããçç¥ã¨ã©ã¼æ°ã«å¯¾ãã¦ã¯ãå¤é¨è£å©ã¨ãã¦ã¦ã¨ã¹ããã¼ãã使ç¨ãããã¯ã¤ã¢ã¬ã¹ã»ãã¼ã»ãã¡ã¤ã³ãã¼ãå°å ¥ããããã¦ç©ã®ç´å¤±ãé²ãã ããAI (artificial intelligence) ã¹ãã¼ã«ã¼ã«ãããªãã¤ã³ãã¼æ©è½ãããã«ã¯å¿ è¦ãªãã®ãæãä»ãããã®å ´ã§AIã¹ãã¼ã«ã¼ã«è©±ããã¨ã«ãã£ã¦è²·ãç©ãªã¹ãã使ãããããæ¹æ³ãç¨ããããã®çµæãCognitive Failures Questionnaireã®æç¸¾ã¯å¥å¸¸è å¹³åãã-3.1æ¨æºåå·®ã¾ã§æ¹åããã
ãèå¯ãã³ã¾ãæ§è»¸ç´¢æå·å¾ã«action slipã®ã¿ãæ®åããçä¾ãå ±åãããä»ã®ç¥çµå¿çæè¦ã¯ãã¹ã¦æ£å¸¸ç¯å²å ã§ãã£ããããæ¬çä¾ã«åºç¾ãã¦ããçç¶ã¯action slipã¨ãã¦æããã¨çè§£ããããã£ããæ¬çä¾ã«çãããããã®ãã¹ã¯ä¸è¬çã«ã¯æ³¨æé害ã¨ãã¦æãããããããªãããªã®è¦³ç¹ããã¯ãããããã¦ã³çã«å¸¸ã«è¡ãè¡çºã«æ³¨æãé ãããã«æ£è ã«æ±ãããã¨ã¯ä¸å¯è½ã§ãããããããããã ã¢ããçã«æããaction slipã®è¦³ç¹ããæ¤è¨ããã¨åããããããããªãã¡ãä¸è¬çãªaction slipã®æ©åºã¨ãã¦ãè¡çºã«é¢ãã¦ç¡æèã«åå¡ãããã¹ãã¼ãï¼ä¸é£ã®è¡çºãæ§æããã²ã¨ã¤ã²ã¨ã¤ã®åä½ã«é¢ããè¨æ¶ï¼ãååã«æ¹èµ·ã§ããªãããaction slipãçããã¨ããèãæ¹ããããç¡æèã§è¡ããã¦ããä¸é£ã®è¡çºã¯å¤æ°ã®åä½ã®éåã§ãããããã¹ãã¼ãã®æ´»æ§ãå¼±ãã¨ä¸é¨ã®åä½ã«çç¥ã¨ã©ã¼ãåºç¾ãã¦ãã¾ã£ãããç½®æã¨ã©ã¼ã§ä»£è¡¨ãããããã«å®¹æã«å¤é¨ããã®å¹²æ¸åºæ¿ã«åä½ãå½±é¿ããã¦ãã¾ã£ããããã®ãããããªããæ¬çä¾ã§å®æ½ããããã«ãæ´»æ§ãå¼±ãã¹ãã¼ããè£å ããããã«åä½ãæèåãããå¤é¨è£å©ãå©ç¨ããããããªã©ã®ãªãããªã¸ã®å¿ç¨ã«ã¤ãªããå¯è½æ§ããããæ¬çä¾ã¯ï¼ä¾ã®ã¿ã®æ¤è¨ã§ããã®ã§ãä»å¾ã¯ã³ã¾ãæ§è»¸ç´¢æå·ãã¯ããã¨ããå¾å¤©æ§è³æå·ã®å¤æ°ä¾ã«ããã¦action slipã®é »åº¦ãæ¥å¸¸çæ´»ä¸ã¸ã®å½±é¿ãããã«ã¯ãªãããªãã¼ã·ã§ã³ã®æ¹æ³ãæ¤è¨ãã¦ããããã
(è¹å±±ééã2021.2.10.)
解説ãæå³ã¨è¡åãæå³ãªãè¡åãæå³ãæ»ãè¡åã
ããããã----- ç°å¢ä¾åçå群ã¨ã¢ã¯ã·ã§ã³ã¹ãªãã -----
äººã¯æå³ããããã®æå³ã«åºã¥ãã¦è¡åãããæå³ã¯ç®çããçã¾ãããããè¡åã¯ç®çã®éæã«åãã¦é²ããããããããã¦äººã¯æ¥ã ã®çæ´»ãéã£ã¦ããã
ã ãæã¨ãã¦ãããªå¸¸èã¯ãã£ããã¨å´©ãããäººã¯æå³ãªãè¡åãåããã¨ãããããããè¡åããããã«ã¯æå³ããã£ãã¯ãã ã¨èããã®ãæ®éã ããç¾ã«è³å
ã«æå³ããã£ãããããè¡åãçºçããã¯ãã ããæ¬äººã«ã¯æå³ããã¨ããæèããªããã¨ããããååã®åå°çè¡åã¯ç¡æèçãªãã®ã ããæ¯æ¥ã®ç¿æ
£çè¡åãç¡æèçã«è¡ããã¦ãããã¨ãå¤ã
ããã
ã¾ããè¡åéå§ã®æã«ã¯ç¢ºãã«æå³ãã¦å§ããã¨ããæèããã£ã¦ããããã«ç¶ãä¸é£ã®è¡åã¯ç¡æèã«é²è¡ãããã¨ããã°ãã°ããããããéã«æèããã¨ããã¡ãªãè¡åã«ãªãå ´åã®æ¹ãå¤ãã¨ãè¨ãããããã¯ããªãã¡ãè³å
ã«ãã§ã«è¡åã®ã¹ãã¼ãschemaãåå¨ãã¦ãããè¡åããã¨ããæèçãªæå³ã¯ããã®ã¹ãã¼ãçºåã®ã¹ã¤ããã«ãããªãã¨è§£éããæ¹ã妥å½ã§ãããã
ã¹ãã¼ããåãªãè§£éã§ã¯ãªãè³å
ã®äºå®ã§ããã¨å®æã§ããã®ã¯ãè³ãæå·ãããæå³ããã¯åé¢ãããè¡åãç¾ããæã§ããããã ãããã¯ä¸è¦ä½æ°ç¡ãçç¶ã®ä¸ã«æ¬è³ªãè¦æãéãè¨åºç観å¯ç¼ããã£ã¦åãã¦è¦ãã¦ãããã®ã§ãããè¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§è¹å±±é¨é·ã®2ã¤ã®ã±ã¼ã¹ã¬ãã¼ãã¯ã¾ãã«ãããå
·ç¾ããä»äºã§ããã
第ä¸ã¯ã大è³ã®åºæ±ãªæå·å¾ã«äººã¸ã®å¼·å¶çãªå¾è¿½ããç¾ããã±ã¼ã¹ã§ãããè¹å±±é¨é·ã¯ãã®çç¶ãç°å¢ä¾åçå群ã®ä¸ã¤ã¨ãã¦æãããç°å¢ä¾åçå群ã¨ã¯ã1986å¹´ã«Lhermitteãè¨è¼ãããã®ã§ãæåéãã®æå³ã¯ãç°å¢ã®cueã¸ã®éå°ãªåå¿ãã§ãããå
·ä½çã«ã¯ãç®ã®åã«ç©ãæç¤ºãããã¨ãããããããã使ç¨ããã¨ããå½ä»¤ã«èªåçã«å¾ããã®ããã«è¡åããã¨ããçç¶ãæããå®ä¾ã¨ãã¦ãé¡è£
ãããçµµãè¦ãã¨å£ã«éãæã£ã¦æ¶ãã¦ãã¾ãã»ããããè¦ãã¨æãè±ãã§ããã«å¯ã¦ãã¾ãããªã©ã®é常ã«å°è±¡çãªä¾ãLhermitteã®è«æã«åçã¨ã¨ãã«ç´¹ä»ããã¦ãããããããåé èæå·ã®ã±ã¼ã¹ã§ãåé èã®é害ã«ãã£ã¦å¾é¨è³ã«åå¨ããã¹ãã¼ããè§£æ¾ãããç¾è±¡ã§ããã¨èå¯ããã¦ãããè¨ãæããã°ãæ¬æ¥ã¯æå³ã«ãã£ã¦çºåãããè¡åããç°å¢ã®cueã«ãã£ã¦çºåãããã¨ãããã¨ã§ãæå³ãªãè¡å=èªå¾æ§personal autonomyã®é害ã§ããã¨è¨ããã
è¹å±±é¨é·ãå ±åããã人ãè¦ãã¨å¾è¿½ãããã«ããããªããã¨ããçç¶ããç°å¢ã®cueã«ãã£ã¦çºåãããæå³ãªãè¡åã¨ããæå³ã§ã¯ç°å¢ä¾åçå群ã®ä¸åã«åé¡ãããã¨ãã§ãããããã®ç¨ãªçç¶(ããããä¸çåã«å ±åãããçç¶)ãè¦ãããã®ã¯ãè¹å±±é¨é·ã®è§£èª¬ã«è¨ããã¦ããããã«ããã®ã±ã¼ã¹ã§ã¯åé è以å¤ã®è³é¨ä½ãæå·ããã¦ãããã¨ãé¢ä¿ãã¦ããã®ã§ããããããã¦Lhermitteã®å ±åã¨æ ¹æ¬çã«ç°ãªãç¹ã¯ãåç©ã®å¹¼çä½ã«è¦ããã親ã追ãã¨ããæ¬è½çãªè¡åãåç¾ããã¦ããã¨ããç¹ã§ãããè³å
ã®è¡åã¹ãã¼ãã®ä¸ã«ã¯ãå
天çãªãã®ã¨å¾å¤©çãªãã®ãæ··å¨ãã¦ããã¨èããããããè¹å±±é¨é·ã®ã±ã¼ã¹ã§è¦ãããã®ã¯å
天çãªã¹ãã¼ãã§ãããã¯åé èæ§ã®åå§åå°ããã髿¬¡ãªå½¢ã§ç¾ãããã®ã¨æãããã¨ãå¯è½ã§ããã
第äºã®ã±ã¼ã¹ã¯ãã³ã¾ãæ§è»¸ç´¢æå·å¾ã«è¦ãããã¢ã¯ã·ã§ã³ã¹ãªããã§ããã
ã飯ãã°ã©ã¹ã«ããã£ã¦ãã¾ã£ããï¼ç½®æã¨ã©ã¼ substitution errorsï¼ãæºå¸¯é»è©±ã財å¸ãå¿ãããï¼çç¥ã¨ã©ã¼ omission errorsï¼ã¨ããçç¶ã¯ãéç¹ç°çãªæ³¨æé害ã¨ãã¦è¦éãããã¦ãã¾ãããã ãããã®ã±ã¼ã¹ã§ã¯æ³¨ææ©è½ã«é¢ããç¥çµå¿çå¦çæ¤æ»æç¸¾ãæ£å¸¸ã§ãããã¨ãããã¦ä½ããç²¾å¯ãªè¨åºè¦³å¯ã«ãããåãªã注æé害ã§ã¯ãªãã¢ã¯ã·ã§ã³ã¹ãªãããããªãã¡ãè³å
ã¹ãã¼ãã®çºåé害ã§ããã¨è¹å±±é¨é·ã¯æ¨æ¸¬ãããã®æ¨æ¸¬ã«åºã¥ãã¦è¨ç»ã»å®è¡ããèªç¥ãªãããªãã¼ã·ã§ã³ã®å¹æã«ãã£ã¦ãæ¨æ¸¬ãæ£ãããã¨ãè£ã¥ããããã®ã±ã¼ã¹ã«è¦ãããè¡åã¯ãæ¬äººã®æå³ã«ãã£ã¦ããé¨åããããã®ã®ãç°å¢ããã®cueã«ãã£ã¦æ¹ä¹±ããã¦ã¨ã©ã¼ã«è³ã£ã¦ãããããã°æå³ããæ»ã£ã¦é¸ããå½¢ãåã£ã¦ããã¨ããæå³ã§ãã¢ã¯ã·ã§ã³ã¹ãªããã¨ãã表ç¾ã«ã¾ãã«åè´ãããã®ã§ããã
ã¢ã¯ã·ã§ã³ã¹ãªããã¯ãå
ã
ã¯ããã¤ãã®ç¡æèè«(ããã¤ãç失è¨: æããæ¬é³ãåºã¦ããslip)ããçºå±ããæ¦å¿µã§ãããå¨ç¥ã®éãããã¤ãã¯ãããç²¾ç¥åæçã«èª¬æãã¦ããããè¹å±±é¨é·ã®ã±ã¼ã¹ã¯ç½è³ªæå·(ã³ã¾ãæ§è»¸ç´¢æå·)ã«ãã£ã¦ãè¡çºã«é¢ããã¹ãã¼ããããã«ã¯æèåãããªãã¬ãã«ã®ã¤ã¡ã¼ã¸ãæ¹èµ·ããããããªã£ã¦ããã¨èããããããã®çç¶ã¯æ¥å¸¸å ´é¢ã®è¡åã®ä¸ã«ã¯ã£ããã¨ããå½¢ã§è¦³å¯ã§ãããã®ãªã®ã§ãå¤å·æ§è³æå·ã®ã²ã¨ã¤ã®ææ¨ã«ãªãããã¨è¹å±±é¨é·ã¯èå¯ãã¦ããã
第ä¸ã®å¼·å¶å¾è¿½ãç¾è±¡ã¯é常ã«é¡èãªçç¶ã§ãã£ãã®ã«å¯¾ãã第äºã®ã¢ã¯ã·ã§ã³ã¹ãªããã¯ã¤ãå¹³å¡ãªçç¶(åãªããã£ãããã¹)ã¨ãã¦è¦éãããããªçç¶ã§ãã£ãã両æ¹ã®ã±ã¼ã¹ã«å
±éããã®ã¯ãæå³ã¨è¡åãçµã¶ã¡ã«ããºã ãããã¦æå³ã¨ç°å¢ã®é¢ä¿ã«ã¤ãã¦ã®ã¡ã«ããºã ããçç¶ã®ä¸ã«ç«ã¡ç¾ãã¦ãããã¨ã§ããã
ãããè¦æãããã«ã¯ä¸¦å¤ãã¦éãè¨åºè¦³å¯ç¼ãå¿
è¦ã§ããããè«æåããã«ã¯ããã«å ãã¦ä¸æä¸å±ã®åªåãå¿
é ã§ãããçä¾å ±åãè«æã¨ãã¦åçããã«ããã®ãè¿å¹´ã®å»å¦çã®å¾åã§ãããã¨ã¯ããç¥ããã¦ãããå¤ãã®è¨åºå®¶ã¯è²´éãªã±ã¼ã¹ã«åºé¢ãè«æåãå¿ãã¦ããªã¸ã§ã¯ããç¹°ãè¿ããã¦æç¨¿ãæå¿µãããããããã¯ããããè«æåãããã¨ããæå³ãæã¨ãã¨ããªããç°å¢ä¾åçå群ã¨ãã¦ã®å¾è¿½ãè¡åã¨ã³ã¾ãæ§è»¸ç´¢æå·ã«è¦ãããã¢ã¯ã·ã§ã³ã¹ãªããã¯ã©ã¡ãããè¹å±±é¨é·ä»¥å¤ã§ã¯ã¾ãéæã§ããªããããã ãã«è¨ãç¥ããªã価å¤ãæã¤è¨åºå ±åã§ããã
(ææ¾å¤ªéã2021.2.27.)
çµé èç£æ°åºæ¿æ³ãç¨ããã¢ã«ããã¤ãã¼åèªç¥çåã³è»½åº¦èªç¥é害ã®ç¥çµççå¦çãã¤ãªãã¼ã«ã¼ï¼ã¬ãã¥ã¼ã¨ã¡ã¿è§£æ
䏿æ (æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ã»ç¥çµç§å¦æå®¤ã大å¦é¢å士課ç¨)Mimura Y, Nishida H, Nakajima S*, Tsugawa S, Morita S, Yoshida K, Tarumi R, Ogyu K, Wada M, Kurose S, Miyazaki T, Blumberger DM, Daskalakis ZJ, Chen R, Mimura M, Noda Y*. Neurophysiological biomarkers using transcranial magnetic stimulation in Alzheimerâs disease and mild cognitive impairment: A systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews 121: 47-59, 2021.
Transcranial magnetic stimulation (TMS)ã¯ã³ã¤ã«ãå©ç¨ãã黿°åºæ¿ã«ããããã®è³ç®è³ªãåºæ¿ããããããå¾ãããèªçºé»ä½ããéåéã®è奮æ§ãè©ä¾¡ãããã¨ãã§ãããSingle pulse paradigm(åååºæ¿)ã§ã¯éåéã®GABA/Glutamateæ©è½ãåæ ããè奮æå¶ãã©ã³ã¹ã®ææ¨ã§ãããResting motor threshold(RMTãå®éæéåé¾å¤)ããPaired pulse paradigm(è¤æ°ååºæ¿)ã§ã¯äºåã®åºæ¿ã®çµã¿åããã§å¾ãããèªçºé»ä½ãè©ä¾¡ãããã¨ã§GABA-Aãåæ ããç®è³ªã®æå¶æ©è½ Short interval intracortical inhibition (SICI)ãGlutamateãåæ ããè奮æ©è½ intra cortical facilitation(ICF)ãã³ãªã³ãåæ ããæå¶æ©è½Short latency afferent inhibition(SAI)ãè¨æ¸¬ã§ãããããã«é »ååºæ¿ã«å¯¾ããåå¿ãã¿ããã¨ã§è³ç®è³ªã®å¯å¡æ§ãè©ä¾¡ãããã¨ãã§ããã
ä»åãæã
ã¯ADæ£è
ããã³MCIæ£è
ã«å¯¾ãã¦TMSãç¨ããç®è³ªè奮æ§ã®ææ¨ãã©ããªã£ã¦ããããå
æ¬çãªã¬ãã¥ã¼ã¨ã¡ã¿è§£æãè¡ã£ãã
çµæã¨ãã¦æçµçã«37æ¬ã®è«æãããã¼ã¿æ½åºãè¡ã£ãã
è§£æã®çµæãAD群ã§ã¯RMT/SICI/SAIãææã«æ¸ãã¦ãããã¨ãããã£ããããã«MCI群ã§ã¯RMT/SAIãæ¸ãã¦ãããã¨ãããã£ããAD群ã§ã¯ICFã¯æ¸ãã¦ããå¾åãè¦ããããææã§ã¯ãªãã£ããèªç¥æ©è½ã¨ãããææ¨ã¨ã®ç¸é¢ã¯è¦ãããªãã£ãã
以ä¸ãã¾ã¨ããã¨æ¬¡ã®ãã¨ããããã
AD群åã³MCI群ã§ã¯éåéã®è奮æ§ãé«ããã¨ãããã£ããéåçç¶ãç®ç«ããªãADã§ãMCIã®æ®µéããéåéã®è奮æ§å¤åã示ããããã¨ã«æç¾©ããããã¾ãAD群åã³MCI群ã§ã¯SAIãæ¸ãã¦ãããã¨ããã³ãªã³æ©è½ãæ¸ãã¦ãããã¨ã示åããããããã¯å®è¨åºã§ãã§ã«ç¢ºèªããã¦ããéãã§ãããéè¦ã§ãã£ãã®ã¯AD群ã«ããã¦SICIãæ¸ãã¦ãããã¨ããGABAæ©è½ãæ¸ãã¦ãããã¨ã示ãããç¹ã§ãããããã«ã¤ãã¦ã¯GABAå容ä½ä½åè¬ãèªç¥æ©è½ã«ä¸ããå½±é¿ã«ã¤ãã¦çµ¡ããªããèå¯ãããä¸è¬çã«ã¯GABAå容ä½ä½åè¬ã¯èªç¥çã«ã¯å¥½ã¾ããªãããGABAæ©è½ãæ¸ãã¦ãããã¨ããã¯ä¸é¨ç ç©¶ã§ç¤ºåããã¦ããGABAå容ä½ä½åè¬ã®ç¥çµä¿è·ä½ç¨ãæ¯æããå¯è½æ§ããããããããªããç¥çµå¯å¡æ§ã«ã¤ãã¦ã¯ç ç©¶æ°ãå°ãªãã¡ã¿è§£æã¯ã§ããªãã£ããAD群å
¨ä½ã¨ãã¦å¯å¡æ§ãè½ã¡ã¦ããã¨ããç¥è¦ã§ä¸è´ãã¦ãããããã¯ä»å¾ã®ä»å
¥ç ç©¶ãåå¾©ç£æ°åºæ¿ã«ããå¯å¡æ§ã®èªå°ãä¸å¿ã¨ãã¦ãã趨å¢ã«ä¸è´ããã
MCIæ£è
ã«ã¤ãã¦ã®çµæãMCIãããã¦ADã¸ã¨é²å±ãã¦ããéç¨ãè¦ã¦ãããã¨ã«çç¾ã¯ããªãã£ãã
èªç¥æ©è½ã¨ç¥çµççææ¨ã¨ã®ç¸é¢ã«ã¤ãã¦ã¯æ®å¿µãªããææãªçµæã¯ãªãã£ãããããã¯éåéã®ç ç©¶ã§ãããã¨ã主ãªåå ã¨èãããããä»å¾ã¯åé åéã«å¯¾ããTMSåºæ¿ãããã¦ãã®ã¢ã¦ããããã¨ãã¦è³æ³¢ãè§£æããTMS-EEGæ³ãADãMCIã®ãããªãç®è³ªæ©è½çè§£ã«å¿
è¦ã§ããã
ä»åã®çµæããã£ã¦ãç¾å¨é²ãã¦ããTMS_EEG-MCIç ç©¶ã«éé²ããæåã§ããã
(䏿æ ã2021.1.1.)
解説ãçµ±åããTMS
ã¾ãã¯åè§£ããããããç§å¦ã®å®æ³ã§ãããåè§£ããªããã°åæã§ããªãããã ããã®ã¨ããæ±ºãã¦åè§£ããåã ã®è¦ç´ èªä½ãéè¦ã ã¨èãã¦ããããã§ã¯ãªãããè¦ç´ ãçµã¿åãããã°å ã®å ¨ä½ãå¾ãããã¨èãã¦ããããã§ããªãããããåè§£ããªããã°åæã§ããªã以ä¸ãç¬¬ä¸æ©ã¨ãã¦ã¯åè§£ãã以å¤ã«ãªãããããæ£ããã¨èª°ããèããããããç§å¦ã®å®æ³ã«ãªã£ã¦ããã®ã§ãããå ¨ä½ãè¦éã«å ¥ããã®ã¯è¦ç´ ã«ã¤ãã¦ã®ååãªç¥è¦ãå¾ããã¦ããããããã«ãã¨ããããã ãã ãææ®µãå¾å¾ã«ãã¦ç®çã¨ãªã£ã¦ãã¾ãã®ã人ã®å¸¸ã ãè¦ç´ ãç§å¦çã«æ£ç¢ºã«åæãããã¨ããã°é«åº¦ã«å°éçãªæè¡ãè¦ããã¨ããäºæ ããã£ã¦ãçå®è¿½ç©¶ã®æå¿ãå¼·ãç ç©¶è ã»ã©è¦ç·ãè¦ç´ ã«åºå®ãããå¾åãæ¢ã¾ããªãããããã¦ãç²¾å¯ãã¤éè¦ã§ã¯ãããã®ã®ããã¤ã©ãã§å½¹ã«ç«ã¤ã®ãããããªããããªãã¼ã¿ãè«æã¨ãã¦æ¬¡ã ã«çºè¡¨ãããç§å¦çã«é«ãè©ä¾¡ã¯å¾ããã®ã®ããã¼ã¿èªä½ã¯åºæãã«ãªã£ãã¾ã¾æãéãã¦ããã¨ããäºæ ãèµ·ãããã¡ã§ãããç¹ã«èªç¥çã®ãããªããã¾ãå ¨äººé¡ã«ã¨ã£ã¦ã®å¤§ããªèª²é¡ã«ã¤ãã¦ã¯ãããããåéã®å°éå®¶ãç ç©¶ã«å¾äºãããã¨ããããã®ãããªäºæ ãèµ·ããããããç¾ã«ç¸äºã®é¢ä¿æ§ãè¦ãã«ããéå¤ãª ----- ã¨è¨ã£ãã失礼ã ãéå¤ã«ããè¦ããªããã㪠----- ç¥è¦ãèç©ããã¦ããã
TMSã¯ãããªç¥è¦ãçµ±åã§ããå¯è½æ§ãç§ãã¦ããããã¼ã¯ã¼ãã¯ç®è³ªè奮æ§ã§ãããããã«çç®ãã䏿æ 大å¦é¢çããæ§ã ãªé åã®ç ç©¶ãã¼ã¿ãçµ±åãããææ³ã§ããTMSã«ããç ç©¶è«æããããã«çµ±åããã¡ã¿è§£æã«ãã£ã¦å¾ãã®ã¯ãMCIããADã¸ã®çºå±ã¨ãããé«é½¢ç¤¾ä¼ã«ãããæéè¦ã¨ãè¨ããåãã¸ã®åçã«è²¢ç®ãããã¼ã¿ã§ãã£ãã
TMSã«ã¯å¼·åãªçµ±ååãæ½å¨ãã¦ããããéåéã®ã¿ã«çç®ããæ¬ç ç©¶ã§ã¯ããã®çµ±ååã®ä¸é¨ã示ãããã«ãããªããä»å¾ãçç®ããè¦ç´ ãæ¡å¤§ãããã¨ã§ã壮大ãªçµ±åç ç©¶ã¸ã®éãéãã¦ããããã®ããå ã«ã¯æ²»çããããå¤ãã®å»å¦è«æã®çµã³ã«ã¯future directionã¨ãã¦æ²»çæ³ã®éçºã¸ã®æå¾ ãè¨ããã¦ããããå¤ãã®å ´åã«ããã¯å½¢éª¸åããæ±ºã¾ãæå¥ã«ãããªããTMSã¯ãã®ç¹ã大ããç°ãªããè³ã«ç´æ¥ä»å ¥ããTMSã¯ãå ·ä½çãã¤éãããªã¬ãã«ã§ã確ãã«æ²»çæ³ã®éçºã«ç´çµãã¦ãããTMSã«éé²ããã¨å®£è¨ãã䏿é¢çã®ç ç©¶ã¸ã®æå¾ ã¯å¤§ãããèªç¥çããã¼ãã§ãã以ä¸ãããã¯å ¨äººé¡ããã®æå¾ ã§ããã
(ææ¾å¤ªéã2021.1.25)
å¥å¸¸è
ã対象ã¨ãããã¼ããã³ç¥çµä¼éã®æå¸¸æ§ç¶æã«é¢ããPETç ç©¶
å±±æ¬ä¿å¤© (æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ã»ç¥çµç§å¦æå®¤ 大å¦é¢åå£«èª²ç¨ / å½ç«ç ç©¶éçºæ³äººãéåç§å¦æè¡ç ç©¶éçºæ©æ§ãéåå»å¦ã»å»çé¨é æ¾å°ç·å»å¦ç·åç ç©¶æãè³æ©è½ã¤ã¡ã¼ã¸ã³ã°ç ç©¶é¨ãè³ç¾æ£ãã©ã³ã¹ã¬ã¼ã·ã§ãã«ç ç©¶ãã¼ã )Yamamoto Y, Takahata K, Kubota M, Takano H, Takeuchi H, Kimura Y, Sano Y, Kurose S, Ito H, Mimura M, Higuchi M.
Differential associations of dopamine synthesis capacity with the dopamine transporter and D2 receptor availability as assessed by PET in the living human brain.
Neuroimage. 2020; 226: 117543.
ãã¼ããã³ï¼DAï¼ç¥çµä¼éã¯ãéåå¶å¾¡ãå ±é ¬æ¢ç´¢è¡åãåæ©ã¥ããªã©ã®è³æ©è½ã«é¢ä¸ãããããã«ãç·æ¡ä½ã«ãããDAç¥çµä¼éã®ç°å¸¸ã¯ãçµ±å失調çãæ°åé害ãªã©ã®æ§ã ãªç²¾ç¥ç¾æ£ããã¼ãã³ã½ã³ç ãªã©ã®ç¥çµç¾æ£ã®ç æ ççã«é¢ä¸ãã¦ãããã¨ãç¥ããã¦ãããæç²¾ç¥ç è¬ã¯ãD2å容ä½é®æä½ç¨ãä»ãã¦ç²¾ç¥ç çç¶ã«å¹æããããããã¨ãç¥ããã¦ãããDAãã©ã³ã¹ãã¼ã¿ã¼é»å®³è¬ãDAä½åè¬ãªã©ã·ããã¹ééã®DAæ¿åº¦ã䏿ãããè¬å¤ã¯ãå¹»è¦ã妿³ãªã©ã®ç²¾ç¥çç¶ãèªçºãããã¨ãå ±åããã¦ããããã®ããã«ãDAç¥çµä¼éãé©åãªã¬ãã«ã«ç¶æãããã¨ã¯ã極ãã¦éè¦ã§ããã¨èãããããå®éã«ãè¬çå¦çä»å ¥ãä¼´ãéå»ã®PETç ç©¶ã§ã¯ãDAç¥çµä¼éã®æ§æè¦ç´ ãç¸äºã«é¢é£ãã¦ãDAç¥çµä¼éãæå¸¸çã«ç¶æããã¦ããå¯è½æ§ã鿥çã«ç¤ºåããã¦ãããä¾ãã°ã6-[18F]Fluoro-L-Dopaãç¨ããéå»ã®PETç ç©¶ã§ã¯ãå¥å¸¸è ã«DAãã©ã³ã¹ãã¼ã¿ã¼é»å®³å¤ã§ããã¡ãã«ãã§ããã¼ããååæä¸ããã¨ãDAçæè½ã22ï¼ æ¸å°ãããã¨ãå ±åããã¦ãããDAçæè½ã¨DAãã©ã³ã¹ãã¼ã¿ã¼å¯åº¦ã¨ã®é¢é£æ§ã示ããã¦ãããããããªãããDAç¥çµä¼éã®çæè½ãå容ä½ããã©ã³ã¹ãã¼ã¿ã¼ãªã©ã®æ§æè¦ç´ ãç¸äºã«é¢é£ãã¦æå¸¸çã«DAç¥çµä¼éãç¶æããã¦ããæ©æ§ã¯ããã¾ã§æããã«ããã¦ããªãã£ããæ¬ç ç©¶ã§ã¯ãå¥å¸¸è ã®ç·æ¡ä½ã«ãããDAçæè½ã¨DAãã©ã³ã¹ãã¼ã¿ã¼ããã³D2å容ä½å¯åº¦ã¨ã®é¢é£ã調ã¹ããã¨ãç®æããã
æ¬ç ç©¶ã§ã¯ãéç æ©æ§ã«ã¦éå»ã«è¡ãããç ç©¶ã§åå¾ãããPETãã¼ã¿ãç¶²ç¾ çã«åéããåè§£æãè¡ã£ããã¾ããL-[β-11C]DOPA- PETæ¤æ»ã¨[18F]FE-PE2I- PETæ¤æ»ã¨ã忥ã«åããå¥å¸¸ç·æ§12å(24.5 ± 4.6æ³)ã®ãã¼ã¿ãç¨ãã¦ã被殻ã¨å°¾ç¶æ ¸ã«ãããDAçæè½ã¨DAãã©ã³ã¹ãã¼ã¿ã¼å¯åº¦ã¨ã®é¢é£ã調ã¹ãããã®çµæã被殻ã«ãã㦠DA çæè½ã¨ DA ãã©ã³ã¹ãã¼ã¿ã¼å¯åº¦ã¨ã®éã«ææãªæ£ã®ç¸é¢ãèªãããããæ¬¡ã«ãL-[β-11C]DOPA-PETæ¤æ»ã¨[11C]raclopride-PETæ¤æ»ã¨ã忥ã«è¡ã£ããå¥å¸¸ç·æ§29å(25.2 ± 3.8æ³)ã®ãã¼ã¿ãç¨ãã¦ãDA çæè½ã¨ D2 å容ä½å¯åº¦ã¨ã®é¢ä¿ãæ¤è¨ããããã®çµæãç·æ¡ä½ã«ãã㦠DA çæè½ã¨ D2 å容ä½å¯åº¦ã¨ã®éã«ææãªç¸é¢ã¯èªããããªãã£ãã
æ¬ç ç©¶ã«ããå¾ããããå¥å¸¸è ã«ãããDA çæè½ã¨ DA ãã©ã³ã¹ãã¼ã¿ã¼å¯åº¦ã¨ã®æ£ã®ç¸é¢ã¯ãDAãã©ã³ã¹ãã¼ã¿ã¼å¯åº¦ã«å¯¾ããDAçæè½ã®æ¯çãä¸å®ã®ã¬ãã«ã§ç¶æããã¦ãããã¨ã示ããDAçæè½ã¨DAãã©ã³ã¹ãã¼ã¿ã¼ã¨ãé¢é£ããã·ããã¹ééã®DAæ¿åº¦ãæå¸¸çã«ç¶æãã¦ããå¯è½æ§ã示åãã¦ãããã¾ããå¯¾ç §çã«ãDA çæè½ã¨ D2 å容ä½å¯åº¦ã«ã¯ææãªç¸é¢ãèªããªãã£ããã¨ããã¯ãã·ããã¹åèªå·±å容ä½ã¨ã·ããã¹å¾å容ä½ã¨ãå«ãD2å容ä½ã®ç·éã¯ããã®èª¿ç¯æ©æ§ã¨ç´æ¥çãªé¢ä¿ãæããªãå¯è½æ§ã示åããããæ¬ç ç©¶ã®ææã¯DAçæè½ã¨DAãã©ã³ã¹ãã¼ã¿ã¼ã®éã®ä¸åè¡¡ããçµ±å失調çãæ°åé害ãªã©ã®ç²¾ç¥ç¾æ£ã®ç æ ççã«é¢ä¸ãã¦ããå¯è½æ§ã示åãããã®ã§ãããå°æ¥çã«ç²¾ç¥ç¾æ£ã®ç æ ççã®è§£æã«å¯ä¸ãããã¨ãæå¾ ãããã
(å±±æ¬ä¿å¤©ã2020.12.10.)
解説ãããçä½å ã§ãã¼ããã³ã観ã
ãã¼ããã³é¢é£ã®åéã§ã¯ãããã¾ã§ã«åç©å®é¨ãæ©è½ç»åç ç©¶ã夿°è¡ããã¦ãããããã¼ããã³ç¥çµä¼éç³»ãæ§æããè«¸æ©æ§ã®é¢ä¿æ§ãããçä½å ã§ç´æ¥æ¤è¨ããç ç©¶å ±åã¯ã»ã¨ãã©åå¨ããªãã£ããæ¬ç ç©¶ã¯DAçæè½ãä¸å¿ã¨ãã¦ãããã¨DAãã©ã³ã¹ãã¼ã¿ã¼ããã³D2å容ä½å¯åº¦ã¨ã®é¢ä¿ããåä¸ã®è¢«é¨è ã§è¤æ°ã®PETãªã¬ã³ããç¨ãã¦æ¤è¨ãããã®ã§ããããã¼ããã³ç¥çµä¼éã®æå¸¸æ§ç¶æã«é¢ããé常ã«è²´éãªãã¼ã¿ãå¾ãããããã®ç¹ãè©ä¾¡ããã¦ãNeuroimageèªã«æ²è¼ããããã®ã¨èãããããçé èè ã®å±±æ¬ä¿å¤©é¢çã¯ãæ¬ç ç©¶ã®ææã22q.11.2æ¬ å¤±çå群ã®ãã¼ããã³ç¥çµä¼éæ©æ§ã«é¢ããç ç©¶ã«ã¤ãªãã¦ãããã®ã¨æå¾ ãã¦ããã
(é«çåè¼ã2020.12.14.)
ãã¤ç
ã«ãããæãã¤è¬æ²»çéå§å¾ã®4é±éæ¯ã®è³æ©è½å¤å
å±±ç¸£ãæ (æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§ãå°ä»»è¬å¸«)Yamagata B, Yamanaka K, Takei Y, Hotta S, Hirano J, Tabuchi H, Mimura M. Brain functional alterations observed 4-weekly in major depressive disorder following antidepressant treatment. J Affect Disord. 2019 Jun 1;252:25-31.
éå»ã®è³ç»åç ç©¶ããã大ãã¤ç æ§é害ï¼major depression disorder; MDDï¼ã§ã¯ãåé èå å´ã辺ç¸ç³»ãç·æ¡ä½ãè¦åºãããã³åè³åºåºé¨ãå«ãåºç¯ãªç¥çµãããã¯ã¼ã¯ã®æ©è½ç°å¸¸ãé¢ä¸ãã¦ãããã¨ãæ³å®ããã¦ãããããããªãããç¾å¨ã¾ã§è¨ºæãæ²»çã«ç´çµããä¸è²«ããçç©å¦çæè¦ã¯è¦ãã ããã¦ããªããããã§ãæãã¤è¬æ²»çã«ããç¥çµãããã¯ã¼ã¯ã®åå¿æ§ã調æ»ãããã¨ã§ãä¸åä¸ãªç æ ã§ããMDDã®çç©å¦çæè¦ã®ä¸å´é¢ãåå®ãã試ã¿ããªããã¦ããã
è¿èµ¤å¤åå æ³ï¼near-infrared spectroscopy; NIRSï¼ã¯ãç£æ°å ±é³´ç»åæ³ï¼magnetic resonance imaging; MRIï¼ã¨æ¯è¼ãä½ä¾µè¥²æ§ã§ãããããçãééã§ç¹°ãè¿ã測å®ãããã¨ãå¯è½ã§ãããæ²»ççµéã«ä¼´ãåé åéã®è³æ©è½ã®å¤åãè©³ç´°ã«æ¸¬å®ã§ããå©ç¹ããããããã§ãããããã¯MDDãå¯¾è±¡ã«æãã¤è¬ã®æ²»çéå§æãã4é±éæ¯ã«NIRSãæ¸¬å®ãã徿¥ã®MRIç ç©¶ã¨æ¯ã¹çæéãã¤é«é »åº¦ã«è³æ©è½ã®å¤åãæãããã¨ãç®çã¨ããã
52ãã£ã³ãã«NIRSã使ç¨ããæªæ²»çã®MDD 11åã対象ã«ãèªæµæ¢æ§èª²é¡ï¼verbal fluency task; VFTï¼ãéè¡ä¸ã®é ¸ç´ åãã¢ã°ããã³(oxygenated hemoglobin; oxy-Hb)ã®è³¦æ´»éãæ¸¬å®ãããå ·ä½çã«ã¯ãã»ã«ãã©ãªã³æ²»çéå§åãéå§å¾4é±éç®ã8é±éç®ã12é±éç®ã®è¨4忏¬å®ããå ¨12é±éã®ç¸¦æç ç©¶ã宿½ããã
ãã¤ç ã®æ²»çåå¾ã®è³è¡æµã®å¤åãæ¤è¨ããéå»ã®è³ç»åç ç©¶ã®å¤ãã¯ãåé åéã«ããã使´»åæ§ãæãã¤çç¶ã®æ¹åã«ä¼´ãæ£å¸¸åï¼normalizationï¼ãããã¨ãå ±åãã¦ãããããããªãããæã ã®çµæã¯å¾æ¥ã®å ±åã¨ã¯ç°ãªããã®ã¨ãªã£ããå ·ä½çã«ã¯ã12é±éç®ã®æç¹ã§MDDå ¨å¡ãå¯è§£ã«è³ã£ãããå·¦ä¸åé åããã³ä¸ã»ä¸å´é åã«ä½ç½®ããè³é åã«ããã¦ã[oxy-Hb]å¤ã¯æ²»çéå§åãæãé«ãã4é±éç®ã«ä¸çªä¸ããããã®å¾ã12é±éç®ã«åãã¦å¾ã ã«ä¸æããã¨ããéå ¸åãªå¤åã示ããã䏿¹ã§ãä»ã®è³é åã§ã¯æéçµéã«ãã[oxy-Hb]å¤ã«ææãªå¤åã¯ã¿ã¨ããªãã£ããæã ã®å è¡ç ç©¶ããVFTéè¡ä¸ã®åé èã®[oxy-Hb]å¤ã¯æãã¤è¬ã®æè¬éã¨åæ¯ä¾ãããã¨ã示ããã¦ããï¼Takamiya et al., 2017ï¼ãæãã¤çç¶ãæ¹åãã¦ããã«ãé¢ãããã[oxy-Hb]å¤ãæ¸å°ãã¦ããçç±ã¨ãã¦æãã¤è¬ã®æç¨ã«ããå½±é¿ã示åãããã
ããã«ã12é±éãéãã¦ä¸è¨ã®è³é åã«ããã[oxy-Hb]å¤ã®ç´å ç¸é¢ä¿æ°ãä¸ç¨åº¦ã§ãã£ããã¨ãã[intra-class correlations (1,1) = 0.468; P < 0.001]ã[oxy-Hb]å¤ã®éå ¸åãªçµæçå¤åã¯å人差ãã¢ã¼ããã¡ã¯ãã®å½±é¿ã§ã¯ãªããå ¨ã¦ã®MDDæ£è ãä¸è²«ãã¦åæ§ã®å¤åããã¦ãããã¨ã示ãããMDD診æã«ãããçç©çæè¦ã§ããå¯è½æ§ã示åããããã¾ããè¨åºçç¶ã¨ã®é¢ä¿ã«ããã¦ã¯ã4é±éç®ã®[oxy-Hb]å¤ã4ãã8é±éç®ã¾ã§ï¼r = â0.727ãP = 0.011ï¼ãããã³4ãã12é±éã¾ã§ï¼r = â0.63ãP = 0.039ï¼ã®ããã«ãã³ãã¤ç å°ºåº¦ã®æ¹ååº¦ã¨ææãªç¸é¢é¢ä¿ãã¿ã¨ããã
以ä¸ããã4鱿¯ã¨ããçãééã§ç¹°ãè¿ãNIRSãæ¸¬å®ãããã¨ã§ãMDDã«ãããå¯è§£ã«åããåé èã®è¡æµå¤åãã¿ã¼ã³ãåå®ããããã«ã»ã«ãã©ãªã³æ²»çã¸ã®åå¿æ§ãäºæ¸¬ããçµæãå¾ããæ¬ç ç©¶ã¯11ä¾ã¨ãµã³ãã«æ°ãå°ãªãããå¦è¡çãªä¿¡é ¼æ§ãä½ããã¨ã¯å¦å®ã§ããªããããããªãããNIRSã®å©ç¹ãæ´»ãããã¨ã§ã徿¥ã®MRIç ç©¶ã§ã¯è¦ãã ããªãMDDã«ãããçç©å¦çæè¦ãæ½åºã§ããå¯è½æ§ã示åãããã
(山縣 æã2020.11.1.)
解説ãå»ã ã観ã
人éã®ç²¾ç¥ç¶æ
ã¯å»ã
ã¨å¤åãããããªãã¡è³ã®æ´»åã¯å»ã
ã¨å¤åããããã®ãå»ã
ãã¨ã¯å
·ä½çã«ã©ã®ç¨åº¦ã®ã¹ã±ã¼ã«ãªã®ããç§ããåããæéããæ¥ããå¹´ãããã£ã¨é·ãã¹ãã³ãããããã¯éã«ããªã»ã³ã³ããããã¤ã¯ãã»ã³ã³ãããããã»ã³ã³ããããã£ã¨çãã¹ãã³ãã
ã©ããçå®ã§ããããç²¾ç¥ç¶æ
ã®ãå¤åããã©ã®ã¹ã±ã¼ã«ã§æãããã«ãã£ã¦ãè³ã®æ´»åã®å¤åã®é©åãªæãæ¹ãæ±ºã¾ãã®ã ã
ã§ã¯ãç¾æ£ã«å¯¾å¿ããè³ã®æ´»åãè¦ããã¨ããã¨ãã¯ãã©ã®ã¹ã±ã¼ã«ã§è¦ãã®ãé©åãªã®ãã
ããã¯ããããªãã¨ããã®ãçå®ã§ããããç¾æ£ã®æ¬è³ªãããããªã段éã§ã¯ãçç¶ã®ã©ã®ãããªå¤åãçã«éè¦ãªã®ãã¯ããããªããããããªããããã¨ããããå¯è½ãªã¹ã±ã¼ã«ã§è¦ã以å¤ã«ãªãããããç¾å®ã§ãããããã¾ã§ã®ã©ã®ç ç©¶ãããããç¾å®ã®å¶ç´ã®ä¸ã§è¡ããã¦ããããã¨ãã°æ²»çã®åå¾ã®è³æ´»åã®å¤åãè¦ãã¨ããã®ã¯ä¸ã¤ã®ãããããã¿ã¼ã³ã§ãããã¯ãã¡ããä¸å®ã®æç¾©ãæãããã¼ã¿ã§ã¯ãããããã¨ããããã§ããæ¤æ»ããã¨ããããã§ããææã«è¡ããã¨ããå´é¢ããããã¨ã¯å¦ããªããæ©è½çMRIãPETããé±åä½ãæ¥åä½ã®ã¹ã±ã¼ã«ã§è¡ãããã«ã¯ãããªãã®ã§ããã
ææ³ãæ¯è¼ç簡便ã§ç¡ä¾µè¥²ãªæ¤æ»ã§ããNIRSã¯ãã®ç¹ã大ããªã¢ããã³ãã¼ã¸ãããããããæå¤§éã«çãããã®ã山縣è¬å¸«ã®æ¬ç ç©¶ã§ããã4é±åä½ã¨ããã¹ã±ã¼ã«ã§è³æ´»åã®å¤åãè¦ããNIRS以å¤ã®æ¤æ»ææ³ã§ã¯äºå®ä¸ä¸å¯è½ãªç ç©¶ãã¶ã¤ã³ã§ãããã¹ã±ã¼ã«ãå¤ããã°ãããã¾ã§ç¡è¦ããã¦ããåãã«çããããå¯è½æ§ãåºã¦ããããã®ä¸ã¤ããããã¦è¨åºçã«éè¦ãªåãã®ä¸ã¤ããè¬ã«å¯¾ããåå¿ã§ãããå¾ããããã¼ã¿ã¯ã徿¥ã®ç ç©¶ææ³ã§åå®ãããè³é¨ä½ã¨ã¯ç°ãªãããã¤ç ã®è³å åºç¤ã追究ããããã§é常ã«ç¤ºåã«å¯ããã®ã§ãã£ãã11ä¾ã¨ããå°æ°ã対象ã§ãããããã¤ãããã¹ã¿ãã£çãªä½ç½®ã¥ãã¨ãªããã夿°ä¾ã«é©ç¨ãããããã¨ãã¾ãNIRSã®å¤§ããªç¹é·ã§ãããæ¬¡ã®ã¹ãããã«å¤§ãã«æå¾ ãããã
(ææ¾å¤ªéã2020.11.30.)
<åèç²¾é¸> å¿ã®è¬ããå¿ã®ç§å¦ã¸ ãææ
: ã¸ã§ã¼ã ãºï¼ãã£ãã³ï¼ããã·ãªã
岩波æ¸åºãã2020å¹´
æ¢
ç° è¡ã»å°å¶ï¨ä¸ (ç£ä¿®)
ææ ã®ç ç©¶ã«ã¯é·ãæ´å²ãããï¼ããã¾ã§æ°å¤ãã®çè«ãææ¡ããã¦ããï¼ãã®ãªãã§ãç¹ã«éè¦ãªçè«ã¨ãã¦ãã°ãã°åãä¸ããããã®ã¯ï¼ãã¸ã§ã¼ã ãºã»ã©ã³ã²èª¬ãã¨ããã£ãã³ã»ãã¼ã説ãã§ããï¼åè ã¯ãææ ã®æ«æ¢¢èµ·æºèª¬ãï¼å¾è ã¯ãææ ã®ä¸æ¢èµ·æºèª¬ãã¨ãã¦ç¥ããï¼ææ ã®æºã身ä½ã«ãããï¼è³ã«ãããã¨ããè«ç¹ããããï¼å¯¾æ¯çãªã¹ã¿ã³ã¹ãåããã¦ããï¼è¿å¹´ã®ææ ã«é¢ããè«æã«ããã¦ãï¼ãããã®è«èª¬ã¯é«é »åº¦ã§å¼ç¨ããã䏿¹ï¼ååã«åèãèªã¿è¾¼ãã ä¸ã§è«ãå±éãã¦ããã¨ã¯æãããï¼å 容çã«ãã¥ã¢ã³ã¹ã®ç°ãªãå¼ç¨ã¾ã§æ£è¦ãããï¼
ãã®2ã¤ã®è«èª¬ãå±éããã¦ããæ°åå¹´ãçµéãï¼ç¥çµç§å¦ã«é¢ããç¥è¦ãç©ã¿éããããæä»£ã«ããã¦ãï¼ãããã®çè«ã«ç«èããå½¢ã§è«ãå±éãããã±ã¼ã¹ãå¤ãï¼ãã®ä»£è¡¨çãªçè«ãï¼ããã·ãªã«ãããã½ããã£ãã¯ã»ãã¼ã«ã¼ä»®èª¬ãã§ããï¼ãã®ä»®èª¬ã¨ã¨ãã«æåãªã®ãï¼ãã¢ã¤ãªã¯ã»ã®ã£ã³ããªã³ã°èª²é¡(IGT)ãã§ããï¼ã½ããã£ãã¯ã»ãã¼ã«ã¼ä»®èª¬ãï¼IGTãç¨ããç ç©¶çµæã«æ¯ãããã¦ãããã¨ã¯ç¢ºãã§ãããï¼ãã®èª²é¡ãèæ¡ããã以åã«ï¼ããã¤ãã®éè¦ãªèªå¾ç¥çµæ´»åã«çç®ããççå¿çç ç©¶ãçºè¡¨ããã¦ããï¼ããããªããï¼IGTã°ãããæåã«ãªã£ã¦ãã¾ãï¼ãã¡ãã®ç ç©¶ææã¯åããã¦ãã¾ã£ãæãå¦ããªãï¼IGTã®ç¹å¾´ãçè§£ããä¸ã§ï¼ãã®ç«æ¡ã®å ã¨ãªã£ãè«æã«è§¦ãããã¨ã¯ï¼æããã«çè§£ãæ·±ãããã¨ã®å©ãã¨ãªããï¼è¿å¹´ã®è«æã§ã¯ãã¯ãã»ã¨ãã©å¼ç¨ãããããªããªã£ã¦ããï¼
以ä¸ã®çç±ããï¼ä»åï¼ããã3ã¤ã®çè«ã®åèã®éª¨åãæ¥æ¬èªã«è¨³ãï¼ããããã¦ããããè¦ãã¦ãããã®ãä½ãã«ã¤ãã¦èãã¦ã¿ããã¨ã¨ããï¼æ¬æ¸ã¯ï¼4ã¤ã®ãã¼ãããæ§æãããï¼æåã®ãã¼ãã¯ãã¤ã³ãããã¯ã·ã§ã³ãã§ããï¼ææ ç ç©¶ã®æ´å²ãæ¯ãè¿ãï¼ã©ã®ãããªèæ¯ã§ãããã®3ã¤ã®çè«ãçã¿åºããï¼ãããçºå±ãã¦ãã£ãããç¹ããï¼ããã«ï¼è¿å¹´ã®ç¥çµç§å¦ãã¯ããã¨ããç ç©¶ã®ææãè¸ã¾ããã¨ï¼ããããã®çè«ãã©ã®ããã«æããããã®ãã«ã¤ãã¦ãæ¦èª¬ããï¼ä»åã®ä»äºã®ãªãã§æãé£ã極ããç¹ã¯ï¼è¨³èªã®çµ±ä¸ã§ããï¼ææ ã®ä¸å´é¢ã表ãè±åèªã«ã¯ï¼emotionï¼affectï¼moodï¼feelingãã¯ããã¨ããè¤æ°ã®æ¦å¿µãåå¨ããï¼ãããã訳åºããéï¼æ¥æ¬èªã¨ä¸å¯¾ä¸å¯¾å¿ããããã¨ã¯å°é£ã§ããä¸ï¼æ¥æ¬èªã®åèªã¨ãã¦ããããããç¬ç¹ã®æå³ãæã£ã¦ããï¼ãããåèªã®æã¤æå³ã¨ã¯ç°ãªãå ´åããããï¼ããããï¼ç¨èªæ¦å¿µã®æ´çãï¼ææ ã®æ¦å¿µã«é¢ããç ç©¶ã«ãªã£ã¦ãã¾ãã¬ãã«ã§ããï¼æ¬æ¸ã§ã¯ï¼ããå¤ãã®æéãã¨ã£ã¦ãããã®ç¹ã«é¢ãã説æã試ã¿ãï¼
ã¤ã³ãããã¯ã·ã§ã³ã«ç¶ããã¼ããï¼3ã¤ã®çè«ã®åèè«æã®æ¥æ¬èªè¨³ã§ããï¼åè«æã«ã¤ãã¦ï¼ã¾ãã¯æé²ã¨ãã¦èæ¯ã¨éª¨åãã¾ã¨ããå¾ã§ï¼åèã®æ¥æ¬èªè¨³ãæç¤ºããï¼ãªãï¼æ¬æ¸ã§ã¯ï¼ããã®ç¿»è¨³å®¶ã«ç¿»è¨³ãä¾é ¼ãï¼æ¢ ç°ããã®ç£è¨³ãè¡ã£ãï¼ã¸ã§ã¼ã ãºã®åèã¯ï¼1890å¹´ã«åºçããâPrinciples of Psychologyâã®25ç« âThe emotionsâã§ããï¼ãã£ãã³ã®åèã¯ï¼1929å¹´ã«åºçãããâBodily changes in pain, hunger, fear, and rageâã®ç¬¬äºçã®æç²ã§ããï¼ãã®èè ã¯ï¼ãã£ãã³ã®æå±ããæåãªæ¦å¿µã§ãããéäºã»éèµ°åå¿ãã®çºæ³ã®åç¹ã¨ãä½ç½®ã¥ããããï¼ç¬¬ä¸çã¯1915å¹´ã«åºçããï¼15ç« æ§æã§ãã£ããï¼æ°ããççå¦ç ç©¶ã®ç¥è¦ããã¨ã«å±éãã第äºçã¯ï¼20ç« æ§æã«ãªã£ã¦ããï¼ç¬¬äºçã§è¿½å ãããè¨5ç« ã¯ï¼ãã®å¤ããææ ã«é¢é£ããè«èã§ããï¼ç¹ã«ç¬¬18ç« ã¯ï¼ã¸ã§ã¼ã ãºã®çè«ã«å¯¾ããæ¹å¤çè«è¿°ã«å½ã¦ããã¦ããï¼æ³¨ç®ã«å¤ããï¼ããã·ãªã®åèã¯ï¼1991å¹´ã«åºçãããâFrontal lobe function and dysfunctionâã¨ããæ¸ç±ã®11ç« ã«åããããï¼âSomatic markers and the guidance of behaviour: Theory and preliminary testingâã§ããï¼
ãããã®è«èª¬ãï¼ææ ãåºãè¦éãã俯ç°ããè¦ç¹ã«ç«ã£ã¦ããï¼æ·±ãè«èã®ä¸ã«æãç«ã£ã¦ããï¼æ´å²çãªèä½ã§ããããï¼åã«äºå®ã¨ããæå³ã§ã¯èª¤ã£ãè¨è¿°ãå«ã¾ããç¹ã¯å¦ããªããï¼ãããè¶ ããèå¯ã®æ·±ãããããã¨ã«çãã®ä½å°ã¯ãªãï¼æ¬æ¸ãï¼ææ ã«é¢ãããããªãçè§£ã®ä¸å©ã¨ãªãã°å¹¸ãã§ããï¼
(æ¢ ç°è¡ã2020.10.18.)
解説ãåèã®å訳ã«ããåè
èè åã¯èãããã¨ããããåèããããã¨ãããç¥ã£ã¦ããããã¤ãèªã¾ãªããã°ãªããªãã¨æã£ã¦ãããã ãçµå±ã¯èªãã§ããªããèªãã§ããªãã®ã«å¼ç¨ãããå¤å ¸çãªåèããããããããäºæ ã¯ãã°ãã°çºçãã¦ãããèªåã®ç ç©¶ã«ç¹ã«é¢ä¿ããé¨åã ãã§ããã£ããèªãã§å¼ç¨ãããªãã¾ã ããããã¾ã£ããèªã¾ãã«å¼ç¨ããããã¨ãããããããã¨å½ç¶ã«åèã®è¨è¼ã¯æªããããå½¢ã§å¼ç¨ãããããããã¾ã誰ããå¼ç¨ããããã¯ã䏿ãªä¼è¨ã²ã¼ã ç¶æ ã¨ãªã£ã¦ãåèã®å 容ã¯çè·¡ãæ®ãã®ã¿ã¨ãªããåèã¯ãåããç¥ããã¦ããã ãã®æãæ®»ã¨åãããããã¦åèã«å»ã¾ãã人é¡ã®è²´éãªå¡æºã¯äººã ããå¿ãå»ããããã§ã«å®çµãã¦ããã¯ãã®è°è«ãä¸ããè¸ãè¿ããããªç ç©¶ãå§ããããã¨ãã䏿¯ãªå¶ã¿ããçºçãããã¨ã«ãªãã
ãã®äºæ
ãæéããããã«èããããæ¹æ³ã¯äºã¤ãããåèãåæã§èªããã¨ãã¾ãã¯ãåèã翻訳ã§èªããã¨ã§ããããã¡ããåæã§èªãæ¹ãæã¾ããããããç¾å®ã«ã¯ããã¯é£ãããå¤å
¸çãªåèã¯ãã°ãã°é·æã§ãããè¶
é·æã®ãã¨ããããèªåã®å°éåéã®ææ°ã®æéè¦æç®ãªãã¨ãããããããåèã¨ã¯è¨ãä½åå¹´ãæã®å¤§è«æãåæã§èªãæéãªã©ãªããªãåãããã®ã§ã¯ãªãã
ããã¨å¤å
¸ãèªãæ©ä¼ã¯ç¿»è¨³ãããªããã ãããã¯å¥ã®æå³ã§é£ããããªããªãå»å¦è«æã®ç¿»è¨³ã®å¤§é¨åã¯ãã¾ãã«ä½å質ã ããã§ããããããªè¨³æãèªãæéãªã©ãåãããã®ã§ã¯ãªãã
ãããªæãã¹ãç¶æ³ãç²ç ããã®ãã岩波æ¸åºã®ãåèç²¾é¸ãã·ãªã¼ãºã®ä¸ã®ä¸åãæ¢ ç°è¡ææ(æ ¶æç¾©å¡¾å¤§å¦æå¦é¨å¿çå¦å°æ»)ç·¨éã®ãææ ãã§ããã
æ¬æ¸ã¯ååºããå訳ã§ãããå訳ã«ä»ä¸ãã£ã¦ãããã¨ã«ã¯çç±ãããã
ã²ã¨ã¤ã¯ã翻訳è
ãããã®ç¿»è¨³å®¶ã§ãããã¨ããã®ç¨®ã®è¨³æ¬ã¯å¤ãã®å ´åããã¼ãã«é¢é£ããç 究室ã®ã¡ã³ãã¼ãåæ
ãã¦ç¿»è¨³ããã®ã宿³ã§ããããããããã§ã¯è¨³æãæå£ã«ãªããã¨ãé¿ããããªããè«æãèªãããã¨ã¨è¨³ãããã¨ã¯å
¨ãå¥ã®ã¹ãã«ãªã®ã§ããã翻訳ã¯ç¿»è¨³ã®ããã«ä»»ããªããã°ãªããªããã ãããã ãã§ã¯ã¾ã ã¾ã ä¸ååã§ããã翻訳ã®ããã¯å»å¦ã®å°éå®¶ã§ã¯ãªããããå»å¦çå
容ã¯ãã°ãã°èª¤è§£ããã¦è¨³ããã¦ããããã¡ããåªãã翻訳家ã¯ãå°éçãªå
容ã¯å°éå®¶ã®æè¦ãèãã¦æ£ç¢ºãæããåªåããããã®ã§ããããããã§ãéçããããã¨ã¯å¦ããªãã
ã§ã¯æ¬æ¸ã¯ãªãå訳ã«ä»ä¸ãã£ãããæ¢ ç°ææããã¹ã¦ã®è¨³æãç²¾å¯ã«ãã§ãã¯ããããã§ãããæ¬ã®è¡¨ç´ã«è¨ããã¦ãããç£ä¿®ãã¯ãåã°ããã®ãã¨ãå¤ããæ¬æ¸ã¯ããã§ã¯ãªããåå®ã¨ãã«æ¢ ç°ææã®æ·±ãåºãç¥è¦ã浸éãã¦ããã
ããã¯è¨³æã ãã«ã¨ã©ã¾ããªããæ¬æ¸ã¯ãåé ã«ææ ç ç©¶ã®æµãã«ã¤ãã¦ã®30ãã¼ã¸ã«åã¶ç§é¸ãªã¤ã³ãããã¯ã·ã§ã³ããããå ãã¦ãåè«æã«æ°ãã¼ã¸ã®å¯åº¦ã®æ¿ã解説ãä»ãããã¦ãããæ¢ ç°ææã«ããã°ããããã®å 容ãè£ãã¨ãå¿ è¦ãããé¨åãå¤ããä¸è¡ã®æç« ãæ¸ãã®ã«æ°åã®å¤å ¸ã«ãããã¨ãã使¥ããããã¨ã®ãã¨ã§ããããã®ã¤ã³ãããã¯ã·ã§ã³ã¨åè«æè§£èª¬ã®ååºãã質ã®é«ãã«ã¯ããããèæ¯ããããç¬ç«ããè«æã¨ãã¦ãåå以ä¸ã«ä¾¡å¤ã®ãããã®ã§ããããããã ããèªãã°ææ ç ç©¶ã«ã¤ãã¦ãã¹ã¦ãããã£ãæ°ã«ãªã£ã¦ãã¾ãã»ã©ã§ããããæ¬æãéèªãããã¨ã§ããã«æ·±ãæ¬æ¸ã®ç価ãåãã¦ä½æã§ãããã¨ã¯è¨ãã¾ã§ããªããåèã§ããåèããå訳ã«ãã£ã¦æ¥æ¬èªã«çã¾ãå¤ãããæçµçã«ã¯ç¿»è¨³æ¸ã¨ããã¸ã£ã³ã«ãè¶ è¶ããåèã¨ãªã£ãã®ãæ¬æ¸ã§ããã
æå¾ã«æ¬æ¸ã®ç®æ¬¡ãè¨ãã
ã¤ã³ãããã¯ã·ã§ã³
ããæ¢
ç°è¡
æ
å
ããWilliam James (1890) 忢éå訳
çã¿ã空è
¹ãæããæãã«ä¼´ã身ä½å¤å --- æ
åã®èå¥®ã®æ©è½ããããæè¿ã®ç ç©¶å ±å
ããWalter B. Cannon (1929) è¤åå¤ä¼½å¤«è¨³
ã½ããã£ãã¯ã»ãã¼ã«ã¼ã¨è¡åæé --- çè«ã¨äºåçæ¤è¨¼
ããAntonio R. Damasio, Daniel Tranel, and Hanna C. Damasio (1991) åå·ç²è¨³
(ææ¾å¤ªéã2020.10.30.)
èªè¦çèªç¥æ©è½ä½ä¸ã訴ããå¥å¸¸é«é½¢è¢«é¨è
ã¸ã®ã¢ã«ããã¤ãã¼ç
çºçå診æã®çµæé示ãä¸ããé·æçãªå¿ççå½±é¿
åæ°£å¤§æï¼æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ã»ç¥çµç§å¦æå®¤ãç ç©¶å¡ï¼Wake T, Tabuchi H, Funaki K, Ito D, Yamagata B, Yoshizaki T, Nakahara T, Jinzaki M, Yoshimasu H, Tanahashi I, Shimazaki H, Mimura M. : Disclosure of Amyloid Status for Risk of Alzheimer Disease to Cognitively Normal Research Participants With Subjective Cognitive Decline: A Longitudinal Study.
Am J Alzheimers Dis Other Demen. 2020;35:1533317520904551. doi: 10.1177/1533317520904551
ã¢ããã¤ãPETã«ããã¢ã«ããã¤ãã¼ç
ã®çºçå診æãä¸çä¸ã®è¨åºç ç©¶ã§è¡ããã¦ãããããèªè¦çèªç¥æ©è½ä½ä¸ï¼Subjective Cognitive Decline: SCDï¼ãã訴ãä¸å®ã®å¼·ã人ã¸ã®PETçµæé示ã®å¿ççå½±é¿ã«ã¤ãã¦ã¯ã»ã¨ãã©æããã«ããã¦ããªãã£ããèªè¦çèªç¥æ©è½ä½ä¸ã¯ã徿¥ã®æ¤æ»ã§ã¯å®¢è¦³çã«ç¥çµå¿çå¦çãªç°å¸¸ãèªããªããã®ã®ãæ¬äººã¯æç¶çã«èªç¥æ©è½ã®ä½ä¸ãèªè¦ãããã¨ã¨å®ç¾©ãããã¢ã«ããã¤ãã¼ç
ãçºçããããã15â20å¹´åã®åè¨åºæã§æ³¨ç®ããã¦ããã
ã¢ããã¤ãβã®ç°å¸¸èç©ã¨ããç
å¤ããã§ã«å§ã¾ã£ã¦ããåè¨åºæã§ä¸å®çç¶ãé«ã¾ãã¨ãå
å æ§ç³è³ªã³ã«ãã³ã¤ãã®ä¸æãéãã¦ãããèæãªèªç¥æ©è½ã®ä½ä¸ãèªçºããã¨ã®ææãããããã®ãããåè¨åºæã§èªè¦çèªç¥æ©è½ä½ä¸ã®ãã人ã¸ã®ã¢ã«ããã¤ãã¼ç
çºçãªã¹ã¯ã®æ
å ±é示ãä¸å®ã墿ªãããªããæ¤è¨¼ãããã¨ã¯å«ç·ã®èª²é¡ã§ãã£ãã
äºåçç ç©¶ã§ã¯ãèªè¦çèªç¥æ©è½ä½ä¸ã®ããå¥å¸¸é«é½¢è
42åã«å¯¾ãã¦ã¢ããã¤ãPETã宿½ãï¼é½æ§10åï¼ãPETã®çµæé示åå¾ã®ä¸å®ããã³æãã¤ã¬ãã«ãæ¯è¼ããã¨ã¨ãã«çµæé示å¾6é±ã®ãã©ã¦ãçç¶ã測å®ãã(æ¬HP 2017.12.ã®è§£èª¬åç
§)ã
æ¬ç ç©¶ã§ã¯ãããã®å
¨è¢«é¨è
ã«å¯¾ãã¦ãããã«çµæé示å¾24é±ã¨52é±ã¾ã§é·æçã«è¿½è·¡ãããPET齿§ã»é°æ§ã®ã©ã¡ãã®ç¾¤ã«ããã¦ããä¸å®ãæãã¤ããã©ã¦ãçç¶ã®ç¶æçå¤åã¯èªãããããè¨åºçã«éè¦ã¨ãªãå¤ä»¥ä¸ã§æ¨ç§»ãããä¸å®ã¨æãã¤ã«é¢ãã¦ã¯åæç¹ã§ä¸¡ç¾¤ã«å·®ã¯ãªãã£ããããã©ã¦ãçç¶ã«é¢ãã¦ã¯ã52鱿ç¹ã§é°æ§ç¾¤ã®ã»ãã齿§ç¾¤ãããææã«é«ãã¬ãã«ã¨ãªã£ããããã«è©³ç´°ãªçµ±è¨å¦çè§£æãè¡ã£ãã¨ãããé°æ§ç¾¤ã«ããã¦ã¯ããã¼ã¹ã©ã¤ã³ã®ä¸å®ã¨52鱿ç¹ã®ãã©ã¦ãã¬ãã«ãå群ã®å¹³åããé«ããµãã°ã«ã¼ãã®åå¨ãæããã¨ãªã£ãã
èªè¦çèªç¥æ©è½ä½ä¸ã®ããå¥å¸¸é«é½¢è
ã«å¯¾ãã¦ãã¢ããã¤ãPETã«ããã¢ã«ããã¤ãã¼ç
çºçå診æã®çµæãé示ãã¦ããé·æçã«æãããªå¿ççå±å®³ãããã¨ã¯è¨ããªããã¨ã示ããããããããã¢ããã¤ãPETé°æ§ç¾¤ã«ã¯ã客観çã«è©ä¾¡ãããèªç¥æ©è½ã¨èªè¦ããèªç¥æ©è½ããã³ããã«ä¼´ãä¸å®ã¨ã®ä¹é¢ã®ç¨åº¦ã«é¢ãã¦ã¹ãã¯ãã©ã ãåå¨ããå¯è½æ§ã示åãããé°æ§ã§ãã£ã¦ãã¢ããã¤ãPETã®çµæéç¤ºã¯æ
éã«è¡ãå¿
è¦ããããã¨ãæããã«ãªã£ãã
å¥å¸¸é«é½¢è ã«å¯¾ããã¢ã«ããã¤ãã¼ç ã®çºçå診æãè¨åºã®å ´ã§å®æ½ãããã¨ã¯ã¬ã¤ãã©ã¤ã³ãä¸é©åã¨å®ãã¦ãããçµæé示ã®ä¸å©çã®ä¸ã¤ã¨æ³å®ãããã®ã¯ãå¿ççãªå±å®³ãã§ããããããå°ãªãã¨ãç¾å¨ã«è³ãã¾ã§ãæ¬ç ç©¶ãå«ãã¦æãããªå±å®³ã¯å ±åããã¦ããªããã¢ã«ããã¤ãã¼ç ã®çºçãªã¹ã¯ãç¥ãããã¨æã声ã¯å¤ããèªãã®äººçã«ã¨ã£ã¦æ¥µãã¦éè¦ãªæå³ãæã¤å¥åº·æ å ±ãç¥ãï¼ç¥ããªãã§ããæ¨©å©ãã©ãä¿éãããããããªãå«çå¦çæ¤è¨¼ãæ±ããããããã®ããä»å¾ã¯æ¬ç ç©¶ãçºå±ãããçè«ã¨å®è¨¼ã®ç¥çµå«çå¦çã¢ããã¼ããçµ±åããããæ´ç·´ãããå«çè¦ç¯ã®æç¤ºãç®æãã
(åæ°£å¤§æã2020.9.18.)
解説ãã¬ã¤ãã©ã¤ã³ã®å½¼æ¹ã«ããå«ç
ã¬ã¤ãã©ã¤ã³ã«å¾ã£ã¦ããã°ééããªããæ¹å¤ãããªããå°éå®¶ãããè¦ãããå®å ¨ã ãã ãã人éã§ãªãã¦ãã§ãããAIãæã¡åºãã¾ã§ããªããå ¥åãããå½ä»¤ãå®è¡ããã ãã®ç¬¬ä¸ä¸ä»£ã®ã³ã³ãã¥ã¼ã¿ã¼ã§ãã¬ã¤ãã©ã¤ã³ã«å¾ããã¨ã¯ååã«ã§ããã人éãªãã¬ã¤ãã©ã¤ã³ã®è£ã«ããäºå®ãèªã¾ãªããã°ãªããªããæãå½ã®ã¢ããã¤ãPETã¤ã¡ã¼ã¸ã³ã°å¤ã®é©æ£ä½¿ç¨ã¬ã¤ãã©ã¤ã³(2017.11.17.)ã«ã¯ããã®æ¤æ»ã®ä¸é©åãªä½¿ç¨ã¨ãã¦ãèªè¦çãªç©å¿ãçã訴ããã客観çã«ã¯èªç¥æ©è½é害ãèªããªãå ´åããç¡çåè ã«å¯¾ããã¢ã«ããã¤ãã¼ç ã®çºçå診æããªã©ãæãããã¦ãããåæ§ã®è¨è¼ã¯å½éçãªã¬ã¤ãã©ã¤ã³(Appropriate Use Criteria for Amyloid PET, 2013)ã«ããããä½ãããã«ã¯ãç¾æç¹ã§ã¯ãã¢ããã¤ãPETã«ããçºçå診æã«ã¯ãããã£ããã¯å°ããã害ã®å¯è½æ§ããããã£ãããä¸åã£ã¦ãããçºçäºé²ã®æ²»çãéçºãããã°ç¶æ³ã¯ééããªãå¤ããã§ããã(At present, the potential harms outweigh the current minimal benefits. The availability of proven preventive therapies undoubtedly would alter this.)ãã¨ä»è¨ããã¦ããã害ã¨ã¯ããªãã¡å¿ççãªå®³ã§ãããPETã§ã¢ããã¤ã齿§ã§ããã°ãèªåã¯ã¾ããªãã¢ã«ããã¤ãã¼ç ãçºçããã®ã§ã¯ãªããã¨ä¸å®ã«ãªãã§ããããä¸å®ã«å§ãæ½°ããæãã¤çã«ãªããããããªãããã¨ãã£ã¦ç¾æç¹ã§ã¯çºçãäºé²ããæå¹ãªææ®µã¯ãªããããã§ããã°PETæ¤æ»ãªã©ããªãã»ãããããã¬ã¤ãã©ã¤ã³ã¯ããæãã¦ãããæå¿«ãªè«çã ãç´å¾ã§ããçç±ã§ãããã ãã人éã§ãªãã¦ããããåç´ãªè«çã ã人éãªãã¬ã¤ãã©ã¤ã³ã®è¨è¼ãæ¸ãæããåªåãããªããã°ãªããªããããã¯ç¾ç¶æéã¸ã®åªåã§ããããã®ããã«ã¯æ¤è¨¼ã¸ã®ç¬¬ä¸æ©ãè¸ã¿åºããªããã°ãªããªããã¢ããã¤ãPETã®çµæãç¥ããã¨ã¯å½äºè ã«æ¬å½ã«å¿ççãªå®³ãããããã®ã? ãããåæ°£ç ç©¶å¡ã«ããæ¬ç ç©¶ã®ãã¼ãã§ãã£ããããã¦ãèªè¦çèªç¥æ©è½ä½ä¸ã®ããå¥å¸¸é«é½¢è ã«å¯¾ãã¦ãã¢ããã¤ãPETã«ããã¢ã«ããã¤ãã¼ç çºçå診æã®çµæãé示ãã¦ããé·æçã«æãããªå¿ççå±å®³ãããã¨ã¯è¨ããªããã¨ã示ããã
ã¬ã¤ãã©ã¤ã³ã¯ä¾¿å©ãªä¸æ¹ã§ã欺çãå«ãã§ãããç¹ã«å«ççãªäºé ã«ã¤ãã¦ã®è¨è¼ã¯ããã®çµ¶å¯¾çã¨ããããå¼·å¶åã¨è£è ¹ã«ãæ ¹æ ã¯åãªãæ¨å®ã«ãããªããã¨ãå¤ãããã°ãã°ç©ºçã§ããããããå«çãåé¢ã«åºãããã¨ãéåãã¦éå«ççã ã¨æå¼¾ããããã¨ãé¿ãããã¨æããã¾ããç¡æ¡ä»¶çã«å¾ãã¨ãããã¨ã«ãªããã¡ã§ããããæ¤æ»çµæãåç¥ãããã¨ã¯å½äºè ã«ã¨ã£ã¦å®³ã¨ãªãããã¨ãçç±ã«ã¢ããã¤ãPETã®æ½è¡ãç¦ããã®ããå«çã®é åã«ããè¨è¼ã§ãããããã¦ç©ºçãªæ ¹æ ãããªãè¨è¼ã§ããã人éãªãã¬ã¤ãã©ã¤ã³ã®å½¼æ¹ã«ããå«çãè¦æããªããã°ãªããªããä»å¾ãç²¾åº¦ãæ¤æ»å¸æè æ°ãæ¥å³»ã«é«ã¾ããã¨ãå¿ è³ã®ã¢ããã¤ãPETããå½äºè ã«æå¤§ã®å©çãããããå½¢ã§çºå±ããã¦ããããã«ã¯ãå«ççäºé ã«ã¤ãã¦ãå®è¨¼ãã¼ã¿ãåºãã¦ãããã¨ããæè¡çãªç ç©¶ã«å¹æµãããæã«ã¯ãã以ä¸ã«éè¦ãªèª²é¡ã§ããããããããç ç©¶ã¯é©ãã»ã©å°ãªããå«çã¬ã¤ãã©ã¤ã³ã¯ãã²ã¨ãã³ããããããã®ã使ãããã¨ãæ¹å¤ããããã¨ãªãç¶æãããã®ã常ãªã®ã§ããã
ã©ã®æä»£ã«ããã©ã®é åã«ãã人ã«ã¯ç¹ã«çããæããªãã¾ã¾ã«æã¡ç¶ãã¦ãã信念beliefã¨ãããã®ãããããããã信念ãåãç´ãç¶ããã½ã¯ã©ãã¹ã®ç³»èãç¶ãå¿ç¨å«çç ç©¶æããªãã¯ã¹ãã©ã¼ã大å¦å²å¦ç§ã«è¨ç½®ããã徿¥ã®å«çå¦ã®æ ãè¶ ããå®è¨¼çã¢ããã¼ããå±éãã¦ãã (https://www.practicalethics.ox.ac.uk/home)ãåæ°£ç ç©¶å¡ã®æ¬è«æã¯ããã®ç ç©¶æãããæ³¨ç®ãããå½éå ±åç ç©¶ãã¾ããªãéå§ããããã¨ãã¦ããã
(ææ¾å¤ªéã2020.9.25.)
ã¿ã¦ã¿ã³ãã¯è³ªãã¿ã¼ã²ããã¨ããPETãªã¬ã³ã11C-PBB3ãç¨ããç²¾ç¥ç
çç¶ãä¼´ãèå¹´æãã¤ç
æ£è
ã«ãããçä½å
å¯è¦åç ç©¶
森å£ç¿ã(æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§ 婿)Moriguchi S, Takahata K, Shimada H, Kubota M, Kitamura S, Kimura Y, Tagai K, Tarumi R, Tabuchi H, Meyer JH, Mimura M, Kawamura K, Zhang MR, Murayama S, Suhara T, Higuchi M.
Excess tau PET ligand retention in elderly patients with major depressive disorder.
Molecular Psychiatry 2020 Jul 1. DOI https://doi.org/10.1038/s41380-020-0766-9
ãã¤ç ã¯ãã¢ã«ããã¤ãã¼åèªç¥çãã¯ããã¨ããèªç¥çã®å±éºå åã§ãããã¨ãç¥ããã¦ãããã¾ããèªç¥çã®ç´3å²ã¯ãã®çºçåã«ä½ããã®ç²¾ç¥ç¾æ£ã§ããã¨è¨ºæããã¦ãããããã®å¤ãã¯ãã¤ç ã§ããããã®ããã«ãã¤ç ã¨èªç¥çã«ã¯ä½ãããã®å ±éç¹ãããã®ã§ã¯ãªããã¨èãããã¦ã¯ãããã®ã®ããã¤ç ã¨èªç¥çã®éã«ããå ±éããç æ ã¡ã«ããºã ã«ã¤ãã¦ã¯ã¯ã£ããã¨ã¯ããã£ã¦ããªãããã®ä¸ã®ã²ã¨ã¤ã®ä»®èª¬ã¨ãã¦ãã¿ã¦ãã¢ããã¤ãβã®èç©ã¯ããã2ã¤ã®ç¾æ£ã«å ±éãã¦ããå¯è½æ§ãè¨ããã¦ããããããã®åå¨ã示åããã¦ãããããã¾ã§ãã¿ã¦ã¨ã¢ããã¤ãβ両æ¹ã«çµåããã¤ã¡ã¼ã¸ã³ã°å¤18F-FDDNPã§è¡ãããèå¹´æãã¤ç ã®PETç ç©¶ã§ã¯ããã¤ç ã®è³å ã§18F-FDDNPã®çµåãé«ãèªãããããã®ã®ããããã¿ã¦èç©ã«ãããã®ãªã®ãã¢ããã¤ãβèç©ã«ãããã®ãã¯ä¸æã®ã¾ã¾ã§ãã£ããæ¬ç ç©¶ã§ã¯ãèå¹´æãã¤ç ã対象ã«ã¿ã¦ãªãã³ã«ã¢ããã¤ãβç¹ç°çã«çµåãã2ã¤ã®ã¤ã¡ã¼ã¸ã³ã°å¤ãç¨ãã¦ãããã®èç©éãªãã³ã«åå¸ã¨ãè¨åºçç¹å¾´ã¨ã®é¢é£ãæããã«ãããã¨ãç®æããã
æ¬ç ç©¶ã§ã¯ã50æ³ä»¥ä¸ã®èå¹´æãã¤ç ã¨å年代ã®å¥å¸¸è ã対象ã«ãã¿ã¦ã«å¯¾ãã¦ã¯ã¤ã¡ã¼ã¸ã³ã°å¤11C-PBB3ãç¨ãã¦ãã¢ããã¤ãβã«å¯¾ãã¦ã¯ã¤ã¡ã¼ã¸ã³ã°å¤11C-PiBãç¨ãã¦PETæ¤æ»ãè¡ããã¿ã¦ããã³ã¢ããã¤ãβã®è³å ã®åé åã«ãããèç©éã調ã¹ãããã®çµæãèå¹´æãã¤ç æ£è ã§ã¯è³å ã®å¤§è³ç®è³ªå ¨ä½ã«ã¿ã¦èç©ãèªãããããã®ä¸ã§ãå帯ç¶ç®è³ªã¨å¼ã°ããè³é¨ä½ã§é«ãå¾åãã¿ããããã¾ããæ£è å ã«ããã¦ç²¾ç¥ç çç¶ã®æç¡ã§åãã¦æ¯è¼ããã¨ãããç²¾ç¥ç çç¶ãæããèå¹´æãã¤ç æ£è 群ã®å¤§è³ç®è³ªå ¨ä½ã«ããã¦ã¿ã¦èç©ãããå¤ãèªããããç¹ã«åé åç®è³ªãå帯ç¶ç®è³ªãå´é èãªã©ã®è³é¨ä½ã§é«ãå¾åãã¿ãããããªããã¢ããã¤ãβã®èç©éã¯ãèå¹´æãã¤ç æ£è 群ã¨å¥å¸¸è 群ã§å·®ã¯ãªãã£ããæ¬¡ã«æ¬ç ç©¶çµæãæ¤è¨¼ãããããæ±äº¬é½å¥åº·é·å¯¿å»çã»ã³ã¿ã¼ã§è¡ãããé«é½¢è ãã¬ã¤ã³ãã³ã¯ããã¸ã§ã¯ãã®æ»å¾è³ãã¼ã¿ãç¨ãã¦ãé¡èãªã¢ããã¤ãβã®èç©ããªããã®ã®ã¿ã¦ã®èç©ãèªããããã±ã¼ã¹ãæãã¤çç¶ã®èªããããçä¾ã§ã¿ããããã¨ãæããã«ãªã£ããããã«ãããPETæ¤æ»ã«ããçµæã¨åæ§ã«ãã¤ç æ£è ã®ä¸é¨ã«ã¿ã¦èç©ãé¢é£ãã¦ããå¯è½æ§ãæ»å¾è³ã§ã示åãããã
æ¬ç ç©¶ã®ææã¯ãä¸é¨ã®èå¹´æãã¤ç ãç¹ã«ç²¾ç¥ç çç¶ãåããæ£è ã«ã¿ã¦ã®èç©ãé¢ä¸ãã¦ããå¯è½æ§ã示åãããããã¾ã§ã®ç²¾ç¥ç¾æ£ã®æä½ç診æåºæºã§ã¯ãè¥å¹´è ã®ãã¤ç ãèå¹´æãã¤ç ããåä¸ã®ãã¤ç ã¨ãã¦è¨ºæãããæ²»çæ¹æ³ãåããã¦ã¯ããªãã£ããããããè¨åºä¸ã¯ãããï¼ã¤ã®ãã¤ç ãæããã«ç°è³ªãªçç¶ãåãã¦ããå ´åãå°ãªããªãã£ãããã®ä¸ã§ãã妿³ãå¹»è¦ãªã©ãåããç²¾ç¥ç çç¶ã¯èå¹´æãã¤ç ã«æ¯è¼çå¤ãèªããããè¥å¹´è ã«ã¯ã»ã¨ãã©èªããããªããã¨ãç¥ããã¦ãããããããèå¹´æãã¤ç ã«æ¯è¼çç¹æãªç²¾ç¥ç çç¶ã¨ãã¦ã¯ããã¤ç ã®ä¸ç¾¤ã¨ãã¦ãèããããã³ã¿ã¼ã«çå群ãªã©ãããããã®ãããªè¨åºç観å¯ã«ããã以åããèå¹´æãã¤ç ã®ä¸ã«ã¯è¥å¹´è ã¨ã¯å¥ã®ã¡ã«ããºã ãé¢ä¸ãã¦ããã®ã§ã¯ãªããã¨è¨ããã¦ããã
æ¬ç ç©¶ã®çµæã¯ãã®ãããªç²¾ç¥ç çç¶ãåããèå¹´æãã¤ç ã«ã¿ã¦èç©ãé¢ä¸ãã¦ãããã¨ã示åãããã®ã§ãã£ãã䏿¹ã§ãæ¬ç ç©¶ã«ããã¦ç²¾ç¥ç çç¶ãåããèå¹´æãã¤ç ã§ãã£ã¦ãã¿ã¦èç©ãèªããããªãçä¾ãèªãããããããä»å¾ãç²¾ç¥ç çç¶ãèªããããã¨ãã¦ãã©ã®ãããªå ´åã«ã¿ã¦èç©ãé¢é£ãã¦ããããæããã«ããããã®ç ç©¶ãå¿ è¦ã¨ãªããã¾ããæ¬ç ç©¶ã®ææã¯è¨ºæã®ã¿ã§ã¯ãªããèå¹´æãã¤ç ã®ä»å¾ã®æ²»çæéã«ã¤ãã¦ãæç¨ã§ããå¯è½æ§ããããã¢ã«ããã¤ãã¼ç ãªã©ã®èªç¥çã§ã¯ãã¿ã¦èç©ãæ¨çã¨ããæ ¹æ¬çãªæ²»çè¬ã®éçºã¨è¤æ°ã®è¨åºè©¦é¨ã宿½ããã¦ãããã¿ã¦ãé¢ä¸ãã¦ããä¸é¨ã®èå¹´æãã¤ç ãæ©æã«è¨ºæãããã¨ãå¯è½ã¨ãªãã°ãããããæ°ããæ²»çæ³ãé©ç¨ã§ããããã«ãªãã¨æå¾ ãããã
(森å£ç¿ã2020.8.17.)
解説ãã«ãªã¹ã®ä¸ã®çå®ãè¦æã
ä½ãããããªããã°ã¨ããããå¤è¦ã§åé¡ãããããªãããããªéãç´ãããçã¾ããã®ãç¾ä»£ã®ç²¾ç¥ç¾æ£ã®åé¡ä½ç³»ã§ãããã ããå¤è¦ãåããªãåãã«ãã´ãªã¼ã«åé¡ãããããããããµã¯ã©ã³ããã¢ã»ãã©ãã¤ã¯ã©ãã赤ãã¦ä¸¸ãã¨ããå¤è¦ã ããåãã«ãã´ãªã¼ã«åé¡ãããããããªä¹±æ´ãªåé¡ããããã¨æ¹å¤ããã®ã¯ããããã¤ã¯ã©ã¨ã¯ä½ã§ããããç¥ã£ã¦ããããè¨ãããã¨ã§ãã£ã¦ãå¤è¦ããè¦ããªããã°ã¨ããããå¤è¦ã§åé¡ããã®ã¯æ±ºãã¦ä¹±æ´ã§ã¯ãªããããããªããã¨ã«ã¤ãã¦ã¯éå°ãªæ¨å®ãããªãã¨ããè¬èã§ç§å¦çãªå§¿å¢ã§ããã
ãæãã¤æ°åããèå³ã®åªå¤±ããç¡ç é害ãã罪責æãã»ã»ã»ããããé ç®ãä¸å®æ°ãããã°ãã¤ç ã¨è¨ºæããã®ããè¬èã§ç§å¦çãªå§¿å¢ã§ããããã¤ç ã®è³å ãã©ããªã£ã¦ããã®ãããããããªããäºå¾ãããããããªããã©ã®æ²»çãå¹ãã®ããããããããªããããããªããã¨ã«ã¤ãã¦éå¼ã«èªãã®ã¯è»½èã§ãããããããã¨ã«ã¤ãã¦ã®ã¿éãã«èªãã®ãè³¢è ã§ãããä»ã¨ãããã確å®ã«ãããã®ã¯ãå¤è¦ã¨ãã¦ã®çç¶ãããªããçç¶ã ãã«åºã¥ãã¦åé¡ãã診æä½ç³»ã¯ãç¾ä»£ã®ç²¾ç¥å»å¦ãé大æããå°éç¹ãªã®ã§ããã
ä½ãããã¯ãã¨ãããããã§ããããéãç´ããã§ãããã¨ãæèãã¦ããªããã°ãªããªãã
ãããããµã¯ã©ã³ããã¢ã»ãã©ãã¤ã¯ã©ãã²ã¨ã¾ã¨ãã«ããã¨ããããã«ç²¾å¯ã«ç ç©¶ãã¦ãããã©ãã赤ãã¦ä¸¸ããã¨ãã以å¤ã®çµæã¯å¾ãããªããããã§ã¯ããã¾ããªã®ã§ãææã¡ã®åææè¡ãçµ±è¨ææ³ãé§ä½¿ããã°ã赤ã¨ããå¤è¦ãçºç¾ãããè²ç´ ã«ã¤ãã¦ã®ç¥è¦ãå¾ããããããããè«æã¯ã§ãããããããããªãããããã¯ãããã«ã¤ãã¦ã®æ¬æ¥ã®ç ç©¶ç®çããã¯ããé¢ãã¦ããããã¤ç ã«é¢ããç¾ä»£ã®è«æã®å¤§å¤æ°ãã¨ã¯è¨ããªãã¾ã§ããç¸å½ã®æ°ããã®åé¡ãå å¨ãã¦ãããå å¨ã¨ããããèå»¶ã¨ãã£ãæ¹ããããããããªããç¾ä»£ã®ãã¤ç æ¦å¿µããã¨ããããã®éãç´ãããçã¾ããæ«å®çãªãã®ã§ãããã¨ãå¸¸ã«æèããªããã°ããããã¨ã¤ã¯ã©ãåä¸è¦ããã¨ãã䏿¡çããå¿ ç¶çã«é¸æãããã«ãªã¹ç©ºéã彷徨ãè«æã°ãããçç£ããç¶ããã
ãã®ã«ãªã¹ã®ä¸ããçå®ãæ½åºããããã«ã¯æ°ãããã¯ããã¸ã¼ãå¿ è¦ã§ãããããã§æ£®å£ç¿å©æã¯11C-PBB3ã¨11C-PiBãæ´»ç¨ãããã©ã¡ããPETã®ã¤ã¡ã¼ã¸ã³ã°å¤ã§ãåè ã¯ã¿ã¦ãå¾è ã¯ã¢ããã¤ãβã«ç¹ç°çã«çµåãããã¿ã¦ãã¢ããã¤ãβã¨ããã°é£æ³ãããã®ã¯ã¢ã«ããã¤ãã¼ç ã§ããã¤ç ã®æèã«ç»å ´ãããã¨ã«ã¯éåæãæããããããããªãããè¨åºç«å¦çã«ã¯ãã¤ç ã¨èªç¥çã®é¢é£æ§ã¯å¾æ¥ããææããã¦ããã¨ããã§ãããã¾ããèå¹´æã®ãã¤ç ã¯ãã°ãã°ç²¾ç¥ç çç¶ãä¼´ããªã©ãè¥å¹´ã®ãã¤ç ã¨ã¯ç°ãªãç²¾ç¥ç çããããã¨ãã¾ãããç¥ããã¦ãããã赤ãã¦ä¸¸ããã¨ããç¹ã¯å ±éãã¦ãã¦ããç´°ãã観å¯ããã°ããã¤ãã®éè¦ãªç¸éç¹ãè¦ãã¦ãããããã¯å¤è¦è¦³å¯ã®æ®µéã§ã¯æ¼ ç¶ã¨ããå°è±¡ã«ãããªããããã¯ããã¸ã¼ã®é§ä½¿ã«ãã£ã¦ãèå¾ã«ããçå®ãå§¿ãç¾ãããæ¬ç ç©¶ã§æ£®å£å©æã示ããã®ã¯ããã¤ç ã®è¨ºæãæ´ç·´ããã®ã¿ãªãããæ²»çæ¹æ³ã®æé©åã«ãç¹ããè²´éãªç¥è¦ã§ããã
(ææ¾å¤ªéã2020.8.26.)
ã1ããã³ãã³ãã³èè¸ç
ã«å¯¾ãããã¬ã¯ã¹ããã©ã¾ã¼ã«ã®å¯è½æ§
ã2ãPisaçå群ãåä½µããPosterior Cortical Atrophyã®ä¸ä¾
䏿æ (æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ã»ç¥çµç§å¦æå®¤ã大å¦é¢å士課ç¨)ã1ãMimura Y, Funayama M, Oi H, Takata T, Takeuchi H, Mimura M: Effectiveness of Brexpiprazole in the Treatment in a Patient with Huntington's Disease. Psychiatry Clin Neurosci. 2020 Jan 13.
ã2ãMimura Y, Kurose S, Takata T, Tabuchi H, Mimura M, Funayama M: Pisa syndrome induced by switching of a choline-esterase inhibitor treatment from donepezil to galantamine: a case report. BMC Neurology (2020) 20:183.
ã1ãè¶³å©èµ¤ååç
é¢ã®ç
æ£ã§çµé¨ãããã³ãã³ãã³èè¸ç
ã®çä¾ãããã³ããå¾ã¦çä¾å ±åãããã
ãçä¾ã40ä»£ç·æ§ãX-7å¹´ãããµãã¤ããçªç¶é£å¨ãè½ã¨ãã¦ãã¾ããªã©ã®çç¶ãåºç¾ãããX-6å¹´ããã¦ãããã¨ãã¦å çããããX-1å¹´ãèªå·è¡çºãæ¿ãããªãå½é¢ã¸ç´¹ä»å診ãã2ã¶æã®å
¥é¢å çãè¡ã£ãããã®éã¯ãã«ããé
¸ã主å¤ã¨ãã¦å¯¾å¿ãè¡åæ§ã¯æ¹åãããéé¢å¾ãéºä¼åæ¤æ»ã®çµæãã³ãã³ãã³ç
ã¨ç¢ºå®è¨ºæããããXå¹´ãå度èªå·è¡çºãæ¿ãããªãåå
¥é¢ã¨ããããã¬ã¯ã¹ããã©ã¾ã¼ã«ã主å¤ã¨ãã¦å çããã¨ãããéåçç¶ã¨ç²¾ç¥çç¶å
±ã«åçãªæ¹åãã¿ããéå§å¾8é±éã§èªå®
éé¢ã¨ãªã£ãã
ãèå¯ããã³ãã³ãã³èè¸ç
ã¯èè¸æ§éåãèªç¥æ©è½ä½ä¸ã«å ãã¦è¡åæ§ãªã©ã®ç²¾ç¥çç¶ããããã¨ã§èããQOLãæ¸ããç¾æ£ã§ãããç²¾ç¥ç§å»ã¨ãã¦è¨ºãã¨ãã«ã¯æ£ç¢ºãªè¨ºæã¯ãã¡ãããèè¸éåãæãã¤ã¤ããã«ç²¾ç¥çç¶ãã³ã³ããã¼ã«ããããéè¦ã§ãããçµé¨ããçä¾ã¯èè¸éåãç®ç«ã¡ãããã«è¡åçãªèªå·è¡çºãæ¿ããå®¶æçè·ãå°é£ãªä¸ä¾ã§ãã£ãã
彿è¬ã«ã¤ãã¦èª¿ã¹ãã¨ããã¢ãã¢ãã³å°èãã©ã³ã¹ãã¼ã¿ã¼é»å®³è¬ã§ããããã©ããã¸ã³ããªã©ã³ã¶ãã³ã鏿è¢ã¨ã®ãã¨ã§ãã£ãã䏿¹ãã¨ãã¹ãã¼ããªãããªã³ã¬ãã«ã§ã¢ãªããã©ã¾ã¼ã«ãæ¨å¥¨ããã¦ããã¨ã®ãã¨ã§ãã£ããããã©ããã¸ã³ã¯èªå·è¡çºã®ããçä¾ã«ã¯ä½¿ç¨ãã«ãããã¾ããªã©ã³ã¶ãã³ãå
¥é¢å¾ã«èª¤å¥æ§èºçãããéé®éã®ãªã¹ã¯ããé¿ãããã¨èããã
ãã¾ãã¾ãã¬ã¯ã¹ããã©ã¾ã¼ã«ãæ¥æ¬ã§ä½¿ç¨ã§ããããã«ãªã£ã¦ããã§ãã£ããã¨ããããã¢ãªããã©ã¾ã¼ã«ãæ¨å¥¨ããã¦ããã®ã§ããã°ãã¢ãªããã©ã¾ã¼ã«ããéé®éãéä½å¤è·¯çç¶ã®ãªã¹ã¯ãä½ããã¬ã¯ã¹ããã©ã¾ã¼ã«ãæ²»çã«é©åãªã®ã§ã¯ãã¨èãå®¶æã«èª¬æã®ä¸å¦æ¹ã¨ããã
çµæã¨ãã¦ãéåçç¶ã¯æ¹åããèªå·è¡çºãç®ç«ããªããªããèº«ä½æå¶ãããã¨ãªãç
æ£çæ´»ãéããã¨ãã§ã䏿¦ã¯èªå®
éé¢ã«ã¤ãªãããã¨ãã§ãããåä½µçããªãã£ãã
ãã¬ã¯ã¹ããã©ã¾ã¼ã«ã¯ã¢ãªããã©ã¾ã¼ã«ã«æ¯ã¹ã¦D2 å容ä½ã«å¯¾ããæ´»æ§ã2/3ç¨åº¦ã§ãããã¨ã5HT1Aã5HT2Aå容ä½ã«å¯¾ããæ´»æ§ãå¼·ããã¨ãå¯ä½ç¨ï¼éé®éãéä½å¤è·¯çç¶ãã¢ã«ã·ã¸ã¢ãã¸ã¹ããã¢ãªã©ï¼ãé¿ãã¤ã¤ãèè¸éåã¨ç²¾ç¥çç¶åæ¹ã«å¹æã示ããå¯è½æ§ãããã¨èå¯ããã
ãã³ãã³ãã³èè¸ç
ã®å¯¾ççæ³ã®é¸æè¢ã¨ãã¦ä»å¾ãããªã使ç¨çµé¨ãç©ã¿ããã
ã2ããè¶³å©èµ¤ååç
é¢ããã®çä¾å ±åã§ããã
ãçä¾ã55æ³ã§çºçããPosterior cortical atrophyï¼PCAã«å¯¾ãã¦ã¬ã©ã³ã¿ãã³ã«ã¦å çããã¨ããPisaçå群ãããããä¸ä¾ãçµé¨ãããçä¾ã¯å
¸åçãªPCAã®çµéã辿ãããããã¸ã«å¡©é
¸å¡©ã§å çãã10mgã¾ã§å¢éãããçºçãã5å¹´å¾ãå¹»è¦å¦æ³ãç®ç«ã¤ããã«ãªããå½é¢ã¸å»çä¿è·å
¥é¢ã¨ãªã£ããåç¨®æ¤æ»ã®çµæãPCAã®é²è¡ã«ããçç¶å¢æªã¨è¨ºæããããããã¸ã«å¡©é
¸å¡©ã¸ã®å¿å®¹æ§ä½ä¸ããã¬ã©ã³ã¿ãã³ã¨ã¡ãã³ãã³ã«ããä½µç¨çæ³ã¸å¤æ´ããã¨ãã2é±éã§Pisaçå群ãçºçãæ©è¡é害ãåºç¾ãããã¬ã©ã³ã¿ãã³ã䏿¢ããã¨ãã2é±éã§æ¹åãããã¬ã©ã³ã¿ãã³ã«ããPisaçå群ã®å ±åã¯å°ãªãããããã¸ã«å¡©é
¸å¡©ãã夿´å¾ã®çºçä¾ã®å ±åã¯ãªããããã¾ã§æå±ããã¦ããã³ãªã³/ãããã³æ©è½ãã©ã³ã¹èª¬ä»¥å¤ã«ç·æ¡ä½å
ã®ãããã³ãã©ã³ã¹ã®ç ´ç¶»ãã ã¹ã«ãªã³/ãã³ãã³ã®ãã©ã³ã¹ãçºçã«å½±é¿ããå¯è½æ§ã示åãããã
ãèå¯ãPisaçå群ã¯1972å¹´ã«åãã¦æç²¾ç¥ç
è¬ã«ããå¯ä½ç¨ã¨ãã¦å ±åãããç¹å¾´çãªä½ä½ãããªãã¡ä½å¹¹ãå·¦å³ã©ã¡ããã¸åä½ããä½è»¸ã®å転ãä¼´ãä½ä½ãåããã¸ã¹ããã¢ã§ãããã³ãªã³ã¨ã¹ãã©ã¼ã¼é»å®³è¬ã§çºçãããã¨ã¯ç¥ããã¦ãããã5å¹´éãããã¸ã«ã§èµ·ãããªãã£ãã¸ã¹ããã¢ãã¬ã©ã³ã¿ãã³ ã¸ã®å¤æ´ã§çºçãããã¨ãè峿·±ãã¨èãå ±åããã
æ¬çä¾å ±åã«ã¯äºã¤ã®ãã¤ã³ããèããã
ä¸ã¤ã¯ã¬ã©ã³ã¿ãã³ ã§çºçãããã¨ã§ãããããã¾ã§ã¬ã©ã³ã¿ãã³ ã§ã®çºçã¯ãããªãã«å¤ãããããçºççã¯ã¬ã©ã³ã¿ãã³ã§ä¸çªå¤ãã¨ããã¦ããããä»ã®ã³ãªã³ã¨ã¹ãã©ã¼ã¼é»å®³è¬ããã®ã¹ã¤ããå¾ã«çºçããä¾ã¯ãªãã£ããã¬ã©ã³ã¿ãã³ã¯ãã³ãã³å容ä½ã«å¯¾ããã¢ãã¹ããªãã¯æ´»æ§åä½ç¨ããããã¨ããããã³ãã³å容ä½ãä»ãã¦ç·æ¡ä½ã®ãããã³æ¾åºãä¿é²ãããã¨ãç¥ããã¦ãããä¸è¦ããã¨Pisaçå群ã¨ã¯ç¸å®¹ããªãããã ããçå´Parkinsonism mouse modelã®å®é¨ãããçå´ã«ã®ã¿ãããã³æ´»æ§ãä¸ããç·æ¡ä½å
ã§ã®ãããã³æ´»æ§ãã©ã³ã¹ãå´©ãããã¨ãçºçã«å¯ä¸ããã®ã§ã¯ãªããã¨èå¯ãããããã«ãã³ãã³-ã ã¹ã«ãªã³éã®ãã©ã³ã¹ã«ããã¦ã¯ã ã¹ã«ãªã³ã«å¯¾ããæ´»æ§ãç¸å¯¾çã«å¼±ããã¨ãéä½å¤è·¯çç¶ãå¼ãèµ·ããã¦ããå¯è½æ§ãããã¨èããã
ããã«ããä¸ã¤ã¯æ¬çä¾ãè¦ç©ºéèªç¥æ©è½ä½ä¸ã主徴ã¨ããPCAçä¾ã§ãã£ããã¨ã§ãããè¦ç©ºéèªç¥æ©è½ãããã«ã¯èº«ä½çå®ä½æ©è½ã®ä½ä¸ããä½å¹¹ã¸ã¹ããã¢ãå¼ãèµ·ãããå¯è½æ§ãããã¨èå¯ããã
(䏿æ ã2020.7.20.)
解説ãCase studyãæãæªæ¥
ãã¸ã§ãã¤ã³å®¶ã®åã¤å(the Genain Quadruplets)ã¨å¼ã°ããæåãªCase studyããããå ±åè
ã§ããNIMHã®é æåããããã¼ã©(N)ãã¢ã¤ãªã¹(I)ããã¤ã©(M)ãã¸ã¹ã¿ã¼(H)ã¨ä»®åãã¤ããããä¸åµæ§ã®å人ã®å¥³å
ã¯ãå
¨å¡ãçµ±å失調çãçºçããã彼女ãã®çºçå¹´é½¢ã¯16æ³ãã24æ³ã¾ã§ã®å¹
ãããããã®å¾ã®ç
åãçµéãå人ã§å°ããã¤éã£ã¦ãããã¨ãã1950年代ããã»ã¼10å¹´ãã¨ã«çä¾å ±åã¨ãã¦çºè¡¨ããã¦ãããCase studyã¨ãã¦ã®æå¾ã®è«æã¯ã39å¹´éã®ãã©ãã¼ã¢ãããã¨é¡ããã66æ³ã«éãããã®4人ã«ã¤ãã¦ã®å ±åã§(Mirsky AF et al: Schizophrenia Bulletin 26; 699-708ï¼2000)ã2019å¹´ã«ã¯å
¨çµéã»å
¨è«æã®ããã¬ãã¥ã¼ãçºåããã¦ãã(Mirsky AF : Monte S. Buchsbaum and the Genain Quadruplets. Psychiatry Research 277; 70-71, 2019)ãããã«ã¯ãç»åæè¦ã¨è¨åºçç¶ãè¬ç©åå¿æ§ã®é¢ä¿(ãç¸é¢ãªãããçµè«)ãç¥çµå¿çå¦çæ¤æ»ã«ç¤ºãããèªç¥æ©è½ã®çµæçå¤å(ãé²è¡æ§ã®æªåãªãããçµè«)ãªã©ãè²´éãªç¥è¦ã溢ãã¦ããããããã®ç¥è¦ã¯ã©ããçµ±å失調çã«ãããæéè¦ã¨ãããè¨åºçãã¼ãã«ãããããã®ã§ãããã夿°ä¾ã対象ã¨ããç ç©¶ã§ã¯å°éãå¾ãªã精緻ãªé åã«åã¶æè¦ã示ããã¦ãããã¨ããGenain Quadruplets Studiesã®ç価ã§ãããçµ±å失調çã«éãããç²¾ç¥ç¾æ£ã¯äººéã¨ãã¦ã®å
¨ä½ãããããç
æ
ã§ããããã¤ãã¹ã¿ã¼ãã®æç¹ã§å
¨ä½ããé¨åãåãåºãã¦æ±ããããããªã夿°ä¾ç ç©¶ã§ã¯æ±ºãã¦è¦ãã¦ããªããã®ãã¾ã ã¾ã è¨å¤§ã«æ®ããã¦ããã¯ãã§ããããããã¯åä¸çä¾ã®ç²¾å¯ãªè¦³å¯ã«åºã¥ãCase studyã«ãã£ã¦ã®ã¿è¿½ç©¶ã§ããæ§è³ªã®ãã®ã§ããã
ããã¦Case studyã¯ãéã観å¯ã«ç
æ
ã«ã¤ãã¦ã®æ·±ãç¥èãå ããã°ãæ¬æ°ãªæ²»çæ³ã®éçºã®éãæãã䏿æ é¢çã®äºã¤ã®è«æããEffectiveness of Brexpiprazole in the Treatment in a Patient with Huntington's Diseaseãã¨ãPisa syndrome induced by switching of a choline-esterase inhibitor treatment from donepezil to galantamine: a case reportãã¯ãã¾ãã«ãããå®ç¾ãããä»äºã§ãããç²¾ç¥ç¥çµçç¶ã®è³å
ã¡ã«ããºã ã«åºã¥ãæ²»çè¬ã®æ±ºå®ã¯ãç²¾ç¥ç§ã«è¬ç©çæ³ãå°å
¥ããã¦ãã試è¡é¯èª¤ãç¹°ãè¿ããã¦ãã¦ãããããªããªãçè«éãã®å¹æã¯å¾ãããªãã¨ããç¾å®ãé·ãç¶ãã¦ããã¨ãããè¿å¹´ããããçè«ã¨è¨åºãä¸è´ããã±ã¼ã¹ãè¦ãããããã«ãªã£ãæãããããã ããã®ããã«ã¯ãè¨åºè¦³å¯ã«ãã£ã¦çç¶ã®æ¬è³ªãè¦æãæ
§ç¼ã¨ãè¨åºã¨åºç¤ã®ä¸¡é¢ã«ãããç²¾å¯ãªç¥èãå¿
è¦ã§ããããã®ä¸¡æ¹ãå
¼ãåãã䏿é¢çã¯ã次ã
ã¨è²´éãªä¸ä¾å ±åãçºè¡¨ãã¦ããããããã¯åççãªæ²»çæ³éçºã¸ã®è²´éãªç¤ç³ã«ãªãã¨åæã«ãå ±åããããæ¬äººã«å¯¾ãã¦ãä»ã§ã¯ã¾ãã§ããªãã£ãæè¯ã®æ²»çãæä¾ãã¦ããã¨ããç¹ã§ãé常ã«å¤§ããªæç¾©ãæã¤ãã®ã§ããã
(ææ¾å¤ªéã2020.7.31.)
ITã«ããã¢ããã¼ããCOVID-19ãã³ãããã¯ã®æéã®ç·åç
é¢ç²¾ç¥ç§ã«ãããç²¾ç¥ç§æ²»çãä¿é²ãããå¯è½æ§
è¹å±±ééã(è¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§é¨é·)New information technology (IT)-related approaches could facilitate psychiatric treatments in general hospital psychiatry during the COVID-19 pandemic.
Michitaka Funayama, Shin Kurose, Shun Kudo, Yusuke Shimizu, Taketo Takata
Asian Journal of Psychiatry 54 (2020) 102239
ãèæ¯ãCOVID-19ã®ãã³ãããã¯ã¯ã身ä½é¢ã®ã¿ãªããç²¾ç¥é¢ã«ãå¤å¤§ãªå½±é¿ãåã¼ããã¨ãæããã«ãªã£ã¦ãããCOVID-19ã®ææè ã«åºç¾ããç²¾ç¥çç¶ãCOVID-19ã®æ²»çè ã«çããç²¾ç¥çãªã¹ãã¬ã¹ã¨ãã£ãææã«ããç´æ¥çãªå½±é¿ã®ã¿ãªããã社ä¼ã®å¤åã«ãã鿥çãªå½±é¿ã大ãããå¤åºèªç²ã妿 ¡ã®é·æä¼æ¥ãããã¯ãã¦ã³ãªã©ã¨ãã£ã社ä¼çéé¢ããã¹ã¡ãã£ã¢ããã®ä¸å®ãç ½ãå ±éã䏿³ãç£æ¥æ§é ã®å¤åãªã©ããã¾ãã¾ãªç¤¾ä¼ã®å¤åãå¤ãã®äººã ã®ç²¾ç¥é¢ã«å½±é¿ãåã¼ãã¦ãããè¶³å©èµ¤ååç é¢ã§åããç¯å²ã§ããã®ã ããCOVID-19ã«ææããã¨ãã妿³ãã1ä¾ã¯èªæ®ºæ¢éããã1ä¾ã¯æ¥µç«¯ãªä½æ é¤ã«è³ã£ã¦äº¡ããªããªã©ãåè¨2人ãCOVID-19ã®ãã³ãããã¯ã«ãã鿥çãªå½±é¿ã«ãã£ã¦äº¡ããªã£ã¦ãããCOVID-19ã«ããç²¾ç¥çç¶ã«é¢ããã¬ãã¥ã¼ããããä¸å®ããã¤ç ã«ä¼´ãçç¶ãå¤ãåºç¾ãããã¨ãæããã«ãªã£ã¦ããããããã®çç¶ã«å¯¾ãã¦ã¯ç·åç é¢ç²¾ç¥ç§ãç²¾ç¥ç§ã¯ãªããã¯ã¨ä¸¦ãã§æ²»çããå ´æã§ããã¯ããªã®ã ããããããã®å¤æ¥ã§ã¯ç·æ¥äºæ 宣è¨å¾ã«ã¯å診ã®äººæ°ããã以åã¨æ¯ã¹ã¦ç´ååã«æ¸å°ãããåæ§ã«ãã¤ã¿ãªã¢ã§ã¯COVID-19ã®ãã³ãããã¯ã«ä¼´ã£ã¦ç·åç é¢ç²¾ç¥ç§ã«å ¥é¢ããæ£è ã®æ°ãæ¸å°ãã¦ãããã¨ãæããã«ãªã£ã¦ããããã®åå ã¯ç·åç é¢ã®ä¸ã§ææãã¦ãã¾ãã¨ããæ£è ã®ææå¿ããã¯ãªããã¯ããã®ç´¹ä»ã®æ·å± ãé«ããªã£ã¦ãããã¨ãåå ã§ããã¨ã¤ã¿ãªã¢ã§ã¯è¨ããã¦ããã
ãè¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§ã§ã®åãçµã¿ããããã®ç¶æ³ãèæ
®ãã¦ãè¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§ã§ã¯ITã«ããæ°ããªã¢ããã¼ããéå§ãã¦ãæ£è
ã®ææã®ææå¿ãæå°éã«ãããã¨ã試ã¿ãã夿¥ã§ã¯ããã§ã«æ
¶æç¾©å¡¾å¤§å¦ç²¾ç¥ç¥çµç§ã§ä»¥åããåãå
¥ãããã¦ããé éå»çãæ©æ¥ã«å°å
¥ãããç·æ¥äºæ
宣è¨å¾ã«ã¯ç
é¢ã®éé¢ãæ§ããããã«æ¥æ¬å
¨å½ã§é»è©±ã«ããåè¨ºãæ¥å¢ããããé»è©±è¨ºçã¨ç°ãªããªã³ã©ã¤ã³ã«ãã診çã§ã¯æ
å ±éãå§åçã«å¤ããç¹ã«ãç²¾ç¥ç§ã®é¢æ¥ã診æã«ããã¦æãéè¦ã§ããæ£è
ã®é°å²æ°ã表æ
ãä»èãæç¢ºã«å¤æã§ãããæ£è
ã«ã¨ã£ã¦ã¯ææã®å±éºæ§ã®å¿é
ãããã«å®å¿ãã¦å診ãã§ããéã«çºç±ãããããã«ç
é¢å
ã«å
¥ãã«ããæ£è
ã«ããªã³ã©ã¤ã³ã«ãã診çã¯ã¹ã ã¼ãºã«è¡ãããé«é½¢è
ãªã©ITã«ç¸ãæ·±ããªãæ£è
ã®å ´åã«ã¯ãITã«è©³ãã夿¥çè·å¸«ããªã³ã©ã¤ã³è¨ºå¯ã®å°å
¥ã«å¿
è¦ãªã¢ããªã®ã¤ã³ã¹ãã¼ã«ãä½¿ãæ¹ã説æãã¦ããã
ç
æ£ã«é¢ãã¦ã¯ãææäºé²ã®ããã«ç²¾ç¥ç§ç
æ£ã®ã¿ãªããå
¨å½ã®ç
é¢ã®ç
æ£ãæ½è¨ã§é¢ä¼ç¦æ¢æªç½®ãæ½è¡ããããããããé¢ä¼ç¦æ¢æªç½®ã«ãã£ã¦å
¥é¢æ£è
ã®ç²¾ç¥ç¶æ
ãæªåããä¾ãæ£è¦ãããããã«ãªã£ããããã§å½é¢ç¥çµç²¾ç¥ç§ç
æ£ã§ã¯ãå®¶æãæ£è
ã®è·ç©ãæ¥ç¨åãæã£ã¦ããéã«ãã¿ãã¬ããé¢ä¼ããå§ãããå®éã«ããã®å½¢å¼ã®é¢ä¼ã«ãã£ã¦å¤§ããªå®å¿ã«ã¤ãªããå ´åããããåç
室ã§ã®free Wi-Fiã®å°å
¥ã«ãã£ã¦ã¯ãã¿ãã¬ããããã½ã³ã³ä¸ã§ã®é¢ä¼ãèªå®
ã¨ç
室ã§ç´æ¥çã«ã§ããããã«ãªãå¯è½æ§ãããã
ãã®é éå»çãã¿ãã¬ããé¢ä¼ã®å½¢å¼ãå¿ç¨ãã¦ãå½é¢ç¥çµç²¾ç¥ç§ç
æ£ã«COVID-19ã®æææ£è
ãå®éã«å
¥é¢ããå ´åã«ã¯ã¿ãã¬ãã診å¯ã試ã¿ããã¨èãã¦ãããããªãã¡ãããç¨åº¦ITã使ããã¬ãã«ã®ç²¾ç¥ç¶æ
ã®æ£è
ã§ããã°ãææäºé²ã®è¦³ç¹ããæ£è
ã¨å»å¸«ãããã¯æ£è
ã¨çè·å¸«ã¨ã®æ¥è§¦åæ°ãæ¸ããããã«ãã¿ãã¬ããã«ãã診å¯ãç¶æ
確èªãæ¨é²ãã¦ãããã¨èãã¦ããã
è«æã«ã¯è¨è¼ããªãã£ãããæ²»çã®å¿
è¦ã®ããæ£è
ã«ç·åç
é¢ç²¾ç¥ç§ã¸ã®å診ãä¿ããããå°å
ã®ä¿å¥æããã³å»å¸«ä¼ãçã®å¥åº·å¢é²èª²ãç²¾ç¥ä¿å¥ç¦ç¥ã»ã³ã¿ã¼ããã®ã¡ã®é»è©±ã«ç¶æ³ãå ±åããå°åã®å¸æ°ãå½é¢ç¥çµç²¾ç¥ç§ã«ã¦å®å
¨ã«ç²¾ç¥ç§æ²»çãåãããããã¨ãå¨ç¥ãã¦é ãããã«ä¿ãããããã«ãä¿å¥æãéãã¦åå®¶åºã«é
å¸ãããåºå ±èªã«ããä¸è¨ã®ä¸é¨ã®å
å®¹ãæ²è¼ãã¦æ
å ±ãåºããã
ãããã®ITãå«ããåãçµã¿ã«ãã£ã¦ãä»å¾ãæç¶çã«èµ·ããã§ãããCOVID-19ã®æµè¡æã«ããå¤ãã®äººã
ã«é©åãªç²¾ç¥ç§å»çãæä¾ã§ããä½å¶ãæ´ãã¦ããã¤ããã§ããã
(è¹å±±ééã2020.6.28.)
COVID-19ã¨èªéçç ç©¶ï¼ä¸çåå°ããã®è¦ç¹
çï¨åä¸ (å½ç«ç²¾ç¥ã»ç¥çµå»çç ç©¶ã»ã³ã¿ã¼ ç²¾ç¥ä¿å¥ç ç©¶æå
ç«¥ã»äºé²ç²¾ç¥å»å¦ç ç©¶é¨ å
ç«¥ã»éå¹´æç²¾ç¥ä¿å¥ç 究室)Kumazaki H, Muramatsu T, Yoshikawa Y, Ishiguro H, Mimura M: COVID-19 and Autism Research: Perspectives from Around the Globe. Autism Research. 13: 844â869. 2020.
COVID-19åã³ãããã¯ãã¦ã³ã¯èªéã¹ãã¯ãã©ã çè ã«ã大ããªå½±é¿ãä¸ãã¦ãããããã¦èªéçç ç©¶ã«ãå½±é¿ãä¸ãããã¨ãäºæ³ããããæ¬è«è©ã¯ä¸çåå°ã®èªéçç ç©¶è ãåå°ååã³ããããã®ç ç©¶é åã®è¦ç¹ããèªéçç ç©¶ã¸ã®å½±é¿ã«ã¤ãã¦è¿°ã¹ããã®ã§ãããæã ï¼çï¨ãææ¾ãåå·ãç³é»ã䏿ï¼ã¯ãã³ããä¸ã«ãããèªéçè ã¸ã®ããããç ç©¶ã®å¿ è¦æ§ãã¨ããã¿ã¤ãã«ã§ãã¾ãã³ããç¶æ³ä¸ã«ããããããããç¨ããæç¨æ§ãæ½å¨æ§ã«ã¤ãã¦è¿°ã¹ãã䏿¹ã§ãããããã®ä½¿ç¨ã«ãããã²ããããã®æªåãããããä¾åãèµ·ããå±éºæ§ã«ã¤ãã¦ãè¨ãããèªéã¹ãã¯ãã©ã çã®æ¯æ´ã«ã¯é·æçè¦ç¹ãä¸å¯æ¬ ã§ããããããããç¨ãããã¨ã§çºçããåé¡ã«çæããªãããç ç©¶ãé²ãã¦ãããã¨ãéè¦ã¨èãã¦ããã
(çå´åä¸ã2020.6.29.)
解説ãCOVID-19ã®ç²¾ç¥ç§ã¸ã®å½±é¿ã¨å¯¾å¿: éå ±
COVID-19 (æ°åã³ããã¦ã£ã«ã¹)ã®æææ¡å¤§ã¯ç²¾ç¥å»çã«ãå½ç¶ã«å·¨å¤§ãªå½±é¿ãä¸ãããç¹ã«æ¥éã«ã¯ãã¼ãºã¢ããããããã®ã¨ãã¦é éå»çã¨ããããã®æ´»ç¨ããããã©ã¡ããæã ã®ã°ã«ã¼ãã徿¥ããéçºã«åãã¦åãæ³¨ãã§ãããã¼ãã§ããããããæ³çè¦å¶çã®ããæè¡ãç¾å ´ã«å±ãã«ããç¶æ ãç¶ãã¦ãããããã®æ©ä¼ã«å£ãåãæãã䏿°ã«èºé²ããæããããããã¦è«æã®å½¢ã«ããä¸çã¸ã®çºä¿¡ãæéã§ãã£ãã
è¹å±±é¨é·ã®è«æã¯ãç²¾ç¥å»çå ´é¢ã§ã®ITå°å ¥ã®å®ä½é¨ãéãã¦ã®ç²¾ç¥ç§æ²»çã®ä¿é²ã®å¯è½æ§ãè«ãããã®ã§ãçå ±ã ãå 容ã¯ããªãè±å¯ã§ãããã¨ãããµãã«è¦ç´ãã¦ãã¾ãã¨çä¾¡ã«æ°ã¥ãã使°ãªãééãã¦ãã¾ãããã ããæãå½ã§COVID-19ç·æ¥äºæ 宣è¨ãåºãããã®ã2020å¹´4æã§ããã®è«æçºåã2020å¹´6æãããã¦ãã®å 容ãå®éã®è¨åºå ´é¢ã§ã®æ°ã ã®è©¦ã¿ã®å ±åã§ãããã¨ãè¦ãã°ãã³ããç¦ã«å¯¾ãã¦è¹å±±é¨é·ãããã«è¿ éãã¤ç²¾åçã«å¯¾å¿ãããã宿ãããã¨ãã§ããããã®èæ¯ã«ã¯æ¥ã ç©ã¿éãã¦ããç ç©¶ã®èç©ãããã¦ãã¡ããå¸¸ã«æ£è ã«ã¨ã£ã¦æåã®å»çãæä¾ãããã¨ããè¹å±±é¨é·ã®è¨åºå®¶ã¨ãã¦ã®ç±æãããã
çå´å®¤é·ã®è«æã¯ãå½¼èªèº«ãEditorãåããAutism Researchããã®ä¾é ¼å稿ã§ãCOVID-19ãã³ãããã¯ã®èªéã¹ãã¯ãã©ã çç ç©¶ã¸ã®å½±é¿ã«ã¤ãã¦ã®ãä¸çä¸ã®ãã®åéã®ç¬¬ä¸ç·ã®ç ç©¶è ãã¡ã®å ±åã®ç¹éã®ä¸ç°ã¨ãã¦æ¸ããããã®ã§ããããã¡ããçå ±ã§ããããè«ç¹ã®è¨è¼ãå¿ è¦ååã«ãªããã価å¤ã®é«ãessayã§ãããã½ã¼ã·ã£ã«ãã£ã¹ã¿ã³ã¹ãæ¨å¥¨ããã社ä¼ã¯ãããããã«ã¨ã£ã¦ã¯ãã¾ã ãã¤ã¦ãªãã£ã追ã風ã§ãããã ãããã«å¥¢ããã¨ãªãããã®ãããªè¿½ã風ã®ä¸ã«ãã£ã¦ãããããããå°å ¥ã«ãããã¤ãã¹é¢ãæèããªããã°ãªããªãã¨ãããçã«è¯å¿çãªå®è·µå®¶ã®å§¿å¢ãæ·¡ã ã¨ããããéå¼ã«ç¶´ããã¦ããã
(ææ¾å¤ªéã2020.6.30.)
èªéçã¹ãã¯ãã©ã çè
ã®éè¨èªæ§ã³ãã¥ãã±ã¼ã·ã§ã³æ¹åãç®æããã¢ã³ããã¤ããããããç¨ããå°±è·é¢æ¥è¨ç·´
çï¨åä¸ (å½ç«ç²¾ç¥ç¥çµå»çç ç©¶ã»ã³ã¿ã¼ç²¾ç¥ä¿å¥ç ç©¶æãå
ç«¥ã»äºé²ç²¾ç¥å»å¦ç ç©¶é¨ å
ç«¥ã»éå¹´æç²¾ç¥ä¿å¥ç 究室ã室é·)Kumazaki H, Muramatsu T, Yoshikawa Y, Corbett BA, Matsumoto Y, Higashida H, Yuhi T, Ishiguro H, Mimura M, Kikuchi M. Job interview training targeting nonverbal communication using an android robot for individuals with autism spectrum disorder. Autism. 23(6):1586-1595. doi: 10.1177/1362361319827134. 2019.
èæ¯ï¼é«æ©è½èªéçã¹ãã¯ãã©ã çï¼HFAï¼è ã«ã¨ã£ã¦ãå°±è·é¢æ¥ã¯é©åãªéè¨èªæ§ã³ãã¥ãã±ã¼ã·ã§ã³ãåããã¨ãé£ãããã¨ããã大ããªéå£ã¨ãªã£ã¦ãããå¤ãã®æ¯æ´è ã¯ãéè¨èªæ§ã³ãã¥ãã±ã¼ã·ã§ã³ã®ã¹ãã«ãæãããã¨ãé£ããã¨æãã¦ããç¾ç¶ããããããããã¯ãã®æ¯ãèãã«è¦åæ§ãèªãããã¨ãç´°ããåãã®èª¿æ´ãå¯è½ãªãã¨ãASDè ãæå 端ã®ç§å¦æè¡ã¸ã®èå³ãèãããã¨ãåã³ASDè ã®å ·ä½çã»è¦è¦çãªå¼·ããèæ¯ã«HFAè ã«ã¨ã£ã¦é åçãªã¤ã³ã¿ã©ã¯ã·ã§ã³ã®å¯¾è±¡ã¨ãªããã¨ãæå¾ ããããã¢ã³ããã¤ãããããã¯å¤è¦ãããã«é ·ä¼¼ããããããã§ããããæ¬ç ç©¶ã§ã¯ãã¢ã³ããã¤ããããããç¨ããæ¨¡æ¬é¢æ¥è¨ç·´ããã°ã©ã ï¼MUAï¼ãéçºããã®å¹æãæ¤è¨¼ããã
æ¹æ³ï¼ MUAã¯ä»¥ä¸ã®3ã¤ã®ã¹ãã¼ã¸ããæ§æããã¦ããã1)ã¢ã³ããã¤ããããããé éæä½ããã¢ã³ããã¤ããããããä»ãã¦é¢æ¥è ã¨ä¼è©±ããï¼é¢æ¥å®ã®å½¹å²ã®æ¨¡æ¬ä½é¨ï¼ã2)ã¢ã³ããã¤ããããããç¨ãã¦å¯¾é¢ã§æ¨¡æ¬å°±è·é¢æ¥ãè¡ãï¼é¢æ¥åé¨è ã®æ¨¡æ¬ä½é¨ï¼ã3)ã¢ã³ããã¤ããããããç¨ãã颿¥ã®æ¯ãè¿ãã¨éè¨èªæ§ã³ãã¥ãã±ã¼ã·ã§ã³ã®ç·´ç¿ãåå è ã¯ããæå¡ã«ãã颿¥æå°ï¼IGTï¼ã¨MUAã®ä½µç¨ä»å ¥ãï¼n=13ï¼ã¨ãIGTåç¬ä»å ¥ãï¼n=16ï¼ã®2群ã«ç¡ä½çºã«å²ãä»ãããããä»å ¥ã®åå¾ã«ã両群ã®åå è ã¯äººéã®é¢æ¥å®ã«ããæ¨¡æ¬é¢æ¥ãåããéè¨èªæ§ã³ãã¥ãã±ã¼ã·ã§ã³ã颿¥ã¸ã®èªä¿¡ã徿¶²æ§ã³ã«ãã¾ã¼ã«ã«ããè©ä¾¡ãè¡ã£ãã
çµæï¼MUAã®å¾ãå¯¾ç §ç¾¤ã®åå è ã¨æ¯è¼ãã¦ãIGTã¨MUAã®ä½µç¨ä»å ¥ãåããåå è ã¯ãéè¨èªçãªã³ãã¥ãã±ã¼ã·ã§ã³ã¹ãã«åã³é¢æ¥ã¸ã®èªä¿¡ã®æ¹åã示ãããã¾ã徿¶²ã³ã«ãã¾ã¼ã«ã®ææãªæ¸å°ã示ããã
çµèªï¼æ¬ç ç©¶ã§ã¯ãã¢ã³ããã¤ããããããç¨ããæ¨¡æ¬é¢æ¥ããã°ã©ã ã®æç¨æ§ã示ãããã
(çå´åä¸ã2020.6.1.)
èªéã¹ãã¯ãã©ã çè
åãã«éçºããç°¡ç´ ãªã´ã¡ã¼ãã£ã«ãªã¼ãã£ã¨ã³ã¹ãç¨ããã¹ãã¼ãç·´ç¿æ³ã®æç¨æ§
çï¨åä¸ (å½ç«ç²¾ç¥ç¥çµå»çç ç©¶ã»ã³ã¿ã¼ç²¾ç¥ä¿å¥ç ç©¶æãå
ç«¥ã»äºé²ç²¾ç¥å»å¦ç ç©¶é¨ å
ç«¥ã»éå¹´æç²¾ç¥ä¿å¥ç 究室ã室é·)Kumazaki H, Muramatsu T, Kobayashi K, Watanabe T, Terada K, Higashida H, Yuhi T, Mimura M, Kikuchi M. Feasibility of autism-focused public speech training using a simple virtual audience for autism spectrum disorder. Psychiatry and Clinical Neuroscience.74(2):124-131.
èæ¯: 大å¢ã®åã§è©±ããã¨ã¯èªéã¹ãã¯ãã©ã çï¼ASDï¼è ã«ã¨ã£ã¦ãã£ã¨ãä¸å®ãå¼ãèµ·ããç¶æ³ã®ä¸ã¤ã§ãããç¾å¨ã¾ã§ã¨ããã³ã¹ã®ããä»å ¥æ¹æ³ã¯ã»ã¨ãã©åå¨ãããããããã¹ãã¼ãç·´ç¿ãè¡ãæ©ä¼ã¯éããã¦ãããæã ã¯ãä¸è¬çãªã´ã¡ã¼ãã£ã«ãªã¼ãã£ã¨ã³ã¹ã¨ã¯ç°ãªããã·ã³ãã«ãªé¡è¡¨æ åã³ç®ã強調ããç¹ã§ç¹å¾´çãªãç°¡ç´ ãªã´ã¡ã¼ãã£ã«ãªã¼ãã£ã¨ã³ã¹ãç¨ãã大è¡ã®åã§ã®ã¹ãã¼ãç·´ç¿æ³(APSV)ãéçºãããæ¬ç ç©¶ã§ã¯ASDè ã®æè²æ¹æ³ã¨ãã¦ã®APSVã«ãããå®è¡å¯è½æ§ã®è©ä¾¡ãç®çã¨ããã
æ¹æ³: 15åã®ASDç·æ§ãã©ã³ãã ã«2群ã«å²ãä»ãããããä¸ã¤ã®ã°ã«ã¼ãï¼8åï¼ã¯APSVã«ããå¦ç¿(APSV群), ããä¸ã¤ã®ã°ã«ã¼ã(7å)ã¯èªç¿å¦ç¿ç¾¤ã¨ããã2æ¥ç®ãã6æ¥ç®ã¾ã§APSV群ãèªç¿å¦ç¿ç¾¤ã¨ãã«ãå®éã«å¤§è¡ã®åã§ã®ã¹ãã¼ãã«ããã¦ããèããã質åã«å¯¾ãã声ãåºãã¦åçããããã«ä¿ããããAPSV群ã§ã¯APSVã·ã¹ãã ã®åã§ç·´ç¿ãè¡ã£ããèªç¿å¦ç¿ç¾¤ã§ã¯ç©ºã室ã§ç·´ç¿ãè¡ã£ããè¨ç·´ã®åå¾ã§ä¸¡ç¾¤ã®åå è ã¯ã¹ãã¼ã模æ¬ç·´ç¿ãç´10åéã10人ã®è´è¡ã®åã§è¡ãã大è¡ã¸ã®ã¹ãã¼ãã«é¢ããèªä¿¡ã«ã¤ãã¦ã®è³ªåç´ã徿¶²ã³ã«ãã¾ã¼ã«ã«ããè©ä¾¡ãè¡ã£ãã
çµæ: è¨ç·´ã®åå¾ã§ãAPSV群ã§ã¯èªç¿å¦ç¿ç¾¤ã¨æ¯ã¹ã¦å¤§è¡ã¸ã®ã¹ãã¼ãã«ã¤ãã¦ã®èªä¿¡ãæ¹åãã徿¶²ã³ã«ãã¾ã¼ã«ã®ã¬ãã«ã¯èããä½ä¸ãããASDè ã«ããã¦ãAPSVã¯èªä¿¡ãæ¹åãããã¹ãã¼ãã«ãããã¹ãã¬ã¹ãä½ä¸ãããã
çµè«: APSVã¯ASDè ã«ã¨ã£ã¦ã¹ãã¼ãã«ã¤ãã¦ã®èªä¿¡ã®æ¹åãã¹ãã¬ã¹ã®è»½æ¸ã«æç¨ãªãã¨ãäºåçã«ç¤ºããããä»å¾ã¯ããå¤§è¦æ¨¡ã§å¤æ§ãªãµã³ãã«ãç¨ããã縦æçãªãã¶ã¤ã³ãç¨ããç ç©¶ãããã«é²ãã¦ãããã¨ãéè¦ã¨èãã¦ããã
(çå´åä¸ã2020.6.2.)
解説ã2種é¡ã®å°æ¥ã«ç®ãåãã¦
ASDè ã¯ã人ã¯è¦æã§æ©æ¢°ã¯å¾æã§ãããããã¯ãã¾ãã«åç´åããããã¾ã¨ãæ¹ã§ã¯ããããå ¨ä½çãªå¾åã¨ãã¦ã¯äºå®ã§ããããããã£ã¦ãã®äºã¤ã®è«æã§çå´å®¤é·ãæ±ã£ã¦ãããããããã´ã¡ã¼ãã£ã«ãªã¼ãã£ã¨ã³ã¹ã¯ASDè ã«ã¨ã£ã¦æé©ã¨ãè¨ãã対象ã§ãããã¨ããããã徿ãªå¯¾è±¡ã ãããã¾ãå°å ¥ãã¹ã ã¼ã¹ã§ãããè¤éã»ææ§ãªæ å ±å¦çãè¦æã§ãå¤åã«ãå¼±ãã¨ããASDè ã®ç¹æ§ã«å¯¾ãããããããã´ã¡ã¼ãã£ã«ãªã¼ãã£ã¨ã³ã¹ã¯å¤è¦³ãåããã·ã³ãã«ã§ãããã¾ããããããã¯å£°ã®ç´°ãã調æ´ãå¯è½ã§ãããã¨ãããè´è¦éæã¸ã®å¯¾å¿ããããããããã¦ç ç©¶ã¨ãã¦è¡ãã¨ããå®é¨ã®ç¶æ³ãã³ã³ããã¼ã«ããããã¨ãã大ããªç¹é·ãè¦éããªããASDè ã¨ç身ã®äººéã¨ã®äº¤æµã§ã¯ãããããç¸æ§ã«ãã£ã¦æ§ã ãªå·®ãçºçãããããããã«å®é¨æ¡ä»¶ããããã¦ããä»ã®äººéã¨ã®äº¤æµã§åãçµæãåºãã¨ã¯éããããã¼ã¿ã®åç¾æ§ã«å¤§ããªåé¡ããããããããã使ç¨ããå®é¨ã§ã¯ãã®åé¡ã¯åé¿ã§ãããããããç§å¦çã«ä¿¡é ¼ã§ãããã¼ã¿ãå¾ããã¨ãã§ããã
ããããã¡ãªãããé§ä½¿ããç ç©¶ã«ãã£ã¦åºãããçå´å®¤é·ã®ãã¼ã¿ãããASDè ã®ç¤¾ä¼é©å¿ã«åãã¦ã®å¤§ããªå¸æãçã¾ãã¦ãããåªããè½åãæã¡ãªããç¤¾ä¼æ§ã®åé¡ã®ããã«é©å¿å°é£ã¨ãªãè½åãçºæ®ãã«ããASDè ã«ããã¦ããããããªã©ã®ãã¯ããã¸ã¼ãæ´»ç¨ããè¨ç·´ã®å¹æã証æãããã¼ã¿ã¯ãå°æ¥ã¸ã®æããæå¾ ãç¹ãã§ããã
ããã§ãããå°æ¥ãã¨ã¯ãASDè å ¨ä½ã«ã¨ã£ã¦ã®æå³ã大ããããåçããã以ä¸ã«éè¦ã§ããã¤æ éãè¦ããã®ã¯ãASDè å人ã«ã¨ã£ã¦ã®å°æ¥ã«ã¤ãã¦ã§ããããã¨ãã°ãASDè ã«ã¨ã£ã¦ãããããã¯ãã¼ã«ããã¼ããã¼ãã¨ããåé¡ããããå°±è·é¢æ¥ã®ã¯ãªã¢ã¨ãããããªçæçã´ã¼ã«éæãç®æãè¨ç·´ã«ããã¦ã¯ãããããããã¼ã«ã§ããã¨ããä½ç½®ä»ãã¯æç¢ºã§ãããããã®ä½¿ç¨ã¯éå®ãããæéã«ã¨ã©ã¾ã£ã¦ããã䏿¹ãããé·æçã§å¤§ããªã´ã¼ã«ããã¨ãã°ã³ãã¥ãã±ã¼ã·ã§ã³è½åã®åä¸ãç®æãã¨ãã¯ãããé·ãæéã«ããã£ã¦ãããã使ç¨ãå¿ è¦ã«ãªãã§ããããããããã¯ãASDè ã«ã¨ã£ã¦å¯¾äººå°é£ã®åå ã¨ãªãè¦ç´ ãæé¤ãããæ¬ä¼¼äººéã¨ããç¹é·ãæã£ã¦ããããããã¯ããªãã¡ããããã¯ãã¼ã«ã§ãªããã¼ããã¼ã«ãªã£ã¦ãã¾ãã¨ããå±éºæ§ãæ½å¨ãã¦ããã¨ãããã¨ã§ããããããä¾åã¨ããåä¾ããããASDè ããããä¾åã«ãªããããã¨ããã®ã¯ãå¤ãã®ç ç©¶ãå ±éãã¦åºãã¦ããçµè«ã§ããã®èæ¯ã«ã¯ãASDè ãæ©æ¢°ã好ãã対人交æµãè¦æããªã©ã®çç±ãããã社ä¼ã¨ããè¦çãªç¶æ³ãããããã«éé¿ããããã«å®ä½ãã¦ãã¾ã£ãçµæãããããä¾åã¨ããç çã«ãªããã²ãããããã¾ãã¾ãå©é·ããã®ã§ããããããããã´ã¡ã¼ãã£ã«ãæ²»çã«ç¨ããã®ã¯äººã¨ã®äº¤æµã¨ããã´ã¼ã«ã®ããã®ã¹ãããã§ãã£ãã¯ãããããã«éé¿ãå®ä½ãããããããã´ã¡ã¼ãã£ã«ããã¼ããã¼ã¨ãããã¨ã§æºè¶³ããããã£ã¦äººã¨ã®äº¤æµããªããªã£ã¦ããç¶æ³ã«ãããªãã°ãããã¯ä¾åã¨ããã¹ãã§ããããä»å¾ã½ã¼ã·ã£ã«ããããããã´ã¡ã¼ãã£ã«ãªã¢ãªãã£ããã£ã¨é²åãæ©è½ãåä¸ããã°ãä¾åã®ãããã¯ããã«å¢å¤§ããã
è«æã«ã¯ãããããã¨ã¾ã§ã¯æ¸ããã¦ããªããã常ã«è¨åºã§å¤ãã®ASDè ã«æ¥ãã¦ããçå´å®¤é·ã®ç ç©¶ã¯ãç®å ã®ãã¸ãã£ããã¼ã¿ã«ã¨ãããããæ¬äººã®æé·ãè¦éã«å ¥ãã¦è¡ããã¦ãããASDè ã«ããã¦ããããããã´ã¡ã¼ãã£ã«ã¯ããã¾ã§è¨ç·´ã®ãã¼ã«ã§ãã£ã¦ã人éã¨ã®äº¤æµã¸ã®ã¹ãããã§ããã¨ããã®ããã®ç¨®ã®ç ç©¶ã®æãéè¦ãªåç¹ã§ããã
(ææ¾å¤ªéã2020.6.28.)
䏿¢æ§èªå¾ç¥çµãããã¯ã¼ã¯ãå«ããè³å
¨ä½ã§è³è¡æµã®äº¢é²ãèªããæªæ§ç·å¼µç
ã®ï¼ä¾
é»ç¬å¿ (è¶³å©èµ¤ååç
é¢ãç¥çµç²¾ç¥ç§ãå»å¡)Kurose S, Koreki A, Funayama M, Takahashi E, Kaji M, Ogyu K, Takasu S, Koizumi T, Suzuki H, Onaya M, Mimura M. Resting-state hyperperfusion in the whole brain: A case of malignant catatonia that improved with electric convulsion therapy. Schizophr Res, 2019. 210. 287-288
ç·å¼µç çç¶ã«èªå¾ç¥çµé害ãã¨ããªãå ´åãæªæ§ç·å¼µç ã¨ãã°ããããã¤ã¦ã¯è´æ»æ§ã«ã¿ããã¢ã¨è¨è¼ããã¦ããããæªæ§çå群ã¨ã®çç¶ã®é¡ä¼¼ç¹ããè¬å¤æ§ã®ãã®éè¬å¤æ§ã®ãã®å«ãã¦ãPhilbrick and Rummansï¼1994ï¼ãæªæ§ç·å¼µç ã¨åä»ãããé »èã»çºæ±ã»çºç±ãªã©ã®èãã交æç¥çµç³»ã®éæ´»åã¨çå¼·åãç æ ã®ä¸æ ¸ã§ãããè±æ°´ãæ¥æ§è ä¸å ¨ã横ç´çèè§£çãå°¿éã»å°¿è·¯ææçãèª¤å¥æ§èºçãæè¡çãæ·±é¨éèè¡æ çã»èºå¡æ çã䏿´èãå¼å¸ä¸å ¨ã¨ãã£ãæ§ã ãªèº«ä½åä½µçãåãããã°ãã°æ²»çã«é£æ¸ããã
ç·å¼µç ã®éå»ã®è³ç»åç ç©¶ã§ã¯ãè£è¶³éåéãå«ãç®è³ªåºåºæ ¸è·¯ãç¼çª©åé ç®è³ªãå«ãåé é é ãããã¯ã¼ã¯ã®ç°å¸¸ãææããã¦ããããèªå¾ç¥çµé害ãä¼´ããªã軽çä¾ã®æ¨ªæç ç©¶ã«ã¨ã©ã¾ã£ã¦ãããæã ã¯å°¿éãå°¿è·¯ææçãæ·±é¨éèè¡æ çã巨大èè±ã巨大çµè ¸ãªã©ã®æ§ã ãªèº«ä½åä½µçãã¨ããªãä¿®æ£å黿°ããããçæ³ã§è»½å¿«ããæªæ§ç·å¼µç ã®ï¼ä¾ã§æ²»çåå¾ã«MRIã®arterial spin labelling (ASL) ã«ããè³è¡æµè©ä¾¡ãè¡ã£ããéå»ã«å ±åããã¦ããè£è¶³éåéã ãã§ãªããå帯ç¶ç®è³ªãå³¶ãææ¡ä½ãè¦åºä¸é¨ãåºåºæ ¸ã§è¡æµã亢é²ãã¦ããã黿°ããããçæ³ã«ããæ£å¸¸åãããç¹ã«ãå帯ç¶ç®è³ªãå³¶ãææ¡ä½ãè¦åºä¸é¨ã¯èªå¾ç¥çµç³»ã調ç¯ãã䏿¢ã§ããthe central autonomic network (CAN)ã§ä¸å¿çãªå½¹å²ãæããããã®é åã®æ´»åæ§ã亢é²ããã¨äº¤æç¥çµç³»ãéå°ã«è³¦æ´»åãããããä»åã®æã ã®çµæãããthe central autonomic network (CAN)ã®ç°å¸¸ãæªæ§ç·å¼µç ã®ç æ ã«é¢ä¸ãã¦ããå¯è½æ§ã示åãããã
æªæ§ç·å¼µç ã®ç«å¦çãªå ±åã¯ãªããçä¾å ±åã¬ãã«ã«ã¨ã©ã¾ãç¨ã§ããã¨ããã¦ãããè¿å¹´ã®ã¬ãã¥ã¼ (Walther et al. 2019) ã§ãèªå¾ç¥çµçç¶ã«ã¤ãã¦ã¯ä»ã®ç·å¼µç çå群ã®çç¶ã¨ã¯å¥ã«èããã¹ãã¨ããã¦ããããç ç©¶ã®å¯¾è±¡ã¨ãªã£ã¦ããã®ã軽çä¾ã§ãããå®éã®è¨åºå ´é¢ã§ã¯ç·å¼µç çå群ãåããæ¥æ§æã®ç²¾ç¥ç ã¨ãã½ã¼ãã«èªå¾ç¥çµçç¶ãã¨ããªããã¨ã¯ç¨ã§ã¯ãªããç¾å¨æã ã¯åæ§ã®çä¾ãèç©ãã¦ãããä»å¾ã軽çä¾ã ãã§ãªãéçä¾ã§ãç ç©¶ãé²ã¿èªå¾ç¥çµé害ãå«ãç·å¼µç ã®ç æ ã®è§£æãé²ããã¨ãæå¾ ãããã
(é»ç¬å¿ã2020.5.3.)
解説ããéçè ã®ãã風æ¯
ç²¾ç¥å»å¦ã®è¨åºç ç©¶ã«ããã¦ãå¯¾è±¡é¸æãã¤ã¢ã¹ã¯æ·±å»ãªåé¡ã§ãããæ¬äººãç ç©¶ã¸ã®åå ã«åæãããã¨ãç 究対象ã¨ãããããã®ç¬¬ä¸æ©ã§ãããããã®ãããªåæãã§ããã®ã¯ç²¾ç¥ç§æ£è å ¨ä½ããã¿ãã°è»½çä¾ã«éãããç æ è§£æãæ²»çæ³ã®éçºã®å¿ è¦ãç¹ã«é«ãéçä¾ã¯ç 究対象ããå¤ããããã¨ã«ãªããããã¦ã軽çä¾ããå¾ãããç¥è¦ãéçä¾ã«ãé©ç¨ã§ããã¨ããæ ¹æ ã¯æ¬ å¦ãã¦ããã«ããããããããã®åé¡ã«ã¯ç®ãã¤ã¶ã£ã¦ããããããã®ç¥è¦ãå ¨ä½ã«éç¨ãããã®ããã«ãã¦ãã¨ããã³ã¹ãªããã®ãæ§ç¯ããã¦ããããããã¦ãè«ææ°ã¯å¢å ããã¨ããã³ã¹ã¯å¢å ããç²¾ç¥å»å¦ã®å¤è¦çãªç§å¦æ§ã¯å¢å ããåãæ®ãããéçã®æ£è ãå¢å ããã¨ããäºæ ãæ¥å¸¸ã®é¢¨æ¯ã«ãªã£ã¦ããã
ç²¾ç¥ç§å»ã«ãªã£ã¦2å¹´ã¨å°ãã®æ°éã®é»ç¬å»å¸«ã«ããæ¬ç ç©¶ã¯ããããªãã ãã風æ¯ã«æ°é®®ãªé¢¨ãå¹ãå ¥ããä»äºã§ãããçå½ã«ãããããæªæ§ç·å¼µç ãç²¾ç¥ç§è¨åºã®éè¦ãªèª²é¡ã§ãããã¨ã¯è«ãã¾ããªãããããç²¾ç¥çç¶ã¨èº«ä½çç¶ãã¨ãã«é篤ãªå¯¾è±¡è ããç§å¦çã«ä¿¡é ¼ã§ãããã¼ã¿ãå¾ããã¨ã¯å°é£ã§ããããããããç ç©¶ã®å¯¾è±¡ã¨ãããã¨ãããã«å°é£ã§ããããã®ããæªæ§ç·å¼µç ã®å¾æ¥ã®ç 究対象ã¯è»½çä¾ã«éããã¦ãããããã®ãã¼ã¿ãéçä¾ã«é©ç¨ã§ãããã¯çåã§ãããããããã軽çã®æªæ§ç·å¼µç ã¨ãããã®èªä½ãè¨åºçã«ã¯ã¤ã¡ã¼ã¸ãã«ãããããããªç ç©¶ãã¼ã¿ãä½ã£ã¦è«æåããããã«ãè»½çæ£è ãç¡çã«æªæ§ç·å¼µç ã¨è¨ºæããã®ã§ã¯ãªããã¨ããçåãçã¾ãããã
ãããªé¢¨æ¯ã«å®ä½ãã¦ãããçã«æå³ã®ãããã¼ã¿ã¯å¾ãããªããæ¬ç ç©¶ã¯ãé»ç¬å»å¸«ããç²¾ç¥ç§ææ¥ã®ç¾å ´ã§ä¸å»ãäºã診çã«å¾äºãã¤ã¤ãåæã«çå®ã追究ããã¨ããç ç©¶ã¸ã®å¼·ãææ¬²ããã£ã¦åãã¦å¯è½ã«ãªã£ããã®ã§ãããä¸è¬çãªç»åç ç©¶ã§ã¯ãäºåã«åæãã¨ãMRIãªã©ã®æ¤æ»æ ãæããã¨ããæç¶ããå¿ è¦ã ããç·å¼µç ã¯ç åãéããã«ç§»ãå¤ããããããã®ãããªæ¹æ³ãåãéããæè¿·ãªã©ã®ç¶æ åãè³ã®æè¦ã¨ãã¦æãããã¨ã¯ä¸å¯è½ã§ãéå¸¸ã®æç¶ããè¶ ããæ¹æ³ãåããªããã°ãªããªããããã¨å«çå§å¡ä¼ã®æ¿èªã容æã§ãªãã¨æ¨æ¸¬ãããããå®¶æã«åæãå¾ãããã§ãæ¹åå¾ã«å度æ£è æ¬äººããåæãã¨ãã¨ããå½¢ã§ã許å¯ããããã®ã ã¨ããã
é»ç¬å»å¸«ã«ããè§£èª¬ã®æå¾ã®ä¸æããä»å¾ã軽çä¾ã ãã§ãªãéçä¾ã§ãç ç©¶ãé²ã¿èªå¾ç¥çµé害ãå«ãç·å¼µç ã®ç æ ã®è§£æãé²ããã¨ãæå¾ ããããã¯æ·¡ã ã¨ããè¨è¿°ã§ãä¸è¦ããã¨è«æã®çµã³ã«ãããã常å¥å¥ã¨ãã¦ééããã¡ã ããç´åã«ããããã«æ·¡ã ã¨ãããç¾å¨æã ã¯åæ§ã®çä¾ãèç©ãã¦ãããã¨ãã䏿ã¨åãããã°ãæªæ§ç·å¼µç ã®è¨åºç ç©¶ã«å®¿å½çã«ä¼´ãæ§ã ãªå°é£ãèªèããã¨ãããã£ããã¨ããéã¿ãæã£ã¦è¿«ã£ã¦ãããç²¾ç¥å»å¦ã®è¨åºç ç©¶ã®é¢¨æ¯ãæ¸ãæããé»ç¬å»å¸«ã®ä»å¾ã®ç ç©¶ã«æå¾ ãããã
(ææ¾å¤ªéã2020.5.27.)
çµ±å失調çã®å
¥é¢æ£è
ã®æ»ã«ã¯ç·å¼µç
ãå¯ããããçªæ¯ãæ°´ä¸æ¯ãèªæ®ºãé¢é£ãã
è¹å±±ééï¼è¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§é¨é·ï¼ãæ¯æ¨æå®ãé«ç°æ¦äººãé»ç¬å¿Michitaka Funayama, Akihiro Koreki, Taketo Takata, Shin Kurose
Catatonia, bedridden status, choking, water intoxication, and suicide are involved in deaths of schizophrenia inpatients
Asian Journal of Psychiatry 51, 2020, 102054
ãèæ¯ãçµ±å失調çã®æ£è
ã¯ãå¥å¸¸è
ã¨æ¯è¼ãã¦11å¹´ãã25å¹´éçå½ã§ããã¨ããç ç©¶çµæããã¾ãã¾ãªç ç©¶ã°ã«ã¼ãããçºè¡¨ããã¦ãããçå½ã«å½±é¿ããæ»å ã¨ãã¦ãèªæ®ºã¨æ¯è¼ãã¦å¿ç¾æ£ãå¼å¸å¨ç¾æ£ãæªæ§è
«çãªã©ã®èº«ä½ç¾æ£ã«ããæ»ãå§åçã«å¤ããã¨ãæããã«ãªã£ã¦ãããããã«ãã®èæ¯ã¨ãã¦ãå¥åº·ã¸ã®é¢å¿ãå°ãªããã¨ãå»çæ©é¢ã¸ã®ã¢ã¯ã»ã¹ãæªããã¨ãªã©ãæãããã¦ãããã¨ããããããããç²¾ç¥ç§å»ãæ®æ®µè¨ºçãã¦ããçµ±å失調çã®å
¥é¢æ£è
ã®æ»äº¡åå ã調ã¹ãç ç©¶ã¯æ¥µãã¦å°ãªããä»åããããã¯ãã®ç¹ãæããã«ããããã«ãèªæ½è¨ã§ã®å¾åãç ç©¶ãè¡ã£ãã
ãæ¹æ³ã1999å¹´ãã2017å¹´ã«è¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§ç
æ£ã«å
¥é¢ããçµ±å失調ç1823ä¾ã®ä¸ã§ãå
¥é¢ä¸ã«æ»äº¡ãã41ä¾ã対象ã¨ãããæåã«ç´æ¥æ»å ãæããã«ãããã®å¾ããã®æ»å ã«ç²¾ç¥çç¶ãæããã«å½±é¿ããä¾ãæããã
ãçµæãç´æ¥æ»å ã¨ãã¦å²åãå¤ãã£ãç¾æ£ã¯ãé çªã«å¼å¸å¨ç¾æ£16ä¾ï¼èºçã12ä¾ãèºè¡æ 塿 ç2ä¾ãªã©)ãæªæ§è
«ç9ä¾ãå¿ç¾æ£6ä¾ï¼å¿ä¸å
¨3ä¾ãé »èæ§ä¸æ´è2ä¾ãå¿çæ¢å¡1ä¾ï¼ã§ãã£ããç²¾ç¥çç¶ãæ»ã«æããã«å½±é¿ããã¨èããããä¾ã¯ã41ä¾ä¸ç´åæ°ã®20ä¾ã«ãä¸ã£ããå
·ä½çã«ã¯ç·å¼µç
ã12ä¾ã極度ã®ã¢ãã·ã¼ã«ããå¯ãããï¼65æ³æªæºã§éª¨æã麻çºããªãå¯ãããã«ãªã£ãä¾ï¼3ä¾ãçªæ¯ã¨èªæ®ºããããã2ä¾ãæ°´ä¸æ¯ã1ä¾ã§ãã£ããç·å¼µç
ããã¯4ä¾ã®èª¤å¥æ§èºçã2ä¾ã®é »èæ§ä¸æ´èã1ä¾ã®èºè¡æ 塿 çã«ããæ»ã«ã¤ãªãã£ããå¯ãããããã¯2ä¾ã®èª¤å¥æ§èºçã1ä¾ã®èºè¡æ 塿 çã®æ»ã«ã¤ãªãã£ãã
ãèå¯ããããã®ç²¾ç¥çç¶ã¯ä»ç§ã®å»å¸«ã«ã¯åããã«ãããç²¾ç¥ç§å»ãããç
æ
ãææ¡ããå¿
è¦ãããããããã®ç²¾ç¥çç¶ãæ¹åãããã¨ã§ãå
¥é¢ä¸ã®çµ±åå¤±èª¿çæ£è
ã®å¤ãã®æ»ãé²ããå¯è½æ§ãããã
ãé¢é£æç®ãæ¬å ±åããã¼ã¹ã¨ãã¦ãããããã®ã°ã«ã¼ãããã¯å
¥é¢ä¸ã®çµ±å失調çã«é¢ãã身ä½ç¾æ£ã«é¢ãã¦ã以ä¸ã®è«æãå ±åãã¦ãããç
æ£æ
å½ã®ç²¾ç¥ç§å»ã«ã¨ã£ã¦æçãªæ
å ±ã§ããã¨æãããèå³ã®ããæ¹ã¯åèã«ãã¦ããã ãã¨çè
ã¨ãã¦ã¯é常ã«å¹¸ãã§ããã
1. ç·å¼µç
ã®èº«ä½åä½µçï¼Psychosomatic Medicine 80: 370-376, 2018
2. çµ±å失調çã«åºç¾ããçªæ¯ï¼General Hospital Psychiatry 59: 73-75, 2019
3. å¯ãããã¨é¢ä¿ããèº«ä½ææã«ãã身ä½åä½µçï¼ General Hospital Psychiatry 62:1-5, 2020
4. æ°´ä¸æ¯ã®çµéä¸ã§çºçããæ©ä¸å¿é«éå´©å£ï¼Schizophrenia Research 125: 300-301, 201
(è¹å±±ééã2020.4.1.)
èº«ä½ææã¯ç²¾ç¥ç¾æ£å
¥é¢æ£è
ã®èª¤å¥æ§èºçã¨æ·±é¨éèè¡æ çã®å±éºæ§ãé«ãã
è¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§ãè¹å±±ééFunayama MichitakaTakata Taketo: Psychiatric inpatients subjected to physical restraint have a higher risk of deep vein thrombosis and aspiration pneumonia. General hospital psychiatry 62, 2019.
DOI: 10.1016/j.genhosppsych.2019.11.003
ãã¯ããã«ãè¿ä»£ç²¾ç¥å»å¦ã®åµå§è
ã®ã²ã¨ãã§ããããã«ãç²¾ç¥ç¾æ£ã®æ£è
ãéããè§£æ¾ãã¦äººéçæ²»çã®å
é£ãåã£ãããã«ãããããç²¾ç¥ç§å»ã¯èº«ä½ææãå¤ããã¨ã人éçã«ãæ²»ççã«ãå¿
è¦ã§ãããã¨ã¯éã
æ¿ç¥ãã¦ãããã¨ããããããå½ã®ç²¾ç¥ç§ç
æ£å
ã§ã®èº«ä½ææã®æéã¯ã¨ã¼ããããã¢ã¡ãªã«ã¨æ¯ã¹ã¦10å以ä¸ã®é·ãæéã«ããããè¿å¹´ã¯èº«ä½ææãè¡ãæ£è
ã®å²åãããã«å¢å ãã¦ãããèæ¯ã«ã¯ãå
¥é¢ä¸ã«è»¢åãã¦éª¨æããå ´åã«ç
é¢å´ã«è²¬ä»»ãæ±ããããå¯è½æ§ããããããå»çè
å´ãéå¤§ã«æãã¦ããå´é¢ãããã転åã®ãªã¹ã¯ãç¹æ»´ã®ç®¡ãªã©ãæå»ããå¯è½æ§ãé«ãã¨ããçç±ã§èº«ä½ææãè¡ãåçæ§ã¯ããã®ããããããèº«ä½ææã«ãã£ã¦èºè¡æ 塿 çãèº«ä½ææã®ç©ççãªå½±é¿ã§æ»ã«è³ãä¾ãå ±åãããããã®è¨åºçãªåãã«å¯¾ããã²ã¨ã¤ã®æ¹æ³ã¯ãèº«ä½ææãè¡ã£ãéã®åä½µçãæç¢ºãªãã¼ã¿ã¨ãã¦ç¤ºããã¨ã§ããããããããã®ç¹ãæããã«ããå
æ¬çãªå¤§è¦æ¨¡ã®ç ç©¶ã¯ä»ã¾ã§ãªããã¦ããªãã£ããæ¬ç ç©¶ã®ç®çã¯ãèº«ä½ææä¸ã«çºçãã身ä½åä½µçãå
æ¬çã«ãã¤å¤§è¦æ¨¡ãªä¾ããã¨ã«èª¿ã¹ããã¨ã§ããã
ãæ¹æ³ã徿¹è¦çã«2012å¹´3æãã2016å¹´3æã¾ã§ã«è¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§ç
æ£ã«å
¥é¢ããå
¨1308ä¾ã対象ã¨ãããå
¥é¢ãã¦ä¸åº¦ã§ãèº«ä½ææãåããèº«ä½ææç¾¤ï¼n=110, 8.4%ï¼ã¨èº«ä½ææãä¸åº¦ãåããªãã£ãéèº«ä½ææç¾¤(n=1198, 91.6%)ã®2群ã«åãããèº«ä½ææç¾¤ã«1%以ä¸çããå身ä½åä½µçã«ã¤ãã¦ã両群ã®çºççãFisherç´æ¥æ¯è¼æ³ã§æ¯è¼ãããå³å¯ã«èº«ä½ææä¸ã«é¢é£ãã身ä½åä½µçãæ¤è¨ãããããèº«ä½ææç¾¤ã«é¢ãã¦ã¯èº«ä½ææã«è³ãåã«çãã身ä½åä½µçã¯é¤å¤ãã¦ãèº«ä½ææãåããæéã®ã¿ã«çãã身ä½åä½µçã«éå®ãããæ½å¨çãªäº¤çµ¡å åã«ããå½±é¿ãã³ã³ããã¼ã«ããããã«å¤å¤éè§£æãè¡ã£ãã
ãçµæãèº«ä½ææç¾¤ã¯æ·±é¨éèè¡æ çï¼OR=6.0ï¼ã¨èª¤å¥æ§èºç(OR=4.1)ã®åä½µãå¤ãã£ã(P<0.01)ãæ½å¨çãªäº¤çµ¡å åï¼å¹´é½¢ãæ§å¥ãå
¥é¢æéãå
¥é¢æã®èº«ä½åä½µçãå¯ãããã®ç¶æ
ãGAFãç·å¼µç
æ§æè¿·ã®æç¡ãæç²¾ç¥ç
è¬ã®ä½¿ç¨ã®æç¡ï¼ãã³ã³ããã¼ã«å¾ããèº«ä½ææç¾¤ã§ã¯æ·±é¨éèè¡æ çã¨èª¤å¥æ§èºçãå¤ãã£ãï¼ããããP<0.01, P=0.01ï¼ã
ãèå¯ãèº«ä½ææã«ãã£ã¦å±éºãªèº«ä½ç¾æ£ãçããå¯è½æ§ãé«ããæå°éã«ããå¿
è¦æ§ã示åããããçè
ã®æè¦ã¨ãã¦ã¯ããããã®å±éºæ§ãèæ
®ããå ´åã転åã®ãªã¹ã¯ãªã©ãçç±ã«èº«ä½ææãããå¿
è¦ã¯ãªãã¨èãã¦ããã
(è¹å±±ééã2020.4.10.)
è§£èª¬ãæ»ã«è³ãpublication bias
äºã¤ã®é大ãªã¡ãã»ã¼ã¸ãããã
第ä¸ã¯ããæ»ã«è³ãç²¾ç¥çç¶ããããã¨ãããã¨ã§ãããæ»äº¡è¨ºææ¸ã«è¨ãããæ»å ã¯å¤§é¨åã®å ´åã«èº«ä½ç¾æ£ã ããããããªããã ããã®èº«ä½ç¾æ£ãå¼ãèµ·ãããã®ãç²¾ç¥çç¶ã§ããã°ããããã¯ç²¾ç¥çç¶ã«ãã£ã¦çãã身ä½ã®ç¶æ
ããã®èº«ä½ç¾æ£ãå¼ãèµ·ãããã®ã§ããã°ãæ»ã«è³ãå æé¢ä¿ã®é£éã®å
ã
ã®åå ã¯ç²¾ç¥ç¾æ£ã§ãããè¹å±±ééé¨é·ã®è«æã¯ãã®ãã¨ãæç¢ºã«ç¤ºãã¦ããããã®é£éãèªèãã¦æ©æã«å¯¾å¦ãããã¨ã¯ç²¾ç¥ç§å»ã§ãªããã°ã§ããªãããããã¯ç²¾ç¥ç§å»ã®ç¾©åã§ããã¨ãè¨ããã
第äºã®ã¡ãã»ã¼ã¸ã¯ã第ä¸ã¨åãããã«é大ã§ããã¤ãæ·±å»ãã¯ç¬¬ä¸ãããã«è¶
ãã¦ããã
ããã¯ããæ»ã«è³ããããå»ççå¦ç½®ããããã¨ãããã¨ã§ããããã®ä»£è¡¨ãèº«ä½ææã ã
èº«ä½ææãè¡æ ãªã©ã®åå ã«ãªããã¨ã¯ä»¥åããç¥ããã¦ãããèº«ä½ææãæ¸ãããã¨ã®å¿
è¦æ§ã¯ç¹°ãè¿ãåæ¹é¢ããææããã¦ããããæãå½ã®èº«ä½ææã¯è«¸å¤å½ããå¤ããã¨ãã¾ãç¹°ãè¿ãåæ¹é¢ããææããã¦ãããããã§ãæ¸ããªããã¨ã«ã¯è¤éãªçç±ãããããã²ã¨ã¤ã«ã¯ãè¯å¿çãªå»çè
ã§ããã»ã©æ£è
ã®å®å
¨ã®ããã«èº«ä½ææãããã¨ããé説çãªäºæ
ããããå¾å¾ã«ãã転åãé²ãããã§ããããããã¯èªæ®ºãé²ãããã§ããã
å
¥é¢æ£è
ã®èº«ä½ææãä¸ååã ã£ãããã«èªæ®ºã¨ããçµæãæããã¨ãã¦è¨´è¨ã«ãªããç
é¢ãæè¨´ããã¨ããå¤ä¾ããã(æ±äº¬å°è£å¹³æ4å¹´(ã¯)14712å·ãæå®³è³ åè«æ±äºä»¶)ãããããã®ãããªå¤æ±ºããå®å
¨ã®ããã«ã¯ãã£ããææãããã¨ããã¡ãã»ã¼ã¸ã§ããã¨åãåãã®ã¯èª¤ãã§ããã夿±ºæãããèªãã°ãç
é¢å´ã«ç¢ºãã«å¤§ããªè½ã¡åº¦ããã£ãã¨ããããå»ç訴è¨ã§ç
é¢ãæè¨´ããäºä»¶ã®å¤ãã¯ããããäºæ
ãããã表é¢çãªå¤æ±ºçµæã ããè¦ã¦é²è¡çã«ãªãã®ã¯ã»ã¨ãã©ã®å ´åã«å¤±å½ãªã®ã§ãããããããèº«ä½ææã¯æ£è
ã®å®å
¨ã®ããã«ãªãã©ããããéã«æ»äº¡ã®å±éºæ§ãå¢ãã¦ãããã¨ãè¹å±±é¨é·ã®æ¬è«æã示ãã¦ãããã¨ããã¿ã¦ããäºæ
ã®ãªã¹ã¯ãæãã¦èº«ä½ææãããã®ã¯æ±ºãã¦è¯å¿çãªå»çè
ã®ã¨ãã¹ãææ®µã§ã¯ãªããããããã®å±éºæ§ãèæ
®ããå ´åã転åã®ãªã¹ã¯ãªã©ãçç±ã«èº«ä½ææãããå¿
è¦ã¯ãªããã¨è¹å±±é¨é·ã解説æãçµãã§ããéãã§ããã
ããã¦ããä¸ã¤ãè«æããã¯èªã¿åããªãã奿¬¡å
ã®æ·±å»ãªã¡ãã»ã¼ã¸ãããã
ããã¯ããã®è«æ(æ»ã«è³ãç²¾ç¥çç¶ããããã¨ã示ããè«æ)ããå®ã«13ã®Journalããrejectãããã¨ããäºå®ã«ç±æ¥ãããè¨åºçã«æå¤§ç´ã¨è¨ããã»ã©ã«éè¦ãªç ç©¶è«æã§ãããã¨ã¯èª°ãè¦ã¦ãæãããªã®ã ããè¨åºçã§ãããããã«éã«ã¢ã¯ã»ããããã«ããã¨ããäºæ
ãçºçãã¦ããã®ã ãå¤ãã®Journalã«ããã¦ããç§å¦çããå®è¨¼çãã«è¦ããä½è£ãæ´ã£ã¦ãããã¨ãæåªå
ã«ãããä¸ä½ãªãã®æå³ããããããããªããããªãã¼ã¿ãè¨å¤§ã«publishããã¦ãã䏿¹ã§ãæ£è
ã®çå½ã«ããããè¨åºçã«ä¾¡å¤ã®é«ãè«æãä¸ã«åºããã¨ã¯é常ã«é£ãããªã£ã¦ãããããã¯æ£è
ãæ»ã«è³ããããpublication biasã§ãããæ¬è«æã¯è¹å±±é¨é·ããã®ãã¾ãã«å¼·ãé風ãã¯ãè¿ããä¸è»¢ã³å
«èµ·ããªãã¬ãåä¸è»¢ã³ååèµ·ãã§publishããè²´éãªãã¼ã¿ã§ããã
(ææ¾å¤ªéã2020.4.30.)
PETãªã¬ã³ã[11C]SL2511.88ãç¨ãããã¤ç
æ£è
ã«ãããè³å
MAO-Bå¯åº¦ã®çä½å
å¯è¦åç ç©¶
森å£ç¿ã(Research Imaging Centre, Centre for Addiction and Mental Health, Canada)(Neurochemical Imaging Program in Mood Disorders, Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Canada)
Moriguchi S, Wilson AA, Miler L, Rusjan P, Vasdev N, Kish S, Rajkowska G, Wang J, Bagby M, Mizrahi R, Varughese B, Houle S, Meyer JH. Greater Monoamine Oxidase B Distribution Volume in the Prefrontal Cortex of Major Depressive Disorder: An [11C]SL2511.88 Positron Emission Tomography Study. JAMA Psychiatry 2019; 76: 634-641.
ãã¤ç
ã®æ²»çã¯æªã ååãªãã®ã§ã¯ãªãç´50%ãæ²»çæµææ§ã§ããã80%ã¯åçºã»åçããã¨è¨ããã¦ãã(Rush and Jaint et al. 2019)ããã®ä¸ã§ãã¢ãã¢ãã³é
¸åé
µç´ (MAO)é»å®³è¬ã¯æ²»çæµææ§ãã¤ç
ãåçºã»åçäºé²(Geddes et al. 2003)ãã¾ãããã®ä»ã®æãã¤è¬ã¸ã®åå¿ã®ä¹ããéå®åãã¤ç
ã«æç¨ãªè¬ã§ãããã¨ãç¥ããã¦ãã(Chockalingam et al. 2019)ãç¾å¨MAOé»å®³è¬ã¯æ¥æ¬ã§ã¯ä½¿ç¨ããã¦ããªããããã®ä¸»ãªçç±ã¨ãã¦MAOé»å®³è¬ã¯ãã©ãã³ãå«ãã é£äºã®å¶éãå¿
è¦ã§ããçæ´»ã«å¶éãå ãããã¨ããããå
æ¥MAOé»å®³è¬ã®ä¸»è¦ãªå¹æã¯è³å
ã®ã»ãããã³ã»ãã«ã¨ããããªã³ã»ãããã³ã¨ãã£ãã¢ãã¢ãã³ã®ä»£è¬ãé»å®³ãããã¨ã§è³å
ã®ã¢ãã¢ãã³ãå¢å ãããã¨æ³å®ããã¦ããããã®ãããã¢ãã¢ãã³ãå¢ããã¨ããåæ§ã®å¹æãããé£äºå¶éçã®å¿
è¦ããªã使ç¨ããããä¸ç°ç³»æãã¤è¬ãSSRIã§ä»£ç¨å¯è½ã¨èãããããã¨ããããMAOé»å®³è¬ã¯å¾ã
ã«ä½¿ç¨ãããªããªã£ã¦ãã£ããããããè¿å¹´ãã¤ç
ã®ç
æ
ã¡ã«ããºã ã«ã¢ãã¢ãã³ä»®èª¬ä»¥å¤ã«ãç¥çµçç仮説(Miller et al. 2009)ãæå±ããã¦ãããMAOã®ä¸ã§ãMAO-Bãè³å
ã®ã¢ã¹ãããµã¤ãã«åºãåå¸ãã¦ãããã¢ãã¢ãã³ã代è¬ããéã«éé
¸åæ°´ç´ ãç£çãããªãã·ãã¼ã¼ã¹ãã¬ã¹ãç¥çµççãå¼ãèµ·ããããã®ãã¨ããã¤ç
ã®ã¡ã«ããºã ã«é¢ãã£ã¦ããã®ã§ã¯ãªããã¨èããããããã«ãªã£ãããã®ããã«MAO-Bã¯ãã¤ç
ã®ç
æ
ççã«éè¦ãªå½¹å²ãããã¨èãããã¦ãããã®ã®è³å
ã§ç´æ¥MAO-Bå¯åº¦ã測å®ãããã¨ã¯æè¿ã¾ã§å°é£ã§ãã£ãããã®ãããªä¸ãè¿å¹´ããã³ã大å¦ã§MAO-Bã«ç¹ç°çã«çµåãã髿§è½ãªæ¾å°æ§ãªã¬ã³ã[11C]SL2511.88ãéçºããã(Rusjan et al. 2014)ã[11C]SL2511.88ã¯MAO-Bã«ç¹ç°çã«çµåãå¯éæ§ã§ãããã¨ã代è¬ç©ãè³å
ã«å
¥ããªãã¨ãã£ãç¹ãªã©ããè¨åºå¿ç¨ãååå¯è½ã§ãããä»åãPETãç¨ãã¦20åã®æªæè¬ãã¤ç
æ£è
ã¨20åã®å¥å¸¸è
ã11ã®è³é åã§æ¯è¼ããããã«æ£è
å
ã«ããã¦çç¶ã¨ã®é¢é£ã¨ã®ç¸é¢ãæ¤è¨¼ããããã®çµæãè
¹å¤å´åé åéã«ããã¦ãã¤ç
æ£è
群ã§MAO-Bå¯åº¦ã®ä¸æãèªãããããã¾ãæ£è
å
ã§ã¯ãã¤ç
ã®çç¶è©ä¾¡å°ºåº¦ãèªç¥æ©è½æ¤æ»ãå¿ç尺度ã¨ã®ç¸é¢ã¯èªããããªãã£ãããç½¹ç
æéã¨MAO-Bå¯åº¦ã¨ã¯è
¹å¤å´åé åéãåé åéç¼çª©é¨ãè¦åºã«ããã¦ææãªæ£ã®ç¸é¢ãèªãããããæ¬çµæã¯ããã¤ç
æ£è
ã«ããã¦ç½¹ç
æéãé·ãã»ã©MAO-Bå¯åº¦ãå¢å ãããã¨ãæå³ãã¦ããããã®ãã¨ã¯MAOé»å®³è¬ã«å¹æãããéå®åãã¤ç
ã§ã¯ç½¹ç
æéãé·ããã¨(Stewart, et al. 2007)ãæéçµéã¨ã¨ãã«ã¡ã©ã³ã³ãªã¼è¦ªååãã¤ç
ãéå®åãã¤ç
ã¸å¤åããå ´åããããã¨(Angust, et al. 2007)ãéå®åãã¤ç
ã«ããã¦ççæ§ãã¼ã«ã¼ã¨ç½¹ç
æéãç¸é¢ãèªãããããã¨(Dunjic-Kostic et al. 2013)ãMAOé»å®³è¬ãåçºã»åçäºé²ã«å¹æããããã¨ã¨ã大ããçç¾ã¯ããªãã¨èãããããMAOé»å®³è¬ã®æ²»çã®ã¿ã¼ã²ãããã»ãããã³ã»ãã«ã¨ããããªã³ã»ãããã³ã®ã¿ã§ããã°éå®åãã¤ç
ãåçºã»åçäºé²ã«æå¹ã§ããã¨ãã£ãä»ã®æãã¤è¬ã¨ç°ãªãæ§è³ªã®å¹æããããã¨ã®èª¬æãå°é£ã§ããããã®ãããMAOé»å®³è¬ã¯MAOã®åããé»å®³ãããã¨ã§ç¥çµççãé²ããªã©ãã®ä»ã®æãã¤è¬ã¨ã¯ç°ãªã£ãã¿ã¼ã²ããã«ä½ç¨ãæãã¤å¹æãå¾ã¦ãããã¨ãæ³å®ãããã
ç¾å¨ãæ¬ç ç©¶ã®ç¶ãã¨ãã¦æã
ã®ãã¼ã ã¯MAOé»å®³è¬ãç¨ãã縦æç ç©¶ãè¡ã£ã¦ããããã®ç ç©¶ã«ããã¦ãå¤ãã®æ£è
ã«MAOé»å®³è¬ã使ç¨ããã¦ããããç§ãè¤æ°ã®æãã¤è¬ã«åå¿ããªãç½¹ç
æéã®é·ããã¤ç
æ£è
ã«æå¹ã§ããé©ããçµé¨ãããããããã®çµé¨ãããã¤ç
æ²»çã®é¸æè¢ã®ã²ã¨ã¤ã«MAOé»å®³è¬ãæå¹ã§ããã®ã§ã¯ãªããã¨èããããã«ãªã£ããã¾ããç¾å¨ä¸é¨ã§ã¯MAOé»å®³è¬ãåèããæµãããã(Entzeroth, et al. 2017)ããã¡ããããã¤ç
ã¯ãµãã¿ã¤ããå¤ããMAOé»å®³è¬ã®ã¿ã§ã¯ãã¤ç
ã®æ²»çã¯å®çµããªãã ãããããããæ²»çã®é¸æè¢ã®ã²ã¨ã¤ã¨ãã¦ç¾å¨ä½¿ç¨ããã¦ããæãã¤è¬ã«å ããMAOé»å®³è¬ã使ããã¨ã¯æ£è
ã«ã¨ã£ã¦æçã§ã¯ãªãã ãããã
(森å£ç¿ã2020.3.16.)
解説ããã¤ç ãç©¶ãã
æ¬HP 2017å¹´2æã§ç´¹ä»ãããããã¤ç ã«ããããã«ã¨ããããªã³ãã©ã³ã¹ãã¼ã¿ã¼å¯åº¦ã®æ©è½ã®æ¤è¨ã(Moriguchi S et al: Norepinephrine Transporter in Major Depressive Disorder: A PET Study.⨠Am J Psychiatry. 2017 Jan 1;174:36-41) ã®èè ã®æ£®å£ç¿é¢ç(彿)ã¯ããã®åå¹´å¾ã«ã¯PET Quantification of the Norepinephrine Transporter in Human Brain with (S,S)-18F-FMeNER-D2.⨠J Nucl Med. 2017 Jul 58: 1140-1145 (æ¥æ¬ç²¾ç¥å»å¦ä¼ã®ç²¾ç¥å»å¦å¥¨å±è³ã®åè³è«æãæ¬HP2018å¹´3æã(S,S)-18F-FMeNER-D2ãç¨ãã大è³ç®è³ªã«ããããã«ã¨ããããªã³ãã©ã³ã¹ãã¼ã¿ã¼ã®å®éè©ä¾¡ã)ãçºè¡¨ããããã¦å士ã®å¦ä½ãåå¾ãã¦å¤§å¦é¢ã忥å¾ããã¤ç ã«ãããããã«é«åº¦ã§ææç¾©ãªPETã¤ã¡ã¼ã¸ã³ã°ç ç©¶ã®ããããã³ãã®ãResearch Imaging Centre, Centre for Addiction and Mental Health, Canada ã«çå¦ãããJAMA Psychiatryã®æ¬è«æã¯ããã®çå¦å ã§ã®ä»äºã§ããããããã¦æ£®å£å士ã¯ãããã¤ç ã®PETç ç©¶ãç©¶ãããããã®éãçã ã¨æ©ãã§ãããããããã®éåãããã¨ãªãé«å質ã®ç ç©¶ææã«ãçã ã¨æ©ãã§ãããã¨ããè¨èã¯ãããä¸é©åã§ããçã¹ãã¼ãã§ç¾èµ°ãã¦ãããã¨è¨ãã¹ãã§ããããããã¦æ¬è«æã®èªèè§£èª¬ã®æå¾ã®ä¸æããæ²»çã®é¸æè¢ã®ã²ã¨ã¤ã¨ãã¦ç¾å¨ä½¿ç¨ããã¦ããæãã¤è¬ã«å ããMAOé»å®³è¬ã使ããã¨ã¯æ£è ã«ã¨ã£ã¦æçã§ã¯ãªãã ãããããã«è±¡å¾´ãããããã«ã森å£å士ã®ç®ã¯å¸¸ã«è¨åºã«åãã¦ããã
MAOé»å®³è¬ããã¤ã¦ã¯ãã¤ç ã®æ²»çè¬ã¨ãã¦æ¥æ¬ã§ã使ããã¦ãããã¨ã¯ãä»ã¨ãªã£ã¦ã¯ç¥ããªãç²¾ç¥ç§å»ãå¤ãããç¹ã«éå®åãã¤ç (æ¨ä»ã®ããå æ¸ãªæ¦å¿µã§ã¯ãªããå¤å ¸çãªéå®åãã¤ç )ã«å¯¾ãã广ã¯å®è©ãããããããã£ã¦MAOã¯ãã¤ç ã®çç©å¦çç ç©¶ã®æåãªã¿ã¼ã²ããã®ä¸ã¤ã§ãã£ããçè ãMAOã®éºä¼å¤åã«æ³¨ç®ããæ°åé害ã¨ã®é¢ä¿ãç ç©¶ãããã¨ãããã(Muramatsu T et al: Monoamine oxidase genes polymorphisms and mood disorder. Am J Med Genet 1997 Sep 19; 74: 494-6.) 1990å¹´åå¾ã«ã¯ããã®ãããªéºä¼åããã®ã¢ããã¼ããä¸çä¸ã§çãã«ãªããã¦ãããããã®æ¹æ³ã§ã¯ç²¾ç¥ç¾æ£ã®è§£æã«ã¯å°éã§ããªãã¨ãããã¨ãå¾ã ã«æããã«ãªããMAOã表èå°ããå»ã£ãæãããã£ããã ãä»å森å£å士ãè¨ãã¦ããããã«ããã¤ç ã®ç æ ççã«ãããéè¦æ§ãå¦å®ããã¦ããããã§ã¯æ±ºãã¦ãªããMAOã¯ãããã°ããã¯ã¹ãã¼ã¸ã§åºçªãå¾ ã£ã¦ãã主役ç´ã®ç©è³ªã§ãã£ãã¨è¨ãããã
ãããªååªã«å ãå½ã¦ãã®ã¯ãããã³ãã§éçºããã髿§è½ãªæ¾å°æ§ãªã¬ã³ã[11C]SL2511.88ã¨ããã¤ç ã«å¯¾ããæ£®å£å士ã®ç±æã§ãæ¬ç ç©¶ã¯ãããè¦äºã«çµæ¶åããææã§ãããæ¬HP2017.2.ã大å¦é¢æä»£ã®æ£®å£å士ã®è«æã®è§£èª¬ã®ã¿ã¤ãã«ã¯ããã¤ç ã®PETç ç©¶ãç©¶ãããã§ãã£ãããå¦ä½ãåå¾ãã¦æµ·ã渡ã3å¹´éã®ããã³ãçå¦ãã帰å½ããæ£®å£å士ã¯ãããã¾ã§å°éã¨ãã¦ããPETç ç©¶ã«éå®ãããããã¤ç ãç©¶ãããããã2020å¹´4æããã¯æ ¶æã§ããã«ã°ã¬ã¼ãã¢ããããç ç©¶ã¨è¨åºãå®è¡ããã
(ææ¾å¤ªéã2020.3.28.)
èªéã¹ãã¯ãã©ã çã®ã¨ã³ããã§ãã¿ã¤ãã¨è¨åºè¨ºæã«é¢ä¸ããç®è³ªè¡¨é¢æ§é
山縣ãæ(æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§ å°ä»»è¬å¸«)Yamagata B, Itahashi T, Fujino J, Ohta H, Takashio O, Nakamura M, Kato N, Mimura M, Hashimoto RI, Aoki YY. Cortical surface architecture endophenotype and correlates of clinical diagnosis of autism spectrum disorder. Psychiatry Clin Neurosci. 2019 Jul;73(7):409-415
èªéã¹ãã¯ãã©ã çï¼ASDï¼ã¯ãã®çºçã«éºä¼è¦å ã大ããé¢ä¸ãã¦ããããã®åèã«ãããçºçãªã¹ã¯ã¯ä¸è¬äººå£ããé«ããéç½¹æ£åèã«ããã¦ãè¨åºæ°´æºä»¥ä¸ã®è¨åºçç¹å¾´ãæãã¦ãããéå»ã®è³ç»åç ç©¶ã§ã¯ASDã¨ãã®éç½¹æ£åèãå ±æããç°å¸¸æè¦ãASDã®éºä¼è¦å ã«é¢ä¸ããçç©å¦çæè¦ï¼ã¨ã³ããã§ãã¿ã¤ãï¼ã¨ãã¦ãããããããªãããã¨ã³ããã§ãã¿ã¤ããæãã群ï¼ASDã¨ãã®éç½¹æ£åèï¼ã«ããã¦ã䏿¹ã¯ASDã¨è¨ºæãããçæ¹ã¯å¥å¸¸ã§ãããã¨ãèæ ®ããã¨ãASD診æã«é¢ä¸ããçç©å¦çæè¦ã«ã¤ãã¦ã¯ã»ã¨ãã©æ¤è¨ããã¦ããªãã
ASDã¨ã³ããã§ãã¿ã¤ã群ï¼ASDã¨ãã®çç©å¦çãªéç½¹æ£åè15ãã¢ï¼30åã¨å®åçºéï¼TDï¼ç¾¤ï¼å¥åº·ãªçç©å¦çãªå å¼15ãã¢ï¼30åã対象ã¨ãããé é¨MRIãæ®åããè³ç®è³ªä½ç©ãç®è³ªåãç®è³ªæ§é ã®è¤éããç®è³ªæºã®æ·±ãï¼SDï¼ãç®è³ªæ§é ãã©ã¡ã¼ã¿ã¨ãããã¾ãããããï¼ã¤ã®ãã©ã¡ã¼ã¿ã®ãã¡ASDã¨ã³ããã§ãã¿ã¤ããåæ ããå¤å¤éãã¿ã¼ã³ãåå®ãããããã«ãTDåèéã®å·®ãèæ ®ããããã§ãASDã¨ãã®éç½¹æ£åèã®å·®ããã¼ãã¹ãã©ããæ³ãç¨ãã¦æ¤è¨ããASD診æã«é¢ä¸ããè³é åãåå®ããã
ã¹ãã¼ã¹ãã¸ã¹ãã£ãã¯å帰åæã¨äº¤å·®æ¤è¨¼ã®çµæãSDãä»ã®ãã©ã¡ã¼ã¿ã¨æ¯è¼ãé«ã精度ï¼73.3%ï¼ã§ASDã¨ã³ããã§ãã¿ã¤ããå¤å¥ãããããã«ãã¼ãã¹ãã©ããæ³ã«ã¦6ã¤ã®è³é åã®SDãASD診æã«é¢ä¸ãã¦ãããã¨ã示ãããããããã®å¤ãã¯â社ä¼è³âã§ãã£ãããASDã¨ã³ããã§ãã¿ã¤ãã¨ASD診æã«é¢ä¸ããé åã¯ã»ã¨ãã©éè¤ããªãã£ãã
SDãASDã¨ã³ããã§ãã¿ã¤ããæãéæã«åæ ããç®è³ªæ§é ãã©ã¡ã¼ã¿ã§ãããSDãç¨ãã¦ASD診æã®ç¥çµåºç¤ãåå®ã§ãããã¨ãæããã¨ãªã£ãã徿¥ã®2群æ¯è¼ã®ç ç©¶ãã¶ã¤ã³ã§ã¯æ¤åºã§ããªãã£ãããASDã®ã¨ã³ããã§ãã¿ã¤ãã¨è¨ºæã«é¢ä¸ããè³é åãããããç°ãªã£ã¦ããå¯è½æ§ã示åãããä»å¾ã®è³ç»åç ç©¶ææ³ã®ä¸å©ã¨ãªããã¨ãæå¾ ãããã
æ¬ç ç©¶ã®ç¬èªæ§ã¯ãASDã¨ãã®éç½¹æ£åèãã¢ã ãã§ãªããTD群ã«ããã¦ãåèãã¢ã対象ã¨ããç ç©¶ãã¶ã¤ã³ãæ¡ç¨ããã¨ããã«ãããç¾æ£ã¨å¥å¸¸ã¨ã®éã«ã¯ãç¾æ£çºçã«é¢ä¸ãã广ã¨ç¾æ£çºçã®éºä¼çèå¼±æ§ã«é¢ãã广ï¼ã¨ã³ããã§ãã¿ã¤ãã¨ããããã ãããã®å¹æã ãã§çºçããªãï¼ãåå¨ãããã¨ãæ³å®ããããã¤ã¾ãã徿¥ã®ç¾æ£æãç¡ãã®2åæ³ã®ç ç©¶ãã¶ã¤ã³ã§ã¯ããã®ä¸¡è ãåãããå¹æãæ¤åºãã¦ãããåã ã®å¹æã«ã¤ãã¦ã®æ¤è¨ãå°é£ã§ãã£ããããã§ãæã ã¯ç¾æ£ç¾¤ã¨å¥å¸¸ç¾¤ããããã«ããã¦åèãã¢ã対象ã¨ãããã¨ã§ä¸¡è ãåé¡ã§ããã®ã§ã¯ãªããã¨ããçæ³ã«è³ã£ããå®éãæ¬ç ç©¶ã«ããã¦å³å´ã®pSTSã®ç®è³ªæºã®æ·±ããæµ ããªããã¨ãASDçºçã«é¢ä¸ããç¥çµåºç¤ã§ãããã¨ãè¦ãã ããããå群15ä¾ã¨ããæ¯è¼çå°ãªããµã³ãã«æ°ãªãããéå»ã®ç ç©¶ã¨çç¾ããªãçµæã¨æ°ããªç¥è¦ãåæã«å¾ããããã¨ã¯ããã®ç ç©¶ãã¶ã¤ã³ã®å¦¥å½æ§ã»æ¤å®åã®ååããæ¯æãããã®ã¨èãããä»å¾ã®å±æã¨ãã¦ã¯ã夿½è¨å¤§è¦æ¨¡ç ç©¶ã宿½ãããã¨ã§ãæ¬ç ç©¶ãã¶ã¤ã³ã®å¦¥å½æ§ãæ¤è¨¼ããå¿ è¦ããããããã«ãçµ±å失調çã忥µæ§é害ã¨ãã£ãå å æ§ç²¾ç¥ç¾æ£ã«ããã¦ãå®¶æå éç©ã®é«ããASDåæ§ã«å ±åããã¦ããããããã®ç¾æ£ã«ããã¦ãæ¬ç ç©¶ãã¶ã¤ã³ãç¨ãããã¨ã§ãç¾æ£çºçã«é¢ä¸ããç¥çµåºç¤ãæ½åºãããã¨ãã§ããä»ç¾æ£ã®è³ç»åç ç©¶ã¸ã®å¿ç¨ãæå¾ ããããæ¬ç ç©¶ã¯PCNã®Editorâs Choiceã«ãé¸ã°ããã
ããã«ãæã ã¯æ¬ç ç©¶ã¨åæ§ã®ç ç©¶ãã¶ã¤ã³ãç¨ãã¦ãå®éææ©è½ççµåãç½è³ªæ§é ã«ããã¦ãè§£æãè¡ãã以ä¸ã®ï¼ã¤ã®è«æãå ±åãã¦ããã
æ©æ¢°å¦ç¿ãç¨ããèªéã¹ãã¯ãã©ã çã®ã¨ã³ããã§ãã¿ã¤ãã®æ©è½ççµåãã¿ã¼ã³ã®åå®
山縣ãæ(æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§ å°ä»»è¬å¸«)
Yamagata B, Itahashi T, Fujino J, Ohta H, Nakamura M, Kato N, Mimura M, Hashimoto RI, Aoki Y. Machine learning approach to identify a resting-state functional connectivity pattern serving as an endophenotype of autism spectrum disorder. Brain Imaging Behav. 2019 Dec;13(6):1689-1698.
èªéã¹ãã¯ãã©ã çã®ã¨ã³ããã§ãã¿ã¤ãã¨è¨åºè¨ºæã«é¢ä¸ããç½è³ªæ§é
山縣ãæ(æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§ å°ä»»è¬å¸«)
Yamagata B, Itahashi T, Nakamura M, Mimura M, Hashimoto RI, Kato N, Aoki Y.
White matter endophenotypes and correlates for the clinical diagnosis of autism
spectrum disorder. Soc Cogn Affect Neurosci. 2018 Sep 4;13(7):765-773.
(山縣æã2020.2.1.)
解説ãASDã¯ãç½¹æ£ãããã®ã
åè(ãããã ã)ã¯ä¼¼ã¦ãããã ãéãã¨ããããã¡ãããããã§ã¯ããã¯åæ§ã®éããªã®ããããã¨ãç æ°ãç æ°ã§ãªããã®éããªã®ããããã第ä¸ã®åãã§ããã
åè(ãããã ã)ã¯ä¼¼ã¦ãããããã¯ããªãã¡ããã®äºäººã¯ä»ã®äººã ã¨ã¯éããã¨ã嫿ãã¦ãããã§ã¯ããã¯ããã®äºäººãå ±éãã¦æã¤åæ§ãªã®ããããã¨ããã®äºäººã¯ä»ã®äººã ã¨ã¯éã£ã¦ç æ°ã¾ãã¯ãã®å åãæã£ã¦ããã®ããããã第äºã®åãã§ããã
ç æ°ã¨å¥å¸¸ã®ç·å¼ããæç¢ºãªå ´åãä¸ã®äºã¤ã®åããçã¾ãããã¨ã¯ãªããã ãç²¾ç¥ç¾æ£ã§ã¯å¾å¾ã«ãã¦ãã®ç·å¼ããææ§ãªãã¨ãããä¸ã®äºã¤ã¯æã«é大ãªåãã¨ãã¦ããããã«è¿«ã£ã¦ããã
èªéã¹ãã¯ãã©ã çASDã«éºä¼æ§ãå¼·ããã¨ã¯åãããªãäºå®ã§ãããå ãASDã®ã¨ããå¼ã«ASDã®å¾åãèªãããããã¨ã¯ããããããã®ã¨ãå¼ã¯ãé¾å¤ä¸ã®ASDãã¨å¼ã°ããããããã¤ã¾ãäºäººã¨ãASDã«é¢é£ããä½ããæã£ã¦ããããã®ä½ãã¨ã¯ãéºä¼åãããã¯è³ã®ä¸ã«è¦åºãããã¯ãã§ããããã®è¦³ç¹ããã®åèç ç©¶ã¯å¤æ°ãããè³ã«ã¤ãã¦ã®é½æ§æè¦ãããã¤ãçºè¡¨ããã¦ããããã®é½æ§æè¦ã¯ä¸ã®ç¬¬äºã®åãã«é¢é£ãã¦ãããããã¯ãASDã¨ããç æ°ãã«å¯¾å¿ãã齿§æè¦ã§ã¯ãªããããASDã®å¾åãã«å¯¾å¿ãã齿§æè¦ã§ããããããã£ã¦ãã®æè¦ãåºç¤ã¨ãã¦ãããã«ä½ãã®å åãå éãããã¨ã§ãASDã¨ããç æ°ããæç«ããã®ã§ãããå ã¯ãã®ãä½ãã®å åããæãã¦ãããå¼ã¯æãã¦ããªãã
ãããã¦æãéè¦ãªãåé ã®ç¬¬ä¸ã®åãã«çããæºåãæ´ããASDã®å ã¨ãASDã§ã¯ãªãããã®å¾åã®ããå¼ã®è³ã®éããããããASDã¨ããç æ°ããæ±ºå®ããæè¦ã§ãããè«ççã«ã¯ä¸ç¹ã®ççµããªãæ¨è«ã§ããã
ããããªããç¾å®ã¯ããåç´ã§ã¯ãªãã第ä¸ã®åããããè¦ã¦ã¿ãããã®åæã«ããããåè(ãããã ã)ã¯ä¼¼ã¦ãããã ãéãã¨ããããã¡ããããããã¨ããæç« ã¯ãASDã®åèãã¢ã ãã«ãã¦ã¯ã¾ããã®ã§ã¯ãªããåèãã¢ä¸è¬ã«ãã¦ã¯ã¾ããã®ã§ããããããã£ã¦ãASDã®å ã¨ãASDã§ã¯ãªãããã®å¾åã®ããå¼ã®è³ã®éãã¯ãåã«åèéã«å¸¸ã«åå¨ããå ã¨å¼ã®åæ§ã®éãã«ãããªããããããªãããã®ãããªåæ§ã®éãã®é¨åãé¤å¤ããªããã°ããASDã¨ããç æ°ããæ±ºå®ããæè¦ã§ããã¨è¨ããã¨ã¯ã§ããªãã
ããã§å±±ç¸£æè¬å¸«ã¯ãASDåèãã¢ã«å ãã¦ãTDåèãã¢ã«ã¤ãã¦ãæ¤è¨ãè¡ã£ããããã«ãã£ã¦ãASDåèãã¢ã®ã¿ã«è¦ããããå ã¨å¼ã®éããæ½åºãããç²¾å¯ãªæèã«åºã¥ãç²¾å¯ã«ãã¶ã¤ã³ããç²¾å¯ãªåæã«ãã£ã¦å¾ãããè²´éãªãã¼ã¿ã§ããã
ããã¦ãã®å ã«ã¯ãã£ã¨å¤§ããªåé¡ãæ§ãã¦ãããå ãASDã§å¼ããé¾å¤ä»¥ä¸ã®ASDãã¨ããã¨ãããã®é¾å¤ã¯ããã«ãã¦æ±ºå®ãããã®ããé¾å¤ã«ãã£ã¦ãå ã¯ãASDã«ç½¹æ£ããå¼ã¯ãASDã«éç½¹æ£ãã¨åé¡ããããããããã¯æ²»çã®å¿ è¦æ§ã«ãããã£ã¦ããããç½¹æ£ããã¦ããã°æ²»çã®é©å¿ã¨ãããã¨ã«ãªããããé¾å¤ã®è¨å®ã¯å»å¦çã«æéè¦ã§ããããããã«ã¯ç¤¾ä¼çã»æåçã»æ´å²çè¦å ãå ¥ã£ã¦ãããããç´ç²ã«å»å¦çãªè¦³ç¹ã®ã¿ããé¾å¤ãè¨å®ãããã¨ã¯ã§ããªãã
ããã«ã¯ãASDã«ãç½¹æ£ããã¦ããããã¨ãã£ã¦ãå¿
ãããæ²»çã®å¯¾è±¡ã«ãªãã¨ã¯éããªãã
ASDã®åå¨ã¯äººé¡å
¨ä½ã«ã¨ã£ã¦ã®æ©æµã®ä¸ã¤ã§ããã¨ããã
Temple Grandin: The world needs all kinds of minds
https://www.ted.com/talks/temple_grandin_the_world_needs_all_kinds_of_minds
ã¨ããç«å ´ã¯æ±ºãã¦ç¹ç°ãªãã®ã§ã¯ãªããæ²»çããã»ããªãã«ã¤ãã¦ã¯ãå½äºè
ã®æè¦ã叿ãèæ
®ãããã¨ãå¿
é ã§ããã
ããã¯ASDã®å¨è¾ºã«ãããããã種é¡ã®çºéé害ãããã¦ããã¤ç ã髿¬¡è³æ©è½é害ãããã«ã¯ç²¾ç¥ç¾æ£ã¨å¼ã°ãããã®ãã¹ã¦ã«ããããç²¾ç¥å»å¦ã®æ ¹æ¬ã«ãããã大åé¡ã§ãããããã®ãããªéæ¹ããªã巨大ãªåé¡ã«å¯¾ãã¦å±±ç¸£è¬å¸«ã¯ãç´°é¨ã®ç²¾å¯ãªåæã®éç©ã«ãã£ã¦æã¿ç¶ããæ¬¡ã ã«ææãçºè¡¨ãã¦ããã
(ææ¾å¤ªéã2020.2.23.)
ç²¾ç¥çç¶ãç¥çµå¿çå¦ããæãã
åç°è²´è¨ãæ¯æ¨æå®ãé»ç¬å¿ã䏿æ ãè¹å±±ééãï¼ä¼ç»è
ãè¹å±±ééï¼
ç¹éãç²¾ç¥çç¶ãç¥çµå¿çå¦ããæãããã ç¥çµå¿çå¦ Vol.35 No.4 176-224 (2019)
ãæ¬ä¼ç»ã®ç®çã
æ¬ä¼ç»ã¯ç²¾ç¥ç§å»ãæ¥å¸¸è¨åºã§è¨ºã¦ããç²¾ç¥çç¶ããç¥çµå¿çå¦ãè¡åå¿çå¦ããããã¯è³ç»åç ç©¶ã®è¦³ç¹ããæ¤è¨ããä¼ç»ã§ãããçµ±å失調çã«èªããããèªæé害ãç·å¼µç çå群ãæé£é害ã常åè¡çºããã ãããããã«ã¯ãã¾ãã¾ãªç²¾ç¥ç¾æ£ã®ãã¼ã¹ã§ããå å容æè¦ã®ç°å¸¸ã¨ãã£ããã¼ãã§ããããããã®çç¶ãä¸è¨ã®è¦³ç¹ã§åãä¸ãããããã¨ã¯å°ãªãããã£ã¬ã³ã¸ã³ã°ãªè©±é¡ãå¤ãã®ã§ãæç¢ºãªçãããªãå ´åãå°ãªããªãã誤ã£ã¦ãããã¨ããããããããªãããããéã«è¨ãã°ãä»å¾çºå±ããå¯è½æ§ãååã«ç§ãã¦ãããããã¯ã§ãããä»åã®ç¹éãããç²¾ç¥çç¶ãçè§£ããä¸ã§ã®è°è«ã®ã¨ã£ãããã«ãªããã¨ãæå¾ ããã
ãåç°è²´è¨: Sense of Agency: èªå·±æèã®ç¥çµå¿çå¦ãã178-186ã
æåã«çµ±å失調çã«èªããããèªæé害ãsense of agencyã®è¦³ç¹ãããã®åéã®ç¬¬ä¸äººè ã§ããåç°è²´è¨å çã«èª¬æãã¦ããã ãããé£åå¼ç·©ã妿³ç¥è¦ã¨ä¸¦ãã§ãçµ±å失調çã«ç¹ç°çãªçç¶ã§ããèªæé害ã¯çè§£ããã®ã¯å°é£ã§ããããã®è«æã§ã¯ãèªåãéç½ãèµ·ããããã天ã®å£°ã«æãããããªã©ã¨ãã䏿è°ãªä¸»è¦³çä½é¨ã®ç¥çµå¿çå¦çãªã¨ããæ¹ã示ãã ãã§ã¯ãªãããã®ç¥çµåºç¤ã¨ãªãããªã®æ¹åæ§ãå«ãåºç¯ãã¤è©³ç´°ãªè§£èª¬ããªããã¦ããã
ãæ¯æ¨æå®: ç²¾ç¥çç¶ã¨å å容æè¦ãã187-196ã
å å容æè¦ã¯å¿æãå¼å¸ã¨ãã£ã主ã«èº«ä½å é¨ã®çççãªæ å ±ã®æè¦ã§ããã身ä½å ¨ä½ã®ãã¡ãªã¹ã¿ã·ã¹ã«é¢é£ãããã¨ãè¨ããã¦ãããè¿å¹´ãå å容æè¦ãææ ãæææ±ºå®ãªã©è³æ©è½ã«å½±é¿ãããã¼ãã¦ãããã¨ãæããã«ãªã£ã¦ãã¦ãããããã«æè¿ã¯ãä¸å®é害ããããã¯é害ãªã©ã®ç²¾ç¥ç¾æ£ã®èæ¯ã¨ãã¦ã®å å容æè¦ã®ç°å¸¸ãç ç©¶ããã¦ãã¦ããããã®æ¦è¦ãæ¯æ¨æå®å çã«è§£èª¬ãã¦ããã ããã
ãé»ç¬å¿: ç·å¼µç çå群ãã197-206ã
é»ç¬å¿å çã«ãé¡ãããç·å¼µç çå群ã¯ããã¾ãã¾ãªç²¾ç¥ç¾æ£ãã¨ãã«ã¯èº«ä½ç¾æ£ã«ãåºç¾ãããè¨åºä¸æ¥µãã¦éè¦ãªç æ ã§ãããç²¾ç¥çç¶ã§ãããªãããã«ã¿ã¬ãã·ã¼ãæè¿·ãªã©ã®ç¹å¾´çãªçç¶ãããã¾ãã¾ãªèº«ä½åä½µçãçºå±ããç æ ã§ããããã®ç æ ã¯ããããããã20ï½30å¹´åããè³ç»åç ç©¶ãé²ãã§ãã¦ãããé»ç¬å çèªèº«ã®è²´éãªè¨åºç ç©¶çµæã¨ã¨ãã«è§£èª¬ãã¦ããã ããã
ã䏿æ : æé£é害ã¨ç¥çµå¿çå¦çæè¦ãã207-214ã
æé£é害ãç¥çµå¿çå¦ããæãã試ã¿ã¯å°ãªããå¿çå¦ããæããç«å ´ãä¸è¬çã§ããããããå®éã®è¨åºã§ã¯ã極度ã®ä½æ é¤ã®ç¶æ ã®ä¸ã§èªç¥æ©è½ãä½ä¸ãã¦ããã¨ããæããªãã±ã¼ã¹ã«é »ç¹ã«åºããããå®éã«æ é¤ç¶æ ãæ¹åããã¨æé£é害è ã®èªç¥æ©è½ãæ¹åãããã¨ãå°ãªããªããããã«ãæé£é害ã«ç¹æã®èªç¥ãã¿ã¼ã³ãããããããæé£éå®³ã®æ²»çã妨ãã¦ããå¯è½æ§ãé«ããããªãåéºçãªè©¦ã¿ã§ãããã䏿æ å çã«èªé¨ä¾ãå«ãã¦è§£èª¬ãã¦ããã ããã徿¥ã®å¿çå¦ããã®ç¥è¦ããã¯ããªãç°è³ªã§ã¯ããããå¿ ãããçç¾ãããã¨ã¯ãªãããããç¸è£çã«æé£é害ã®ç æ ã®ææ¡ã¸ã®ã¤ãªããã®ã§ã¯ãªããã¨èããããã
ãè¹å±±éé: 常åè¡çº/è¡åã¨ãã ãããã215-224ã
æå¾ã«è¹å±±ããå¾å¤©æ§è³æå·ã夿§ç¾æ£ã«åºç¾ããç¹°ãè¿ãã®è¡çº/è¡åã¨ãã ããã«ã¤ãã¦æ¦èª¬ãããå¼·è¿«æ§é害ã®å¼·è¿«çç¶ã¨ãããã®ç¹°ãè¿ãã®è¡çº/è¡åãåºå¥ããã«ç¨èªãç¨ãã¦ãããã¨ãããããä»åã¯ãã®éãã強調ãããã¨ã試ã¿ãããã®çç±ã¯ããã®èæ¯ãåºå¥ãããã¨ã«ãã£ã¦ç¥çµåºç¤ãã¢ããã¼ããå¤ããå¯è½æ§ãããããã§ããããã ããã«ã¤ãã¦ã¯ãå¨å²ã¸ã®å½±é¿ãå¼·ããå¤å·æ§è³æå·ãªã©ã®å¾å¤©æ§è³æå·ã«ã¦å¨å²ãæãå°ãçç¶ã§ããã«ãããããããä»ã²ã¨ã¤ç ç©¶ããªããã¦ããªãããã«åãä¸ãããçè èªèº«ã¯ãã ããã䏿¬¡çã«ããã®ã§ã¯ãªããèæ¯ã«ããèªç¥æ©è½ã®ä½ä¸ã«æ³¨ç®ãã¹ãã§ããã¨èãã¦ããã
(è¹å±±ééã2020.1.7.)
ã¤ã³ã¿ã¼ããã䏿¯ã¨è¨åºãã¢ã°ã©ãã£ãã¯ããã³è¡åè¦ç´ ã®é¢é£
ã ãã³ããã»ã¨ã«ãµã«ããï¼æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ã»ç¥çµç§å¦æå®¤ãå
±åç ç©¶å¡ï¼
ElSalhy, Muhammad, Takahiro Miyazaki, Yoshihiro Noda, Shinichiro Nakajima, Hideki Nakayama, Satoko Mihara, Takashi Kitayuguchi, Susumu Higuchi, Taro Muramatsu, and Masaru Mimura. Relationships between internet addiction and clinicodemographic and behavioral factors. Neuropsychiatric disease and treatment 15 (2019): 739.
ã¤ã³ã¿ã¼ãããã¯ç§ãã¡ã®ç¾ä»£çæ´»ã«ä¸å¯æ¬ ãªæ§æè¦ç´ ã«ãªã£ããããã®è² ã®å½±é¿ãã¤ã¾ãã¤ã³ã¿ã¼ããã䏿¯ï¼IAï¼ã«ã¤ãã¦ãã彿°ã¨å¦è¡ã®æ³¨ç®ãéã¾ã£ã¦ãããè¨åºãã¢ã°ã©ãã£ãã¯ããã³è¡åå åã¯ãIAã®ã¡ã«ããºã ã«ä»®èª¬çã«é¢ä¿ãã¦ãããããã®ãããªå åãIAã®éç度ã«ã©ã®ããã«é¢é£ãã¦ãããã¯ã¾ã ã»ã¨ãã©ä¸æã®ã¾ã¾ã§ããããããã£ã¦ããã®ç ç©¶ã¯ãIAã®éç度ã¨ããã¾ãã¾ãªæè²æ®µéã«ããã¦ã®æ¥æ¬äººå¦çã®IAã«æ½å¨çã«é¢é£ããè¦å ã¨ã®éã®é¢ä¿ã調æ»ãããã¨ãããæ¬ç ç©¶ã®æ¹æ³ã¨ãã¦ã¯ã¢ã³ã±ã¼ããã¼ã¹ã®èª¿æ»ã§ããã4119人ããã®ååãããã ããæçµçã«ç ç©¶ã«å«ã¾ããã®ã3224人ã®åçã§ããã調æ»ã®ã¢ã³ã±ã¼ãã«ã¯ããªã³ã©ã¤ã³æ´»åã®ã¿ã¤ãã¨è¨åºãã¢ã°ã©ãã£ãã¯æ å ±ã«é¢ãã質åãIAéç度ã®IAãã¹ããããã³å¿ççè¦çã®K6ã¹ã±ã¼ã«ãå«ã¾ãã¦ããã対象ã«ããã®ã¯å°å¦çãã大å¦çã¾ã§ã®å¹ åºã年齢層ã«èª¿æ»ããããã¼ã¿ãéãã¦ããéå帰åæã宿½ããè¨åºãã¢ã°ã©ãã£ãã¯ããã³è¡åå åã«ããIAéç度ãäºæ¸¬ããã
ãã®ç ç©¶ã§ä¸»ã«å¾ãçµæã¯ãIAã®éç度ã¯ããªã³ã©ã¤ã³ã¡ãã»ã¼ã¸ããã§ã¼ã¹ããã¯ãªã©ã®ã½ã¼ã·ã£ã«ãããã¯ã¼ãã³ã°ãµã¼ãã¹ï¼SNSï¼ããªã³ã©ã¤ã³ã²ã¼ã ã伿¥ã®ã¤ã³ã¿ã¼ããã使ç¨ãå¿ççè¦çã表ãK6ã¹ã³ã¢ã«ææã«æ£ã®é¢é£ãããã¨ã¿ããããããããæè²ç®çã§ã®ã¤ã³ã¿ã¼ãããã®ä½¿ç¨ããåãã¦ã®ã¤ã³ã¿ã¼ãããã使ã£ãå¹´é½¢ãããã³ç¡ç æéããã®ï¼ã¤ã®è¦ç´ ãä¸ããã°ä¸ããã»ã©ãIAã®éç度ãä¸ããã¨ã¿ãããã æ¬ç ç©¶ã§ã®å¹´é½¢ã®ç´æ¥å½±é¿ãã¿ãããªãã£ããããããå¹´é½¢ã«ãã£ã¦ãã¤ã³ã¿ã¼ãããã®ä½¿ç¨æ´»åãç°ãªãããã®æ´»åã«ãã£ã¦IAã®éç度ãå¤ããã
çµè«ï¼IAã¯ãã¾ãã¾ãªãªã³ã©ã¤ã³æ´»åã¨å¿ççè¦çã®ç¨åº¦ã«ãªã³ã¯ããã¦ãããããã¯ãIAãããã«çè§£ããããã«ããªã³ã©ã¤ã³è¡åã¨å¿ççè¦å ã®å æ¬çãªè©ä¾¡ã®éè¦æ§ã示ãã¦ããã
(ã ãã³ããã»ã¨ã«ãµã«ãã2019.12.1.)
解説ãç¬¬ä¸æ©ãããã¦éããªãèºé²
æ°ãã¤ãããæ·±å»ãªåé¡ã«ãªã£ã¦ãããã¨ããäºæ ã¯é¿ããããã®ã ããé¿ãããããã®ã§ããããããã¦é¿ããããã£ãã¨ãã¦ããæ°ã¥ãããä¸å»ãæ©ã対çãç«ã¦ããã¨ãå¿ è¦ã§ããããã®ããã®ç¬¬ä¸æ©ã¯ãç¾ç¶ãææ¡ãããã¨ã§ããã
ã¤ã³ã¿ã¼ããã䏿¯ (IA: Internet Addictionããã®addictionã䏿¯ã¨è¨³ãããä¾åã¨è¨³ãããåçã¨è¨³ããã¯æ©ã¾ããåé¡ã ããããã¯ã ãã³ããã»ã¨ã«ãµã«ãå士ã®è¨³èªã䏿¯ããæ¡ç¨ãããã¨ã«ãããã¡ãªã¿ã«ä¸ã®è§£èª¬æã¯ãå½¼èªèº«ããã¹ã¦æ¥æ¬èªã§æ¸ãããã®ã§ãã)ããã®ä¸ã¤ã§ãã¨ã¸ããããã®çå¦çã»ã ãã³ããé¢çã«ãããæãå½ã®çå¾ã»å¦çã®IAããããç¶æ³ã詳ãã調æ»ããæ¬ç ç©¶ãã¼ã¿ã¯ãããããã¾ãã¾ãæ¡å¤§ããã¨æãããIAã«ã¤ãã¦ã®å®å¹ãã対çãç«ã¦ãåºç¤ãã¼ã¿ã¨ãªãè²´éãªãã®ã§ããããã®è«æã§å¦ä½ãåå¾ãå»å¦å士ã¨ãªã£ãã ãã³ããé¢çã¯ãç¾å¨ã¯ãªãã¼ã³ã«å¨ä½ããæ¥æ¬ã®å»å¸«å½å®¶è©¦é¨åæ ¼ãç®æãã¦åå¼·ã«å±ãã§ãããã¤ã¾ãå°æ¥ã¯ã¾ãæ¥æ¬ã«æ»ãäºå®ã®ããã§ãããããã®å¾ã®æ´»åå å®¹ãæ´»å空éã«ã¤ãã¦ã®å½¼ã®è¨ç»ã¯æã ã®æ³åãè¶ ããéããªãèºé²ãç§ãã¦ããã
ãå½éåãã¨ããè¨èã¯ããè³ã«ããããæ¥æ¬äººã®ãããå½éåãã®å¤ãã¯ã欧米åãã§ãã£ã¦ãçã®å½éåããã¯ç¨é ãã®ã宿 ã§ããããã¢ã©ãã¢èªã»æ¥æ¬èªã»ãã¤ãèªã»è±èªãé§ä½¿ãã軽快ãªãããã¯ã¼ã¯ã§å°çä¸ãç§»åããã ãã³ããå士ããã¯çã®å½é人ã¨ããå¼ã³åã«ãµãããããå½¼ã®é¢å¿ã¯IAã«ã¨ã©ã¾ãããè¡ååçãããã¦äººéã®è¡åå ¨ä½ã«åºãã£ã¦ãããæ¥æ¬äººã«ã¯ãªãè¦ç¹ããã®æ´»èºã大ãã«æå¾ ãããã
(ææ¾å¤ªéã2019.12.21.)
é é¨å¤å·ã®é
çºæ§è³é害ãå¼ãèµ·ããç°å¸¸ã¿ã³ãã¯è³ªãçä½å
ã§å¯è¦åãããã¨ã«æå
é«çåè¼ã(å½ç«ç ç©¶éçºæ³äººãéåç§å¦æè¡ç ç©¶éçºæ©æ§ æ¾å°ç·å»å¦ç·åç ç©¶æãè³æ©è½ã¤ã¡ã¼ã¸ã³ã°ç ç©¶é¨ãè³ç¾æ£ãã©ã³ã¹ã¬ã¼ã·ã§ãã«ç ç©¶ãã¼ã )
Takahata K, Kimura Y, Sahara N, Koga S, Shimada H, Ichise M, Saito F, Moriguchi S, Kitamura S, Kubota M, Umeda S, Niwa F, Mizushima J, Morimoto Y, Funayama M, Tabuchi H, Bieniek KF, Kawamura K, Ming-Rong Zhang, Dickson DW, Mimura M, Kato M, Suhara T and Higuchi M. PET-detectable tau pathology correlates with long-term neuropsychiatric outcomes in patients with traumatic brain injury. Brain 2019; 142: 3265â3279.
ç ç©¶ã®èæ¯ï¼ã³ã³ã¿ã¯ãã¹ãã¼ãã§å¼ãèµ·ããããé é¨ã¸ã®å復æ§ã®è³éçªãã交éäºæ ãªã©ã«ãã£ã¦å¼ãèµ·ããããé度é é¨å¤å·ã¯ãæ°å¹´ãæ°åå¹´å¾ã«é²è¡æ§ã®ç¥çµå¤æ§ç¾æ£ãå¼ãèµ·ãããã¨ããããé çºæ§è³é害ã¨å¼ã°ãã¦ãããæ»å¾è³ãç¨ããç¥çµç çå¦çæ¤æ»ã«ãããé é¨å¤å·ã«ããé çºæ§è³é害ã®å¤ãã¯è³å ã«ã¿ã¦ãéå°ã«èç©ããã¿ã¦ãªããã¼ã®ä¸ç¨®ã§ãããã¨ã夿ãã¦ããããã®ä»£è¡¨çãªç æ ããç¾å¨ç±³å½ãä¸å¿ã«å¤§ããªåé¡ã¨ãªã£ã¦ããæ ¢æ§å¤å·æ§è³ç(chronic traumatic encephalopathy: CTE)ã§ãããCTEãªã©ã®é çºæ§è³é害ã®åé¡ã¯ãã¿ã¦ã®èç©ãçä½å ã§æ¤åºããæè¡ãåå¨ããªãããã«åå½ä¸ã«è¨ºæãããã¨ãä¸å¯è½ã§ããã¨ããç¹ã«ãã£ãããã®ãããé çºæ§è³é害ã«å¯¾ããæ©æä»å ¥ãå°é£ã¨ãªããã¿ã¦ãæ¨çã¨ããæ²»çæ³ã®éçºã«åããåãçµã¿ã«ããã¦ã大ããªéå£ã¨ãªã£ã¦ãããããããåé¡ã¯ãã³ã³ã¿ã¯ãã¹ãã¼ããé é¨å¤å·ã®ãªã¹ã¯ãä¼´ãè·æ¥ã«å¾äºãã人ã ã«å¤§ããªæ¸å¿µãããããã¦ããããã®ãããªçµç·¯ãããèè ã¯é é¨å¤å·ã«ãã£ã¦å¼ãèµ·ããããé çºæ§è³é害ã®åå ã¨ãªãè³å ã¿ã¦ã®èç©ãçä½å ã§æãã診ææè¡ã®éçºãå¿ è¦ã¨èãã¦ããã
ç ç©¶ãéå§ããçµç·¯ï¼ èè ãæå±ããéç æ©æ§ã¯ã2013å¹´ã«ç¬¬ä¸ä¸ä»£ã¿ã¦ãã¬ã¼ãµã¼ã®ä¸ã¤ã§ãã11C-PBB3ãä¸çã«å é§ãã¦éçºãããå½åã¯ãã¢ã«ããã¤ãã¼ç ãé²è¡æ§æ ¸ä¸æ§éº»çºãªã©ã®ç¥çµå¤æ§ç¾æ£ãä¸å¿ã¨ããç ç©¶ã«é¢ããäºå®ã§ãã£ãããåãææã«ç±³å½ããã³ã³ã¿ã¯ãã¹ãã¼ãã¨è³å ã¿ã¦èç©ã®é¢é£ã示åããä¸ç©ãªå ±åãç¸æ¬¡ãã§ãªããããã¨ã転æ©ã¨ãªã£ããã¢ã¡ãªã«ã³ããããã¼ã«ãã¢ã¤ã¹ããã±ã¼ãªã©ã®ã³ã³ã¿ã¯ãã¹ãã¼ãã§æ´»èºãã鏿ãå¼éå¾ã«èªæ®ºã殺人ãç¯ããªã©ã®æ²æ¨ãªåºæ¥äºãç¶ãã¦ãããã¨ã亡ããªã£ã鏿ã®è³ãç çè§£åã«ãã£ã¦èª¿ã¹ãã¨ãããããããè³å ã«å¤éã®ã¿ã¦ã¿ã³ãã¯è³ªãèç©ãã¦ãããã¨ãªã©ããã»ã³ã»ã¼ã·ã§ãã«ã«å ±éãããã®ã§ãããé é¨å¤å·ãç¥çµå¤æ§ç¾æ£ã«ãã£ã¦å¼ãèµ·ããããå¨è³ªæ§ç²¾ç¥é害ã«å¼·ãé¢å¿ããã£ã¦ããèè ã¯ãç±³å½ããçºããããé é¨å¤å·ã®é çºæ§è³é害ã«é¢ããä¸é£ã®å ±åã«æ³¨ç®ãã¦ãããããããææã«éç æ©æ§ã§11C-PBB3ãéçºããããã¨ãããçä½å ã§ã¿ã¦ãå¯è¦åãããã¸ããã³æå±¤æ®å½±(PET)æè¡ãæ ¢æ§å¤å·æ§è³çã®æ©æè¨ºæãå°æ¥ã®æ²»çè¬éçºã«ã¨ã£ã¦æç¨ãªæè¡ã«ãªãã¨èããé é¨å¤å·ã«ããé çºæ§è³éå®³ãæ¨çã¨ããã¿ã¦PETç ç©¶ãéå§ããã
ç ç©¶ã®ææï¼æ¬ç ç©¶ã§ã¯ãéç æ©æ§ã¨æ ¶æç¾©å¡¾å¤§å¦ç é¢ã¨ã®å ±åç ç©¶ã¨ãã¦è¡ããããéç æ©æ§ã§ã¯ãçä½è³ã§ã¿ã¦ãå¯è¦åããæè¡ãç¨ãã¦é é¨å¤å·ã«ããé çºæ§è³é害ãçºçããå¯è½æ§ã®ãã被é¨è ã®è³å ã¿ã¦èç©éãé侵襲çã«æ¸¬å®ããæ ¶æç¾©å¡¾å¤§å¦ç é¢ã§ã¯æ£è ãªã¯ã«ã¼ãããã³ç¥çµå¿çæ¤æ»ãè¡ã£ãããã®çµæãæ§ã ãªã¿ã¤ãã®é é¨å¤å·ã§ã¿ã¦ã®èç©ãçä½å ã§æãããã¨ã«åãã¦æåãããããã«ãè³ã®ç°ç½è³ªã¨ã®å¢çé¨ã«è¿æ¥ããç½è³ªã®è¡¨å±¤é¨ã®ã¿ã¦èç©ãé çºæ§è³é害ã®çç¶ã«é¢é£ãã¦ãããã¨ãç½è³ªå ¨ä½ã®ã¿ã¦èç©éãå¤ããã°å¤ãã»ã©ç²¾ç¥ç çç¶ãéçåããã¨ããé¢ä¿æ§ããããã¨ãæããã«ããããããã®ææã¯ãé çºæ§è³é害ãç²¾ç¥çç¶ãå¼ãèµ·ããæ©åºã®ä¸ç«¯ãæããã«ããã ãã§ãªããPETæè¡ã«ããæããçä½è³ã«ãããã¿ã¦èç©ãé çºæ§è³éå®³ã®æ©æè¨ºæã®ããã®è©ä¾¡ææ¨ã«ãªãå¾ããã¨ã示ããã®ã§ãããå°æ¥çã«ãé çºæ§è³é害ã«ãããã¿ã¦èç©ãæ¨çã¨ããæ²»çæ³ã®éçºã«å¯ä¸ãããã¨ãæå¾ ããããæ¬ç ç©¶ã§å¾ãããææãè¸ã¾ããç¾å¨ã¯ã¿ã¦æ¤åºè½ãåä¸ãã第äºä¸ä»£ã¿ã¦ãã¬ã¼ãµã¼ãç¨ããç ç©¶ãé²ãã¦ããã
æå¾ã«ãªãããæ¬ç ç©¶ãéå§ããã«ããã£ã¦å¤§ããªå©è¨ãé ããæ å è¤å ä¸éå çã«å¯¾ãã¦å¿ããæè¬ã®æãæ§ãããã
(é«çåè¼ã2019.11.2.)
ãã¬ã¹ãªãªã¼ã¹ (2019å¹´9æ2æ¥)
https://www.keio.ac.jp/ja/press-releases/2019/9/2/28-60411/
解説ã3å人ã®ã¢ã¹ãªã¼ãã®ããã«ãããã¦ã
é ãæã¤ã¨ãè³ã«æ°¸ç¶çãã¤é²è¡æ§ã®æå·ãçºçããå¾ãããããæ¬è«æã§é«çåè¼å士ã示ããé®®çãªã¡ãã»ã¼ã¸ã§ããããã®ã¡ãã»ã¼ã¸ã¯ãã³ã³ã¿ã¯ãã¹ãã¼ã(ãã¹ã¦ã®æ ¼éæã¨ã©ã°ãã¼ãã¢ã¡ãªã«ã³ããããã¼ã«ããµãã«ã¼ãªã©ã®çæãå«ã)ã®ããæ¹ãå¤ããã«ã¨ã©ã¾ãããè³ã®å¤å·å¦ã®æç§æ¸ãæ¸ãæããããã«ã¯ç²¾ç¥ç¾æ£ã®æå ã«ã¤ãã¦ã®å¸¸èã¾ã§ãå·æ°ãããé©å½çãªç¥è¦ã§ããã
èæ¯ããããé«çå士ã¯è§£èª¬ã«ããè¨ãã¦ããã
æ»å¾è³ãç¨ããç¥çµç çå¦çæ¤æ»ã«ãããé é¨å¤å·ã«ããé çºæ§è³é害ã®å¤ãã¯è³å ã«ã¿ã¦ãéå°ã«èç©ããã¿ã¦ãªããã¼ã®ä¸ç¨®ã§ãããã¨ã夿ãã¦ããããã®ä»£è¡¨çãªç æ ããç¾å¨ç±³å½ãä¸å¿ã«å¤§ããªåé¡ã¨ãªã£ã¦ããæ ¢æ§å¤å·æ§è³ç(CTE)ã§ããã
ãã¯ã·ã³ã°ãªã©ã§é é¨ã«æ¿ããææãåããã¨è³ã«å¾éºçãçºçãããã¨ã¯ããã³ããã©ã³ã«ã¼ããã¯ãµã¼è³çã®åã§æããããç¥ããã¦ãããã§ã¯ãã®ãæ¿ããææãã¨ã¯ã©ã®ç¨åº¦ãªã®ããããã¯ã¢ã¦ã(=è³éçª)ã«è³ããªããã°åé¡ãªãã®ãããã«ã¡ããã§é²è·ããã¦ããã°åé¡ãªãã®ãããµãã«ã¼ã®ããã£ã³ã°ç¨åº¦ãªãåé¡ãªãã®ãããããã¯ãã¹ã¦ä¸æã§ãã£ãã䏿ã§ãã£ããããã®é·å¹´ããã¶ã£ã¦ããåé¡ããç±³å½ã®ã¢ã¡ãªã«ã³ããããã¼ã«ãªã¼ã°(NFL)ã§20ä¸ç´æ«ã«æ¥éã«ã¯ãã¼ãºã¢ãããããã®ã§ããã
å§ã¾ãã¯ãã¤ã¯ã»ã¦ã§ãã¹ã¿ã¼ã®æ»ã ã£ãã
âIron Mikeâã¨å¼ã°ããå½¼ã¯ã NFLãããããã¼ã°ã»ã¹ãã£ã¼ã©ã¼ãºã®åã»ã³ã¿ã¼ã§ãã£ããç±³å½ã§ã¯ç¥ãã¬è ãããªãã»ã©ã®ã¹ã¿ã¼ã§ãã£ããã¤ã¯ã®äººçã¯ãããããå¼éå¾ã«æè»¢ãããç²¾ç¥ãä¸å®å®ã«ãªããçæ´»ã大ããä¹±ãããæµªè²»ãæ æ°ãè¬ç©ä¹±ç¨ãèªç¥æ©è½ä½ä¸ãæãã¤ãå¹»è´ãç¾ãããç¾å½¹æä»£ã«ç²å¾ãã豪é¸ãå®¶æã失ããã¼ã ã¬ã¹ã¨ãªãã坿³ã¾ããã¦ããå»è»å ã§å¿çæ¢å¡ãèµ·ãããã®ä¸çãã¨ããã50æ³ã§ãã£ãã
ããã¾ã§ã§ããã°ãããããã¹ã¿ã¼ã®æ²¡è½ç©èªã§çµãã£ããããããªããã ãå½¼ã®æ¤æ»ãæ å½ãããªãã«å»å¸«(Dr. Bennet I. Omalu)ãããã¤ã¯ã®åèªãå復ããããã¤ã¯ã®æ»å¾è³ã®åçãå ç«æè²ããè³ã®åºæ±ãªé¨ä½ã«ã¿ã¦ã¿ã³ãã¯ãè¦åºããã®ã§ããããã¯ãµã¼è³çãããªãã¡ãé é¨ã«æ¿ããææãç¹°ãè¿ãåããå ´åã«çããè³çã«ãã¿ã¦ã¿ã³ãã¯ãèªãããããã¨ã徿¥ããç¥ããã¦ãããããããããããã¼ã«ã¨ãããç¸å¯¾çã«å¼±ãè³ã¸ã®ææã§ãçãããã¨ããªãã«å»å¸«ã¯çºè¦ããã®ã§ããã(Omalu BI, Kekosky ST, Minster RL et al: Chronic traumatic encephalopathy in a National Football League Player. Neurosurgery 57; 128-134, 2005.)
ãã®è«æãçºè¡¨ãããªãã«å»å¸«ã¯ãç¡éªæ°ã«ãèªåã¯NFLããæè¬ãããã¨ä¿¡ãã¦ãããããããã¼ã«é¸æãè³çããå®ãæ¹æ³ã®éçºã«è²¢ç®ããç¬¬ä¸æ©ã«ãªãã¨èããããã§ããã
ããã¯ç§å¦çäºå®ã«åºã¥ããçæ¯ãªèãã§ãã£ããã社ä¼çç¶æ³ã«åºã¥ãã°ãã¾ãã«çãèãã§ãã£ãããªãã«å»å¸«ã®çºè¦ãæ£ããã¨èªããããã°ãããããã¼ã«é¸æã®è³ã«ã¯ãã¬ã¤ã«ããæ·±å»ãªå¾éºçããããã¨ã«ãªããNFLã¸ã®è²¬ä»»è¿½åãå¿ è³ã ããã§ãããå§åçãªè²¡åãæã¤NFLã«éããã(ã«éããªã)権å¨ããå»å¸«éããã®ãªãã«è«æã¸ã®æ»æã¯ã©ãã¤ãã¾ã§ã«å¼·çãªãã®ã§ããã®çµç·¯ã¯Fainaru-Wada M and Fainaru S: League of Denial. The NFL, Concussions, and the Battle for Truth. Three Reivers Press, NY, 2013.ã«è©³è¿°ããã¦ããããã£ã¨æè»½ãªè³æã¨ãã¦ã¯ã2015å¹´ã«å°åãããæ ç»Concussion(é¦é¡: ã³ã³ã«ãã·ã§ã³)ã§ãNFLããã®æå½¢ç¡å½¢ã®å§åã«è¦æ©ãããªãã«å»å¸«ãã¦ã£ã«ã»ã¹ãã¹ãè¦äºã«æ¼ãã¦ããã(Concussion. Columbia Pictures Industries, 2015.)
å»å¦ã¨ç¤¾ä¼ã¨éãé¯ç¶ãããã®äºãã¯ãæçµçã«ã¯ãªãã«å»å¸«ã®çºè¦ãæ£ãããã¨ã証æããããã¨ã§æ±ºçããå¼éãããã¬ã¼ã¤ã¼ç´4500人ããã®éå£è¨´è¨ã«å¯¾ãNFLã¯ç·é¡8åãã«ã®åè§£éãæ¯æããã¨ã«ãªãããªãã«å»å¸«ã¨NFLã®é¸æéã¯åå©ããã®ã§ããã
ã ãã3åäººãæ®ããããä¸çã®ã³ã³ã¿ã¯ãã¹ãã¼ãã®ç«¶æäººå£3å人ã«ã¨ã£ã¦ããªãã«å»å¸«ã®çºè¦ã¯éãè¦åã«ã¯ãªã£ã¦ããæ©æµã«ã¯ãªã£ã¦ããªãããªãã«å»å¸«ã®çºè¦ã¯ç»æçã§ãã£ããã®ã®ãããã¯æ»å¾è³ã®åçãé¡å¾®é¡ã§è¦ã¦åãã¦è¨ºæã§ãããã®ã§ãã£ã¦ãããªãã¡æ»ãªãªããã°è¨ºæã§ããªããããã§ã¯å®è¨åºã®å½¹ã«ã¯ç«ããªããä»ã¾ãã«è¨ºæã¨æ²»ç(ããã¦æã«ã¯è£å)ãå¿ è¦ã¨ããå½äºè ã®æ©æµã«ã¯ãªããªããå½¼ãã®ããã«ã¯ãè³ç»åæ¤æ»ã§ã¿ã¦ã¿ã³ãã¯ã®èç©ãç®ã«è¦ããªããã°ãªããªãã
ãããå¯è½ã«ããã®ãæ¬ç ç©¶ã§ãããé«çåå£«ã®æ¬è§£èª¬ã®ã¿ã¤ãã«ãé é¨å¤å·ã®é çºæ§è³é害ãå¼ãèµ·ããç°å¸¸ã¿ã³ãã¯è³ªãçä½å ã§å¯è¦åãããã¨ã«æåãã¯ããã®å·¨å¤§ãªæç¾©ãéãã«ããããé«ããã«åç¥ãã¦ããã
æä»£ãå§ã¾ãã
æ ¢æ§å¤å·æ§è³ç(CTE)ã®æ©æçºè¦ãå¯è½ã«ãªããé 鍿æã®å±éºæ§ãæ£ç¢ºã«ç¤ºãããã°ãäºé²ãå¯è½ã«ãªããããã«ã¯ãã¿ã¦ã¿ã³ãã¯ã®å¢æ®ãæå¶ããæ²»çæ³ã®éçºã«ãã¤ãªãããCTEã®çç¶ã¯å¤å½©ã§ãããä¼çµ±çãªç²¾ç¥å»å¦ã§å å æ§ã¨å¼ã°ãã¦ããç²¾ç¥ç çç¶ãåºç¾ããã仿¹ãå¤å·ã«èµ·å ããªãç²¾ç¥ç çç¶ããé«é½¢è ã«ããã¦ã¯ãã°ãã°ã¿ã¦ã¿ã³ãã¯ã®èç©ãé¢ä¸ãã¦ãããã¨ãæããã«ããã¤ã¤ãããè³ç»åã¨ãã¦ã®ã¿ã¦ã¿ã³ãã¯ã®å¯è¦åãããã«æ´ç·´ãããã°ãCTEãè¶ ããããããç²¾ç¥ç¾æ£ã®è¨ºæã¨æ²»çã®çºå±ã«ãã®è²¢ç®ç¯å²ãæ¡å¤§ããããã¨ã¯çããªããæ ¶æã®å¤§å¦é¢çãå«ãéç æ©æ§(æ¾å»ç )ã»é«çãã¼ã ã®è¨åºã®æ §ç¼ã¨æå 端ã®ãã¬ã¼ãµã¼æè¡ãããã¦ç§å¦ççå®ã追究ããã¨ãã«ã®ã¼ãããããç¾å®ã®ãã®ã«ãã¦ãããç²¾ç¥å»å¦ã®é»ææããäºè¨ããã¦ãããå å ã¨å¤å ãçµã¶è¬ã®å®ç¸ããä»ãå§¿ãç¾ããã¤ã¤ããã
(ææ¾å¤ªéã2019.11.27.)
大ãã¤ç
æ§é害ã«ãããæ²è¦³çæªæ¥æ§æèã«é¢ä¸ããåé æ¥µã®æ´»å
çå±±ãå¥çåãï¼æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ã»ç¥çµæå®¤ã大å¦é¢å士課ç¨ï¼
Frontopolar cortex activation associated with pessimistic future-thinking in adults with major depressive disorder.
Katayama N, Nakagawa A, Umeda S, Terasawa Y, Kurata C, Tabuchi H, Kikuchi T, Mimura M.Â
NeuroImage: Clinical 2019 ; 23 : 101877
大ãã¤ç æ§é害ï¼Major Depressive Disorder :MDDï¼ã¯ä¸çã§ç´3å人ãç½¹æ£ãã¦ããæç çã®é«ãç²¾ç¥ç¾æ£ã§ãã(World Health Organization, 2018)ãMDDæ£è ã¯æªæ¥ã«å¯¾ãã¦æ²è¦³çã§ããããã¯çµ¶ææã¨ãé¢é£ãã(MacLeod et al, 1998)ãAron T. Beckã®èªç¥çè«ã§ã¯ãMDDã¯å ·ä½çã«èãããããå°æ¥ãæ³åããè½åã®æ¸å°ãææãã¦ãã(Beck A.T, 1963)ãICD-10ãDSM-5ã§ãå°æ¥ã«å¯¾ããæ²è¦³ã¯MDDã®ä¸»è¦ãªçç¶ã®ï¼ã¤ã¨ãã¦ãããå¥å¸¸è ã«ãããè³ç»åç ç©¶ã§ã¯ãæªæ¥ãèããæï¼æªæ¥æ§æèï¼ã«ã¯ä¸»ã«åé æ¥µï¼Brodmann area [BA] 10ï¼ã®é¢ä¸ãå ±åããã¦ãã(Benoit et.al, 2011)ãããã¾ã§ã®MDDã®ç»åç ç©¶ã§ã¯èªå·±åç §ããã»ã¹ã«é¢é£ããè¡åç°å¸¸ãåè»ï¼ã«ããã¼ã·ã§ã³ï¼ãèªè²¬æãªã©ã®çç¶ã«BA10ã®æ©è½ã®é¢é£æ§ãææããã¦ãã(Johnson et.al, 2009; Jones et.al, 2017)ãããããMDDã«ãããæªæ¥æ§æèä¸ã®è³ç¥çµæ´»åã¯æªè§£æã§ãããæã ã¯MDDã«ãããæªæ¥æ§æèã®ç¥çµåºç¤ã®è§£æãç®çã¨ããç ç©¶ãè¡ã£ãã
対象è ã¯MDDæ£è 23人ã¨å¥å¸¸è 23äººãæªæ¥æ§æèã®è©ä¾¡å°ºåº¦ã§ããFuture Thinking Implicit Relations Assessment Procedure(Kosnes et.al, 2013)ãæ¹å¤ããæªæ¥æ§æè課é¡ãç¨ãã¦è³æ©è½ç»åï¼functional MRIï¼ã試è¡ãããæªæ¥æ§æè課é¡ã¯ãé ãæªæ¥/è¿ãæªæ¥ãæ³åããæ¡ä»¶ã¨é ãéå»/è¿ãéå»ãæ³èµ·ããæ¡ä»¶ã®4æ¡ä»¶ãããæªæ¥ãæ³åãããããã¯éå»ãæ³èµ·ããéã®è³ç¥çµæ´»åãMDDã¨å¥å¸¸è ã¨æ¯è¼ããããã«BA10ã®æ´»åã¨æ²è¦³ã®å¼·ãããã³ãã¤ç ã®éç度ã¨ã®ç¸é¢ãæ¤è¨ãããã¾ããå®éæfunctional MRIãç¨ãã¦BA10ãåºç¹ã¨ããå®éæè³æ©è½ççµåæ§ãæ¤è¨ããã
å¥å¸¸è ã¨æ¯è¼ãã¦ãMDDæ£è ã¯ãå°æ¥ã«ã¤ãã¦æ²è¦³çã§ãããç¹ã«é ãæªæ¥ããã¦ãã¸ãã£ãã«åå¿ãããã¨ã«å°é£ããèªãããããã¦MDDæ£è ã¯é ãæªæ¥ãæ³åããæãå å´ã®åé æ¥µ(BA10)ã®æ´»åãå¢å ã(family-wise error correction p <0.05)ããã®BA10ã®æ´»åã¯é ãæªæ¥å¯¾ãããã¬ãã£ã度ããã³ãã¤ç ã®éçåº¦ã¨æ£ã®ç¸é¢ãèªãããããã«ãå®éæfMRIã§ã¯MDDã¯å¥å¸¸è ã¨æ¯è¼ãã¦å³BA10é åã¨å¾å¸¯ç¶ç®è³ªï¼PCCï¼ã¨æ©è½ççµåæ§ã®å¢å¼·ãã¦ããã
é ãæªæ¥ã«å¯¾ãã¦æ²è¦³çã§ããMDDæ£è ã¯ãé ãæªæ¥ãèãã¦ããæã«åé æ¥µ(BA10)ã®æ´»åãããé«ããå®éæã«ããã¦ãPCCã¨ã®çµåæ§ãé«ã¾ã£ã¦ããããããããMDDæ£è ã®æ²è¦³ãçµ¶æã«ãBA10ã®æ©è½ä¸å ¨ãéè¦ãªå½¹å²ãæããã¦ãããã¨ã示åããããæ¬ç ç©¶ã¯ãã¤ç ã«ãããé æªæ¥æ§æèæã®å å´BA10ã«ãããè³æ´»åã¨æªæ¥ã«å¯¾ãããã¬ãã£ããªèªç¥ã®åãã®é¢ä¿ãè©ä¾¡ããæåã®ç ç©¶ã§ãããé æªæ¥æèæã®å å´BA10ã®æ©è½é害ã¯ãã¤ç ã«ãããæªæ¥ã«å¯¾ããå¦å®çãªèªç¥ãåæ ããèªç¥è¡åçæ³ï¼CBTï¼ãªã©ã®èªç¥æ©è½ãæ¹åãããæ²»ç广ãè©ä¾¡ãããã¥ã¼ããã¼ã«ã¼ã¨ãªãå¯è½æ§ã示åãããã
(çå±±å¥çåã2019.10.1.)
解説ãå°æ¥ã夢ãã»ã»ã»
ãå°æ¥ã夢ããã¨ããæåãæç¤ºããããæ°ç§å¾ã«ãå¶ãã(ã¾ãã¯ãå¶ããªãã)ã¨ããæåãæç¤ºãããèªåã«å½ã¦ã¯ã¾ããã©ããããã¯ãããããããã®ãã¿ã³ãæ¼ãã¦çããããããçå±±å¥çå大å¦é¢çãç¨ããæªæ¥æ§æè課é¡ã®ä¸ä¾ã§ãããä»ã®ä¾ã¨ãã¦ããå°æ¥ãåªåãè©ä¾¡ãããããã/ããããªããããè¿ããã¡ã«ãç®æ¨ãéæããã§ããã/ãã§ããªããããæãèªåã«èªä¿¡ããããã£ãã/ããªãã£ãããããã®åãç©äºã«éä¸ããã§ããã/ãã§ããªãã£ãããªã©ãããããããã®ãã¡ããå°æ¥ãã§å§ã¾ãæãé ãæªæ¥ããè¿ããã¡ã«ããè¿ãæªæ¥ããæããé ãéå»ãããã®åããè¿ãéå»ã§ãããæ¬ç ç©¶ããã¤ç (MDD)æ£è ã®åå¿ã¯ãå¤å ¸çç²¾ç¥ç çå¦ãæããéããæªæ¥ã«ã¤ãã¦æ²è¦³çã§ãããããã¦functional MRIã®ä¸»è¦ãªçµæã¯ããã¤ç æ£è ã§ã¯é ãæªæ¥ã«ã¤ãã¦æ³åããã¨ãã«BA10ã®æ´»åãå¼·ãã¨ãããã®ã§ãã£ããBA10ã¯ãã¤ç ã®ä¸æ ¸çç¶ã§ããèªè²¬æã¨ã®é¢ä¿ã示ããã¦ããé¨ä½ã§ãããã
ãã¤ç ã®è¨ºæã¯ãç¾ä»£ã®æä½ç診æåºæºã«åºã¥ããå ´åã§ããå¤å ¸çãªå¾æ¥è¨ºæã«åºã¥ããå ´åã§ããçµå±ã¯çç¶é ç®ã®ç¢ºèªã«ãã£ã¦ãªãããããã åè ã§ã¯ããã§ããã¦æèã忢ããã®ã«å¯¾ããå¾è ã§ã¯ãã®å ã¾ã§è¦éããã¨ããç¹ã大ããç°ãªããè¦éããã¨ããæ¸å½ãªåªåãéãã¦ããçç¶ã®è¦³å¯ããå°éã§ãããã¨ã«ã¯ãããè¨ã£ã¦éãããããæªãè¨ãã°ä½ããªãã¨ããç¾å®ãè¦ãã¦ãããã¨ã§ãæä½ç診æåºæºãèªçããããã ããããã¯ããã£ã¦ç²¾ç¥ç¾æ£ç ç©¶ãæªãã¦ãã¾ã£ãã¨ããåçãæ¹å¤ãæ ¹å¼·ããã®ãããã
ãããªç¶æ³ã®æéçã¨ãã¦å¤§ãã«æå¾ ããã¦ããã®ã¯ãè³ã¨ããè¦ç¹ã®å°å ¥ã§ãããæ²è¦³çæèã¨èªè²¬æããBA10ã¨ããå ±éããè³é¨ä½ã«åæãããã¨ã示ããçå±±é¢çã®æ¬ç ç©¶ã¯ãç²¾ç¥ç çå¦ã¨è³ç§å¦ãèåãããã¨ã§ããã¤ç ã®è§£æã«åãã¦å¤§ããªä¸æ©ãè¸ã¿åºãããã®ã§ãããæ¬è«æã§å¦ä½ãåå¾ããçå±±é¢çã¯ããã§ç«ã¡æ¢ã¾ããã¨ãªãããã¤ç æ£è ã«èªç¥è¡åçæ³ãè¡ãã¨æªæ¥æ§æèä¸ã®BA10ã®æ´»åãã©ãå¤åãããã¨ããç ç©¶ãç²¾åçã«é²ãã¦ãããããã¯ç²¾ç¥ç çå¦ã¨è³ç§å¦ã®èåãããã«æå¹ãªæ²»çã«çºå±ããããã¨ãã試ã¿ã§ãè¿ãå°æ¥ã«å®ãçµã³ãé ãå°æ¥ã«æ¸¡ã£ã¦é«ãè©ä¾¡ãããã§ãããã
ã¨ããæªæ¥ã«ã¤ãã¦ã®äºæ¸¬=æªæ¥æ§æèã¯ãæããå¥å ¨ãªãã®ã§ãããããã«å¯¾ãã¦ãã¤ç æ£è ã¯å°æ¥ã«ã¤ãã¦æ²è¦³çãªã®ã§ãããããã®ãæ²è¦³çãã¨ã¯ãããã¾ã§ãå¥å¸¸è ã¨æ¯è¼ãã¦ã®ç¸å¯¾çãªæå³ã§æ²è¦³çã¨ãããã¨ã§ãã£ã¦ãå°æ¥ã夢ãã»ã»ã»ãå¶ããã¨æãããã¨ãç¾å®çãå¦ãã¯ã¾ãå¥ã®è©±ã§ãããå®ã¯ãã¤ç æ£è ã®æèã®æ¹ãå¥å¸¸è ããç¾å®çã§ããã¨ãã depressive realism ã¨ããè¨èãããã(âYesterday, all my troubles seemed so far awayâ ã¨åæ³ããâNow it looks as though theyâre here to stayâã¨èªèã§ããã®ãå·éãªrealismã¨ãããã®ã§ããã)
ã ãç ç©¶ã®ã´ã¼ã«ã¨ã¯ãå人ã®å¤¢ã§ã¯ãªããä¸ã¤ä¸ã¤ã®è«æã¯ã確ãã«ä¸ã¤ã®è²´éãªææç©ã§ã¯ãããããã¨ãã°ãã¤ç ã®æ¬è³ªã®è§£æãç»æçãªæ²»çæ³ã®éçºã¨ãã£ãã´ã¼ã«ã¯ãæ°å¤ãã®è³ªã®é«ãè«æãéç©ããã¦åãã¦å°éã§ãããã®ã§ãããå¶ããã©ããã¯ãå人ã¨ãã¦ã§ã¯ãªãã人é¡ã¨ãã¦ã©ããã¨ããè¦ç¹ããèããªããã°ãªããªãã夢ã¨ã¯ãå¶ããå¶ããªãããåããã®ã§ã¯ãªãã追ãç¶ãããã®ãªã®ã§ãããã
(ææ¾å¤ªéã2019.10.28.)
è³è¡ç®¡é害ã«ãã失èªçã«å¯¾ããååãªè¨èªãªãããªãã¼ã·ã§ã³ãè¡ã£ãå¾ã®äºå¾äºæ¸¬å å
è¹å±±éé (è¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§é¨é·)
Yoshitaka Nakagawa, Yoko Sano, Michitaka Funayama, Masahiro Kato.
Prognostic factors for long-term improvement from stroke-related aphasia with adequate linguistic rehabilitation. Neurol Sci. 2019 Jun 10. doi: 10.1007/s10072-019-03956-7. [Epub ahead of print]
ãéå»ã®å¤±èªçã®äºå¾ç ç©¶ã
失èªçã¯è³è¡ç®¡é害å¾ã®å¾éºçã®ä¸ã§ãæãé »ç¹ã«åºç¾ããçç¶ã®ãã¡ã®ã²ã¨ã¤ã§ãããæ£è ã®äººçã«å¤§ããªå½±é¿ãä¸ãããè³è¡ç®¡é害ã«ãã失èªçã®äºå¾äºæ¸¬å åã«ã¤ãã¦ã¯ãã§ã«ããã¤ãã®ç ç©¶ããªããã¦ãã¦ããã¼ã¹ã©ã¤ã³ã®å¤±èªçã®éç度ãé³é»æ©è½ãç å·£ã®å¤§ãããã¦ã§ã«ããã±éã®æå·ãªã©ãäºæ¸¬å åã¨ãã¦æãããã¦ããããããããããã®ç ç©¶ã¯ããããçºçå¾1年以å ã®äºå¾ç ç©¶ã§ãããå®éã®è¨åºã§ã¯ãã®å¾ãé·æã«ããã£ã¦å¤±èªçãæ¹åãããã¨ãç¥ããã¦ãããããã«ãä»ã¾ã§ã®å¤±èªçã«é¢ããäºå¾ç ç©¶ã®å¯¾è±¡ä¾ã¯ã失èªçã®ãªãããªãã¼ã·ã§ã³ãåããä¾ã¨åãã¦ããªãä¾ãæ··å¨ãã¦ããããããåé¡ãå æãããããä»åããããã¯å·¦åçã®ã¿ã«æå·ãããè¨èªãªãããªãã¼ã·ã§ã³ã2å¹´é以ä¸è¡ã£ãè³è¡ç®¡é害å¾ã®å¤±èªç121ä¾ããã失èªçã®äºå¾äºæ¸¬å åãæ±ããã
ãé·æã®ãªãããªãã¼ã·ã§ã³ãåãã失èªçã®äºå¾äºæ¸¬å åã
失èªçã®äºå¾äºæ¸¬å åãæ±ãããããã¹ãããã¯ã¤ãºæ³ãç¨ããéå帰åæãè¡ã£ãã説æå¤æ°ã«ã¯çºçå¹´é½¢ãæ§å¥ãæè²æ´ãè³åä¸ã®ã¿ã¤ãï¼è³æ¢å¡/è³åºè¡ï¼ãå·¦åçå ã®6ç å·£ï¼ããã¼ã«é åï¼ä¸å¿ååãç¸ä¸åï¼ä¸å¿å¾åãè§åãã¦ã§ã«ããã±éãå«ãä¸å´é åãä¸å´é åãåºåºæ ¸ï¼ãç å·£ã®å¤§ããããã¼ã¹ã©ã¤ã³ã®å¤±èªçã®éçåº¦ï¼æ¨æºå¤±èªçæ¤æ» 10ç¹æºç¹è©ä¾¡ï¼ããã¼ã¹ã©ã¤ã³ã®åè¨èªæ©è½ï¼æå³æ©è½ã¨ãã¦æ¼¢åã®çè§£ã¨æç« ã®çè§£ãé³é»æ©è½ã¨ãã¦èªããã³æã®å¾©å±ã¨ä»®å䏿åã®é³èªãããã«å¼ç§°è½åï¼ãç¨ãããç®ç夿°ã¨ãã¦ãçºç2å¹´å¾ã®å¤±èªçã®éçåº¦ï¼æ¨æºå¤±èªçæ¤æ» 10ç¹æºç¹è©ä¾¡ï¼ãç¨ããã
çµæã¯ã失èªçã®äºå¾ã¯çºçå¹´é½¢ï¼è¥å¹´çºçã§ããã°äºå¾ãè¯å¥½ï¼ãã¦ã§ã«ããã±éãå«ãå·¦å´é åã®ç å·£ããã¼ã¹ã©ã¤ã³ã®å¤±èªçã®éç度ããã³ãã¼ã¹ã©ã¤ã³ã®æ¼¢åã®çè§£ã§è¡¨ãããæå³æ©è½ã¨ä»®å䏿åã§è¡¨ãããé³é»æ©è½ã«ãã£ã¦äºæ¸¬ã§ãããã¨ãåãã£ãããããã®çµæã¯ãéå»ã®çºçå¾çæéã®äºå¾äºæ¸¬ç ç©¶ã¨çç¾ãããã¨ã¯ãªããé·æã®ãªãããªãã¼ã·ã§ã³ãåãã失èªçã®äºå¾ã¯ãå¹´é½¢ãç å·£ããã¼ã¹ã©ã¤ã³ã®è¨èªæ©è½ã«ãã£ã¦äºæ¸¬ã§ããå¯è½æ§ã示åãã¦ãããã¾ããä»åã®ç ç©¶ããè¥å¹´çºçä¾ã¯è¨èªæ©è½ã大ããå復ãããã¨ã夿ãããããè¨èªãªãããªãã¼ã·ã§ã³ãããä¸ã§ã¯ãã®ç¹ãèæ ®ã«å ¥ããå¿ è¦ãããã
(è¹å±±ééã2019.9.1.)
解説ã失èªçå½äºè ã®çã®å©çã追æ±ãã
åªåãéãã¦ãçµæãåºãã¨ã¯éããªããè¯ãçµæãåºã¦ãåªåã¨å æé¢ä¿ãããã¨ã¯éããªããåªåã¨å æé¢ä¿ããã£ãã¨ãã¦ãããã®çµæãä¸è¬åã§ããã¨ã¯éããªããæ²»çè¡çºã«ã¯å¸¸ã«ããããåé¡ãã¤ãã¾ã¨ãã
è³æå·ã«å¯¾ãããªãããªãã¼ã·ã§ã³ã§ã¯ç¹ã«é¡èã§ãããèªç¶çµéã«ãã£ã¦ããç¨åº¦ã¯å復ããã¨ããæ§è³ªä¸ãçµæã®ãã¡ã©ãã¾ã§ããªãããªãã¼ã·ã§ã³ã®å¹æã§ãããã®å¤å®ã¯å®¹æã§ãªããè¯ãçµæã¯åªåã®ææã ã¨èããã®ã¯é¡æã«ãããªãã®ã§ãã£ã¦ã顿ãä¿¡ãããã¨ã¯å¿ã®å®å¯§ã«ã¯ç¹ãã£ã¦ããç¾å®ããä¹é¢ããä¿¡ä»°ããå¾ãããå®å¯§ã¨å¤ãããã®ã§ã¯ãªãã
ãªãããªãã¼ã·ã§ã³ã«ã¯ãã¡ããçè«çè£ä»ãããããã ãå»å¦ã®æ´å²ãæ¯ãè¿ã£ã¦ã¿ãã°ã广ãå ã§çè«ãå¾è¿½ãã®æ²»çæ³ã¨ãçè«ãå ã§å¹æãå¾è¿½ãã®æ²»çæ³ã®2種é¡ããããåè ã®ä»£è¡¨ã¯é»æ°ããããçæ³ã§ã广ã¯ã¯ããæã«è¨¼æãããããããã®å¹æã¯ä»ã«æããåºã¦å¼·åã§ããããã¡ã«ããºã ã®è§£æããã¾ã éã®éä¸ã§ãããã¨ã¯ãå»å¦çæ²»çã«ããã广ã®çè«çè§£æã®å°é£ãã象徴ãã¦ããããã®å°é£ãã¯åæã«ãéã«çè«ããæ²»çæ³ãéçºãããã¨ãããã¨ã®å°é£ããã¾ãç©èªã£ã¦ããã
ã ããããªçå±ãè¨ãåãã®ã¯ã»ã©ã»ã©ã«ãã¦ãè¡åããªããã°ãªããªããåã«è¸ã¿åºããªããã°ãªããªããå®ç¤¾ä¼ã«ã¯30ä¸äººã50ä¸äººã®å¤±èªçã®äººã ãå復ãåæããæ¯æ¥ãéã£ã¦ããã®ã ãå»çè ã«æ±ããããã®ã¯å¦åççè«ã§ã¯ãªããçã«å®å¹ããå»çè¡çºãæ´ç·´ãã¦ããããã®ç ç©¶ã§ããããããã«å¤±èªçã«ã¤ãã¦ã®è¨åºç ç©¶ãã¾ã ã¾ã ä¸ååã§ãã£ããã¨ã¯ãäºå¾ç ç©¶ã¨ãã£ã¦ã1年以å ã®èª¿æ»ã«ã¨ã©ã¾ããä½ãããªãããªãã¼ã·ã§ã³ãåããä¾ã¨åãã¦ããªãä¾ãæ··å¨ãã¦ãããã¼ã¿ãããªããã¨ããã¿ã¦ãããã¾ãã«æããã§ããã
è¹å±±é¨é·ã®æ¬ç ç©¶ã¯ããããªç¶æ³ã大ããå¤ãããã¨ãã試ã¿ã§ããããè¨èªãªãããªãã¼ã·ã§ã³ã2å¹´é以ä¸è¡ã£ãè³è¡ç®¡é害å¾ã®å¤±èªçã®äºå¾ç ç©¶ãã¨ãããã¶ã¤ã³ã¯ä¸è¦ããã¨ç¹ã«ä¸»å¼µã®ãªãå°å³ãªãã®ã®ããã«è¦ãããã失èªçããããç¶æ³ãåºãæ·±ãè¦ãã°ãå»å¦çã«ã社ä¼çã«ãç»æçãªãã®ã§ãããã¨ã«æ°ã¥ãããã¡ãããã®ç ç©¶ã ãã§ããªãããªãã¼ã·ã§ã³ã®å¹æã証æãã¦ããã¨ã¯è¨ããªããããªãããªãã¼ã·ã§ã³ãè¡ãªã£ãä¾ã®äºå¾äºæ¸¬å åãæããã«ãããã¼ã¿ã¯ãå½äºè ã®çã®å©çã追æ±ããããã§ã®è²´éãªåºç¤è³æã«ãªããã®ã§ããã
(ææ¾å¤ªéã2019.9.28.)
ã1ã黿°ããããçæ³ã®æµ·é¦¬æ¯ç¶åã«å¯¾ããæ¥æ§æã»é·æã®å½±é¿ã¨è¨åºå¹æã®é¢é£
ã2ã黿°ããããçæ³ã®é»æµæºå¯åº¦ã¨ä½ç¸åæã«ä¸ããå½±é¿ã¨è¨åºå¹æã®é¢é£
é«å®®ãå½°ç´ï¼æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ã»ç¥çµç§å¦æå®¤ã大å¦é¢å士課ç¨ï¼
ã1ãAcute and long-term effects of electroconvulsive therapy on human dentate gyrus
Akihiro Takamiya, Eric Plitman, Jun Ku Chung, Mallar Chakravarty, Ariel Graff-Guerrero, Masaru Mimura and Taishiro Kishimoto
Neuropsychopharmacology, 2019 https://doi.org/10.1038/s41386-019-0312-0
ã2ãElectroconvulsive Therapy Modulates Resting-State EEG Oscillatory Pattern and Phase Synchronization in Nodes of the Default Mode Network in Patients With Depressive Disorder.
Akihiro Takamiya, Jinichi Hirano, Bun Yamagata, Shigeki Takei, Taishiro Kishimoto and Masaru Mimura
Front. Hum. Neurosci. doi: 10.3389/fnhum.2019.00001
黿°ããããçæ³ (electroconvulsive therapy: ECT) ã¯éçãªãã¤ç ã«å¯¾ãã¦æãæå¹ãªæ²»çã§ããããä¸éæ§ã®èªç¥æ©è½é害ã®ãªã¹ã¯ãæãããECTã®ä½ç¨æ©åºã«ã¯ä¸æãªç¹ãå¤ããECTã®æãã¤å¹æãèªç¥æ©è½é害ã«é¢ããç¥çµåºç¤ã®è§£æã¯ãé«ãæ²»ç广ãç¶æãå¯ä½ç¨ãæ¸å¼±ããæ°ããè³åºæ¿æ³ãããã¯é©æ°çãªæãã¤æ²»çã«ã¤ãªããå¯è½æ§ãããéè¦ãªèª²é¡ã§ãããããã¾ã§ã®ç ç©¶ã¯ãECTåå¾ã®è³ç»åãããã¯ç¥çµççææ¨å¤åã«é¢ããå ±åãå¤ãã£ãããããåãªãECTåå¾ã®å¤åã«ã¯ãè¨åºçãªå¤åã¨é¢ä¿ã®ããå¤åï¼æãã¤å¹æã«é¢ããå¤åãèªç¥æ©è½é害ã«é¢ããå¤åï¼ãè¨åºçãªå¤åã¨é¢ä¿ã®ãªãå¤åï¼é»æ°åºæ¿ãã®ãã®ãçºä½ã«ããå½±é¿ï¼ãæ··å¨ãã¦ããã¨èãããããæã ã¯è¨åºå¹æã¨é¢é£ããè³æ§é ãè³æ©è½å¤åã®è§£æã®ããã以ä¸ã®2ã¤ã®ç ç©¶ãè¡ã£ãã
ã1ãåç©å®é¨ã§ã¯ãECTã¯æµ·é¦¬æ¯ç¶åã«ããããã¥ã¼ãã³ãã°ãªã¢ã®å¯å¡çãªå¤åãèªå°ãããã¨ã1970年代ããå ±åããã¦ãããæã ã¯ã¡ã¿è§£æã®ææ³ã§ECTãMRIã§æ¸¬å®ãããæµ·é¦¬ä½ç©ãå¢å¤§ããããã¨ãå ±åãã (Takamiya et al., 2018)ãããããECTã®æµ·é¦¬ä½ç©ã¸ã®å½±é¿ã«é¢ãã¦ãè¨åºçç¶æ¹åã®å¤åã¨ã®é¢é£ãé·æçãªå¤åã«ã¤ãã¦ã¯æªè§£æ±ºã ã£ãããã®ãããECTã¨æµ·é¦¬ã®é¢é£ã«é¢ãã¦è©³ç´°ãªæ¤è¨ãè¡ããããMRIãç¨ãã縦æç ç©¶ã«ããECTã®æµ·é¦¬æ¯ç¶åã®ä½ç©ã«å¯¾ããæ¥æ§æã¨3ã¶æå¾ã®å½±é¿ã調ã¹ãã
ã¡ã©ã³ã³ãªã¼åã®ç¹å¾´ãä¼´ãæãã¤ã¨ãã½ã¼ãã«å¯¾ãã¦è¨åºçã«ECTãåãã25åã®æ£è ããªã¯ã«ã¼ãããECTåå¾ã¨3ã¶æå¾ã«è¨åºçç¶ã®è©ä¾¡ã¨MRIã®è©ä¾¡ãè¡ãªã£ãããã®çµæãECTã«ããæµ·é¦¬ä½ç©ã®å¢å¤§ã¯æ¯ç¶åã®ä½ç©å¢å¤§ã®å¯ä¸ãæã大ããããã®å¢å¤§çã¯å¹´é½¢ã¨è² ã®ç¸é¢ãèªãããã¾ããæ¥æ§æã«å¯è§£ç¶æ ã«è³ã£ãåå è ã®æ¯ç¶åã®ä½ç©å¤åã¯å¯è§£ã«è³ããªãã£ãåå è ã®å¤åããã大ããã£ããããããå¯è§£ç¶æ ãç¶æãã¦ããåå è ã®æ¯ç¶åä½ç©ãã3ã¶æå¾ã«ã¯æ²»çåã®ãã¨ã®ä½ç©ã¬ãã«ã¾ã§æ»ã£ã¦ããã
æ¬ç ç©¶ã§ã¯ãECTã®æµ·é¦¬ã¸ã®å½±é¿ã¯ä¸»ã«æ¯ç¶åã«ããå½±é¿ã§ãããåç©å®é¨ã®çµæã¨çç¾ããªãçµæã ã£ããããã«ECTã®æ¥æ§æã®æãã¤å¹æã®èæ¯ã«æµ·é¦¬æ¯ç¶åã®å¯å¡çãªå¤åããããã¨ã示åããããããããé·æã®å¯è§£ç¶æãããã¯åçºã®ç¥çµåºç¤ã¯æµ·é¦¬ä»¥å¤ã®è³é¨ä½ãå«ããä»å¾ã®ç ç©¶ãå¿ è¦ã§ãããã¾ããECTã§ãæ¹åããªãæéçã®ãã¤ç æ£è ã¯è³ã®å¯å¡æ§ãèããä½ä¸ããããã¯ç¥çµå¤æ§éç¨ãå§ã¾ã£ã¦ããå¯è½æ§ã示åãããèªç¥çã¨ã®é¢é£ãå«ãããPETãªã©å¤æ§ãªã¢ããªãã£ã§ã®è©ä¾¡ãå¿ è¦ã¨èããããã
ã2ãECTãæ¥æ§æã«è³æ³¢ã®å¾æ³¢åãå¼ãèµ·ãããã¨ã¯1930年代ããç¥ããã¦ããã黿°ççå¦çãªå¤åã®è¨åºçæç¾©ã¯ä¸æã ã£ããæ¬ç ç©¶ã§ã¯ã13åã®ECTãåãããã¤ç æ£è ããªã¯ã«ã¼ãã*ãECTã®é»æµæºå¯åº¦ (CSD) ã¨ä½ç¸åæã¸ã®å½±é¿ãè¨åºçç¶ã®å¤åã®é¢é£ã調ã¹ãã
ECTã¯åé¨å¸¯ç¶åãåé æ¥µ/å å´åé åç®è³ªãå³ä¸åé èã¨ãã£ãããã©ã«ãã¢ã¼ããããã¯ã¼ã¯ (DMN) ã®ä¸»è¦ãªçµç¯ç¹ã®CSDãå¤åããããããããã®å¤åã¨æãã¤çç¶ãå ¨è¬çèªç¥æ©è½ã®å¤åã«é¢é£ãèªããªãã£ããä½ç¸åæã«é¢ãã¦ã¯ãECTã¯theta帯åã®å³å¾é¨å¸¯ç¶åã¨åé åç®è³ªã®ä½ç¸åæã䏿ãããbeta帯åã®å·¦å¾é¨å¸¯ç¶åã¨å·¦å´é é¨ã»å·¦å³¶ç®è³ªãå³ä¸é é èã¨å³å³¶ç®è³ªã®ä½ç¸åæãä½ä¸ããããå·¦åçã®beta帯åã«ãããä½ç¸åæã®å¤åã¯å ¨è¬çèªç¥æ©è½ã®å¤åã¨é¢é£ãèªããã
ECTã¯DMNã®ä¸»è¦ãªçµç¯ç¹ã®æ´»åæ§ãä½ä¸ãããããã®å¤åã¯PETç ç©¶ã®ã¡ã¿è§£æã«ãããECTã®DMNçµç¯ç¹ã®è¡æµã»ä»£è¬ä½ä¸ã¨ããçµæã¨ãä¸è´ãããDMNã®å¤åã¨ãã¤çç¶ã®å¤åã¨ã®é¢é£ï¼æ¬ç ç©¶ã§ã¯MADRSç·å¾ç¹ã¨ã®é¢é£ï¼ã¯èªããªãã£ããDMNã®å¤åã¯è¨åºçæç¾©ããªãå¯è½æ§ãããããããçµè«ã¥ããåã«DMNã«é¢ããåè»ãªã©ç¹å®ã®çç¶ããããã¯èªä¼çè¨æ¶ãªã©ã®èªç¥æ©è½ã¨ã®é¢é£ã調ã¹ãå¿ è¦ãããã¨èãããããå·¦åçã®ä½ç¸åæã®ä½ä¸ã¯å ¨è¬çèªç¥æ©è½ã®ä½ä¸ã¨é¢é£ãèªãããããã®çµæã¯å³çå´åºæ¿ã®èªç¥æ©è½ä½ä¸ã®å°ãªããæ¯æãããããããªãã
ãªããECTã¨DMNã®é¢é£ã®ããã¾ã§ã®ç¥è¦ã«ã¤ãã¦ã¯æ¥æ¬èªã®æèï¼é«å®®å½°ç´ä». 黿°ããããçæ³ã¨default mode network. CLINICAL NEUROSCIENCE 2019; 37(2): 220â 222 http://www.chugaiigaku.jp/item/detail.php?id=2800ï¼ãåèã«ããããã
*æ¬ç ç©¶ã¯ã1ãã®ç ç©¶ã¨ã¯å¥ã®ã³ãã¼ãã§ããã
(é«å®®å½°ç´ã2019.8.1.)
解説ãå éããECTç ç©¶
ECTã¯ãªãå¹ãã®ãã
ãã®åãã«çãããã¨ãç®æããç ç©¶ããè¿å¹´ãæ¥æ¿ã«å¢å¤§ãã¦ãããECTã«ããè³ã¸ã®å½±é¿ãæããã«ããã¨ããã®ãããã®ææåãªãã¶ã¤ã³ã§ãããã ãçºè¡¨ãããè«æãèªãã¨ãããã«ç¤ºãããè³ã®å¤åã¨è¨åºå¹æã®é¢é£ãä¸æç¢ºãªãã®ãé常ã«å¤ãã¨ããç¾ç¶ããã£ããããã«å¯¾ãã¦é«å®®é¢çã®ä»åã®2ã¤ã®è«æã¯ãã1ããæãã¤å¹æã¨é¢é£ããè³ã®å¤åãã2ããèªç¥æ©è½å¤åã¨é¢é£ããªãè³ã®å¤åããæç¢ºã«ç¤ºãããã®ã§ããããã®ããã«æ´ç·´ãããç ç©¶ã®èç©ã®å
ã«ãECT广ã®ã¡ã«ããºã ã®è§£æã¨ããã®ã¡ã«ããºã ã«ç¹åããæ²»çæ³ãããªãã¡å¯ä½ç¨ãæå°åãããæ²»çæ³ã®éçºãããã
ECTã¯ãªãå¹ãã®ãã
ãã®åããå ã
ã¨åé¢ã«åºãããããã«ãªã£ãã®ã¯æè¿ã®ãã¨ã§ãããECTããããã¦ããå¹ãæ²»çæ³ã§ãããã¨ã¯ã20ä¸ç´åã°ããããã£ã¦ãããã«ãããããããç ç©¶ãé
ã
ã¨ãã¦é²ã¾ãªãã£ã大ããªçç±ã¯åè¦ã§ãããç²¾ç¥ç¾æ£ã¸ã®åè¦ããç²¾ç¥å»çã¸ã®åè¦ãæ²»çæ³ã¸ã®åè¦ã«å§¿ãå¤ãã¦ãåºãæ·±ãèå»¶ãã¦ãããç²¾ç¥ç¾æ£ã«è¦ãã人ã
ãæãæ¹æ³ã®é²æ©ãããã®åè¦ã«ãã£ã¦ãã¬ã¼ããããããã¦ãããç¾å¨ããã¬ã¼ãã¯è§£é¤ããã¦ããªãããããªåè¦ãæµ´ã³ã¦ããæ²»çæ³ã®ä»£è¡¨ã§ããECTã«ã¤ãã¦ãä»ãããªãå¹ãã®ããã¨ããåããæ£é¢ããç ç©¶ã§ããæä»£ã«ãªã£ããå
人ã®åªåã®ç²æãã£ã¦ãECTã¯ããããå¥å
¨ãªè©ä¾¡ã¨é²æ©ã®ã«ã¼ãã«ä¹ãã¤ã¤ããã®ã ãECTç ç©¶ã®æ©ã¿ã¯ãåè¦ã«ããããã¦ãããã®ãå¥å
¨ãªå½¢ã«è»éä¿®æ£ãã¦é²æ©ãããå®è·µã®ã¢ãã«ã«ãªãã§ãããã
ECTã¯ãªãå¹ãã®ãã
ãã®åãã®è§£æã«åããå½éååãé²è¡ãã¦ãããã2ãã®è«æãã¹ã¤ã¹ã§è¡ãããå½éå¦ä¼(22nd Organization for Human Brain mapping) ã§çºè¡¨ããé«å®®é¢çã¯ãåå½ã®ECTç ç©¶è
ã¨discussionãéãããã®çµæãECTå½éå
±åç ç©¶ã°ã«ã¼ãGEMRIC (The Global ECT-MRI Research Collaboration) https://mmiv.no/gemric/ ã®ã¡ã³ãã¼ã¨ãªããECTã®çã
ã®çºå±ã«åãã¦ã®åé²ãç¶ãã¦ããã
(ææ¾å¤ªéã2019.8.21.)
çµ±å失調çã«ãããAgencyãããã¯ã¼ã¯ã®Dysconnectivity
æ¯æ¨æå® (ä¸ç·ç²¾ç¥å»çã»ã³ã¿ã¼ / St Georgeâs University of London)
Koreki A, Maeda T, Okimura T, Terasawa Y, Kikuchi T, Umeda S, Nishikata S, Yagihashi T, Kasahara M, Nagai C, Moriyama Y, Den R, Watanabe T, Kikumoto H, Kato M, Mimura M. Dysconnectivity of the Agency Network in Schizophrenia: A Functional Magnetic Resonance Imaging Study. Front Psychiatry. 2019 Apr 3;10:171.
çµ±å失調çã®èªæé害ã®èª¬æã¨ãã¦ãSense of Agency (SoA)ã®ç°å¸¸ãææããã¦ãããSense of Agencyã¨ã¯ãä½ãã¤ãã³ããèµ·ããã¨ãã«ããããèªåã®è¡çºã«ãã£ã¦å¼ãèµ·ãããããã®ã§ããã¨ããæè¦ã§ãããèªåã®ä½ãèªåã®ãã®ã§ããã¨ããæè¦ã§ããSense of Ownershipã¨åç§ããªãèªæã®åºæ¬æ§æè¦ç´ ã¨èãããã¦ãããSoAã®æ ¸ã¨ãªãç¥çµåºç¤ã¯å³¶ç®è³ªããã³é é èä¸é¨ã§ããã¨ãããã¦ããããããè¿å¹´ãAgencyã®å¦ç¿ã¨ãã観ç¹ããç·æ¡ä½ãç¹ã«å°¾ç¶æ ¸ã®é¢ä¸ãææããã¦ããã䏿¹ãçµ±å失調çã®PETç ç©¶ãããå°¾ç¶æ ¸ã®ç°å¸¸ãææããã¦ããããããã®ãã¨ããå³¶ç®è³ªãé é èä¸é¨ã«å°¾ç¶æ ¸ãå«ããè³å ãããã¯ã¼ã¯ãAgency Networkã¨ãã¦æããçµ±å失調çã§ã¯ãã®ãããã¯ã¼ã¯ã«ç°å¸¸ãããã®ã§ã¯ã¨ãã仮説ãç«ã¦ãæ ¶æçAgency課é¡ãç¨ããfMRIå®é¨ãè¡ãªã£ãã
çµ±åå¤±èª¿çæ£è 15åããã³å¥å¸¸è 15åã被é¨è ã¨ãªã£ãã課é¡ã§ã¯ãç»é¢ã®ä¸ããåè§ãç¾ããä¸è¡ããé³ãé³´ã£ãã¨ããã§è¢«é¨è ã¯ãã¿ã³ãæ¼ãããã«æç¤ºããããããã¨æ°ç¾ããªç§ã®ã¿ã¤ã ã©ã°ã®å¾ã«åè§ã¯ä¸ã«ã¸ã£ã³ããããã®å¾ãã¿ã³ãæ¼ãåã¨åæ§ã«ä¸è¡ãã¦ç»é¢ããæ¶ããã被é¨è ã¯ãã®ã¸ã£ã³ããèªåãèµ·ãããæãããããã©ãããçããããã«æç¤ºãããããªãã¿ã¤ã ã©ã°ã¯è¢«é¨è ã®åçã«ãã£ã¦èª¿æ´ããããã®è¢«é¨è ã«ã¨ã£ã¦æã夿ã«è¿·ãç¶æ ãç¶æããã
課é¡ä¸ã®è³ã®æ©è½çé£é¢ãè§£æããã¨ãããå¥å¸¸è ã§ã¯é é èä¸é¨ã®ç¹ã«ç¸ç¶åã¨å°¾ç¶æ ¸ã®æ©è½çé£é¢ãèªããããçµ±åå¤±èª¿çæ£è ã§ã¯ãã®é£é¢ã®ææãªä½ä¸ãèªãããã¾ããã®ç°å¸¸ã¯æ£è ã®é½æ§çç¶ã¨ã®ç¸é¢ãææãªå¾åã§èªããã
ãã®çµæã¯ãçµ±å失調çã«ãããAgency Networkã®ç°å¸¸ã示åãããã®ã§ãçµ±å失調çã®ä¸æ ¸ã¨ãªãç æ ççã«è¿«ãæè¦ã¨èãããããå°¾ç¶æ ¸ã¯ç®æ¨æåè¡åã«ããã¦ãè¡çºã®çµæãäºæ¸¬ã§ãã¦ããã¨ãã«æ´»åããé¨ä½ã§ãããäººãæ°ããªç°å¢ã§é©å¿çãªSoAãå¦ç¿ãã¦ããä¸ã§éè¦ãªå½¹å²ãæ ã£ã¦ãããã®ã¨èãããã¦ããããã®ããçµ±å失調çã«ãããç·æ¡ä½ãç¹ã«å°¾ç¶æ ¸ã®ç°å¸¸ã¯ãä¸é©åãªSoAã®å¦ç¿ãéãã¦èªæé害ãå¼ãèµ·ããã¨èããããã
(æ¯æ¨æå®ã2019.7.1.)
解説ã空ä¸åè§£ã黿¢ãããããã¯ã¼ã¯
èªæé害ã¯çµ±å失調çã®æ¬è³ªã«è¿«ãå¯ä¸ã¨ãè¨ãã¹ããã¼ã¯ã¼ãã§ããããå ·ä½çãªçç¶ã¨ã®é¢ä¿ã§èª¬æãããã¨ããã¨ãªããªãé£ãããããæããããä¾ã¯ããããä½é¨ã§ã確ãã«ããã¯ããããããä¾ã§ã¯ãããã®ã®ãã§ã¯çµ±å失調çã®è¨åºã§å ¸åçãªããããä½é¨ãã©ãã ãèªãããããã¨ããã¨ã決ãã¦ãããµããçç¶ã§ã¯ãªããããèªæé害ãããæ¬è³ªã ã¨ãã説æã¯è¿«åã«æ¬ ãããå®éã«ã¯èªæé害ã¯ãæ¥æ§æããæ ¢æ§æã«è³ãçµ±å失調çã®ãããã諸ç¸ã«å¤å½©ãªæ§ç¸ãåãã¦ç¾ããã»ã»ã»ãªã©ã¨æ£è«ãå±éãã¦ããå ·ä½çã«ç®ã«è¦ããå½¢ã§ããã示ãããªããã°ãæºä¸ã®æ£è«ã¨ã¿ãªããèããé¿ãã°ããã§ãããããã§èªæé害ã®ããå ·ä½çãªè¡¨ç¾ã¨ãã¦ãã·ã¥ãã¤ãã¼ã¯èªå·±æå±æ§ Meinhaftigkeitã¨è¨ããå³¶å´ææ¨¹ã¯èªå¾æ§ Autonomie ã®æèã®é害ã¨è¨ã£ããããã«å®æ°¸æµ©ã®ãã¡ã³ãã çè«ã¯ç°å¸¸ä½é¨ãè³æ©è½ã«è¿ããã¨ã°ã§è¨è¿°ãããã¨ããé©å½çãªè©¦ã¿ã§ãã£ããã ããããã®ç¢§å¦ã«ããè¨è¿°ã¯ãç¾ä»£ã®ç²¾ç¥å»å¦ã«ãããèªç¥åº¦ã¨ããé¢ããè¦ãã¨ã夿æ¸ã®å¥¥æ·±ãã«åããã¦ããæããããããããåªããçè«ã§ããç§å¦çãªæ¤è¨¼ææ®µããªããã°ãããããå ã«ã¯é²ã¾ãªããããã©ãããéã«çµ±å失調çã¯ãDSM-5ã«ä»£è¡¨ãããããã«ãåã ã®ããããããçç¶ãå¯ãéããã ãã®åã«è§£æ¶ããã¤ã¤ãããå¯ãéãã¨ã¯ããªãã¡ãæ¡æ£ã¨é²æ£é§æ¶ã«ã»ããªããªãã
ãããªæ²è¦³çãªç¶æ³ãæ¬æ¥ã®å½¢ã«ä¿®æ£ããåãç§ãã¦ããã®ããSense of Agency (SoA)ã¨ããããå®è¨¼çã«ç¤ºããã¨ãã¦åç°è¬å¸«ãéçºããæ¹æ³è«ãSoA task (Keio Method)ã§ãããæ¬ãµã¤ããã®ãã¼ã¸ã®ä¸çªä¸ã2014å¹´3æã«åç°è¬å¸«ãç´¹ä»ãã¦ãããã®ã¿ã¹ã¯ãæ¦å¨ã¨ããSoAç ç©¶ã¯é²åãç¶ããã¤ãã«çµ±å失調çã®è³ã«æãããã£ãã®ãæ¬è«æã§ããã
大å¦é¢ã忥å¾ãã³ãã³ã«çå¦ããæ¯æ¨å士ãä¸å¿ã¨ãªã£ã¦è¡ã£ããã®ä»äºã¯ãè³å ã®Agency networkã¨çµ±å失調çã«ããããã®ãããã¯ã¼ã¯ã®ç°å¸¸ã示ãããã®ã§ãç¾æ£ã®è³ç§å¦çç ç©¶ã¨ãã¦ã¯ã¹ã¿ã¼ãã©ã¤ã³ã«ã¤ããã«ãããªãã¨ãè¨ãããã空ä¸åè§£ã®å ããããã£ãçµ±å失調çãè³å ãããã¯ã¼ã¯ã¨ããå½¢ãããã®ã示ããã¨ã§èªæé害ã¨ãããã¼ãã«å¼ãæ»ããä»å¾ããã¹ãæ¹åæ§ã示ããè²´éãªç ç©¶ã§ããã
(ææ¾å¤ªéã2019.7.30.)
èªè¦çèªç¥æ©è½ä½ä¸æ£è
ã«ãããã客観çèªç¥æ©è½æ¤æ»ãè³è¡æµã·ã³ãã°ã©ãã£ãç¨ããã¢ããã¤ãβèç½èç©ã®äºæ¸¬
è¹æ¨æ¡ (æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§ã大å¦é¢å士課ç¨)
Can we predict amyloid deposition by objective cognition and regional cerebral blood flow in patients with subjective cognitive decline?
Funaki K, Nakajima S, Noda Y, Wake T, Ito D, Yamagata B, Yoshizaki T, Kameyama M, Nakahara T, Murakami K, Jinzaki M, Mimura M, Tabuchi H.
Psychogeriatrics. 2019 Jan 27. doi:10.1111/psyg.12397. [Epub ahead of print] PubMed PMID: 30688000.
ã¢ã«ããã¤ãã¼ç ï¼Alzheimerâs diseaseï¼ADï¼ã¯èªç¥çã®åæ°ä»¥ä¸ãå ãããæ ¹æ¬çæ²»çæ³ã¯æªã ãªããç¾å¨ã¯ãã»ã¨ãã©èªç¥æ©è½ä½ä¸ã®ãªãADãã¤ãªã¹ã¯è ã対象ã¨ãããæ©æä»å ¥ã«ããçºçäºé²ãæ¨çã¨ããæ²»é¨ãè¡ããã¦ããã
軽度èªç¥é害ï¼Mild Cognitive Impairmentï¼MCIï¼ã¯ADãã¤ãªã¹ã¯ç¾¤ã¨ãã¦åºãç¥ããã¦ããããããã«å段éã§ããèªè¦çèªç¥æ©è½ä½ä¸ï¼Subjective Cognitive Declineï¼SCDï¼ããã¤ãªã¹ã¯ç¾¤ã¨ãã¦æ³¨ç®ããã¦ãããSCDãã¢ããã¤ãβèç½ï¼Beta-amyloidï¼Aβï¼ã¨èªç¥æ©è½ã®é¢é£æ§ã縦æçã«èª¿ã¹ãå
è¡ç ç©¶ã§ã¯ãSCDãã¤AÎ²é½æ§è
ãæãèªç¥æ©è½ä½ä¸ãé¡èã§ãã£ããããªãã¡ãSCDã«ãããAÎ²é½æ§è
ãåå®ãããã¨ã¯è¨åºçã«éè¦ã§ãããAβèç©ã¯ã¢ããã¤ãPETï¼Positron Emission Tomographyï¼ã§å¤å®ã§ããããè²»ç¨ãè¨åã侵襲ãªã©ããç 究使ç¨ã«éå®ããããããæ¥å¸¸è¨åºã§è¡ããã¦ããæ¤æ»æè¦ããSCDæ£è
ã«ãããAβèç©ãäºæ¸¬ã§ããã°æç¨ã§ããã
æ¬ç ç©¶ã§ã¯ãSCDæ£è
ã«ãããAβèç©ã®æç¡ã¨ç¥çµå¿çæ¤æ»ãç²¾ç¥çç¶è©ä¾¡ãSPECTï¼Single photon emission computed tomographyï¼è³è¡æµæè¦ã¨ã®é¢é£ã調æ»ãããã¨ãç®çã¨ãã¦æ¨ªæç ç©¶ãè¡ã£ãã
èªç¥æ©è½ä½ä¸ãèªã訴ãå½é¢ã¡ã¢ãªã¼ã¯ãªããã¯ãç²¾ç¥ã»ç¥çµç§å¤æ¥ãå診ããMini Mental State Examinationï¼MMSEï¼ãã¦ã¨ã¯ã¹ã©ã¼è¨æ¶æ¤æ»ã®è«çè¨æ¶ï¼Logical Memoryï¼ãClinical Dementia Ratingï¼CDRï¼ãæ£å¸¸ç¯å²ã§ãã£ãSCDæ£è 42åï¼å¥³æ§22åãå¹³å年齢 74.5±4.7æ³ï¼ã対象ã¨ããã18F florbetabenããã¬ã¼ãµã¼ã«ç¨ãã¦ã¢ããã¤ãPETãæ½è¡ãã対象ãAÎ²é½æ§ç¾¤ï¼10åï¼ãé°æ§ç¾¤ï¼32åï¼ã®2群ã«åãããã¾ãADã®éºä¼ãªã¹ã¯å åã§ããã¢ããªãã¿ã³ãã¯è³ªEï¼Apolipoprotein Eï¼APOEï¼4ã®æç¡ãæ¡è¡ã«ã¦èª¿ã¹ããè©ä¾¡é ç®ã¯ãè´è¦è¨æ¶ãè¦è¦è¨æ¶ãæ³¨ææ©è½ãéè¡æ©è½ãèªæ³èµ·è½åãªã©ã測ãç¥çµå¿çæ¤æ»ãèªè¦çèªç¥æ©è½ä½ä¸ã®å¼·ãã表ãMemory Complaint Questionnaire ï¼MAC-Qï¼ãä¸å®ã»æãã¤ãã¢ãã·ã¼ãªã©ã測ãç²¾ç¥çç¶è©ä¾¡ãSPECTè³è¡æµæè¦ã¨ãããçµ±è¨å¦çææ³ã¨ãã¦ã¯ãäºåè§£æã¨ãã¦tæ¤å®ãç¨ãã¦åè©ä¾¡é ç®ã®ç¾¤éæ¯è¼ãè¡ã£ãã主解æã¨ãã¦ãAβèç©ã®æç¡ãå¾å±å¤æ°ã人å£çµ±è¨å¦çç¹å¾´ã¨tæ¤å®ã§ææãªç¾¤éå·®ï¼P<0.05ï¼ãèªããé ç®ãç¬ç«å¤æ°ã¨ãã¦äºé ãã¸ã¹ãã£ãã¯å帰åæãè¡ã£ãã
両群ã®äººå£çµ±è¨å¦çç¹å¾´ã§ã¯æè²æ´ãAPOE4ãå«ãææå·®ãèªããªãã£ããtæ¤å®ã§ã¯è«çè¨æ¶ã®ç´å¾åç-é å»¶åç/ç´å¾åçã§ã¯ãAÎ²é½æ§ç¾¤ã§ææãªæç¸¾ä½ä¸ãèªããï¼P=0.04)ãããããäºé ãã¸ã¹ãã£ãã¯å帰åæã§ã¯Aβèç©ã¨ææã«ç¸é¢ããå åãèªããªãã£ãã
æ¬ç ç©¶ã§ã¯èªç¥æ©è½ä½ä¸ã訴ãèªçºçã«è¨ºçæ©é¢ãå診ããSCDæ£è ã対象ã«ã詳細ãªç¥çµå¿çæ¤æ»ãç²¾ç¥çç¶å°ºåº¦ãSPECTè³è¡æµæè¦ãè§£æãããAβèç©ã®æç¡ãè¨åºæè¦ããäºæ¸¬ãããã¨ãåºæ¥ãªãã£ããè¨åºå ´é¢ã§ã¯SCDæ£è ã対象ã«è³ç»åæ¤æ»ãå§ã種ã ã®æ¤æ»ããªããã¦ããããè¨åºæ¤æ»æè¦ããSCDã«ãããADãã¤ãªã¹ã¯ç¾¤ãçµãè¾¼ããã¨ã¯å°é£ã§ããå¯è½æ§ã示åããããä»å¾ã対象æ°ãå¢ããã縦æçè©ä¾¡ãè¡ããªã©æ´ãªãæ¤è¨¼ãå¿ è¦ã¨èããã
(è¹æ¨æ¡ã2019.6.1.)
è§£èª¬ãæªæ¾æã®ã¹ã±ã¼ã«
æ©æçºè¦æ©æä»å
¥ãæ²ããã°ã100%ã®æ¯æãå¾ãããã®ã常ã ã
ç
æ°ãæ©æçºè¦ã§ããããã¦æ©æä»å
¥ã§ããã°ãç
ã®è¦ãã¿ã¯æ¿æ¸ããå»çè²»ãæ¿æ¸ãããç¹ã«è¶
é«é½¢å社ä¼ã§ããæãå½ã«ããã¦èªç¥çã®æ©æçºè¦æ©æä»å
¥ãã§ããã°ãå人ã«ã社ä¼ã«ãéããªã大ããªæ©æµã«ãªãã
ã ãç¾å®ã¯ããåç´ã«ã¯è¡ããªããã
æ©æçºè¦æ©æä»å
¥ã100%ã®æ¯æãå¾ãããã®ã¯ãæ©æçºè¦ãã§ããã°ããæ©æä»å
¥ãã§ããã°ãã¨ããæ¡ä»¶ã¤ãã§ãããååã®æ©æçºè¦ã®æ®µéãããã§ã«é£é¡ãå±±ç©ãã¦ãããç²¾å¯ãªææ³ãæ¤æ»ãç¨ãã¦ãã100%æ£ç¢ºãªè¨ºæã¯ä¸å¯è½ã§ãå¿
ãä½%ãã®å½é½æ§ã¨å½é°æ§ãçããã¨ããã®ããã®é£é¡ã®ä¸ã¤ã§ããããããã1%ç¨åº¦ãªãåªããæ¹æ³ã§ããã¨ä¸è¬çã«ã¯è¨ããããæªæ¾æã®é«é½¢è
人å£ãæ±ããæãå½ã§ã¯èªç¥çäºå群ãã¾ãæªæ¾æã®ã¹ã±ã¼ã«ã§ããããããã¨ã1%ã®å½é½æ§ã»å½é°æ§ã§ãã£ã¦ããã®å®æ°ã¯è¨å¤§ã§ãã¯ããã¦ããã§ãæçãªæ©æçºè¦ææ³ã¨è¨ãããã©ããã¨è¿«ãããã¨çãã«ã¤ã¾ããã¨ã«ãªãã
ããããããã£ã¦ç«ã¡å°½ããã¦ãããã¡ã«ãé«é½¢åã¯ã©ãã©ãé²è¡ãã¦ããããã®å ã«ã¯æã®ã»ã©ããããããªããªãå±é¢ãè¦ãã¦ãããããã§è¹æ¨æ¡é¢çãçç®ããã®ã¯SCDã§ãã£ããSCD (Subjective Cognitive Decline:èªè¦çèªç¥æ©è½ä½ä¸)ã¯ããã¨ãã°æ ¶æç é¢ã®ã¡ã¢ãªã¼ã¯ãªããã¯ã®ããã«èªç¥çãæ±ãå»çæ©é¢ã®åè¨ºåæ©ã¨ãã¦æãå¤ã訴ãã®ä¸ã¤ã§ãããã¢ããã¤ãPETã«ã¿ãAβèç©ãã¢ã«ããã¤ãã¼ç ã®è¨ºæãã¼ã«ã¼ã¨ä½ç½®ã¥ããSCDã®äººã ã対象ã¨ããç¥çµå¿çå¦çæ¤æ»ãç²¾ç¥çç¶å°ºåº¦ãSPECTã«ãã£ã¦Aβèç©ãäºæ¸¬ã§ãããã¨ããã®ãæ¬ç ç©¶ã§è¹æ¨é¢çãç«ã¦ãåãã§ããã
çµæã¯ããäºæ¸¬ã§ããªããã§ãã£ãã
ãã®ãã¼ã¿ã¯ãããæ¹åããè¦ãã°ãèªç¥æ©è½ä½ä¸ã®èªè¦çç¶ã¯ã¢ã«ããã¤ãã¼ç
æ©æçºè¦ã®å½¹ã«ã¯ç«ããªãã¨ãã¬ãã£ãã«æãããã¨ãã§ãããå¥ã®æ¹åããè¦ãã°ãèªç¥æ©è½ã®èªè¦çç¶ãããããã¨ãã£ã¦ã¢ã«ããã¤ãã¼ç
ãå¿é
ããå¿
è¦ã¯ãªãã¨ãã¸ãã£ãã«ã¨ããããã¨ãã§ããã
ã©ã¡ããä¸é¢çãªè¦æ¹ã§ãããéå°ãªè§£éã¯ç¦ç©ã§ããããã¨ããåèè«æã¨ã¯ãæªç¥ã®äºå®ãç©¶æããããã®å¤§ããªçµµã®ä¸é¨ãªã®ã§ãããç¹ã«èªç¥çã¨ããæªæ¾æã®ã¹ã±ã¼ã«ã®å¯¾è±¡ãæ±ãå ´åã¯ãã®æå³åããå¼·ããä¸ã¤ã®ç ç©¶çµæããè¨ãããã¨ã¯éããã¦ãããããã¯æ±ºãã¦ãã¼ã¿ã®ä¾¡å¤ãä½ãè©ä¾¡ããã¨ãããã¨ã§ã¯ãªãã大ããªçµµã®ä¸é¨ãæ§æããã¨ããé度ã«ããã¦éè¦ãªç¥è¦ã§ããã¨è©ä¾¡ãã¹ããã®ã ã
æ¬ç ç©¶ã¯è¹æ¨é¢çã®å¦ä½è«æã§ãããå½¼ã¯å¤§å¦é¢ã忥å¾ãæ ¶æç é¢ã®ã¡ã¢ãªã¼ã¯ãªããã¯ã§ã®å¤æ¥ãç¶ç¶ãã¤ã¤ã訪å診çã軸ã«ããé«é½¢è å»çã«åãå ¥ãã¦ãããç ç©¶ãè¨åºã«çããã¨ããè¹æ¨é¢çã®å®è·µã¯ãå¾è¼©ã®å¤§å¦é¢çãç¯ã¨ãã¹ãä¸ã¤ã®ã¢ãã«ã¨è¨ããã§ãããã
(ææ¾å¤ªéã2019.6.28.)
æ¡æ£ãã³ã½ã«ãã©ã¯ãã°ã©ãã£ãç¨ãã忥µæ§é害ã®è§£æ
ä»äºç°ãã¡ã(æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§ãç¹ä»»å©æ)
Aberrant Anterior Thalamic Radiation Structure in Bipolar Disorder: A Diffusion Tensor Tractography Study.
Niida R, Yamagata B, Niida A, Uechi A, Matsuda H, Mimura M.
Front Psychiatry. 2018 Oct 24;9:522. doi: 10.3389/fpsyt.2018.00522.
ï¼ï¼²ï¼©ã®é²æ©ã«ä¼´ãæ¡æ£ãã³ã½ã«ãã©ã¯ãã°ã©ãã£ã¼ç»åï¼diffusion tensor tractographyï¼ï¼¤ï¼´ï¼´ï¼ãç¨ããç¥çµç·ç¶ã®ç»ååãå¯è½ã¨ãªã£ããDTTã¨ã¯æ°´ç´ ååã®æ¡æ£ã®æ¹åãç¨åº¦ãæããæ¡æ£ãã³ã½ã«ç»åï¼diffusion tensor imageï¼DTIï¼ããç¥çµç·ç¶ã®èµ°è¡ã追跡ãããã¨ã«ããã大è³ç½è³ªã®å¾®ç´°æ§é ã®ç°å¸¸ãç¥çµç·ç¶ã®æ´åæ§ãè©ä¾¡ãããã¨ãã§ãããï¼ï¼²ï¼©ç»åæ®å½±æã«ï¼¤ï¼´ï¼©æ®åæ³ã4ï¼5åå ãããã¨ã§æ¥ã ã®è¨åºå¿ç¨å¯è½ã§ããã
忥µæ§é害ã«ããã¦ç½è³ªï¼WMï¼çµ±åæ§ã®éå®³ãææããã¦ããã æã ã¯åè¦åºæ¾ç·ï¼anterior thalamic radiation :ATRï¼ã®æ§é ç㪠WM ç°å¸¸ãDTTã«ãã£ã¦è¦è¦çã«è©ä¾¡ããããã¨ãã§ãããã©ããã調ã¹ããç 究対象ã¯ã57人ã®BDæ£è ã¨57人ã®å¥å¸¸è ï¼HCsï¼ã«ãã114人ããã 1æ¬ã®ATR ç¹ç¶æãç°ç½è³ªã¨ç½è³ªã®å¢çã«éãããã¨ãã§ããªãã£ããã®ãæåºä¸è¯ãªATRã¨å®ç¾©ããã ATR æåºä¸è¯ã¯HCsããBDã®å·¦ATRã§ææã«é«ãã£ãã(p=0.042)ã ããã«ãæã ã¯FAå¤ã調æ´ããATR ã®æåºãæ«æ¢¢å´ã¾ã§å±ããªãå¤ãæé©ãª FA é¾å¤ã¨å®ç¾©ãããæé©ãª FA é¾å¤0.28ãç¨ãããã¨ã«ããå³ã®ATRã§accuracy 71.1%ï¼sensitivityï¼89.5%ã¨specificityï¼52.6ï¼ ï¼BD ã¨HCsãåºå¥ã§ãã (AUC=0.76)ãä»åã®çµæã¯æé©ãª FA é¾å¤ãBD ã¨HCsãåºå¥ããçç©å¦çææ¨ã¨ãªããã¨ã示åãã ãDTTã«ããATR ã®è¦è¦çè©ä¾¡ãè¨åºã®å ´ã§BD ã®ããã®æç¨ãªè£å©ç診æãã¼ã«ã¨ãªããããããªãã
DTT解æã¯ãéä½è·¯ãæè¦è·¯ãè¦æ¾ç·ãªã©ã®ç¥çµç·ç¶ã®èµ°è¡ã¨ç å¤ã¨ã®ä½ç½®é¢ä¿ã観å¯å¯è½ã§ããããè³å¤ç§é åã§æ²»çè¨ç»ãè¡åã·ãã¥ã¬ã¼ã·ã§ã³ã§ã®å¿ç¨ã«ç¨ãããããã¨ãå§ã¾ãã§ãããä»å¾ã®ï¼¤ï¼´ï¼´ã®å¿ç¨ã¯è¨åºç§ã®å£æ ¹ãè¶ ãå¤å²ã«ããã£ã¦ãããæã ã¯æ ¶æå¤§å¦ç é¢ã§667ä¾ï¼2019å¹´ï¼ææ«ç¾å¨ï¼ã®DTTè§£æãè¡ã£ã¦ãã¦ãããå¤ãã®ç²¾ç¥ç¾æ£ã«ã¤ãã¦ã®ç¥è¦ãèç©ãã¤ã¤ããã
(ä»äºç°ãã¡ã2019.5.2.)
解説ãæãå±ã(ãããããªã)èæ¯
ç²¾ç¥å»å¦ã«ã¯æ ¹å¼·ãèæ¯ä¼èª¬ãããã
ãè¿ä»£ç²¾ç¥å»å¦ã®æ´å²ã®ä¸ã§ããã¾ãã¾ãã¾ã çºè¦ããã¦ããªãç
å ã®åå¨ãåæã¨ããç¾æ£åä½ã¢ãã«ãæåãåãããã¨ã(ãç²¾ç¥å»å¦ã®å®å¨ã¨èæ§ããæäºä¿åèãæ¥æ¬è©è«ç¤¾)ã
京é½å¤§å¦ã®æäºææã¯ãããèæ¯ä¼èª¬ã®ç¬¬ä¸ã®è¦å ã ã¨è¿°ã¹ã¦ãããããã§ãããç¾æ£åä½ã¢ãã«ã®æåãã¨ã¯ãã¡ããç¥çµæ¢
æ¯ã®ãã¨ãæãã¦ãããçç¶-çµé-ç
çæè¦-ç
å ã®è¨¼æã«ããç¥çµæ¢
æ¯ã¨ããç¾æ£åä½ã®ç¢ºç«ãããã¦æ²»çæ³ã®éçºã¯ãã²ã¨æåã®ç²¾ç¥å»å¦ã®æç§æ¸ã«ã¯å¿
ãè¨ããã¦ããå²å®ã§ããã
ãèæ¯ãã¨ã¯ã´ã¼ã«ã®è±¡å¾´ããä¼èª¬ãã¨ã¯éç¾å®ã®è±¡å¾´ããããã¦ãèæ¯ä¼èª¬ãã¨ã¯ãå
¥æä¸å¯è½ãªå®ãç®æãã叿ã®ãªã夢ç©èªã§ãããã¨ã示åãã¦ãããéå»ã«ã¯æåã®è¼ãããå®ç¸¾ãããã®ã«ãªã夢ç©èªãªã®ããããã¯æåãããã¾ãã¾ãã ã£ãããã§ãããç¥çµæ¢
æ¯ã¯ããã¾ãã¾ãåä¸ã®åå ã«ãã£ã¦èµ·ããåä¸ç¾æ£ã ã£ããããã¦ãã®åå ã¯ããã¾ãã¾ãå½æã«æ´»ç¨å¯è½ãªæè¡ãããªãã¡åæ¤è³ã®ç
çå¦çæ¤ç´¢ã«ãã£ã¦çºè¦ã§ããæ§è³ªã®ãã®ã ã£ããç¥çµæ¢
æ¯ã¯ããã®äºã¤ã®ããã¾ãã¾ãããããããã£ã¦å¥åãå¾ãã¨ããå¶ç¶ã®æåä¾ã ã£ãã®ã§ããã
ç²¾ç¥ç§ç
é¢ã«ç¥çµæ¢
æ¯æ£è
ãããµãã¦ããæ
æ¯ãå®ä½é¨ãã¦ããªãæã
ã«ã¯å®æãã«ãããããã®æåã«ãã£ã¦å½æã®ç²¾ç¥ç§ã大å¤ãªèå¥®ã¨æ´»æ°ã«å
ã¾ãããã¨ã¯æ³åã«é£ããªããæåä½é¨ã®è¨æ¶ã¯äººã«å¸æãæãããåé²ã¸ã®åååã«ãªããã ã仿¹ãæã«ã¯æåã¢ãã«ã¨æ¹æ³ã¸ã®å¼·ããã ããã«äººãå°ããããã¦ã¤ãã«ã¯ãæåã®è¨æ¶ãæ¶éãã¦ãã硬ç´ããæ¹æ³è«ã ããæ
£æ§ã®æ³åã«æ¯é
ããã¦ãããã®ããã«å»¶ã
ã¨ç¶ããããªãã¡ã決ãã¦æã®å±ããªããèæ¯ãã®æ¢ç©¶ã§ããããããã¦ãéºä¼åè§£æãç»åè§£æãªã©ã®æ°ããæè¡ãéçºããããã³ã«ãã¨ã¦ãåä¸ç¾æ£ã¨ã¯èããããªããç¾æ£ãã®ä¾æ°ãéãã¦ã¨ã«ããè§£æãã¦ã¿ãã¨ãã䏿¯ãªå¶ã¿ãç²¾ç¥å»å¦ç ç©¶ã¨ãã¦ç¹°ãè¿ããã¦ããããããªç¾ç¶ãè¦ç´ããè¨èã¨ãã¦ãèæ¯ä¼èª¬ãã¯ã¾ãã«ç®´è¨ã§ãããéå»ã®æ å
ã«ãããã®ã¯æ¨ããªå§¿ã§ããããããã¨æ°ã¥ããã«éå»ã®æ å
ã«ç¸ããã¦ããã®ã¯éåã§ãããªãã
ãããªç¶æ
ãæéããèæ¯ãè¦éå
ã«æããã®ãæ¬ç ç©¶ã§ãããæ¬ç ç©¶ã®æåã¯æ±ºãã¦ããã¾ãã¾ãã§ã¯ãªãå¿
ç¶ã¨è¨ãããã®ã§ãã£ãããã®çç±ã¯ç¬¬ä¸ã«ãç²¾ç¥ç¾æ£ã®ãã¡ãå質æ§ãé«ããã¨ãæå¾
ã§ãã忥µæ§é害ã鏿ãããã¨ã§ããã忥µæ§é害ã¯ãæ°åãã¹ã¤ããããã¨ãããä»ã®ç²¾ç¥ç¾æ£ã«ã¯ãªãé¡èãªç¹å¾´ãæã£ã¦ãããèºãã¤ç
(ã¯ã¬ããªã³)ã循ç°ç
(ã·ã¥ãã¤ãã¼)ãããã¦å極æ§é害ã¨ååã¯å¤ãã£ã¦ãã常ã«ãã®ç¹å¾´ããã®ååã«æ ãåºããã¦ãããã¨ã¯ãæä»£ãè¶
ãã¦ç¾æ£ã®æ¬è³ªãèªèããç¶ãã¦ãããã¨ã示ãã¦ããã¨è¨ãããã第äºã¯ãè¨å¤§ãªç»åè¨ºææ³ã®ä¸ãããæ¡æ£ãã³ã½ã«ãã©ã¯ãã°ã©ãã£(DTT)ã鏿ãããã¨ã§ããã
ããã¾ãã¾ãã«é ¼ããã¨ãªããåççãªç ç©¶ã®å®æ½ãå¯è½ã«ããã®ã¯ãæ¾å°ç·å»å¦ã¨ç²¾ç¥å»å¦ã®ä¸¡æ¹ã®å°éå®¶ã§ããä»äºç°ãã¡ç¹ä»»å©æã®è¦èã¨æ
§ç¼ã§ããã忥µæ§é害ã®åè¦åºæ¾ç·ãDTTã§è§£æããã¨ããçºæ³ã¯ãæ¾å°ç·ç§å»ã«ãç²¾ç¥ç§å»ã«ãã¾ãçã¾ãå¾ãªããã®ã§ã両æ¹ã®åéã®å°éç¥èããã£ã¦åãã¦æ³å°ã§ããç ç©¶è¨ç»ã§ããã
æ¬è«æã®abstractã«ã¯ãThe present results suggest that the optimal FA threshold can serve as a biological marker that distinguishes individuals with BD from HCsã¨è¨ããã¦ãããBiological marker ã¯ããèªä½èæ¯ã§ã¯ãªãããèæ¯ã®ä¸é¨ãè¦ããã¨ã¾ã§ã¯è¨ããã¨ãã§ããããè¦ããããããæãå±ããã¾ã§ã«ã¯ã¾ã ã¾ã è·é¢ããããããè¦ããããã¨ã§å極æ§é害ã®èæ¯ã«ä¿ç¶è¿ã¥ãããã¨ã¯ééããªãã
æ²ç¸ã¨æ±äº¬ã宿çã«å¾å¾©ããä»äºç°å©æãæ
¶æç¾©å¡¾å¤§å¦ç
é¢ã§DTTè§£æãæ½è¡ãã667ä¾ã¯ãèªç¥çã髿¬¡è³æ©è½é害ãçºéé害ã¨å¤å²ã«åãã§ããããããããç²¾ç¥å»å¦ã®èæ¯ä¼èª¬ãææ¢ã«åãå´©ããã¨ããä»äºã§ããã
(ææ¾å¤ªéã2019.5.27.)
ç¥è¦å¤å®¹ãé¡èã§ãã£ãæNMDAå容ä½è³çã®2ä¾
è¹å±±ééï¼è¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§é¨é·ï¼
Michitaka Funayama, Jin Mizushima, Taketo Takata, Akihiro Koreki, Masaru Mimura.
Altered perception might be a symptom of anti-N-methyl-D-aspartate receptorã(NMDAR) encephalitis.
Neurocase. 2019 https://doi.org/10.1080/13554794.2019.1573260
ã³ã¿ã¼ã«çå群ãåããæNMDAå容ä½è³çã®1ä¾
è¹å±±ééï¼è¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§ï¼
Michitaka Funayama, Taketo Takata, Masaru Mimura
Cotardâs syndrome in anti-N-methyl-D-aspartate receptor encephalitis
Psychiatry Clin Neurosci. 2018 Jun;72(6):455-456. doi: 10.1111/pcn.12658
ãèæ¯ã
æNMDAå容ä½è³çã¯ãç åæã«å¤ãã®ä¾ã§ç²¾ç¥çç¶ãåãã¦ç²¾ç¥ç§ã«å診ãããæ©æã«æ²»çãéå§ããã°å ¨ãå¾éºçããªãä¾ãå¤ããã䏿¹ã§éå¥ã§ããã«ä¸æ¢æ§å¼å¸é害ãªã©ã«ãã£ã¦æ»ã«è³ããã¨ããããããç²¾ç¥ç§å»ã®éå¥è¨ºæã極ãã¦éè¦ã§ããããããããã®ææ¨ã¨ãªãç²¾ç¥çç¶ã¯å¹»è¦å¦æ³ãªã©ã¨ä¸æ¬ããã¦ããã®ãç¾ç¶ã§ããããã®ï¼ã¤ã®ã±ã¼ã¹ã¬ãã¼ãã§ã¯ã詳細ãªç²¾ç¥çåå¦ãç¨ãã¦ç²¾ç¥ç§å»ã«ããæNMDAå容ä½è³çã®è¨ºæçãé«ããå¯è½æ§ããã¤ã³ãã¨ãã¦ããã
ãçä¾å ±åã
ã¬ãã¼ãã®3ä¾ã¯ããããè¶³å©èµ¤ååç é¢ç¥çµç²¾ç¥ç§ã§æ²»çããæNMDAå容ä½è³çã§ãããç¹å¾´çã§ãããã¨ã¯ãåè¨ºãæ²»çãéé¢å¾ã®ãªãããªãã¼ã·ã§ã³ããã¹ã¦ç²¾ç¥ç§å»ãè¡ãã詳細ãªç²¾ç¥çç¶ã®è¨è¼ã«ã¤ãªãã£ãç¹ã§ããã
ã¯ããã®2ä¾ã®ã±ã¼ã¹ã¬ãã¼ãï¼Neurocaseï¼ã§ã¯ãæéæè¦ãç¥è¦ã®å¤å®¹ãç®ç«ã¤ä¸æ¹ã§ãçµ±å失調çã«ã¿ãããããé£åå¼ç·©ãèªæé害ããªãã¨ããç¹ãå ±åããã2ä¾ã¯ããã¿ããªã®åããã¹ãã¼ã¢ã¼ã·ã§ã³ã«è¦ããããæéãéãã¾ã«ãªã£ã¦ããããå³ããèããã話ã¯ç¾å¨ãå·¦ããèããã話ã¯éå»ã«æããããæãæéãéããæµãã¦ããããã«èããããå対åããªæããããã¬ãã®é³ãæ£é¢ã§ã¯ãªããä¸ã¨ãå¾ãã®æ¹ããèããã¦ããããã·ã©ã¹ã®ç®ãæãããå£ã®å°ããªç©´ã«å¸ãè¾¼ã¾ãããããªã©ã¨è©±ãã¦ããããããããèªã£ã¦ããæéã¯çµ±å失調çããè¨åãè¡åã«ã¾ã¨ã¾ãããã£ãã
次ã®ã±ã¼ã¹ã¬ãã¼ã (Psychiatry and Clinical Neuroscience) ã¯ãé¢äººçã身ä½ã®ç¥è¦å¤å®¹ããã³ã¿ã¼ã«çå群ã«è³ã£ãçä¾ã§ãããããã®ä¾ãæãã¤æ°åãé£åå¼ç·©ãèªæé害ã¯èªããªãã£ãããä½ããèªåãæããã¿ãããç§ã«ä½ããªãã¿ããããããã£ã¨ããããåã£ã¦ãã¦ã常ã«éãã«ãªã£ã¦ããããç£ç³ã®ããã«ä½ãå£ã«å¼ã£å¼µããã¦ãå£ã«å¸ãè¾¼ã¾ãããããä¸çãçµãã£ãã¿ããããç§ã¯æ»ãã ãå¿èããªããè¡ãå ¨é¨æããããä½ãããªããªã«åãããããªã©ã¨ãæ¯è¼çæ´ç¶ã¨è©±ãã¦ããã
ãèå¯ã
ä¸è¨ã®ããã«ãæNMDAå容ä½è³çã®ä¸ã«ã¯è¦è¦ã身ä½ãæéæè¦ãå¤å®¹ããã¨ãããåããNMDAå容ä½ãæå¶ããã±ã¿ãã³ä¸æ¯ã¨é¡ä¼¼ããçç¶ãæ¯è¼çç´ç²ã«åºç¾ããä¾ãåå¨ããã®ã§ã¯ãªããããã¡ããå ¨ä¾ã«ãããã®çç¶ãåºç¾ããã®ã§ã¯ãªããããããã®çç¶ã«ãã£ã¦çµ±å失調çã¨ã®éå¥ã«ã¤ãªãããç´ æ©ãæ²»çã«ãã£ã¦æ»äº¡çãäºå¾ãæ¹åãããã¨ãã§ããå¯è½æ§ããããä»ã«ããæ åã®èããå¤åãã¨ãã½ã¼ãè¨æ¶é害ãå£é¨ã¸ã¹ããã¸ã¢ã髿¶²æè¦ãåµå·£å¥å½¢è «ã®æç¡ãéå¥ã«éå¸¸ã«æå¹ã§ããããåè¨ºã«æ¥ãå ¨ä¾ã«é«æ¶²æ¤æ»ãè¡ããã¨ã¯ä¸å¯è½ã§ãããããããç²¾ç¥ç§å»ãæ¥å¸¸è¨åºã®éå ·ã§ããç²¾ç¥çåå¦ãç¨ãã¦ãæNMDAå容ä½è³çã¨çµ±å失調çãä¸å¿ã¨ããç²¾ç¥ç¾æ£ã®éå¥ãã§ããã®ã§ã¯ãªãããä»å¾ãæNMDAå容ä½è³çã®ç²¾ç¥çç¶ã詳細ã«åãããã確ããªç²¾ç¥çç¶ãæããã«ãã¦ããããã
(è¹å±±ééã2019.4.1.)
解説ãè±ã®è²ã¯å¹»è¦
ãã¨ãã°è±ãåé¡ããã
è²ã§åé¡ããã°ããããããããããããã§ã¯ãã¾ãã«æ£æçã ã¨èª°ããæãã§ãããã
ã§ã¯è±ã³ãã®æ°ã§åé¡ããã®ã¯ã©ããããããããããããããè²ã§ãªãæ°ã«çç®ããã¨ããã ãã§ããã¯ããã å¤è¦ã§åé¡ããã¨ããã«ãããªããæ°éåããã°ããã§ããã¨ãããã®ã§ã¯ãªãã客観æ§ã¯ç¢ºãã«ããããããã ãã§ããã
ããã§å¯¾ç§°æ§ã§åé¡ãã¦ã¿ããç¹å¯¾ç§°ã®å½¢ããã¦ããè±(ãã¨ãã°æ¢
)ãæ¾å°ç¸ç§°è±ãç·å¯¾ç§°ã®å½¢ããã¦ããè±(ãã¨ãã°è¤)ãå·¦å³ç¸ç§°è±ã¨ãããããã¯å¤è¦ã«ããåé¡ã¨ããç¹ã§ã¯åãã§ããåãªãå½¢ã®å
ã«ããè±ã®æ©è½ã®é²åã¨ããè¦ç´ ãå
¥ã£ã¦ããã®ã§ãããæ¬è³ªã«æ¥è¿ããåé¡ã§ããã¨è¨ãããè±ã®å±æ§ã¨ãã¦æãç®ç«ã¤è±ã®è²ãè±ã³ãã®æ°ã ãã«ã¨ãããã¦ããããæ±ºãã¦ãã®çºæ³ã¯çã¾ããªããä¸äººåãããæ çµã¿ããè§£æ¾ãããã¨ãã«åãã¦é²æ©ãããã®ã ã
ç²¾ç¥ç
çç¶ã«ã¤ãã¦ã¯ã©ããã
ãããã®ããããªããã¨ãè¨ã£ã¦ããããæå³ä¸æã®ãã¨ãè¨ã£ã¦ããããªã©ãç²¾ç¥ç
ãçãç¬¬ä¸æ©ã§ããããããã ãã§ã¯ã©ãã«ããã©ãçããªããããã§ããããªæ··æ²ã®ä¸ããå¥å¸¸è
ã§ã追ä½é¨å¯è½ãªè¦ç´ ãæ½åºããã代表ã¯å¹»è¦ã¨å¦æ³ã§ããã確ãã«å¹»è¦ã¨å¦æ³ã¯ç®ç«ã¤ãã ãããããããããããææ¨ã«çç®ãã¦åé¡ãã¦ãã¾ãã®ã¯ãè±ãè²ã§åé¡ãã¦æºè¶³ãã¦ããã®ã¨åæ§ã§ãæ¬è³ªã¸ã®æ¥è¿ãé»å®³ããæ
度ã«ã»ããªããªããå¹»è¦ã妿³ãæ£è
ã«èªããããã¨ãããçµ±åå¤±èª¿çæ§ã®çç¶ãã¨åä»ããããã¡ã§ããã®å¹»è¦ã妿³ãçµ±å失調çã«ç¹å¾´çãªæ§è³ªãæã£ã¦ãããå¦ãã¯ã»ã¨ãã©è«ãããããã¾ãã¦ãå¹»è¦å¦æ³ä»¥å¤ã®ç²¾ç¥ç
çç¶ã¯ãæå³ä¸æãã¨ä¸æ¬ããã¦ãã®å
ã«ã¯é²ã¾ãæè忢ãã¦ãã¾ã£ã¦ãããã¨ããã¾ãã«å¤ãã
ä»åè¹å±±ééé¨é·ãã¾ã¨ããè¤æ°ã®çä¾å ±åã¯ãããã®å ãã«è¸ã¿è¾¼ãã è²´éãªè«æã§ããããã°ãã°ãçµ±åå¤±èª¿çæ§ãã¨è¡¨ç¾ãããNMDAå容ä½è³çã®ç²¾ç¥çç¶ãç²¾å¯ã«åæãããã®ä¸»çç¶ã¯ç¥è¦å¤å®¹ã§ãã£ã¦ãé£åå¼ç·©ãèªæé害ã¯èªããªããã¨ã示ãããã¨ã¯ãç²¾ç¥ç ã®è³å ã¡ã«ããºã ãå ¨ãä¸æã®æä»£ã®å 人ãã¡ãéçºã»çºå±ãããç²¾ç¥çåå¦ã«å¤§ããªä¾¡å¤ããããã¨ãåèªèãããã®ã§ããã
ããã ãã§ã¯åãªãæå¤è¶£å³ã ãããã®ç ç©¶ã«ã¯ããã«ãã®å ããããã²ã¨ã¤ã«ã¯ãæ©æã«çµ±å失調çããéå¥ãã¦è³çã®æ²»çãéå§ãããã£ããã«ãªãã¨ããå½¢ã§ãããã«ã§ãè¨åºã«å½¹ç«ã¦ããã¨ãã§ãããã¾ããè¹å±±é¨é·ã®è§£èª¬æã«è¨ããã¦ããããã«ãããã§æ½åºãããçç¶ã¯ãNMDAå容ä½ãæå¶ããã±ã¿ãã³ä¸æ¯ã¨é¡ä¼¼æ§ãæãã¦ãããã¨ã注ç®ãããããããå¶ç¶ã§ããã¯ãã¯ãªããããã«ç²¾ç¥ç çç¶ããã¼ããã³é¢é£ã®ãã®ã¨NMDAé¢é£ã®ãã®ã«å³»å¥ã§ããå¯è½æ§ãè¦ãã¦ãããç²¾å¯ãªç²¾ç¥çåå¦ã¨ãã¥ã¼ããµã¤ã¨ã³ã¹ã®èåããçã¾ããæªæ¥ã¸ã®æå¾ ã¯å¤§ããã
(ææ¾å¤ªéã2019.4.23.)
åæã»éåææ£è
ãå®¶æã対象ã¨ãã黿°ããããçæ³ã®æºè¶³åº¦èª¿æ»
é«å®®ãå½°ç´ï¼æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ã»ç¥çµç§å¦æå®¤ã大å¦é¢å士課ç¨ï¼
Attitudes Toward Electroconvulsive Therapy Among Involuntary and Voluntary Patients
Akihiro Takamiya, Kyosuke Sawada, Masaru Mimura and Taishiro Kishimoto
Journal of ECT 2019. DOI: 10.1097/YCT.0000000000000571
黿°ããããçæ³ (electroconvulsive therapy: ECT) ã¯æå¹æ§ãå®å ¨æ§ã確ç«ããã¦ããªãã誤解ãåè¦ã®å¤ãæ²»çã§ããã1ã¤ã®è¦å ã¨ãã¦ã¡ãã£ã¢ãECTã®æ£ããæ å ±ãä¼ãã¦ããªãã¨ããå ±åããã (Sienaert. Brain Stimul 2016)ãECTã¯ç·å¼µç æ§æè¿·ãç²¾ç¥çç¶ã®ããã«æé£æè¬ã¨ãªã£ã¦ããããããã¯å¥ã®çç±ã«ãã身ä½çã«å±éºãªç¶æ ã«ãããªã©ãç·æ¥æ§ã®é«ãå ´åã«æ£è ã®å½ãæãããã«å¿ è¦ãªæ²»çã§ãããç²¾ç¥çç¶ãæ¿ãããããã¯æè¿·ç¶æ ã®æã«ã¯æ¬äººããæ²»çã®åæãã¨ããªããã¨ãå°ãªããªãã諸å¤å½ã§ã¯ãæ¬äººåæã®ãªãECTã¯å»æ¢ãã¹ãã§ããã¨ããæè¦ããECTèªä½ã廿¢ãã¹ãã¨ããæè¦ã表æããå£ä½ãå人ããããããããç²¾ç¥ç§ææ¥å»çç¾å ´ã«ããã¦ã¯ãç·æ¥æ§ãé«ãECTãå¿ è¦ã¨ãªãã±ã¼ã¹ã¯å°ãªããªããã¾ããè¬ç©çæ³ãç²¾ç¥çæ³ã§æ¹åããªãå ´åãECTã§åçã«æ¹åããã±ã¼ã¹ãå°ãªããªãã
ECTã®èª¤è§£ãåè¦ãè§£ãç¬¬ä¸æ©ã¨ãã¦ãECTãåããæ£è æ¬äººã¨ãã®å®¶æã®ä½é¨ãã¾ã¨ãããã¨ãå¿ è¦ã§ããã¨èããæã ã¯ECTãåããæ£è 53åã¨ãã®å®¶æ44åã«å¯¾ãã¦ã¢ã³ã±ã¼ã調æ»ãè¡ãªã£ãã質åé ç®ã¯ECTãåããçµé¨ãECTã®æå¹æ§ã¨æå®³äºè±¡ãå度ECTãåãããã¨ã¸ã®æè¦ãECTã®ã¤ã¡ã¼ã¸ã«é¢ããåè¨19ã®è³ªåã§æ§æããã¦ããã-3ç¹ãã3ç¹ã¾ã§ã®7段éã®ãªãã«ã¼ã尺度ãç¨ãããçµæã®è¡¨ç¤ºã«é¢ãã¦ããã¤ãã¹ã®è©ç¹ã¯å¦å®çããã©ã¹ã®è©ç¹ã¯è¯å®çã¨ãã¦ã«ãã´ãªã¼ã«ããåé¡ãè¡ã£ããè©ä¾¡ã¯å¹æã«å¯¾ããè¯å®çãªãã¤ã¢ã¹ãèªç¥æ©è½ã¸ã®å¦å®çãªãã¤ã¢ã¹ãçããããECTç´å¾ã®ææãé¿ãããããæçµECTããå¹³å30æ¥ã®ééã空ãã¦æ½è¡ãããã¾ããå¦å®çãªæè¦ã表æããããããã«å¯¾é¢ã®ã¤ã³ã¿ãã¥ã¼å½¢å¼ã§ã¯ãªãèªè¨å¼ã®ã¢ã³ã±ã¼ããè¡ãªã£ãã
80%以ä¸ã®æ£è ã¨å®¶æã¯ECTã®æå¹æ§ã«è¯å®çã ã£ããç´60%ã®æ£è ã¯åçºæã«å度ECTãåãããã¨çããECTã¯å®å ¨ã§ãECTã¯è¨æ¶ã«æªå½±é¿ããªããæ¯ç§æ²»çãåãããããæããªãã£ãã¨åçãã¦ãããå®¶æã¯æ£è æ¬äººãããæ²»ç广ã«å¯¾ããæºè¶³åº¦ãææã«é«ãã£ãã23åã¯å®¶æã®åæã®ã¿ã®ECTã®æ½è¡ã ã£ãããæ¬äººåæã®åå è ã®åçã¨æ¯è¼ãã¦ãã¤çç¶ã®æ¹å度ããã¢ã³ã±ã¼ãã®ã»ã¼å ¨ã¦ã®åçãææãªå·®ã¯èªããªãã£ãã
æ¬ç ç©¶ã§ã¯æ¬äººåæã®æç¡ã«é¢ãããECTã®æºè¶³åº¦ã¯é«ãã£ããECTã«é¢ãã¦ãç¹ã«éåææ£è ã¸ã®ECTã®æ¯éãè«ããéã«ã¯ãå®éã«æ²»çãåããæ£è æ¬äººããã®å®¶æã®æè¦ãåèã«ãããã¨ã¯éè¦ã¨èããããã
(é«å®®å½°ç´ã2019.3.18.)
解説ãå½äºè ã®çã®å©çã¨ã¯
å°å¶å主ãæåããããªã©ã¨ã¯æ±ºãã¦èããªãã®ã大人ã®ãããªã¿ã¨ãããã®ã§ãããããã¯èªåã®èº«ã®å®å ¨ã®ããã ãã§ã¯ãªããå°å¶ã¨ããã¨ããã«ã横æ´ã§ä¸æ¡ç100%ã®ããã ããããããã¯å¤ãã®äººããæ¯æãããããããå主ã«ãªã£ãã®ã§ãã£ã¦ãã®ã¿ãªããããã®å°ä½ãç¶æããã¦ããã®ã¯å¤ãã®äººã®æ¯æãããããã ã¨ããäºå®ãèªããªããã°ãªããªããæµ èãªæ£ç¾©æããæåãèããã®ã¯å±éºãªç¬åã§ãããè¡åãèµ·ããåã«ã人ã ã®å¹¸ç¦ã¨ã¯ä½ãã¨ããæ ¹æ¬ã«ç«ã¡è¿ã£ã¦ãåºãæ·±ãæ éã«èæ ®ããªããã°ãªããªãã
ç¾ä»£ã®æ¥æ¬ã«ã¯å°å¶å主ã¯åå¨ããªãããå°å¶å主çãªåèªã¯ããã¤ãããããã¨ãã°ãå人æ å ±ããä¿è·ã®å¿ è¦æ§ãèªãããã¦é«ãå°ä½ãç²å¾ããã¾ã§ã¯ãããæã¾ããçµéã ã£ããããå人æ å ±ã¯æ£ç¾©ãåè«ããè ã¯è³è»ãã¨ãªã£ã¦ã誰ããæ²é»ããã¨ããå¥å¦ãªç¶æ³ãç«ã¡ç¾ããããã£ããå人æ å ±ã ã¨å®£è¨ããããããããæ¬å½ã«å人æ å ±ã«ããããã©ãããæ¤è¨¼ãããã¨ããã ãã§å°å¶å主ã®éé±ã«è§¦ãããã人権ãããããã被害è ãããããªä¾ã ããããæ¬å½ã«äººæ¨©ã«ãããã®ãããããã¯æ¬å½ã«ãã£ãã®ããæ¤è¨¼ãããã¨ããã°èº«ã®å±éºãè¦æããªããã°ãªããªããå人æ å ±ã人権ãããã被害è ããå°éãã大åã«æ±ãããã®ãå½ç¶ã ããæè¦ãããã¨ãã許ããªãå°å¶å主ã¨ãªãã°è©±ã¯å¥ã«ãªã£ã¦ããã
å»çç¾å ´ã§ããã«è¿ãåèªã®ä¸ã¤ã«ãåæãããããæ¬äººã®åæã¯å°éããã®ãå½ç¶ã ãå°éããªããã°æ¬äººã®å¤§ããªä¸å©çãçãããããã§ã¯ãæ¬äººã«åæè½åããªãå ´åã¯ã©ãããããç èããªãå ´åã¯ã©ãããããå°å¶å主ã«ã¯å¾ãã®ã大人ã®ãããªã¿ã§ãããããåæããªããã°æ²»çã¯ããªãã®ã身ã®å®å ¨ã®ããã«ã¯å¾çã§ãããæå¹ãªæ²»çæ³ããã£ã¦ãåæããªããã°ããªããå®å ¨ãªæ²»çæ³ããã£ã¦ãåæããªããã°ããªããå°å¶å主ã«ã¯éãããªããã ãããã§ã¯å½äºè ã®å¤§ããªä¸å¹¸ãæãã
黿°ããããçæ³ã¯æå¹ã§å®å ¨ãªæ²»çæ³ã§ããããã æå¹ã¨ããã ãã§ãªããå°ãªãã¨ãä¸é¨ã®ãã¤ç ã«ã¨ã£ã¦ã¯æãæå¹ã§ã广ã¯ã¾ãã«åçã§ãããæ±ºãã¦é£æ²»ä¾ã®ããã®æå¾ã®ææ®µã§ã¯ãªãããããæåã®ææ®µã¨ãã¦è¡ããã¨ã§ãæ¬äººã®è¦ãã¿ãéããã«åãé¤ããã ãã§ãªããå»ççµæ¸çã«ãã¡ãªããããããã¨ããå¤ãã®è«æã«ãã§ã«è¨ããã¦ããããããªã®ã«ãªãååã«æ®åããªãã®ããä¸ã¤ã«ã¯ãåæãã¨ããå°å¶å主ã«ãããããã¯ãããã黿°ããããçæ³ãå¿ è¦ãªå½äºè ã»ã©ãåæè½åãç èãä¸ååã ã¨ããã®ã¯è¨åºçãªäºå®ã§ãããããã§ç´ã¡ã«ãå½äºè ã幸ç¦ã«ããããã«å°å¶å主ãæåãããã¨èããã¨ããã°ãããã¯ãã¾ãã«æµ èãªæ£ç¾©æã«åºã¥ãçºæ³ã§ãããå°å¶å主ãåæãããã®åå¨ã人ã ã®å©çã«ãªãæ¯æããã¦ããããããé«ãå°ä½ãç¶æãã¦ããã®ã§ãã£ã¦ãå°éããå§¿å¢ã¯å æããããã§ã®ç¾å®ã®æ¹åçãèããªããã°ãªããªãã
é«å®®å¤§å¦é¢çãæ¬è«æã§ç¤ºããã®ã¯ãæ¬äººã®å©çæåªå ã大åæã«ããããã§ã®ç»æçãªã¢ããã¼ãã§ãããåæãã®ãã®ãæåããããªã©ã¨ããæµ èãªãã¨ã¯ããªãããæºè¶³åº¦ãã¨ãããç¾ä»£ã®æ¥æ¬ã§å°å¶å主ã®å°ä½ãç²å¾ãã¤ã¤ããå¥ã®åèªãããåæãã¨ããå 輩å°å¶å主ã®é å°ã«éãè¾¼ã¿ãå·éãªè©ä¾¡ãä¿ããã®ã§ããã
åæã¯ããããããã®å ã«ããå½äºè ã®æºè¶³ã¨ãã大ããªç®çã«åãã¦ã®ä¸ç¶ç¹ã«ãããªããåæãå°å¶å主ã®å°ä½ã«ããã®ã¯ãä¸ç¶ç¹ãç®çåãããã®ã«ã»ããªããªããæ¬æ¥ã¯å½äºè ã®å©çã®ããã§ãã£ãã¯ãã®ãåæãããããèªä½ãç®çã¨ãªã£ãç¬éã«å½¢éª¸åããéã«å½äºè ã®ä¸å©çãä¿é²ãããã®ã«å¤èº«ããå°å¶å主ã®å°ä½ã«ããã¾ã£ã¦ããã¨ããã°ã人ã ã«ã¨ã£ã¦ãããªä¸å¹¸ã¯ãªãã
æå¹ã§å®å ¨ãªæ²»çæ³ãããããå¿ è¦ã¨ãããã¹ã¦ã®äººãåããããããã«ããããããªå½ããåã®ãã¨ãå®ç¾ããã¾ã§ã«ãæ§ã ãªéå£ãããã®ãç²¾ç¥ç§è¨åºã§ããã黿°ããããçæ³ã®çç©å¦çè§£æãç®æãã¨åæã«ãç¾å ´ã§ã®å®è¡ãé»ãéå£ã®æ°·è§£ã«åãã¦åªåãç¶ããé«å®®é¢çã¯ãè¨åºç ç©¶è ã®ããã¹ãå§¿ãå ·ç¾ãã¦ããã
(ææ¾å¤ªéã2019.3.25.)
æ¥æ¬èªçRapid Dementia Screening Testä¿®æ£çã«é¢ããæ¤è¨(2)
Yasushi Moriyama, Aihide Yoshino, Taro Muramatsu, and Masaru Mimura:
Detailed analysis of the Japanese version of the Rapid Dementia Screening Test using Arabic-hiragana conversion.
Psychogeriatrics 18(6): 446-450, 2018
æ¥æ¬èªç Rapid Dementia Screening Test(Japanese version of the Rapid Dementia Screening Test: RDST-J)ã¯,ã¹ã¼ãã¼ãã¼ã±ãã課é¡ã¨æ°åå¤æèª²é¡ã®2é¡ãããªã. ã¹ã¼ãã¼ãã¼ã±ãã課é¡ã¯,1åã®éã«ãã¹ã¼ãã¼ãã¼ã±ãããã³ã³ããã¨ã³ã¹ã¹ãã¢ã§è²·ãããã®ããçãã¦ãããè¨èªæµæ¢æ§èª²é¡ã§ãã. ã¾ãæ°åå¤æèª²é¡ã¯,ã¢ã©ãã¢æ°åãæ¼¢æ°åã«å¤æãã2é¡ï¼209âäºç¾ä¹,4054âååäºååï¼ã¨,æ¼¢æ°åãã¢ã©ãã¢æ°åã«å¤æãã2é¡ï¼å ç¾å «åä¸â681,äºåäºåä¸â2027ï¼ãããªã. æ¬æ¤æ»ã¯3ï½5åã§æ½è¡å¯è½ã§Mini Mental State Examination (MMSE)ç¨ã®æéãè¦ãã,å¤å¿ãªè¨åºã«ãããèªç¥çã®ã¹ã¯ãªã¼ãã³ã°æ¤æ»ã¨ãã¦æç¨ã§ãã.
ããããã¯ä»¥å,RDST-Jãå¥å¸¸ç¾¤ã¨ CDR0.5 ã®éå¥è£å©ã«æç¨ã§ãããã¨ã示ãã (Moriyama Y et al: Psychogeriatrics. 2016; æ¬ãµã¤ã 2015.10. 軽çã¢ã«ããã¤ãã¼ç ã®è¨ºæè£å©ã«ã¯,æè¨æç»èª²é¡ãããæ¥æ¬èªçRapid Dementia Screening Testãæç¨ã§ããã).ããã«RDST-Jä¿®æ£çã«ãããæ¤è¨ã§,æ°åå¤æèª²é¡ã®æ¼¢æ°åã®è³ªåã»åçå½¢å¼ã横æ¸ããã縦æ¸ãã«å¤æ´ããä¿®æ£çã¯,åçã¨æ¯ã¹ã¦CDR 0.5ã®ã¹ã¯ãªã¼ãã³ã°æ¤æ»ã¨ãã¦ä½ãæåº¦ã¨é«ãç¹ç°åº¦ãæãããã¨ãå ±åãã¦ãã(Moriyama Y et al, Psychogeriatrics.2017.; æ¬ãµã¤ã 2017.7. æ¥æ¬èªçRapid Dementia Screening Testä¿®æ£çã«é¢ããæ¤è¨).
ä»åä¿®æ£ç¬¬2çã¨ãã¦,æ°åå¤æèª²é¡ãã¢ã©ãã¢æ°å/æ¼¢æ°åããã¢ã©ãã¢æ°å/ã²ãããªã«å¤æ´ãããã¨ã®å½±é¿ã調ã¹ã.ããªãã¡RDST-Jåçï¼ã¢ã©ãã¢æ°å/æ¼¢æ°åï¼ã¨ä¿®æ£çï¼ã¢ã©ãã¢æ°å/ã²ãããªï¼ã¨ã®èªç¥çã¹ã¯ãªã¼ãã³ã°ããããªãä¸ã®æåº¦ã»ç¹ç°åº¦ãæ¯è¼ãã.
対象ã¯clinical dementia rating scale (CDR)0.5群45ä¾ã¨å¥å¸¸ç¾¤52ä¾ã§,åçã¨ä¿®æ£çã¨ã®éã«,å¹²æ¸èª²é¡ã¨ãã¦MMSEã¨æè¨æç»èª²é¡ããããªã£ã.
çµæã¯CDR 0.5群ãå¥å¸¸ç¾¤ã¨éå¥ããä¸ã§, ã«ãããªãå¤ã8/9ã«è¨å®ããå ´å, RDST-Jåçã§ã¯æåº¦73.1%,ç¹ç°åº¦75.5% ã§ãã£ãã®ã«å¯¾ã,ä¿®æ£çã§ã¯æåº¦71.8%, ç¹ç°åº¦73.0%ã§ãã£ã.
以ä¸ã²ãããªçRDST-Jã®æåº¦ã»ç¹ç°åº¦ã¯åçã¨ã»ã¼åçã§ãã£ã.
(森山泰ã2019.3.1.)
解説ãããºã«ããããã¯å±±
é«ã¿ãç®æãã¦å±±ãç»ãã¨ãããã¨ãã®ã»ããæ ¼èª¿é«ãã®ã ããã¾ãã¯ãã£ã¨æ°è»½ã«ã§ããã¸ã°ã½ã¼ããºã«ã®ãã¨ãããå§ãããããã¼ã¹ãæ£ããä½ç½®ã«ç½®ãã¦ãããã¨ã«ãã£ã¦ãã¾ã è¦ãã¬çµµãè¦ãããã®ã«ãã¦ããã®ãã¸ã°ã½ã¼ããºã«ã§ããããã ããã§ãã¨ãã¨ãã¦åºãã¸ã°ã½ã¼ããºã«ã¯ã第ä¸ã«ãçµµã¨ã¯ç¡é¢ä¿ã®ãã¼ã¹ãããããããã¨ããç¹ãæ®éã¨ã¯ç°ãªããã¤ã¾ãè¨å¤§ãªãã¼ã¹ã®ä¸ãããçµµãæ§æãããã¼ã¹ã ããé¸ã°ãªããã°ãªããªãã®ã§ãæ ¼æ®µã«é£ããããºã«ã«ãªããã ããã²ã¨ãã§ã¯ãªãå¤ãã®äººã ãååãã¦ä»ä¸ããã¨ããç¹ãæ®éã®ããºã«ã¨ç°ãªã第äºã®ç¹ã§ããã
ãã®ããºã«ãè§£ãããã«ã¯ãç¡é¢ä¿ãªãã¼ã¹ãé¤å¤ãã¦ããã¨ãã使¥ãéãããã¨ãå¿ è¦ã«ãªãããã®ä½æ¥ããã£ã¦åãã¦ãæ£ãããã¼ã¹ãæ£ããç½®ãã¦ãããã¨ãå¯è½ã«ãªãããããã¼ã¹ã«ã¤ãã¦ããããçµµãæ§æãããã¼ã¹ã§ãªãã¨ç¢ºèªãããããã®ãã¨ãåºãç¥ããããã¨ã大åã ããããããªããã°ãã¾ãå¥ã®äººãåããã¼ã¹ã¨æ ¼éããã¨ããç¡é§ãªåªåããããã¨ã«ãªããããºã«ã®å®æã¯å¤§ããé å»¶ããã
ç¾ä»£ã®å»å¦ç ç©¶ã¯ãããªã¸ã°ã½ã¼ããºã«ã«ä¼¼ã¦ãããçµµãæ§æããªããã¼ã¹ã«ãããã®ã¯ãã¬ãã£ããã¼ã¿ã§ããããã¸ãã£ããã¼ã¿ããªãã¡çµµãæ§æãããã¼ã¹ãçºè¦ããç ç©¶è ãèå ãæµ´ã³ãã¡ã ãããã®å½±ã§ã¯èª°ããç¡é¢ä¿ãªãã¼ã¹ãåãé¤ãç¶ãã¦ããããã¸ãã£ããã¼ã¿ã¨ãã¬ãã£ããã¼ã¿ã¯ããããã£ã¦ãçå®ãç®æãå¶ã¿ã§ããç ç©¶ã¨ããä¸çã§ã¯åã価å¤ãæã£ã¦ããã
å±±ãç»ããã¨ãã§ãåããã¨ã表ç¾ã§ãããé ä¸ã«è³ãæ£ããéã¯ã©ããããããç¥ãããã«ã¯ã誤ã£ãéãã©ãã§ããããæç¢ºã«ç¤ºããã¨ã«ãã£ã¦ã人ãè¿·ãéã«å ¥ãè¾¼ããã¨ãé²ããã¨ã大åã§ããã誤ã£ãéããªãã¡ãã¬ãã£ããã¼ã¿ãããããã£ã¦ãæ£ããéããªãã¡ãã¸ãã£ããã¼ã¿ã¨åã価å¤ãæã£ã¦ããã
森山åå£«ã®æ¬è«æã¯æ¥æ¬èªçRapid Dementia Screening Test(RDST-J)ã®æ¹è¯éç¨ã«ããããã¬ãã£ããã¼ã¿ã示ãããæåéãæ¥ã«æ¥ã«å¤§ããªåé¡ã«ãªã£ã¦ããèªç¥ç対çã®ä¸ç«¯ãæ ããã¨ãæå¾ ããããã®æ¤æ»ã宿ã«åããããã®ãéè¦ãªä»äºã®ä¸ã¤ã§ããã
å±±ã®ãã¨ãã¯é«ã¿ãç®æãã¨ããã¤ã¡ã¼ã¸ãããããæ ¼èª¿é«ãããããå±±ãç»ãã®ã¯ç¸å½ãªè¦å´ãããä»äºã§ãããããã¦é ä¸ã徿ããã¨ãã¦ããç¾å®ã¨ãã¦å¾ãããã®ã¯éææã ãã§ããã仿¹ãã¸ã°ã½ã¼ããºã«ã¯æ°è»½ã«æ¥½ãããã¨ãã§ãã宿ããã°å®è³ªçãªææç©ãå¾ããããRDST-Jã«ã¤ãã¦ã®ç ç©¶ã¯ã©ã¡ãã«ãã¨ããã®ãé©åã ããããããã«çããè³æ ¼ãæã£ã¦ããã®ã¯ããã®æ¤æ»ã®éçºã«å¿è¡ã注ãã§ããå®è·µè ã§ããæ£®å±±å士以å¤ã«ã¯ããªãã§ãããã
(ææ¾å¤ªéã2019.3.15.)
æ²æå®° (æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§ç¹ä»»å©æãé·è°·å·ç
é¢)
è¨ç®è«çç²¾ç¥å»å¦: æ
å ±å¦çéç¨ããèªã¿è§£ãç²¾ç¥é害ãåèæ¸æ¿ãã2019å¹´1æ20æ¥çºè¡
å½é æå½¦, çå¹³ å¥å¤ªé, æ²æ å®°, å±±ä¸ ç¥ä¸(å
±è)
æ¬æ¸ãæ±ããè¨ç®è«çç²¾ç¥å»å¦ãã¨ã¯ï¼ç²¾ç¥é害ã®çè§£ã«ããã¦ï¼æ å ±å¦çã·ã¹ãã ã§ããè³ã®è¨ç®åçãæ°ççã«è¡¨ããã¢ãã«ãç¨ããç ç©¶ææ³ã®ãã¨ã§ããï¼ç²¾ç¥å»å¦ã®æ°ããç ç©¶åéã§ãããç²¾ç¥å»å¦ã®æ´å²ã«ããã¦ã¯ï¼ç¾å¨éçãæ¥µããçç©å¦çãªç ç©¶æ¹æ³ã«éããï¼ç¥çµå¿çå¦ãç²¾ç¥ç çå¦ãªã©ã¨ãã£ãï¼ããã°ãå¿èº«äºå è«ãã®ç«å ´ã§ç²¾ç¥é害ãè¨è¿°ãï¼ãã®ç æ çè§£ã試ã¿ãã¨ããã¢ããã¼ããã¨ããã¦ãã¦ããããããã¯ç²¾ç¥é害ã®ç ç©¶ã ãã§ãªãç²¾ç¥ç§å»çã®è¨åºã®åºç¤ããªãåéã§ããã䏿¹ã§ï¼ç¾å¨ã®ç²¾ç¥é害ã®ç¾ç åé¡ãï¼çç©å¦çåºç¤ãç å è«ã«åºã¥ãã¦ããªããã¨ï¼è¿å¹´ã®çç©å¦çç¥è¦ã®èç©ã«ãã£ã¦ãï¼ãã®ç¾ç åé¡ã®çç©å¦ç妥彿§ãå¦å®ããã¤ã¤ãããã¨ãªã©ï¼ç¾ä»£ç²¾ç¥å»å¦ãæ±ããéè¦ãªåé¡ãæµ®ã彫ãã«ãªã£ã¦ãã¦ãããç±³å½å½ç«ç²¾ç¥è¡çç ç©¶æï¼NIMHï¼ã®ç¾æé·Joshua A. Gordon æ°ã¯ï¼åæã§åº¦ã è¨ç®è«çç²¾ç¥å»å¦ã«è¨åãï¼NIMH ã«ããã¦âComputational Psychiatry Programâãéå§ãããªã©ï¼è¨ç®è«çã¢ããã¼ããä¸è¨ãããããªç¾ä»£ç²¾ç¥å»å¦ãæ±ããåé¡ã«è²¢ç®ã§ããå¯è½æ§ã強調ãã¦ãããã¾ãï¼æµ·å¤ã§ã¯ãã§ã«ï¼ç¥çµç§å¦ã»ç²¾ç¥å»å¦ã®ä¸æµèªã¸è¨ç®è«çç²¾ç¥å»å¦ã«é¢ããã¬ãã¥ã¼ã次ã ã¨æ²è¼ããï¼æ¸ç±ãè¤æ°åºçããããªã©ï¼ãã®åéã®å¿ è¦æ§ã»éè¦æ§ãèªèããã¦ãã¦ããã
ãããã£ãä¸ççç¾æ³ã®ä¸ã§ï¼æ¬æ¸ã®èè ãã¯ããããï¼å½å ã§ã¯ä»ã«å é§ãã¦è¨ç®è«çç²¾ç¥å»å¦ç ç©¶ã«åãçµãã§ããç ç©¶è ã§ï¼2015 å¹´ããã¯ãè¨ç®è«çç²¾ç¥å»å¦ã³ããã¦ã ãã¨é¡ããç ç©¶ä¼ãéå¬ãï¼ãã®åéã«èå³ãæã¤ç ç©¶è ã®ãããã¯ã¼ã¯æ§ç¯ãè¡ã£ã¦ãããæ¬æ¸ã¯ããã§ã®è°è«ã®ææããçã¾ããï¼å½å æåã®è¨ç®è«çç²¾ç¥å»å¦ã®è§£èª¬æ¸ã§ãããããã¦è¨ç®è«çç²¾ç¥å»å¦ã®æ¦è¦ããæå 端ã®å ·ä½çãªç ç©¶äºä¾ï¼å®éçãªçè«çç¥èã¾ã§å¹ åºãã«ãã¼ãããããã«æ¬æ¸ãæ§æããã
æ¬æ¸ã¯å¤§ãã3 鍿§æã«ãªã£ã¦ããã第1 é¨ã§ã¯ï¼è¨ç®çè«ã¨ã¯ã©ã®ãããªãã¨ãæãã®ãï¼è¨ç®è«çç²¾ç¥å»å¦ã§ã¯ï¼ã©ã®ãããªç ç©¶ãã¶ã¤ã³ãçµã¾ããã®ããªã©ã«ã¤ãã¦è§£èª¬ãããè³ã®æ å ±å¦çéç¨ãæ°çã¢ãã«åããã¨ããæå³ã§ã®è¨ç®çè«ã¨ï¼é«åº¦ãªæ°ççãã¯ããã¯ãç¨ãã¦ãã¼ã¿ãè§£æãããã¼ã¿ãµã¤ã¨ã³ã¹ã»æ©æ¢°å¦ç¿ã¨ã®é¢ä¿ã«ã¤ãã¦ãæ¦èª¬ããã第2 é¨ã§ã¯ï¼è¨ç®è«çç²¾ç¥å»å¦ã«ããã¦ç¨ãããã代表çãªæ¹æ³è«ã§ããçç©ç©çå¦çã¢ãã«ï¼ãã¥ã¼ã©ã«ãããã¯ã¼ã¯ã¢ãã«ï¼å¼·åå¦ç¿ã¢ãã«ï¼ãã¤ãºæ¨è«ã¢ãã«ã®æ¦è¦ãç´¹ä»ãããããã«ï¼ç²¾ç¥é害ã®ç¾ç åé¡å¦ã«ãããåé¡ã®å æã«åããåãçµã¿ã§ããNIMH ã«ããææ¡ãããç ç©¶é ååºæºï¼Research Domain Criteria: RDoCï¼ã¨å¾æ¥ã®ç¾ç åé¡å¦ã¨ãè¨ç®è«çã¢ããã¼ãã«ãã£ã¦çµ±åãã試ã¿ã«ã¤ãã¦ãç´¹ä»ããã第3 é¨ã§ã¯ï¼æå 端ã®å ·ä½çãªè¨ç®è«çç²¾ç¥å»å¦ç ç©¶äºä¾ãç´¹ä»ãï¼åæã«ï¼ç¬¬2 é¨ã§ç´¹ä»ããæ¹æ³è«ãã©ã®ããã«ç¨ãããã¦ããã®ãã解説ããã
æ¬æ¸ã§ã¯ï¼æ°çã¢ãã«ã®è§£èª¬ã«ã¤ãã¦ã¯ï¼çè«ã®éè¦ãªæ¦å¿µãçè§£ããããã«æ¬ ãããªãé¨å以å¤ã¯ï¼æ¥µåæ°å¼ã«ãã表ç¾ãé¿ãã¦ï¼åå¦è ãçè«ã®æ¦è¦ãçè§£ããããããã«å¿ããããã¾ãï¼è³ã®ã¢ãã«ã¨ãã¦ã¯ã©ããæå 端ã®ãã®ã§ããã®ã§ï¼ç²¾ç¥å»å¦ãç 究対象ã¨ãã¦ããªãèªè ã«ã¨ã£ã¦ãï¼è³ã®æ°çã¢ãã«ã»è¨ç®çè«ã®ããããããå ¥éæ¸ã¨ãã¦ååå½¹ç«ã¦ã¦ããã ãããã®ã§ããã¨èããã
(æ²æå®°ã2019.2.6.)
è§£èª¬ãæªæ¥ã¸ã®ã¤ã³ããã
客観çãªçç¶ã«åºã¥ãã°çç©å¦ããããé¢ãããçç©å¦ã«åºã¥ãã°è¨åºçç¶ã¨ä¸è´ããªãã主観çãªè¨´ãã«åºã¥ãã°åä¸ç´ã¨å¤§åå°ç°ãå¦ä½ã«ãã¦ãå ¨æ¹ä½ããã®æ¹å¤ãé£ãã§ããã®ãç²¾ç¥ç¾æ£ã®åé¡ã§ããã
èæ¯ã«ã¯å¯¾å¿ã®ç¥è©±ããããç²¾ç¥ç¾æ£ã®åå ã«ã¯ãéºä¼åãããã¯ããè³é害ãããã¯ããã¹ãã¬ã¹ãããã¯ãããã®ã¯ãã¾ã§ã¯æ£ããã¯ãã ããã©ããç¾æ£ã¨ä¸å¯¾ä¸ã«ã¯å¯¾å¿ããªããããã§geneã¯polygeneã«ãå±å¨ã¯ãããã¯ã¼ã¯ã«ãã¹ãã¬ã¹ã¯å ¨çæ´»å²ã«ãã¨ããããã«ç¾æ£ã«å¯¾å¿ããè¦å ã¯æ¡å¼µããã¦ãããããã¦ç¾æ£ãã®ãã®ãå¢çç·ãè¶ãã¦æ¡å¼µããããã«ã¯èåããã¦ãããDSMãICDããç¾æ£åä½ã¨ããæ¦å¿µããã£ããæ¾æ£ãã¦ãæ°ããªç¾æ£åé¡ã®åºçºç¹ã«ããã¨ããããªã·ã¼ããçã¾ããéå¿çãªè©¦ã¿ã§ãã£ãããã©ãããããã£ã¦éã«ç ç©¶ã®æ¹åæ§ãæªãã¦ããã®ã§ã¯ãªããã¨ããè¦è§£ãåªå¢ã«ãªã£ã¦ããã2008å¹´ã«ããã¥ã¼ããRDoC (Research Domain Criteria)ã¯ãâis not meant to serve as a diagnostic guide, nor is it intended to replace current diagnostic systems (NIMHã®ãµã¤ããã)âã¨ããã¦ã¯ãããã®ã®ãå®ã®ã¨ããã¯ã¢ã³ãDSMã®é®®çãªå ·ç¾ã¨æãããã¨ãã§ãããã
徿¥ã®ç¾æ£åä½ãå®å ¨ã«è§£ä½ããç¾ä»£ã®çç©å¦çç¥è¦ã«åºã¥ããçç¶åæã»æ´çãç®æããRDoCã¯ãçè«çã«ã¯éããªããç¾ä»£ã®ç¥ãçµéããã·ã¹ãã ã§ããã¨ããæãããã ããããããã®å ·ä½çå 容ãè¦ãã°ããã¾ãã«è¤éã§ããã§ä½¿ãç©ã«ãªãã®ãã¨ããæãå¦ããªããæ±ããã¦ãã夿°ãå¤ããã¦ãã¨ã¦ãæ®éã®äººéã«ã¯å ¨è²ãææ¡ããããªãã®ã§ãããããã¯æ±ºãã¦RDoCã®ç½ªã§ã¯ãªãã人éã®ç²¾ç¥ã®è¤éããåæ ããããã¨ããã°ããã®ãããªå§¿ã«ãªãã®ãå³ç¶ããäºå®ã¨ãããã¨ãªã®ã§ãããã
ãããªç¶æ³ã®æä¸ä¸»ã«ãªããã¨ãæå¾ ã§ããã®ããè¨ç®è«çç²¾ç¥å»å¦Computational Psychiatryã§ãããæ²æå®°å士ãã«ãã£ã¦ä¸æ¢ããããç²¾ç¥å»å¦ã®é åã§æãå é§çãªåºçç©ã¨ãããæ¬æ¸ã«ã¯ãRDoCãã観å¯å¯è½ãªè¡åææ¨ã¨ããã«å¯¾å¿ããç¥çµåè·¯æ©è½ã®åºæ¬çãªæ§æè¦ç´ ã«åºã¥ããå¥å¸¸ããç°å¸¸ã«ãããã¹ãã¯ãã©ã (é£ç¶ä½)ã¨ãã¦ç²¾ç¥é害ãã¨ãããã¨ããç ç©¶æ¹ç¥ã§ãããã¨ç´¹ä»ããããã§ãããã«è¨ç®è«çç²¾ç¥å»å¦ãã©ã®ããã«å¿ç¨ã»è²¢ç®ã§ããããè¨ããã¦ããããã¯ãä¸ã®ä¸ã®å¤ãã®äºè±¡ãã人éã®èªç¥æ©è½ã§ã¯å¦çããããªãé åã§æ±ãããæä»£ã¨ãªã£ã¦ããããç²¾ç¥ç¾æ£ã®åé¡ãããã«å£ããã¨ã§åãã¦çã®ãã¬ã¼ã¯ã¹ã«ã¼ãå¾ãããã¨æããããã®ããã«ã¯è¨ç®è«çç²¾ç¥å»å¦ã®ææ³ãå¿ é ã§ããã¨è¨ãããããããªãã
å¦ä½ã«ãã¯ããã¸ã¼ãã®ãã®ãç§é¸ã§ãã£ã¦ããã¤ã³ããããããã¼ã¿ãææ§ã§ã¯å¨åã¯çºæ®ã§ããªããããã¯è¦éããããã¡ã§æ·±å»ãªåé¡ã§ãç²¾ç¥å»å¦ã®è¨åºç ç©¶ã«ããã¦ããã¨ã¦ãå³å¯ã¨ã¯ãããªãè©ä¾¡å°ºåº¦ã質åç´ããå¾ãããã¹ã³ã¢ããå³å¯ãªçµ±è¨å¦çè§£æã«ããã¦ãããããçµè«ãå°ããè«æã夿°åå¨ããããè¨å¤§ãªç¡é§ã§ãããã¨ã¯ããé ããªãå°æ¥ã«æããã«ãªãã§ããããè¨ç®è«çç²¾ç¥å»å¦ã¨ããæ¬æ°ã§å¼·åãªæ¦å¨ãç¨ããç ç©¶ã«ããçã«ææç¾©ãªçµæãåºãããã«ã¯ãã¤ã³ããããããã¼ã¿ããªãã¡ä¸è¿°ã®ã観å¯å¯è½ãªè¡åææ¨ããç²¾å¯ã§ãããã¨ã絶対ã¨ããããå¿ è¦æ¡ä»¶ã§ãããããã¯å³æ ¼ãªçç¶è«ã®ã¿ããå¾ããããã®ã§ãã£ã¦ãéã«ãã¨ãã°ãçµ±å失調çã®å¹»è´ã¨ãè§£é¢æ§é害ã®å¹»è´ã¨ãè³å¨è³ªç¾æ£ã®å¹»è´ããåããå¹»è´ãã¨ãã¦ã¤ã³ããããããããªãã¨ãããã°ãè³æ©è½ã¨ã®å¯¾å¿ã¯ã¨ã¦ãæå¾ ã§ãã¾ããææ°ã®ãã¯ããã¸ã¼ã®éçºã¯ãç²¾ç¥ç çå¦ã®ç²¾å¯ãªçç¶è«ã¨ãçç¶ã®éã ãã§ãªã質ãç²¾å¯ã«åæããç¥çµå¿çå¦ã®ä¾¡å¤ãåçºè¦ããçµ¶å¥½ã®æ©ä¼ã«ããªã£ã¦ããã
(ææ¾å¤ªéã2019.2.22.)
人ã®è¯ãæªãã®å¤æã«å½±é¿ãåã¼ãã®ã¯ä½ã?
æ±å£æ´åã(æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§ç ç©¶å¡ã»å¿ç士)
Komeda H, Eguchi Y, Kusumi T, Kato Y, Narumoto J, Mimura M.
Decision-Making Based on Social Conventional Rules by Elderly People.
Front Psychol. 2018 Aug 13;9:1412. doi: 10.3389/fpsyg.2018.01412. eCollection 2018.
https://www.frontiersin.org/articles/10.3389/fpsyg.2018.01412/full
æ¶ç©ºã®äººç©ã«é¢ããç¶æ³èª¬ææãèªã¿ããã®äººç©ã«å¯¾ãã¦è¯ãã»æªãã®ã©ã¡ãã«å¤æããããé«é½¢è ã¨è¥å¹´è ãæ¯è¼ãã¦ä¸ä»£ã«ããå·®ç°ããããã©ããã夿ã«ã¯ã©ã®ãããªç¹æ§ãé¢é£ããã®ãã«ã¤ãã¦ãã¤ã³ã¿ã¼ãããã«ãã調æ»ã¨å®é¨ãè¡ããæ¤è¨ããã
対象è ã¯ãè¥å¹´ç¾¤ã¯å¹³åå¹´é½¢25.7æ³ã§ç·å¥³å50åãé«é½¢ç¾¤ã¯å¹³åå¹´é½¢63.6æ³ã§ç·å¥³å50åã§ããã¹ã¦ã®åå è ã¯å¤§å¦åã§ããããããã®å¯¾è±¡è ã«å®é¨ï¼ãï¼ã¨ä¿¡é ¼ã«é¢ãã質åç´ï¼Yamagishi & Yamagishi, 1994ï¼ã宿½ããã
ãå®é¨ï¼ããã³ã³ãã¥ã¼ã¿ã®ç»é¢ã«ãï¼æï¼ã»ç¹æ§ï¼äººç©ã®ç¹æ§ãï¼æï¼ã»è¡çºï¼äººç©ã®è¡çºãï¼æï¼ã»çµæï¼ç¶æ³ã®çµæããæãã¨ã«çµæçã«å示ããæï¼ãèªãã å¾ã«ãæ¶ç©ºã®äººç©ãè¯ãäººãæªã人ãã®å¤æããããã群Ãç¹æ§Ãè¡çºÃçµæã®4è¦å ã®åæ£åæããããªã£ãçµæãé«é½¢ç¾¤ã¯è¥å¹´ç¾¤ãããæ¶ç©ºã®äººç©ããè¯ã人ãã¨å¤æããã¨ããçµæãå¾ãã
ãå®é¨ï¼ãæ¶ç©ºã®äººç©AãBã«ã¤ãã¦ãï¼æï¼ã»ç¹æ§ï¼ãï¼æï¼ã»è¡çºï¼ãï¼æï¼ã»çµæï¼ã®3æããã²ã¨ã¤ã®ç»é¢ã«åæã«å示ãããæï¼ã¨æï¼ã¯äººç©AãBã§ç°ãªã£ãå 容(ãã¨ãã°ãè¯ãç¹æ§ã»æªãè¡çºvs.æªãç¹æ§ã»è¯ãè¡çº)ã¨ããæç« ã®çµæã¨ãªãæï¼ã¯äººç©AãBã®ã©ã¡ããåãã§ãããç»é¢å示å¾ã人ç©AãBã®ã©ã¡ããè¯ã人ï¼ãããã¯æªã人ï¼ãã鏿ããããæï¼ããå¾ãæ å ±ãåªå ãã¦ãã夿ãBehavioral-Based Judgmentsï¼ãã¨ãã°ãè¯ã人ã鏿ããã試è¡ã§ã¯ãæï¼ã§è¯ãè¡çºï¼ä¸è¬çã«è¯ãå°è±¡ãä¸ãããµãã¾ãï¼ããã人ç©ãé¸ãã å ´åï¼ã¨ããBehavioral-Based Judgmentsã®å²åãç®ç夿°ã¨ããéå帰åæããããªã£ãçµæãä¸ä»£ãæ§å¥ãä¿¡é ¼ã«é¢ãã質åç´ã«ãããä¸è¬çä¿¡é ¼å¾åã¨ç¨å¿æ·±ãããè¡çºã§äººç©ã夿ããããã¨ã«å½±é¿ãä¸ãããã¨ã示åãããã
å®é¨ã®çµæãã¾ã¨ããã¨ãé«é½¢è ã¯è¥å¹´è ããã人ç©ãè¯ã人ã§ããã¨å¤æããå¾åãããï¼å®é¨ï¼ï¼ãé«é½¢ã女æ§ãä¸è¬çä¿¡é ¼å¾åãé«ããç¨å¿æ·±ããä½ãã»ã©ã人ç©å¤æã®éã«ã¯è¡çºã®æ å ±ããã使ç¨ãããã¨ï¼å®é¨ï¼ï¼ã示åãããã
(æ±å£æ´åã2019.1.22.)
解説ãå人ã¨ç¤¾ä¼ã®é¯ç¶ããé¢ä¿
é«é½¢åãã¦ããæ¥æ¬ç¤¾ä¼ã¨ãããã«ä¼´ãé«é½¢è ãçã£ãè©æ¬ºã®å¢å ãããã®è«æ(åæ)ã®ã¤ã³ããã®åé ã§ææããã¦ãããã人ã®è¯ãæªãã®å¤æã«å½±é¿ãåã¼ãã®ã¯ä½ããã追究ããæ¬ç ç©¶ã¯ãè©æ¬ºè¢«å®³ã®å¯¾çãè¦éã«å ¥ããã社ä¼çæèã§ã®å¤§ããªæç¾©ãæã¤ä»äºã§ããããé«é½¢è ã¯è¥å¹´è ããã人ç©ãè¯ã人ã§ããã¨å¤æããå¾åãããã¨ããçµæãåãã¦ãããã¯è©æ¬ºé²æ¢ããã°ã©ã éçºã«æç¨ãªãã¼ã¿ã«ãªãå¾ãã¨ããæ¬è«æ(åæ)ã®ã¾ã¨ãã«ã¯èª¬å¾åããããã ããã®çµæã¯å¥ã®ããã¤ãã®è§åº¦ããå ãå½ã¦ããã¨ã§ãããã«è峿·±ã風æ¯ãè¦ãã¦ããã
ãã¨ãã°ãã²ã¨ã¤ã¯è©æ¬ºã«é¢ãã¦ã§ããã
é«é½¢è
ãè©æ¬ºè¢«å®³ã«éããããçç±ã¯èªç¥çãMCIã®å½±é¿ã¨èããã®ãããèªç¶ã§ããããæ¬è«æã®ãã¼ã¿ã¯ãèªç¥æ©è½ãä½ä¸ãã¦ããªãã¦ãé«é½¢è
ã¯äººãä¿¡ç¨ãããã=è©æ¬ºè¢«å®³ã«éããããå¾åããããã¨ã示ãã¦ãããããã¯ãã¡ããè©æ¬ºã®é²æ¢è¨ç»çå®ã¨ãã観ç¹ããéè¦ãªãã¤ã³ãã§ããããéã«ç¯ç½ªè
ã®è¦³ç¹ããè¦ãã°ããé«é½¢è
ã¯ãèªç¥çã§ãªãã¦ãè©æ¬ºã®ã«ã¢ã«ãããããã¨ããè²´éãªãã¼ã¿ã§ãããè©æ¬ºã®å®è¡è¨ç»çå®ã«ããã¦ãéè¦ãªãã¤ã³ãã«ãªãã§ãããã
ãã¨ãã°ãããã²ã¨ã¤ã¯ä¿¡ç¨ã«é¢ãã¦ã§ããã
é«é½¢è
ã¯äººãä¿¡ç¨ããããããè©æ¬ºã«éããããããã示ãããã¨ã人ãä¿¡ç¨ããªããã¨ã大åãªãã ã¨ç´ ç´ã«ç´å¾ãããã ãã人ãä¿¡ç¨ããã®ã¯ã人éã¨ãã¦æ¬æ¥ã¯å¥½ã¾ããç¹å¾´ã§ã¯ãªãã£ãã®ããéã«äººãä¿¡ç¨ããªã=ççå¿ãå¼·ãã®ã¯ããªãã»ã©è©æ¬ºè¢«å®³ã«ã¯éãã«ãããããããªããã人éã¨ãã¦å¥½ã¾ããç¹å¾´ã¨ã¯è¨ããªãã§ããããççå¿ãå¼·ããã¨ã好ã¾ããã¨ãããã¨ããã°ãããã¯è©æ¬ºã«æº¢ããèãã 社ä¼ã§ãããã ããããã社ä¼ã«è©æ¬ºã溢ããã®ã¯ã人ã人ã宿ã«ä¿¡ç¨ããããããã§ãã£ã¦ã溢ããããªãããã«ã¯ççå¿ãå¿
è¦ ----- ã¨æããããããã°ãããã«ã¯å人ã¨ç¤¾ä¼ã®é¯ç¶ããé¢ä¿ãç«ã¡ç¾ããã
æ¬ç ç©¶ã§å¾ããããã¼ã¿ã¯ãè©æ¬ºã¸ã®è¨åã§å§ããããè©æ¬ºã¸ã®è¨åã§çµã¶è«æã¨ãã¦ã¾ã¨ãããããã¨ã§ãé åçãªãã®ã¨ãªã£ã¦ãããè«æãpublishããããã«ã¯ãèªè ã¸ã®ã¤ã³ãã¯ããå¿ é ã§ãããããã¨é«é½¢è ã®è©æ¬ºè¢«å®³ãå¤ãä»ã¨ããæä»£ã«ããããã¹ãã¼ãªã¼ã¨ãã¦è¦ãããã¨ã¯publishã¨ããç®çã«ããªã£ã¦ãããã仿¹ã§ãã®ãã¼ã¿ã¯ãè¦æ¹ã«ãã£ã¦å¤å½©ãªå ãæ¾ã¤æå³æ·±é·ãªãã¼ã¿ã§ããããæ¬HPã«å¯ããããæ±å£ç ç©¶å¡ã®è§£èª¬æã«ã¯ãè©æ¬ºã«ã¤ãã¦ã®è¨è¿°ãä¸åãªããã¨ã«æ³¨ç®ãã¹ãã§ããããçµæã ããæ·¡ã ã¨ç¶´ã£ãæ±å£ç ç©¶å¡ã®è§£èª¬ã¯ããã¼ã¿ã«å¯¾ããèè ãã®èª å®ãªå§¿å¢ãéãã«ãããéå¼ã«ç¤ºãã¦ããã
(ææ¾å¤ªéã2019.1.28.)
大ãã¤ç
é害ã¨å極æ§é害ã«ããã屿è³ä½ç©ã®æ¸å°
âï¼¶ï¼¢ï¼ã«ããè§£æï¼
ä»äºç°ãã¡ï¼æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§ãç¹ä»»å©æï¼
Richi Niida, Bun Yamagata, Hiroshi Matsuda, Akira Niida, Akihiko Uechi, Shinsuke Kito, Masaru Mimura: Regional brain volume reductions in major depressive disorder and bipolar disorder: An analysis by voxel-based morphometry.
International Journal of Geriatric Psychiatry 2018 Oct 17ã https://doi.org/10.1002/gps.5009
帯ç¶åç®è³ªã¯å¤§è³è¾ºç¸ç³»ã®ä¸»ãªçµç¹ã§ããããè³æ¢èé¨ããå»å´ãèä¸é¨å帯ç¶åï¼Subgenual anterior cingulate cortexï¼sgACCï¼ã¨ããBrodmanné éï¼BAï¼ã§ã¯ 24ã33éã®ä¸é¨ã®é åã«ç¸å½ãããèä¸é¨å帯ç¶åã®å»å´ã«é£æ¥ããé¨ä½ã¯æ¢ä¸éï¼Subcallosal areaï¼SCAï¼BA25éã«ããããBora ãã«ããMRIã®VBMãç¨ãã¦è³ã®ä½ç©æ¸å°ãã¿ãè«æã®ã¡ã¿è§£æã«ããã°ãMDD(大ãã¤ç æ§é害)ã«ããã¦æãä¸è²«ãã¦é屿§ã«ä½ç©æ¸å°ãã¿ãããé åã¯sgACCã§ããã¨å ±åããã¦ãããSCAã¯Maybergãã飿²»æ§ãã¤ç æ£è ã«å¯¾ãã¦åé¨ãã¿ã¼ã²ããé¨ä½ã¨ããè³æ·±é¨åºæ¿çæ³ï¼Deep Brain Stimulation: DBSï¼ã«ã¦åçãªç²¾ç¥çç¶æ¹åãå ±åãã¦ä»¥æ¥æ³¨ç®ããã¦ããé¨ä½ã§ãããããã¾ã§sgACCã¨SCAãåãã¦è©ä¾¡ããããã¨ã¯ãªãããªãã£ãããæã ã¯MRIã®ãã¯ã»ã«ãã¼ã¹ã®å½¢æ è¨æ¸¬ï¼VBMï¼ãç¨ãã¦å ¨è³æ¤ç´¢ãè¡ã£ã¦åé¢ãããsgACCã¨SCAã®é¢å¿é å (Volume of Interest: VOI)ãè¨å®ãããã¨ã«æåããMDDã®ä½ç©æ¸å°é¨ä½ã«é¢ãã¦ç¸¦æçãæ¨ªæçãªãªãµã¼ãã試ã¿ããã¾ããæ¨ªæç ç©¶ã§ã¯æ²»çä¸ã®MDDæ£è 群ã§ã¯sgACCã®ä½ç©æ¸å°ãèªãããã縦æççµéã¨ã®é¢é£ãåæããã¨ããå¹´é½¢ãæ§å¥ãç¾æ£ã®éçåº¦ãæ²»çæéãç½¹ç æéã使ç¨è¬å¤ã«é¢ä¿ãªãsgACCã®ä½ç©æ¸å°ãèªãããããæ´ã«ãã®é åã®ä½ç©æ¸å°ã¯MDDç·©è§£å¾ãæç¶ããããã®å¾ä¸¹å¿µã«ç»åã¨å®éã®è¨åºã®æ£è çç¶ã¨ãç §ããåããã¦ãã使¥ã®ä¸ãSCAã ãã®ä½ç©æ¸å°ã®æ£è ã¯ãBD(忥µæ§é害)ã®æ£è ãå¤ã妿¹ã®ã³ã³ããã¼ã«ãå°é£ã§ããã¨ããçµæãä½µãã¦å¾ãããã
ç®çï¼ä»åæã ã¯æ©æã¢ã«ããã¤ãã¼åèªç¥çè¨ºææ¯æ´ã·ã¹ãã (Voxel-Based Specific Regional Analysis System for Alzheimerâs Disease: VSRAD)ãç¨ãã¦å¤§ãã¤ç é害ï¼MDDï¼ã¨å極æ§é害ï¼BDï¼ã®VBMãç¨ããè³é åã®ä½ç©æ¸å°ãè§£æããã
æ¹æ³/ãã¶ã¤ã³ï¼ãã®ç ç©¶ã§ã¯ãMDDæ£è 92人ãBDæ£è 32人ãããã³43人ã®å¥å¸¸å¯¾ç §ï¼HCï¼ã対象ã¨ãã¦sgACCãSCAã¨æµ·é¦¬ã®è³é åã«ãããä½ç©æ¸å°ã®ç¨åº¦ãzã¹ã³ã¢ã¨ãã¦è¨ç®ãããããã®é åã«ãããzã¹ã³ã¢ã®å·®ç°ãMDDãBDãHC群ã§è§£æããã
çµæï¼æµ·é¦¬ã®zã¹ã³ã¢ã§ã¯ææå·®ã¯èªããããªãã£ãããsgACCã®zã¹ã³ã¢ã¯MDD群ã§BDããã³HC群ãããææã«é«ããSCAã® zã¹ã³ã¢ã¯MDD群ããã³BD群ã§ã¯HC群ãããé«ãã£ãã
çµè«ï¼sgACCã®ä½ç©æ¸å°ã¯MDDã®å¯è½æ§ãé«ããSCAã®ã¿ã«ä½ç©æ¸å°ãããã¨ãBDã®å¯è½æ§ãããã¨èãããããsgACCãSCAã®ä½ç©æ¸å°ã¯ãMDDã¨BDãéå¥ããããã®å®¢è¦³çãªè£å©ãã¼ã«ã¨ãã¦æç¨ãããããªãã
ãã®ç ç©¶ã®éçã¯54æ³ï½80æ³ã対象ã¨ãããã¨ã§ããããããã18æ³ãã53æ³ã®MDDãBDã«ã¤ãã¦ãæã ã¯ãã§ã«10代ãã¨ã®ãã¼ã¿ãã¼ã¹ã使ãã¦ãããæµ·é¦¬ååãsgACCãSCAã®VOIã¨è¨åºæè¦ã®é¢ä¿ãç ç©¶ãã¦ãããä¾ãã°è¥å¹´ã§éè¦ãªç æ ã®ä¸ã¤ã§ããç£å¾ãã¤ã¯BDã®å¯è½æ§ãé«ããããããç£å¾ãã¤ã§ãsgACCã«ä½ç©æ¸å°ããªãSCAã«ä½ç©æ¸å°ãæããã¨ãç åæã«MRIã§ç¢ºèªãããã¨ãã§ããããå°æ¥ã¯BDã«ãªãçµéäºæ¸¬ãã§ãããããããªãã
ãªãsgACCã®ä½ç©æ¸å°ã¨MDD群ãé¢é£ãã¦ããã®ãï¼æ ¹åºã«ããã¡ã«ããºã ã¯ã¾ã æããã«ããã¦ããªãããsgACCã¯ç®è³ªä¸ã®ä¸ã§ã»ãããã³ãã©ã³ã¹ãã¼ã¿ã¼ã®å¯åº¦ãæãé«ãé¨ä½ã§ããããã®é¨ä½ã®ä½ç©æ¸å°ã¯ç¥çµç´°èãã®ãã®åã³ã°ãªã¢ç´°èã®å¯åº¦ã®ä½ä¸ãåæ ãã¦ããã¨ã®å ±åããããã¾ãMDDã¨ä½å ççã«é¢ããå ±åããããsgACCã§ãã¯ãã°ãªã¢æ´»æ§ãå ±åããã¦ãããç¥çµççãé«é½¢çºçMDDã®éè¦ãªã¡ã«ããºã ã§ã¯ãªããã¨æ¨æ¸¬ããã¦ãããMDDãæããæ£è ã¯ãççä¿é²æ§ãµã¤ãã«ã¤ã³ã®ä¸æã示ããã¹ãã¬ã¹ã§æ´»æ§åããããã¯ãã°ãªã¢ã¯è³å ã§ççæ§ãµã¤ãã«ã¤ã³ãéé¢ã,ãµã¤ãã«ã¤ã³ã¯ãsgACCãéå°ã«æ´»æ§åãç¶ãããã®çµæsgACCã®ã°ãªã¢ç´°èãé害ãããæ©åºãæ¨æ¸¬ããã¦ãããsgACCã®ä½ç©æ¸å°ã¯trait markerã§ããå¯è½æ§ããããççãã¹ãã¬ã¹ããã®ä»ã®å åãå ããé«é½¢ã«MDDã®çºçãå¢ãããã¨ãæ¨æ¸¬ãããã
(ä»äºç°ãã¡ã2018.12.5.)
解説ãéå°ã¨è¬æã®åæç¹ãç®æãã¦
ãã¤ç ã¯åçºã®æç¹ã§ç¢ºå®è¨ºæãããã¨ã¯ä¸å¯è½ã§ããã診æã確å®ããããã«ã¯çµéã観å¯ããªããã°ãªããªããçµéã®ä¸ã«èºç¶æ ãç¾ããã°å極æ§é害ã¨è¨ºæãããç¾ããªããã°å極æ§ãã¤ç ã¨è¨ºæããã
ãªãã¨é ¼ããªãè¨ºææ¹æ³ãªã®ããã¨å観è ã¯è¨ãã§ããããã ããããç²¾ç¥ç§è¨ºæã®ç¾å®ã§ãããç²¾ç¥çç¶ãããæçµçãªè¨ºææ ¹æ ã§ãã以ä¸ãããã¦ç²¾ç¥çç¶ã¨ã¯æã å»ã ã¨å¤åãããã®ã§ãã以ä¸ããçµéãã¿ãªããã°ç¢ºå®è¨ºæã§ããªããã¨ããã®ã¯åªãã¦çå®ãåæ ããè§£æ±ºæ¹æ³ãªã®ã ã
æ¬ é¥ãããæ¹æ³ãæ£å½åããããã«ãã®ããã«çå±ãæã£ã¦æ¥ãã®ã¯ãããããä¸ç¨®ã®éãç´ãã§ãããããã¯é²æ©ã忢ããããããã§éãç´ãã«å®ä½ãã䏿©è¸ã¿åºããéå»ããæªæ¥ã«ãããé·ãçµéãç²¾å¯ã«è¦³å¯ãã¦ã¿ããããã¨ã徿¥å極æ§ãã¤ç ã¨ããã¦ãããã®ãç¹ã«é£æ²»æ§ã¨ããã¦ãããã®ã®ä¸ã«ã¯å極æ§é害ãç¸å½æ°å«ã¾ãã¦ãããã¨ãææãããããã«ãªã£ã¦ãããéå»ã®çµéãããè¦ãã°ãããã«ã¯èºç¶æ ã®è²å½©ãããçç¶ãè¦éããã¦ãããã¨ããããããã¨ãæä½ç診æåºæºä¸ã¯å極æ§é害ã¨ã¯è¨ããªãã¦ããçç©å¦çã«ã¯å極æ§é害ã®è¦ç´ ãããããããªãã°æ²»çæ¹æ³ã忥µæ§ãã¤ç ã¨ã¯éã£ã¦ãããé·ãéãç´ãã®æä»£ã¸ã®ååããã£ã¦ããã®bipolarityã®æ¦å¿µãç²¾ç¥å»å¦çã§èå ãæµ´ã³ãããã«ãªã£ããããã¾ã§å極æ§ã¨èª¤è¨ºããã¦ãã忥µæ§é害ã®äººã ãæãéãéããã¨ããããã§ããã
ã ãèå ã¨ããå ã¯å¤§ããªé°ãçã¿åºããã忥µæ§é害ã®éå°è¨ºæã§ããããã䏿çãªä¸ç ãããã䏿çãªææããã䏿çãªæ´»åæ§ããã®ä¸ã«ã¯ç¢ºãã«bipolarityã®è¨¼ã¨ã¿ãªããããã®ãããããæ£å¸¸ãªå¿çå¤åã®ç¯å²å ã®ãã®ããã¡ãããããè¦åããããã«ã¯æ éãã¨æ §ç¼ãå¿ è¦ã§ãããããããè¦ãéãæ£å¸¸ç¯å²ã§ãããã¨è¨ãããããä¸è¦æ£å¸¸ã«è¦ãããã®ã®ä¸ã«ããè¦ã人ãè¦ãã°ç çæ§ãé ãã¦ãããã¨ãããããã¨è¨ãã»ãããããã«ãæ·±ãæ´å¯ãæããããããããã¦å極æ§é害ã®éå°è¨ºæãæ¢ã¾ããªãã
ã²ã¨ãã³æ°ããªæ¦å¿µãè¨ºæææ³ãæå±ãããã¨ãããã¾ã§ã®éå°è¨ºæããéã®éå°è¨ºæã¸ã¨å¤§ããæ¯ãããç²¾ç¥å»å¦ã§ã¯ç¹°ãè¿ãè¦ããã¦ãã風æ¯ã§ã忥µæ§é害ã«éã£ãåºæ¥äºã§ã¯ãªããããã¦éå°è¨ºæã¸ã®å éããæ°è¬ã®è²©å£²ä¿é²ã®ææã¨ä¸è´ãã¦ããã®ãå¶ç¶ã§ã¯ãªãããã¤ç ã®SSRIãçµ±å失調çã®èªç¥æ©è½ãæ¹åããã¨ç§°ããè¬ãããã¦æ¢åã®è¬ã®å極æ§é害ã¸ã®é©å¿æ¡å¤§ãä»å¾ãåããããªãã¨ãç¹°ãè¿ãããã§ãããããã ãè¬ã¯éå°è¨ºæãä¿é²ããä¸è¦å ã«ããããçç¶ãæçµçãªè¨ºææ ¹æ ã¨ããéããéå°è¨ºæã¨éå°è¨ºæã®å¤§ããªæ¯å¹ ã¨æ··ä¹±ã¯ç²¾ç¥å»å¦ã®å®¿å½ã§ããã
ãã®æ··ä¹±ãæ ¹æ¬çã«è§£æ¶ããææ®µãããã¨ããã°ãããã¯è¨ºææ ¹æ ã¨ãã¦ã®çç©å¦çã»å®¢è¦³çææ¨ã®åå®ã§ããã忥µæ§ãã¤ç ã¨èä¸é¨å帯ç¶åã®ä½ç©æ¸å°ã忥µæ§éå®³ã¨æ¢ä¸éã«éå®ãããä½ç©æ¸å°ã®é¢ä¿ã示ããæ¬è«æãã¾ãã«ãã®ï¼ã¤ã§ãæ°åé害ã®è¨ºæææ³ãé©å½çã«å¤ããããã³ã·ã£ã«ãæã£ã¦ããã
æ¬ç ç©¶ãå¯è½ã«ããã®ã¯ãæ¾å°ç·å¦ä¼è¨ºæå°éå»ã§ããããã¤ç²¾ç¥ç¥çµå¦ä¼å°éå»ã§ãããä»äºç°ãã¡ç¹ä»»å©æã®åºãæ·±ãå¦èã¨å®è¡åã§ããã彼女ã®è¨åºè¨ºæã®æ£ç¢ºãã¨ãè³ç»åã®èªå½±ã®ç²¾å¯ãããã®ç»æçãªãã¼ã¿ãæ¯ãã¦ãããã¨ã¯çãä½å°ããªãã
éãç´ãã¸ã®ååãéå°è¨ºæãªããçç¶ãæ ¹æ ã¨ãã診æã¸ã®ååãNeuroreductionismã§ãããè³ã®æè¦ã示ããã¨ã«ãã£ã¦ç²¾ç¥ç¾æ£ã説æã§ããã¨ããNeuroreductionismã¯ãå診ãâãæ¤æ»ãâã確å®è¨ºæãã¨ãã身ä½å»å¦ã®è¨ºææ¹æ³ã«ä¸è´ãããã¨ããã£ã¦ãç²¾ç¥ç¾æ£ã®ãç§å¦çãè¨ºææ¹æ³ã¨ãã¦é«ãè©ä¾¡ãåããããã客観çã«ç¤ºããã¨ãå¯è½ãªæè¦ã¸ã®éå°ãªä¾åã¯ã人éã®ç²¾ç¥æ´»åã®è¤éããå¿ãããéã«éç§å¦çãªå¶ã¿ãªã®ã§ãããã
ã ãæ¬ç ç©¶ãNeuroreducionismã¸ã¨çºå±ãããã¨ã屿§ããã®ã¯ææã§ãããä¸è¨èè 解説æã®ããªãã以ä¸ã®æçµæ®µè½ã«ã¤ãã¦ãä»äºç°ç¹ä»»å©æã¯æ²è¼ãèºèºãã¦ãããæ¬ç ç©¶ã§ææç¾©ãªçµæãå¾ããããã¨ã¯äºå®ã§ãããããã®çµæã«ã¤ãã¦ã®è§£éã¯è¬æçã«è¡ãã¨ããã®ã彼女ã®åºæ¬çãªå§¿å¢ãªã®ã§ãããæ¾å°ç·è¨ºæã®å°éå®¶ã¨ããã¨ãç»åãä½ããä¿¡ããè¨åºçç¶ã¨ãããã¡ã¸ã¼ãªãã®ã¯ç¡è¦ããªãã¾ã§ã価å¤ãä½ãã¿ãã®ã§ã¯ãªããã¨ããã¤ã¡ã¼ã¸ãæãããã¡ã§ããããä»äºç°ç¹ä»»å©æã¯ããããã¹ãã¬ãªã¿ã¤ãã¨ã¯ããé¢ãã¦ãããç²¾ç¥ç¥çµå¦ä¼å°éå»ã¨æ¾å°ç·å¦ä¼è¨ºæå°éå»ã«å ãã¦ãå¿èº«å»å¦ä¼å ç§å°éå»ãæ±æ´å»å¦ä¼èªå®å»ã®è³æ ¼ãæããã¨ããåºãå¦èãããã¦1ã¶æã®ãã¡3é±éã¯æ±äº¬ã§ã1é±éã¯æ²ç¸ã§è¨åºã¨ç ç©¶ã«å¾äºããã¨ããåºãè¡åç¯å²ãä»äºç°ç¹ä»»å©æã®ããæ°å¹´ã®æ¥å¸¸ã§ããã客観çæè¦ã¨ä¸»è¦³çæè¦ã®é©åãªèåããããã®ç²¾ç¥å»å¦ã«ã¯å¿ é ã§ããããä»äºç°ç¹ä»»å©æã¯ã¾ãã«ãããå®è·µãã¦ããããã®å®è·µã®ä¸ããçã¾ããã®ãæ¬è«æã§ããã
(ææ¾å¤ªéã2018.12.25.)
å·¦åé èç¼çª©é¨æå·å¾ã«åºç¾ããç©åã人ç©ãå ´æã®èª¤èª
è¹å±±éé (è¶³å©èµ¤ååç
é¢ç²¾ç¥ã»ç¥çµç§é¨é·ï¼
Delusional misidentification of inanimate objects, persons, and places after a left orbitofrontal cortex injury
Miki Tanabe, Michitaka Funayama, Yota Narizuka, Asuka Nakajima, Isamu Matsukawa, Tomoyuki Nakamura
Cortex 2018 Sep 18. pii: S0010-9452(18)30273-9. doi: 10.1016/j.cortex.2018.08.021. [Epub ahead of print]
ãèæ¯ãè³æå·å¾ã«äººç©ãå ´æã«é¢ãã誤èªãçãããã¨ããã°ãã°å ±åããã¦ãããéå»ã®å ±åããã¯å³å´ãä¸å¿ã¨ããåé èã®æå·ã«ããä¾ãå¤ããæ©åºã«ã¤ãã¦ã¯å½¢æ ã¨æ åã®èªç¥ã®çµ±åãã§ããªãã¨ãã£ã説ãè¦ªè¿æã失ãããã¨ãã£ã説ããããä»åããããã¯å·¦åé èç¼çª©é¨æå·å¾ã«äººç©ãå ´æã«éãããç©åã«å¯¾ãã¦èª¤èªãé »ç¹ã«çããä¾ãå ±åããåé èç¼çª©é¨ã§èª¤èªãçããèæ¯ãæ¤è¨ããã
ãçä¾ã61æ³ç·æ§ãå交éåèç¤ç ´è£ã«ããã¯ã¢èä¸åºè¡ï¼Hunt and Kosnik â ¢ï¼ã«ã¦å ¥é¢æ²»çã¨ãªããåèç¤ã«å¯¾ãã¦ã¯ã¯ãªããã³ã°è¡ããæ°´é çã«å¯¾ãã¦VPã·ã£ã³ãè¡ãè¡ã£ããé é¨CTã§ã¯å·¦åé èç¼çª©é¨ã¨å·¦åé æ¥µã«æå·ãèªããã麻çºãæè¦é害ã¯ãªããçºç2ãæå¾ã«ã¯ç æ£å ã®ADLã¯ããããèªç«ããããã¨ãã½ã¼ãè¨æ¶ã®é害ãä½è©±ã誤èªãç®ç«ã£ããç 室ã®ãã¢ãéãã¦èªåã®ä»äºå ´ã«è¡ããªã©ã®ä½è©±ã親ãããã¦ãã姪ã妹ã«ç æ£ã¹ã¿ããã誤èªãã人ç©èª¤èªãèªåãä»äºå ´ã«ãããªã©ã®å°ççå®ä½é¯èª¤ããã°ãã°èªããã
è¡çºã«ã¤ãã¦ã¯æ¨æºå使§æ¤æ»ã«ã¦ç°å¸¸ã¯èªãããæ¤æ»å ´é¢ã§ã¯å¤±è¡ã¯ãªãã¨èããããã䏿¹ã§ãç©åã®èª¤èªãé »ç¹ã«èªãããããçªåããã¯ãã¿ã¨ãã¦ä½¿ããå®éã«è¥è¶³ãçªåãã§åã£ã¦ãããæ¯ç£¨ããä»ããæ¯ãã©ã·ã§ã²ãããããã¨ãã¦ãããé¨å±ã®ä¸ã§ã¯æµããã¯ãã¼ã¼ããã¨èª¤èªããå£ã«å·èµåº«ãè¨ç½®ããã¦ããã¨èª¤èªãã¦ã¹ããã¯ãå ¥ãããã¨ãã¦ããã黿°ããããä½¿ãæ¨ã¦ãã¼ãã¼ã¿ãªã«ã®ããã¯ã¹ã ã¨èª¤èªããä½¿ãæ¨ã¦ãã¼ãã¼ã¿ãªã«ãåããã¨ãã¦ããããããã®èª¤èªã¯é »ç¹ã«å室ã§ã¯é »ç¹ã«åºç¾ãããã2人é¨å±ã«ç§»ãã¨å¤§å¹ ã«æ¸å°ããã
ãèå¯ãç©åã®èª¤èªã«é¢ããéå»ã®å ±åä¾ã§ã¯ãåã種é¡ã®ç©åãå£åããå質ã«ç½®ãæãã£ãã¨ããå 容ã§ãã£ãããæ¬ä¾ã®ç¹å¾´ã¯ãçªåããã¯ãã¿ã«èª¤èªãããªã©ç°ãªã£ãç©åã¸ã®èª¤èªãçãããã¨ã§ãããå³åé èã§ã¯ãªãå·¦åé èæå·ã§ãã£ãç¹ã¯ãç©åã®ä½¿ç¨ãå·¦åçã®æ©è½ã¨é¢é£ãããã¨ãåæ ãã¦ããã®ãããããªãã
ã¨ããã§ãåé èç¼çª©é¨ã¯å¤çã¨å çãåºå¥ããæ©è½ãæãããã¨ãéå»ã®ç¥çµå¿çç ç©¶ããæããã«ãªã£ã¦ãããè§£åå¦çã«ãåé èç¼çª©é¨ã¯ãã¹ã¦ã®ç¨®é¡ã®æè¦ã«é¢é£ããç®è³ªããã®é£çµ¡ãæã¤å¯ä¸ã®ç®è³ªã§ãããããã«è¾ºç¸ç³»ã¨ã®é£çµ¡ãå¼·ããæè¦ã«é¢é£ããç®è³ªãå¤çã®æ å ±ãã辺ç¸ç³»ãå çã®æ å ±ãé£çµ¡ããã¨èããã¨ãåé èç¼çª©é¨ã§å¤çã¨å çã®æ å ±ãæ´çãã¦ããå¯è½æ§ãååã«ããã
æ¬çä¾ã«å½ã¦ã¯ããã¨ãæ£è ã親ããã£ã姪ã¨ä¼ãããã¨èããã¨ãç æ£ã¹ã¿ããã姪ã«èª¤èªããã®ãããããªããä»äºã«è¡ãããã¨ãã¯ãé¨å±ã®ãã¢ãä»äºå ´ã«éãããã¢ã§ããã¨èª¤èªãããããããªããã²ããããããã¨èããã¨ã·ã§ã¼ãã¼ããªãã¨ãæ¯ç£¨ãã®ã¤ããæ¯ãã©ã·ã§ã²ãããããã¨ããããè¥è¶³ãåãããã¨ãã¯çªåããã¯ãã¿ã¨ãã¦ä½¿ç¨ãããããã®ãããããªãããã®ããã«ãåé èç¼çª©é¨ã®å¤çã¨å çãåºå¥ããæ©è½ãé害ãããã¨ãç©åã人ç©ãå ´æã«å¯¾ãã誤èªãä½è©±ãçããå¯è½æ§ãèããããã
(è¹å±±ééã2018.11.6.)
解説ãè¦ãããããããã¾ã§ã¯ã¾ã è¦ããªã
è¦ãã°ããããããã常èã ãã¨ãããè³ãæå·ãããã¨è¦ã¦ãããããªããªããã¨ãããããã®çç¶ã¯æ¥å¸¸çæ´»ã¸ã®å½±é¿ã大ãããã¡ã«ããºã ã®ä»®èª¬ãç«ã¦ãããããã®ä»®èª¬ã®æ¤è¨¼ããããããç¶²èã¸ã®å ¥åãããããããã¾ã§ã®çµè·¯ãé ã«ãã§ãã¯ãã¦ããã°ãããè¦ãã¦ããã®ããè¦ãããã®ãåã¨ãã¦è³å ã«çµã°ãã¦ããã®ãããã®åãååã¨é£çµãã¦ããã®ããæå³ã¨é£çµãã¦ããã®ããè¨æ¶ã¨é£çµãã¦ããã®ããç¥çµå¿çå¦çæ¤æ»ãç²¾å¯ã«è¡ããã¨ã«ãããããã®åãã®ä¸ã¤ä¸ã¤ã«çãã¦é害ã¬ãã«ãåå®ãããã¨ãã§ããå¼ç§°é害ãè¦è¦å¤±èªãæå³è¨æ¶é害çã ã®åç§°ãé害ãã¨ã«ã¤ãããã¦ããããããã¦ãè¦ã¦ãããããªããã¨ããçç¶ã«ã¤ãã¦ã¯ããã§ã«å ¨è²ãè¦ãã¦ãããæç§æ¸ã®è¨è¼ã¯ãã¯ã確åºããä¸åã®ç¥è¦ã®ããã«æããã
ã ãæ¬è«æã®ã±ã¼ã¹ã¯ãããã¾ã§ã«ç¥ããã¦ããã©ããªçç¶ã¨ãç°ãªãã
å½¼ã¯ç¢ºãã«è¦ãã¦ãããããã¦è¦ããç©ãä½ã§ããããããããã¨ã®æ¹ãå¤ããã¨ãããç¶æ³ã«ãã£ã¦ã¯ããããªããã¨ããããç¶æ³ã«ããèªç¥æ©è½ã®å¤åã¯ããã®åºç¤ã«æèã®å¤åãããã¨èããã®ãå»å¦ã®å¸¸èã ããå½¼ã®æèã¯éå¸¸ã®æå³ã§ã¯å¸¸ã«æ¸
æã§ãããããã¨ãã®çç¶ã¯å¤å
¸çãªããããéå¤±èªæ§å¼ç§°é害(non-aphasic misnaming; Weinstein, 1952) ã«ä¼¼ã¦ãããã誤èªããç©åã使ãç¶ããã¨ããè¡çºã¯ãããã¨ã¯ç°ãªããã¾ãããç
室ã®ãã¢ãéãã¦èªåã®ä»äºå ´ã«è¡ããã¨ããã¨ãã½ã¼ãã¯ä½è©±ã¨ãã¨ãã䏿¹ãéè¤æ§è¨æ¶é¯èª¤ã®è¦ç´ ãããããã ãããããã«ããå½¼ã®èªç¥æ©è½é害ã¯ããã ãã§ã¯ã¨ã¦ã説æã§ããªããããã¨ããã¯ãæªç¥ã®æ°ãã種é¡ã®è³æ©è½é害ãªã®ã§ããã
æå·é¨ä½ãåé èç¼çª©é¢ã§ãããã¨ã¨ã観å¯ãããçç¶ãããå¤çã¨å çãåºå¥ããæ©è½ã®é害ãè¿°ã¹ãè¹å±±é¨é·ã®ä»®èª¬ã¯é åçã§ãããããã¦ã姪ã¨ä¼ãããã¨èããã¨ãç æ£ã¹ã¿ããã姪ã«èª¤èªãããã®ããã«ãçç¶åºç¾ã«ã¯æ¬äººã®é¡æãé¢ä¸ãã¦ããã¨æããããã¨ãè¦éããªãéè¦ãªç¹å¾´ã§ãããããªãã¡ãç¶²èã¸ã®å ¥åãããããããã¾ã§ã®è³å ã®çµè·¯ã ããããã«ç²¾å¯ã«æ¤æ»ãã¦ãããã®ã±ã¼ã¹ã®ã¡ã«ããºã ãè§£æãããã¨ã¯ã§ããªããææ ãèªç¥ã大ãã修飾ããã®ã ãè¹å±±é¨é·ãç«ã¦ã仮説ãä»å¾ããã«ãã¦æ¤è¨¼ãã¦ãããããæ¬è«æãæãããã¦ããåºæ¿çãªèª²é¡ã§ãããããã«ã¯ç義ã®èªç¥æ©è½æ¤æ»ã¨ã¯å¥ã®æ¬¡å ã®æ¤è¨¼æ¹æ³ãå¿ è¦ã§ãããè³ã¨å¿ã«ã¤ãã¦ã®æ·±é ãªä¸çãåºãã£ã¦ããã
(ææ¾å¤ªéã2018.11.30.)
ããã«ãã»ãã©ã³ãã®å±éºãªå
åããç²¾ç¥ç§å»ãã¡ã¯æ¢ãã¦åçºãã
ãã³ãã£ã»ãªã¼ç·¨ãææ¾å¤ªé訳ãã岩波æ¸åºãã2018å¹´10æçºå£²
The Dangerous case of Donald Trump. Bandy Lee St. Marinâs Press New York
ãã¹ã³ãã«åºã¦ããç²¾ç¥ç§å»ã®ã³ã¡ã³ãã®å¤§é¨åã¯ã§ãããã§ãããã§ãããã§ãªãå ´åãå
¨ãçå¤ãã§ãããããã¯äºä»¶ã®å®¹çè
ã®çã®å§¿ã¨ã³ã¡ã³ãã対æ¯ããæ©ä¼ããã度ã«ããããã¨å®ä½é¨ã§ãããã¨ã§ãããããããªæ©ä¼ãªã©ãªãã¦ãã§ãããã ã¨ãããã¨ã¯å®¹æã«æ¨å®ã§ãããæ¬äººãä¸åº¦ã診å¯ãããã¨ãªããå ±éãããããããããªæ
å ±ã«åºã¥ãã¦è¿°ã¹ãã³ã¡ã³ããæ£ããã¯ãããªãããããªã®ã«ä½ãäºä»¶ããã度ã«åºãããã³ã¡ã³ãã¯ãç²¾ç¥å»å¦ã®ä¿¡é ¼æ§ã®ä¸éã«è²¢ç®ãããã¨ã ãããã®åå¨æç¾©ã¨ãªã£ã¦ããã
以ä¸ã¯æ¥æ¬ã®è©±ã
ã¢ã¡ãªã«ã§ã¯å
¨ãäºæ
ãç°ãªããç²¾ç¥ç§å»ã«çºè¨ãç¦ããã´ã¼ã«ãã¦ã©ã¼ã¿ã¼ã«ã¼ã«ã¨å¼ã°ããå«çè¦å®ããç±³å½ç²¾ç¥å»å¦ä¼ãå®ãã¦ããããã§ããã
ããããè¦å®ãããä¸ãããã«ãã»ãã©ã³ãæ°ã«ã¤ãã¦ã20å以ä¸ã®ç²¾ç¥ç§å»ããã®ç
çãææããæ¬æ¸ã¯ãã¿ãã¼ãä¹ãè¶ããç¦æã®çºè¨éã(翻訳æ¸ã®å¸¯ã®è¨è¿°)ã§ããã
å¼·åãªå½å®¶å
é¦ãç²¾ç¥é害è
ã§ãããã¨ã¯ã決ãã¦çãããã¨ã§ã¯ãªããã¦ã£ã¹ãã³ã»ãã£ã¼ãã«ã¯ãã¤ç
ã ã£ããã¨ã¤ãã©ãã ã»ãªã³ã«ã¼ã³ããã¤ç
ã ã£ããã¸ã§ã³ã»Fã»ã±ããã£ã¯ã¹ããã¤ãç²¾ç¥ç
ã ã£ããã¯ã¬ãããã¼ã¯æ¬¡ã®ããã«è¿°ã¹ã¦ãã(The Psychology of Men of Genius. Ernst Kretchmer. Translated by R. B. Cattell.
Kegan Paul, Trench, Trubner & Co. Ltd. London. 1931. p.4. )ã
天æã¨å¼ã°ãã人ã®å¤ãã¯ãçæ°(madness and insanity)ãååºããäººã®æé«ã®ç¹è³ªã¨ãã¦ç§°ãã¦ãããã¨ãããä¼è¨ä½å®¶ã¯å¤©æã®åã«ç«ã¡ã¯ã ããã両æãæãã¦å½¼ããå®ããç²¾ç¥ç§å»ã天æãåçããªãããã«è¦å¼µã£ã¦ããã®ã§ããã
ã¢ã¡ãªã«ã§ãã¹ãã»ã©ã¼ã«ãªã£ãæ¬æ¸ã§ç²¾ç¥ç§å»ã®èè ãã¡ããã©ã³ãæ°ã®è¨ºæåã¨ãã¦ç¤ºåãã¦ããã®ã¯ãèªå·±ææ§ãã¼ã½ããªãã£é害ããµã¤ã³ãã¹ãèªç¥çãªã©ãå¤å²ã«ããã£ã¦ãããã´ã¼ã«ãã¦ã©ã¼ã¿ã¼ã«ã¼ã«ãç ´ã£ã¦çºè¨ãããã¨ã«ã¤ãã¦ã¯ãå«ççãªé¢ããããã¾ããè¨ºææ ¹æ ã®é¢ãããã説å¾åããçç±ãè¿°ã¹ããã¦ããããã®ä¸ã§èªç¥çã¯ç¥çµå¿çå¦ã«å¯æ¥ã«ãããããã®ã§ãé«é½¢ã®æå°è ã«ã¯èªç¥æ©è½ãåãããã¨ã義åã¥ããã¹ãã ã¨ãã主張ã¯ãããªã±ã¼ããªåé¡ãå«ãã§ãããã®ã®ãããããã®ç¤¾ä¼ã§ã¯é¿ããããªãè°è«ã§ããã¨è¨ãããã
ããã¯ããã¨ããã©ã³ãæ°ã®ç²¾ç¥ç¶æ ã«ã¤ãã¦è«ããæ¬æ¸ã®èè ãã¡ãä¸è²«ãã¦è¿°ã¹ã¦ããã®ã¯ãå½¼ãç²¾ç¥ç¾æ£ã§ããã¨ãããã¨ã§ã¯ãªããå½¼ãå±éºã§ããã¨ãããã¨ã§ãããæ´å²ä¸ã®å主ã¯ä¸ã®åä½ã§äººã殺ãããããããªãããç¾ä»£ã®ã¢ã¡ãªã«å¤§çµ±é ã¯ãå°çãä½åãæ¶æ» ãããå¨åã®ããæ¦å¨ãæã«ãã¦ããã®ã§ãããèè ãã¡ã®ãããè¦åãã義åãã¯é¦è¯ã§ãããå½¼ãã¯ç±æãæã£ã¦ããããå·éã«ãæ£ç¢ºã«è¦åãã¦ããããã¾ããè¦åãããè ã®ç¾©åãã¨ã¯ä½ããèããæãªã®ã§ãããã
(ææ¾å¤ªéã2018.10.30.)
æäººADHDã«ãããåé èæ©è½ç°å¸¸
å±±ç¸£ãæ (æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§ å°ä»»è¬å¸«)
Yamagata B, Takei Y, Itahashi T, Pu S, Hirano J, Mimura M, Iwanami A
Aberrant spatial and temporal prefrontal activation patterns in medication-naiÌve adults with ADHD.
Front Psychiatry. 2017 Dec 5;8:274.
éå»ã®è¿èµ¤å¤ç·ã¹ãã¯ããã¹ã³ãã¼ï¼NIRSï¼ç ç©¶ãããæäººã®æ³¨ææ¬ å¦å¤åæ§é害ï¼ADHDï¼ã¯ãå¥å¸¸ç¾¤ï¼HCï¼ã¨æ¯è¼ãã¦èªæµæ¢æ§èª²é¡ï¼VFTï¼éè¡ä¸ã®åé åéã«ããã¦ãé ¸ç´ åãã¢ã°ããã³ï¼oxy-Hbï¼ã®è³¦æ´»éãææã«ä½ä¸ãã¦ãããã¨ãå ±åããã¦ãããADHDã®è¨ºæã«ããã¦ãç¹ã«æäººã®å ´åã幼尿ã®è©³ç´°ãªçºéå²ãè´åã§ãããæ¬äººã®ä¸»è¦³çãªè¨´ãã«ã®ã¿åºã¥ãã¦è¨ºæããããå¾ãªãã±ã¼ã¹ãå¤ããããéå°è¨ºæã®å±éºæ§ãææããã¦ããããã®ããã診æè£å©ã®ããã®å®¢è¦³çãªçç©å¦çãã¼ã«ã¼ã確ç«ãããã¨ãéè¦ã¨èããããã
ããããªãããç¾å¨ã®NIRSç ç©¶ã«ã¯ä»¥ä¸ã®ãããªåé¡ç¹ãããã
1. å¤ãã®ç ç©¶ãã賦活課é¡éè¡ä¸ã®oxy-Hbã®å
¨ã¦ã®å¤åéãæéã§å¹³åããå¤ãç¾¤éæ¯è¼ã®ãã©ã¡ã¼ã¿ã¼ã¨ãã¦ä½¿ç¨ãã¦ãããæéæ
å ±ãå
¨ãå©ç¨ãã¦ããªããã¤ã¾ããNIRSã®æã¤0.1ç§ã¨ããé«ãæéåè§£è½ãæ´»ç¨ã§ãã¦ããªãã
2. NIRSï¼ETG-4000è£
ç½®ï¼ã¯ä¸¡å´ã®åé å´é é¨ãã«ãã¼ãã52ãã£ã³ãã«ã§æ§æããã¦ãããããã«æ¸¬å®æéã¯1251ã®ã¿ã¤ã ãã¤ã³ããæããï¼èª²é¡å
¨ä½ã®é·ãã¯125.1ç§ï¼0.1ç§ã®æéåè§£è½ï¼ããã®ãã被é¨è
æ¯ã«æ°ä¸åä½ã®ãã¼ã¿ãã¤ã³ããæãããã¨ã«ãªãããã®å ´åãå¤éæ¤å®ã«ã¤ãã¦èæ
®ããå¿
è¦ãããããé常ã®family-wise errorè£æ£ã¯NIRSãã¼ã¿ã«ã¯é度ã«å³å¯ã§ãããããä»ã®çµ±è¨è§£æææ³ãå¿
è¦ã¨ãªãã
ä¸è¨ã®åé¡ã解決ããããã«ãæã ã¯cluster-based nonparametric randomization testãç¨ãã¦ãADHDã«ç¹ç°çãªåé åéã®è³¦æ´»ãã¿ã¼ã³ãæ½åºãããã¨ãç®çã¨ããã
æ¬ç ç©¶ã¯ã63åã®ä¸æ¢ç¥çµåºæ¿è¬ãæªä½¿ç¨ã®æäººADHDã¨38åã®HCããªã¯ã«ã¼ããããADHDã¯ã両å´ã®åé åéï¼ããå·¦å´ï¼ããã³å´é èé åï¼ããå·¦å´ï¼ã«ä½ç½®ãããã£ã³ãã«ã«ããã¦ãHCã¨æ¯è¼ãã¦VFTéè¡ä¸ã®[oxy-Hb]ã®è³¦æ´»éãææã«ä½ä¸ãã¦ãããããã«ãADHDã«ããã[oxy-Hb]ã®è³¦æ´»éã®ä½ä¸ã®ç¨åº¦ãã課é¡éè¡ä¸ã®æé帯ãè³é åã«ãã£ã¦ç°ãªãã¨ããç¹å¾´çãªè³¦æ´»ãã¿ã¼ã³ãè¦åºãããã
ä»åãåãã¦cluster-based nonparametric randomization testãç¨ãããã¨ã§ã徿¥ã®NIRSç ç©¶ã§ã¯è¦ãåºããªãã£ãADHDã«ããããã詳細ãªåé ããã³å´é èã®è³¦æ´»ãã¿ã¼ã³ãæ½åºãããã¨ã«æåãããä»ã®è³ç»åæ¤æ»ã¨æ¯ã¹ãNIRSã¯ãã®é侵襲æ§ãã³ã¹ãã®å®ãã坿¬æ§ã¨ãã£ãå©ç¹ããããæ¬ç ç©¶ã®çµæã¯NIRSã®è¨åºå¿ç¨ã®å¯è½æ§ã示åãããã®ã§ãã£ãã
(山縣æã2018.9.23.)
解説ãç²¾å¯è¨ºæãç®æãã¦
é害忧è«ã¨ããè¨èãããããã¤ã¦é害è ç½æ¸ã«æ²è¼ããããã®æç« ããã®ä»£è¡¨ã§ããã
æã ã®ä¸ã«ã¯æ°ã®å¼·ã人ãããã°å¼±ã人ããããè¨æ¶åã®ãã人ãããã°å¿ãã£ã½ã人ããããæã®ä¸æãªäººãããã°ä¸æãªäººããããããã¯ããããã®äººã®åæ§ãæã¡å³ã§ãã£ã¦ãããã§ä¸ã®ä¸ã®äººãäºã¤ã«åãããã¯ããªããåãããã«é害ãå人ãæã£ã¦ããåæ§ã®ä¸ã¤ã¨æããã¨ãé害ã®ãã人ã¨ãªã人ã¨ãã£ãä¸ã¤ã®å°ºåº¦ã§ä¸ã®ä¸ã®äººãäºåããå¿ è¦ã¯ãªããªãããããªãã°ãã¨ããã«ç¤¾ä¼ã¸ã®çµ±åãªã©ã¨è¨ããªãã¦ããä¸ç·ã«æ¥½ããã ããå§å©ãããããå°ã£ã¦ããã¨ãã«ã¯ããäºãã«å©ããããæ¯ãããæ®éã®äººéé¢ä¿ãç¯ãã社ä¼ã«ãªãã§ãããã¨ãããã®ã§ããã
ããã«æããã¦ããã®ã¯ä¸ã¤ã®çæ³ç¤¾ä¼ã§ãããç½æ¸ãªã®ã§ç¡¬ãæç« ã«ãªã£ã¦ããããããããããã¹ã¿ã¼ã«ã§ãããã®ã§ããã°ããé害ãªãã¦ãã»ãã¨ã¯ãã®ä¸ã«ãªããã ãã¨ããããªãã£ããã³ãã¼ãã¤ãããã§ãããé害ãé害ã¨å¼ã¶ãã¨ãããããééãã®å§ã¾ãã ã£ããã¡ãã£ã¨å¤ãã£ã人ã«ãããªããããã¾ã§é害ã¨å¼ã°ãã¦ãããã®ã¯ãåæ§ã¨å¼ã¶ã¹ãã ããããé害忧è«ã§ããã誰ããé害ã®å容ããªã©ã«æ©ã¾ãªãã¦ãããçæ³ã®ç¤¾ä¼ãããã«ã¯ç«ã¡ç¾ããã»ã»ã»ã
ã¨ããããã«ãæªæã®èªæè
ã¯ãæ
æã®ç¬é¡ã§è¿ã¥ãã¦ããã
é害è
ã¨ãããã®ã®åå¨èªä½ãå¦å®ããé害忧è«ããããå½ãæ²ããæããã®ãã©ã«ã¼ãã®è£ã«ã¯ããé害è
æ½çä¸è¦ãã¨æ¸ããã¦ããã
é害ã¯åæ§ãé害è
ã¯é害è
ã¨ãã¦ã§ãªããä»ã®èª°ã¨ãåããä¸äººã®äººéã¨ãã¦æ±ãã¹ããã§ããã°ãé害è
æ½çã¯ãããªãã¨ããã®ã¯ããå½ç¶ã§ããããããã£ã¦ãé害è
ã®ããã®äºç®ããããªãã¨ããçµè«ã«å°éãããã¨ã«ãªãã
ãé害ãã¨ãããã¬ãã£ããªè¨èãããåæ§ãã¨ãããã¸ãã£ããªè¨èã«ç½®ãæãããããã¯ãå½ãé害è
ãæé¤ããããã®ã¬ããªãã¯ãªã®ã§ããã
ã¨ããã®ããé害忧è«å対è
ã®ä¸»å¼µã§ããã
ãããã¾ããç½æ¸ãæ¸ããå®åãæ
æã®ç¬é¡ã§ä»®é¢ããæªæã®èªæè
ã§ãããªã©ã¨ãããã¨ã¯ãªãã§ããããäºç®åæ¸ãªã©ã¨ããé°ã®æå³ã§ã¯ãªããçæ¯ã«é害è
ã®ãã¨ãèãã¦ããããçæ³ã ã¨ãããã®ãæã¡åºããã®ã§ãããããããã ã¨ãã¦ãçæ³ã¯ç¾å®ã§ã¯ãªããããããä»ã®ç¤¾ä¼ã人ã¨äººãã©ãã ãæ¯ããã£ã¦ããã¨ãããã®ããæ¯ããã£ã¦ããªãå±é¢ãããããããããããªç¾å®ã横ç®ã§è¦ãªãããé害忧è«ãæ²ãã誰ããããã¸ã ã¦ãªããæ¯ããã社ä¼ããã¨ããã¹ãã¼ã¬ã³ã«ã¯ãèããé¿ããæ¼ãã
é害忧è«ã®æ¯éã¯ã¨ããããç²¾ç¥ç¾æ£ã®ä¸ã®ãå°ãªãã¨ãä¸é¨ã¯ãåæ§ã¨ã®å¢çãææ§ã§ãããADHDã¯ãã®ä»£è¡¨ã§ãæ²»çè¬ã®å¸å ´æ¡å¤§ã®ãã診æãä¹±çºããã¦ããã¨ããæ¹å¤ã¾ã§ããã仿¹ã§ã¾ã£ããéã«ã診æãããªãããã«å»çã®æ©æµãåãããã¨ãã§ããè¦æ©ãã¦ãã人ã
ã夿°åå¨ããããã®åé¡ã¯ã診æãè£ä»ãã客観çæè¦ã«ä¹ããã¨ããç²¾ç¥ç¾æ£ã®ç¹æ§ã«èµ·å ããã¨ããã大ãããã¨ããææã¯ãããªããã確ãã«ããã¯éè¦ãªä¸å ã§ã¯ããããã¯ããã«å¤§ããéè¦ãªåé¡ã¯ãã§ã¯ã©ã®ãããªå®¢è¦³æè¦ãããã°ãç²¾ç¥ç¾æ£ã¨ç¢ºå®è¨ºæããæ ¹æ ã«ã§ãããã¨ããåãã§ããã身ä½ç¾æ£ã§ããã°ãèå¨ã«æè¦ãããã°ç
æ°ã§ããã確å®è¨ºæã®æ ¹æ ã«ãªãã§ããããã§ã¯ç²¾ç¥ç¾æ£ã¯ãè³ã«æè¦ãããã°ç
æ°ã¨ããããã¨ããã°ãããåç´ã«ã¯ãããªããããããç²¾ç¥ç¾è±¡ã¯è³ã®æ´»åã®ç¾ãã§ãã以ä¸ããããçç¶ã§ãããåæ§ã§ãããããã«å¯¾å¿ããè³ã®æ´»åãããã®ã¯å½ç¶ã§ããããè³ã«æè¦ãè¦åºããããã¨ã¯ãããã¯ããã¸ã¼ã®é²æ©ã«ããã対å¿ããè³ã®æ´»åãè¦åºããã¨ãå¯è½ã«ãªã£ããã¨ãããã¨ã«ããããæ±ºãã¦ãç
æ°ãããç°å¸¸ããæå³ãããã®ã§ã¯ãªãã
ããã«ã¯ãæè¦ã¨ã¯ããããä½ãã¨ããåé¡ãããã
è³æ©è½ç»åã«ããã¦ã¯ãããã®ãã¼ã¿ããæçµçãªç»åãæåºãããã¾ã§ã®ããã»ã¹ã«ãæ§ã
ãªä»®å®ããä¸é¨ã¯æ£æçãªæä½ãå ãããã®ã§ãããããã¯ããã¸ã¼ã鲿©ããããã¦ç´°ååãã¦ããç¾ä»£ã«ããã¦ã¯ã大é¨åã®æ¤æ»ã大é¨åã®äººã
(ããã«ã¯å»å¦ã®å°éå®¶ãå«ã)ã«ã¨ã£ã¦ãã©ãã¯ããã¯ã¹ã¨åãã¦ããã
ããããæ§ã
ãªåé¡ããã¹ã¦ææ¡ããããã§ãADHDã®è¨ºæã«è²´éãª1ãã¼ã¸ãå ããã®ãã山縣è¬å¸«ã®æ¬ç ç©¶ã§ãããADHDã®è¨ºæã¯ç²¾å¯ã§ãªããã°ãªããªããããã¯ãçç©å¦çã«ç²¾å¯ãªã ãã§ãªãã社ä¼çã«ãç²¾å¯ã§ãããã¨ãæ±ãããããææ°ã®ãã¯ããã¸ã¼ããè¨åºã¾ã§ãå
¨æ¹ä½ãè¦éã«ããã¦åãã¦ãçã®ãç²¾å¯ãªã診æãå¯è½ã«ãªããããã¦ããããåãã¦å½äºè
ã«ã¨ã£ã¦æé©ãªä»å
¥ã»æ²»çãè¡ããã¨ãã§ããã
山縣è¬å¸«ã¯ã¾ãã«ãããå®è·µãã¦ãããããã¦å½¼ãæè¿æ
¶æç
é¢ã§éè¨ããçºéé害å°é夿¥ã¯ããã§ã«äºç´ã溢ããç¶æ
ã«ãªã£ã¦ããã
(ææ¾å¤ªéã2018.9.28.)
æ¥å¸¸å ´é¢ã«ãããè¨æ¶ï¼è¿å¹´ã®ç ç©¶ææã¨ãã®åè
æ¢
ç°è¡ (æ
¶æç¾©å¡¾å¤§å¦æå¦é¨ææ)
Tsukiura, T., & Umeda, S. (Eds.) Memory in social context: Brain, mind, and society. Springer. 2018.
ç§å¦çãªè¨æ¶ç ç©¶ã®åç¹ã¯ï¼ãã«ãã³ã»ã¨ãã³ã°ãã¦ã¹ (1850-1909)ã¨ããã¦ããï¼å®é¨å®¤ã¨ããçµ±å¶ãããç°å¢ã§ï¼äººãã©ã®ç¨åº¦ã®è¨æ¶æ©è½ãçºæ®ã§ããã®ãï¼ãã¾ãã¾ãªè§åº¦ããæ¤è¨¼ãããï¼åææï¼ãããã¯ãããã以åã«ãï¼ç²¾ç¥ç¾æ£ãç¥çµç¾æ£ã«ãããè¨æ¶ã®é害ã«ã¤ãã¦ã¯ï¼çä¾ããã¼ã¹ã¨ããå ±åãæ°å¤ããªããã¦ããï¼è¨æ¶ãç§å¦çã«æ¢æ±ããããã®ãç´ æããæã£ã¦ãããã¨ã¯äºå®ã§ããï¼ãããï¼ãããã©ã®ãããªçè«çæ çµã¿ã§æãããã«ã¤ãã¦ã¯ï¼ä¸å®ããè¦è§£ã«ä¹ããï¼çµæã¨ãã¦ï¼ç ç©¶è ãç¬èªã«è¨æ¶åé¡ãææ¡ããã¨ããæä»£ãé·ãç¶ããï¼ãã®çµæã¨ãã¦ï¼çæè¨æ¶ï¼é·æè¨æ¶ï¼è¿æè¨æ¶ï¼é éè¨æ¶ï¼ã¨ãã½ã¼ãè¨æ¶ï¼æå³è¨æ¶ï¼å®£è¨çè¨æ¶ï¼æç¶ãè¨æ¶ï¼æ½å¨è¨æ¶ï¼é¡å¨è¨æ¶ï¼å±æè¨æ¶ï¼åæ³è¨æ¶ï¼èªä¼çè¨æ¶ãªã©ï¼ããè¨æ¶ãã¨å¼ã°ããæ¦å¿µãå±±ã»ã©ææ¡ãããï¼è¿å¹´ï¼MRIãè³æ³¢è¨ãªã©ãç¨ãããã¥ã¼ãã¤ã¡ã¼ã¸ã³ã°æ³ãå°é ãï¼è¨æ¶æ©è½ã®èå¾ã«ããæ§é çã»æ©è½çã¡ã«ããºã ãå¾ã ã«æããã«ããã¤ã¤ããï¼å¥å¿çãèªç¥çã«ãããè¨æ¶ã®æ©è½ä½ä¸ã®è¬ãå°ããã¤è§£ããã¦ãã¦ããï¼ãã®ãããªæµãã®ä¸ã§ï¼ä¸è¨ã®ããè¨æ¶ãã¨ããæ¦å¿µãå¤§å¹ ã«è¦ç´ããï¼ç¾ä»£ã®è¨æ¶ç ç©¶ã§ç¨ããããæ¦å¿µã¯ããªãæ´çããã¦ããã¨ãããï¼
ã§ã¯ï¼ãã®ãããªç ç©¶ãçºå±ããçµæã¨ãã¦ï¼è¨æ¶ã®å§¿ã¯æ¬å½ã«è¦ãã¦ããã¨ãããã®ã ãããï¼ãã®åãã¯ï¼è¨ãæ¹ãå¤ããã¨ï¼ãå®é¨å®¤ã§æ¸¬å®ããè¨æ¶æ©è½ã¯ï¼æ¥å¸¸çæ´»ã«ãããè¨æ¶ã®ããã©ã¼ãã³ã¹ãæ£ç¢ºã«åæ ãã¦ããã¨ãããã ããããã¨ããåãã«ç½®ãæãããã¨ãã§ãããããããªãï¼è¨åºå ´é¢ã§ã®æ¤æ»ã®æç¸¾ã¯æ±ºãã¦æªããªãã®ã«ï¼æ¥å¸¸çæ´»ã§ã¯ç©å¿ããç®ç«ã¤ã¨ãããã¨ã¯ååã«ãããããï¼ã¾ããã®éãããããï¼ãã¤ã¦ï¼ãã¬ããªãã¯ã»ãã¼ãã¬ãã (1886-1969)ã¯ï¼ã¨ãã³ã°ãã¦ã¹ã«ãããç¡æå³ã¤ã¥ããã®ãããªäººå·¥çãªææãç¨ããè¨æ¶å®é¨ãæ¹å¤ãï¼æ¥å¸¸çæ´»ã«ããããçããè¨æ¶ãã対象ã¨ãããã¨ã®éè¦æ§ã主張ããï¼ããã¦ï¼å®é¨å®¤ã¨æ¥å¸¸çæ´»ã«ãããè¨æ¶ã®ããã©ã¼ãã³ã¹ã«ä¹é¢ããããã¨ãå®è¨¼ããï¼ãã®æµãã¯ï¼ã¢ã¼ãªãã¯ã»ãã¤ãµã¼ (1928-2012)ã«åãç¶ããï¼ã観å¯ãããè¨æ¶ (Memory observed: Remembering in natural contexts) (1982)ãã¨ããæ¸ç©ã®åºçã«è³ãï¼è¨æ¶ç ç©¶è ã«å¤§ããªå½±é¿ãä¸ããï¼
ãããã35å¹´ã®æ³æãçµã2017å¹´ï¼æã 㯠"Memory in social context: Brain, mind, and society" ã¨ããæ¸ç©ãåè¡ããï¼æ¬æ¸ã¯ï¼4ã¤ã®ãã¼ããããªãè¨18ç« ã§æ§æããã¦ããï¼æ¬æ¸ã§åãä¸ãã¦ããå 容ã¯ï¼1) è¨æ¶ç ç©¶ã¸ã®ã¢ããã¼ãï¼2) 社ä¼çã»æ¥å¸¸çæèã«ãããè¨æ¶ç ç©¶ã®è«¸å´é¢ï¼3) çºéçå´é¢ããã¿ãè¨æ¶ã®å¤åï¼4) è¨æ¶ç ç©¶ã®å¿ç¨çå´é¢ã¨ãã4ã¤ã®è¦³ç¹ã§ã¾ã¨ãããã¦ããï¼åç« ã§ã¯ï¼ããããã®è¦³ç¹ã«ã¤ãã¦ï¼è¨æ¶ã®è¡åçç¹å¾´ã¨ç¥çµåºç¤ãªã©ãæãä¸ãã¦ããï¼è¿å¹´ã®è¨æ¶ç ç©¶ã®é²æ©ã«ã¤ãã¦ï¼ç¶²ç¾ çã«ç¥ããã¨ãã§ããï¼åç« ã®æ¦è¦ãåãä¸ãããã¨ã¯ããã§ã¯é¿ãããï¼å ¨ä½çãªå°è±¡ã¨ãã¦ã¯ï¼ç¤¾ä¼çæèãèæ ®ããè¨æ¶ï¼ããªãã¡ãçããè¨æ¶ãã®è¡åã»ç¥çµã¡ã«ããºã ã«é¢ããçè§£ã¯ï¼ããªãé²ãã ã¨æããï¼ä¸æ¹ï¼ç´°ååãé²ãã§ãããã¨ãå¦ããªãäºå®ã§ããï¼ããã«ä¸æãªç¹ãã©ãããè¦ãã¦ããã¨ããé¢ãããï¼è¨æ¶ç ç©¶ã«éã£ããã¨ã§ã¯ãªããï¼ç ç©¶ã大å±çãªè¦ç¹ããä½ç½®ã¥ãããã¨ãéè¦ã§ãããã¨ã«ããããã¦æ°ã¥ããããã®ã¯ç¢ºãã§ããï¼ç°åéé飿ºãå½ããåã«ãªãã¤ã¤ããç¾å¨ï¼ä¸è¬åå¯è½ãªçè«æ§ç¯ãå®ç¾ããããã«ã¯ï¼ä»ã®åéã®é²æ©ã«ç®ãé ã£ã¦ãããã¨ã¯æ¥µãã¦éè¦ã§ããï¼æ¬æ¸ãéãã¦ï¼èªè ã®çããã«ãã®ãã¨ã«æ°ã¥ãã¦ããã ãããªãã°ï¼ä¸ç·¨è ã¨ãã¦å¹¸ãã§ããï¼
(æ¢ ç°è¡ã2018.8.20.)
Impairment in judgement of the moral emotion guilt following orbitofrontal cortex damage
Michitaka Funayama, Akihiro Koreki, Taro Muramatsu, Masaru Mimura, Motoichiro Kato and Takayuki Abe
Journal of Neuropsychology 2018 Apr 19. doi: 10.1111/jnp.12158.
åé èç¼çª©é¨æå·ã¯ç½ªæªæãæããç¶æ³ã«å¯¾ãã夿ã®ä½ä¸ã«ã¤ãªãã
è¹å±±éé(è¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§é¨é·)ãæ¯æ¨æå®ãææ¾å¤ªéã䏿å°ãå è¤å
ä¸éãé¿é¨è²´è¡
ãèæ¯ãã¢ã©ã«ã¨è³ã¨ã®é¢ä¿ã¯ãç¾å¨ã®ç¥çµç§å¦ã®ãããã¯ã®ãã¡ã®ã²ã¨ã¤ã§ããããã®ä¸ã§ãã¢ã©ã«ã¨åé èç¼çª©é¨ã¨ã®æ·±ãé¢é£ã¯è³ã¤ã¡ã¼ã¸ç ç©¶ã«ãã£ã¦æããã«ãªã£ã¦ãããããããå®éã®äººéã®æå·ä¾ã§ã®ç ç©¶ã¯ã»ã¨ãã©è¡ããã¦ããªãã£ããä»åããããã¯ãè³è¡ç®¡é害ä¾ã対象ã¨ãã¦ãã®åé¡ã«åãçµãã ã
ãæ¹æ³ã72ä¾ã®è³è¡ç®¡é害ä¾ã«å¯¾ãã¦ã4ã¤ã®èª²é¡ãè¡ã£ãã1ã¤ã¯ã³ã³ããã¼ã«èª²é¡ã¨ãã¦é·ãã®éããæ±ããç¥è¦èª²é¡ã次ã«å ·ä½çãªãã®ã§ããéèã®é¸å¥½èª²é¡ãæå¾ã«ã¢ã©ã«ã«é¢ããå¤æèª²é¡2ã¤ï¼æã課é¡ã¨ç½ªæªæèª²é¡ï¼ãè¡ã£ããç¥è¦èª²é¡ä»¥å¤ã¯ã8ã¤ã®ãã®ãã¢ã©ã«ã«é¢ããç¶æ³ãï¼ã¤ãã¤ã®çµã«ãã¦ãã©ã¡ãã®ãã®ãç¶æ³ã好ãã/æããè¦ããã/ç½ªæªæãæãããã«ã¤ãã¦å¤æãããããããã®èª²é¡ã«é¢ãã夿ã®ä¸è²«æ§ã®ãªãï¼å¤æã®ããããããªãã¡ã夿ã®ä½ä¸ï¼ãæ±ããã夿ã®ãããã«å¯¾ãã¦ãç å·£ï¼åé èç¼çª©é¨ãåé èèå´é¨ãé é èãå´é èãå¾é èã大è³åºåºæ ¸ãè¦åºï¼ãç å·£ã®å¤§ãããç¥çµå¿çæè¦ï¼ç¥è½ãè¨æ¶ãéè¡æ©è½ï¼ãå¹´é½¢ãæ§å¥ãæè²æ´ãè³è¡ç®¡é害ã®ç¨®é¡ï¼è³æ¢å¡ãè³åºè¡ï¼ã説æå¤æ°ã¨ããéå帰åæãè¡ã£ãã
ãçµæãç½ªæªæèª²é¡ã®å¤æã®ãããã¯åé èç¼çª©é¨ã®æå·ã¨ã®ã¿é¢é£ãã¦ãããä»ã®èª¬æå¤æ°ã¯ç½ªæªæèª²é¡ã®ã¿ãªããããããã®å¤æã®ãããã«ãé¢é£ãã¦ããªãã£ãã
ãèå¯ãããããã®äººéã®è³æå·ä¾ã§ã®çµæã¯ãåé èç¼çª©é¨ãã¢ã©ã«ã«é¢ããææ ã®ä¸ã§ãä¸å¿çãªææ ã§ããç½ªæªæã¨é¢é£ãããã¨ã示ãã¦ãããåé èç¼çª©é¨ãæå·ããããµã«ã§ã¯ãå®éã«ã¯ãã®å ´ã«ãªãæ³åãè¦ãã課é¡ã§ããã°ããã»ã©ä¾¡å¤å¤æãä½ä¸ãããã¨ãç¥ããã¦ãããç½ªæªæã¯éèã®å¥½ãå«ããæãã®ææ ã¨ã¯ç°ãªããå®éã®åºæ¥äºã¨ã¯éãå¥ã®é¸æè¢ããã£ããçµæã¯ã©ãã§ãã£ããæ³åããåäºå®çæè(counterfactual thinking)ãè¦ããã¨è¨ããã¦ãããè§£åå¦çã«ãåé èç¼çª©é¨ã¯ç¶æ³ãæ³åããåé èèå¤å´é¨ã¨ææ ã¨ãããã辺ç¸ç³»ã¨å¼·ãé£çµ¡ãæã¤ãç½ªæªæãªã©ç¶æ³ãæ³åããå¿ è¦ãããå ´é¢ã§ã¯ãåé èç¼çª©é¨ãæå·ãããã¨ãã®ç¶æ³ã«ä¼´ãææ ãæ¹èµ·ããã«ããã®ãããããªãã
(è¹å±±ééã2018.7.1.)
解説: ã¢ã©ã«ç ç©¶ãéãæ
è³ã«æå·ããããæ©è½ã«é害ãããã¨ããç¥çµå¿çå¦ã®æ¬é ãçºæ®ãããã®ã常ã§ãããã¢ã©ã«ã¯äººéã«ã¨ã£ã¦ç¹ã«éè¦ã§è峿·±ãæ©è½ã§ãããåé èç¼çª©é¢æå·ã«ãã£ã¦ã¢ã©ã«ãé害ããããã¨ã¯æããããç¥ããã¦ãããã¨ããã人éã®è³æå·ä¾ã§ã®ã¢ã©ã«ããã¼ãã¨ããç ç©¶ã¯ããã¾ã§ã»ã¨ãã©è¡ããã¦ããªãã£ããäºã¤ã®å¤§ããªéå£ãããããã§ããã
ä¸ã¤ã¯ãåé èç¼çª©é¨ã®æ©è½ãè¤éã§ãããã¨ãæå¶ãé¸å¥½å¤æã注æã®ã·ãããå ±é ¬å¦çãææ å¦çãªã©ã夿°ã®èª¬ããããã©ãã«ããããªãã®æ ¹æ ã¨ãªããã¼ã¿ãããããã©ãããã¾ã å®èª¬ã«è³ã£ã¦ããªãã
ããä¸ã¤ã¯ãã¢ã©ã«ã¨ããæ©è½ãè¤éã§ãããã¨ããã¢ã©ã«ãã¨ããåä¸ã®æ©è½ãããã¨ã¯å°åºèããããªãããã«ã測å®ãããã¨ãå°é£ã§ãããããæ¹æ³è«ãå®ãã«ããã
ã¢ã©ã«ã¨ããæ©è½ã®éè¦æ§ã¯èª°ããèªèãã¤ã¤ãã誰ããè °ãå¼ãã¦ããèæ¯ã«ã¯ããããäºæ ããããããã«ææ¢ã«ææ¦ããã®ãè¹å±±é¨é·ã®æ¬ç ç©¶ã§ããã
è¤éæ§ãçªç ´ããããã«ä¸»ã¨ãã¦äºã¤ã®æãç¨ãããããã²ã¨ã¤ã¯ç½ªæªæã«ã¤ãã¦ã®å¤æã®ããããããæ¸¬å®ããã¨ããç¹ã§ãããç½ªæªæã¯ãæãã»ç¡ãã®äºåæ³ã§çããæ±ããã®ã¯ããã«ãä¹±æ´ã§ããããæ°å¤åãããã¨ã«ãéçããããããã§ã夿ã®ãããã大ãããã°ãå½è©²å¤æåã«ã¯é害ãããã¨å¤å®ããã¨ããææ³ãç¨ããã®ããè¨åºç¥çµå¿çå¦ã«ç²¾éããè¹å±±é¨é·ã®ç¹ç´°ãªæã§ãããããã²ã¨ã¤ã¯éå帰åæã®é©ç¨ã§ãã¢ã©ã«ã¨ããè¤éãªæ©è½ã«ã¤ãã¦ã¯åãªãã±ã¼ã¹-ã³ã³ããã¼ã«ã¹ã¿ãã£ã§ã¯éé³ã®æ··å ¥ãå¤ããã¦ä½ãå¤å®ãã¦ããã®ãããããªãã¨ããåé¡ãè§£æ¶ãã¦ããããã®çµ±è¨ææ³ã®é©ç¨ã«å¿ è¦ãªç便°(åé èç¼çª©é¢æå·ä¾32åãã³ã³ããã¼ã«ã¨ãã¦ã®ä»é¨ä½æå·ä¾ã40å)ãéããã¨ããåããæã®å®ç¾ãæ¯ãã¦ããã¨ããäºå®ãè¦éããªãã
ãã®ããã«åã¨æãé§ä½¿ãã¦å¾ãããçµæã¯ããç½ªæªæã®ä½ä¸ãã§ãã£ããããªãã¡ãç½ªæªæãã¯ããªãç¹ç°çã«åé èç¼çª©é¢ã«é¢é£ãã¦ããã¨ãããã¨ã§ãã¢ã©ã«ã®è³ç ç©¶ã«ããã大ããªä¸æ©ãæ¬ç ç©¶ã«ãã£ã¦è¸ã¿åºãããã¨è¨ããã
次ã®ã¹ãããã¯ãã§ã¯ç½ªæªæã¨ã¯ä½ããã¨ãããã¨ã«ãªãããåç©å®é¨ãå«ããå¤ãã®ç ç©¶ãããç½ªæªæã¨ã¯ãä»®æ³çãªäºæ ãæ³åãããã®äºæ ã«ã¤ãã¦ã®ä¾¡å¤å¤æ(åäºå®çæè: counterfactual thinking)ã®ä¸åã§ããã¨ããã¦ããã
ãã®ãã¨ã¯ãã¢ã©ã«ãé¢ä¸ãã究極ã®ç¶æ³ãããªãã¡åäºäºä»¶ã«ããã被å人ã®éé£ããå½è©²ç¯è¡ãæãã¨ã©ã¾ãã¨ããå坾忩ãå½¢æã§ãããå¦ããéè¦ãã¦æ±ºããããã¨ãããã¨ã®é¢é£ã«ããã¦é常ã«è峿·±ãããå坾忩形æãã¨ããæ³ã®è¨èãããåäºå®çæèãã¨ããè³ç§å¦ã®è¨èã¨æ¥æ¥è¿ããæ³ç夿ã«è³ç§å¦ã®é©ç¨ãæ¬ ãããªãæä»£ãç®ã®åã«æ¥ã¦ãããã¨ã宿ããã«ã¯ããããªãã
è³ã«æå·ããããæ©è½ã«é害ãããã¨ããç¥çµå¿çå¦ã®è²¢ç®ã¯ãè³ã®ã¡ã«ããºã ãçè§£ããã¨ãããã¥ã¼ããµã¤ã¨ã³ã¹ã®é åã¨ãçç¶ãè©ä¾¡ãçåå¦ã確ç«ãæ²»çããªãããªã®éçºã«çµã³ã¤ããã¨ããè¨åºã®é åã®äºã¤ã§ããã¨ããã®ãéä¾ã ããã¢ã©ã«ã¨ããæ©è½ã«é¢ãã¦ã¯ãããã«éé£/ç§°è³ã¨ãã第ä¸ã®é åãç«ã¡ç¾ããããã®é åãæãæç¢ºåãããã®ãç¯ç½ªéé£ã®å ´é¢ã§ããããå坾忩ãå½¢æã§ããªããã¨ãè³æ©è½é害ã®ä¸çç¶ã§ããã¨ããã°ããªããããéé£ã§ããã®ãã¨ããæ·±å»ãªåãã«çããå¿ è¦ãçºçãããã失èªã失è¡ã失èªã¨ãã£ãçç¶ãéé£ãããã¨ã¯å ¨ã䏿¡çã§ãã以ä¸ãã¢ã©ã«ã®ä½ä¸ã¨ãããçç¶ããéé£ãããã¨ã«åçæ§ãè¦åºãã®ã¯å®¹æã§ãªãã
ããã¦éé£ã®å¯¾æ¥µã«ããç§°è³ã«ã¤ãã¦ã®åãã¯ããã«æ·±å»ã§ãããã¢ã©ã«ã®æè¦ãé«ã人(ããã¦ãã®æè¦ã«åºã¥ããè¡åãåã人)ã¯ããäººæ ¼è ãã¨ãã¦å°æ¬ãããã®ã社ä¼ã®å¸¸ã§ããããã¢ã©ã«ã髿¬¡è³æ©è½ã®ä¸ã¤ã§ãã以ä¸ãã¢ã©ã«ã¨ããæ©è½ã®ã¿ã«ãäººæ ¼ãã¨ããç¹æ¨©çãªå°ä½ãä¸ãããã¨ã«åçæ§ãè¦åºããã¨ã容æã§ãªããããã¨äººã人ãå°æ¬ããã¨ã¯ä¸ä½ä½ãªã®ããã¢ã©ã«ç ç©¶ã¯å¾æ¥ã®é«æ¬¡è³æ©è½ç ç©¶ã触ããªãã£ãæ°ããé åã®æãéãã人ã¯ä¸æ¡çã§åºå£ã®è¦ããªãè¿·è·¯ã«è¿·ãè¾¼ãã
(ææ¾å¤ªéã2018.7.26.)
䏻使§ã®ç²¾ç¥ç
çå¦ï¼âèªæé害âããçç¶è«ã»ç
æ
è«ã»æ²»çå復è«ã«ã¤ãã¦èããã¼
åç°è²´è¨ (æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§å¦æå®¤ãå°ä»»è¬å¸«)
ç²¾ç¥ç§æ²»çå¦, 33(1);5-12, 2018.Â
âèªæé害âãçµ±å失調çã®ä¸æ ¸çç¶ã¨ãã¦è¦æ®ããâèªæé害âãåãå£ã¨ãã¦ãçµ±å失調çã®çç¶è«ã»ç æ è«ã»æ²»çå復è«ã«ã¤ãã¦èãã¦ããï¼ç å è«ã«ã¤ãã¦ã¾ã§ã¯é£ããï¼ããããããèªæãã¨ããæ¦å¿µã¯å¤ç¾©çã§ææ§ãªæ¦å¿µã§ãããã¾ããå®ä½ã¨ãã¦ã¨ããããããã®ã§ã¯ãªããããã«ãåã®å奿§ã»åºææ§ã»æ´å²æ§ã»ä¸åæ§ã«ã¤ãã¦ã嫿ãã¦ãããããå»å¦ã«ããã¦ã¯æ±ãã«ããããèªæããã主ä½ãã¸ã¨ãæ¦å¿µãç½®ãæãããã¨ã§ãâèªæé害âãå»å¦çã«æ±ããã¨ãã§ããã®ã§ã¯ãªããã¨èãã¦ããã
ã主ä½ã¨ã¯ãæãæå¿ããã£ã¦ãæãèªèã®ãã¨ã«ãæãè¡çºãããç°å¢ã«ä½ç¨ãããã®ã®ãã¨ããã¨å®ç¾©ãããã主ä½ã¯ãç°å¢ã®ä¸ã§ãç°å¢ããã³ä»ã®ä¸»ä½ã¨ç¸äºä½ç¨ããçå½çåä½ã¨ãã¦ã¨ããããã¨ãã§ãã観測å¯è½ã¨ããæå³ã§ãèªç¶ç§å¦ã®æ¹æ³ãç¨ãããã¨ãã§ããã主ä½ã«ã¯èªè主ä½ã¨ãã¦ã®å´é¢ã¨ãè¡çºä¸»ä½ã¨ãã¦ã®å´é¢ãããããç¹ã«è¡çºä¸»ä½ã®å´é¢ã«çç®ããå ´åãagent/agencyã¨ããç¨èªãç¨ããããã
主ä½ã¨èªæã®é¢ä¿ã«ã¤ãã¦è¨ãã°ãâèªæï¼ç§ï¼âã¨ããæèãçã¾ãã以åãããåä½ã¯çç©ã¨ãã¦æ¢ã«ç°å¢ã®ä¸ã§é©å¿ãã¹ã主ä½çã«çãã¦ããããã®ã¨ãå¿
ããã主ä½ãèªèº«ã«ã¤ãã¦æèçã§ããå¿
è¦ã¯ãªãã主ä½ã¯ãâèªæï¼ç§ï¼âã¨ããæèã«å
ç«ã£ã¦ããããã®ä¸ã§ãèªã¨ä»ã¨ããä½é¨ãååãã¦ããã®ã§ããããã®ãããªåæã«ç«ã¦ã°ãçµ±å失調çã§ã¯ãèªã¨ä»ã¨ããä½é¨ãååãæç«ããã¦ããæ©æ§ã«é害ããããã¦ããã¨ããç
æ
仮説ãå°ãããããï¼
ã䏻使§ãã®ç²¾ç¥ç
çå¦ã¯ãç²¾ç¥ç
çå¦ã¨ãèªç¶ç§å¦ã¨ãã¦ã®çç©å¦ããã«ã¯è³ç§å¦ã¨ã®é£ç¹ãç®æã試ã¿ã§ããããããã¯çµ±å失調çã®ã¿ãªããç²¾ç¥å»å¦å
¨ä½ã®èª²é¡ã§ããããã®ä¸ã¤ã®ã¢ãã«ã¨ãªãã°ã¨èãã¦ããã
(åç°è²´è¨ã2018.6.28.)
解説ã主観ã®å¤±å°åå¾©ã¯æ¥å
ç²¾ç¥å»å¦ã®è¨åºã¯ã主観è³ä¸ä¸»ç¾©ã§ããã
ç²¾ç¥ç§ã§ã¯ã診æã¯æ£è
ã®è¨´ãã®åæã«ãã£ã¦æ±ºå®ããããæ£è
ã®è¨´ãã¨ã¯æ£è
ã®ä¸»è¦³çä½é¨ã«ã»ããªããªããããã¦æ²»ç广ããæ£è
ã®ä¸»è¦³çä½é¨ã®å¤åã«åºã¥ãã¦å¤å®ãããã診æãæ²»çã主観ãé ¼ããã¤ã¾ãã¯ä¸»è¦³è³ä¸ä¸»ç¾©ã§ããã
ãã£ã¨ããç¾å¨ã§ã¯è³ã®ç»å診æããããç¥çµå¿çå¦çæ¤æ»ã«ãã£ã¦ãè³ã®æ©è½ã®è¡¨åºã客観çã«æ¸¬å®ãããã¨ãå¯è½ã§ãããã主観è³ä¸ä¸»ç¾©ãã¯éå»ã®ç²¾ç¥å»å¦ã®è¨åºã§ãã£ã¦ãã主観è³ä¸ä¸»ç¾©ã ã£ããã¨ããéå»å½¢ãæ£ãããç¾å¨ã¯éãã¨ããã®ãã¾ãåççãªä¸»å¼µã§ããããã ããããã®æ¤æ»ã¯ã¾ã ã¾ã è£å©ææ®µã«ãããªããç¾å¨ã§ããªããç²¾ç¥å»å¦ã®è¨åºã§ã¯ä¸»è¦³çä½é¨ãæãéè¦ã§ãããã¨ã«å¤ããã¯ãªããã主観è³ä¸ä¸»ç¾©ã§ãããã¯è¨ãéãã ã¨ããã®ã§ããã°ãã主観è³ä¸ä¸»ç¾©ã«ããªãè¿ããã¨è¨ãç´ããã
ã主観è³ä¸ä¸»ç¾©ã ã£ããæä»£ãæ£è
ã®ä¸»è¦³çä½é¨ã¯ç²¾å¯ã«ç ç©¶ãããããã®çµæãçµ±å失調çã®çç¶è«ã¯é ç¹ã¨ãããã¬ãã«ã«ã¾ã§çºå±ãããããã¦ä»ã¯éåãã¦ãããåç°è¬å¸«ãæ¬è«æã«ãçç¶å¦ã¯æµ
èåãã»ã»ã»ãã¨è¨è¼ãã¦ããéãã§ããã
çç¶å¦ã¯ãªãæµ
èåããã®ããç²¾ç¥å»å¦ãæ§æ¥ã«ã客観è³ä¸ä¸»ç¾©ãã«ãããã¨ãã風潮ã主å ã§ããããã¡ãã客観åãç§å¦åã¯å¿
è¦ã§ãããæè¿ãã¹ãé²åã§ãããã ãã客観å(ããã¯å»å¦ã§ã¯ã»ã¼æ°éåã¨å義ã«ç¨ãããã¦ãã)ã§ããªãé¨åãçéè¦ããç²¾ç¥å»å¦ç ç©¶ã¯ãå®ä½ãç¡è¦ãã¦å½±ã ããæ±ã£ã¦ããã«çãããç¹ã«çµ±å失調çã¨ããç²¾ç¥å»å¦ã®æéè¦èª²é¡ã«ã¤ãã¦ã¯ã主観çä½é¨ãä¸å¿ã«ãããªãæ¹æ³è«ã®éçã¯ãã¾ãã«æããã§ããã
æ¬è«æã䏻使§ã®ç²¾ç¥ç çå¦ãã¯ãããããç¶æ³ãååã«æèããåç°è²´è¨è¬å¸«ãã夿¥ããçµ±å失調çã®åºæ¬é害ã¨ããã¦ãããèªæé害ããçç©å¦çãªç ç©¶ã®å¯¾è±¡ã¨ãããã¨ãç®æãã試ã¿ã§ããããã®è¦ç¹ã¯ä¸è¨åç°è¬å¸«èªèº«ã®ç´¹ä»æã®éãã§ããããåæãæã«åã£ã¦ã¿ãã¨ãæ¬æå ¨7é ã®ãã¡ããã¯ããã«ãã2é ã¨ããç°ä¾ã®å¤§é¨ãå ãã¦ãããã¨ãç®ãã²ããããã«ã¯çµ±å失調çã«é¢ãã¦ã®ä¸éå端ãªèªç¶ç§å¦çãªç¥è¦ããã¨ã«åç´åãããçç¶è«ã¨ããããæ´¾çããåé¡ãããã¦ä¸ã«è·æãã¦ããæ¹æ³è«ç誤謬ã«ã¤ãã¦ã®ãåç°è¬å¸«ã®ç±ãæ¹å¤ãç¶´ããã¦ããã
ã ãããã¦è¨ãã°ãçµ±å失調çç ç©¶ã§ç¾å¨ä¸»æµã¨ãªã£ã¦ãã客観è³ä¸ä¸»ç¾©ã®æ¹æ³è«ã«ã¯æ ¹æ¬çãªåé¡ããããã¨ã¯ãåç°è¬å¸«ã«ææãããã¾ã§ããªãæããã§ããã¨ããã®ãäºå®ã§ããããçµ±å失調çã¨ã¯ã主観ã客観åãã客観ã主観åãããã¨ããé害ã§ãã(ããåç´ã«ã¯è¨ããªããã¨ãæ¬è«æã§ææããã¦ããããããã¯ã¨ãããã¨ãã¦)ãã客観è³ä¸ä¸»ç¾©ãã®èªç¶ç§å¦çææ³ã®å°ç¨ããé¸è±ããé åã«çç®ãããã¨ãªãã«ã¯å°éã§ããªãé害ãªã®ã§ãããçµ±å失調çã主観ã¨å®¢è¦³ã®ãå¢çãã®é害ã§ããã¨ããã°ã客観çæè¦ã«åéããç¾å¨ã®çµ±å失調çç ç©¶ã¯ä¸»è¦³ã¨å®¢è¦³ã®ãä¸åè¡¡ãã«è´å½çãªåé¡ãããã¨è¨ãããã
ç²¾ç¥å»å¦ã主観è³ä¸ä¸»ç¾©ã§ãããã¨ã¯ããã®è¨åºã ãã«ã¨ã©ã¾ããªããå°ãªãã¨ãã客観è³ä¸ä¸»ç¾©ããã¯ã¯ããã«ä¸»è¦³è³ä¸ä¸»ç¾©ã«è¿ããã ããã¨ãã£ã¦ä¸»è¦³çä½é¨ã®è¨è¿°ã®ã¿ãç¹°ãè¿ãã¦ãã¦ã鲿©ã¯ãªãã主観ã¨ããé åã«åãè¾¼ãæ°ããªæ¹æ³è«ãå¿ è¦ã§ãããåç°è¬å¸«ã®ã䏻使§ã®ç²¾ç¥ç çå¦ã¯ãã»ã»ã»ãçµ±å失調çã®ã¿ãªããç²¾ç¥å»å¦å ¨ä½ã®èª²é¡ã§ããããã®ã¢ãã«ãã¯ãã¾ãã«ç®´è¨ã§ããã
(ææ¾å¤ªéã2018.6.30.)
èªç¥çã®å»å¦ã¨æ³å¦
ææ¾å¤ªé èãä¸å¤å»å¦ç¤¾ã2018å¹´6æçºå
解説ãNeuro-: -psychology; -law; -ethics; -criminology
ç¥çµå¿çå¦ Neuropsychologyã¯ãNeurologyã¨Psychologyã®åæèªã§ããããã¤ã¦ãå¿ã®å¦åã¨è³ã®å¦åã¯å ¨ãå¥ã ã«çºå±ããäºã¤ã®éã«æ¥ç¹ãè¦åºããã¨ã¯ã§ããªãã£ããé·ãæä»£ãçµã¦Neurologyã¨Psychologyãæçããå¿çå¦ãè³ã¨é¢é£ã¥ãã¦èªããããã«ãªã£ãã¨ããNeuropsychologyã¨ããåéãæç«ããã®ã§ããã
ç¾ä»£ã«ããã¦ã¯ãNeurolaw, Neuroethics, Neurocriminologyã¨ãã£ãåéãèªçãã¦ããããã¤ã¦ã¯èªç¶ç§å¦ã¨ã®æ¥ç¹ãªã©å ¨ããªãã£ãæ³å¾ãå«çå¦ãç¯ç½ªå¦ããè³ã§èªããæä»£ã«ãªã£ã¦ããã®ã§ãããããã¦æ³ã¨ã¯ãå¦åã§ããã¨åæã«ã常ã«å®è·µã§ãããã社ä¼ããäºããçµ¶ãããã¨ã¯ãªãã社ä¼ã¯å¸¸ã«äºãã®è§£æ±ºã«å¤å¤§ãªã¨ãã«ã®ã¼ã注ãã§ãããããã«ã¯å¿ ãæ³ããããã§ã¯æ³ããå«çããç¯ç½ªããè³ã§èªããããã«ãªãã¤ã¤ããä»ãã©ã®ãããªè°è«ãè¡ããã¦ããã®ããä»å¾ã©ã®ãããªæ¹åã«é²ãã®ããç¾å®ã®è£å¤ãç´ æã¨ãã¦ãããèªããã¨ãç®æããã®ãæ¬æ¸ãèªç¥çã®å»å¦ã¨æ³å¦ãã§ããã
æ°äºç¯ã«ã¯ããã¨ãã°éºè¨è½åããããéºè¨ãããã®ã¯å¤ãã®å ´åé«é½¢è ã§ããã®ä¸ã«ã¯èªç¥æ©è½ãä½ä¸ãã¦ããããããã«ã¯èªç¥çã«ç½¹æ£ãã¦ãããããã±ã¼ã¹ããããããããå ´åãéºè¨ã¯æå¹ãªã®ãç¡å¹ãªã®ããããã¦éºè¨ã¯ãæ¬äººãæ¸ãæ¿ãããã¨ããããæ®éã«èããã°ãæ¸ãæ¿ããããå¾ã®éºè¨ãå½¼/å½¼å¥³ã®æçµçãªçæã¨è§£ãããããã ã第ä¸ã®éºè¨ãã第äºã®éºè¨ã«è³ãéã«ãèªç¥æ©è½ãä½ä¸ãã¦ããããèªç¥çãçºçãã¦ããå ´åã¯ã©ãèãããããã®ãããããã¯ãç´ç²ã«æ¬äººãå®ããã¨ããæå³ãæã£ãå®¶æã«ãã£ã¦æ½è¨å ¥æããããããã¨ãæ¨ãã§ãéºè¨ãæ¸ãæ¿ããããå ´åã¯ã©ãèãããããã®ãããããã¯ã親身ã«ãªã£ã¦ä»è·ãã¦ããå®¶æãBPSDã®å¦æ³ã«ãã£ã¦æ¨ã¿ãéºè¨ãæ¸ãæ¿ããããå ´åã¯ã©ãèãããããã®ããã©ã®éºè¨ãæ£å½ã¨èªããã®ãæ£ç¾©ãªã®ããèªç¥çæ¬äººã®çæã¯ã©ããããããã人ã®çæã¨ã¯ä½ãã
åäºç¯ã«ã¯ããã¨ãã°åé å´é åèªç¥ç FTDããããFTDã¨ç¯ç½ªã«é¢é£æ§ããããã¨ã¯å¤æ¥ããç¥ããã¦ãããç¾ä»£ã®FTDã®ç¯ç½ªã§ã¯å½ç¶ã«è²¬ä»»è½åãåé¡ã¨ãªãã責任è½åã¨ã¯å¼èè½å(æ¯éåæªã®å¤æè½å)ã¨å¶å¾¡è½å(å¼èè½åã«å¾ã£ã¦èªåã®è¡åãå¶å¾¡ããè½å)ããæãã¨æ³ã¯å®ãã¦ãããã ãè¡åãæ±ºå®ããã¾ã§ã®è³å ã¡ã«ããºã ãå¼èè½åã¨å¶å¾¡è½åã¨ãã2段éããæã£ã¦ããã¨ããä¿è¨¼ã¯ãªããã¨ããããããããªå¯è½æ§ã¯ã»ã¨ãã©ãªãã¨è¨ã£ãã»ããããã§ããããæ³å¾ãå®ããã¡ã«ããºã ã¯ã人ãå¶ç´ããåã¯ãã£ã¦ãè³ãå¶ç´ããåãªã©ããã¯ãããªãããããæ³ã責任è½åãå¼èè½åã¨å¶å¾¡è½åã«åããã®ã¯1931å¹´ã§ã彿ã¯Lawã¨Neuroscienceã®æ¥ç¹ã¯çç¡ã§ãã£ããã ãæ¹æ£ãããªãéãæ³ã¯åºãéµå®ãããªããã°ãªããªãã®ã§ãã£ã¦ãFTDã®è²¬ä»»è½åã¯å¼èè½åã¨å¶å¾¡è½åã§èªãããªããã°ãªãããçµæã¨ãã¦ã¯æ³å»·ã§ã¯å¶å¾¡è½åãããã種ãããã¦å¥æªãªè«çã®é©ç¨ã«ãã£ã¦è«ãããã夿±ºãä¸ããã¦ããã
æ¬æ¸ã§åãä¸ãã25ä¾ã®1ä¾1ä¾ã«ãã®ãããªæ³ã¨å»ã®ç¸å ãããããã®ç¸å ããä»å¾ã®è³ç§å¦ã®çºå±ã«ãããã£ã¦ã©ãå¤åãã¦ãããã¯å¤§å¤è峿·±ããã®ã ãããè峿·±ããã¨ä½è£ãæã£ã¦çºãã¦ããããç¶æ³ã§ã¯ãªããé«é½¢å社ä¼ã¨ãªã£ãæ¥æ¬ã§ããã§ã«æ£è æ°ã400ä¸äººä»¥ä¸ã«éãã¦ããèªç¥çã¯ãéºè¨ã財ç£ç®¡çãèªåè»é転ãããã¦ç¯ç½ªã«è³ãã¾ã§ãå»å¸«ã責任ãæã£ã¦ãããããªããã°ãªãããæã«ã¯è¨´è¨å½äºè ã«ãªããªã¹ã¯ãé£åããã§ãããã¾ããã²ã¨ãã³æ³çäºãã«ãªã£ãã¨ããæ£ç¢ºãªè¨ºæã¨èªç¥æ©è½ã®è©ä¾¡ããã£ã¦ã¯ããã¦æ£ç¾©ãè¡ä½¿ãããã¨ããæå³ã§ã¯ãå»ã®å½¹å²ã¯é常ã«éãã
èªç¥çã¨ãã®è£å¤ã¯ãå»ã¨æ³ã®æ¥ç¹ã§ããã¨ã¨ãã«ãèªç¶ç§å¦ã¨ç¤¾ä¼ç§å¦ãåºä¼ãå®è·µã®å ´ã§ãããã
èªç¥çã®å»å¦ã¨æ³å¦ãç®æ¬¡
æ°äºç¯
第1ç« ã財ç£è¢«å®³
Case 1 ææè½åã妻ã»é·ç·vsé·ç·ã®å¦»
Case 2 å
¬åºè¯ä¿ãä¿ä½äººvsä¸åç£ä¼ç¤¾
Case 3 é¯èª¤ãé¤åvsä¸åç£ä¼ç¤¾
第2ç« ãé¤åç¸çµ
Case 4ãä¸å¯©ãç¸çµã¯æå¹ã
Case 5ãäºå¯©ãé転ãç¸çµã¯ç¡å¹ã
第3ç« ãéºè¨è½å
Case 6ãé·ç·vs次ç·ãéºè¨æå¹
Case 7ãç¥vsä»äººãéºè¨ç¡å¹
Case 8ãæ¯vs次女ãéºè¨æå¹
第4ç« ãå¾å¾äºæ
Case 9ãå±å¤ã§ã®åæ»
Case 10ãä»å®³ã¨ãã¦ã®ééäºæ
第5ç« ãèªåè»é転
Case 11ãçç¶ã¨ãã¦ã®èªåè»éè»¢äºæ
第6ç« ãè³æå·
Case 12ã交éäºæ
å¾ã®ã¢ã«ããã¤ãã¼ç
çºç
Case 13ã交éäºæ
å¾ããå¦ãããã¦èªç¥ç
Case 14ã髿¬¡è³æ©è½é害
Case 15ãç»åæè¦ãªãè³æå·
Case 16ãã¢ã¡ãªã«ã³ããããã¼ã«é¸æéå£è¨´è¨
åäºç¯
第7ç« ãåäºè²¬ä»»è½å
Case 17ãèèä»è·æ®ºäººãå¿ç¥èå¼±
Case 18ãåé èé害ã¨çªçãå¿ç¥èå¼±
第8ç« ãåé å´é åèªç¥ç
Case 19ã夫殺ããå®å
¨è²¬ä»»è½å
Case 20ãæ¼¬ç©æ³¥æ£ãå¿ç¥åªå¤±
Case 21ããªã³ã´æ³¥æ£ãå®å
¨è²¬ä»»è½å
Case 22ã大åãã£ã¹ã«ã¦ã³ãã·ã§ããé£ç¶æ¾ç«äºä»¶ãå®å
¨è²¬ä»»è½å
第9ç« ã訴è¨è½å
Case 23ãã¢ã«ããã¤ãã¼ç
ãå
¬å¤åæ¢ã
Case 24ãã³ã«ãµã³ãçå群ãå
¬å¤åæ¢ã
Case 25ãå
¬å¤åæ¢19å¹´ãè£å¤æã¡åã
çµç« ãæ³ã¨å»ãçµã¶èªç¥æ©è½
(ææ¾å¤ªéã2018.5.26.)
黿°ããããçæ³ã®æµ·é¦¬ã¨ææ¡ä½ä½ç©ã«å¯¾ããå½±é¿ï¼ã·ã¹ãããã£ãã¯ã¬ãã¥ã¼ã¨ã¡ã¿è§£æ
é«å®®ãå½°ç´ï¼æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ã»ç¥çµç§å¦æå®¤ã大å¦é¢å士課ç¨ï¼
Effect of electroconvulsive therapy on hippocampal and amygdala volumes: systematic review and meta-analysis
Akihiro Takamiya, Jun Ku Chung, Kuo-ching Liang, Ariel Graff-Guerrero, Masaru Mimura and Taishiro Kishimoto
Br J Psychiatry. 2018 Jan 212: 19â26
黿°ããããçæ³ (electroconvulsive therapy: ECT) ã¯éçãªãã¤ç ã«å¯¾ãã¦æãæå¹ãã¤å³å¹æ§ã®ããæ²»çã§ããããã®ä½ç¨æ©åºã¯ããããã£ã¦ããªãç¹ãå¤ããã1930年代ã®ç»å ´ä»¥æ¥å¤ãã®ä»®èª¬ãæå±ããã¦ãããè¿å¹´ã¯ãæãã¤å¹æã«é¢ããç¥çµå¯å¡çãªå¤åãæ³¨ç®ããã¦ããããã¦ã¹ããµã«ã®ç ç©¶ããECTã¯ä¸»ã«æµ·é¦¬ã«ãããè³ã®å¯å¡çãªå¤åï¼ç¥çµæ°çãè¡ç®¡æ°çãªã©ï¼ãèªå°ãããã¨ãææããã¦ãããããã対象ã¨ããç ç©¶ã§ã¯ã2010å¹´ã«ECTãé é¨magnetic resonance imaging (MRI) ãç¨ãã¦æ¸¬å®ãããè³ã®æµ·é¦¬ã®ä½ç©ãå¢å¤§ãããã¨ãå ±åããã (Nordanskog et al., 2010)ããã以éãECTã«ããè³ã®ä½ç©å¤åã®å ±åãããã¦ããã
ãã®ãããªèæ¯ã®ãã¨ãæã ã¯ECTãæµ·é¦¬ã¨ææ¡ä½ã®ä½ç©ã«ä¸ããå½±é¿ã«é¢ãã¦ã·ã¹ãããã£ãã¯ã¬ãã¥ã¼ã»ã¡ã¿è§£æãè¡ããããã«ECTã«ããä½ç©å¤åã¨é¢é£ããè¨åºç¹æ§ããããã©ããã¡ã¿å帰åæãè¡ãªã£ãã
ã¡ã¿è§£æã§ã¯8ã¤ã®ç ç©¶ (193人) ã®ãã¼ã¿ãç¨ãã¦ãæ¨æºåå¹³åå·® (standardized mean difference: SMD) ãè¨ç®ããããã®çµæãECTã¯ï¼çå´ã»ä¸¡å´åºæ¿ã«é¢ãããï¼ä¸¡å´ã®æµ·é¦¬ã»ææ¡ä½ã®ä½ç©ãå¢å¤§ãããã¡ã¿å帰åæã§ã¯æµ·é¦¬ã®ä½ç©å¢å¤§ã¯å¹´é½¢ã¨è² ã®ç¸é¢ã示ãã ãããªãã¡ã海馬ã®ä½ç©å¤åã¯é«é½¢è ã»ã©å°ããå¯è½æ§ãããã¨ãããã¨ã§ãããããã¯ãã¦ã¹ã§å¾ãããå¹´é½¢ã¨å¯å¡çå¤åã®ç¥è¦ãããªãã¡é«é½¢ãã¦ã¹ã»ã©ECTã«ããæµ·é¦¬ã®å¯å¡çå¤åãå°ããã¨ããç¥è¦ã¨çç¾ããªãã
ããããMRIã§æ¸¬å®ããããä½ç©ã®å¢å¤§ãã¯ä½ãæå³ããã®ã ããããããã®è³ã«ããããä½ç©ã®å¢å¤§ãããããããã¯ããªå¤åã¾ã§ã¯ç¾æç¹ã®æè¡ã§ã¯ããããªãããä»å¾ã®æè¡çºå±ãå¾ ã¤ã»ãã¯ãªããå°ãªãã¨ãECTã«ããæµ·é¦¬ã®å¤åã¯ãæ¡æ£ãã³ã½ã«ç»åãªã©ã®ç ç©¶ããåãªãæ°´åã®ç§»åãããªãã¡æµ®è «ã®å½±é¿ã§ãªããã¨ã¯ç¤ºããã¦ããããã®ä»ããã¦ã¹ã¨ãµã«ã®ç ç©¶ããããã£ã¦ãããã¥ã¼ãã³ãã°ãªã¢ãè¡ç®¡ãªã©ãã¯ããªå¤åã«ã¤ãã¦ã®å¤åã¯è«æã®Discussionãåç §ããããã
ã¾ããä½ç©å¤åã®è¨åºçãªæç¾©ã¯ä½ã ããããæ®å¿µãªããä»åã®ã¡ã¿è§£æã§ã¯ECTã«ããæµ·é¦¬ã®ä½ç©å¢å¤§ã¨è¨åºçç¶ã®æ¹å度åãã«æ£ã®é¢é£ãããã¨ããåç´ãªçµè«ã¯è¦ãã ããªãã£ããå¦å®çãªè¦æ¹ãããã°ãECTã«ããæµ·é¦¬ã®ä½ç©å¤åã¯é»æ°åºæ¿ãããã¯çºä½ã«ããåãªãå¯ç£ç©ã§è¨åºçæç¾©ã¯ãªãã®ãããããªããå¥ã®å¯è½æ§ã¨ãã¦ã¯ã海馬ã®ä½ç©å¤åã¯è¨åºçç¶ã®æ¹åã§ã¯ãªãECTã«ããèªç¥æ©è½ã®å¤åãåæ ãã¦ããã®ãããããªãããããECTã«ããæµ·é¦¬ã®ä½ç©å¤åã¨èªç¥æ©è½ã®å¤åã調ã¹ãå¯ä¸ã®ç ç©¶ã§ã¯ããã®é¢é£æ§ã¯å¦å®çã ã£ããç¾æç¹ã§ã¯ECTã¨æµ·é¦¬ã®ä½ç©å¤åã«ã¤ãã¦ã¡ã¿è§£æã®çµæããæ©æ¥ã«çµè«ã¥ããã®ã§ã¯ãªããè¨åºçç¶ã®è©³ç´°ãªè©ä¾¡ãããåå¥ã®ãã¼ã¿ãç¨ããå¤å¤éè§£æã夿½è¨å ±åç ç©¶ã«ããå¤§è¦æ¨¡ãªãã¼ã¿è§£æã«ããæ¤è¨ããå¿ è¦ãããã¨èããããã
(é«å®®å½°ç´ã2018.4.23.)
è§£èª¬ãæ´¾æãªæ²»çã®çå®ãªç ç©¶
ãã¤ç
ã®æ²»çã«çå£ã«åãçµãã§ããè¨åºå»ã§ããã°èª°ã§ãã黿°ããããçæ³(ECT)ã®åçãªå¹æã宿ãã¦ãããç¹ã«ãæé度ã®ãã¤ç
æ£è
ã®è¦æ©ãç´è¦ããã°ãECTãªãã§ã¯ç²¾ç¥ç§ã®è¨åºã¯ã¨ã¦ããããªãã¨ãã£ã¦ãéè¨ã§ã¯ãªãã
ãããã1930年代ããè¡ããã¦ããæ²»çã§ããã«ãããããããECTã®çºå±ã¯æ¸æ»ãã¦ããã
ãã®åå ã®ä¸ã¤ã¯åè¦ãããä¸ã¤ã¯æ©åºã䏿ãªãã¨ã§ããã
åè¦ã®æ¹ã¯é·ãæéãããã¦è§£æ¶ãã¦ãã¦ããããæ©åºã®æ¹ã¯æéã ãã§ã¯æããã«ãªãã¯ãããªããç ç©¶ãå¿
è¦ã§ãããã¨ã¯èªæã ããããªã®ã«ç ç©¶ã¯é
ã
ã¨ãã¦é²ãã§ããªããECTãæ½è¡ãããã®ã¯éçãªãã¤ç
ã«éãããã®ãéä¾ãªã®ã§ãçµ±è¨çãã¼ã¿ãåºãã«è¶³ããµã³ãã«ãµã¤ãºããªããªãå¾ãããªããã¨ããã®ä¸»å ã®ä¸ã¤ã§ãã£ãã
ããã§é«å®®å¤§å¦é¢çã¯ã¡ã¿è§£æãè¡ã£ããè§£æã®å¯¾è±¡ã¨ãªã£ãè«ææ°ã¯8æ¬ã§ã決ãã¦å¤§è¦æ¨¡ãªç ç©¶ã¨ã¯è¨ããªãããBritish Journal of Psychiatryã¨ãã䏿µèªãé«ãè©ä¾¡ãæ¡ç¨ããèæ¯ã«ã¯ãECTã¨ããéè¦ãªæ²»çæ³ããããä¸è¨ã®äºæ ã大ããã¨ã¿ãã®ã妥å½ã§ãããã
çµæã¯ããæå³ãå°å³ãªãã®ã§ãã£ããECTãæ½è¡ããã¨æµ·é¦¬ã®ä½ç©ãå¢å¤§ãããããã®åº¦åãã¯å¹´é½¢ã¨è² ã®ç¸é¢ã示ããã¨ãããã®ã§ããã
ã§ã¯ãã®ä½ç©å¤åã¯ä½ãæå³ããã®ããå½ç¶èå³ã¯ããã«ç§»ãããé«å®®é¢çã¯æ´¾æãªèå¯ããããã¨ã¯é¿ããæ·¡ã
ã¨äºå®ã®ã¿ãç¶´ã£ã¦ããã
è«æã®Discussionã«ã¯ãClinical relevance of hippocampal changesã¨ããsectionããããã¤ãä»ãé£ã°ãã¦ãããèªã¿ãããªãããããé«å®®é¢çã«ããã°ããã®sectionã¯å½åã®ãã©ããã«ã¯ãªããBr J Psychiatryã®editorããã®æç¤ºã§å¾ãã追è¨ããã¨ã®ãã¨ã ã£ãã
ããæã£ã¦èªããããããã®é¨åã®æç« ã¯ä»ã¨ã¯éããæ¬å½ã¯è¨ããããªããã¨ãè¨ãããã¦ãããããªé°å²æ°ãæããããããã®ãããªæ¨å®çãªèå¯ãè¨ãã®ã¯èè
ã¨ãã¦ä¸æ¬æã ã£ãã®ãããããªãã(é«å®®é¢çæ¬äººã«ã¯æªç¢ºèªã§ããã)
è«æã®Conclusionã¨ãã¦è¨ããã¦ããã®ã¯ããã ãã§ãã:
ECT increased brain volume in the limbic structures. The clinical relevance of volume increase needs further investigation.
確åºããçµæã¯å¾ããããçµæããã®éå°ãªæ¨å®ã¯ããªãããã ããããã®ç ç©¶ã®åå°ã¨ãã¦ã®ãã¼ã¿ãæä¾ããã®ã¿ãããã¯ç§å¦ç ç©¶è«æã®æ¬æ¥ããã¹ãå§¿ã§ãããé«å®®é¢çã®ä¸è²«ããç ç©¶å§¿å¢ã§ããããECTã®ä½ç¨æ©åºã¯ãæå ç«¯ã§æ³¨ç®ãããåéã§ããã ãã«ä¸å±¤ãæ´¾æãªçµè«ã«é£èºããªãå·éãªé«å®®é¢çã®çå®ãªåé²ã«æå¾ ãããã
(ææ¾å¤ªéã2018.4.25.)
(S,S)-18F-FMeNER-D2ãç¨ãã大è³ç®è³ªã«ããããã«ã¨ããããªã³ãã©ã³ã¹ãã¼ã¿ã¼ã®å®éè©ä¾¡
森å£ç¿ã(Research Imaging Centre, Centre for Addiction and Mental Health, Canada)PET Quantification of the Norepinephrine Transporter in Human Brain with (S,S)-18F-FMeNER-D2.
Moriguchi S, Kimura Y, Ichise M, Arakawa R, Takano H, Seki C, Ikoma Y, Takahata K, Nagashima T, Yamada M, Mimura M, Suhara T.
J Nucl Med. 2017 Jul 58(7): 1140-1145
ãæ¬ç ç©¶ã«ã¤ãã¦ã
ãã«ã¨ããããªã³ã¯èªç¥æ©è½ããã¤ç
ãã¯ããã¨ããç²¾ç¥ç¾æ£ãªã©ã«ããã¦éè¦ãªå½¹å²ãæããã¦ãããã¨ãç¥ããã¦ãããããã¾ã§ãæãã¤è¬ã®ä½ç¨ã¡ã«ããºã ã«é¢ããç ç©¶ããã¤ç
æ£è
ã®æ»å¾è³ç ç©¶ããã¤ç
ã®ã¢ãã«åç©ã®ç ç©¶ã«ããããã¤ç
ã®ç
æ
ççã®1ã¤ã¨ãã¦è³å
ã®ç¥çµä¼éç©è³ªã§ãããã«ã¨ããããªã³ã®é¢ä¸ã示åããã¦ããããã®ä¸ã§ãæãã¤è¬ã®ã¿ã¼ã²ããã«ããªã£ã¦ãããã«ã¨ããããªã³ãã©ã³ã¹ãã¼ã¿ã¼ã¯æ³¨ç®ããã¦ãããããããçä½å
ã§ç´æ¥è¦³å¯ãããã¨ã¯ããã¾ã§å°é£ã§ãã£ããããããè¿å¹´ãçä½å
ã®ãã«ã¨ããããªã³ãã©ã³ã¹ãã¼ã¿ã¼ã®å¯åº¦ãPETã§å®éåãããã¨ãå¯è½ã¨ãªã£ããç¾å¨ã使ç¨ããã¦ãããã«ã¨ããããªã³ãã©ã³ã¹ãã¼ã¿ã¼ã対象ã¨ãã2ã¤ã®ä¸»ãªãªã¬ã³ãï¼(S,S)-11C-MRB ã(S,S)-18F-FMeNER-D2ï¼ã¯è¦åºãè³å¹¹ã§å®éå¯è½ã§ã¯ãã£ããããã®ä»ã®å¤§è³ç®è³ªã§ã®æ¸¬å®ã¯å°é£ã§ãã£ãããã®çç±ã¨ãã¦(S,S)-11C-MRBã¯ãªã¬ã³ãã®åæ
ãå®å®ããããã«ã¨ããããªã³ãã©ã³ã¹ãã¼ã¿ã¼å¯åº¦ã®ä½ãç®è³ªã§ã®æ¸¬å®ãå°é£ã§ãã£ãã䏿¹ã§(S,S)-18F-FMeNER-D2ã§ã¯ãªã¬ã³ãã®åæ
ã¯å®å®ãã¦ãããã®ã®ãªã¬ã³ãã®è±ããç´ åã«ãã18Fã¤ãªã³ã骨ã«èç©ãã¦ãã¾ããæ¾å°è½ãç®è³ªã¸å½±é¿ãä¸ãã¦ãã¾ãããã¾ã§ã®å®éæ¹æ³ã§ã¯å¤§è³ç®è³ªã§ã®æ¸¬å®ã¯å°é£ã¨ãªã£ã¦ãããããã§æ¬ç ç©¶ã«ããã¦ã大è³ç®è³ªã§ã®å¯åº¦ã®æ¸¬å®ãå¯è½ãã©ãããæ¤è¨ãããã¾ãã240åéæ®åãã(S,S)-18F-FMeNER-D2ã®PETç»åãã18Fã¤ãªã³ã骨ã«èç©ããªãæéå¸¯ãæ½åºããããã®çµæã0åãã90åã®æé帯ã§å®éãããã¨ã«ãã£ã¦ããã¾ã§å°é£ã§ãã£ãç®è³ªã«ããããã«ã¨ããããªã³ãã©ã³ã¹ãã¼ã¿ã¼å¯åº¦ã®æ¸¬å®ãå¯è½ã¨ãªããã¨ãããã£ãã
ãçå¦ã«ã¤ãã¦ã
ç§ã¯ç¾å¨ããã³ã大ã«ä»å±ããCAMH(Centre for Addiction and Mental Health)ã¨ããç ç©¶æ½è¨ã«ã¦æ°åé害ã対象ã¨ããPETç ç©¶ãè¡ã£ã¦ããã¾ãããã¡ãã®æ½è¨ã§ã¯æ¥æ¬ã§è¡ã£ã¦ããPETç ç©¶ã¨ææã§ã¯ä¼¼ã¦ããé¨åãå¤ãã®ã§ãããæ¥æ¬ã¨ã®ç ç©¶ã®ããæ¹ã®éããããè²ã
ã¨åå¼·ã«ãªãã¾ããä¾ãã°ã被é¨è
ã®ãªã¯ã«ã¼ããããããã«ã«ãã§ã«åéã®ãã©ã·ãè²¼ã£ã¦ãããªã©æ¥æ¬ã§ã¯ãã¾ãè¦ãããªãå
æ¯ã§ããã¾ãPETç ç©¶ã§ã¯ãã¬ã¼ãµã¼ã«ãã£ã¦ã¯åèè¡æ¡è¡ãé »ç¹ã«è¡ããªããã°ãªããªããã¬ã¼ãµã¼ããããç§ãåå ãã¦ããããã¸ã§ã¯ãã§ã¯åèè¡æ¡è¡ãå¿
è¦ã¨ãã¾ããæ¥æ¬ã§åèè¡æ¡è¡ãè¡ãå ´åã¯æ¡è¡ãã鿬ã代è¬ç©ã®æ¸¬å®ã¾ã§å»å¸«ãè¡ãç¯å²ãåºããã䏏䏿¥ãããã®å¤§ä»äºã§ãã䏿¹ã§ããã³ãã§ã¯åæ¥ãé²ãã§ããåèã©ã¤ã³ãåãå°éã®äººãããããæ¡è¡ã鿬ãã人ããããã¨ãã²ã¨ãã²ã¨ãã®å½¹å²ãæç¢ºã«åããã¦ãã¾ãã人件費ã¯ãããã®ã§ãããããããå°éã®äººãè¡ãããããªãã¹ã ã¼ãºã§ããçå¦éå§å½åãæåãè¨èã®å£ãããæ¸æããã¨ãå¤ãã£ãã®ã§ãããåå¹´ã»ã©ãã¤ã¨ãã¡ãã®ç ç©¶ç°å¢ã«ã¯å¾ã
ã«æ
£ãã¦ãã¾ãããã¨ã¯è¨ã£ã¦ãã¾ã ããããªããã¨ãå¤ããã¹ã ã¼ãºã«ç ç©¶ããããããã¨ã¯ã¾ã ã¾ã é£ããã®ã§ã©ãã®æ¦åã«ãªããããä»å¾ä¸å±¤åªåãããã¨æã£ã¦ãã¾ãã
(森å£ç¿ã2018.3.1.)
解説ãç²¾ç¥å»å¦å¥¨å±è³åè³
æ¬ãµã¤ã2017å¹´2æããã¤ç ã«ããããã«ã¨ã¨ããããªã³ãã©ã³ã¹ãã¼ã¿ã¼å¯åº¦ã¨æ©è½ã®æ¤è¨ã(è«æåºçã¯2017å¹´1æ)ã®å·çè ã®æ£®å£ç¿å士ã2017å¹´7æã«åºçããè«æã§ããããããã®è«æãã¯ããã¨ããä¸é£ã®ä»äºãç²¾ç¥ç¥çµå¦ä¼ããããã«ã¨ããããªã³ã»ãã©ã³ã¹ãã¼ã¿ã¼ã®PETç ç©¶ã«åãçµã¿ãä¸çåã®æè¦ãªã©ã®å é²çãªææãè¤æ°ã®åªããè«æã¨ãã¦çºè¡¨ãã¦ãããã¨èªããããæ£®å£å士ã¯2017å¹´ã®ç²¾ç¥å»å¦å¥¨å±è³ãåè³ããã
https://www.jspn.or.jp/modules/activity/index.php?content_id=45
ãã®è³ã¯ãç²¾ç¥å»å¦ã®çºå±ã®ããé¡èãªæ¥ç¸¾ãä¸ããè¥æ(40æ³æªæº)ã®ç ç©¶è ã表彰ããå¶åº¦ã§ãããç²¾ç¥å»å¦ã®å¦åçãªã¬ãã«ã®åä¸ãå³ãç®çã§è¨ç½®ããããã®ã§ãæ ¶å¤§å¤§å¦é¢æä»£ã«çæããPETç ç©¶ãç¾å¨çå¦ä¸ã®CAMH(Centre for Addiction and Mental Health, Canada)ã§çºå±ããã¦ããæ£®å£å士ã®ç ç©¶ã¹ã¿ã¤ã«ã»æ¥ç¸¾ã«ã¾ãã«ãµãããããã®ã§ããã¨è¨ããããããã¤ç ã®PETç ç©¶ãç©¶ããã(æ¬ãµã¤ã2017.2ã®è§£èª¬ã®ã¿ã¤ãã«)ãã®ãã®ã®éããå½¼ã¯æ©ã¿ã¤ã¤ããã
(ææ¾å¤ªéã2018.3.24.)
髿©è½èªéã¹ãã¯ãã©ã çå
ã好ãå¤è¦ã®å¥½ã¿ã«ã¤ãã¦ã®äºåçç ç©¶ï¼æ²»çç®çã®ä½¿ç¨ã¸ã®ç¤ºå
çå´åä¸ã(éæ²¢å¤§å¦åã©ãã®ãããã®çºéç ç©¶ã»ã³ã¿ã¼ãç¹ä»»åææ)Kumazaki H, Warren Z, Muramatsu T, Yoshikawa Y, Matsumoto Y, Miyao M, Nakano M, Mizushima S, Wakita Y, Ishiguro H, Mimura M, Minabe Y, Kikuchi M. A Pilot Study for Robot Appearance Preferences Among High-Functioning Individuals with Autism Spectrum Disorder: Implications for Therapeutic Use. PLOS ONE.
doi.org/10.1371/journal.pone.0186581
ãæ¬ç ç©¶ã®ç®çãæè¿ã®ããããæè¡ã®é²æ©ã¯èãããå»çç¨ããããã®æ´»èºãç®è¦ãããã®ããããããããã¯ãã®æ¯ãèãã«è¦åæ§ãèªãããã¨ãç´°ããåãã®èª¿æ´ãå¯è½ãªãã¨ãèªéçã¹ãã¯ãã©ã (Autism Spectrum Disorder: ASD)å ãç±ä¸ãã¦ããããã«é¢ãããã¨ãåã³ASDå ã®å ·ä½çã»è¦è¦çãªå¼·ããèæ ®ããã°ãããããã®ãã¯ããã¸ã¼ãASDå ã«å¯¾ãã¤ã³ã¿ã©ã¯ã·ã§ã³ãä¿ãéå ·ã¨ãã¦æç¨ã§ããã¨æå¾ ããããå®éãASDå ã®ã³ãã¥ãã±ã¼ã·ã§ã³è½åãç¤¾ä¼æ§ã®æ¹åãç®æãããããããç¨ããã»ã©ãã¼ã®ã¨ããã³ã¹ãèç©ããã¦ãã¦ãããã¨ããã§ããããã»ã©ãã¼ã«ããã¦ããããã®å¤è¦ãè¡åãåã©ããã¡ã«ä¸ããå½±é¿ã¯å¤§ããã課é¡ãå¤ãã®ãç¾ç¶ã§ãããASDå ã¸ã®ä»å ¥ã«ç¨ããããããã«ã¯ãããã«å¤è¦ã®è¿ããã¥ã¼ããã¤ãããããããå¤è¦ã人ã«ã¯ç¨é ãããã³ãã¥ã¼ããã¤ãã¾ã§å¤æ§ã§ããã好ã¿ã®å¹ ãçãASDå ã¸ã®ä»å ¥ã«ããã¦ãåã ã®å ã®ç¹å¾´ãä»å ¥ã«åããã¦é©åãªããããã鏿ãããã¨ãéè¦ã«ãªãã
ãç ç©¶ã®æ¦è¦ãæ¬ç ç©¶ã§ã¯10æ³ãã17æ³ã®é«æ©è½ASDå 16åã対象ã¨ããã (1)æäººå¥³æ§åããããã(2)å°åã®äººéåããããã(3)ã¬ãããã¿åããããã®3ä½ãå¥ã ã®è¨ºå¯å®¤ã«é ç½®ãããå ã¯å»å¸«ã®æç¤ºã®ãã¨ã診å¯å®¤ã«å ¥å®¤ãåããããã¨ãããã5åç¨åº¦ã®é¢ãããæã£ããåããããã«ã¯PCãç¨ãã¦é éæä½ã§ä¼è©±ãè¡ããç¶æ³ãä½ã£ããå»å¸«ã¯å ã¨ããããã¨ã®é¢ããã観å¯ãè¨é²ãããã¾ãäºå¾ã«å ãæ¯è¦ªããã¢ã³ã±ã¼ã調æ»ãè¡ã£ããå¹´é½¢ãèªéçã¹ãã¯ãã©ã ææ°(Autism-Spectrum Quotientï¼AQ)ãWISC-â £ãããã£ã¼ã«ã¨ã®ç¸é¢ã«ã¤ãã¦æ¤è¨ãããASDå ãã·ã³ãã«ãªãã®ã好ãç¹æ§ãããå°åã®äººéåãããããã¬ãããã¿åããããã好ãå ãå¤ããã¨ãäºæ³ãããä¸ã§ãAQï¼èªéçã®éç度ï¼ã®é«ã群ã§ã¯ãããæäººå¥³æ§åããããã好ãã¨ã®çµæãåºããèæ¯ã«ãAQã®é«ã群ã§ã¯æå ç«¯ã®æè¡ã好ãå¾åãé«ããã¨ã大人ã£ã½ãé¡ã好ãå¾åããããã¨ãå½±é¿ãã¦ããå¯è½æ§ã示åããããASDå ã«ã¨ã£ã¦ã·ã³ãã«ãªå¤è¦ãæã¤ã¨ããè¦ç´ ã¯éè¦ã§ããããæäººå¥³æ§åãããããç身ã®äººéããã¯è¡¨æ ãã·ã³ãã«ã§ããã¨ãããã¨ãéè¦ã¨èãããããASDå ã®ã»ã©ãã¼ã«ããã¦ãããããã®å¤è¦ãã©ãã¾ã§ã·ã³ãã«ã§ããå¿ è¦ããããã«ã¤ãã¦ã¯ä»å¾ã®èª²é¡ã¨ãªã£ãã
(çå´åä¸ã2018.2.15.)
ã¢ã«ããã¤ãã¼ç
ã«ãããæ°åå¤æèª²é¡ã¨è¨ç®èª²é¡ã®æç¸¾ã®é¢ä¿ã«ã¤ãã¦
森山泰ï¼é§æ¨éç
é¢ç²¾ç¥ç§è¨ºçé¨é·ï¼æ£®å±±æ³°,åéç¸è±,ç§å±±ç¥å,ææ¾å¤ªé,䏿å°: ã¢ã«ããã¤ãã¼ç
ã«ãããæ°åå¤æèª²é¡ã¨è¨ç®èª²é¡ã®æç¸¾ã®é¢ä¿ã«ã¤ãã¦. ç²¾ç¥ç§æ²»çå¦ (32) 1355-1360, 2017.
æ°åå¤æèª²é¡ã¨è¨ç®èª²é¡ã¯å¿ è¦ã¨ãããèªç¥æ©è½ãªã©ã«ããã¦ã¯ç°ãªãé¨åãå¤ããã®ã®,æ°ãæä½ãã失ç®é¢é£ã®æ¤æ»ã¨ããç¹ã§ã¯å ±éãã¦ãã.ä»åããããã¯ã¢ã«ããã¤ãã¼ç ã«ãããè¨ç®èª²é¡ã¨æ°åå¤æèª²é¡ã®æç¸¾ã®é¢ä¿ã«ã¤ãã¦æ¤è¨ãã.対象ã¯Mini Mental State Examination (MMSE) 12ï½26ç¹ï¼18.2±4.3ï¼ã®very mildï½severe AD219ä¾ï¼ç·æ§101ä¾,女æ§118ä¾ï¼ã§, Clinical Dementia Ratingã¯0.5ï½3ã§ãã. å¿çæ¤æ»ã¨ãã¦MMSE, æè¨æç»ãã¹ã, RDST-J(the Japanese version of the Rapid Dementia Screening Test), è¨ç®èª²é¡ããããªã£ã. æ°åå¤æèª²é¡ã¯RDST-Jã«å«ã¾ãããã®ã§ã¢ã©ãã¢æ°åãæ¼¢æ°åã«å¤æãã2é¡ï¼209âäºç¾ä¹,4054âååäºååï¼ã¨,æ¼¢æ°åãã¢ã©ãã¢æ°åã«å¤æãã2é¡ï¼å ç¾å «åä¸â681,äºåäºåä¸â2027ï¼ãããªã,ããããæ£è§£ã§1ç¹ãã¤ãä¸ãããã(æé«4ç¹).
è¨ç®èª²é¡ (Serial 7 Subtraction test: 7 series)ã¯Japanese version of MoCA ã«å«ã¾ãããã®ã¨åæ§ã«100-ï¼,93-ï¼,86-7,79-7,72-7ã®ãããã5課é¡ããããªã£ã.䏿¹é ç¹ã¯å課é¡ã®æ£çæ°ãè©ä¾¡ãããã¨ãããMoCA-Jã®æ¹æ³ã¨ã¯ç°ãªãããããæ£è§£ã1å¾ç¹ã¨ããï¼æé«5ç¹ï¼.
çµæã¯è¨ç®èª²é¡ã¨æ°åå¤æèª²é¡ã¯ä¸ç度ã®ç¸é¢ã示ããã®ã¿ãªãã,ãããããMMSE,æè¨æç»ãã¹ãã¨ä¸ç度ã®ç¸é¢ã示ãã¦ãã.
æ°åå¤æèª²é¡ã¨è¨ç®èª²é¡ã¯å¿ è¦ã¨ãããèªç¥æ©è½ãªã©ã«ããã¦ç°ãªãé¨åãå¤ã䏿¹ã§,両課é¡ã¯æ°ãã®ãã®ãæä½ããã¨ããç¹ã§ã¯å ±éãã¦ãã.ãããä»åã®çµæã¯,æ°ã®æä½ã¨ãã£ãæ¯è¼ç髿¬¡ã®èªç¥æ©è½ã§ã¯ãªã,ç¸å¯¾çã«ä½æ¬¡ã®èªç¥æ©è½ã§ããæ³¨æé害ãé¢ä¿ãã¦ããã¨èããã®ã妥å½ã§ããã.
(森山泰ã2018.2.1.)
æ¥æ¬ã«ãããèªç¥çä»è·è
ã®å¿ççè¦çã«é¢ããäºæ¸¬å åï¼æ¨ªæçç ç©¶
è²æ¬æ¶¼ï¼æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ã»ç¥çµç§å¦æå®¤ã大å¦é¢å士課ç¨ï¼Predictive factors associated with psychological distress of caregivers of people with dementia in Japan: a cross-sectional study.
Shikimoto R, Sado M, Ninomiya A, Yoshimura K, Ikeda B, Baba T, Mimura M
Int Psychogeriatr. 2017 Nov 10:1-10. doi: 10.1017/S1041610217002289. [Epub ahead of print]
人å£ã®é«é½¢åã«ä¼´ãèªç¥çè æ°ã¯å ¨ä¸çã§æ¥å¢ãã¦ããããããå½ã«ããã¦ã¯ä¸çã«é¡ãã¿ãªãéãã§å¢å ããã¨äºæ¸¬ããã¦ãããèªç¥çè ã®å¤ãã¯èªå® ã«ã¦å®¶æã«ããä»è·ãåãã¦ããããèªç¥çä»è·è ã¯å¿ççè¦çãã¿ã¨ãããããæã«ãã¤ç ã®ãããªç²¾ç¥ç¾æ£ã«ãããããããã£ã¦ãããä»è·è ã®å¿ççè¦çã®ãªã¹ã¯ãæ¤è¨ãã¦ãããã¨ãéè¦ã§ããããããå½ã«ããã¦ååãªãã¼ã¿ã«ãã£ã¦ããããæ¤è¨ããå ±åã¯è¡ããã¦ããªããæ¬ç ç©¶ã®ç®çã¯ãæ¥æ¬ã«ãããèªç¥çä»è·è ã®å¿ççè¦çã« é¢é£ããäºæ¸¬å åãæ¤è¨ãããã¨ã§ããããã¶ã¤ã³ã¯æ¨ªæç ç©¶ã§ãæ¥æ¬ã«ãããèªç¥çã®çµæ¸çè©ä¾¡ã®ç ç©¶ã®ä¸é¨ã¨ãã¦å®æ½ããããã¤ã³ãã©ã¼ãã«ã±ã¢æé調æ»ã«åå ããã1,437åã®èªç¥çè ã¨ãã®ä»è·è ã対象ã¨ããã è©ä¾¡é ç®ã¯ãèªç¥çè ããã³ãã®ä»è·è ã®åºæ¬çèæ¯ã1é±éã®ã¤ã³ãã©ã¼ãã«ã±ã¢æéãBehavioral and Psychological Symptoms of Dementia (BPSD)ã¨ãã¦å¹»è¦ã妿³ãæ¼å¤éè»¢ãæ´è¨ãæ´åãä»è·æµæãå¾å¾ãç«ã®ä¸å§æ«ãç°é£ãæ§çé¸è±è¡çºã®æç¡çã¨ãããåæã¯ãä»è·è ã®å¿ççè¦çãKesslerâs Psychological Distress Scale (K6)ã§æ¸¬å®ãããã®äºæ¸¬å åãéå帰åæããã³ãã¸ã¹ãã£ãã¯å帰åæãç¨ãæ¤è¨ããããã®çµæãèªç¥çä»è·è ã®69ï¼ ã¯K6ç¹æ°ã5以ä¸ã§ã18ï¼ ã¯K6ç¹æ°ã13ç¹ä»¥ä¸ã§ãã£ããéå帰åæã®çµæãK6ç¹æ°ã¯èªç¥çè ã®BPSDã身ä½åä½µçãã¤ã³ãã©ã¼ãã«ã±ã¢æéãä»è·åº¦ãä»è·è ã®æ§å¥ãä»è·è ã®äººæ°ã¨é¢é£ããããã¸ã¹ãã£ãã¯å帰åæã®çµæãK6ã®ã«ãããªãã4/5ã¨ããå ´åãK6ç¹æ°ã¯èªç¥çè ã®BPSDã身ä½åä½µçãã¤ã³ãã©ã¼ãã«ã±ã¢æéãèªç¥çè ã¨ä»è·è ã¨ã®åå± ãä»è·è ã®äººæ°ãä»è·åº¦ã¨é¢é£ãããK6ã®ã«ãããªã12/13ã¨ããå ´åãK6ç¹æ°ã¯èªç¥çè ã®BPSDã身ä½åä½µçãä»è·è ã®æ§å¥ãã¤ã³ãã©ã¼ãã«ã±ã¢æéã¨é¢é£ãããããããã¹ã¦ã®è§£ææ¹æ³ã«ããã¦ãã¤ã³ãã©ã¼ãã«ã±ã¢æéãæ´è¨ãä»è·æµæãå¾å¾ã¯K6ç¹æ°ã¨é¢é£ãããã¾ãBPSDã®ä¸ã§ã¯ç¹ã«ãæ´è¨ (OR 2.03; 95%CI 1.48â2.77)ãä»è·æµæ (OR 2.35; 95%CI 1.72â3.22)ãå¾å¾ (OR 1.72; 95%CI 1.21â2.44) ã®ãªããºæ¯ãé«ããã¨ã示ããããæ¬ç ç©¶ã«ããã¦ãèªç¥çä»è·è ã®å¿ççè¦çã®ç¹æ°ã¯é常ã«é«ããèªç¥çè ã®BPSDãèªç¥çä»è·è ã«é¢é£ãã¦ãããã¨ã示ããããããã®çµæã¯å è¡ç ç©¶ã«ä¸è´ãã¦ãããä»å¾ã¯ãèªç¥çè ã®ç²¾ç¥çç¶ãæ¹åããããä»è·è ã®è² æ ã軽æ¸ãããããªä»å ¥ã®éçºãæ±ãããã ã
(è²æ¬æ¶¼ã2018.1.15.)
解説ãäººãæ¯ããããã«
éè¦ãå¢ããã¨ããäºæ¸¬ãããã°å¢ç£ãããã¹ãããå¢ããã®ãªãé»åæ©å¨ãå¢ç£ããã人å£ãå¢ããã®ãªã飿ãå¢ç£ãããã¤ã³ãã«ã¨ã³ã¶ãå¢ããã®ãªãã¯ã¯ãã³ãå¢ç£ãããæ¨å®ãããéè¦å¢ã«å¿ããæ°ã確ä¿ãããã¨ãå°æ¥ã®å®å®ã¸ã®éµã§ããã
ãã ãéè¦ãã人ãã®å ´åãããåç´ã«ã¯ãããªãã
å»å¸«ä¸è¶³ãäºæ¸¬ããããããå»å¦é¨ã®å®å¡ãå¢å¡ãããã ãå»å¸«ã®æ°ã ãããããå¢ãã¦ããå°ååå¨ãè§£æ¶ããªããã°ãåé¡ã®è§£æ±ºã«ã¯ãªããªããäººã¯ææãæã£ã¦ããã人ã¯å¿ãæã£ã¦ãããå¿
è¦ãªæ°ã ããããæ£ç¢ºã«è¨ç®ãã¦ããè¡åã¾ã§ã¯è¨ç®ã§ããªãã
ããããã®æ¥æ¬ã§ç¢ºå®ã«éè¦ãå¢ããã®ã¯ãé«é½¢åã«ä¼´ãèªç¥çã®å¢å ã«ä¼´ãä»è·è ã§ãããèªç¥çæ£è ã®å¤ãã¯å®¶æããä»è·ãåãã¦ããããã®éãã«ããã¦ä»è·è ã®æ°ã¯å è¶³ããã¦ããããã«è¦ãããã ãããã¯éè¦ãã人ãã§ããã¨ããéè¦ãªäºé ãç¡è¦ããæ½è±¡è«ã§ãããèªç¥çã®ä»è·ã«ã¯ã¹ãã¬ã¹ãã¤ããã®ã§ãããã¹ãã¬ã¹ã®ããã«ä»è·è ããã¦ã³ããã°ãèªç¥çãæ¯ããåå°ãå´©ããåå°ãå´©ããã°ãã¹ã¦ãå´©ããã
èªç¥çãæ¥éã«å¢å ãããã¨ãããã£ã¦ããªããçéããã¦ãããã®ä»è·è ã®å¿ççè¦çã®åé¡ããè²æ¬æ¶¼å¤§å¦é¢çã®å¦ä½è«æã®ãã¼ãã§ãããèªç¥çã«ä¼´ãå¤å½©ãªçç¶ããæ¬ç ç©¶ã«ãã£ã¦æ½åºãããé ç®ã¯ããã®ã¾ã¾åªå çãªæ²»çã¿ã¼ã²ããã«ãªãããªã¢ã«ã¿ã¤ã ã§å¢ãç¶ããèªç¥çãåã«ãã¦ããããèªç¥çã®æ ¹æ²»çæ³ãã¾ã ã¾ã è¦åºããªãç¾å¨ããã¾ä½ããã¹ãããä½ã«åãæ³¨ãã¹ããã®æ±ºå®ããå»çè ã«ã社ä¼ã«ãæ±ãããã¦ãããæ¬ç ç©¶ã¯ãèªç¥çãæ¯ããåå°ã§ããä»è·è ãæ¯ããããã®è²´éãªãã¼ã¿ã示ãã¦ããã
(ææ¾å¤ªéã2018.1.30.)
ã¢ããã¤ãPETã®çµæåç¥ãæ¥æ¬äººé«é½¢è
ã«ä¸ããå¿ççå½±é¿ ã¼çç¶ã®ãªãèªè¦çèªç¥æ©è½ä½ä¸è
ã«é¢ããäºåç調æ»ã¼
åæ°£å¤§æï¼æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ã»ç¥çµç§å¦æå®¤ãç ç©¶å¡ï¼Wake T, Tabuchi H, Funaki K, Ito D, Yamagata B, Yoshizaki T, Kameyama M, Nakahara T, Murakami K, Jinzaki M, Mimura M. The psychological impact of disclosing amyloid status to Japanese elderly: a preliminary study on asymptomatic patients with subjective cognitive decline. Int Psychogeriatr. 2017 Nov 2:1-5. doi: 10.1017/S1041610217002204. [Epub ahead of print]
åç¥ã¯å¿ççã«ã害ããªããã®ãï¼
ââããªãã¯ã10å¹´å¾ã«ã¢ã«ããã¤ãã¼ç ãçºçããå±éºæ§ãé«ãã§ã
ããããçºçå診æãæè¡çã«å¯è½ã«ãªãã¤ã¤ãããã¢ã«ããã¤ãã¼ç ï¼ADï¼ã®çç¶ãã¾ã ç¾ãã¦ããªããã®ã®ããã®åå ã¨ãããã¢ããã¤ãããã±ã質ãç°å¸¸ã«èç©ãã¦ããæ®µéã¯ããã¬ã¯ãªãã«ã« ADã¨å¼ã°ãããADã®æ ¹æ²»ã«ã¯ããã®ãã¬ã¯ãªãã«ã« ADã«ãããè¶ æ©æã®ä»å ¥ãå¿ è¦ã¨ã®æè¦ãå¼·ã¾ã£ã¦ãããè¨ºææ¹æ³ã¨ãã¦ã¯ãã¢ããã¤ãPETã«ããè³ç»åæ¤æ»ãæåã¨ãããã
ããã§éè¦ã¨ãªãã®ããæ¬¡ã®åãã§ãããããªãã¡ãæ ¹æ²»è¬ããªãç¾å¨ããã®çµæãåç¥ãããã¨ã¯å«ççã«æ£ããè¡çºãªã®ãããããã¯ééã£ããã¨ãªã®ãï¼ããã«çããã¹ããã¾ãã¾ãªè¦³ç¹ããè°è«ãç¶ãããã¦ãããã䏿 ¸çãªè«ç¹ã®ã²ã¨ã¤ã¯ãåç¥ã«ããå¿ççãªæªå½±é¿ã§ããã
ã¨ãããè峿·±ããã¨ã«ãã¢ããã¤ãPETã«ããçºçå診æã®åç¥ãä¸ããå¿ççãªå½±é¿ã«ã¤ãã¦ã¯ã»ã¨ãã©ããã£ã¦ããªããã¨ããããç¥çµå¿çå¦çæ¤æ»ãªã©ã®å®¢è¦³çãªè©ä¾¡ã§ã¯èªç¥æ©è½ãæ£å¸¸ã§ããããèªè¦çãªèªç¥æ©è½ã®ä½ä¸ï¼Subjective Cognitive Decline: SCDï¼ã®ããç¾¤ã¯æ³¨æãè¦ããããªããªãSCD群ã¯ADã®åé§çç¶ã¨èãããããã¨ã«å ããSCDã®ãªãå¥å¸¸è ã¨æ¯è¼ãã¦ä¸å®ãæãã¤ãå¼·ãã¨ææããã¦ãããåç¥ã«å±éºæ§ãã¨ããªãããã§ããã
æ¬ç ç©¶ã§ã¯ã客観çã«ã¯èªç¥æ©è½ãæ£å¸¸ã§ããããèªè¦çãªèªç¥æ©è½ã®ä½ä¸ã®ãã群ï¼SCD群ï¼42åã«å¯¾ãã¦ã¢ããã¤ãPETã宿½ããADçºçã®ãé«ãªã¹ã¯ç¾¤ï¼n = 10ï¼ãã¨ãä½ãªã¹ã¯ç¾¤ï¼n = 32ï¼ãã®2群ã«ããããåç¥åã¨åç¥å¾6é±éå¾ã«ãç¶æ ä¸å®ããã³æãã¤ã測å®ããåç¥6é±å¾ã«ãã©ã¦ãã®ã¬ãã«ã測å®ããããã®çµæãç¶æ ä¸å®ã¨æãã¤ã®ã¬ãã«ã¯ã両群ã¨ãåç¥åå¾ã«ããã¦ã«ãããªãå¤ä»¥ä¸ã§æ¨ç§»ããåæç¹ã§ä¸¡ç¾¤ã®å¾ç¹ã«å·®ã¯ãªãã£ãããã©ã¦ãå¾ç¹ããåç¥6é±å¾ã§ä¸¡ç¾¤ã«å·®ããªãã£ãã
以ä¸ãããæ¥æ¬äººSCD群ã«å¯¾ãã¦ã¢ããã¤ãPETã®çµæãåç¥ãã¦ããçæçã«ã¯å¿çç¶æ ãæªåããªããã¨ã示åãããã
ããå½ã§ã¯ãADçºçå¾ã¯ããããçºçåã®åç¥ãä¸ããå¿ççãªå½±é¿ã«ã¤ãã¦å®è¨¼çãªç ç©¶ãã¾ã£ããè¡ããã¦ããªãã£ããããã«ãããããããã¢ããã¤ãPETãç ç©¶ã診æã®ããã«ä½¿ç¨ããçµæãåç¥ãã¦ããæ½è¨ãããã¨ã¿ããããããã«ããã¬ã¯ãªãã«ã«ADã対象ã«ã¢ããã¤ãPETãç¨ããå¤§è¦æ¨¡è¨åºç ç©¶ãè¿ãå§ã¾ããã¨ãã¦ããã
ãã®ãããªç¶æ³ã®ãã¨æ¬ç ç©¶ã¯ãADçºçå診æã®çµæåç¥ã®æ¯éã«é¢ãã¦ãå«ççåºç¤ãå®è¨¼çã«æä¾ãããã®ã¨èããããã
(åæ°£å¤§æã2017.12.1.)
解説ãããããã®å·
å·ãããå©ãã¦!ãã¨ãã声ãèããããè¦ãã°äººã溺ãã¦ãããå·ã«é£ã³è¾¼ã¿ãå©ãããããããã¨æã£ãã®ãæã®éãã¾ããå©ãã¦!ãã®å£°ãèããããé£ã³è¾¼ã¿å©ãããããã¨ã¾ããå©ãã¦!ãã®å£°ã»ã»ã»ãããå©ãã¦ãããããªããã§ã¯ã©ããããããã®ããå·ã®ä¸æµã«è¡ãã人ãå·ã«è½ã¡ãåå ãè¦åºã解決ããã¨ããã®ãçã«ãªãã
ããã¯ãå ¬è¡è¡çã®éè¦æ§ãè¿°ã¹ãã¨ãå¿ ãã¨è¨ã£ã¦ããã»ã©ã¤ã³ããã«ä½¿ãããæ¿è©±ã§ãããè¨ãã¾ã§ããªããå·ã«è½ã¡ã人ãå©ããã®ãé常ã®å»çã®æ²»çã§ã䏿µã§å¯¾çãè¬ããã®ãäºé²å»çã«ããã
ã¢ã«ããã¤ãã¼ç ã䏿µã§è§£æ±ºããéããã¾ãéãããã¨ãã¦ãããã¢ããã¤ãPETã«ããæ©æè¨ºæã§ããããã¬ã¯ãªãã«ã«ADãçºè¦ããå·ã«è½ã¡ãåã«ä½ã¨ãããã®ãã人å£ã®é«é½¢åãæ¥éã«é²è¡ãã¦ããæãå½ã®å ¬è¡è¡çã®å«ç·ã®èª²é¡ã§ããã
ã ãè¦éããªãã®ã¯ããã®å·ã®ãã¨ãã¯äºæ®µéããæã£ã¦ãããã¨ã§ãããç¬¬ä¸æ®µéã¯ã䏿µã«ããåå ã®åå®ãç¬¬äºæ®µéã¯ãã®åå ã®è§£æ±ºãå·ã«è½ã¡ãåå ãããã£ãããããã«æµãä½ãã°ãããã ãç¾å®ã¯ããç°¡åã«ã¯ãããªããã¢ããã¤ãPETã®å°å ¥ã«ãã£ã¦ãã¢ã«ããã¤ãã¼ç ã®å·ã¯ç¬¬ä¸æ®µéã«éãããç¬¬äºæ®µéã¯ã¾ã å ã§ãããåå ã ãåå®ããã¦ã対çã¯ã¾ã ãªããå·å ¨ä½ã管çããç«å ´ããã¯åå ã®åå®ã¯æå ±ã ããå½äºè æ¬äººã«ã¨ã£ã¦ã¯ããã¨ã¯éããªããããªãã¯ã¢ã«ããã¤ãã¼ç ã«ãªãã¾ããæ¢ãããã¨ã¯ã§ãã¾ããã以ä¸ãæ å ±æä¾ã§ããããããªæ å ±ã人ã¯ã»ãããã ããããããã£ã¦æ®ãã®äººçãæãããã ããªã®ã§ã¯ãªãããæ°ãã診ææè¡ã®è¯ãããã«æµ®ããããã¨ãªããå½äºè ã®ãã¨ãçæ¯ã«èããã°å½ç¶æ°ã«ãããªããã°ãªããªããã®åé¡ãããã¾ã§ã»ã¨ãã©ç¡è¦ããã¦ãã¦ããã¨ããç¾ç¶ã¸ã®çªç ´å£ãéããã®ããåæ°£ç ç©¶å¡ã«ããæ¬ç ç©¶ã§ããã
çµæã¯ä¸è¨ã®éãã§ãåç¥ã¯å¿ççã«å®³ããªããã¨ã¯ãªãã¨ãããã®ã§ãã£ããè«æã¿ã¤ãã«ã示ãéãããã¡ããããã¯ã¾ã äºåçç ç©¶ã®æ®µéã§ããããå®è¨¼ãã¼ã¿ã示ãããã¨ã®æç¾©ã¯å¤§ããã
äºé²ãæ©æä»å ¥ã®éè¦æ§ã説ãããã§å·ã®ãã¨ãã¯ç§é¸ã ããç¾å®ç¤¾ä¼ã¯ãããããã®äººãåãã²ã¨ã¤ã®å·ãæµãã¦ããããã§ã¯ãªããã²ã¨ãã²ã¨ãããããããã®å·ã®æµããçãã¦ããã®ã ã䏿µãã䏿µã«ãªã¢ã«ã¿ã¤ã ã§æµããå·ã®ä¸ã«äººã¯ããã®ã§ãã£ã¦ãé¡ããã¨ã¯ã§ããªããèªåã§å¤ãããããã¨ãããã¨ãã¦ããããã¯ä¸æµé¨åã ãã§ããã
åæ°£ç ç©¶å¡ã¯ãæ ¶æç¾©å¡¾å¤§å¦æ³å¦é¨æ¿æ²»å¦ç§ã忥ããå¾ãèªç±æ°ä¸»å æ¬é¨ã§8å¹´éå¤åããå¾ã«æ¸¡ç±³ãããã¼ãã¼ã大å¦å½éåé¡ç ç©¶æã§ãã§ãã¼ã1å¹´éåãããã®å¾ãã¹ãã³ã»ã«ã¬ãã¸ã§ã«ã¦ã³ã»ãªã³ã°å¿çå¦ãå¦ã³ä¿®å£«å·ãåå¾ããã¹ãã³ã®ã«ã¦ã³ã»ãªã³ã°ã»ã³ã¿ã¼ã§ã¡ã³ã¿ã«ãã«ã¹ã»ã«ã¦ã³ã»ã©ã¼ã¨ãã¦1å¹´éå¤åã帰å½ããã¨ããç°è²ã®çµæ´ãæã£ã¦ãããæ°¸ç°çºããå¿çè·ã«è»¢åããã®ã¯ãªãã?ã誰ããèããããªããã®åãã«åæ°£ç ç©¶å¡ã¯ã転åã§ã¯ãªãã¨çãããå½¼ã®é¢å¿ã¯ãããçããã¨ã¯ã©ããããã¨ããã¨ããä¸è²«ãããã®ã§ãããæ¿æ²»å¦ãå¿çå¦ããå½¼ã«ã¨ã£ã¦ã¯æ»çå¦ã«éããææ®µãªã®ã§ããã
äºé²å»çã¯éè¦ã ãã䏿µã°ãããè¦ã¦ããã¨ãä»ãã©ãçãããã¨ããæãéè¦ãªãã¨ãå¿ããããã¡ã§ãããå·ã®æä¸æµã«ããæ»ãæèãããã¨ããªããã°ã人ã«ã¨ã£ã¦çã«ä¾¡å¤ããå ¬è¡è¡çã¯æç«ããªãã§ããããã¢ã«ããã¤ãã¼ç ã彿°å ¨ä½ã®èª²é¡ã«ãªãã¤ã¤ããä»ãçã¨æ»ãè¦ã¤ããåæ°£ç ç©¶å¡ã®ä»å¾ã®ç ç©¶çºå±ãæå¾ ãããã
(ææ¾å¤ªéã2017.12.27.)
é«ç¨éã®æãã¤è¬ã¨NIRS波形
é«å®®ãå½°ç´ï¼æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨å¤§å¦é¢å士課ç¨ï¼High-dose antidepressants affect near-infrared spectroscopy signals: A retrospective study.
Takamiya A, Hirano J, Ebuchi Y, Ogino S, Shimegi K, Emura H, Yonemori K, Shimazawa A, Miura G, Hyodo A, Hyodo S, Nagai T, Funaki M, Sugihara M, Kita M, Yamagata B, Mimura M.
Neuroimage Clin. 2017 Feb 13;14:648-655.
è¿èµ¤å¤ç·ã¹ãã¯ããã¹ã³ã㣠(near-infrared spectroscopy: NIRS) ã¯ã大è³ç®è³ªæ©è½ãé侵襲çã«ç°¡ä¾¿ã«é«ãæéåè§£è½ã§æ¸¬å®å¯è½ãªæ¤æ»ã§ããè¨èªæµæ¢æ§èª²é¡ (Verbal Fluency Task: VFT) æ½è¡ä¸ã®è³è³¦æ´»ã®ç¹å¾´ããã¤ç ã忥µæ§é害ãçµ±å失調çã§ç°ãªããããæãã¤ç¶æ ã®éå¥è¨ºæè£å©ã¨ãã¦ãã®æç¨æ§ã示ããã¦ãããããå½ã§ã¯2014å¹´ãããæãã¤ç¶æ ã®éå¥è¨ºæè£å©ãã¨ãã¦NIRSãä¿éºåè¼ãããããã«ãªã£ã¦ãã¾ããããããåç²¾ç¥è¬ãNIRS波形ã«ä¸ããå½±é¿ãä½ç³»çã«èª¿ã¹ãç ç©¶ã¯åå¨ãã¾ããã§ãããããã§æã ã¯ãåç²¾ç¥è¬ã®å æéã¨NIRS波形ã®é¢é£ã調ã¹ãäºãç®çã«ã«ã«ã調æ»ãè¡ãã¾ããã
æ¬ç ç©¶ã®å¯¾è±¡ã¯ã2012å¹´ãã2015å¹´ã®éã«æ ¶æç¾©å¡¾å¤§å¦ç é¢ç²¾ç¥ã»ç¥çµç§ãæãã¤ç¶æ ã§å診ãã52ãã£ãã«ã®NIRSæ¤æ»ãåããã20æ³ãã65æ³ã®æ¹ã§ããNIRS波形ã®ä¸»ãªææ¨ã¯VFTæ½è¡ä¸ã®é ¸ç´ åãã¢ã°ããã³ã®å¹³åå¤ãç¨ãã¾ãããåç²¾ç¥è¬ã®å æéã¯æãã¤è¬ãæç²¾ç¥ç è¬ããã³ã¾ã¸ã¢ã¼ãã³ã«ã¤ãã¦WHOã®å®ããDefined Daily Dose (DDD)ã¨ãã1æ¥ãããã®å¹³åçæè¬éã®åºæºãç¨ãã¦è¨ç®ãã¾ããã
æ¬ç ç©¶ã§ã¯40ä¾ã®ãã¼ã¿ãè§£æã«ç¨ãã両å´åé å´é é¨ã®åºç¯ãªé åã§æãã¤è¬å æéã¨NIRS波形ã§è² ã®ç¸é¢ãèªãã¾ãã (FDRè£æ£p <0.05)ãç¹ã«å³å´é é¨ã®ãã£ãã« (ch22)ã®NIRS波形 ã¯å¹´é½¢ãæ§å¥ãæãã¤ã®éç度ã®å½±é¿ãèæ ®ãã¦ãææãªç¸é¢ããã (p = 0.002) ãããã«æãã¤è¬ãé常ç¨éãããå¤ã使ç¨ããã¦ããé«ç¨é群ã§ã¯é常ç¨é群ãããææã«NIRS波形ã®å¤ã¯å°ãããªã£ã¦ãã¾ãããããã«ãããå½ã«ããã¦éå¥è¨ºæè£å©ã¨ãã¦ä½¿ç¨ããã¦ããåé é¨éå¿å¤ãç¨ãã診æè£å©ã¸ã®åç²¾ç¥è¬ã®å æè¬éã®å½±é¿ã調ã¹ãã¨ãããæãã¤è¬ã®é«ç¨é群ã»ã©å極æ§é害ãçµ±å失調çã®NIRSãã¿ã¼ã³ã¨è¨ºæãããããå¾åã«ããã¾ãããæç²¾ç¥ç è¬ããã³ã¾ã¸ã¢ã¼ãã³ç³»è¬å¤ã§ã¯ææãªç¸é¢ã¯èªãããã¾ããã§ãããæ¬ç ç©¶ã®çµæã¯ãæãã¤è¬ã®å æéã¯NIRSæ¤æ»ã®çµæã«å½±é¿ãä¸ããå¯è½æ§ããããç¹ã«é«ç¨éã®æãã¤è¬ãå æãã¦ããå ´åã¯ãã®è§£éã«æ³¨æãè¦ãããã¨ã示åãã¦ãã¾ãã
(é«å®®å½°ç´ã2017.11.1.)
解説ãNIRSã¨ããè½
ç²¾ç¥ç¾æ£ã対象ã¨ããNIRSç ç©¶è«æ(è±æ)ã®2/3ãæ¥æ¬çºã§ãããã¨ä¸ã¤ãåã£ã¦è¦ã¦ããNIRSã¯ä»ã«ä¾ãè¦ãªãç¹ç°ãªå°ä½ãå ãã¦ããææ³ã§ãããã¨ãããããæ ¶æã§ã¯2012å¹´ã®å°å ¥ä»¥æ¥ã夿°ã®è¨åºä¾ãèç©ããã¦ãã¦ãããæ¬ç ç©¶ã¯é«å®®å¤§å¦é¢çãä¸å¿ã¨ãªããç²¾ç¥ç¥çµç§ã®å°æ»å»ã®å ±å使¥ã«ãã£ã¦å®æãããã®ã§ãå ±èè ã®å¤ãã¯å ¥å±2å¹´ç®åå¾ã®è¥ãå»å¸«ã§ããã
åç²¾ç¥è¬ãNIRS波形ã«å½±é¿ããã¨ããæ¬ç ç©¶çµæã¯ãç²¾ç¥çç¶ã®æ¹åã«æã广ãããæ²»çæ³ãåç²¾ç¥è¬ã«ããè¬ç©çæ³ã§ããã¨ããç¾å®ã«ç §ããã°ãNIRSã®æ³¢å½¢ã¯ç²¾ç¥ç¾æ£ã®çç©å¦çåå ã«ç´çµããæç¾©ãæãã¦ããã¨ããæ¨å®ãå°ããã¨ãå¯è½ã ããé«å®®é¢çã¯ãã®ãããªæ´¾æãªçµè«ã«é£èºãããã¨ãªãããæãã¤è¬ã®å æéã¯NIRSæ¤æ»ã®çµæã«å½±é¿ãä¸ããå¯è½æ§ããããç¹ã«é«ç¨éã®æãã¤è¬ãå æãã¦ããå ´åã¯ãã®è§£éã«æ³¨æãè¦ãã The results emphasize the need for caution when analyzing NIRS signals in patients receiving high dose of antidepressants. ãã¨ãããæå¶ã®å©ãã表ç¾ã«ã¨ã©ãã¦ããã
å é§çã§æ°ãããã¯ããã¸ã¼ã¯ãé大è©ä¾¡ããããããã®ã§ãããããã«ã¯äººã ã®æå¾ ããããNIRSã«æå¾ ãè¨ããã®ã¯å½ç¶ã§ãããç²¾ç¥ç§ã®è¨ºæã¯ç¾ä»£ã«ããã¦ããªã主観è³ä¸ä¸»ç¾©ã§ããããããªç²¾ç¥ç§ã®é·ãæ´å²ããNIRSã¯æ¸ãæ¿ããå¯è½æ§ãç§ãã¦ããããã ãããã¯ã¾ã å¯è½æ§ã«ãããªããå¯è½æ§ãæå¾ ã«æè¯ãããã¨ã¯æ¨å¥¨ãããããã ããã®æå¾ ãé大è©ä¾¡ã«ã¾ã§æ°´å¢ãããã°ãç è ã«ä¸å¹¸ãããããããããé²ãã®ã¯å»å¸«ã®å½¹å²ã®ã¯ãã ããæ®å¿µãªããNIRSã¯æãå½ã®è¨åºã®å ´ã§ãã§ã«æ¿«ç¨ãããèªå¤§åºåããã誤ã£ãè§£éãè©ä¾¡ãè·³æ¢è·æãã¦ãããããç ç©¶ã®å ´ã§ãåãäºãèµ·ããã°ãNIRSã«æªæ¥ã¯ãªããNIRSã®è«æã®2/3ãæ¥æ¬çºã¨ããç¾ç¶ã¯ãæ¥æ¬ãä¸çããªã¼ããã¦ããã¨è¦ããã¨ãã§ãã䏿¹ãå½é社ä¼ã¯NIRSã¨ããææ³ã«æå¾ ã¯æãã¦ããããæ¥æ¬ã®ç ç©¶ã«å·ããããªç®ãåãã¦ããã¨è¦ããã¨ãã§ãããNIRSã¨ããè½ã伸ã³ãã«æ¯ããããããã¨ã大ããæé·ãããã¯ãéçãè¦å®ãã¦ã®è¨åºã§ã®æ´»ç¨ã¨ãçå®ã«ãã¼ã¿ãç©ã¿éããç ç©¶ã®ç¶ç¶ã«ããã£ã¦ãããè¨åºçµé¨ãéããå¾ããããã¼ã¿ãã確å®ã«å°ãããã¨ã ããæç¤ºããé«å®®é¢çã®æ¬ç ç©¶ã¯ããããå®è·µãããã®ã§ããã
(ææ¾å¤ªéã2017.11.28.)
èªéã¹ãã¯ãã©ã çè
ã«å¯¾ãã¦ã¢ã³ããã¤ããé éæä½ãããã¨ãã表æ
çè§£ãä¿ãã表æ
表åºãå¢å ããã
çå´åä¸ (éæ²¢å¤§å¦åã©ãã®ãããã®çºéç ç©¶ã»ã³ã¿ã¼ãç¹ä»»åææ)Kumazaki H, Muramatsu T, Yoshikawa Y, Matsumoto Y, Miyao M, Ishiguro H, Mimura M, Minabe Y, Kikuchi M. Tele-Operating an Android Robot to Promote the Understanding of Facial Expressions and to Increase Facial Expressivity in Individuals With Autism Spectrum Disorder. American Journal of Psychiatry. 174(9) 904â905. https://doi.org/10.1176/appi.ajp.2017.17030257
ãå ±åã®ç®çãé¡ã®è¡¨æ 表åºã¯ææçéã«éè¦ã§ããããèªéã¹ãã¯ãã©ã çè ã§ã¯è¡¨æ 表åºã¯å°ãªããã¨ãç¥ããã¦ããã䏿¹ã§è¡¨æ 表åºãå¢ããããã®å¹æçãªæ²»çã«ã¤ãã¦ã®å ±åã¯ç¾å¨ã¾ã§ã»ã¨ãã©è¡ããã¦ããªãã
ãçä¾ã®æ¦è¦ãæ¬ä¾ï¼Aã¨ããï¼ã¯18æ³ã®é«æ©è½èªéã¹ãã¯ãã©ã çè
ã§ãããã³ãã¥ãã±ã¼ã·ã§ã³è½åæ¹åã®ããã«ç¾å¨ã¾ã§ãè¡åçæ³ãã¯ããã¨ããå¤ãã®ä»å
¥ãè¡ãããããã©ããæ¹åã«ã¯ã¤ãªãããªãã£ãã
ã¢ã³ããã¤ãã¯ããã«å¤è¦ãé
·ä¼¼ããããããã§ãçå¯ããé ¬å¼ããå¼å¸ã¨ãã£ãèªå¾åä½ã®ä»ã«å¾®ç¬ã¿ãããããããªããã¨ãã£ãé éæä½ã«ãããã³ãã¼ãã«ãªã³ãã¥ãã±ã¼ã·ã§ã³åã³å¯¾è©±ãå¯è½ã¨ãªã£ã¦ãããå§¿å¢ã®å¤åãé ãç®ã®åããè¸ã§å¼å¸ããæ§åã¨ãã£ã人éãããåãã®æ¨¡å£ã®ã»ãã対é¢ã«å±
ã人ã®ç°¡åãªåä½ï¼æãæ¯ããé¡ãåããããè¾åãªã©ï¼ãè¦è¦ã®ã·ã¹ãã ã§åå°ç¹ã追ããé¢ç¯ã®åããè¨ç®ãã追å¾ããããã¨ãå¯è½ã§ãåä½ãè¨æ¶ãåç¾ãããã¨ãã§ãããæã
ã¯è¢«é¨è
ãã¢ã³ããã¤ããæä½ããã¢ã³ããã¤ããéãã¦å¯¾è©±è
ã¨ä¼è©±ããã¨ããã·ã¹ãã ãç¨ãã¦ãAã«å¯¾è©±è
ã¨ã³ãã¥ãã±ã¼ã·ã§ã³ãã¦ããã ãããAã¯ã¢ã³ããã¤ããæä½ãããã¨ã§è¡¨æ
ãæã¤æå³ã¨ãã®éè¦æ§ã«ã¤ãã¦çè§£ã§ããããã«ãªã£ããã¢ã³ããã¤ããæä½ãã¦ä»¥æ¥ãæ¥ã
ã®çæ´»ã§ã表æ
ãåºãããã«ãªããã¾ãã³ãã¥ãã±ã¼ã·ã§ã³ã«ãèªä¿¡ãã¤ããã
ãæ¬ä¾ããã®ç¤ºåã表æ ã表åºãããã¨ã¯ãä»è ã®è¡¨æ çè§£ã«ã¤ãªãããã¨ãç¥ããã¦ãããæ¬çä¾ã§ã¯ã¢ã³ããã¤ããæä½ããèªèº«ã®ä»£ããã«ã¢ã³ããã¤ãã®è¡¨æ ã表åºãããã¨ããä»è ã®è¡¨æ çè§£ã«ã¤ãªãã£ãã¨èãããããæ®æ®µã¯ã³ãã¥ãã±ã¼ã·ã§ã³ã«èå³ãæã¡ã«ããèªéã¹ãã¯ãã©ã çè ã®å¤ãããæå ç«¯ã®æè¡ã«ã¯èå³ãæã¤å¾åããããã¢ã³ããã¤ãã®æè¡ã¸ã®èå³ãã¢ã³ããã¤ããæä½ãããã¨ã«ããã³ãã¥ãã±ã¼ã·ã§ã³ã¸ã®ã¢ããã¼ã·ã§ã³ãæãããå¯è½æ§ãèããããã
(çå´åä¸ã2017.10.1.)
解説ã人éãã£ãã
American Journal of Psychiatryã«æ²è¼ãããçå´åææã®ãã®è«æãã¼ã¸ãéãã¨ãèª å®ãããªè¥è ã®åçãã¾ãç®ãã²ããããã¯èè ã®è¿å½±ã»ã»ã»ã§ã¯ãªãã¦ããã®ç ç©¶ã§ä½¿ãããã¢ã³ããã¤ããACTROID-Fã§ããããããããåç»ã§è¡¨æ ã®åããè¦ãããã°ã人éãã®ãã®ã§ãããã¨ãããã«å®æã§ããã§ããããä½ãå§¿å¢ã大ããå¤ããããããã«ã¯ä½ããã¦ããªããããå¤éã座ä½ã®ã¾ã¾é¨å±ã«ä¿ç®¡ããã¦ãããæ·±å¤ã«ãããè¦ãè¦åå¡ããäººãæ½ãã§ããã¨æãè °ãæãããã¨ããå®è©±ããããACTROID-Fã¯ãã®ããã人éãã£ãããªãããããªã®ã§ããã
èªéã¹ãã¯ãã©ã çã®ã³ãã¥ãã±ã¼ã·ã§ã³è½åæ¹åãç®çã¨ãã¦ãããããå©ç¨ããææ³ã¯ãè¿å¹´æ¥éã«ç ç©¶ãé²ãããã¦ããããã®å¤ãã¯ãèªéã¹ãã¯ãã©ã çè ããè¦æã¨ããã人ãã§ã¯ãªããããããããç¸æã«ã³ãã¥ãã±ã¼ã·ã§ã³ãè¨ç·´ããã¨ããå½¢ã§ãããèªéã¹ãã¯ãã©ã çè ã®æ©æ¢°ã好ãã¨ããä¸è¬çç¹å¾´ã¨ç¸ã¾ã£ã¦ããã®ææ³ã«ã¯å¤§ãã«æå¾ ãå¯ãããã¦ãããã対ã»ããããã§å¦ãã ãã¨ã社ä¼ã§ã®å¯¾ã»äººéã®å ´é¢ã«æ±åããæ®µéã大ããªããã¯ã«ãªã£ã¦ããã
æ¬ç ç©¶ã§çå´åææãæ¡ã£ãã®ã¯ã徿¥ã®ææ³ã¨ã¯æ£å対ã¨è¨ãããã®ã§ãèªéã¹ãã¯ãã©ã çè ã対ããããã§è¨ç·´ããã®ã§ã¯ãªããèªãããããããæä½ãã¦å¯¾äººã³ãã¥ãã±ã¼ã·ã§ã³ãè¡ãã¨ããç»æçãªãã®ã§ãã£ãã人éãã£ããã®ã¢ã³ããã¤ãACTROID-Fã®ç²¾å·§ãããããå¯è½ã«ããããã®ç ç©¶ã«åå ãã被é¨è Aåã¯ãããã¾ã§ã¯èªãã®ã³ãã¥ãã±ã¼ã·ã§ã³é害ã®ããå°æ¥ã®å¤¢ãããããããã¦ããã®ã§ããããã¢ã³ããã¤ãæä½ã§é©åãªè¡¨æ ã®è¡¨åºçãå¦ãã§ããã¯èªä¿¡ãã¤ããå¿æãã¦ãã大å¦ã«ãåæ ¼ãã大ãã«èªå°å¿ãé«ããçµæã¨ãªã£ã¦ããã
ç¾ä»£ç¤¾ä¼ã¸ã®ããããã®æµ¸éã¯èãããå»çã«ããã¦ããå¤ç§æè¡ã®åéãªã©ã§ã¯ãã§ã«å®ç¨åãããªãé²ãã§ããããã¢ã³ããã¤ãã®ç»å ´ã«ãã£ã¦ãç²¾ç¥å»çã¸ã®å¿ç¨å¯è½æ§ã䏿°ã«é«ã¾ã£ã¦ãããããã¦æ¬ç ç©¶ã§çå´åææã示ããã¢ã³ããã¤ãã®è¦äºãªæ´»ç¨ã¯ãçºæ³ã転æãããææ³ã«ãã£ã¦ãããã«ã§ãç²¾ç¥ç§æ£è ã®å©çã«è³ãããã¨ãå¯è½ãªæ®µéã«æ¥ã¦ãããã¨ã宿ããã¦ããããã®ã§ããã
(ææ¾å¤ªéã2017.10.22.)
è¦åºæå·ã«ããæå³æ§ã¸ã£ã«ã´ã³ã¯æ³¨æé害ã¨é¢ä¿ãã
è¹å±±ééï¼è¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§é¨é·ï¼Attentional dysfunction and word-finding difficulties are related to semantic jargon after a thalamic lesion: a case report
Asuka Nakajima and Michitaka Funayama
Aphasiology 2017ãã(published online 20 July 2017)
ãæ¬ç ç©¶ã«ã¤ãã¦ã失èªçã®ã¸ã£ã«ã´ã³ã¯éå®å¨èªãé »çºããæ°é èªã¸ã£ã«ã´ã³ã«ã¤ãã¦ã¯å¤ãå ±åãããã®æ©åºãé³é»ã®é害ãªã©ãã¾ãã¾ãªèª¬æããªããã¦ãã¦ããããå®å¨èªã®ã¿ã«ããã¸ã£ã«ã´ã³ã§ããæå³æ§ã¸ã£ã«ã´ã³ã«ã¤ãã¦ã®å ±åã¯æ¥µãã¦å°ãªããä»åããããã¯ãè¦åºæå·å¾ã«æå³æ§ã¸ã£ã«ã´ã³ãåããçä¾ã8å¹´ã«ãããçµéã追ããæ¬çä¾ã®æå³æ§ã¸ã£ã«ã´ã³ã®æ©åºãæ¤è¨ãã
æ¹æ³ã¨ãã¦ãçºç2å¹´å¾ã4å¹´å¾ã8å¹´å¾ã¨çµæçã«è¨èªãç¥è½ãæ³¨ææ©è½ã®å¤åã調ã¹ããè¨èªé¢ã®è©ä¾¡ã¯å¤±èªçèªå½æ¤æ»ã®å¼ç§°èª²é¡ã«ãã£ã¦åèªè½åãåé¡å¥ã®é¯èªï¼ç¹ã«æå³æ§ã¸ã£ã«ã´ã³ã®ä¸»è¦å ãªãç¡é¢é£é¯èªã®å²åï¼ã調ã¹ããç¥è½ã¯ã¬ã¼ãã³è²å½©ãããªãã¯ã¹æ¤æ»ã«ã¦ãæ³¨ææ©è½ã¯æ¨æºæ³¨æè©ä¾¡æ³ã®é¸ææ§æ³¨æèª²é¡ãç¨ããã
çµæã¯ä»¥ä¸ã®2ç¹ã§ãããç¡é¢é£é¯èªã®æ¸å°ãé¸æçæ³¨æèª²é¡ã®false positiveåå¿ã®æ¸å°ã¨ä¸¦è¡ããããåèªè½åã®å¤åã¨ã¯ä¸¦è¡ããªãã£ããããããç¡é¢é£é¯èªãã»ã¼æ¶æ» ãã8å¹´å¾ã«ããã¦ãåèªå°é£ã¯æ®åããã
ãæå³æ§ã¸ã£ã«ã´ã³ã¨è¦åºã®è¨èªæ©è½ã«å¯¾ããå½¹å²ãæ¬ä¾ã®çµéããã¯ãè¦åºæå·å¾ã®æå³æ§ã¸ã£ã«ã´ã³ã¯æ³¨æé害ã¨åèªå°é£ãé¢é£ãããã¨ã示åããããç¹ã«é¸æç注æã®false positiveåå¿ã¨ç¡é¢é£é¯èªã¯ãæ³¨ææ©è½ã¨è¨èªæ©è½ã¨ããéããããããç¡é¢é£ãªåå¿ãçãã¦ãã¾ãã¨ããç¹ã§é¡ä¼¼ããã
å æ¥è¦åºã®å½¹å²ã¯æ å ±ã®ãã£ã«ã¿ã¼æ©è½ãéè¦è¦ããã¦ããããè¿å¹´ã¯å¿ è¦ãªæ å ±ãæ´»æ§åãã¦ä¸å¿ è¦ãªæ å ±ã䏿´»æ§åããæ³¨ææ©è½ã強調ããã¦ãããæ¬çã«ç §ããåãããã¨ãè¦åºæå·ã«ã¦ç®çã¨ãªãèªãã¤ã¡ã¼ã¸ãååã«æ´»æ§åã§ãããåæã«ç¡é¢é£ã®èªãã¤ã¡ã¼ã¸ãååã«ä¸æ´»æ§åã§ããªãã¨ããã¡ã«ããºã ãæ¨å¯ãããã
è¦åºå¤±èªã¯ã復å±ã¯ä¿ããçè§£é害ã軽度ã§ããã«ãé¢ããããç¡é¢é£é¯èªãæå³æ§ã¸ã£ã«ã´ã³ãçãããå æ¥è¨èªæ©è½ã¨æ³¨ææ©è½ã®çéã¨ãããä¸è¬çãªå¤±èªã¨ã®éãã強調ããã¦ãããæ¬çä¾ã®çµéããã¯ãè¦åºæ©è½ã®é害ãã®ãã®ãç¡é¢é£é¯èªãæå³æ§ã¸ã£ã«ã´ã³ã«ã¤ãªããå¯è½æ§ã示åãããããã®æ©åºãè¦åºå¤±èªã®æ¬è³ªãããããªãã
(è¹å±±ééã2017.9.1.)
解説ãè³ã®è¨èãè´ã
ãã®è«æã«ã¯æ¬¡ã®ãããªå¯¾è©±ãç´¹ä»ããã¦ãã
æ£è
ããåºè¾°å·³ã«ç³¸ããªãã£ã?ã
----- ã©ããªç³¸ã®ãã¨ã§ãã?
æ£è
ããç´°èã®ä¸è´ã
----- ãããä½ã«ä½¿ããã§ãã?
æ£è
ããå£ã®ä¸100度ã«ãªã£ãã10度ã«ãªã£ãããã¦ãã¾ãé«ãé³ã«ã¯ãªããªãããã©ã100度ã¨ã120度ã«ãªãããã
æ£è ã¯æµæ¢ã«è©±ããã¢ã¯ã»ã³ãã¯ããèªç¶ã§ãããç¥çæ©è½ã¯æãªããã¦ããªããã ãè¨èã¯ãã®ããã«ããã®ããããªããã®ã«ãªã£ã¦ãããå½¢å¼ä¸ã¯æ¥æ¬èªã¨ãã¦æç«ãã¦ããããæèã¨é¢é£ã®ãªãåèªã«æº¢ãã¦ãããæå³æ§é¯èªã¨å¼ã°ããåèªã§ãããæå³æ§é¯èªãå¤çºããçºèªãæå³æ§ã¸ã£ã«ã´ã³ã§ããã
ãã®æ£è ã¯ãè¦åºåºè¡å¾ã«æå³æ§ã¸ã£ã«ã´ã³ãåããããã«ãªã£ããè¦åºæå·ã«ããè¨èªçç¶ã¯å¤æ¥ããè¦åºå¤±èªã¨å¼ã°ãã¦ãããããã®ã¡ã«ããºã ã¯ãã¾ã ã«è¬ã®ã¾ã¾ã§ãããè¹å±±é¨é·ã¯ãã®æ£è ã8å¹´éã«ããã£ã¦ç²¾å¯ã«ãã©ãã¼ã¢ããããçç¶ã®å¤åã¨æ¤æ»æè¦ã®é¢é£ã追究ãããããã¦ä¸è¨ã®éããç¡é¢é£é¯èªã®æ¸å°ãé¸æçæ³¨æèª²é¡ã®false positiveåå¿ã®æ¸å°ã¨ã®é®®ãããªç¸é¢ãè¦åºããã
ãã¤ãããã²ãããã馬ãããã¢ãã«ããç·è·¯ãããé¤ ããªã©ã¨çãããããããæ¤æ»å ´é¢ã§ãã®æ£è ã«èªããããç¡é¢é£é¯èªã§ããã仿¹ãé¸æçæ³¨æèª²é¡ã¨ã¯ãç´ã«æ¸ããã¦ããè¨å·ããä¸è§å½¢ãã¿ã¼ã²ããã¨ãã¦é¸ãã§æç·ãã¤ãããã®ã§ããã®ã¨ããåãååãªã©ãã¿ã¼ã²ãã以å¤ã®è¨å·ã«æç·ãã¤ãã¦ãã¾ãã®ãfalse positiveåå¿ã§ããã両è ãç¸é¢ããã¨ãããã¨ã¯ããªãã¡ãç¡é¢é£é¯èªã¨ã¯ãè³å ã«æµ®ããã 夿°ã®åèªã®ä¸ã§ããã®æç¹ã§é¸æãã¹ãåèªã«ãã©ã¼ã«ã¹ãçµããã¨ãã§ããªãããã«ãä»ã®ç¡é¢é£ãªåèªãçºè©±ããã¦ãã¾ãã¨ããã¡ã«ããºã ã«ãã£ã¦çºçãããã¨ãå¼·ã示åãã¦ããã
è³ã®æ·±é¨ã«åº§ããè¦åºããã®æ©è½ã¯ãä¸å¿ è¦ãªæ å ±ã䏿´»æ§åããå¿ è¦ãªæ å ±ãæ´»æ§åãããããªãã¡æ³¨æã®ãã©ã¼ã«ã¹ã§ããã¨ãã説ãæåã§ãããã¾ãã«ãã®æ©è½ãã¿ãæ¤æ»ã§ããé¸æçæ³¨æèª²é¡ã®false positiveåå¿ã¨ç¡é¢é£é¯èªã«æç¢ºãªç¸é¢ããããã¨ã8å¹´éããã¦ç¤ºããæ¬è«æã¯ãè¦åºæå·ã«ãã£ã¦çããæå³æ§ã¸ã£ã«ã´ã³ããæ³¨æã®é¸æã¨ããè¦åºæ©è½ã®é害ããç´æ¥èª¬æã§ãããã¨ãéå¼ã«ç¤ºãã¦ããã
è³ã®ä¸ã¯ç®ã«è¦ããªãããã¥ã¼ãã¤ã¡ã¼ã¸ã³ã°ãå¦ä½ã«é²åãã¦ãè¦ããã®ã¯è³ã®ãã¼ãé¨åã«éããããç²¾ç¥æ©è½ãã©ã®ããã«ããã°ã©ã ãããã©ã®ããã«åãã¦ããããç¥ãããã«ã¯ãçç¶ã®ç²¾å¯ãªåæãä¸å¯æ¬ ã§ãããä¸ã§ãè¨èªçç¶ã¯ãè³ãèªãã®ç¶æ ã訴ãããããè³ã®è¨èã¨ãè¨ãã¹ãè²´éãªè¡¨åºã§ãããæ¬è«æã§è¹å±±é¨é·ãè¡ã£ãã è¨èãç²¾å¯ã«åæããææ³ã¯ãããããç²¾ç¥ç¾æ£ã®è§£æã«ç¹ãããã®ã§ããããã®å ã«ã¯çã«åççã§æå¹ãªæ²»çããªãããªã®å§¿ãè¦ãã¦ããã
(ææ¾å¤ªéã2017.9.20.)
èªçºçãªè¨æ¶æ³èµ·ã®èå¾ã«ã¿ãããèªå¾ç¥çµæ´»å<å±æè¨æ¶ã¨å
å容æè¦ã®é¢ä¿æ§>
æ¢
ç°è¡(æ
¶æç¾©å¡¾å¤§å¦æå¦é¨ææ)Umeda S, Tochizawa S, Shibata M, Terasawa Y (2016)
Prospective memory mediated by interoceptive accuracy: A psychophysiological approach. Philosophical Transactions of the Royal Society B: Biological Sciences, 371.
å±æè¨æ¶ (prospective memory) ã¨ã¯ï¼èªãã®äºå®ãä»äººã¨ã®ç´æã®ãããªï¼æªæ¥ã«å®è¡ãããã¨ãæå³ããè¡çºã®è¨æ¶ãæå³ããï¼è¨æ¶ã¨ããã¨ï¼åèªã®åçã»åèªãã¹ãã«ä»£è¡¨ããããããªï¼éå»ã«ä½é¨ããã¨ãã½ã¼ãã®è¨æ¶ãæå³ãããã¨ãå¤ãï¼ããããªããï¼æ¥å¸¸çæ´»ã«ããã¦ã¯ï¼ãã®ãããªãéå»ã®è¨æ¶ãã°ããã§ãªãï¼ãæªæ¥ã®è¨æ¶ããå¿ è¦ã¨ãããå ´é¢ãå¤ãï¼æªæ¥ã®è¨æ¶ã§ããå±æè¨æ¶ã®æå¤§ã®ç¹å¾´ã¯ï¼æ³èµ·ã«ã¿ã¤ãã³ã°ãå¿ è¦ã¨ãããã¨ããç¹ã§ããï¼å¤ãã®è¨åºå ´é¢ã«ãããè¨æ¶ãã¹ãã§ã¯ï¼åºæ¿ãè¦ãã¦ããã£ãå¾ã«ãã¯ãï¼æãåºãã¦ãã ãããã¨æç¤ºãï¼è¢«é¨è ã«è¨æ¶ã®åçãåèªãä¿ãï¼ãããï¼æã ã®æ¥å¸¸çæ´»ã§ã¯ï¼å¸°ãã«ãã³ãè²·ã£ã¦å¸°ãï¼é§ ã§å°çãæå½ããï¼3æã«ãªã£ããããããã«é»è©±ãããããªã©ï¼èª°ã«ä¿ããããã¨ããªãï¼èªçºçã«äºå®ãæ³èµ·ããªããã°ãªããªãå ´é¢ãå¤ãï¼å±æè¨æ¶ã«ã¯ï¼ã¿ã¤ãã³ã°ããï¼èªçºçã«æ³èµ·ããã¹ãã«ãå¿ è¦ã¨ãããã®ã§ããï¼
ã§ã¯ï¼ããµã¨æãåºãããã¨æãããããªå ´é¢ã§ï¼ãã£ããä½ãæ³èµ·ãä¿ãããªã¬ã¼ã¨ãã¦åãã¦ããã®ã ãããï¼å¿ã®ä¸ã§ã¯ããµã¨æãåºãããã¨æãã¦ãã¦ãï¼ç¥çµç³»ã§ã¯ä½ããã®ã¤ã³ããããããã¨èããã®ã妥å½ã§ããï¼æã ã®èãã仮説ã¯ï¼ãèªçºçæ³èµ·ã®ããªã¬ã¼ã¨ãªã£ã¦ããã®ã¯ï¼èº«ä½ç¶æ ã®å¤åã§ãããã¨ãããã®ã§ããï¼æ¬ç ç©¶ã§ã¯ãã®ä»®èª¬ã®å¦¥å½æ§ã«ã¤ãã¦æ¤è¨¼ããï¼
æ¬å®é¨ã§ã¯ï¼åå è ã®å¿æãè¨æ¸¬ããªããï¼ã¯ã¼ãã³ã°ã¡ã¢ãªã®2-back課é¡ãå®è¡ãã¦ããã£ãï¼ç¨ããåºæ¿ã¯ã¢ã«ãã¡ãããæåã§ããï¼2ã¤åã«æç¤ºãããæåã¨åããªãã° "1" ã®ãã¼ãï¼éã£ã¦ããã° "2" ã®ãã¼ãæ¼ãããã«æç¤ºããï¼ããã«ï¼å±æè¨æ¶èª²é¡ã®æç¤ºã¨ãã¦ï¼ããæ¯é³ã®æå (A,E,I,O,U) ã®ãããããæç¤ºããããï¼ãã®ã¨ã㯠"3" ã®ãã¼ãæ¼ãããã«æç¤ºããï¼ããã¦ï¼å±æè¨æ¶èª²é¡ã®æç¸¾ã¨ãã¦ï¼æ¯é³ã®æåãåºãã¨ãã«ã¯ï¼2-back課é¡ãããå±æè¨æ¶èª²é¡ãåªå ãï¼æ£ãã "3" ãæ¼ããæ¯ç(æ£çç)ãæ±ããï¼
ãã®çµæï¼ãã®æ£ççãé«ã被é¨è ã»ã©ï¼å±æè¨æ¶ã®ã¿ã¼ã²ããåºæ¿ã§ããæ¯é³ã®æåãåºãã¨ãã«ï¼å¿æãéã¾ã£ã¦ãããã¨ãããã£ãï¼ããã«ï¼èªèº«ã®å¿æã®åããã©ã®ç¨åº¦æ£è§£ã«ææ¡ã§ããããè¡¨ãææ¨ã§ããå¿ææ¤åºèª²é¡ãç¨ãã¦ï¼åå è ã®å å容æè¦ã®æ£ç¢ºã (interoceptive accuracy) ã調ã¹ãã¨ããï¼å å容æè¦ãæ£ç¢ºãªè¢«é¨è ã»ã©ï¼å±æè¨æ¶èª²é¡ã®æ£ççãé«ããã¨ã示ãããï¼ãããã®çµæã¯ï¼å±æè¨æ¶ã®èªçºçãªæ³èµ·ã«ï¼å¿æã®å¤åãæ½å¨çãªããªã¬ã¼ã«ãªã£ã¦ããå¯è½æ§ã示åãã¦ããï¼
ããµã¨æãåºãããã¨æããç´åã«ï¼ãã£ããä½ãèµ·ãã¦ããã®ãï¼ãã®çåã«åãçµãã ããã¾ã§ã®ç ç©¶ã¯ï¼å¿ãè³ã®æ©è½ã°ããã«çç®ãã¦ããï¼ãã®çµæï¼ã©ãã表é¢çã§ï¼ç¾è±¡çãªã¨ããã³ã¹ãèç©ãããã«ã¨ã©ã¾ã£ã¦ããï¼ãã®çåã«åãçµãããã«ã¯ï¼å¿ãè³ã ãã§ã¯ãªãï¼èº«ä½ãå«ããå¤è§çãªå´é¢ããã®ã¢ããã¼ããå¿ è¦ã§ãããã¨ãï¼æ¬ç ç©¶ã«ãã£ã¦ç¤ºãããã®ã§ããï¼ä»å¾ã¯ï¼æ±å¿æ§ã»é å¿æ§ã®åæ¹åã®ä¿¡å·ä¼éãæ³å®ããªããï¼èº«ä½ã«ãããèªå¾ç¥çµæ´»åã¨è³æ´»åã®ã¤ã³ã¿ã©ã¯ã·ã§ã³ãããè©³ç´°ã«æ¤è¨ãï¼èªçºçæ³èµ·ã®è¬ã®è§£æãé²ãã¦ããå¿ è¦ãããï¼ããã¦ï¼è»½åº¦èªç¥é害 (MCI) ãåæã®èªç¥çã«ããã¦ï¼å±æè¨æ¶ã®æ©è½ä½ä¸ãé¡èã«ç¾ããåå ãå¤é¢çã«æ¢ã£ã¦ããããï¼
(æ¢ ç°è¡ã2017.8.8.)
解説ãããµã¨ãã®å æå¾
ããµã¨æãåºãããã¨ãã®ããµã¨ãã¨ã¯ä½ã?ãæ¢ ç°ææãç«ã¦ã仮説ã¯ã身ä½ç¶æ ã®å¤åãã§ãã£ããããã¦2ã¤ã®ã¿ã¹ã¯ãé§ä½¿ãã¦ãã®ä»®èª¬ã«æãã ãä¸ã¤ã¯ä¸è¦åç´ãªå¿ææ¤åºèª²é¡ Heart Beat Detection Taskã§ãããããä¸ã¤ã¯ã¯ã¼ãã³ã°ã¡ã¢ãªã¨å±æè¨æ¶ãçµã¿åãããããã«ãè¤é㪠dual task ã§ããããããã®ã¿ã¹ã¯ã«ã¤ãã¦æ¢ ç°ææã«ããã«ãèããããã¾ãã¯ä¸è¦åç´ãªæ¹ã®ããèªåã®å¿èããã¾é¼åããã¨èªè¦ã§ããããã¨ããã誰ã«ã§ãããã«è¿½ä½é¨ã§ããã¿ã¹ã¯ã«ã¤ãã¦ã§ããã
ææ¾: å
æ¥ã®ç¥çµå¿çç ç©¶ä¼ã§ã¯å¤§å¤è峿·±ããã¬ã¼ã³ãã¼ã·ã§ã³ããããã¨ããããã¾ãããä¸é£ã®ãä»äºã®ä¸ã®Royal Societyã®è«æã«åºã¦ããå¿ææ¤åºèª²é¡ããã®ãã¨ç§ãå®éã«ãã£ã¦ã¿ãã¨ãããèªåã®å¿æãæãåããã¨ãã¦ã(æ¤åºãããã¨ãã¦ã)ãå
¨ãæ¤åºã§ãã¦ããæããããªãã®ã§ãããããã¯ç§ã®å
å容æè¦ãéãã¨ãããã¨ã§ãããã?ããã¨ãããã ãã¦ããä»ã®å¤ãã®äººãç§ã®æè¦ããèããéãã¨ã¯ã¡ãã£ã¨èãã«ããã®ã§ãå¤ãã®äººã
ã¯ããªãå¾®å¦ãªãæè¦ãã«ä¾æ ãã¦ããèªåã¯å¿æãæ¤åºãããã¨å ±åãã¦ããã®ã§ã¯ãªããã¨äºæ³ãã¦ãã¾ãã
ç§èªèº«ããç¡çããã¦ãå¿æãæãã¦ãããã¨èªè¦ãããã¨ããã°ã§ããªããã¨ããªãã®ã§ãããããã¯èªåã®å¿ææ°ããããã60ã ã¨ç¥ã£ã¦ãããã¨ã«åºã¥ãã¦æ¨å®ãã¦ããã¨ããè¦ç´ ãå¼·ãããã«æãã¾ãã
ãã®çåãã¤ã¾ããå¿æãæ¤åºããã¨ãã£ã¦ãããã¯çã«æ¤åºãã¦ããã®ã§ã¯ãªãããã æ¨å®ãã¦ããã ãã§ã¯ãªãããã¨ããã®ã¯ãå¿ææ¤åºèª²é¡ã«ããã¦ã¯ãããã誰ããæã¤çåã ã¨æãã¾ããè«æä¸ã«ã¯æéæ¨å®èª²é¡time estimation taskã®æç¸¾ã¨ç¸é¢ããªãã¨ããå®é¨ãã¼ã¿ã示ããã¨ã«ãã£ã¦æ¨å®ã§ãªããã¨ãæ
ä¿ããã¨è¿°ã¹ããã¦ãã¾ãããããã§ã¯æ
ä¿ã§ãã¦ããªãã®ã§ã¯ãªãã§ãããã?ããã¤ã¾ããä»®ã«ãã人ç©ã®å¿ææ¤åºèª²é¡ã®æç¸¾ãè¯ããã¨ããå½¼ã®æéæ¨å®è½åãåæ ãã¦ããã¨ä»®å®ããå ´åãããããå¿ææ¤åºèª²é¡æç¸¾ã¨æéæ¨å®èª²é¡ã®ç¸é¢ã®ç¨åº¦ãã«ãã£ã¦è¨¼æããããã«ã¯ãæåã®å¿æ(ç¬¬ä¸æ)ãèµ·ç¹ã¨ãã¦ã®æéæ¨å®ã測å®ããå¿
è¦ãããã(ã¤ã¾ããèµ·ç¹ãããã¦ãããããããæéæ¨å®ãæ£ç¢ºã§ãå¿ææ¤åºã¯æ£ç¢ºã«ã¯ãªãå¾ãªã)ãåãªãæéæ¨å®èª²é¡ã®çµæã ãã§ã¯ã人ç©ã®å¿ææ¤åºèª²é¡ã¨ã®é¢é£ãè¨ããã¨ã¯ã§ããªãã®ã§ã¯ãªãã§ããããã
æ¢
ç°: 確ãã«å¿ææ¤åºèª²é¡ã ãã§ã¯éçãããã¾ããï¼æéæ¨å®ãã³ã³ããã¼ã«ã¨ãã¦ãéçãããã¨ããã®ã¯ãã®éãã§ãï¼å
å容æè¦ã®ç ç©¶é åã§ã¯ï¼ãã®ææã¯ããã¶ãåããããï¼ãã¾ãã¾ãªå·¥å¤«ããªããã¦ãã¾ãï¼æã
ãå¿æã«å¿ããã¿ããã³ã°ããããã¦ã¿ã¦ï¼ã¡ããã¨ã¿ã¤ãã³ã°ãåæãã¦ãããã¨ãããã¨ã調ã¹ããã¨ãããã¾ãï¼ããããã¨ï¼ãã¯ãå¿ææ¤åºèª²é¡ã®æç¸¾ããã人ã»ã©ï¼åæã®ç²¾å¯åº¦ã§é«ããã¨ããããã¾ãã(ããã¯æªå
¬åã§ãã)ï¼
ã¾ãï¼å¼å¸ã®å
å容æè¦(叿°è² è·)ãèã®å
å容æè¦(è¨æºæ)ãªã©ã¨ã®ç¸é¢ã調ã¹ãç ç©¶ãããï¼ããããããªãã«é«ãç¸é¢ã示ããã¦ãã¾ãï¼
æè©®ï¼ä¸»è¦³å ±åã§ãã®ã§ï¼ç¡è«ï¼éçã¯ããã®ã§ããï¼ä»¥ä¸ã®ãããªå¨è¾ºçã¨ããã³ã¹ã®èç©ã«ããï¼ãå¿ææ¤åºèª²é¡ã¯ããã»ã©æªããªãææ¨ã§ãããã¨ãããã¨ãèªãããã¦ããï¼ä»åããã®èª²é¡ãè¸è¥²ãã¦ä½¿ã£ã¦ãã¾ãï¼
ã¡ãªã¿ã«ï¼å¥å®é¨ã¨ãã¦ï¼ä»ããã®èª²é¡ã®å¦¥å½æ§ã«ã¤ãã¦ã¯æ¤è¨¼ãç¶ãã¦ããï¼ãããè«æåä¸ã§ãï¼ ãã®å¦¥å½æ§ã®æ¤è¨¼æ¹æ³ã¨ããã®ã¯ï¼ã¤ã¾ãã¯ï¼å®éæã§ã¯ãªãç¶æ
ã§å¿ææ¤åºèª²é¡ãå®è¡ããã¨ãããã®ã§ãï¼ããã§ãã¨ï¼ç¥èããã®ããããã¦ã³ã®å½±é¿ã¯éå®çã§ãã®ã§ï¼å¦¥å½æ§ãå¢ããã®ã¨èãã¦ãã¾ãï¼
ææ¾: æ¬è«æã®ã¡ã¤ã³ã¨ãªããå±æè¨æ¶ã¨ã¯ã¼ãã³ã°ã¡ã¢ãªã®dual taskã®å·§å¦ãã«ã¯æéãåãã¾ããããã®2ã¤ã®ã¿ã¹ã¯ã®çµæãä¹é¢ããããã«ã¯ãããããã®ã¿ã¹ã¯ã®é£æåº¦ãå½±é¿ããã¨èãããã¾ãã®ã§ãé£æåº¦ã®æ±ºå®ã¯ç¸å½ã«ç²¾å¦ã«ãªãããå¿ è¦ããã£ãã¨äºæ³ããã¾ãããããã¯å¦ä½ã«ãã¦è¡ã£ãã®ã§ãããããç¸å½ãªäºåå®é¨ãè¡ã£ã?ãã«ãã¦ãæ°ãé ããªããããªæ°ããã¾ããã»ã»ã»?
æ¢ ç°:ããã¯å±æè¨æ¶ã®è¡åå®é¨ã¨ãã¦ï¼ããã¾ã§ã«è¨å¤§ãªæ°ã®è«æãããï¼èæ¯èª²é¡ã¨åæ¯èª²é¡ã®ããããã®é£æåº¦ã«ãã£ã¦ï¼ã©ã®ããã«å¤åããããæ¤è¨ããã¦ãã¾ãï¼ ããããç´°ããã¬ãã¥ã¼ãï¼ä»åã®èª²é¡ããã¹ããªããã¹ãã§ãããã§æ¨å¯ãï¼ããã«äºåå®é¨ãè¡ã£ãä¸ã§æçµæ±ºå®ãã¾ããï¼ããªãæéã®ãããããã»ã¹ã§ãã£ããã¨ã¯äºå®ã§ãï¼ å®è·µçãªæå³ã§ããã¨ï¼å±æè¨æ¶èª²é¡ã®ã¨ã©ã¼ãããç¨åº¦ã®è©¦è¡æ°ï¼ç¢ºä¿ããªãã¨ï¼çµ±è¨çãªåæã«è¼ãããã¾ããã®ã§ï¼ãã®è¾ºãã®èª¿æ´ãéè¦ã§ãï¼
ææ¾: èæ¯èª²é¡ã¨ãã¦ã¯ã¼ãã³ã°ã¡ã¢ãªèª²é¡ã¯æé©ãªã®ã§ãããã?ãå±æè¨æ¶èª²é¡ã®æç¸¾ã«ã¯ã¾ãã«targetãåºãæç¹ã®inner stateã大ããå½±é¿ããã¨ç´æçã«èãããã¾ãããã¯ã¼ãã³ã°ã¡ã¢ãªèª²é¡(2-back task)ã¯ããé·ãtime spanã«ãããinner stateãå½±é¿ããã¨èããããã®ã§ã¯ãªãã§ãããããã ã¨ããã°ãæ¯è¼å¯¾è±¡ã¨ãã¦ã¯2-backã§ã¯ãªãããé©åãªã¿ã¹ã¯ãããã®ã§ã¯?
æ¢
ç°: ä»°ãéãï¼ãã®å®é¨ã§ã¯ï¼å±æè¨æ¶èª²é¡ã«å¯¾ããcardiovascular responseã¨ï¼ã¯ã¼ãã³ã°ã¡ã¢ãªè² è·ã«å¯¾ããcardiovascular responseã®ä¸¡æ¹ã質çã«ç°ãªãå½¢ã§ï¼èªå¾ç¥çµã«å½±é¿ãåã¼ãã¦ããã¨èãã¦ãã¾ãï¼
ãã ãï¼å
çããææã®ããã«ï¼ããã質çã«é¡ä¼¼ããtime-spanã«å¯¾ããå½±é¿ãåã¼ããã¨ãåæã«èæ¯èª²é¡ãé¸å®ãã¦ãã¾ãã¨ï¼ä»åº¦ã¯å¿æã®å½±é¿ãã©ã¡ãã®èª²é¡ã«ãããã®ããæãã«ããããå¯è½æ§ãããããã«æãã¾ãï¼ãã®èª²é¡ã§çµæããã¾ãåºãã®ã¯ï¼ç°è³ªçãªèªå¾ç¥çµç³»ã¸ã®å½±é¿ããã£ãããã§ã¯ãªããã¨èãã¦ãã¾ãï¼
è«æã«ã¯ã¿ã¹ã¯ãã®ãã®ã«ã¤ãã¦ã®èª¬æã¯ããããã¿ã¹ã¯æ±ºå®ã«è³ãçµç·¯ã«ã¤ãã¦ã®è¨è¼ã¯ãªããå®éã«ã¯ä¸è¨ã®éãã精緻ãªèå¯ã¨è¨å¤§ãªäºåå®é¨ã«æ¯ãããã¦åãã¦æ±ºå®ãããã¿ã¹ã¯ãªã®ã§ãããããã¯strong paperã®å¸¸ã§ãããæ±ºãã¦ããµã¨ãæãã¤ãã¦å®è¡ã§ãããã®ã§ã¯ãªããæã ã®ã¾ããã«ã¯å¤ãã®ããµã¨ãããããããµã¨ãã«è¦ãããã®ããããããµã¨ãã®å¸°çµã¯æã«é©ãã»ã©æ£ç¢ºãªãã®ã ãããã®æ£ç¢ºæ§ã®èå¾ã«ã¯ãç´°å¿ã®æ³¨æã«æºããããç²¾å¦ãªéç¨ãé ããã¦ããã®ã§ããã
(ææ¾å¤ªéã2017.8.14.)
æ¥æ¬èªçRapid Dementia Screening Testä¿®æ£çã«é¢ããæ¤è¨
森山泰(é§æ¨éç
é¢ç²¾ç¥ç§è¨ºçé¨é·)Yasushi Moriyama, Aihide Yoshino, Taro Muramatsu, and Masaru Mimura
Detailed analysis of Japanese version of the Rapid Dementia Screening Test, revised version
Psychogeriatrics. DOI:10.1111/psyg.12248 [Epub ahead of print]
æ¥æ¬èªç Rapid Dementia Screening Test(Japanese version of the Rapid Dementia Screening Test: RDST-J)ã¯,ã¹ã¼ãã¼ãã¼ã±ãã課é¡ã¨æ°åå¤æèª²é¡ã®2é¡ãããªã. ã¹ã¼ãã¼ãã¼ã±ãã課é¡ã¯,1åã®éã«ãã¹ã¼ãã¼ãã¼ã±ãããã³ã³ããã¨ã³ã¹ã¹ãã¢ã§è²·ãããã®ããçãã¦ãããè¨èªæµæ¢æ§èª²é¡ã§ãã. ã¾ãæ°åå¤æèª²é¡ã¯,ã¢ã©ãã¢æ°åãæ¼¢æ°åã«å¤æãã2é¡ï¼209âäºç¾ä¹,4054âååäºååï¼ã¨,æ¼¢æ°åãã¢ã©ãã¢æ°åã«å¤æãã2é¡ï¼å
ç¾å
«åä¸â681,äºåäºåä¸â2027ï¼ãããªãï¼é
äºã,2006). æ¬æ¤æ»ã¯3ï½5åã§æ½è¡å¯è½ã§Mini Mental State Examination (MMSE)ç¨ã®æéãè¦ãã,å¤å¿ãªè¨åºã«ãããèªç¥çã®ã¹ã¯ãªã¼ãã³ã°æ¤æ»ã¨ãã¦æç¨ã§ãã.
ããããã¯ä»¥å,RDST-Jã¯æè¨æç»èª²é¡ã¨æ¯è¼ã,å¥å¸¸ç¾¤ã¨ CDR0.5 ã®éå¥è£å©ã«æç¨ã§ãããã¨ã示ãã (Moriyama et al,2016).
RDST-Jã®æ°åå¤æèª²é¡ã«ãããæ¼¢æ°åã®è³ªåã»åçå½¢å¼ã¯æ¨ªæ¸ãã¨ãªã£ã¦ãã.ãããæ¼¢æ°åã¯æ¬æ¥,縦æ¸ãã§æ¸ããããã®ã§ãã.ããã§ä»å,æ¬èª²é¡ã§æ¼¢æ°åã縦ã¨ããå½±é¿ã調ã¹ã.ããªãã¡RDST-Jåçï¼æ¼¢æ°åãæ¨ªï¼ã¨ä¿®æ£çï¼æ¼¢æ°åã縦ï¼ã¨ã®èªç¥çã¹ã¯ãªã¼ãã³ã°ããããªãä¸ã®æåº¦ã»ç¹ç°åº¦ãæ¯è¼ãã.
対象ã¯ã¢ã«ããã¤ãã¼ç
(Alzheimerâs disease: AD) 211ä¾ã¨å¥å¸¸ç¾¤42ä¾ã§,AD群ã®MMSEã¯12-26ç¹,clinical dementia rating scale (CDR)ã¯3-0.5ã§ãã.ä¿®æ£çã¨åçã®éã«,å¹²æ¸èª²é¡ã¨ãã¦MMSEã¨æè¨æç»èª²é¡ããããªã£ã.
ãã®çµæ,æ°åå¤æèª²é¡ã®4課é¡ã¯ãããã縦ãã¼ã¸ã§ã³ã¯æ¨ªã®ãã®ã«æ¯ã¹ã¦æç¸¾ãææã«é«å¾ç¹ã§ãã£ã.次㫠CDR 0.5群(38ä¾)ãå¥å¸¸ç¾¤(42ä¾)ã¨éå¥ããä¸ã§, ã«ãããªãå¤ã7/8ã«è¨å®ããå ´å, RDST-Jåçã§ã¯æåº¦63.8%,ç¹ç°åº¦76.6% ã§ãã£ãã®ã«å¯¾ã,ä¿®æ£çã§ã¯æåº¦60.1%, ç¹ç°åº¦85.8%ã§ãã£ã.
以ä¸RDST-Jä¿®æ£çã¯,åçã¨æ¯ã¹ã¦CDR 0.5ã®ã¹ã¯ãªã¼ãã³ã°æ¤æ»ã¨ãã¦ä½ãæåº¦ã¨é«ãç¹ç°åº¦ãæãã¦ãã.
(森山泰ã2017.7.1.)
解説ãã¿ããã¨ã³ã«ããã®ã§ã¯ãªã
ãã¡ããå½éåã¯å¿
è¦ã ããå½éåã¯ææ®µã§ãã£ã¦ç®çã§ã¯ãªãã
è«æãè±èªã§æ¸ããã¨ã®ã¿ãç®æãã¨ãæªãã ç ç©¶ãçã¾ãããæè¿ãã°ãã°ç®ã«ãããã®ã¯ãå¤å½ã§ä½æããã質åç´ã®ç¿»è¨³ããã¼ã«ã¨ãã¦ç¨ããç ç©¶ã«å
å¨ããåé¡ã§ãããPublishãããè±èªè«æã ãããããèªãã§ããã®åé¡ã¯è¦ãã¦ããªãããããã«ãä¸èªç¶ãªæ¥æ¬èªãé£ãããã質åç´ãå ã
ã¨ä½¿ããã¦ããã¨ããã®ãçå®ã§ãããã¨ãããããããã®ã¨ããback translationãå½¢å¼çä¿¡é ¼æ§ã®å
罪符ã§ãããªããã¨ã¯ããã£ããè«æåãããã¨ãã®è³ªåç´ã¯ãã¯ãã»ã¨ãã©ä½¿ããããã¨ããªããã¨ãããæããã§ããã診æãæ¤æ»ã®ãã¼ã«ãä½ãããã«ã¯ãåãªã翻訳ã§ã¯å
¨ãä¸ååãªã®ã§ãã£ã¦ãWAIS-â
¢ãWMS-Rããæ¥æ¬ã®æåã«ãããã¦åæã«ç¶¿å¯ãªä¿®æ£ãå ãã¦åãã¦æ±ç¨ãããæ¤æ»ã¨ãã¦æç«ãã¦ããã
Rapid Dementia Screening Testã«ã¤ãã¦ã®æ£®å±±å士ã®ä¸é£ã®ä»äºããçã®æ¤æ»ãç®æã妥åã®ãªãæ©ã¿ã§ãããæ¬è«æã¯ãã®ä¸ã®ä¸æ©ã¨ãã¦ã徿¥ã¯ã¨ã³ã«è¨ãã¦è¡ã£ã¦ããæ¼¢æ°å課é¡ãã¿ãã«è¨ããã¨ã«ãã£ã¦ç¹ç°åº¦ãå¢ãããã¨ã示ãããã®ã§ãããããä¸ç度以ä¸ã®èªç¥çã対象ã«ããã®ã§ããã°ãããã¾ã§ã®ç²¾åº¦ã¯å¿ è¦ãªããããããªããã ãCDR 0.5 ã¨ããå¾®å¦ãªèªç¥æ©è½é害ãæããããã«ã¯ãã©ãã¾ã§ãç²¾å¯ããè¦æ±ãããã®ã§ãã£ã¦ãããã«ã¯è¨è¿°ã®ã¿ãã¨ã³ã®ãããªæåçè¦ç´ ãåãå ¥ããæ¤æ»ãå¿ è¦ã§ãããã¨ãæ¬ç ç©¶ã¯éå¼ã«èªã£ã¦ããã
ãã¡ããå½éåã¯å¿ è¦ã§ãããä½ãå»å¦ç ç©¶ã«ãããå½éåã¯ãçå®ã®æ¢ç©¶ã¨ããç®çãéæããããã®ææ®µã¨ãªã£ã¦åãã¦æå³ãæããããé¡ç®ã¨ãã¦ã®å½éåã¨å½¢å¼çç©è¨¼ã¨ãã¦ã®è±èªè«æã®éç£ã®ããã«ãåã«ã¿ãã®ãã®ãã¨ã³ã«ãããã®ãããªè«æã墿®ãã¦ããç¾ä»£ã«å¯¾ããè¦éããæ¬è«æã®ä¸ã«èªã¿åããã¨ãå¯è½ã§ãããã
(ææ¾å¤ªéã2017.7.23.)
å¾å¤©æ§è³æå·ä¾ã«ãããç°é£çã¯æå³è¨æ¶é害ã¨é¢é£ãã
è¹å±±ééï¼è¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§ é¨é·ï¼Semantic memory deï¬cits are associated with pica in individuals with acquired brain injury.
Michitaka Funayama, Taro Muramatsu, Akihiro Koreki, Motoichiro Kato, Masaru Mimura, Yoshitaka Nakagawa
Behavioural Brain Research 2017: 329: 172-179
ç°é£çã¯ä»è·ä¸ã§æã大ããªåä»ãªçç¶ã®ãã¡ã®ã²ã¨ã¤ã§ãããæ¥æ§ã®ä¸æ¯ãçªæ¯ãè ¸ç®¡ã®ç©¿åãªã©ç·æ¥æ²»çãè¦ãããã¨ãå°ãªããªããèªå® ã§ã®ä»è·ãããããæ½è¨å ¥æãå¿ è¦ã¨ãªããã¨ãå°ãªããªããã¨ããã§ãç°é£çã¯å¤æ§ç¾æ£ãå¾å¤©æ§è³æå·ãçµ±å失調çãèªéçã¹ãã¯ãã©ã é害ãå¦å©¦ã乳幼å ãªã©ã«åºç¾ããããæ©åºã¯æããã«ãªã£ã¦ããªãã£ããããããã¯ããã¾ã§è¡ããã¦ããªãã£ãç°é£çã®æ©åºãè§£æããç ç©¶ãè¡ã£ãã
対象ã¯ã夿§ç¾æ£ãé¤ããå¾å¤©æ§è³æå·ä¾ã«ã¦ç°é£çãåºç¾ããç°é£ç群11ä¾ã¨å¯¾ç §ç¾¤ã¨ãã¦ç°é£ã«ã¯è³ããªããå¼·ãå£åå¾åã示ãå£å群ã®8ä¾ã§ãããç ç©¶æ¹æ³ã¨ãã¦ãããã2群ã«å¯¾ãã¦ç¥çµå¿çå¦çæè¦ã¨è³ç»åã®æ¯è¼ãè¡ã£ããç¥çµå¿ççæè¦ã¨ãã¦ã¯ãåé èã®è§£æ¾ç¾è±¡ï¼ææ¡åå°ãå¸å¼åå°ãå©ç¨è¡åï¼ãæå³è¨æ¶ï¼æ¥å¸¸ç©åã®ä½¿ç¨è½åãæå³è¨æ¶é害ã«é¢ããä»è·è ã¸ã®è³ªåç´ãæ¥å¸¸ç©åããã³é£äºåä½ã®éã®æå³ç誤使ç¨ã«ã¤ãã¦ã®ä»è·è ã¸ã®æ§é ç颿¥ï¼ãé£è¡åã®ç°å¸¸ã«ã¤ãã¦èª¿ã¹ããçµæã¯ãç°é£ç群ã¯å£åç¾¤ã¨æ¯è¼ãã¦åé èã®è§£æ¾ç¾è±¡ã¯å¼±ãã䏿¹ã§æå³è¨æ¶é害ã¯é篤ã§ãã£ããè³ç»åã§ã®æ¯è¼ã§ã¯ãç°é£ç群ã®ç å·£ã¯å£å群ã®ç å·£ã¨æ¯ã¹ã¦å·¦åªä½ã®ä¸å´é èå徿¹ãä¸å¿ã§ãã£ãã
æ¬ç ç©¶ã®ç¥çµå¿çå¦çæè¦ã¨è³ç»åæè¦ã¯çç¾ãããç°é£çã¯å·¦åªä½ã®ä¸å´é å徿¹ãä¸å¿ã¨ããæå·ã«ããæå³è¨æ¶é害ãé¢ä¿ããå¯è½æ§ãèãããããå¾å¤©æ§è³æå·ã«éããã夿§ç¾æ£ãèªéçã¹ãã¯ãã©ã é害ã乳幼å ã«ããã¦ããæå³è¨æ¶ã®é害ãªããã¯å½¢æãä¸ååã§ããããã«ç°é£çãåºç¾ããå¯è½æ§ããããã¾ããæå³è¨æ¶ã®ç¥çµåºç¤ã¯å´é èã§ãããã¨ãå®èª¬ã§ããããæ¬ç ç©¶ã®æè¦ã¯çç¾ããªãçµæã§ãã£ããããã«éå ·/人工ç©ã«é¢ããæå³è¨æ¶ã¯å·¦ä¸å´é å徿¹ãä¸å¿ã¨ããå·¦åçãç¥çµåºç¤ã§ããã¨ããç ç©¶ãå°ãªããªãããæ¬ç ç©¶ã§ã®ç°é£ã®å¯¾è±¡ã®å¤ãã¯æ¯ç£¨ãç²ãæ´å¤ãã¹ãã³ã¸ãªã©ã®éå ·/人工ç©ã§ãããã¨ããããããçç¾ããªãçµæã¨ãªã£ãã
ããããã¯ç°é£ã¨ããåä»ãªçç¶ã«å¯¾ãã¦ãæå³è¨æ¶ã«ããè¦ç¹ãåãå£ã¨ãã¦çç¶ã®çè§£ãæ·±ããç°å¢èª¿ç¯çã«ããäºé²ãè¡ããã¨ãã§ãããããããªãã
(è¹å±±ééã2017.6.1.)
解説ãã¨ããããé£ã¹ã
é£ã¹ç©ã§ã¯ãªãç©ãå£ã«å ¥ãé£ã¹ãããããç°é£çPica ã§ãããç°é£çã¯èªç¥çãªã©ã®è³é害ã®çç¶ã¨ãã¦æããããç¥ããã¦ãããã ãã¡ã«ããºã ã¯ä¸æã§ãã£ãã
ç´ã¡ã«é£æ³ããã®ã¯ä¹³å¹¼å ã®è¡åã§ããããåãä½ã§ãå£ã«å ¥ããã®ã¯ãä¸ã®è¦ªã«å ±éããé ã®çãåé¡ã§ããã
ç°é£çã¯ãããªä¹³å¹¼å ã®è¡åã«ä¼¼ã¦ãããã ããåå§åå°ãé¢ä¿ãã¦ããã®ã ãããéè¡ç¾è±¡ã ãããå±å¨çã«ã¯åé èã主ã«é¢é£ãã¦ããã®ã ããããããåå ã«ã¤ãã¦ã®ç´ ç´ã§èªç¶ãªèãæ¹ã ã
ãããããã§ã¯ãªãã£ããé¢é£ããé¨ä½ã¯å´é èãé¢é£ããçç¶ã¯æå³è¨æ¶é害ãè¹å±±é¨é·ãæ¬ç ç©¶ã§æããã«ãããã®çµæã¯ã人ã ã®ç´æã«åãããã®ã§ãã£ãã
ç©ã®æå³ãããããªããªãã®ãæå³è¨æ¶é害ã§ãããã¤ã¾ãç®ã®åã®ç©ãä½ã§ããããããããªããªããæå³è¨æ¶é害ã¯äººã«ä½ãããããããç´ ç´ã§èªç¶ãªèãæ¹ã¯ãç©åã®èª¤ç¨ã§ãããã ã誤ç¨ã®ä¸ã§ããé£ã¹ããã ããçªåºãã¦ç¾ããã¨ã¯èããªãããã¨ãã°æ´å¤ãä½ãããããªãå ´åããã¨ãã°ã¹ãã³ã¸ãä½ãããããªãå ´åããããã誤ç¨ã®ãªãã·ã§ã³ã¯å¤å²ã«ãããããã®ä¸ã§ç¹ã«ãé£ã¹ããã¨ãã誤ç¨ãçªåºãã¦ç¾ããã¨ããã°ããã¯å¥ç°ã§ãç°é£ãæå³è¨æ¶é害ã®äºæ¬¡çãªçç¶ã®ã¿ã§èª¬æãããã¨ã¯å°é£ã§ããã
ããã¨ãé£ã¹ããã¯äººéã®æ ¹æºã«ããè¡åãªã®ããæ¬è«æã®Discussionã«ã¯æ¬¡ã®ããã«è¨ããã¦ããã
We human beings might be inclined to eat unrecognizable substances when we are unable to understand their meanings through any sensory modalities.
ç®ã®åã®ç©ãä½ã ãããããªããã°ã¨ããããé£ã¹ã¦ã¿ããããã人éã®è³ã«ããã°ã©ã ãããè¡åã ã¨ããæ¨å®ã¯ãçå½ç¶æããããã®ãé£ã¹ãããã¨ã®éè¦æ§ã«ç §ããã°ãç´ ç´ã§èªç¶ãªèãæ¹ã®ããã«ãæããããããããã¾ãä½ããã®æ¹æ³ã«ããæ¤è¨¼ãå¿ è¦ã§ãããã
åªããè¨åºç ç©¶ã¯è¨åºã«éå ã§ãããç°é£çã¯è¨åºä¸æ·±å»ãªåé¡ã§ãå±éºç©ãèã«å ¥ãã°æ¥æ§ä¸æ¯ãæ¶å管穿åã®ãããããããããããçå½ã®å±éºã«ç´çµãããæ¬è«æã§ç¤ºãããç°é£çã®ã¡ã«ããºã ã¯ããã®äºé²ãæ²»çã«è²´éãªç¤ºåãä¸ãããã®ã§ããã
å ãã¦æ¬ç ç©¶ã¯ã人ã«ãé£ã¹ãããã¨ã®æå³ãèããããã人éã®æ°ã ã®è¡åã«ããããé£ã¹ãããã¨ã®ç¹æ¨©çãªå°ä½ãèãããããè³ã«ã¤ãã¦ã®åªããè¨åºç ç©¶ãã¼ã¿ã«å å¨ãããã®åºãããããç¥çµå¿çå¦ã®çé«ã§ãããè¹å±±é¨é·ã®ä¸é£ã®è¨åºç ç©¶ã«ã¯å¸¸ã«ãããè¦åºããã¨ãã§ããã
(ææ¾å¤ªéã2017.6.28.)
ãã¤ç
ã®å»å¦ã¨æ³å¦ããä¸å¤å»å¦ç¤¾ã2017å¹´6æåºç
èãææ¾å¤ªé (æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§åææ)
解説ã鵺ã®å¦ã
夿±ºæã¯æ³ã¨ããç°çããè¦ããã¤ç
è«ã§ããã
ãã¨ãã°éå´èªæ®ºãå´åè
å´ã¯ä¼ç¤¾ã®è²¬ä»»ã追åãããééãªå´åãããããã ããèªæ®ºã«è¿½ãè¾¼ã¾ããããã®ã¨ãããééãªå´åãã¨ãèªæ®ºããçµã¶ã®ãããã¤ç
ãã§ãããæ³ã®ä¸çã§ã¯èªæ®ºã¯èªå·±è²¬ä»»ã§ããããããã¤ç
ãã¨ããç
æ°ãä»å¨ããããã¨ã«ãã£ã¦ã責任ãä¼ç¤¾ã«åãããããã¨ã«ãªãã
ãã¨ãã°æ¡å¤§èªæ®ºãæ¯åå¿ä¸ã§åã亡ããªãæ¯ãå½ãã¨ãã¨ããã¨ããæ¯ã¯æ®ºäººç½ªã®è¢«å人ã¨ãªãããã®ã¨ãå¼è·äººã¯æ¯ããã¤ç
ã«ç½¹æ£ãã¦ããã¨ä¸»å¼µãããæ®ºäººã¯è¨ãã¾ã§ããªãé罪ã§ããããããã¤ç
ãã¨ããç
æ°ãä»å¨ããããã¨ã«ãã£ã¦ã被å人ã®åäºè²¬ä»»ã¯å¤§ããå¤ããå¾ãã
ç®çããããæ³å»·ã«ãã¤ç ãæã¡åºãããã¨ããããã«ã¯ç®çããããä¼ç¤¾ã®è²¬ä»»è¿½åã被å人ã®è²¬ä»»è©ä¾¡ããã®ã»ãå¦ä½ãªãäºä¾ã§ãã£ã¦ããããããã«ç®çããããããããã®ç®çã«åãããå½¢ã§ãã¤ç ãæã¡åºããããããã¦ç¾ä»£ç²¾ç¥å»å¦ã«ããããã¤ç ã¨ã¯ä¸å®å½¢ã®æ¦å¿µã§ãããããæ³ã¯ããããã®äºä¾ã®ç®çã«åãé¨åã ããæ½åºãããããã¯ä¸å®å½¢ã®ç¹å®é¨åãä¸èªç¶ã«å¼·èª¿ããããå¥å¦ãªããã¤ç ãã¨ãªã£ã¦ããã
ããã¦æ³å»·ã¨ã¯éé空éã§ã¯ãªããå¤ä¾ã¯ç¤¾ä¼ã«ç¤ºãããè¡åæéã¨ããæ§è³ªãæã¡ããããã£ã¦æ³ã®ãã¤ç è«ããå»ã¯ç¡è¦ãããã¨ã¯ã§ããªããæ³å»·ã¨ããç°çã§ããããã®ç®çã«åããã¦æ¹é ããã夿±ºæã¨ãã¦ç¤¾ä¼ã«æ»ããããã¤ç ã¯ã鵺ã®å¦ã奿 ãªãã®ã¨åãã¦ãããããããã¾ããã¤ç ã§ããã¨ãç²¾ç¥å»å¦ã¯èªããªããã°ãªããªãã
䏿¹ãç²¾ç¥å»å¦ã«ãç®çããããæ²»ç?ã確ãã«ãããä¸ç¾©çã§ããããããããæ´¾çããææ®µã¯ãã°ãã°ç®çã¨åãããè¬ã®è²©å£²ã®ããã®ç æ°æ¦å¿µã®æ¡å¤§ãæ°ããªæ²»çæ³é©ç¨ã®ããã®ç æ°æ¦å¿µã®æ¹å¤ãç ç©¶ã®å®¢è¦³æ§æ ä¿ã®ããã®ç æ°æ¦å¿µã®åç´åãç æ°ã¯å»å¦ã®ç¸å¼µãã ã¨å»å¦è ã¯ç¡éªæ°ã«ä¿¡ãã¦ããããå»å¦çã§æ¥å¸¸çã«è¡ããã¦ããå¶ã¿ã¯ãå¥ã®ä¸çããè¦ãã°ç°çã®ææ¥ã§ãã£ã¦ãç¾ä»£ã®ãã¤ç æ¦å¿µã¯ç°æ§ãªå¤è¦³ãåãã¦ããã°ããã§ã¯ãªããç°èããæ¾ã£ã¦ããã®ãããããªãã
æ³ã¨ããç°çããã®éå ã¯ããããªå»ã®ç¾ç¶ãæ ãåºããç°çã®ãã¤ç è«ããå¤ä¾ãããåäºã»æ°äºãããã¦22ä»¶ãå³é¸ãå»ã®ç«å ´ããè«ããæ¬æ¸ã¯ãæ³ã¨å»ã®ä¸¡æ¹ã®å®åã«è³ãããã¨ãç®æãã¦èãããã®ã§ããããåæã«æ··ä¹±ã®æ¸¦ä¸ã«ããç¾ä»£ç²¾ç¥å»å¦ã®ãã¤ç è«ãè¦ç´ããä¿®æ£ã¸ã®éæ¨ã示ããã¨ãããã®ã§ãããã
(ææ¾å¤ªéã2017.5.30.)
ééå ±é
¬ã«ããintentional bindingã®äºå¾ç修飾ä½ç¨ã«é¢ããç ç©¶
é«çåè¼ (å½ç«ç ç©¶éçºæ³äºº éåç§å¦æè¡ç ç©¶éçºæ©æ§ æ¾å°ç·å»å¦ç·åç ç©¶æ è³æ©è½ã¤ã¡ã¼ã¸ã³ã°ç ç©¶é¨ ç ç©¶å¡)Itâs Not My Fault: Postdictive Modulation of Intentional Binding by Monetary Gains and Losses
Takahata K, Takahashi H, Maeda T, Umeda S Suhara T, Mimura M, Kato M.
PLos One 2012: 7(12): E53421
éæéåã®ãéæããä½ãæå³ããã®ãã¯ããªããªãé£ããåé¡ã§ãããä¾ãã°ããè ãä¸ã«åããããã¨ããè¡çºã®äºå®ã¨ããè ãä¸ã«ç§»åãããã¨ããç©ççäºå®ã¨ã¯æ±ºãã¦ã¤ã³ã¼ã«ã§ã¯ãªããããå²å¦è ã¯ãâWhat is left over if I subtract the fact that my arm goes up from the fact that I raise my arm?â ã¨ããåããç«ã¦ã (Wittgenstein, 1953) ããã®åãã«å¯¾ãã¦ãç¾ä»£èªç¥ç§å¦ã¯ããè ãæã¡ä¸ãããã¨ããæå³ã(intention)ã¨ããèªããè ãä¸ã«ä¸ãã£ããã¨ã®èµ·å 主ä½ã§ããã¨ããä½é¨ã (sense of agency) ã¨ããï¼ã¤ã®ä½é¨è¦ç´ ã§ããã¨ããä¸å¿ã®è§£çãä¸ãã¦ãã (Haggard et al., 2005)ãéæéåã®ä¸»è¦³æ§ãæ§æããã¨ãããããããï¼ã¤ã®ä½é¨è¦ç´ ã¯ç²¾ç¥å»å¦ã«ããã¦ãé常ã«éè¦ãªæ¦å¿µã§ãããä¾ãã°ããä»äººã®æå¾´åãã¨å¼ã°ããçåãintentionã®éå®³ã¨æããç«å ´ããçµ±å失調çã«ãããèªæé害ã®ä¸æ ¸çè¦ç´ ãsense of agency ã®é害ã§ããã¨ãã仮説ããããããããèæ¯ãããéåæå³(Will)åã³sense of agencyã«å¯¾ããå¿çå®é¨ãæ°å¤ããªããã¦ããã
ã¾ããéæéåã«ãããintentionã«é¢ããå¤å ¸çç¥è¦ã¨ãã¦ã¯ãBenjamin Libetãè¡ãªã£ãæåãªå®é¨ããã(Libet et al., 1983)ãLibetã¯ã2560ããªç§ã§å転ããæè¨ãè¦ããªããã被é¨è ã«éåæå³ãæèã«ä¸ã£ãç¬éã«ãã¿ã³ãæ¼ãã¨ããéæéåãè¡ãããã¨åæã«è³æ³¢ãè¨é²ãããããã«ãéåæå³ãæèã«ä¸ã£ãã¿ã¤ãã³ã°(W)ã¨ãã¿ã³ãæ¼ããã¿ã¤ãã³ã°(M)ããæè¨ã®éã®ä½ç½®ã«ãã£ã¦çãããããå®é¨ã®çµæãéåæå³ãçãã以åã«ãæ¢ã«è³å ã§ã¯ç¡æèçãªç¥çµæ´»å(readiness potential)ãéå§ãã¦ãããã¨ã示ãããããã®çµæãã©ã®ããã«è§£éãããã«ã¤ãã¦ã¯ã大ããªè°è«ããªãããããLibetã®çµæèªä½ã¯è¤æ°ã®å®é¨ã§åç¾ããã¦ãã(Haggard et al.,1999;Susan Pocket et al.,2007)ãæ¦ãæ£ãããã®ã¨ã¿ãªããã¦ãããããã¦ãç¾å¨ã§ã¯éåæå³ã¯è³ãä½ãåºããé¯è¦ã«éããªãã¨ããã©ãã£ã«ã«ãªä»®èª¬ã¾ã§æå±ããã¦ãã(Wagner DM, 2003)
䏿¹ãSense of agencyã«ã¤ãã¦ã¯ã1965å¹´ã«éç§°alien handå®é¨ã¨å¼ã°ããéæéåã«é¢ããå¤å ¸çãªç ç©¶ (Nielsen et al, 1965)ããªãããã®ã端ç·ã§ããã以å¾ãã®ææ³ãæ§ã ãªå½¢ã«ä¿®æ£ããã¦sense of agencyã®æ¤è¨ã«ç¨ãããã¦ãããNielsenã®alien handå®é¨åã³ãã®å¤æ³ã¯é常ã«å·§å¦ãªææ³ã§ãããããããsense of agencyã¨ããä½é¨ã«ã¤ãã¦æç¤ºçã«(explicit)ã«è³ªåãè¡ãã¨ããç¹ã§è¢«é¨è ã®ãã¤ã¢ã¹ããããããããããå®éçãã¤implicitãªææ¨ãæ±ãããã¦ãããããã§ã2002å¹´ã«ãã³ãã³å¤§å¦ã®Patrick Haggardã¯ãä¸è¿°ã®Libetã®ææ³ãæ¹å¤ãããã¨ã«ãããsense of agencyãimplicitã«å®éè©ä¾¡ããææ³ã確ç«ãã(Haggard et al., 2002)ããã®å®é¨ã§ã¯ãLibetã¨åæ§ã«è¢«é¨è ã«2560ããªç§ã§å転ããæè¨ãè¦ãããããã¦ã被é¨è ã«éåæå³(will)ãæèã«ä¸ã£ãç¬éã«ãã¿ã³ãæ¼ãã¨ããéæéå(action)ãè¡ããããããã¨ããã¿ã³ãæ¼ããã250ããªç§å¾ã«çãbeepé³(effect)ãé³´ããæå¾ã«ãæè¨ã®éã®ä½ç½®ã§ããã¿ã³ãæ¼ããã¿ã¤ãã³ã°(action)ãã¨ãbeepé³ãé³´ã£ãã¿ã¤ãã³ã°(effect)ããçããããã¨ããæé ã§ãããå®é¨ã®çµæãéæé忡件ã§ã®ã¿ãactionã¨effectã®ä¸»è¦³çãªæéééãå§ç¸®ãããã¨ããç¾è±¡ãçºè¦ãããããã¯ãintentional binding(ã¾ãã¯action-effect binding)ã¨å¼ã°ããç¾è±¡ã§ãsense of agencyã®implicitãªææ¨ã§ããã¨ã¿ãªããã¦ãã(Moore et al. 2012)ã
æã ã¯ãHaggardã®å®é¨çµæãè©³ç´°ã«æ¤è¨¼ããéç¨ã§ãintentional bindingã®å¼·åº¦ãéæéå(action)ã«ãã£ã¦ããããããçµæ(effect)ã«ãã£ã¦äºå¾çã«å¤åããã®ã§ã¯ãªããã¨ãã仮説ãç«ã¦ãããã®ä»®èª¬ãæ¤è¨¼ãããããHaggardã®èª²é¡ãæ¹å¤ãå¥å¸¸è ã対象ã«å®é¨ãè¡ãªã£ããéæéå(action)ã®é¨åã¯Haggardã®æ¡ä»¶ã¨åä¸ã§ããããè¡çºã®çµæ(effect)ã«å¯¾ãã¦+500å(positiveæ¡ä»¶)ã+0å(neuralæ¡ä»¶)ã-500å(negativeæ¡ä»¶)ã¨æ å価ãå²ãæ¯ãããªãã©ã³ãæ¡ä»¶ä»ããè¡ãªã£ããå®é¨ã®çµæãnegativeæ¡ä»¶ã§ã¯intentional bindingãå¼±ã¾ããã¨ãçºè¦ããä»®èª¬ãæ£ãããã¨ã確èªãããIntentional bindingãsense of agencyã®ææ¨ã¨ã¿ãªãã°ãæã ãå¾ãçµæã¯ãè¡çºã®çµæã«ãã£ã¦sense of agencyãäºå¾çã«ä¿®é£¾ããå¾ããã¨ã示ãã¦ãããã¾ãæã ã®çµæã¯ãå¥å¸¸è ããã¬ãã£ããªåºæ¥äºã®åå 帰å±ãä»è ã«åããå¾å(èªå·±å¥ä»ãã¤ã¢ã¹)ã¨ãä¸è´ãã¦ããããã®èæ¯ã«sense of agencyã®æ åã«ããäºå¾ç修飾ãé¢ä¸ãã¦ããã®ã§ã¯ãªããã¨èãããããã®çµæããã³èå¯ãæ¬è«æã¨ãã¦å ±åããããªããèè ã¨ãã¦ã¯ãä»åã®çµæããã£ã¦agencyãé¯è¦ã§ããã¨ãã主張ãè¡ãæ°ã¯å ¨ããªãããããäºå¾çã«æè»ã«å¤åããagencyã®å¼¾åæ§ããããå¿ã®å¥åº·ã«é¢ãã£ã¦ããã¨èãã¦ããã
ãªãããã¤ç æ£è ã§ã¯ãèªå·±å¥ä»ãã¤ã¢ã¹ã¨ã¯éã«ãæ¬æ¥èªãã¨é¢ä¿ã®ãªããã¬ãã£ããªäºè±¡ãèªå·±ã«éå°ã«å¸°å±ãããå¾åãæã¤ãããã¯ãself-blaming bias ãããã¯depressive realismã¨å¼ã°ããããã¤ç æ£è ã®ããããå¿çå¦çå¾åãæã ã®èª²é¡ã«ãã£ã¦å®éè©ä¾¡ãã§ããã®ã§ã¯ãªããã¨èãããã¤ç æ£è ã対象ã«ããç ç©¶ãè¡ãªã£ã¦ãããè¿ã ãã®çµæãçºè¡¨ããäºå®ã§ããã
æå¾ã«ãªãããæ¬ç ç©¶ã¯æ å è¤å ä¸éææã¨åç°è²´è¨å çã®å ¨é¢çæå°ã«ãã£ã¦ãªããããæããããã2015å¹´3æã«äº¡ããªãããå è¤å ä¸éå çã«å¯¾ãã¦ãæ¬è§£èª¬ã§ãã£ã¦æ·±ãæè¬ã®æãæ§ãããã
(é«çåè¼ã2017.4.21.)
é éæä½ããããã®ç ç©¶éçºã«ãããSense of Agencyã®éè¦æ§
åç°è²´è¨ã(æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§è¬å¸«)Strength of Intentional Effort Enhances the Sense of Agency
Minohara R, Wen W, Hamasaki S, Maeda T, Kato M, Yamakawa H, Yamashita A, Asama H.
Frontiers in Psychology ãAugust 2016 Vol. 7 Article 1165
æ¬è«æã¯ãæ±äº¬å¤§å¦å·¥å¦é¨ç²¾å¯å·¥å¦ç§ã®æ·ºé䏿æã®ã°ã«ã¼ãã¨ã®å ±åç ç©¶ã§ãçé èè ã®ç°åååã¯ä¿®å£«èª²ç¨ã®å¤§å¦é¢çã§ãããæ·ºéææã¯ããããå·¥å¦ã®å°éå®¶ã§ãç¹ã«äººã®çæ´»ãè±ãã«ããããã®ãµã¼ãã¹ã»ãããã£ã¯ã¹ããå°éã§ããï¼ä»è·æ¯æ´ãããããé éæä½ãããããç¨ãã¦ã®ç½å®³ã¬ã¹ãã¥ã¼ãåçºå»çå¦çããããã®ç ç©¶éçºãªã©ï¼ãããããã®é éæä½ã«ããã¦ããã®âæä½æ§âãé«ããä¸ã§ãSense of Agency(以ä¸SoA)ã¯æ¥µãã¦éè¦ãªæè¦ã§ããããç¹ã«å·¨å¤§éæ©ã®æç¸¦ãç¹ç´°ãªä½æ¥ãå¿ è¦ã¨ãããããªããããã®é éæä½ã«ããã¦ã¯ãã¿ã¤ã ã©ã°ã500msec以ä¸ãã£ãããããã«ãã®ã¿ã¤ã ã©ã°ã«æºãããããã¨ãSoAãæ¸å¼±ãæä½æ§ã¯æ¥æ¿ã«ä½ä¸ãã¦ãã¾ããã¿ã¤ã ã©ã°ããã®æºãããå ¨ããªãããããã製ä½ãããã¨ã¯æè¡çã«å°é£ã§ããããããã®ãããªå¶ç´æ¡ä»¶ã®ãã¨ã§ããSoAãå¼·ãããã¨ã«ãããé éæä½ã«ãããæä½æ§ãåä¸ãããããã®åºç¤ç ç©¶ãé²ãã¦ããã
æ¬è«æã§ã¯ãSense of Agency Task (Keio method)ã«ããã¦ããã¿ã³æä½ã®éã«å¿ è¦ãªåã®ç°ãªã3æ¡ä»¶ãç¨æãããã¨ã§ï¼0.10N, 0.65N, 2.70Nã®ï¼ç¨®é¡ï¼ãã¿ã¹ã¯ã«è¨ã被é¨è ã®âã¨ãã©ã¼ãâãå¤åãããã¨ããå®é¨è¨å®ã¨ãªã£ã¦ãããSoA夿ã«è¿·ããããªããã¾ãæ¡ä»¶ã§ã¯ãããã¨ãã©ã¼ããè¦ããæ¡ä»¶ã®æ¹ãSoAãå¼·ã¾ããã¨ã示ãããç°¡åã«è¨ãã°ãããããã®é éæä½ã«ããã¦ãæä½è ã®ã¨ãã©ã¼ããè¦ããæ©å¨ã®æ¹ãSoAãå¼·ã¾ããæä½æ§ãé«ã¾ãã¨ãããã¨ã§ãããããã¯ãããããé éæä½ã¨ããæ¥µãã¦ç¹ç´°ãªä¸çã«ããã¦ã¯ã極ãã¦éè¦ãªç¥è¦ã§ãããä»å¾ãæã ã®çæ´»ã«ããã¦çã ãããããå°å ¥ããã¦ããã¨æãããããæ·ºéææãã¨ä¼´ã«ãSoAã¨ãã観ç¹ãããé éæä½ããããã®æè¡éçºãé²ãã人ã®å®å ¨ã»å®å¿ãªçæ´»ãããã¦è±ããªçæ´»ã«è²¢ç®ã§ããã°ã¨èãã¦ããã
ãªããæ¬è«æã®ç²¾ç¥å»å¦ã«ãããæç¾©ã«ã¤ãã¦è¿°ã¹ãã¨ãèªæé害ã¨ãã¦ã®SoAç°å¸¸ãæ¥ããã¦ããçµ±å失調çã«ããã¦ãSoAã«å½±é¿ããã諸æ¡ä»¶ãæããã«ãªããã¨ã¯ãSoAç°å¸¸ã«å¯¾ããæ²»çã»ãªãããªãã¼ã·ã§ã³ã«ããã¦ãéè¦ãªç¤ºåãå¾ããã¨ã«ãªãããã¨æããä¾ãã°ãçµ±å失調çã«ããã¦ã¯ãæãä¸ç¾¤ãæãæ¡ä»¶ä¸ã«ããã¦SoAãéå°ã«ä½é¨ããã¦ãããã¨ã示ããã¦ãããï¼Maeda et al., 2012; 2013, Koreki et al., 2015ï¼ãæ£è ããã«ã¨ãã©ã¼ããæ¢ãã¦æ§ãããããã¨ã§SoAç°å¸¸ã調å¾ããã¨ããæ²»çã»ãªãããªãã¼ã·ã§ã³æ¦ç¥ãæãç«ã¤ã®ã§ã¯ãªããã¨èãã¦ããã
æã ã®ãããä¸ã¤ã®å°ç¨ã¨ãã¦ãä»å¾ãé é診çã«ããã¦é éæä½ãããããå°å ¥ããã¦ããã§ããããããããããä»ãã¦ã®é éç²¾ç¥çæ³ã«ã¤ãã¦ã®åºç¤ç ç©¶ã¨ãããã¨ãç®æãã¦ããã
(åç°è²´è¨ã2017.3.28.)
解説ãä¸ä½æã¸ã®å¸æ±
æã«æã¤åç´ãªæ¦å¨ã§ããããå·¥å ·ã§ããããæ¥½å¨ã§ãããããããã¯èªè»¢è»ãèªåè»ã§ãããã人éã¯éå ·ã¨ã¨ãã«æ©ãã§æ¥ããéå ·ãä½ãã使ããã¨ã§ã人éã¯ç¤¾ä¼ãä½ããæ´å²ãä½ã£ã¦æ¥ããããã¦åªããéå ·ã®æ¡ä»¶ã¯ã人éã¨ä¸ä½æãæãããããã¨ã§ãããæã«ãªãããè¡ãéããä½ã®ä¸é¨ã«ãªããéå ·ã«ã¤ãã¦ã®ããããè¨èªè¡¨ç¾ã¯ãSense of Agency (èªå·±ãè¡çºã®ä½ç¨ä¸»ä½agentã§ããã¨ããæè)ãSense of Ownership (身ä½ã»è¡çºãªã©ãèªåã®ãã®ã§ããã¨ããæè)ããã¹ã ã¼ã¹ãªéå ·ä½¿ç¨ã«ä¸å¯æ¬ ã§ãããã¨ãåæ ãã¦ãããå¤ãã®äººã«ã¨ã£ã¦æã身è¿ãªãéå ·ããPCã«ãªã£ãç¾ä»£ãããã¯åæ§ã§ãããè¿æªæ¥ã§ã®æ±ç¨ãäºæãããããããã«ããã¦ã¯ãSoAãSoOã®éè¦æ§ã¯ããã«å¤§ãããªãã§ãããã
åç°è¬å¸«ãæ±å¤§å·¥å¦é¨ã¨å ±åã§è¡ã£ãæ¬ç ç©¶ã¯ããããªè¿æªæ¥ãè¦ã¤ããä»äºã§ãããä¸å®ã®æ¡ä»¶ä¸ã«ããã¦ã¯ãããã¨ãã©ã¼ã(åªå)ãè¦ããæ¡ä»¶ã®æ¹ãSoAãå¼·ã¾ãã¨ããçµæã¯ãæ¥å¸¸æè¦çã«ãç´å¾ã§ããã¨ã¨ãã«ãæä½æ§ã¨ã¯æ¥½ãªã楽ãªã»ã©ããã¨ããããã§ã¯ãªããã¨ãåèªèãããããã¨ããç¹ã§ããããã¦ç¤ºåçã§ãããåªåã¨ãããã®ãå ¨ãå¿ è¦ã¨ããªãä¸çã§ã¯ã人éã¯SoAã失ããåæã«çãç²æã失ãã®ã§ããããããã«ã¯ãã©ã®ç¨åº¦ã®åªåãSoAçã«ã¯è³é©ãªã®ããããã¦ãã®è³é©ãªåªåéã¯ãæä»£ãæåã«ãã£ã¦å¤åããã®ãã¨ããã®ãèå³ããã¨ããã§ããã
ããããå²å¦çæç´¢ä»¥åã«ãæ¬è«æã®ç¾å®çãªæç¾©ã¯å¤§ããåºããç ç©¶ã主å°ãããæ±å¤§å·¥å¦é¨ã°ã«ã¼ããå°éã¨ããç½å®³ãããããä»è·ããããçã®æä½æ§åä¸ã¯ç¾ä»£ç¤¾ä¼ã®å«ç·ã®èª²é¡ã§ããããå»å¦ã®é åã§ãããç®ã®åã«æ¥ã¦ããé é診çããããéçºã«ããã¦ãå¿ é ã®åºç¤ãã¼ã¿ã«ãªãã§ãããã
ä¸ä½æã¨ããè¨èã¯ããã®æºã§ããèªåãä¸ã¤ã®ã¾ã¨ã¾ãããåå¨ã§ãããã¨ã大åæã§ãããã¨ã¯è¨ãã¾ã§ããªãããã®å¤§åæãå´©ããã®ãçµ±å失調çã§ãããSense of Agency Task(Keio method)ã¯ãã®ç ã®ç ç©¶ã®ããã«éçºããããã®ã§ãã(æ¬ãµã¤ã 2014å¹´3æ ãçµ±å失調çã®èªæé害ã«ã¤ãã¦ã®å®è¨¼çç ç©¶ãåç §)ãããããç ç©¶ã«è²¢ç®ããã¨ããå±éã¯ããã®ãã¼ã«ãéçºè ã®SoAããé¢è±ãèªå¾æ§ãç²å¾ãããã®å¦ãæããããããã®èªå¾æ§ã¯å·¥å¦ã®ä¸çã§æ°ããªç¥è¦ãå å¡«ãããçµ±å失調çã®ãªãããªãã¼ã·ã§ã³ã«å¿ç¨ãæå¾ ãããå§¿ã¨ãªã£ã¦å»å¦ã®ä¸çã«å¸°éãã¦ããã人éã«ã¨ã£ã¦SoAã¯éè¦ã ããç»æçãªçºå±ãçã®åµé æ§ã¯SoAã®å½¼æ¹ã«ããã®ãããããªãã
(ææ¾å¤ªéã2017.3.31.)
ãã¤ç
ã«ããããã«ã¨ããããªã³ãã©ã³ã¹ãã¼ã¿ã¼å¯åº¦ã¨æ©è½ã®æ¤è¨
森å£ç¿ã(æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨å¤§å¦é¢å士課ç¨)Norepinephrine Transporter in Major Depressive Disorder: A PET Study.
Moriguchi S, Yamada M, Takano H, Nagashima T, Takahata K, Yokokawa K, Ito T, Ishii T, Kimura Y, Zhang MR, Mimura M, Suhara T.
Am J Psychiatry. 2017 Jan 1;174(1):36-41
ããã¾ã§ããã¤ç ã®ç æ ççã«ãè³å ç¥çµä¼éç©è³ªã®1ã¤ã§ãããã«ã¨ããããªã³ã®é¢ä¸ãã»ãããã³ã¨ä¸¦ãã§ææããã¦ããããã¤ç æ£è ã®æ»å¾è³ã§ã¯ãè³ã®éææ ¸ã«ããã¦ãã«ã¨ããããªã³ãååãè¾¼ã¿ããæ©è½ã®ãããã«ã¨ããããªã³ãã©ã³ã¹ãã¼ã¿ã¼ï¼NETï¼å¯åº¦ãå¤åãã¦ãããã¨ãããã«ã¨ããããªã³æ¾åºã調ç¯ãã¦ããã¨èãããã¦ããα2A-ã¢ãã¬ããªã³å容ä½å¯åº¦ãå¤åãã¦ãããã¨ãå ±åããã¦ããããããã®ç ç©¶ãNETãæ¨çã¨ãããã¥ããã»ãã³ããã«ãã·ãã©ã³ã¨ãã£ãæãã¤è¬ãç²¾ç¥ç§ã®è¨åºã§åºã使ããã¦ãããã¨ããããã¤ç ã®ç æ ççã«ãã«ã¨ããããªã³ãéè¦ãªå½¹å²ãæããã¦ãããã¨ã示åããã¦ããã
ããããããã¾ã§ãã¤ç ã®çä½ã«ããã¦NETå¯åº¦ããã®æ©è½ãæ¤è¨ããç ç©¶ã¯ãªãã夿§ãªãã¤ç ã®ç æ ã«ããã¦ãã«ã¨ããããªã³ãã©ã®ããã«é¢ãã£ã¦ãããã¯ä¸æã§ãã£ããããã§æ¬ç ç©¶ã§ã¯ããã¤ç æ£è ã®è³ã«ããããã«ã¨ããããªã³ç¥çµä¼éæ©è½ã調ã¹ããããçä½ã®è³ã«ãããNETå¯åº¦ãè©ä¾¡ããã¾ããã«ã¨ããããªã³ã注æã»è¦éãªã©ã®æ©è½ã«ä½ç¨ãããã¨ã«çç®ãããã¤ç æ£è ã®èªç¥æ©è½ã®å¤åã¨ã®é¢é£ãæããã«ãããã¨ãç®çã¨ãç ç©¶ãè¡ã£ãã
ãã¤ç æ£è 19åãå¥å¸¸è 19åã対象㫠è³å ã®NETã«çµåãã(S,S)-[18F]FMeNER-D2ã¨ããè¬å¤ãç¨ãã¦PETæ¤æ»ãè¡ã£ããæ£è ã¨å¥å¸¸è ã§ãããã®å®éå¤ãæ¯è¼ããã¨ãããæ£è ã®è¦åºã®NETå¯åº¦ãå¥å¸¸è ããã29%é«ããã¨ã夿ãããããã«ãè¦åºå é¨ãæ©è½çã«ç°ãªãï¼ã¤ã®é åã«åå²ãã¦ãããããã®é åã®NETã®å¯åº¦ãè©ä¾¡ããããã®çµæãåé èã¨ç·ç¶é£çµ¡ãæã¤é åã«ããã¦ãæ£è ã®NETå¯åº¦ã28.2%é«ããã¨ãæããã¨ãªã£ããæ¬¡ã«ãæ£è ã®NETå¯åº¦ã¨æ³¨ææ©è½ã¨ã®é¢é£ãæ¤è¨ããããã«æ³¨ææ©è½æ¤æ»ã宿½ããæ£è ã®NETå¯åº¦ã¨æ³¨ææ©è½ã¨ã®ç¸é¢è§£æãè¡ã£ãããã®çµæãè¦è¦æ§æ³¨æã調ã¹ãæ¤æ»ï¼Trail Making Test Aï¼ã«ããã¦ãæ£è ã® è¦åºã®NETå¯åº¦ãé«ãã»ã©ãåå¿æéãéããè¦è¦çæ¢ç´¢æ©è½ãé«ããã¨ãæããã«ãªã£ããããã¯ããã¤ç æ£è ã«ããã¦ã¯æ³¨æã»è¦éæ©è½ã¯ãããé«ã¾ã£ã¦ããããã®å¤åã¨ãã«ã¨ããããªã³ã·ã¹ãã ãé¢é£ãã¦ãããã¨ã示åãã¦ããã
ãã¤ç æ£è ã«ããã¦NETå¯åº¦ã®ç°å¸¸å¢å ã示åããããã¨ã¯ããã¤ç æ²»çã§ã¯ãã«ã¨ããããªã³ç¥çµä¼éæ©è½ã®èª¿æ´ãæå¹ã§ãããã¨ã示ãã¦ãããä»å¾ã夿§ãªçç¶ãç¾ãããã¤ç ã®æ²»çã«ããã¦ãè³å ã®ç°å¸¸ãæ³å®ãã广çãªæãã¤è¬ã®é¸æã¨æ²»çæ¦ç¥ã«ã¤ãªãããã¨ãæå¾ ãããã
(森å£ãç¿ã2017.2.20.)
解説ããã¤ç ã®PETç ç©¶ãç©¶ãã
ãã¤ç ã¨ããä»ã人é¡ã«ã¨ã£ã¦ã®å¤§åé¡ã¨ãªã£ãç¾æ£ã¨PETã¨ããæ¥é²ææ©ã®ãã¯ããã¸ã¼ããã®äºã¤ãçµåãããã¨ããã®ã¯èª°ããæã¤çºæ³ã§ãç¾ã«ãã¤ç ã®PETç ç©¶è«æã¯å¢ãç¶ãã¦ãããã ãããã¯ãããã¤ç ãã¨ããç¾æ£ã«ãPETãã¨ããæ¤æ»ãæ½è¡ãã¦ãå¾ããããç»åããè¦ãã°ä½ããããã¨ãã£ãåç´ãªãã®ã§ã¯ãªããããããåç´ãªçºæ³ã§é²ããããç ç©¶ã¯ããã¤ç ã«ã¤ãã¦çºçãã¦ããæ··ä¹±ãããã«æªæãç ´å£ã«åããããã°ããã§ããã
第ä¸ã«ããã¤ç ã¨ã¯ä½ãã¨ããåé¡ããããç¾ä»£ã«ããã¦ãã¤ç ã¨å¼ã°ãã¦ãããã®ã¯ãçç©å¦çã«ã¯éå¤ãªç¾æ£ã®éåä½ã§ãããããã¯è¨ºæåºæºããããå³å¯ã«ç¨ãã¦ã解決ããªãããããæã¨ãã¦ç¡ç¯æã«ãªããã¦ããæè¬ãæ··ä¹±ã«æè»ãããã¦ãããããããåé¡ãã¯ãªã¢ãã¦åãã¦ããã¤ç ã«ã¤ãã¦ã®ææç¾©ãªãã¼ã¿ãå¾ããã¨ãã§ããã
森å£å¤§å¦é¢çã®æ¬ç ç©¶ã¯ããã¤ç
ç ç©¶ã«ããã¦æéè¦ãªã対象è
ã®å³é¸ã¨ããåºçºç¹ã«ç´°å¿ã®æ³¨æãæããã¦ãããã¾ã大åæã¨ãã¦ã®DSM診æãããã®ã¯å½ç¶ã¨ãã¦ã19åä¸16åã¯æãã¤è¬æç¨æ´ãªãã3åã¯å°ãªãã¨ã2å¹´éã¯æç¨ãªãã®ãã¤ç
æ£è
ã§ãããè³å
ã®ç¥çµä¼éç©è³ªç ç©¶ã«ããã¦ã¯æãã¤è¬ã®å½±é¿ã®ãªãæ£è
ã対象ã¨ãããã¨ããã¼ã¿ã®ç´ç²æ§ã®ããã«ã¯å¿
é ã¨ã¯ãããããããæ£è
ããªã¯ã«ã¼ãããã®ã¯é常ã«å°é£ãªãã¨ã§ãããããã«ã¯å¤§é¨åã«ããã17åã¯MINIã§ã¡ã©ã³ã³ãªã¼åã®åºæºãæºãããã¨ã§ãç¾å®çã«å¯è½ãªç¯å²ã§ãã¤ç
ã¨ãã¦ã®å質æ§ãé«ãã¦ããã
çµæã¯æ£®å£é¢çã®è§£èª¬æã®éãã§ãè¦åºã®ãã«ã¨ããããªã³ãã©ã³ã¹ãã¼ã¿ã¼å¯åº¦ã«ã¤ãã¦ãããã¦æ³¨ææ©è½ã¨ã®é¢é£ã«ã¤ãã¦ããã¤ç
è§£æã®ããã®å°æ¥ã®ç ç©¶ã«ç¹ããè²´éãªãã¼ã¿ãå¾ããã¦ããã
PETã«ã¤ãã¦ã¯ãçµæã¨ãã¦å¾ãããç»åã®è§£éãé大ãªåé¡ãå å¨ãã¦ãããç¾ãã䏿ã®åçãå示ãã解説ãããã¨èª¬å¾åã¯æç¾¤ã§ããã®åçããè¦ãã°éè¦ãªç¥è¦ãèªã¿åãããã®ããã«é¯è¦ããã¡ã§ããããPETãåãã¨ããè³æ©è½ç»åã¯çµ±è¨çå¦çãé§ä½¿ããããã°ã´ã¡ã¼ãã£ã«ãªçµµã«ããããæ£ããè§£éããããã«ã¯çµµã®ä½æéç¨ã«ã¤ãã¦ã®æ·±ãçè§£ãå¿ é ã§ããã
ããªãã¡ãã¤ç
ã®PETç ç©¶ã¯ã
対象ã§ããããã¤ç
ãã¨ã¯ããã£ããä½ãè¦ã¦ããã®ãã
æ¹æ³ã§ãããPETãã¨ã¯ããã£ããä½ãè¦ã¦ããã®ãã
ã¨ããããããã¦éè¦ãªäºã¤ã®åé¡ãããã
ã ãéã«è¨ãã°ããã®äºã¤ã®åé¡ãã¯ãªã¢ããã°ããã¤ç ã®PETç ç©¶ã«ãã£ã¦ç¡éã®æ°ä¸çãéãããã¨ã大ãã«æå¾ ã§ããã
森å£é¢çã¯æ¬è«æå®æã®å¾ã¾ããªãããã³ãã®ãResearch Imaging Centre, Centre for Addiction and Mental Health, Canada ã«çå¦ãããã¤ç ã«ãããããã«é«åº¦ã§ææç¾©ãªPETã¤ã¡ã¼ã¸ã³ã°ç ç©¶ã追究ãã¦ããã
(ææ¾å¤ªéã2017.2.28.)
ãã¤ç
ã®æ°è³ªãæ§æ ¼ã¨æ²»ç广: 6ãæéååãäºåç ç©¶
å·¥è¤ç±ä½³ (æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨å¤§å¦é¢å士課ç¨ã群馬ç
é¢)Kudo Y, Nakagawa A, Wake T, Ichikawa N, Kurata C, Nakahara M, Nojima T, Mimura M.
Temperament, personality, and treatment outcome in major depression: a 6-month preliminary prospective study.
Neuropsychiatric Disease and Treatment 2016; 13: 17-24.
ãã¤ç ã¯ãçºç奿©ãçç¶ãçµéãè»¢å¸°ã«æ¸¡ããå®ã«æ§ã ã§ãããè¬ç©çæ³ãæ²»çã®ä¸å¿ã§ãããããã ãã§å復ãã人ãããããåçºãå¤ããå¯è§£ã«è³ããªã人ããããé·æçãªå復ãç®æãã«ã¯ãèªåã®ç¹å¾´ãçè§£ããåããã¿ã¼ã³ã«é¥ããªãããã«ããç²¾ç¥ã»å¿ççæ³ãè¡ããã¨ãéè¦ã«ãªããããã®ããã«ã¯ãæ£è ãã©ã®ãããªã¿ã¤ãããè¦æ¥µããªããã°ãããªããããããããã¾ã§ã«æå±ããã¦ãããã¤ç ã®åé¡ã«ã¯ãæ²»ç鏿ãæèãããã®ãã»ã¨ãã©ãªãã£ãã
ããã§Gordon Parkerãã¯ãéã¡ã©ã³ã³ãªã¼æ§ã®ãã¤ç ã«å¤ãè¦ãããæ°è³ªã¨æ§æ ¼å¾åã«æ³¨ç®ããããããã®æ°è³ªã¨æ§æ ¼å¾åã«å¿ããç²¾ç¥ã»å¿ççæ³çã¢ããã¼ããææ¡ãããå½¼ãã¯ãThe Temperament and Personality Questionnaire (T&P)ã使ãããã¤ç ã«å¤ãè¦ãããæ°è³ªã¨æ§æ ¼å¾åã¨ãã¦ãä¸å®ãå¼·ãã人ã«å é¢ãè¦ããªããå®ç§ä¸»ç¾©ãæåºæ¿æ§ã社交åé¿ãæçµ¶ã«ææãèªå·±æ¹å¤çãèªå·±ä¸å¿çã®ï¼ã¤ãè¦åºããã
æã ã¯ãæ¥æ¬èªçT&Pã使ããä¿¡é ¼æ§ã妥彿§ãè©ä¾¡ããç ç©¶ãè¡ããè¨åºä½¿ç¨å¯è½ãªå°ºåº¦ã§ããã¨ãã¦å ±åããï¼Kudo et al, 2016)ãä»åã¯ãæ¥æ¬èªçT&Pã使ã£ã¦ãããããã®æ°è³ªã¨æ§æ ¼å¾åãæããæ£è ãã©ã®ãããªè»¢å¸°ããã©ããã観å¯ããååãç ç©¶ãè¡ã£ãã
å¯¾è±¡ã¯æ ¶æç¾©å¡¾å¤§å¦ç é¢ã¨ç¾¤é¦¬ç é¢ã®ãã¤ç 夿¥ã§æ²»çãåãã20ï½75æ³ã®éã¡ã©ã³ã³ãªã¼æ§ã®ãã¤ç æ£è 51åããã¼ã¹ã©ã¤ã³ã§T&Pãè¡ãããã¼ã¹ã©ã¤ã³ã¨ï¼ã¶æå¾ã«ãã¤ç éç度ã®å°ºåº¦ã§ããããã«ãã³ãã¤ç è©ä¾¡å°ºåº¦ãè¡ã£ãã
å¯è§£ãããããªããã«Tï¼Pã®åå¾åã®ç¹æ°ãã©ã®ç¨åº¦å¯ä¸ãããã調ã¹ãããã6ã¶æå¾ã«å¯è§£ããæ£è (ããã«ãã³ãã¤ç è©ä¾¡å°ºåº¦â¦7, n=23)ã¨å¯è§£ã«è³ã£ã¦ããªãæ£è (n=28)ãåããT&Pã®ç¹æ°ãæ¯è¼ãããçµæã¯ãå¯è§£ã«è³ã£ã¦ããªãæ£è ã®æ¹ãã人ã«å é¢ãè¦ããªããæçµ¶ã«ææãèªå·±æ¹å¤çå¾åã§é«ãç¹æ°ã§ãã£ãããã¼ã¹ã©ã¤ã³ã®ããã«ãã³ãã¤ç è©ä¾¡å°ºåº¦ã調æ´ãããã¸ã¹ãã£ãã¯å帰åæã§ã¯ãå¯è§£/éå¯è§£ã«å½±é¿ãä¸ããã®ã¯ã人ã«å é¢ãè¦ããªãå¾åã®ã¿ã¨ããçµæã§ãã£ãã
ä»åã®ç ç©¶ã§ã¯ãæ²»ç転帰ä¸è¯ãäºæ¸¬ããã®ã¯ã人ã«å é¢ãè¦ããªãå¾åã§ãã£ãã人ã«å é¢ãè¦ããªãå¾åãæã¤æ£è ã¯ãèªåã®å é¢ã人ã«èªããã¨ãè¦æã§ãããããç²¾ç¥ã»å¿ççæ³ã§ãã»ã©ãã¹ãã«å¯¾ããèªåã®å é¢ãèªããã¨ãé£ããå ´åãå¤ãããã®ãã¨ãæ²»ç転帰ä¸è¯ã¨é¢ä¿ãã¦ããå¯è½æ§ããããä»å¾ã¯ã人ã«å é¢ãè¦ããªãå¾åãæã£ãæ£è ã«å¯¾ãã¦ãGordon Parkerããææ¡ãã¦ããã対人é¢ä¿ã¹ãã«æè²ãä¸å®ã¸ã®ã¢ããã¼ããªã©ã診çã®ä¸ã«åãå ¥ããå½¼ãã®åå¾©ãæ´å©ã§ããã°ã¨èãã¦ããã
(å·¥è¤ç±ä½³ã2017.1.26.)
解説ãç²¾ç¥ç§å»ã«æ²»çææ¬²ãåã
ãã¡ã©ã³ã³ãªã¼æ§ãã¤ç
ã«ã¯çç©å¦çæ²»ç(è¬ç©çæ³ã黿°ããããçæ³)ãæå¹ãã¯ãç²¾ç¥å»å¦ã«ããã¦ããªã確ç«ãã¦ããå½é¡ã§ããã
ãããã«å¯¾æ¯ããã®ã¯ãéã¡ã©ã³ã³ãªã¼æ§ãã¤ç
ã«ã¯éçç©å¦çæ²»çãæå¹ãã§ããã¯ãã ãããã¡ãã®æ¹ã¯ç¢ºç«ããã¦ããã¨ã¯å°åºè¨ãé£ãã確ç«ã©ããããæ¤è¨¼ã®å¯¾è±¡ã¨ãã¦è¿°ã¹ããããã¨èªä½ãå°ãªããç¾ä»£ã®ç²¾ç¥ç§è¨åºã§ã¯ãããéã¡ã©ã³ã³ãªã¼æ§ãã¤ç
ã®å診è
ã®æ¹ãæ°ã¨ãã¦ã¯å¤ãã«ãããããããããã¯ã©ããããã¨ããä¸ã¤å¤§ããªçç±ã¯ãéã¡ã©ã³ã³ãªã¼æ§ãã¤ç
ã¨å¼ã°ãã¦ãããã®ã®ä¸ã«å¤ç¨®å¤æ§ãªãã®ãå«ã¾ãã¦ãã¦ãä¸ã¤ã®ã«ãã´ãªã¼ã¨ã¿ãªããã¨ã«å¤§ããªç¡çãããããã§ããã
ããã§ãªã¼ã¹ãã©ãªã¢ã®Gordon Parkerããæå±ãã¦ããã®ããæ°è³ªã¨æ§æ ¼ã«åºã¥ããã£ã¡ã³ã¸ã§ãã«ãªè¡¨ç¾ã§ãããå½¼ãã®ããæ°è³ªtemperamentã¨ã¯éºä¼ã§è¦å®ããããã®ãæ§æ ¼personalityã¨ã¯ããã«ç°å¢çã®å åãå ãã£ã¦å½¢æããããã®ãæãã¦ãããå½¼ãã«ããT&Pã®æ¥æ¬èªçã使ããä¿¡é ¼æ§ã¨å¦¥å½æ§ãæ¤è¨¼ããã¨ããä¸å¯§ãªä½æ¥ãçµã¦ å·¥è¤å¤§å¦é¢çãçæããååãç ç©¶ã®æåã®ææãæ¬è«æã§ããã
ç²¾ç¥å»å¦ã®50å¹´ãæ¯ãè¿ãã¨ãDSMãICDãæ¹è¨ãç¹°ãè¿ããããã¨ã«ãã£ã¦ãç²¾ç¥é害ã®åé¡ã¯çºå±ãç¶ãã¦ããããããæ²»çæ³ãåé¡ã¨ä¹é¢ãã¦ããã®ãç¾ç¶ã§ãããæ²»çã¨ãã観ç¹ãç¡è¦ãã表é¢çãªã«ãã´ãªã¼åé¡ããªããã¦ããã¨ãããã£ã¨ããªæ¹å¤ããããç²¾ç¥ç§å»ã«ã¯åé¡ææ¬²ã¯ãã£ã¦ãæ²»çææ¬²ããªãã®ãã
å·¥è¤é¢çã¯ãã¾ãéã¡ã©ã³ã³ãªã¼æ§ãã¤ç ã¨ããä¸ç¾¤ãã«ãã´ãªã¼ã¨ãã¦æ½åºããæ°è³ªã¨æ§æ ¼ã¨ãããã£ã¡ã³ã¸ã§ãã«ãªè¦³ç¹ãã転帰ã調æ»ããããã¤ç ã«ã¤ãã¦ã®è¨åºç¥è¦ã®å®æ ã«ãããã¦ã«ãã´ãªã¼ã¨ãã£ã¡ã³ã¸ã§ã³ããã¤ããªãããããã®ç§é¸ãªç ç©¶ãã¶ã¤ã³ã«ãã£ã¦ãæ²»çè¨ç»ã«ç´çµããè²´éãªãã¼ã¿ãå¾ããã¨ã«æåãã¦ããããã®åªãã¦è¨åºçãªç ç©¶ãå¦ä½è«æã¨ããå·¥è¤é¢çããããããã®ç ç©¶ã«ããã¦ããã¤ç ã®æ²»çã«ã¤ãã¦ã®ããã«æ°ããªç¥è¦ãéãã¦ãããã¨ãæå¾ ãããã
(ææ¾å¤ªéã2017.1.31.)
ç¼çª©é¨ç®è³ªã¨è³æ¢èç´ä¸å¸¯ç¶åã®æå·ã«ã¦æ²»çæµææ§ãã¤ç
ãæ¶å¤±ããä¾
è¹å±±éé (è¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§ é¨é·)Funayama M, Kato M, Mimura M.
Disappearance of treatment-resistant depression after damage to the orbitofrontal cortex and subgenual cingulated area: a case study.
BMC Neurology (2016) 16: 198
ãå ±åã®ç®çãè³åä¸å¾ãã¤ç post stroke depressionã¯ããç¥ãããæ¦å¿µã§ããããç åã®ãã¤ç ãã©ã®ããã«å¤åãããã¨ããå ±åã¯æ¥µãã¦å°ãªããè³æå·å¾ã®ãã¤ç ã®å¤åã調ã¹ããã¨ã§ããã¤ç ã®ã¡ã«ããºã ãæããã«ã§ããå¯è½æ§ãããã
ãçä¾ã®æ¦è¦ãæ¬ä¾ã¯55æ³çºçã®æ²»çæµææ§ãã¤ç
ã®ã±ã¼ã¹ã§ããã義ç¶ã®ä»è·ãä¸ååã§ãã£ãã¨èªè²¬çã«å¾æãããã¨ããã£ããã«ãã¤ç
ãçºçã3ç°ç³»æãã¤è¬ãSNRIãé·æã«ä½¿ç¨ãããã®ã®çºçå¾14å¹´éãã¤ç
ãæ¹åããªãã£ãããã¤ç
ã®ä¸ã§ãTellenbachã®ããã¡ã©ã³ã³ãªã¼åã§ãããä»è
ã®ããã«èªåãç ç²ã«ããã¡ã§ãããéå°ãªè²¬ä»»æãè¨ç»æ§ãæã¡åãããéå»ã®åºæ¥äºãé度ã«å¾æãã¦ããã
69æ³æã«å交éåèç¤ç ´è£ã«ããããèä¸åºè¡ãç½¹æ£ãããéç度ã¯Hunt and Hessåé¡ã®3度ã§ãããã¯ãªããã³ã°è¡ãè¡ã£ããè³å®è³ªã®æå·é¨ä½ã¯ç¼çª©é¨ç®è³ªã¨è³æ¢èç´ä¸å¸¯ç¶åã§ãã£ããæ£è
ã¯çºç2ã¶æå¾ã«ã¯éé¢ãã6ã¶æå¾ã«ã¯èªç«ããçæ´»ãéããã¾ã§æ¹åãããå種ç¥çµå¿çæ¤æ»ã§ã¯ç¥è½ãè¨æ¶ãéè¡æ©è½ã¨ãã«æãããªä½ä¸ã¯èªãããã¢ãã·ã¼ãèªããªãã£ãã䏿¹ã§ããèä¸åºè¡ç´åã«ãèªæ®ºå¿µæ
®ãä¼´ãé度ã®ãã¤ç¶æ
ã§ãã£ãããããèä¸åºè¡ç´å¾ãããã¤ç
ãæ¶å¤±ãããéå°ãªè²¬ä»»æãè¨ç»æ§ã¯ãªããªããé©åº¦ã¨ãªã£ããéå»ã®åºæ¥äºã徿ãããã¨ããªããªã£ãããã®å¾81æ³ã§äº¡ããªãã¾ã§12å¹´éãã¤ç
ã¯åçºããªãã£ãã
ãæ¬ä¾ããã®ç¤ºåãæå·é¨ä½ã§ããç¼çª©é¨ç®è³ªã¨è³æ¢èç´ä¸å¸¯ç¶åã¯ããã¤ç ã®æ¶å¤±ã«å½±é¿ãä¸ãããã®ã¨èãããããCamille et al 2004ã¯ç¼çª©é¨ç®è³ªãã徿ãã®ææ ã¨é¢é£ãæ·±ãã¨è¿°ã¹ã¦ããããæ¬ä¾ã¯ç¼çª©é¨ç®è³ªã®æå·å¾ã«å¾æãããã¨ããªããªã£ã¦ãããè³æ¢èç´ä¸å¸¯ç¶åã¯ãæ²»çæµææ§ãã¤ç ã«å¯¾ãã¦Maybergããè¡ã£ã¦ããæ·±é¨é»æ°åºæ¿ã®ã¿ã¼ã²ããé¨ä½ã§ããã彼女ãã¯ãã®é¨ä½ãæ²»çæµææ§ãã¤ç ã§ã¯ä»£è¬ã亢é²ãã¦ãããããæ·±é¨é»æ°åºæ¿ã«ãã£ã¦ä»£è¬ãæå¶ãããã¨ãæ·±é¨é»æ°åºæ¿æ²»çã®æ ¹æ ã§ããã¨è¿°ã¹ã¦ããããã®ããã«ãæ¬ä¾ã®ãã¤ç ãæ¶å¤±ããçµéã¯ç¥çµå¿çå¦çã«ãè³ççå¦çã«ãçç¾ããªããæ¬å ±åã¯ããã¾ã§ãã±ã¼ã¹ã¬ãã¼ãã§ãããããã¤ç ã®ã¡ã«ããºã ã«ã²ã¨ã¤ã®ç¤ºåãä¸ããå¯è½æ§ãããã
(è¹å±±ééã2016.12.1.)
解説ãéã«ãã©ãçå®
æå·ãå
ã§çç¶ãå¾ã ã
次ã«è¦³å¯ãæ¥ããçç¶ã®ç¶¿å¯ãªè¦³å¯ãæå·é¨ä½ã®æ£ç¢ºãªåå®ãããã¦ä¼¼ãæå·é¨ä½ãä¼¼ãçç¶ã®å¤æ°ä¾ã®è¦³å¯ãããã«ã¯ä»é¨ä½æå·ä¾ã®è¦³å¯ã«ããäºéè§£é¢ã®è¨¼æãçµã¦ãè³ã®ç¹å®é¨ä½ã¨ç¹å®çç¶ã®é¢é£æ§ã確ç«ããããã®å¶ã¿ãæ°éããªãåæ°ç¹°ãè¿ãããè³æ©è½ã®å±å¨ãæããã«ããã¦ããããããBroca以æ¥ã®ç¥çµå¿çå¦ã®æ´å²ã§ãããããã¦20ä¸ç´æ«ã«è³æ©è½ç»åã¨ãããã¯ããã¸ã¼ãå°å
¥ããã¦ãããè³æ©è½ã®ãããã³ã°ã¯ç²¾ç·»åãæ¥éã«é²è¡ãã¦ãããæ©è½å±å¨ã¨ããæå³ã§ã¯ãè³ã®å
¨è²ã®è§£æã¯ããæã®å±ãã¨ããã«ããã¨ããæããããæä»£ã«ãªã£ãã
ã ããã®æ¹æ³è«ã§ã¯ã©ããã¦ãå°éã§ãããã«ãªãç¾æ£ãããã
å
å æ§ã®ç²¾ç¥é害ã§ããã
ãã¡ããè³ã®å±å¨æå·ã«ãã£ã¦ãå
å æ§ã®ç²¾ç¥é害ã«ä¼¼ãçç¶ãç¾ãããã¨ã¯å¤æ°å ±åããã¦ããããããããã¯ä¼¼ã¦ã¯ãã¦ãéãªãçç¶ã§ããããã¨ãã°çµ±åå¤±èª¿çæ§(Schizophrenia-like) ã¨çµ±å失調ç(Schizophrenia)ã¯ãçç¶ããå¹»è¦ãã妿³ãã¨ããåèªã«ç®å°åãã¦ãã¾ãã°å·®ç°ã¯è¦ããªããªãããç¾æ£ã®æ¬è³ªã«ããããã¬ãã«ã«ããã¦ã¯ä¸¡è
ã¯å
¨ãç°è³ªã®ãã®ã§ããã
䏿¹ããã¤ç
ã§ã¯äºæ
ãç°ãªãããã«ãæããããã¨ãã°poststroke depressionã¯ãâdepressionâ ã§ãã£ã¦ âdepression-likeâ ã§ã¯ãªããè³æå·ã«ãã£ã¦ã確ãã«depressionã¯ç¾ããã
ã ãããã¯depressionã¨ããç¨èªã®å¤ç¾©æ§ã«èµ·å ããããªãã¯ã§ããã
è±èªã® âdepressionâ ã¨æ¥æ¬èªã®ããã¤ç
ãã®æå³ã®éãã¯ãã®éæªãã¨ãã¦ãããã¤ç
depressionã¨ããèªã¯ãã¾ãã«å¤ç¨®å¤æ§ã®ç¶æ
ãå
å«ãã¦ããããã¯ãããã¤ç
ãã¨ã²ã¨ã¾ã¨ãã«ãã¦ç ç©¶ã®å¯¾è±¡ã«ããç¬éããçµæã®ç¡æå³ããè¦ããã¨ãã£ãç¶æ³ã«ãªã£ã¦ããã
ã ãå
å æ§ãã¤ç
ã¯å¥ã ãTellenbachãã¯ããã¨ããæ
§ç¼ã«ãã£ã¦è¦åºãããå
å æ§ãã¤ç
ã¯ããã¤ç
depressionã®ç念åIdealtypusã¨ãã¦ã®å°ä½ãç¾å¨ããªãç¶æãç¶ãã¦ããã
ããã¦ãã®å
å æ§ãã¤ç
ã¯ãè³æå·ã«ããå·£çç¶ã¨ãã¦ç¾ãããã¨ã¯çç¡ã¨è¨ã£ã¦ãããããã¯å
å æ§ç²¾ç¥é害ã®ç
çã®æ·±ãã»è¤éãã®è¨¼ã§ããã¨ããã°ãã®éãã§ããããè³æ©è½ã¨ã®é¢é£ãå
·ä½çã«è¦åºããªããã¨ããå
å æ§ç²¾ç¥é害ã®ç
æ
è§£æã®ãããã¦æ²»çéçºã®é²æ©ãé»ãã§ããã®ãã¾ãäºå®ã§ããã
è¹å±±é¨é·ã®æ¬ç ç©¶ã¯ããã®ç¶æ³ã大ããæéãã端ç·ã«ãªãç»æçãªè«æã§ããã14å¹´éæ²»çæµææ§ã®å
å æ§ãã¤ç
ã§ãã£ãæ£è
ããå交éåèç¤ç ´è£ã«ããããèä¸åºè¡ãæ©ã«çªç¶å®å
¨å¯è§£ããããã®è«æã«å ±åããã¦ããäºå®ã¯ããã®ã¿ã§ãããçç¶ãå
ã§æå·ãå¾ã¨ããç¹ãé¤ãã°ãã·ã³ãã«ãªä¸ä¾å ±åã«ãããªããã ãããã«ããã¡ãã»ã¼ã¸ã¯æ´å²çãªéã¿ãæã£ã¦ãããããªãã¡ãã®è«æã¯ã夿¥ããå
å ã¨ããã¦ãããä½ãããè³å
ã«ãããã¨ã®è¨¼æã«ãªã£ã¦ããã®ã§ããã
æ´å²ç課é¡ã®è¨¼æã¯ãç´ã¡ã«è¿æªæ¥ã®æãéããããã¯å
å æ§ç²¾ç¥éå®³ã®æ ¹æ²»çæ³ã®éçºã§ããã
ãã¤ç
ã«éããã飿²»æ§ã®ç²¾ç¥ç¾æ£ã«ããã¦ã¯ãè³ã«ç´æ¥ä»å
¥ããææ³ãç»æçãªæ²»çæ³ã¨ãã¦æå¾
ããã¦ããããã®å®ç¾ã«ããã£ã¦ã¯æè¡çã«ãå«ççã«ã解決ããªããã°ãªããªãæ§ã
ãªéå£ããããããå
å ããè³å
ã«ãããã¨ãããã¦ããç¨åº¦ã¾ã§ã¯å±å¨ãããã¨ã®è¨¼æããªããã°ãè³ã¸ã®ä»å
¥ã¯ãã®åºçºç¹ã«ããã¦æ ¹æ ã失ããããæ¬ç ç©¶ã®çä¾ã®æå·é¨ä½ã§ããè³æ¢èç´ä¸å¸¯ç¶åã¯ãMaybergãã®æ²»çæµææ§ãã¤ç
ã®æ²»çã¨ãã¦ã®è³æ·±é¨åºæ¿Deep Brain Stimulationã¿ã¼ã²ããé¨ä½ã«ä¸è´ãã¦ãããæ¬è«æã¯å½¼å¥³ãã®æ²»çã®æ£å½æ§ãå´é¢ããæ¯æãããã®ã§ããã¨è¨ããã
æå·ãå ã§çç¶ãå¾ã«æ¥ãã®ãè¨åºã®å¸¸èã§ãããããããéã«ãã©ã£ãè¹å±±é¨é·ã®ç ç©¶ã¯ãä»ã¾ã§å§¿ãé ãã¦ããå å æ§ãã¤ç ã®çå®ã«æ¥è¿ãã¦ãããããã¦ãã®å ã«ã¯æ²»çã¨ããå ãè¦ãã¦ããã
(ææ¾å¤ªéã2016.12.31.)
ç²¾ç¥å»å¦ã«ãããã¹ãã¯ãã©ã ã®ææ³ã妿¨¹æ¸é¢ã2016å¹´11æåºç
責任編éãæäºä¿å+ææ¾å¤ªé
解説ãç²¾ç¥ç§è¨ºæå¦ã®å²å¦è«ç¨¿é
ä»ã©ã叿ã§è²´éãªç¡¬æ´¾ã®åºç社ã§ãã妿¨¹æ¸é¢ã®éåãªMOOKã<<ç²¾ç¥å»å¦ã®åºç¤>>ã®ç¬¬3å·»ã¨ãã¦åºçãããã®ãæ¬æ¸ã§ããããã®ã·ãªã¼ãºãâPower MOOKâ ã¨ããåã«ãµããããåã®ããã£ãæ¬ããã§ã«2ååºçããã¦ããã(ãè¬ç©çæ³ãç²¾ç¥ç çå¦çè¦ç¹ããèãããã¨ããã¤ç 診çã®è«çã¨å«çã)ãæ¬æ¸ããããã«ä¸¦ã¶powerfulãªãã®ã§ã京é½å¤§å¦ã®æäºææã®ã¾ãããã«è¨ããã¦ããéããç²¾ç¥ç§è¨ºæå¦ã®å²å¦è«ç¨¿éãã¨å ãããã«ãµããããä»ä¸ããã«ãªã£ã¦ããã
診æã¨ã¯ç²¾ç¥ç§ã«éããã«ãã´ãªã¼çã«å®ç¾©ãããã®ãéä¾ã§ãããããã¾ã æ¬æ 䏿ã®ç²¾ç¥ç¾æ£ãã¯ãªã¢ã«ã«ãã´ãªã¼åé¡ãããã¨ã«ã¯æ·±å»ãªçç¾ãå å¨ãã¦ãããã¨ã¯å¦å®ãé£ããããã§è¿å¹´ã§ã¯ãèªéçã¹ãã¯ãã©ã ããçµ±å失調çã¹ãã¯ãã©ã ãã®ããã«ãé£ç¶çã«æãããã¨ãããææ³ããåªå¢ã«ãªã£ã¦æ¥ã¦ãããã¿ã¤ãã«ã®ãç²¾ç¥å»å¦ã«ãããã¹ãã¯ãã©ã ã®ææ³ãã¯ãããªç¾ä»£ã®ç¶æ³ãæãã¦ããã
ç²¾ç¥ã®ç ã¨ãããã®ãçæ¯ã«è¦ã¤ããã°ãããã¥ã¢ã«ãè©ä¾¡ã¹ã±ã¼ã«ã¯ãã®ããããéãããä¸é¢ã¨ã®æ¥ç¹ããæãã¦ããããç ã®è¡¨é¢ã«ããèç®ããªãã£ã¦ããã«ãããªããç ã®çå®ã«æ¥è¿ããããã«ã¯ããã°å²å¦çã¨ããããè«èãå¿ é ã§ããããããæ·±ãçè§£ãã¦ããå·çé£ã®ç±æãæ¬æ¸ã«çµæ¶ãã¦ããã
彿室é¢ä¿è ã¯ä»¥ä¸ã®é ã«ç»å ´ãã¦ããã
â 対è«ãç²¾ç¥å»å¦ã«ãããã¹ãã¯ãã©ã ã®ææ³ããæäºä¿å/ææ¾å¤ªé
æ¬æ¸ã®ãã¼ãããããããè¶ã®æ°´ã®å¦å£«ä¼é¤¨ã§ã®å¯¾è«ã§ãããå°å·ãããè¨é²ãèªãã¨å¯¾çã®è°è«ãå±éãã¦ãããããªé°å²æ°ãæµãã¦ããããå®éã®å¯¾è«å ´é¢ã§ã¯æäºææã®æ·±ãå¦èã«æå¿ãããããã°ããã§ãã£ãã
â çµ±å失調çã«ãããã¹ãã¯ãã©ã ã¨ããã¡ã¿ãã¡ã¼ã®å°å
¥ã®æç¾©ã¨åé¡ç¹
åç°è²´è¨/æ²æå®°/éåå
çµ±å失調çã®è¨ºæã¨ãããç²¾ç¥å»å¦ã®æ ¹åºã«æµãã大åé¡ã«ã¤ãã¦æ°ããªå
ãå½ã¦ãåä½ãã¹ãã¯ãã©ã ã¨ããã¨ãé£ç¶ãã¨ã¤ã¡ã¼ã¸ããããã¨ãå¤ãããæ¬æ¥çã«ã¯ããã¯ä¸æ£ç¢ºãªæãæ¹ã§ãã£ã¦ãäºç©ããã軸ã«ãã£ã¦ä¸¦ã¹ç´ããã¨ãã«ç«ã¡ç¾ãããã®ãããã¹ãã¯ãã©ã ã§ããããã®ãããªæ¬è³ªè«ã«ç«èãã¦é²ããè«ã¯ããã«ãåç°è¬å¸«ãããè¿«åã«æº¢ãããã®ã«ãªã£ã¦ããã
â ã«ãã´ãªã¼/ãã¤ã¡ã³ã¸ã§ã³ã¨ç²¾ç¥éå®ããææ¾å¤ªé
åäºäºä»¶ã»æ°äºäºä»¶ãåãããæ³å»·ã§ã¯ç²¾ç¥ç¾æ£ãããªãå¼·å¼ãªææ³ã§ã«ãã´ã©ã¤ãºãããã¨ããã°ãã°è¦ããã¦ãããããã¯ããã®å ´ã§åæªãåã¡è² ãã®çµè«ãåºããªããã°ãªããªãã¨ããæ³çäºãã®æ§è³ªã«éã¿ãã°ç®çã«ããªã£ã¦ããã¨è¦ããã¨ãå¯è½ã ããç²¾ç¥å»å¦ã®ç«å ´ããã¯ããã«ãæ£æçã»éç§å¦çãªææ³ã¨ããæãå
ããªãããããæ¯ãè¿ã£ã¦ã¿ãã°ãç²¾ç¥å»å¦çã§è¡ããã¦ãã診æåé¡ã«ã¤ãã¦ããå®ã¯æ°´é¢ä¸ã«ã¯åæ§ã®åé¡ãæ½ãã§ããã®ã§ã¯ãªãããæ²»çããç ç©¶ããæã«ã¯å売ã¨ãã£ãç®çè«ã«ãã£ã¦ãç§å¦ããããã¦äºå®ããç¡è¦ããæ£æçãªã«ãã´ãªã¼åããªããã¦ããã®ã§ã¯ãªãããæ³å»·ã¨ããç°çããç²¾ç¥å»å¦ãç
§å°ããè«èã§ããã
â ã¹ãã¯ãã©ã ã®æ¦å¿µããèããç²¾ç¥ç§è¬ç©çæ³ããå¨ç°ç幸
ã¹ãã¯ãã©ã æ¦å¿µã®æ¡å¤§ã¯éå°è¨ºæã®æ¡å¤§ã«ã¤ãªããããã«ã¯éå°ãªè¬ç©çæ³ã«ã¤ãªããã¨ãããç¾ä»£ã®ç²¾ç¥å»çã§é²è¡ãã¤ã¤ããåé¡ã«å³ããè¦éãé³´ããã¦ããã診æè«ãä¸å¿ã®æ¬æ¸ã«ãã£ã¦ã診æã®å
ã«ããã¹ãããã§ããããã¤ãå»çã§æãéè¦ãªç®çã§ãããæ²»çãããã¼ãã«ããè²´éãªä½åã§ããã
â 髿¬¡è³æ©è½é害ãç¹ã«åé èæ©è½ãæå¶é害ã¨ãã¦æãããã鹿島æ´é
ç¥çµå¿çç 究室ã®åµå§è
ã§ãã鹿島ææã«ããå·»é ã¨ãã»ã¤ã§ãããç¥çµå¿çå¦ã«ã¤ãã¦ã®é¹¿å³¶ææã®æç´¢ã®éª¨åã3ãã¼ã¸ã«å縮ãã¦ããã
(ææ¾å¤ªéã2016.11.30.)
ã¤ã³ã¿ã¼ãããä¾åã®æ¦å¿µã¨æ²»ç
Muhammad ElSalhy (æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨å¤§å¦é¢å士課ç¨)
BRAIN and NERVE ----- ç¥çµç ç©¶ã®é²æ© 2016å¹´10æå·
ã ãã³ããã»ã¨ã«ãµã«ããææ¾å¤ªéãæ¨å£é²ã䏿 å°
æ¬ç¨¿ã§ã¯ã¤ã³ã¿ã¼ãããä¾åã®å®ç¾©ããçç¶ãªã©ç´°ããå 容ã«å ãããªãã¤ã³ã¿ã¼ãããã«ä¾åãã¦ãã¾ãã®ãããã®æ²»çæ¹æ³ã«ã¤ãã¦ã¾ã¨ããã
â ãã¤ã³ã¿ã¼ãããä¾åã®æ¦å¿µ
ã¤ã³ã¿ã¼ãããä¾åã®å®ç¾©ã ããç¾ç¶ã¾ã çµ±ä¸ããã¦ããªããä»ã®ã¨ããããã¤ã³ã¿ã¼ããã使ç¨ã®éå°ãããã¯ã³ã³ããã¼ã«å°é£ãªã¨ãããä¿è¿«ã»è¡åã§ãçµæã¨ãã¦é害ãè¦æ©ãçºçãããã¨ããã¦ããã
ã¤ã³ã¿ã¼ãããä¾åã¯è¡ååçã®ä¸ç¨®ã§ãããçç¶ã¨ãã¦ã¯ãSalienceï¼ãªã³ã©ã¤ã³æ´»åã人çã®æå¤§ã®éè¦äºé ã¨ãªããä»ã®æèã»ææ ã»è¡åãå§åãã¦ãã¾ãï¼ãèæ§ï¼ã¤ã³ã¿ã¼ããã使ç¨ã®æéã質ãªã©ãå¢ãã¦ãã¾ãï¼ãªã©ã®æ§æè¦ç´ ãå½ã¦ã¯ã¾ãã
ã¤ã³ã¿ã¼ãããä¾åã®ãªã¹ã¯ãã¡ã¯ã¿ã¼ã¨ãã¦ã
â å¹´é½¢ã¨æ§å¥
â¡ç²¾ç¥ç¾æ£
â¢æ¬²æã¢ãã«
â£å®¶æå
ã®ã³ãã¥ãã±ã¼ã·ã§ã³ãå®¶ææ©è½ã®ä¸å
¨
â¤æ§æ ¼å¾å
ãªã©ãæããããã
â ¡ãã²ã¼ã ä¾åã¨SNSä¾å
ã¤ã³ã¿ã¼ãããä¾åã®ã¿ã¤ãã¨ãã¦ã大ããã²ã¼ã ä¾åã¨SNSä¾åã®ã«ãã´ãªã¼ãæããããã
1.ã²ã¼ã ä¾å
1990年代ããç¾ãããªã³ã©ã¤ã³ã²ã¼ã ã¯ãã½ã³ã³ããã¼ããã½ã³ã³ãã¹ãã¼ããã©ã³ããã¼ã¿ãã« ã²ã¼ã æ©ãªã©ãæ§ã
ãªæ©æ¢°ãéãã¦ãã¤ã³ã¿ã¼ãããç°å¢ã§ããããã°ãã©ãããã§ãã¢ã¯ã»ã¹ã§ããã²ã¼ã ã§ãããåæã«ããããã®åå è
ããªã¢ã«ã¿ã¤ã ã§ã³ãã¥ãã±ã¼ã·ã§ã³ããªãããäºãã»ååãããªã©ãã¤ã¤ã²ã¼ã ãé²ãããã¦ãããã®ã§ãçµäºæç¹ã¨ãããã®ãåå¨ããªããã¾ããä¸äººã§ã§ããã¿ã¹ã¯ãããã°ããã¼ã ã§ååããªããã°ãªããªãã¿ã¹ã¯ããããã½ã¼ã·ã£ã«ãªè¦ç´ ãããç¹ããªã³ã©ã¤ã³ã²ã¼ã ã¨ãªãã©ã¤ã³ã²ã¼ã ã®æå¤§ã®éãã§ããã¨ãè¨ããããã®ãããå¤ãã®äººã
ã«ã¨ã£ã¦ãªã³ã©ã¤ã³ã²ã¼ã ã®æ¹ã楽ããæºè¶³æãé«ãããã®ããå®çæ´»ãæµ¸é£ããã¨ããçµæã«ãªã£ã¦ããã
2.SNSä¾å
SNS (ã½ã¼ã·ã£ã«ãããã¯ã¼ã¯ãµã¤ã)ã¨ã¯ãç¾å®ã®å人ãè¦ç¥ãã¬äººã¨ã³ãã¥ãã±ã¼ã·ã§ã³ãããã¼ãã£ã«ã³ãã¥ããã£ãæãã SNSä¾åã§æãåé¡ã«ãªã£ã¦ããSNSã¯Facebookã§ããããªã³ã©ã¤ã³ã²ã¼ã ã¨éã£ã¦ãSNSã¯ç¾å®(ãªãã©ã¤ã³)ã®åéã¨ã®é¢ä¿ãç¶æããããã«ä½¿ããã®ãé
åã ã¨ããã¦ããããæã«ã¯ãã®SNSã常㫠ãã§ãã¯ããªãã¨ã¯ã¿ã ãè
ã«ãªã£ãããå¨ãã®ã¿ããªã«ã¤ãã¦ãããªãã¨æãããªã³ã©ã¤ã³ã½ã¼ã·ã£ã«ãããã¯ã¼ã¯ã«ç©æ¥µçã«åå ãããã¨ã«å¼·ããããã¨ãããã¿ã¼ã³ãå°ãªãã¯ãªãã
ã¾ããSNSã§ã¯ã対é¢ã§ã¯è¨ãã«ãããã¨ãè±æå¶çã«è¨ããããã«ãªããããå人é¢ä¿ã®ç¶æã§ã¯ãªãç ´å£ã«ã¤ãªãããã¨ããã°ãã°èªãããã¦ããã
SNSä¾åã«ã¯ãSNSç¹æã®åå ãããã¤ããããSNSã¯æ¬è³ªçã«èªå·±ä¸å¿çãªæ§é ãæãã¦ããã®ã§ãèªå·±ææ§æ ¼ãæºè¶³ãããããã¨ããç¹æ§ããã®ä¸ã¤ã§ããã
Facebookãæãä¾åæ§ãé«ããã¨ã®çç±ã«ã¤ãã¦ã¯ä»®èª¬ãããã¤ãããããä»äººã¨é£çµ¡ã§ããã ãã§ãªããé»è©±ãã²ã¼ã ãªã©ã®æ§ã ãªå¨¯æ¥½ãå å¨ãã¦ããã夿§ãªã¢ããã¼ã·ã§ã³ãæºè¶³ãããã¨ããç¹æ§ãããããã¨ããçç±ãæ ¹å¼·ãã
â ¢ãã¤ã³ã¿ã¼ãããä¾åã®äºé²ã»æ²»ç
ã¤ã³ã¿ã¼ãããä¾åã«éãããè¡ååçã®æ²»çç®æ¨ã¯ãå®å ¨ã«ãããããã¨ã§ã¯ãªãã使ç¨ã®ã³ã³ããã¼ã«ãç®æ¨ã«ãªããããã¦ä½ããéè¦ãªæçµç®æ¨ã¯ãæ¬äººã®å¹¸ç¦ã§ãããä¾åã«é¥ã£ã¦ããæ¬äººã¯ã¤ã³ã¿ã¼ãããããã¦ããæãæã幸ç¦ã ã¨æã£ã¦ãããããããããããæ¬å½ã«å¹¸ç¦ã§ãããã¨ããåããçºããå¿ è¦ãããã
ã¤ã³ã¿ã¼ãããä¾åã¯ã欲æãæºãããããã¨ããªãããã«ããã£ã¨ããç¶ãã¦ããã®ã§ãããæ²»çè ã®å½¹å²ã¯æ¬äººã«ã¤ã³ã¿ã¼ãããããããããæç¤ºãããã¨ã§ã¯ãªããæ¬äººã¨ã½ã¼ã·ã£ã«ãããã¯ã¼ã¯ãã²ã¼ã ã«ã¤ãã¦ãããã¦ãªãå½¼ããä¾åã«é¥ã£ããã話ãåããã¨ã§ããã
æ£è æ¬äººã«ã¨ã£ã¦éè¦ãªãã¨ã¨ãã¦ãèªèº«ã®å¼·ãç¹ãå¼±ãç¹ã欲æã«ã¤ãã¦ããç¥ããããããè¸ã¾ããå°æ¥ãèæ ®ãããã¨ãæããããããããããã¨ã«ãã£ã¦æ¬äººã¨ã¨ãã«å¹¸ç¦ã追æ±ãã¦ãããã¨ãããæ²»çè ã®å½¹å²ã¨è¨ããã
é©åãªã²ã¼ã ããé©åãªæéã ãè¡ãã®ã§ããã°ããã¸ãã£ããªç¹ã¯ããã¤ãããããã¨ãã°èªå°å¿ãé«ããããåå°ç¥çµãåå¿æéãè¨æ¶åãè«ççæèãæ¦ç¥çæèã社交çã¹ãã«ãã³ãã¥ãã±ã¼ã·ã§ã³ã¹ãã«ãªã©ãæ¹åãããã¨ãã§ããã
(ã ãã³ããã»ã¨ã«ãµã«ãã 2016.10.10.)
解説ãæãè¶ ã空éãè¶ ã
ã¨ã¸ããããã®çå¦çã§ããã ãã³ããã»ã¨ã«ãµã«ãé¢ç(Dr. Muhammad ElSalhy)ã¯ãã¢ã¬ããµã³ããªã¢å¤§å¦å»å¦é¨åã®å»å¸«ã§ãããæµæ¢ã«æ¥æ¬èªã話ããèªã¿ãæ¸ããä¸è¨ã®ç´¹ä»æããã¹ã¦å½¼ãä¸äººã§æ¸ãããã®ã§ãæ¥æ¬äººã®æã¯ä¸åå ãã£ã¦ããªããã ãã³ããé¢çã¯ãã¡ããè±èªãã§ãããããã¤ãèªãã§ãããæ¯å½èªã¯ã¢ã©ãã¢èªã§ããã
ãããªå½é人ãã®ãã®ã®å½¼ã®å¤§å¦é¢ã§ã®ç ç©¶ãã¼ãã¯ãã¤ã³ã¿ã¼ãããä¾åã®å½éæ¯è¼ã§ããããã¤ã³ã¿ã¼ãããä¾åã®æ¦å¿µã¨æ²»çãã¨é¡ãããæ¬è«æã¯ãBRAIN AND NERVE --- ç¥çµç ç©¶ã®é²æ©ãã®ç¹éãã¢ãã£ã¯ã·ã§ã³ ----- è¡åã®åçã¨ãã¦ãã«åè¼ããã¦ããããã¡ãããã¹ã¦æ¥æ¬èªã§æ¸ããã¦ããã
ã ãã³ããé¢çã®ä¸è¨ç¬¬ä¸æã«è¨ããã¦ããéããã¤ã³ã¿ã¼ãããä¾åã«ã¯ã¾ã å®ç¾©ããªããããã©ããããåå¨ãã®ãã®ããå
¬å¼ã«ã¯èªç¥ããã¦ããªãã2013å¹´ã«åºçãããDSM-5ã®ãç©è³ªé¢é£é害ããã³åçæ§é害群 Substance-Related and Addictive Disordersãã®ä¸ä½é
ç®ã«ãéç©è³ªæ§é害群 Non-Substance-Related Disordersããããããããã«ã¯ã¤ã³ã¿ã¼ãããã«é¢é£ããé害ã¯ãªããDSM-5ã§å¯ä¸è¨è¼ãããã®ã¯ãä»é²çä½ç½®ã¥ãã§ããSection â
¢ã®ã4ãä»å¾ã®ç ç©¶ã®ããã®ç
æ
ãã®ãã¤ã³ã¿ã¼ãããã²ã¼ã é害ãInternet Gaming Disorderãã®ã¿ã§ããã
ãããå®éã«ã¯ãã¤ã³ã¿ã¼ãããã®æ¥éãªæ®åã«ä¼´ããã¤ã³ã¿ã¼ãããä¾åã¯åå½ã§æ·±å»ãªåé¡ã«ãªã£ã¦ãããããã¦ããã¯ãæåã«ãã£ã¦ãã²ã¼ã ãããããSNSä¾åãä¸å¿ã«ãªããªã©ãæ§ã
ãªå½¢ãåããããã§ããæåã¨ã¯ãã¤ã³ã¿ã¼ãããç°å¢ãå«ãããã¨ãã°éä¿¡é度ã®éããä¾åå½¢æ
ã«å¤§ããå½±é¿ãããä¸ä¾ãæããã°ãã¢ã¯ã·ã§ã³ã²ã¼ã ã¸ã®ä¾åã¯ãéä¿¡é度ãä¸å®ä»¥ä¸ã«éãç°å¢ã®å½ã§ã¯ããã¦æç«ããç¾è±¡ã§ãããããã¦ã¤ã³ã¿ã¼ãããç°å¢ã¨ã¯ããã¯ããã¸ã¼ã®é²æ©ã«ä¼´ããã¾ããåå½ã®æ¿æ²»çµæ¸çäºæ
ã«ãããå»ã
ã¨å¤åãã¦ããã
DSM-5ãå¦ä½ãªãæ±ãããã¦ãããã«ããããããã¤ã³ã¿ã¼ãããä¾åã¯ãè¡ååçãã®ä¸ã¤ã«ä½ç½®ã¥ããããç
æ
ã§ãããè¡ååçã®è³ç§å¦ããã¾å¤§ãã«æ³¨ç®ããã¦ãããã¨ã¯ãä»åã®BRAIN AND NERVEèªãç¹éã¨ãã¦åãä¸ãã¦ãããã¨ã«ãå¦å®ã«è¡¨ãã¦ããã
ãã®ããã«ãã¤ã³ã¿ã¼ãããä¾åã®ç ç©¶ã§ã¯ãè³æ©è½ããæåæ´å²ã¾ã§åºå¤§ãªé åãè¦éã«å ¥ãããã¨ãæ±ãããããããã¯ã ãã³ããé¢çã®ãããªçã®å½é人ã«ãã¦ã¯ããã¦å¯è½ã«ãªããã®ã§ãããå½¼ãç¾å¨æ ç¹ãç½®ãã¢ã¸ã¢ãããã¦ãã¼ã ã°ã©ã¦ã³ãã§ãã䏿±ã»ã¢ããªã«ãããã«ã¯è¥¿æ¬§ã¾ã§ã®å°çè¦æ¨¡ã®ç©ºéã«ç®ãåããã¾ãåå½ã®ç°å¢ã®æéçå¤åãç²¾å¯ã«ææ¡ãã¤ã¤é²ãã¦ããã ãã³ããã»ã¨ã«ãµã«ãé¢çã®ç ç©¶ã®å¤§æãæå¾ ãããã¨ããã§ããã
(ææ¾å¤ªéã 2016.10.29.)
æå人ã®é¡ãå«ã¾ãã社ä¼çåºæ¥äºåçãç¨ããé éè¨æ¶æ¤æ»ä½æã®è©¦ã¿
æ±å£æ´åã(æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§ç ç©¶å¡ã»å¿ç士)ã»ç©´æ°´å¹¸åã»æè¤ææµ
èªç¥ãªãããªãã¼ã·ã§ã³, 21(1), 5-20, 2016
æ±å£æ´åï¼ï¼ã穴水幸åï¼ï¼ãæè¤ææµãé¿é¨æ¶åï¼ï¼ãæ¾ç°åå²ï¼ï¼ãï¼ï¼ã䏿ãå°ãå è¤å
ä¸é
ï¼ï¼å¼çå»ç§å¤§å¦ãå½éå»çã»ã³ã¿ã¼
ï¼ï¼å½éå»çç¦ç¥å¤§å¦ ä¿å¥å»çå¦é¨ è¨èªè´è¦å¦ç§
ï¼ï¼å½ç«ç²¾ç¥ã»ç¥çµå»çç ç©¶ã»ã³ã¿ã¼ãè³ç
æ
çµ±åã¤ã¡ã¼ã¸ã³ã°ã»ã³ã¿ã¼
è¨æ¶é害ã¯å¤§å¥ããã¨ãçºçå¾ã«æ°ãããã¨ãè¦ããããªãã¨ããååæ§å¥å¿ã¨ãçºç以åã®éå»ã®ã¨ãã½ã¼ãã«é¢ããè¨æ¶ãæãåºããã¨ãã§ããªãã¨ããéåæ§å¥å¿ã«åé¡ããããéåæ§å¥å¿ãçããã¨ãéå»ã®æãåºãå®¶æãå人ã¨å
±æã§ããªããªãããã®ãã¨ãå¨å²ã®è
ã«å¤±æãåªå¤±æãå¿ççãªæçµ¶ãçã¿åºããã¾ãæ£è
èªèº«ãå¨å²ã®ãã®ãããªæ
åº¦ã«æ¥ããä¸å
¨æãèªå·±ã®ä¸ç¢ºå®æãæãããã¨ãããï¼å
å´ãã1997ï¼ãã¾ããè³å¤å·å¾ã«å®¶æå
ã§åãæ±ºãã¦ããã«ã¼ã«ãå¿ããæ¥å¸¸çæ´»ã§åé¡ãçããå ´åãããï¼å
«æ¨ãã2013ï¼ã
éåæ§å¥å¿ã«é¢ãã¦ã客観çã«ããã¤å¹³æã«è©ä¾¡ã§ãããã¨ã¯ãæ£è
æ¬äººã¨å¨å²ã®è
ãçç¶ã®ç¨åº¦ãå
±æããæ¥å¸¸çæ´»ã§çããåé¡ç¹ãäºæ¸¬ãã¦äºåã«å¯¾å¿çãç«ã¦ãããä»å¾ã®èªç¥ãªãããªã®æ¹ç¥ãèæ¡ãããããããã«ãéè¦ã§ããã
æ¬ç ç©¶ã§ã¯ãè¿å¹´ã®ç¤¾ä¼çåºæ¥äºã«é¢ããè¨æ¶ã«ã¤ãã¦ãè¨åºçã«æç¨ãªæ¤æ»ã使ãããã¨ãç®çã¨ãã¦ã徿¥ã®è¦è¦æ§é éè¨æ¶æ¤æ»ï¼æ±å£ã, 1996ï¼ããã¨ã«ãã¦æ¤æ»å¯è½ãªæéãå»¶é·ããé éè¨æ¶æ¤æ»ã使ãããããã«ãã®ä¿¡é ¼æ§ã¨å¦¥å½æ§ã«ã¤ãã¦ãæ¤è¨ããã®ã§å ±åããã
æ¬ç ç©¶ã§ã¯ã20æ³ä»£ï½80æ³ä»£ã®å¥å¸¸è¢«æ¤è
199åã«å¯¾ãã¦ãæå人ã®é¡ãå«ã¾ãã1970å¹´ãã2010å¹´ã¾ã§ã«çãã社ä¼çåºæ¥äºåç31æãè¦ããæå人ã®â ååã®åçãâ¡ååã®åèªãâ¢åºæ¥äºã«é¢ãããã¼ã¯ã¼ãã®åçãæ±ããä¸ä»£å¥ã®åå¾ç¹çã調ã¹ãã使ã®ããã®èª¿æ»ã¯ã徿¥ã®å¯¾é¢ã§èª¿æ»ããæ¹æ³ã«å ãã¦ãã¤ã³ã¿ã¼ããããç¨ãã¦åºç¯å²ã«å±
ä½ããè
ãã簡便ã«ãã¼ã¿ãåéããæ¹å¼ãæ¡ç¨ããã
æ¤æ»ã®ä¿¡é ¼æ§ã¯ãæ¤æ»ï¼åæ¤æ»æ³ã«ããå¾ç¹çã®ç´å
ç¸é¢ä¿æ°ï¼interclass correlation coefficient ; ICCï¼ãç®åºãããçµæãåè¨å¾ç¹çã®1åç®ã¯76.3%ã2åç®ã¯82.2%ã§ãICCã¯0.87ã¨ãªããå¼·ãç¸é¢ãèªããï¼p < 0.01ï¼ã
æ¬¡ã«æ¬æ¤æ»ãè³æå·æ£è
ã®è¨åºè©ä¾¡ã«ç¨ãããã¨ã®å¦¥å½æ§ãæ¤è¨ããããã«ãå¥å¿çä¾3ä¾ã«æ¬æ¤æ»ã宿½ããããã®çµæãæ¬äººãå®¶æã®è´åããå¾ãããå¥å¿çæ£è
ã®éåæ§å¥å¿ã®æ§æ
ããæ¬æ¤æ»ã®çµæããã説æã§ããã
以ä¸ã®ãã¨ãããæ¬æ¤æ»ãéåæ§å¥å¿ã示ãå®¢è¦³æ§ææ¨ã¨ãã¦æç¨ã§ãããã¨ã示åã§ããã
æ¤æ»ã®åé¡ç¹ã¨éçã¨ãã¦ãæ¬æ¤æ»ã®é ç®ã«å¯¾ããå人ã®ç¤¾ä¼çåºæ¥äºã«é¢ããæ´é²ã®å·®ã®åå¨ã¨ãé ç®ã追å ãã¦æ¹æ£ãç¶ããªããã°ãªããªãã¨ãã使ä¸ã®åé¡ãæãããããããã«ã¯ãè¿å¹´ã®çæ´»æ§å¼ã®å¤åã¨å¤æ§æ§ã社ä¼çåºæ¥äºã®è¨éã«ããã¼ãå½±é¿ã«ã¤ãã¦ããä»å¾ã®æ¤æ»ã®æ´æ°æã«ã¯èæ ®ããå¿ è¦ãããã
(æ±å£æ´åã2016.9.27.)
解説ãã·ã¸ãã©ã¹ã®å²©ãéã³ä¸ãã
髿¬¡è³æ©è½ã®ä¸ã§ãè¨æ¶ç ç©¶ã®æ´å²ã¯å¤ãããã®çç±ã¯è¤åçã ããä¸ã¤ã®å¤§ããªè¦å ã¯è¨æ¶ã¨ããæ©è½ã®æ¸¬å®ã®ãæãã§ããããå示ãããæ å ±ãã©ãã ãè¦ãããããã調ã¹ãããã®åç´ãªåçã»åèªãã¿ã¼ã³ã®æ¤æ»ã§ãè¨æ¶ã¯ããªãå®éçã«æ¸¬å®å¯è½ã§ããã
ã ãé éè¨æ¶ã«ã¤ãã¦ã¯ããã¯ãããªãã
è¨æ¶æ¤æ»ãåç´ã¨è¨ããã®ã¯ãåçã»åèªèª²é¡ã®å
容ãåç´ãªå ´åã§ãããé éè¨æ¶æ¤æ»ã®ããã¯æ±ºãã¦åç´ã§ã¯ãªããããæå³ãããªãæ¤æ»èª²é¡ããè¤éã§ãããé éè¨æ¶æ¤æ»èª²é¡ã®å
容ã¯éå»ã«ç²å¾ããæ
å ±ã«ãªãããä¸äººã²ã¨ãã®è¢«æ¤è
ã«ã¤ãã¦ã®è©³ç´°ãªéå»ã¯ç¥ãå¾ãªãããã§ãããããã§æåãªç¤¾ä¼çåºæ¥äºã®ãªã¹ãã課é¡ã«ããã®ã宿³ã¨ãªã£ã¦ãããããã¥ã¼ã¹çã¸ã®æé²ã®ç¨åº¦ã¯è¢«æ¤è
ã«ãã£ã¦å¤§ããç°ãªãã¨ããæ§è³ªä¸ãæ¨æºåããã¾ã§ã«ã¯ç¹ç´°ãªä½æ¥ãå¿
è¦ã«ãªããã¾ãããã£ããç²¾å¯ã«æ¨æºåãã¦ãã社ä¼çåºæ¥äºã¯æ¥ã«æ¥ã«æ´æ°ããããããæ¤æ»ã¯æ¥ã«æ¥ã«å¤ããªããé éè¨æ¶æ¤æ»ã®ä½æã¨ã¯ãæ°¸é ã«æ¹æ£ãç¹°ãè¿ããªããã°ãªããªãã¨ããç¹ã§ãã·ã¸ãã©ã¹ã®å²©ãæãããä»äºãªã®ã§ãããæ±å£ç ç©¶å¡ã¯ãã®å°é£ãªä»äºã1996å¹´ã«è¡ãããè¦è¦æ§é éè¨æ¶æ¤æ»ãã¨ãã¦å®æãããããä»åãæ°ãã«ä½æããã®ãæ¬ç ç©¶ãæå人ã®é¡ãå«ã¾ãã社ä¼çåºæ¥äºåçãç¨ããé éè¨æ¶æ¤æ»ä½æã®è©¦ã¿ãã§çºè¡¨ãããæ¤æ»ã§ããã
ç¾ä»£ã®è¨æ¶ç ç©¶ã¯ãè³ç»åç ç©¶ããéºä¼åç ç©¶ãåç©ç ç©¶ã¨å¤åéãæ¨ªæãããã®ã«çºå±ãã¦ãããè¨åºç ç©¶ã§ã¯ããããåéã¨ã®ã¯ãã¹ãã¼ã¯ãçã éè¦ã«ãªã£ã¦ããããã®ããã«ã¯éå®³ãæ£ç¢ºã«åæ ããå®éåãå¿ é ã§ããã¨ãããæ±å£ç ç©¶å¡ãé·å¹´ä¸æã«åãçµãã§ããé éè¨æ¶æ¤æ»ã¯ã¾ãã«ããã«åè´ãã¦ããã åºå¤§ãªå¦åé åã¨äº¤æµããããã®ãã¼ã«ã¨ãã¦ãéããªãæç¾©ãæãã¦ããã
ã®ãªã·ã¢ç¥è©±ã®ã·ã¸ãã©ã¹ã®å²©ã¯ãå±±é ã«éããç´åã§è»¢ããè½ã¡ããã¨ãç¹°ãè¿ããã¨ãããå¾å´ã®è±¡å¾´ã¨ãããããããæ±å£ç ç©¶å¡ãã®é éè¨æ¶æ¤æ»ã¯ã宿ã»è«æåã¨ããå±±é ã«éãããããã¯æ¥ã«æ¥ã«æ´æ°ãããéå½ã«ããå±±é ã§ããããããã«éãã¦åãã¦è¦ãã風æ¯ã¯éããªãåºããæå¤§éã®æ´»ç¨ãæå¾ ãããã¨ããã§ããã
(ææ¾å¤ªéã2016.9.29.)
ã1ãJapanese version of the Rapid Dementia Screening Test(RDST-J)æ°åå¤æèª²é¡ã«é¢ããæ¤è¨
森山泰 (é§æ¨éç
é¢ç²¾ç¥ç§è¨ºçé¨é·)
Yasushi Moriyama, Aihide Yoshino, Taro Muramatsu, and Masaru Mimura
Detailed analysis of error patterns in the number transcoding task on the Japanese version of the Rapid Dementia Screening Test (RDST-J)
Psychogeriatrics. 27 JUN 2016 | DOI: 10.1111/psyg.12207 [Epub ahead of print]
ã2ãJapanese version of The Rapid Dementia Screening Test (RDST-J) ã¹ã¼ãã¼ãã¼ã±ãã課é¡ã®clusteræ°,switchæ°ã«é¢ããæ¤è¨
森山泰 (é§æ¨éç
é¢ç²¾ç¥ç§è¨ºçé¨é·)
Yasushi Moriyama, Aihide Yoshino, Taro Muramatsu, and Masaru Mimura
Detailed analysis of the Supermarket task included on the Japanese version of the Rapid Dementia Screening Test
Psychogeriatrics. 2016 Jun 30. doi: 10.1111/psyg.12209. [Epub ahead of print]
ã1ãJapanese version of the Rapid Dementia Screening Test(RDST-J)æ°åå¤æèª²é¡ã«é¢ããæ¤è¨
Japanese version of the Rapid Dementia Screening Testã«å«ã¾ããæ°åå¤æèª²é¡ã¯,æ¼¢å表è¨ã¨ã¢ã©ãã¢è¡¨è¨ã«ããæ°è¡¨ç¾ã®ç¸äºå¤æèª²é¡ã§ä»¥ä¸ã®4課é¡ãããªãï¼209âäºç¾ä¹,4054âååäºåå, å ç¾å «åä¸â681,äºåäºåä¸â2027
軽çã¢ã«ããã¤ãã¼ç (Alzheimerâs disease: AD)ã®æ£è ããã«æ¬æ¤æ»ãæ½è¡ãã¦ããä¸ã§681ã60801,600801ãªã©ã¨ééãããã¨ãå¤ãè¨åºçå°è±¡ãæã£ã.ããªãã¡ããã¯äººé¡ã®å大ãªçºæã®1ã¤ã§ããâã¢ã©ãã¢æ°åã®ä½åãâã«é¢ããé害ã§ãã,ããã«æ¬ç¾æ£ã®èªç¥éå®³ã®æ¬è³ªã«è¿ããã®ãæã,ãã®ä»ã®èª¤ããå«ãã¾ã¨ãããã¨æã£ãã®ãæ¬ç ç©¶ã®åæ©ã§ããï¼ãªãã¢ã©ãã¢æ°åã¯0ãã9ã¾ã§ã®10ã®æ°åã§å ¨ã¦ã®æ°ã表ç¾ã§ããä½åãè¨æ°æ³ã§ãã䏿¹ã§,æ¼¢æ°åã¯æ¡ãè¡¨ãæ¼¢åãåå¨ããæ··ååè¨æ°æ³ã§ããï¼.
æ¬ç ç©¶ã§ã¯ADã®éç,軽ç群ã§,ãã®ãã¾ãã¾ãªèª¤ããã¿ã¼ã³ã®åºç¾é »åº¦ãç°ãªãããæ¤è¨ãã. 対象ã¯250ä¾ã§, MMSE12ï½26ç¹, CDR 0.5ï½3ã§ãã.誤ãã®åé¡ã¯ããã¾ã§æ¬é¦ã§å ±åããã¦ãããã®15åã¨,ãã以å¤ã®å¾æ¥å ±åããã¦ããªã誤ãã®è¨19種ã¨ã,ãã®åºç¾é »åº¦ã,軽çAD群(CDR0.5ï½1)ã»éçAD群(CDR2ï½3)ã§çµ±è¨å¦çã«æ¯è¼ãã. 誤ããã¿ã¼ã³ã¯ä»¥ä¸ã®19種ã§ããï¼
1)209âäºç¾ä¹èª²é¡
æ°åã®èª¤ãï¼ä¾ï¼209âä¸ç¾ä¹ï¼; æ¡èªã®èª¤ãï¼ä¾ï¼209âäºåä¹ï¼; shift errorï¼ä¿ç¶ç誤ãï¼ä¾ï¼209âäº0ç¾ä¹ï¼; ç°¡ç¥åãã表è¨ï¼éµä¾¿çªå·è¡¨è¨æã®è¨è¼æ³ï¼ä¾ï¼209âäºãä¹ï¼; 徿¥å ±åããã¦ããªã誤ã
2)4054âååäºåå課é¡
æ°åã®èª¤ãï¼ä¾ï¼4054âäºåäºååï¼; æ¡èªã®èª¤ãï¼ä¾ï¼4054âåç¾äºååï¼; shift errorï¼ä¿ç¶ç誤ãï¼ä¾ï¼4054âå0åäºååï¼; ç°¡ç¥åãã表è¨ï¼éµä¾¿çªå·è¡¨è¨æã®è¨è¼æ³ï¼ä¾ï¼4054âåãäºåï¼; 徿¥å ±åããã¦ããªã誤ã
3)å
ç¾å
«åä¸â681課é¡
æ°åã®èª¤ãï¼ä¾ï¼å
ç¾å
«åä¸â781ï¼; è¤æ°ç©ã¿éã表è¨ï¼ä½åã表è¨ã®èª¤ãï¼ä¾ï¼å
ç¾å
«åä¸â60801ï¼; shift errorï¼ä¿ç¶ç誤ãï¼ä¾ï¼å
ç¾å
«åä¸â6ç¾81ï¼; ï¼ã®èª¤ãï¼181ãâãã£ã²ããã¯ã¡ãã
ããã¡âã¨èªã¾ãªããªã©æ¥æ¬èªã§ã¯âï¼âã«é¢ããç¬ç¹ã®æ³åãããï¼ä¾ï¼å
ç¾å
«åä¸â680ï¼; 徿¥å ±åããã¦ããªã誤ã
4)äºåäºåä¸â2027課é¡
æ°åã®èª¤ãï¼ä¾ï¼äºåäºåä¸â3027ï¼; è¤æ°ç©ã¿éã表è¨ï¼ä½åã表è¨ã®èª¤ãä¾ï¼äºåäºåä¸â20207ï¼; shift errorï¼ä¿ç¶ç誤ãï¼ä¾ï¼äºåäºåä¸â20å27ï¼; 徿¥å ±åããã¦ããªã誤ã
âShift errorâ,âæ¡èªã®èª¤ãâ,âæ°åã®èª¤ãâã¯æä½çã«ï¼åã¾ã§ã¨ã,ãã以ä¸ã®å ´åã¯â徿¥å ±åããã¦ããªã誤ãâã«å«ãã. ã¾ãâ徿¥å ±åããã¦ããªã誤ãâ以å¤ã¯è¤æ°ã®èª¤ãåé¡ãèªãã.
ãã®çµæ, éçAD群ã§ã¯4課é¡å
¨ã¦ã®â徿¥å ±åããã¦ããªã誤ãâã®åºç¾é »åº¦ãææã«å¤ã䏿¹ã§, 軽çAD群ã§ã¯4054âååäºåå課é¡ã®âæ¡èªã®èª¤ãâ, âç°¡ç¥åãã表è¨âã®åºç¾é »åº¦ãææã«å¤ãã£ã.ãã®ä»ã®13ã®èª¤ãã§ã¯åºç¾é »åº¦ã«ææå·®ãèªããªãã£ã.
以ä¸, ä½åãã®èª¤ãã¯ADéã»è»½ç群ã«ããã¦ãã®åºç¾é »åº¦ã«çµ±è¨çææå·®ãèªããªãã£ãã,ADã®éã»è»½ç群ã§ã¯åºç¾é »åº¦ã®ç°ãªã誤ããã¿ã¼ã³ãåå¨ãããã¨ã示ããã.
ã2ãJapanese version of The Rapid Dementia Screening Test (RDST-J)ãã¹ã¼ãã¼ãã¼ã±ãã課é¡ã®clusteræ°,switchæ°ã«é¢ããæ¤è¨
Japanese version of the Rapid Dementia Screening Test (RDST-J)ã«å«ã¾ããã¹ã¼ãã¼ãã¼ã±ãã課é¡ã¯1åéã®å¶éæéå ã«ãã¹ã¼ãã¼ãã¼ã±ããã§è²·ãããã®ããã§ããã ããã£ã¦ãããè¨èªæµæ¢æ§èª²é¡ã§ãã. æ¬æ¤æ»ããããªã£ã¦ããä¸ã§å¥å¸¸ç¾¤ã§ã¯ãéè,ãã£ã¨ç½è,ãã£ãã,ããã,ãã³ã¸ã³ãã¨ãã£ãããã«ã¾ãä¸ä½æ¦å¿µãæ³èµ·ãããã¨ã«ä¸ä½æ¦å¿µãæ³èµ·ããæ¦ç¥ãã¨ãã®ã«å¯¾ã,軽度èªç¥çã®æ£è ããã§ã¯ä¸ä½æ¦å¿µãæ³èµ·ãã«ããã¨ãã£ãè¨åºçå°è±¡ããã£ã.æç®ã調ã¹ããã¡ã«ãããããã詳細ã«èª¿ã¹ããã¼ã«ã¨ãã¦Troyerãã®å®ç¾©ããClusterã»Switchæ°ããããã¨ãç¥ã£ã.ããªãã¡åçãClusterã¨å¼ã°ããã«ãã´ãªã¼ã«åé¡ããï¼è¡¨åç §ï¼. Mean Clusteræ°ã¯åæ¬ã§ã¯åã ã®åé¡ã®åçæ°ããï¼ãå¼ã,ãã®ç·è¨ããã¨ã,ãããåçãããã«ãã´ãªã¼æ°ã§å²ã.Switchæ°ã¯1èªä»¥ä¸ã®clusterã®ç·æ°ãæ±ãã.ä¾ãã°ã¹ã¼ãã¼ãã¼ã±ãã課é¡ã§ã®åçãããªã³ã´,ããã,ãã³ã¸ã³,ããã,é¶è,è±èãã®å ´å,Mean Clusteræ°ã¯1 (2 [ãªã³ã´,ããã]-1 + 2 [ãã³ã¸ã³,ããã] â 1 + 2 [é¶è,è±è] â 1=3, 3÷3ï¼1). 䏿¹Switchæ°ã¯3 (3ã¤ã®ãµãã«ãã´ãªã¼ããªãã¡ [æç©, éè, è])ã¨ãªã.
ããã§Troyerããå®ç¾©ããåæµæ¢æ§èª²é¡ã«ãããã«ãã´ãªã¼æ°ã¯è¨èªæµæ¢æ§èª²é¡ï¼F,A,Sï¼ã¯ããããï¼ã«ãã´ãªã¼ãªã®ã«å¯¾ãã¹ã¼ãã¼ãã¼ã±ããã»åç©èª²é¡ã¯14ã«ãã´ãªã¼ã§ãã.ããªãã¡ã«ãã´ãªã¼æ°ãå¤ãã¹ã¼ãã¼ãã¼ã±ããã»åç©èª²é¡ã¯Cluster,Switchæ°ã®ããè©³ç´°ãªæ¤è¨ãå¯è½ã§ãããã¨ãäºæ¸¬ããã.
ã¾ãã¹ã¼ãã¼ãã¼ã±ãã課é¡ã¯14ã«ãã´ãªã¼ï¼ä¸ä½æ¦å¿µï¼ãå¤åéã«ããã,ããã«å±ããä¸ä½æ¦å¿µã«å«ã¾ããç¨èªãå¤ããããä¸ä½æ¦å¿µãæ³èµ·ãããã¨ã«ä¸ä½æ¦å¿µãæ³èµ·ããæ¦ç¥ããé »ç¨ããã®ã§ããèªç¥çã®æ£è ããã®èªç¥é害ãããéæã«æ¤åºã§ããã¨èãã.ããã§ä»åã¢ã«ããã¤ãã¼åèªç¥çï¼ADï¼ã®éç度ã¨Cluster,Switchæ°ã¨ã®é¢é£ã調ã¹ã.ããã«Clusteræ°ã¨Switchæ°ã¯ä¸æ¹ãæ¸ãã¨ä¸æ¹ãå¢ããï¼ããªãã¡trade offï¼ã®é¢ä¿ãããã¨èãããããã«ã¤ãã¦ã調ã¹ã.
対象㯠very mild ï½ severe AD250ä¾ã§, MMSE12ï½26ç¹,Clinical Dementia Rating 0.5ï½3ã¨å¯¾ç §ç¾¤49ä¾ã§ãã. ã¹ã¼ãã¼ãã¼ã±ãã課é¡ã®åçãTroyerãã®åæ³ããã¨ã«,æåçéããªã©ãèæ ®ãè¥å¹²ã®æ¹å¤ããããªã£ãï¼è¡¨ï¼.
Clusteræ°ã¯åæ³ã¨åæ§æç©ã¨ãã£ãä¸ä½æ¦å¿µèªã¯ããã,ãããã¨ãã£ãä¸ä½æ¦å¿µèªãåæã«åçãããå ´åæ£è§£æ°ã«å«ããªã䏿¹ã§,åæ³ã¨ç°ãªãçµ±è¨å¦çæ¤è¨ããããªããããããããåçãããã«ãã´ãªã¼æ°ã§å²ããã¨ããããªããªãã£ã.ãã¨ãã°ããã,ããã,æç©, é¶è,è±èãåçãããå ´å,2[ããã,ããã,ããªãã¡æç©ã¯ã«ã¦ã³ãããªã]-1ï¼2[é¶è,è±è]-1 =2 ãã®2ã2[æç©,èã®2ã¤ã®ã«ãã´ãªã¼æ°]ã§å²ããªãã®ã§Clusteræ°ã¯2ã¨ãªã.ãSwitchæ°ã¯åæ³ã¨åæ§1èªä»¥ä¸ã®clusterã®ç·æ°ï¼ãã¨ãã°ããã,ããã,æç©ãåçãããå ´åãã¹ã¦cluster1ã«å«ã¾ããã®ã§Switchæ°ã¯1ã¨ãªãï¼ãæ±ãã.
çµæã以ä¸ã«ç¤ºãï¼1)Switchæ°ã¨Clusteræ°ããããCDRãé«å¤ã«ãªãã®ã«å¿ãã¦ä½å¤ã¨ãªã£ã¦ãã;2)CDR0.5ã¯å¥å¸¸ç¾¤ã¨æ¯è¼ãã¦Clusteræ°ã¯ä½ä¸ãã¦ããã,Switchæ°ã¯å¥å¸¸ç¾¤ã¨ææå·®ãèªããªãã£ã;3) Switchæ°ã¨Clusteræ°ã¯è»½åº¦ã®ç¸é¢ã示ãã(r=0.34, p<0.01)
以ä¸1)ADã®ã¹ã¼ãã¼ãã¼ã±ãã課é¡ã«ãããClusterã»Switchæ°ã¯èªç¥çã®éç度ã«å¿ãã¦ä½ä¸ãã¦ãã;2) Hodgesãã¯æå³è¨æ¶é害ã®ç«å ´ãã軽çADã«ããã¦ã¯ä¸ä½æ¦å¿µãä¸ä½æ¦å¿µã«æ¯ã¹ã¦ç¸å¯¾çã«ä¿ããã¦ããã¨ãã¦ããã,æ¬ç ç©¶ã§ãåæ§ã§ãã£ãï¼ããªãã¡CDR0.5ã§ã¯ä¸ä½æ¦å¿µ(Switchæ°)ã§ãªãä¸ä½æ¦å¿µï¼Clusteræ°ï¼ãé害ããã¦ããï¼ï¼3)Clusteræ°ã¨Switchæ°ã¯trade offã®é¢ä¿ã«ãªã,ãããå ±éããé¨åãå¤ãã£ã.
表ï¼ã¹ã¼ãã¼ãã¼ã±ãã課é¡ã«ããã14ã®cluster
1.æç©ï¼ããã,ããã,ãã³ã´ãªã©
2.éèï¼ã¢ãã¬ã,è±,ã«ããããªã©
3.乳製åï¼ãã¼ãº,åµ,ã¨ã¼ã°ã«ã,çä¹³ãªã©
4.èï¼ãã¼ã³ã³,é³¥,é,ãã³ãã¼ã¬ã¼ãªã©
5.飲æï¼ã³ã¼ãã¼,çä¹³,ã¯ã¤ã³ãªã©
6.èª¿å³æï¼å®æããæçã«ä½¿ç¨ããï¼ï¼ã±ãã£ãã,ãã¼ãã¬ã¼ã,ãµã©ããã¬ãã·ã³ã°ãªã©
7.é¦è¾æï¼æç宿åã«ä½¿ç¨ããï¼ï¼ãããã,å¡©,ããã©ãªã©
8.èåé¡ï¼ãã£ã³ãã£ã¼,ã±ã¼ã,ã¢ã¤ã¹ã¯ãªã¼ã ãªã©
9.ç©ç©ï¼ãã³,ãã«ãã,ç±³ãªã©
10.ãã³,ã±ã¼ããä½ãæã®è©¦æï¼ãµããã¾ãç²,ã¨ãããããç²,å¡©ãªã©
11.å¼å½ãªã©ã®å®æåï¼ãµã©ãæ²¹,ã±ãã£ãã,ã¹ãã²ããã£ã¼ãªã©
12.é貨ï¼ãã£ãã·ã¥,éèª,åæãªã©
13.大è±å å·¥åï¼ç´è±ã»å³åã»è±è
ãªã©
14.éé¡ã»æµ·è»é¡ï¼ããã¿ã»éã»ã¡ããã»ãã¤ã¾ããã»ããã¶ã»ããããªã©
(森山泰ã2016.8.12.)
è§£èª¬ãæ¤æ»ã®ç価ã¨ã¯
çµæãã¹ã³ã¢ã¨ãã¦å¾ãããããããæ¤æ»ã®é·æã§ãããã¨ã¯è¨ãã¾ã§ããªããã§ã¯ãªãã¹ã³ã¢ã¨ãã¦å¾ããããã¨ãé·æãªã®ãã
ã¹ã³ã¢ã客観çã ãããã
ããã§ã¯ãªãã
ã¹ã³ã¢ãè¨åºçç¶ãåæ ãã¦ããããã§ããã
ããæ£ç¢ºã«ã¯ããè¨åºçç¶ããã¹ã³ã¢ã¨ãã客観çãªãã®ã«åæ ããã¦ãããããã¨ãããã¨ã«ãªããã
ãã®ã¨ãæãéè¦ãªã®ã¯ããã¹ã³ã¢ãè¨åºçç¶ãåæ ãã¦ããããã¨ã§ãã£ã¦ããã¹ã³ã¢ã客観çãã¨ããã®ã¯ããã®ã¹ã³ã¢ãè¨åºçç¶ãåæ ãã¦ããã¨ãã大åæãã£ã¦ã®ãã¨ã§ãããå½ç¶ããããããå½ç¶ã®ãã¨ã ã
ã ããã®å½ç¶ããããããå½ç¶ã®ãã¨ã¯ãã°ãã°å¿ããããã¡ã§ãããè¨åºçç¶ããåãé¢ãããã¹ã³ã¢ã®è§£æã®ã¿ãåé¢ã«åºãããç ç©¶è«æãã¨ã¦ãå¤ãã®ãä¸ã®ä¸ã®ç¾ç¶ã§ãããè¨åºçç¶ã¨ã¹ã³ã¢ã®å¯¾å¿é¢ä¿ãç²¾å¯ã§ãªããã°ãã¹ã³ã¢ããããçµ±è¨çã«ç²¾å¯ã«è§£æãã¦ãç¡æå³ã ã確ãã«ã¹ã³ã¢ã®è§£æã«éä¸ããã»ããç§å¦çãªä½æ¥ã«è¦ããããè«æãå¤ãçç£ããããã§ãããããããããã¯æããã«æ¬æ«è»¢åã§ããããã®æè¡ãé¿ããããã«ã¯ãè¨åºçç¶ãã¹ã³ã¢ã«åæ ãããã¹ããæ¤æ»ãä¸æã«æ¹è¯ãã¦ãããã¨ãå¿
è¦ã§ããã
ã¾ãã«ãããå®è·µããä»äºããæ£®å±±å士ã®ãJapanese version of the Rapid Dementia Screening Test(RDST-J)æ°åå¤æèª²é¡ã«é¢ããæ¤è¨ãã¨ãJapanese version of The Rapid Dementia Screening Test (RDST-J) ã¹ã¼ãã¼ãã¼ã±ãã課é¡ã®clusteræ°,switchæ°ã«é¢ããæ¤è¨ãã§ãããæ£®å±±å士ãããããRDST-Jã«çç®ããã®ã¯ãæ±ç¨ããã¦ããæè¨æç»èª²é¡ããããRDST-Jã®ã»ãã軽度èªç¥çã®è¨åºçç¶ãããåæ ãã¦ããã¨ããè¨åºçå°è±¡ã§ãã£ãã(æ¬ãµã¤ã 2015.10. ã軽çã¢ã«ããã¤ãã¼ç
ã®è¨ºæè£å©ã«ã¯,æè¨æç»èª²é¡ãããæ¥æ¬èªçRapid Dementia Screening Testãæç¨ã§ãããåç
§)
RDST-Jã¯æ°åå¤æèª²é¡ã¨ã¹ã¼ãã¼ãã¼ã±ãã課é¡ããæãæ¤æ»ããããªã¼ã§ãããæ£®å±±å士ã¯ãã®æ¤æ»ãèªç¥çã®è¨åºã§æ½è¡ãã¦ããä¸ã§ãæ°åå¤æèª²é¡ã§ã¯ä½åãã®èª¤ããå¤ããã¹ã¼ãã¼ãã¼ã±ãã課é¡ã§ã¯ãå¥å¸¸è
ã§ã¯ãéèããã£ã¨ç½èããã£ããããããããã³ã¸ã³ãã¨ãã£ãããã«ã¾ãä¸ä½æ¦å¿µãæ³èµ·ãããã¨ã«ä¸ä½æ¦å¿µãæ³èµ·ããæ¦ç¥ãã¨ãã®ã«å¯¾ãã軽度èªç¥çã§ã¯ä¸ä½æ¦å¿µãæ³èµ·ãã«ããã¨ããå°è±¡ãæã¡ãããããå®è¨¼çã«ç¤ºããã¨ã§ä¸è¨2ã¤ã®è«æãã¾ã¨ããããã
å½ç¥çµå¿çç 究室åµå§è ã§ãã鹿島æ´éåææ(ç¾ã»å½éå»çç¦ç¥å¤§å¦ææ)ã¯ãç¥çµå¿çå¦çæ¤æ»ãå®éçã¢ããã¼ãã¨å®æ§çã¢ããã¼ãã«äºåãã¦ãããå®éçã¢ããã¼ãã¨ã¯ãæ¤æ»çµæãã¹ã³ã¢ã¨ãã¦å®éçã«å¾ããããã®ãæãã宿§çã¢ããã¼ãã«ã¤ãã¦ã¯æ¬¡ã®ããã«è¿°ã¹ã¦ãã:
宿§çã¢ããã¼ã
主ã¨ãã¦è¨åºå®¶ãéçºãçºå±ããã¦ããã¢ããã¼ãã§ãããåã
ã®è¢«æ¤è
ã«ããããç¨åº¦ã®æè»æ§ãå¯å¤æ§ããã£ãæ¤æ»èª²é¡ãç¨ããçµæã¯ã¹ã³ã¢ãªããç¾è±¡çãªè¨è¿°ã¨ãã¦å¾ããããçµæã¯è¨åºæè¦ãåªå
ããããã«åºã¥ãã¦ä¸»è¦³çã宿§çã«æå³ã¥ãããã夿ããããè¨åºå®¶ãè³æå·è
ã®è¨ºççµé¨ãéãã¦å·¥å¤«ãã¦ããããã°âç´æçâæ¤æ»ã§ãããæ¨æºåã¯é£ããããããã£ã¦åºæºããªããã®ãå¤ããæ¤æ»ã®å¦¥å½æ§ã¯è¨åºççµé¨ããä¿è¨¼ããããæ¤æ»ææã¯åã
ã®è¢«æ¤è
ã®ç¶æ
ã«å¿ããæè»ãªå¤æ´ãä¿®æ£ãå¿
è¦ã¨ãããã®ãå¤ããå³å¯ãªå®å¼åã¯å°é£ã§ãããæ¤æ»ã®ä¿¡é ¼æ§ã¯æ¤è
ã®çµé¨ãè½åã«å¤§ããå·¦å³ãããã
ç¥çµå¿çå¦çæ¤æ»ã®çæ³ã¯å®éçã¢ããã¼ãã¨å®æ§çã¢ããã¼ãã®é·æãããããã¤ãããã°âä¸åº¸çâã¢ããã¼ãã§ãããã
(ç¥çµå¿çå¦çæ¤æ» --- å®éçã¢ããã¼ãã¨å®æ§çã¢ããã¼ã.
ç¾ä»£ç²¾ç¥å»å¦å¤§ç³»ãå¹´åç â88-A. ä¸å±±æ¸åºãæ±äº¬. 1988.)
ããã¦é¹¿å³¶ææã¯ãä¸åº¸çã¢ããã¼ãã®å®ä¾ã¨ãã¦ã¦ã£ã¹ã³ã³ã·ã³ã«ã¼ãå顿¤æ»ãæãã¦ããããã®æ¤æ»ã¯ååã®éãã¦ã£ã¹ã³ã³ã·ã³å¤§å¦ã§éçºãããåé èæ©è½æ¤æ»ã ããå®éã«å¤æ°ã®è¨åºä¾ã«æ½è¡ãã¦ã¿ãã¨ãåé èæå·è ã«ç¹å¾´çãªæè¦ã®ããã¤ããã¹ã³ã¢ã«åæ ãããªããã¨ãæããã«ãªã£ã¦ãããããã§å½ç¥çµå¿çç 究室ã§åæ³ã«æ¹è¯ãå ãã¦å®æããã®ãç¾å¨æ±ç¨ããã¦ãã48æã®ã«ã¼ããç¨ããæ¹æ³(KWCST; æ ¶æå¼ã¦ã£ã¹ã³ã³ã·ã³ã«ã¼ãå顿¤æ»)ã§ããã
森山åå£«ã®æã«ããRDST-Jã®æ¹è¯ã»é²åã¯ãKWCSTã®éçºéç¨ã彷彿ã¨ããããã®ã§ããã鹿島ææã¯ãçæ³ãã¨å¼ãã ããå®éçã¢ããã¼ãã¨å®æ§çã¢ããã¼ãã®ä¸¡æ¹ãä½µãæã¤ãã¨ããããæ¤æ»ã®ãç価ãã¨è¨ãã¹ãã§ããããæ£®å±±å士ã®åªåã«ãã£ã¦ãRDST-Jããçæ³ãã«æ¥è¿ãããç価ããåºãç¥ããããã¨ã大ãã«æå¾ ãããã
(ææ¾å¤ªéã2016.8.24.)
ã¢ã«ããã¤ãã¼ç
ã®å¦æ³ã¨ç¥çµåºç¤
仲ç§ç§å¤ªé(æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§ç¹ä»»åææ)Nakaaki S, Sato J, Torii K, Oka M, Negi A, Nakamae T, Narumoto J, Miyata J,
Furukawa TA, Mimura M. (2013) : Decreased white matter integrity before the onset of
delusions in patients with Alzheimer's disease: diffusion tensor imaging.
Neuropsychiatric Disease and Treatment, 9, 25-29.
ã¢ã«ããã¤ãã¼ç
ã®æ£è
ã§ã¯ããã®ã¨ãã妿³ãèªãããã¨ãå¤ãã
ã財å¸ããªãã®ã§ã誰ãã«çããããã¨ããå
容ã¯ãäºè§£å¯è½ã§ããã
çµ±å失調çã§ãã°ãã°åºç¾ããäºè§£ä¸å¯è½ãªå¦æ³ã¨ã¯ç°ãªããèªç¥çã®å¦æ³ã¯èªç¥æ©è½ä½ä¸ã«ããä¸ç¨®ã®èª¤èªã§ãããããããä»ã®ã¨ãã妿³ã¨ããå®ç¾©ä»¥å¤ã®é©åãªç¨èªããªãã®ã§ãèªç¥çã®å¦æ³ãã妿³ãã¨å¼ã¶ããã®èªç¥çã®å¦æ³ã«ã¯ãèªç¥çã®èªç¥æ©è½ä½ä¸ã®å¤æ§ãªç¹æ§ãåæ ãã¦ããã®ãããããªãã
èªç¥çï¼ã¢ã«ããã¤ãã¼ç ï¼ã§åºç¾ãã妿³ã¯åºç¾é »åº¦ãé«ããä»è·è ã®è² æ ã«ããªããããèªç¥çã«ãããè¨åºç ç©¶ã«ããã¦éè¦ãªèª²é¡ã§ãããã¢ã«ããã¤ãã¼ç ã®ç²¾ç¥çç¶ï¼å¦æ³ï¼ã«ã¯ãå¹´é½¢ãæ§å¥ãç½¹ç æéãªã©ã¯é¢é£ããªãã¨ãããã¦ãããããã®çºç¾æ©åºã¯ãã¾ã 䏿ãªç¹ãå¤ããèè ãã¯ãã¢ã«ããã¤ãã¼ç ã«ããã¦ç²¾ç¥çç¶ãçºç ããæ£è ã§ã¯ããã®çºç ãé¡å¨åããåãããç®è³ªéã®é£åç·ç¶ãªã©ã®ç½è³ªç·ç¶ã®å¾®ç´°æ§é ç°å¸¸ãèªããå¯è½æ§ãé«ãã¨æ¨æ¸¬ãããããããç¾æç¹ã§ã¯ãé é¨MRIç»åã«ããç½è³ªç·ç¶æã«çç®ããèªç¥çã®ç²¾ç¥çç¶ã®åºç¾äºæ¸¬ã«é¢ããç ç©¶ã¯ãå½å å¤ã§ç¢ºç«ããã¦ããªãã
æ¬ç ç©¶ã§ã¯ãç²¾ç¥çç¶ï¼å¦æ³ï¼ãä½µçºãã¦ããªã軽度ã®ã¢ã«ããã¤ãã¼ç æ£è ãï¼å¹´é追跡調æ»ãããã¼ã¹ã©ã¤ã³ã®æç¹ã§æ®å½±ããé é¨MRIç»åã®æ¡æ£ãã³ã½ã«ç»åãFSLã§è§£æããã
縦æçãªçµéã§å¦æ³ã®åºç¾ããã¢ã«ããã¤ãã¼ç æ£è ã¯ã妿³ãåºç¾ããªãã£ãã¢ã«ããã¤ãã¼ç æ£è ã«æ¯è¼ãã¦ããã¼ã¹ã©ã¤ã³ã§ã®æ¡æ£ãã³ã½ã«ç»åã®å·¦é é èâå¾é èãè³æ¢ä½é¨ãªã©ã®FAï¼æ¡æ£ç°æ¹åæ§ï¼å¤ãææã«ä½ä¸ãã¦ããã
å·¦é é èâå¾é èãè³æ¢ä½é¨ã®FAå¤ã®ä½ä¸ã¯ãã¢ã«ããã¤ãã¼ç ã®ç²¾ç¥çç¶åºç¾ã®èå¼±æ§ã¨é¢é£ãã¦ããããããã®é¨ä½ã®ç½è³ªç¹ç¶ã®å¾®ç´°ãªæ§é ç°å¸¸ãèªããæ£è ã¯ãå¤çã®æ å ±ã®èªèæ©è½ãä½ä¸ããæ å ±ã®èª¤èªããããããã¨æ¨æ¸¬ãããã
æ¬ç ç©¶ã§ãã¢ã«ããã¤ãã¼ç ã®ç²¾ç¥çç¶ã¸ã®èå¼±æ§ã¨ããã«é¢é£ããè³åºç¤ãå½å å¤ã§åãã¦æ¤è¨ããæããã«ããæç¾©ã¯éè¦ã§ãããã¢ã«ããã¤ãã¼ç ã®ç²¾ç¥çç¶ã®çºç¾ã«é¢ä¸ããæ°ããªç æ ã¢ãã«ãæä¾ã§ããçºç åããã®æ©æä»å ¥ãå¯è½ã«ãªããç²¾ç¥çç¶ã®çºç äºé²ãäºå¾ã®æ¹åãæå¾ ãããã
ã¢ã«ããã¤ãã¼ç ã§å¦æ³ãåºç¾ããããè³ã®èå¼±æ§ãããæ£è ã¯ãããã«ãªãããã®èªå ï¼å¿ç社ä¼çè¦å ãç°å¢è¦å ï¼ãå ããã妿³ãåºç¾ããã®ãããããªããæ¬ç ç©¶ã§ã¯ãµã³ãã«ãµã¤ãºãå°ããããã®ãããªèªå ãæããã«ã§ããªãã£ããä»å¾ã®æ¤è¨èª²é¡ã§ããã
(仲ç§ç§å¤ªéã2016.7.27.)
解説ã妿³ç ç©¶ã¸ã®æ°é¢¨
妿³ã¨ããã°ç²¾ç¥ç çç¶ã®ä»£è¡¨ã ããã§ã¯å¦æ³ã¨ã¯ä½ãã¨æ£é¢ããåãããã¨ãåçã¯å®¹æã§ãªãã妿³ã®ç«¯çãªå®ç¾©ã¯ãè¨æ£ä¸è½ã®èª¤ã£ã確信ãã§ããããããã«å¾ãã°ãçµ±å失調çã®èåç¡ç¨½ãªå¦æ³ãã妿³æ§é害ã®ããç¨åº¦äºè§£ã§ãã妿³ããå¥å¸¸è ã«æããè¦ãããå¼·ãæãè¾¼ã¿ããããã¦ã¢ã«ããã¤ãã¼ç ã®ãããããã®çãã妿³ãããã¹ã¦å¦æ³ã¨ããè¨èã«å æ¬ããããã¨ã«ãªããããã¯ã©ãè¦ã¦ãä¸åçã§ãããã
ããã§ç²¾ç¥å»å¦ã¯å¤æ¥ããã妿³ã¨ã¯ä½ãã¨ããåãã«ã¤ãã¦æ§ã ãªè°è«ãéãã¦æ¥ããããããæãããç¥ããã¦ããã®ã¯ã«ã¼ã«ã»ã¤ã¹ãã¼ã¹ãæãããã並ã ãªãã¬ä¸»è¦³ç確信ããè¨æ£ä¸è½æ§ããå 容ãããããªããã¨ãã¨ããä¸ã¤ã®ç¹å¾´ã§ãããããã®ãã¡ãã並ã ãªãã¬ä¸»è¦³ç確信ãã¯ã輪éãææ§ãªå°è±¡ãåããããããããã妿³ã¨ããçç¶ã®æ¬è³ªã§ããã¨ããç«å ´ããããããã¯æè¨ããã°ã主観ã¨å®¢è¦³ã®æ··åãã¨ãè¨ãã¹ãçç¶ã§ããã妿³ã ãã§ãªããç²¾ç¥ç æ§ã®çç¶(çµ±å失調çã妿³æ§é害ã®çç¶)ã«å ±éããæ ¹æ¬çãªç¹å¾´ã§ããã¨è¦ããã¨ãã§ããããã®ç·ã«ãã£ã妿³ã®å®ç¾©ã¨ãã¦ã·ã¥ãããã¡ã¼ã¯ãå½¢å¼çã«ã¯èªå·±ã®å¿çç¶æ ã«å¯¾ããé³è¿°ã®ãã¨ã話ãããããå 容çã«ã¯é主観ç(客観ç)ã«æ¥è¿å¯è½ãªäºå®ã«ã¤ãã¦ã®é³è¿°ããæå±ãã¦ããããããããã«ããå®ç¾©ã§ããããè¨ããã¨ããã¨ããã¯ãã客観çãªç¾è±¡ã«ã¤ãã¦ã主観çãªç¾è±¡ã¨åã確信ãæã£ã¦è¿°ã¹ããã¨ãããã¨ã§ããã
ã¨ãããµãã«å¦æ³ã¨ããç²¾ç¥çç¶ã«ã¤ãã¦ã®è°è«ãå§ããã¨çµããç¡ãå»¶ã ã¨ç¶ããã¨ã«ãªããã¡ã§ãããããã¯ããã§ææç¾©ãªå¶ã¿ã§ããããè¨è¿°çãªæ¹æ³è«ã®ã¿ã«ä¾æ ãã追究ã«ã¯éçããããã¨ãã¾ãå¦ããªãã
ãã®ç¶æ³ã®æç ´ãæå¾ ã§ããã®ããæ¬ç ç©¶ã§ä»²ç§ç¹ä»»åææãæ¡ã£ãæ¹æ³è«ã§ããããããããã®çãã妿³ãå¤çã®èª¤èªã«åºã¥ãçç¶ã§ãããã¨ã¯çåè«ãããæ¨å®ããã¦ããããããã«æ¬ç ç©¶ã«ãããè³åºç¤ã¨ãã観ç¹ããã®ãã¼ã¿ãæ°ãã«å ãããããã¨ã«ãªãããã®çµæã¯ãã¢ã«ããã¤ãã¼ç ã«ã¤ãã¦ã®çè§£ãæ·±ããã¨ãã大ããªæç¾©ããããã¨ã¯ãã¡ãããç²¾ç¥å»å¦ã§æéè¦ã¨ãè¨ããçç¶ã§ãã妿³ã«ã¤ãã¦ã®ä¼çµ±çãªè°è«ã«æ°ããªé¢¨ãå¹ãè¾¼ã¿æ´»æ§åããå¯è½æ§ãå å«ããåºæ¿çãªãã®ã§ããã
(ææ¾å¤ªéã2016.7.29.)
åé 辺ç¸ç³»ç¥çµåè·¯ã«ããã女æ§åªä½ãªä¸ä»£éä¼éãã¿ã¼ã³
山縣ãæã(æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§ 婿)Yamagata B, Murayama K, Black JM, Hancock R, Mimura M, Yang TT, Reiss AL,
Hoeft F. Female-Specific Intergenerational Transmission Patterns of the Human
Corticolimbic Circuitry. J Neurosci. 2016;36(4):1254-60.
親ã¯åä¾ã®èªç¥ãè¡åããã¦è³ã®çºéã«å¯¾ã大ããªå½±é¿ãæãã¦ããããããä¸ä»£éä¼é(Intergenerational transmission)ã¨å¼ã¶ï¼Curley, 2011ï¼ãããã¯éºä¼çè¦å ãåºçåã®èå ã§ã®å½±é¿ãããã«åºçå¾ã®ç°å¢è¦å ãç¸äºçã«é¢ä¸ãã¦ããã¨èãããã¦ããããã®ãããªè¦ªåã«ããã广ã¯çµ±å失調çããã¤ç ã¨ãã£ãç²¾ç¥ç¾æ£ã§ããã°ãã°èªãããããä¾ãã°ããã¤ç ã®è¦ªãæã¤åä¾ã¯å¥åº·ãªè¦ªãæã¤åä¾ã«æ¯ã¹2ã3åãã¤ç ãçºçãããªã¹ã¯ãé«ã(Lieb, 2002)ãç¹ã«æ¯è¦ªããã¤ç ã®å ´åãæ¯åã§ã¯ãªãå¨ã®æ¹ããã¤ç ãçºçãããªã¹ã¯ãé«ã(Goodman, 1999; 2007)ãã¤ã¾ãããã¤ç ã«ã¯å¥³æ§åªä½ã®ä¸ä»£éä¼éããããã¨ã示åããã¦ããã
䏿¹ãéå»ã®è³ç»åç ç©¶ãããæ åå¶å¾¡ã«é¢ä¸ããè³ç¥çµåºç¤ã¨ãã¦ææ¡ä½ã海馬ãåé¨å¸¯ç¶åãèå¤å´åé åéãè ¹å å´åé åéãå«ãç®è³ªè¾ºç¸ç³»ç¥çµåè·¯ã®æ©è½ããã³æ§é ç°å¸¸ããã¤ç ã«ããã¦ä¸è²«ãã¦ææããã¦ãã(Price, 2010)ãéå»ã®åç©ç ç©¶ããããã¤ç çºçã«é¢ä¸ããç¥çµåè·¯ã«ããã¦å¥³æ§åªä½ãªä¸ä»£éä¼éãããå¯è½æ§ã示åããã¦ããï¼Weinstock, 1992; Zhu, 2004ï¼ãããããªãããç¾å¨ã¾ã§äººéã®è³ã«ããããã®ä¸ä»£éä¼éã«ãããæ§å·®ã«ã¤ãã¦èª¿ã¹ãç ç©¶ã¯ãªãã
ããã§ãæã ã¯ãå¥åº·ãª35çµã®çç©å¦çãªè¦ªåãå¯¾è±¡ã«æ§é magnetic resonance imaging (MRI)ãç¨ãã¦ç®è³ªè¾ºç¸ç³»ã«ãããå親åãã¢ã®ç°ç½è³ªä½ç©ã®ç¸é¢ã®ç¨åº¦ã®éãã調æ»ãããVoxel-based correlation analysisãè¡ãªã£ãçµæãç®è³ªè¾ºç¸ç³»ç¥çµåè·¯ãæ§æããææ¡ä½ã海馬ãç¼çª©åé åéãç´åãåé¨å¸¯ç¶åã«ããã¦ãæ¯ã¨å¨ã®ç°ç½è³ªã®ä½ç©ããä»ã®3ã¤ã®è¦ªåãã¢ï¼æ¯ã¨æ¯åãç¶ã¨å¨ãç¶ã¨æ¯åï¼ã¨æ¯è¼ãã¦ãææã«é«ãæ£ã®ç¸é¢ã示ããï¼P < 0.05, FWE-correctedï¼ã
æ¬ç ç©¶ãããæ¯è¦ªããã¤ç çºçã«é¢ä¸ããç®è³ªè¾ºç¸ç³»ç¥çµåè·¯ã«ããã¦è³æ§é ç°å¸¸ãæãã¦ããå ´åãæ¯åã§ã¯ãªãããã®å¨ãé¡ä¼¼ã®è³æ§é ç°å¸¸ãæãã¦ããå¯è½æ§ã示ããããã¤ç ã«ããã女æ§åªä½ãªä¸ä»£éä¼éã«é¢ä¸ããçç©å¦è¨¼æ ã示åãããã
æ¬ç ç©¶ã®å ã«ã¯ãç²¾ç¥ç¾æ£ã®çºçãªã¹ã¯ã«ãããæ§å·®ã®è§£æãããããã¤ç ã¯å¥³æ§ãç·æ§ãã2ã3åçºçãªã¹ã¯ãé«ããçµ±å失調çã§ã¯ãç·æ§ã¯è¥å¹´çºçã§å¥³æ§ã¯30代åå¾ã®çºçãå¤ããçºçå¹´é½¢ã«æ§å·®ããããããã«åºæ±æ§çºéé害ã§ã¯ç·æ§ã®çºççãé«ãããã®ãããªç²¾ç¥ç¾æ£ã«ãããæ§å·®ã®çç©å¦çåºç¤ãæ¢æ±ãããã¨ã¯ãç æ è§£æã¸ã®å¤§ããªåé²ã«ç¹ããã¨èããã
(山縣æã2016.6.1.)
解説ã親ã¨åãç·ã¨å¥³
åã¯è¦ªã«ä¼¼ããããã¯äºå®ã§ãããã§ã¯ãªãä¼¼ãã®ããããã¯è¤éã§ãããéºä¼ããããã¨ãç°å¢ããéºä¼ã ã¨ããããã©ã®éºä¼åããç°å¢ã ã¨ããããã©ã®ç°å¢ããèå ããè²ã¦æ¹ããããããã¯ãããè¨å¤§ãªå åãæ§ã ãªçã§å¯ä¸ãã¦ããã®ã§ããããé¡ãä½åã¯éºä¼ã®å¯ä¸çã大ãããã§ãããè·æ¥é¸æã¯ç°å¢ã®å¯ä¸çã大ãããã§ãããã§ã¯æ§æ ¼ã¯ã©ãããç²¾ç¥ç¾æ£ã¯ã©ãããçµå±ã®ã¨ããã確å®ãªã®ã¯ãåã¯è¦ªã«ä¼¼ããã¨ããäºå®ã ãã§ãã£ã¦ãããã¨è¦ªããåã®ä¸ä»£ã«ãä½ãããä¼éããã¦ããã¨ã¾ã§ããè¨ããªãããããä¸ä»£éä¼éã¨ããè¨èã®æå³ã§ããã
親ããã¤ç ã ã¨åã¯ãã¤ç ã«ãªãããããããã¯äºå®ã§ãããã ããªããªããããã®ããããã¯è¤éã§ããããã®åãã«æããã夿¥ããç²¾ç¥å»å¦ãæ¡ã£ã¦ããæ¹æ³è«ã¯ãåçå ç ç©¶ã»é¤åç ç©¶ã§ãããããã®çµæããè¨ããã®ã¯éºä¼ã®è¦å ã¨ç°å¢ã®è¦å ã®ã©ã¡ãã大ãããã¨ãããã¨ã¾ã§ã§ããããç ç©¶ãã¶ã¤ã³ã®æ§è³ªä¸ãç¬ç«ããåæ¤è¨¼ã¯ã»ã¼ä¸å¯è½ã ãããä¿¡é ¼æ§ã«ãããªãã®éçããããçµå±ã®ã¨ãããç²¾ç¥ç¾æ£ã®ä¸ä»£éä¼éã®ã¡ã«ããºã ã«ã¤ãã¦ã¯ããéºä¼ããç°å¢ããã¨ããè³æ¥µå½ç¶ã®ãã¨ããè¨ããªãã¨ããã®ãããã¾ã§ã®ç¶æ³ã§ãã£ãã
ãã®éå¡ããç¶æ³ã大ããæºãã¶ããæ°ããªéãéããã®ã山縣åå£«ã®æ¬ç ç©¶ã§ããã山縣å士ãã¾ã注ç®ããã®ã¯ãç¹ã«æ¯ããã¤ç ã ã¨å¨ããã¤ç ã«ãªããããã¨ããè¨åºçäºå®ã§ãã£ããç¶ã¨æ¯ãæ¯åã¨å¨ã誰ã誰ã«ä¼¼ããããã®çµåãã¯2x2ã®4éãããã山縣å士ã¯ãã®4éãã«ã¤ãã¦ãè³ã®æ§é ãç²¾å¯ã«è¨æ¸¬ãããããã¦å¾æ¥ãããã¤ç ã«å¯æ¥ã«é¢é£ãã¦ãããã¨ã示åããã¦ããé¨ä½ã«ããã¦ãæ¯ã¨å¨ã«ææãªç¸é¢ãè¦åºãããæ¯ããã¤ç ã ã¨å¨ããã¤ç ã«ãªããããã¨ããè¨åºç観å¯ã«ã¯ãè³å ã«ãã®åºç¤ããããã¨ã示ãããã®ã§ããã
ãã¤ç ã¯å¥³ã«å¤ãã¨ãã£ã¦ãããã¤ç çºççã®ç·å¥³å·®ã¯ããã»ã©é¡èã§ã¯ãªãããããç²¾ç¥ç¾æ£ã§ã¯ãçºççã«ã¯ã£ããããç·å¥³å·®ããããã®ãããã¤ãããã女ã«å¤ããã®ã¯ãæé£é害ãå¢çæ§ãã¼ã½ããªãã£é害ãè²æ ãã©ãã¤ã¢ãè§£é¢æ§å䏿§é害ãã¯ã¬ããããã¢ãç·ã«å¤ããã®ã¯ãåºæ±æ§çºéé害ãå社ä¼çãã¼ã½ããªãã£é害ãã¢ã«ã³ã¼ã«ä¾åçããã§ãã£ã·ãºã é害ãçªè¦é害ãé²åºé害ããããã®ç·å¥³å·®ãçãã§ãããã®ã¯ä½ãããè³ãã¨çããã°ããã¯æ®éçãªæ£è§£ã ããçã®åãã¯ããã®è³ã®éããçãã§ãããã®ã¯ä½ãã¨ãããã¨ã§ãããããã¯éºä¼ãç°å¢ãã両æ¹ã§ããããã§ã¯å¯ä¸ã®ç¨åº¦ã¯ã©ãããããã¦éºä¼åã®ä¸ã®ã©ãããç°å¢ã®ä¸ã®ã©ããããã®éããçãã§ããã®ããããã«ã¯è³ã®ç·å¥³å·®ãå½¢æããã¾ã§ã®é²åãèå¯ããªããã°ãªããªããããã«ã¯ä½ä¸å¹´ã¨ããåä½ã®çç©çé²åããåå¹´ç¾å¹´åä½ã®ç¤¾ä¼æåçé²åãå«ã¾ãããåãªãè³ã®ç·å¥³å·®ã ãã§ãªããä¸ä»£éä¼éã¨ããå±é¢ã¾ã§è¸ã¿è¾¼ãã 山縣åå£«ã®æ¬ç ç©¶ã¯ããã¤ç ã«ã¤ãã¦ã®ç»æçãªçç©å¦çãã¼ã¿ã§ãããã¨ã«ã¨ã©ã¾ãããç·ã¨å¥³ã®éãã¨ãã人éã«ã¨ã£ã¦æ®éçãªé¢å¿é åã«æ°ããªå ãå½ã¦ããã®ã§ãããã
ãªãããã®è«æã¯å½é社ä¼ãããæ³¨ç®ãæµ´ã³ã¦ããã2016å¹´1æã«ã¯Scientific Americanã«Like Mother, Like Daughter --- the Science Says No, Too.ã¨ããè¦åºãã®ä¸ã«ç´¹ä»ããã¦ããã
http://www.scientificamerican.com/article/like-mother-like-daughter-the-science-says-so-too/
ããã«2016å¹´2æã«ã¯ReutersãMothers may pass daughters a brain wired for depressionã¨ãã¦é
ä¿¡ãã¦ããã
http://www.reuters.com/article/us-health-neuroscience-mothers-depressio-idUSKCN0VR2WN
(ææ¾å¤ªéã2016.6.29.)
妿³ã®å»å¦ã¨æ³å¦ããä¸å¤å»å¦ç¤¾ã2016å¹´6æåºç
èãææ¾å¤ªéã(æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§åææ)
解説ãå»ã¨æ³ã¯åäºè£å¤ã§åºä¼ããè³ã«åãã
妿³ãèªãããã«ã¯ãäºå®ãèªããªããã°ãªããªãã
æ¬æ¸ã妿³ã®å»å¦ã¨æ³å¦ãã§æ±ã£ã¦ããã®ã¯åäºè£å¤ã®å¤ä¾ã§ãããããã«ã¯å¦¥åã¯åå¨ããªããã©ãã¾ã§ãäºå®ãèªãã®ãè£å¤ã§ããã詳細ãªçä¾å ±åã®é示ã諸çç±ã§é£ãããªã£ã¦ããç¾ä»£ã«ããã¦ãå¤ä¾ã¯å¦æ³ãèªãããã®æé«ã®ææã¨ãªã£ã¦ããã
ç¯è¡ã妿³ã«åºã¥ããã®ã§ããã°ãåã¯æ¸è»½ãããå¯è½æ§ããããã ããå¼è·äººã¯ã被åäººã®æèã¯å¦æ³ã§ããã¨ä¸»å¼µããã対ãã¦æ¤å¯å®ã¯ã妿³ã§ã¯ãªããåãªãæãè¾¼ã¿ã§ããã¨ä¸»å¼µãããã©ã¡ããæ£ããããç²¾ç¥å»å¦ã«åãããããã®æãç²¾ç¥å»å¦ã®ææ§ããé²åãããç²¾ç¥å»å¦ã§ã¯æéè¦ã¨ãè¨ããçç¶ã§ããã«ãããããããã妿³ã¨ã¯ä½ããã¨ããåãã«ãç²¾ç¥å»å¦ã¯æç¢ºãªçãå示ã§ããªãã®ã§ããã
妿³ã¨ã¯ä½ãã¨ããåãã¯ãç
æ°ã¨ã¯ä½ãã¨ããåãã«æè¯ããã
ãã®æãå»å¦ã®ææ§ããé²åããã
å»ã®èµ·æºã¯ãæ£è
ãè¦æ©ããæããã¨ã§ãããããã§ãè¦æ©ãç
æ°ã¨åã¥ãã診æã¨æ²»çãä½ç³»åããå»å¦ãæç«ãããããã¹ã¦ã¯æ£è
=æ¬äºº=å½äºè
ã®ãããã¨ããããã¯ã©ãã¹ã®èªãã¯ãç´å
åããç¾ä»£ã¾ã§ãè¨åºå»å¦ã®æ ¹æ¬åçã§ããç¶ãã¦ããã
ã ãåäºè£å¤ã«ã¯ãå対å½äºè ã¨ãããã®ãåå¨ãããå½äºè =æ£è =被å人ãè¦æ©ããæããã¨ã¯ãå対å½äºè =被害è ã®è¦æ©ãæ·±å»ã«ããã¨ããäºæ ãçºçãããããã§ã¯ããã¯ã©ãã¹ã®èªãã¯ãå ¬æ£ä¸ç«ãªå¤å®ãæãªãããã¯ã©ãã¹ãã¤ã¢ã¹ã¨åãã
ãã¤ã¢ã¹ããé¢ããã¨ããè¨åºã¨ã¯å
¨ãå¥ã®é¢¨æ¯ãç¼åã«éããã
è³æ©è½ãæ¨æºããé¸è±ãã¦ãããã¨ãç
æ°ã¨å®ç¾©ãããªãã°ã殺人è
ã¯ã¿ãªç
æ°ã§ããããè£å¤æã¯ããã¯èããªããç
æ°ã¨ã¿ãªãã¦æ²»çãå½ããã®ã§ã¯ãªãã罪ã¨ã¿ãªãã¦ç½°ãå½ãããæ®ºäººè
ã®å¿æ§ãç
æ°ã§ã¯ãªãæ§æ ¼ã¨èªå®ããããã§ããããããè³æ©è½ã®æ¨æºããã®é¸è±ã¨ããæå³ã§ã¯ãç
æ°ã¨æ§æ ¼ãå³»å¥ããæ ¹æ ã¯åå¨ããªããã§ã¯ç
æ°ã¨æ§æ ¼ã¯ã©ããéãã®ããç¥çµå¿çå¦ã«éãããè³ã®ç ç©¶ã¯å¿
ããã®åé¡ã«ãã©ãçããè³ã®ç
æ°ãæ²»çãããã¨ã¯ãæ§æ ¼ã»äººæ ¼ãæ¹å¤ãããã¨ã¨ã©ããéãã®ãã
è£å¤ã¯æ²»çå ´é¢ã§ãããªããã®ã®ãç æ°ã¨æ§æ ¼ããããåé¡ã¯ãä»ã®ã©ããªå ´é¢ãããçã ããé¡ç¾ããããã®å ´ã§çãåºããªããã°ãªããªãããã§ããããã®çã¯ãç¡ç½ªããæ»åã¾ã§æå¤§éã®æ¯ãå¹ ãæã£ã¦ããã妿³ãè«ç¹ã¨ãªãåäºè£å¤ã§ã¯ãç¹ã«ãã®åé¡ãé²ãã«ãªããã妿³ã®å»å¦ã¨æ³å¦ãã§åãä¸ããã©ã®å¤ä¾ã«ãããã®åé¡ãåºã«æµãã¦ãããããã¦æå¾ã®14ãã¼ã¸ã§ã¯ãç¾ä»£ã®å»å¦ã¨æ³å¦ã®å°éç¹ã®æç¤ºã試ã¿ãã
妿³ã®å»å¦ã¨æ³å¦ã¯åäºè£å¤ã®æ³å»·ã§åºä¼ããæã«æãåã£ã¦è³ã«åãããããããæã«æãåã£ã¦ãã¯èè ã®é¡æã«ãããªããè³ã«åããå»ã¨æ³ã®æ©ã¿ã¯ã両è ãçµã³ã¤ããã®ããããã¨ãæ¥è¿ã絶対çã«é»ãæ·±ãçµ¶å£ããããã¨ã示ããã¨ã«çµããã®ããããã¯ããããã®åäºè£å¤ã®ä¸ã«è¦ãã¦ããã§ããããã妿³ã®å»å¦ã¨æ³å¦ãã¯ããã®éæ¨ã¨ãªããã¨ãç®æããæ¸ã§ããã
(ææ¾å¤ªéã2016.5.31.)
å
±æã岩波æ¸åºã2014å¹´9æåºç
ç·¨éãæ¢
ç°è¡ã(æ
¶æç¾©å¡¾å¤§å¦æå¦é¨ææ)èãæ¢
ç°è¡ã(æ
¶æç¾©å¡¾å¤§å¦æå¦é¨)
ããæ¿åæäº (京é½å¤§å¦å¤§å¦é¢æå¦ç ç©¶ç§)
ããå¹³ç°è¡ã(京é½å¤§å¦éçåç©ç ç©¶ã»ã³ã¿ã¼)
ããé è¤ç±ç¾ã(é¢è¥¿å¤§å¦ç¤¾ä¼å¦é¨)
ããå使·³ã(Birkbeck, University of London, Centre for Brain and Cognitive Development)
ããå è¤å
ä¸éã(æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨)
ãã䏿çã(å®é½å®®å¤§å¦å½éå¦é¨)
解説ãå ±æãæ¡å¤§ãã
ç¾ä»£ç¤¾ä¼ã§ã¯ãã¼ãºã¢ããããã¦ãããããããDVãªã©ã®å¿ã®åé¡ã®æ ¹åºã«ã¯ãå ±æä¸è¶³ã¨ãããã¼ã¯ã¼ããè¦åºããã¨ãã§ãããæ¢ ç°è¡ææãç·¨éããæ¬æ¸ãå ±æãã¯ã岩波è¬åº§ãã³ãã¥ãã±ã¼ã·ã§ã³ã®èªç¥ç§å¦ã®2å·»ã¨ãã¦ã®é æ¬ã§ãç¾ä»£ç¤¾ä¼ã®å¿ã®åé¡ãç§å¦çã«èªã¿è§£ããå¯è½æ§ãç§ããåºæ¿çãªæ¸ã§ãããå ±æã®ç§å¦ <èªç¥ç¥çµç§å¦ããã®ã¢ããã¼ã> / å ±æã®çºé <ããã«ãã¦è²ã¾ããã>ã/ãå ±æã®é²å / 社ä¼çæèããå ±æãèãã / å ±æã®èªéã¹ããã¯ã©ã ç / å ±æã®ç ç / å ±æã¨å社ä¼çè¡åã<éå£éç´äºã®åé¡ãéãã¦èãã> ã®åç« ããæããå½ç ç©¶å®¤ã®æ¢ ç°è¡ææã 第1ç« å ±æã®ç§å¦ããå è¤å ä¸éææã 第6ç« å ±æã®ç çããããããå·çãã¦ããã
第1ç« ãæ¢
ç°ææã®ãå
±æã®ç§å¦ãã¯ãç·¨è
ã«ããåé ã®ç« ã«ãµãããããå
±æã«ã¤ãã¦ã®ç ç©¶ã®ååã®æ´ç·´ãããã¾ã¨ãã¨ãªã£ã¦ãããããã«ã¯åãªãã¾ã¨ããè¶
ãã身ä½åå¿ã¨ã®é¢ä¿ã¨ããææ°ã®è¦ç¹ãæç¤ºããã¦ãããæè¿ã®å¿çå¦ã¯å
±æãèªç¥çå
±æ(cognitive empathy)ã¨æ
åçå
±æ(emotional empathy)ã«äºåãããåè
ã¯ããã°ãã¯ã¼ã«ãªå
±æãã§ããä»è
ã®å¿ã®ç¶æ
ãé ã®ä¸ã§æ¨è«ããçè§£ããããã®ã§ãããå¾è
ã¯ããã«èº«ä½åå¿ãä¼´ããããã°ãããããªå
±æãã§ãããåè
ã¯æå³çã«ã¹ã¤ããããªãã«ãããã¨ãã§ããã(ã¤ã¾ããå
±æãæå¶ãããã¨ãã§ããã)ãå¾è
ã¯ãããã§ããªãããã®ããã«ãå
±æã身ä½ã®åå¿ã¨ããè¦ç¹ããæãããã¨ã¯ãç¥çµç§å¦ã®åéã§ããç¥ããã¦ããSomatic Marker 仮説ã¨ãMirror Neuron仮説ãç¹ãããã¤ãç¾ä»£ç¤¾ä¼ã«åºããå¿ã®åé¡ã«è¿«ããã®ã§ããã
æ¢
ç°ææã¯å
±æã«ããã身ä½åå¿æ§ã«ç¹ã«æ·±ãé¢å¿ãæã¡ãæ¬æ¸ã®ã»ãã«ã
ãå¿çå¦è©è«ãã57å·»1å·ãç¹éå·ããææ
ã¨èº«ä½ã
ãç·¨éããåèªã«
ææ
ã¨èº«ä½ã®çµ±åççè§£ã«åãã¦
ã¨ããç°¡æãªè«æãæ²è¼ãã¦ããã
å
±æã®èº«ä½åå¿æ§ã«ã¤ãã¦ã¯ãæ¢
ç°ææã«ããããã«æ·±ã詳ããèæ¸ãæå¾
ãããã¨ããã§ããã
第6ç« ãå è¤å ä¸éææã®ãå ±æã®ç çãã¯ãèªç¥çå ±æã®ä½ä¸ / ä¿æã»äº¢é²ã¨ãæ åçå ±æã®ä½ä¸ / ä¿æã»äº¢é²ã® 2 x 2 ã®è¡¨ã®åã»ã«ã«ãçµ±å失調çã»èªéçã»å¢çæ§äººæ ¼é害ã»ç´ è¡é害ã»åç¤¾ä¼æ§äººæ ¼é害ã»ã¦ã£ãªã¢ã ãºçåç¾¤ãæ´çããããã«ã¯å ±æã®ãã¼ã¯ãµã¤ãã¨ãè¨ãã¹ãã·ã£ã¼ãã³ããã¤ã(æ¬ãµã¤ã 2015.3åç §)ã«ãè¨åããã¦ãããæ¬ç« ãèªãã¨ãç²¾ç¥ç§ã«ãããå®ã«å¤ãã®ç æ ããå ±æã®ç çã¨ããè¦ç¹ããæãããããã¨ã«æ°ã¥ãããããããã¦ç´ã¡ã«ããã¤ãã®åããçã¾ãããè³æ©è½ã¨ã®é¢ä¿ã¯ã©ãããæ²»çã¸ã®çºå±æ§ã¯ã©ãããå è¤ææãç¹ã«é¢å¿ãæã£ã¦ããããèªç¥é²åããã¯ã©ã®ããã«èª¬æã§ãããããããã«ã¤ãã¦ã¯ãå è¤ææã«ããããã«æ·±ã詳ããèæ¸ãæå¾ ãããã¨ããã§ãããããã¯ç¥çèå¥®ã«æº¢ããåèã«ãªã£ããã¨ã§ãããã
(ææ¾å¤ªéã2016.4.27.)
æ²»çã«å¯¾ããåæè½ååé¡ã«ã¤ãã¦
æ±å£æ´å(æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§ç ç©¶å¡ã»å¿ç士)å»çå¾äºè
ã®ããã®åæè½åè©ä¾¡ã®é²ãæ¹ã»èãæ¹ãæ°èå»å¦åºç社ã2015å¹´9æåºç
ç£ä¿®ãä¸æå° (æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§ ææ)
ç£è¨³ãææ¬è¿
ã(京é½åºç«å»ç§å¤§å¦å¤§å¦é¢å»å¦ç ç©¶ç§ç²¾ç¥æ©è½ç
æ
å¦ãåææ)
訳ã坿°¸æè¡ã(京é½åºç«å»ç§å¤§å¦å¤§å¦é¢å»å¦ç ç©¶ç§ç²¾ç¥æ©è½ç
æ
å¦)
ãã仲ç§ç§å¤ªéã(æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§ãç¹ä»»åææ)
ããæ¾å²¡ç
§ä¹ã(京é½åºç«å»ç§å¤§å¦å¤§å¦é¢å»å¦ç ç©¶ç§ç²¾ç¥æ©è½ç
æ
å¦)
ããå è¤ä½ä½³ã(京é½åºç«å»ç§å¤§å¦å¤§å¦é¢å»å¦ç ç©¶ç§ç²¾ç¥æ©è½ç
æ
å¦)
ãã飯干ç´ä»£å (å¿å¸é¤¨å¤§å¦äººéé¢ä¿å¦é¨)
ããæ±å£æ´å (æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§)
ããå°æµ·å®ä¹ã(è±å大å¦ç¤¾ä¼ç¦ç¥å¦é¨)
ããææ¬è¿
ã(京é½åºç«å»ç§å¤§å¦å¤§å¦é¢å»å¦ç ç©¶ç§ç²¾ç¥æ©è½ç
æ
å¦)
å¹³æ24å¹´10æãã27å¹´9æã«ããã¦ç§å¦æè¡æ¯èæ©æ§ï¼ç¤¾ä¼æè¡ç ç©¶éçºã»ã³ã¿ã¼ï¼RISTEXï¼ã§è¡ããããã³ãã¥ããã£ã§åµãæ°ããé«é½¢ç¤¾ä¼ã®ãã¶ã¤ã³ãç ç©¶éçºé åã®ãèªç¥çé«é½¢è ã®å»ç鏿ããµãã¼ãããã·ã¹ãã ã®éçºãããã¸ã§ã¯ãã®åç»ã¡ã³ãã¼ã«ããæ¬æ¸ã翻訳ãã¾ããã
èªç¥æ©è½ãä½ä¸ããã¨æ²»çæ¹éã«å¯¾ããæææ±ºå®ãå°é£ãªãã¨ãããã¾ããæ¥æ¬ã§ã¯ãç¬å±
ã§èº«å¯ãã®ãªãé«é½¢è
ãèªç¥çé«é½¢è
ãå¢å ããç²¾ç¥ç§ä»¥å¤ã®è¨ºçç§ã§ãèªç¥æ©è½ãä½ä¸ããæ£è
ã«ééãããã¨ãç¨ãªãã¨ã§ã¯ãªããªãã¾ãããããã¸ã§ã¯ãã§ã¯ãæ¬äººã®ææãåæ ãããå½¢ã§ãèªç¥çã®äººãé©åãªå»çãåããããããã«ãããããæ¬äººã¨å®¶æã»å»çå¾äºè
ï¼éå°éå»ï¼ã»å¨å®
æ¯æ´è
ãåèã«ã§ããå»çã«é¢ããæææ±ºå®æ¯æ´ã¬ã¤ãã使ãã¾ããã
æ¬æ¸ã¯ãããã¸ã§ã¯ããé²ããããã§ã大ãã«åèã«ãªã£ãè³æã®ä¸ã¤ã§ãã
ããã§ã¯ãç§ã翻訳ãæ
å½ãããï¼ç« ãè§£éãã«ã¤ãã¦ãä¸é¨ç´¹ä»ãããã¾ãã
ï¼ç« ã§ã¯ããã¾ãã¾ãªãã¼ã«ã§å»çåæè½åãè©ä¾¡ããå¾ãã©ã®ããã«è§£éãã¹ããã«ã¤ãã¦è©³ç´°ã«è¿°ã¹ããã¦ãã¾ãã
å»çåæè½åãæ£ç¢ºã«è©ä¾¡ããã¨ãã¦ããããæ²»çã«å¯¾ããå»çåæè½åã®æç¡ãå¤å®ãããã¨ã¯é£ããã¨ãã¦ãã¾ããããã¯ãæ²»çæ¹æ³ã«ããäºæããããªã¹ã¯ããããã£ãããç°ãªããèªåã®ç¶æ³ã«ç
§ããåããã¦ãããã¤ãã®æ²»çæ¹æ³ãæ¯è¼ããªããã°ãªããªãã¨ããç¶æ³ã®è¤éããåå¨ããããã§ããæ²»çæ¹æ³ãã¨ã«å»çåæè½åãã©ã®ç¨åº¦å¿
è¦ãã¨ããåºæºã決ãã¦ããã°ããã®æ²»çã«å¯¾ããæ¬äººã®è½åã®æç¡ãå¤å®ãããã¨ãå¯è½ã«ãªãã¾ãããå®éã®æ²»çæ¹æ³ã«å¯¾ãããªã¹ã¯ã¨ãããã£ãããæ¯è¼è¡¡éããããã®æç¢ºãªæ¹æ³ã¯ä»ã®ã¨ããããã¾ããã
èè
ã¯ãªã¹ã¯ã¨ãããã£ããã®ãã©ã³ã¹ãï¼ã¤ã®ã«ãã´ãªã¼ï¼é«ãªã¹ã¯ï¼ä½ãããã£ãããä¸ï¼ä¸ãä½ï¼é«ãä½ï¼ä½ï¼ã«åé¡ããâCompetence balance scaleâãï¼æ³çãªå¤æè½åã®å¤©ç§¤ï¼ã¨ããæ¦å¿µãç¨ãã¦çè§£ãããã¨ããGrisso T.ã¨Appelbaum P.S.ã®è©¦ã¿ã«ã¤ãã¦ãç´¹ä»ãã¦ãã¾ããæ¬äººã®èªå¾ã¨ä¿è·ã天秤ã«ãããé常ã¯èªå¾ã®å°éã®ããã«å¤©ç§¤ã¯èªå¾ã«å¾ãããã«æ¯ç¹ãä½ç½®ãã¦ãã¾ãããã«ãã´ãªã¼ãåç
§ãã¦æ¯ç¹ã®ä½ç½®ãèæ
®ãããã¨ã«ãããèªå¾ã¨ä¿è·ã®ã©ã¡ããåªå
ããããã夿ãã¾ãããã¨ãã°ãè¤æ°ã®æ²»çæ¹æ³ãæ¯è¼ãã¦ãèªåã«ã¨ã£ã¦æããã«ä¸å©çãªæ¹æ³ã鏿ããå ´åã«ã¯ãä¿è·ã«å¾ãããã«æ¯ç¹ãç§»åãããä¸ã§ãæ¬äººã®è½åã®æç¡ãå¤å®ãã¾ãããã®ããã«æ²»çã®ãªã¹ã¯ã¨ãããã£ããã®ãã©ã³ã¹ãåç
§ãã¦ã天秤ã®å¾ããèããã°ãããæ²»çã«å¯¾ããå»çåæè½åã®å¤å®ãå¯è½ã«ãªãã¨ãããã¨ã§ãã
æ¬ç« ã§ã¯ããã®ä»ã«è½åã®å¤å®ãå°é£ãªä¾ãããã¤ãæãã¦è§£èª¬ãã¦ãã¾ãããã¨ãã°ãç°¡æã®èªç¥æ©è½æ¤æ»ã®çµæãè¯å¥½ãªé«é½¢è
ãããªã¹ã¯ã¯ä½ããããã£ãããé«ãæ²»çãæå¦ããä¾ã§ãããã®é«é½¢è
ã¯èªç¥æ©è½ãä¿ããã¦ããããã«ãæ²»çæå¦ã¯æ¬äººã®ææã¨ãã¦ã¿ãªãããå¯è½æ§ãããã¾ãããããããé£ããèªç¥æ©è½æ¤æ»ããã¦èªç¥æ©è½ãä½ä¸ãã¦ããã¨ããçµæãããããå¦ã®å½±é¿ãæããããæ²»çæå¦ã¯å»çåæè½åãä½ä¸ãã¦ããããã§ããããã¨ããã¾ããããã®ããã«ãå»çåæè½åã«ã¤ãã¦å¤å®ããã«ã¯ãæ¬äººã®æ£ããç
ç¶ãç¶æ³ãææ¡ãããã¨ãéè¦ã¨ããã¦ãã¾ãã
æ¬ç« ã§ã¯ãæå¾ã«è½åå¤å®ã«éã®è¨é²ã«ã¤ãã¦ãæ¨å¥¨ãã¦ããè¨è¼äºé
ã«ã¤ãã¦ãè¿°ã¹ã¦ãã¾ãã
ãã®ããã«ãããæ²»çã«å¯¾ããå»çåæè½åã®æç¡ãã©ã®ããã«å¤å®ããã®ããå»çé¢ä¿è ãå®¶æãæè¯ã¨èããæ²»çãæ¬äººãæå¦ããå ´åã¯ã©ã®ããã«èããããªã©ãè¨åºç¾å ´ã§å»çå¾äºè ã夿ã«è¿·ãã¨ãã«ãæ¬ç« ã¯å½¹ã«ç«ã¤ãã¨ã¨æããã¾ãã
(æ±å£æ´åã2016.3.30.)
解説ã大åæã®å´©ãã«å¯¾å¿ãã
人é社ä¼ã¯ãä¸äººä¸äººãèªç±ææãæã¡ãèªåã«ã¤ãã¦ã®éè¦äºé ã«ã¤ãã¦æ£ããæ±ºå®ã§ãããã¨ãåæã¨ãã¦æãç«ã£ã¦ãããã ãæ¬äººãç²¾ç¥ç¾æ£ãèªç¥çã«ç½¹æ£ãã¦ããã¨ãããã®å¤§åæãå´©ãããã¨ãããããã®ã¨ãã徿¥ã®å»çå«çãåç´ã«ã¯éç¨ããªãå±é¢ãç«ã¡ç¾ãããã©ãã¾ã§ãæ¬äººã®ææãå°éããã¨ããã®ã¯çæ³ã§ããããæ¬äººãèªå·±ã«ã¨ã£ã¦æè¯ã®å»çã鏿ã§ããªãäºæ ã«ç´é¢ããã¨ããããã¯çæ³ã§ãã£ã¦ãç¾å®çã§ãªããå»çå¾äºè ã«ã¯æ éãªããã«ãæ éãªå§¿å¢ãæ±ãããããããããªããããããªãå»çè¡çºããªã¹ã¯ã¨ãããã£ããã®ãã©ã³ã¹ã®ä¸ã«æãç«ã¤ãã®ã§ãããä½ãæåã§ããããä¸ç¾©çã«æ±ºå®ãããã¨ãä¸å¯è½ã§ãã以ä¸ãæ éã§ããã ãã§ã¯ä¸ååã§ãä½ããã®åºæºãããããã¯åºæºã«ã¯è³ããã¨ããåºæ¬ã¨ãªãèãæ¹ãå ±æããã¦ãããã¨ãå¿ è¦ã§ãããç¾ä»£ã«ããã¦å¤§ããã¯ãã¼ãºã¢ããããã¦ãã¦ãããã®åé¡ã«å¯¾ãããå»çå¾äºè ã®ããã®åæè½åè©ä¾¡ã®é²ãæ¹ã»èãæ¹ãã¯è¨åºå ´é¢ã§ã®æçãªæéãç¤ºãæ¸ã§ããã
忏ã¯ã
Scott Y.H. Kim:
âEvaluation of Capacity to Consent to Treatment and Researchâ
ï¼Best practices in forensic mental health assessment seriesï¼
Oxford University Press 2009
ã§ãå½ç 究室ããã¯ä»²ç§ç¹ä»»åææãæ±å£ç ç©¶å¡ã翻訳ãåæ
ãã䏿ææãç£ä¿®ãã¦ããã
æ¬æ¸ã®ååã§ããåºç¤ç·¨ã¯ãAppelbaum P.S. ã¨Grisso T. ãæå±ãã4ã¤ã®è½åã¢ãã«ãããªãã¡ãçè§£ããå understandingããèªèããå appreciationããè«ççã«èããå reasoningãã鏿ã表æããå expressing a choiceã ãä¸å¿ã«å±éããåæè½å capacity to consent ã®æ¦å¿µã®æ£ç¢ºãªææ¡ã«åãã¦æ§æããã¦ããã
ããã¦å¾åã®å¿ç¨ç·¨ã¯ãè©ä¾¡ã®æºå段éãããã¼ã¿åé: æ£è
ã¸ã®é¢æ¥ããè§£éããã¢ã»ã¹ã¡ã³ãå¾ãã¨ãè¨åºç¾å ´ã§ã®æéçæµãã«ããããå®è·µçãªè¨è¼ã®ç« ãç¶ããæçµç« ã¨ãã¦ãç ç©¶åå ã¸ã®åæè½åããè¨ãããã¦ãããããã¯æ¬æ¸ã®åé¡ãâEvaluation of Capacity to Consent to Treatment and Researchâã«å¯¾å¿ãã¦ããã
æ¬æ¸ã¯æ°èå»å¦åºç社ã®ãã¼ã ãã¼ã¸
http://shinkoh-igaku.jp/mokuroku/data/859.html
ã«ãç´¹ä»ããã¦ããã
(ææ¾å¤ªéã2016.3.31.)
çµ±åå¤±èª¿çæ£è
ã®èªå·±ä¸»ä½æã«ãããäºæ¸¬ã·ã°ãã«ã®é
ãã®è¡åå¦çã¨ããã³ã¹
æ¯æ¨æå®(æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨å¤§å¦é¢å士課ç¨)Koreki A, Maeda T, Fukushima H, Umeda S, Takahata K, Okimura T, Funayama M, Iwashita S, Mimura M, Kato M. Behavioral evidence of delayed prediction signals during agency attribution in patients with schizophrenia. Psychiatry Res. 2015. Nov 30;230(1):78-83.
ãã®è«æã¯2013å¹´å¤ã«ASSC (Association for the Scientific Study of Consciousness)ã®å¦ä¼ã§ãã¹ã¿ã¼çºè¡¨ããå 容ã«ããã詳細ãªèå¯ãå ãã¦å½¢ã«ãããã®ã§ããã
çµ±å失調çã®ç æ ã¯æªè§£æã ãããã®ä¸æ ¸çç¶ã¯èªæé害ã¨ãããã¦ããããã®èªæé害ãèªç¥ç¥çµç§å¦ã®ç¥è¦ããã©ã®ããã«èª¬æããããè¿å¹´æ´»çºã«è°è«ããã¦ãããç¹ã«èªå·±æè(Self-consciousness)ã®ç ç©¶ã«æ³¨ç®ãéã¾ã£ã¦ããã
èªå·±æèã«ã¯ï¼ã¤ã®å´é¢ããããä¸ã¤ã¯èªå·±æå±æ(Sense of Ownership)ã§ããããã®æã¯ãç§ã®ããã®ã ã¨ãã£ããããªæè¦ãæããããä¸ã¤ãèªå·±ä¸»ä½æ(Sense of Agencyï¼SoA)ã§ãããä¾ãã°ä½ãç©ãåããã¨ãã«ããç§ããåããã¦ããã¨ãã£ããããªãç§ãã¨ããæè¦ãæãããã®SoAã¯çµ±å失調çã®çç¶ã«ãé常ã«é¢é£ãã¦ãããä¾ãã°èªåã®è¡çºã誰ãã«æããã¦ãã¾ãã¨ãã£ãæè¦ã¯SoAãä½ä¸ãã¦ããç¶æ ã§ããã¨ããããéã«èªåã®è¡çºãå¨å²ã¸éå°ã«å½±é¿ãåã¼ãã¦ãã¾ãã¨ããçç¶ã¯SoAãéå°ã«ãªã£ã¦ããçç¶ã¨ããããå®éã«æ§ã ãªç¥çµå¿çå¦çãªç ç©¶ã§çµ±å失調çã«ãããSoAã®ç°å¸¸ã示ããã¦ãã¦ããã
SoAã®æç«æ©åºã¯Forward modelã§èª¬æãããã人ãä½ãè¡çºãããã¨ãããã®è¡çºã®çµæãäºæ¸¬ããããã®äºæ¸¬ã¨å®éã®è¡çºã®çµæã¨ãä¸è´ãã¦ããã°ããèªåãããã®çµæãèµ·ãããã¨æãããã¨ãã§ããããããSoAãçããå ´åã§ãããä¾ãã°ã黿°ãã¤ãããã¨ããã¨ãã黿°ãã¤ãã¨äºæ¸¬ãã¦ã¹ã¤ãããæ¼ããæãéãã«é»æ°ãã¤ãã°ãèªåãã黿°ãã¤ããã¨æããã䏿¹ã§äºæ¸¬ã«åãã¦ãªããªã黿°ãã¤ãã1åå¾ã«é»æ°ãã¤ããå ´åãä»äººãã©ããã§ã¹ã¤ãããæ¼ãã¦é»æ°ãã¤ããã®ã ããã¨æããã ããã
ãã®ããã«ãäºæ¸¬ãã¯SoAã®æç«ã«é常ã«éè¦ã ãããã®è³åºç¤ã¯åé èããæè¦é£åéã¸ã¨ç½è³ªãéãã¦ä¼ããã·ã°ãã«ã ã¨èãããã¦ãã(Efference copyãCorollary dischargeã¨ãããã)ã
çµ±å失調çã§ã¯äºæ¸¬ã·ã°ãã«ã®ç°å¸¸ããããã¨ã示ããã¦ãããã¾ããã®ç¥çµåºç¤ã¨ãªãããç½è³ªã®ç°å¸¸ã示ããã¦ãã¦ãããããããããå è¡ç ç©¶ã¯SoAç ç©¶ããå¾ããããã®ã§ã¯ãªãããã®ããSoAã¨äºæ¸¬ã·ã°ãã«ã®ç°å¸¸ã¨ã®é¢ä¿ãè«ããã«ããããSoAãã©ãã¤ã ã®ä¸ã§äºæ¸¬ã·ã°ãã«ã®ç°å¸¸ã示ãå¿ è¦æ§ããã£ãã
ä»åãå¥å¸¸è ããã³çµ±åå¤±èª¿çæ£è å30åã«å¯¾ãã¦SoA task(Keio Method)ãæ¹å¤ãã¦è¡ã£ãã¨ãããçµ±å失調çã®äºæ¸¬ã·ã°ãã«ã®é ãã示ãçµæãå¾ããããããã«ã¯ãã®äºæ¸¬ã·ã°ãã«ã®é ããéå°ãªSoAã¸ã¨ç¹ããçµæã示ãããã
ãã®çµ±å失調çã«ãããäºæ¸¬ã·ã°ãã«ã®é ãã¯ãç½è³ªã®ç°å¸¸ã¨ã®é¢ä¿ãæ³å®ãããDisconnection ä»®èª¬ãæ¯æãããã®ã¨èãããããçµ±åå¤±èª¿çæ£è ã¯ãã®é ãã«ãã£ã¦æ¥å¸¸çæ´»ã«ãããæ§ã ãªç¶æ³ã§SoAã®ç°å¸¸ãæ¥ããå¯è½æ§ããããäºæ¸¬ã·ã°ãã«ãé ãã¦ããåãå¥å¸¸è ã¨ã¯éãç¶æ³ã§SoAãæããéã«é常ã§ã¯SoAãæããç¶æ³ã§æ£è ã¯SoAãæããªããããã¯èªæé害ã ãã§ãªãå¹»è´ã妿³ãªã©çµ±å失調çã®æ§ã ãªçç¶ã«ãç¹ããå¯è½æ§ããããããã«ãã®ç¥è¦ã¯äºæ¸¬ã·ã°ãã«ã®é ããä¿®æ£ãããããªãªãããªãã¼ã·ã§ã³ãªã©æ§ã ãªæ²»çæè¡ã®éçºã«ãä»å¾ç¹ããã¨èãã¦ããã
(æ¯æ¨æå®ã2016.2.22)
解説ãèªæé害ãè³ç§å¦ã§èªã
çµ±å失調çã®èªæé害ãç§å¦ã®å°ç¨ã«å¼ãå¯ãããã¨ãç®æãã¦åç°è²´è¨è¬å¸«ãéçºããSoA task (æ¬ãµã¤ã2014.3.åç §)ãæ´»ç¨ããä¸é£ã®ç ç©¶ã®ã²ã¨ã¤ãKoreki et al: Behavioral evidence of delayed prediction signals during agency attribution in patients with schizophrenia. ã§ãããæ¯æ¨é¢çã®è§£èª¬æã«ãããæ¹å¤ãã¨ã¯ãtrial-by-trialãããªãã¡ãå試è¡ãã¨ã«SoA課é¡ã®delay(é ã)ãå»¶é·ãã¦ãããã¨ãæãã¦ããããã®æ¹å¤ãæ½ããæ¹æ³è«ã«ãããçµ±å失調çã«ãããèªå·±ä¸»ä½æã®é ãã客観çãªãã¼ã¿ã¨ãã¦å¯è¦åããããã¨ãæ¬è«æã®éª¨åã§ããã
æ¬ç ç©¶ã§è¨å®ããdelayã¯50msecã§ããããã®50msecã¨ããæ°åã¯ãçµ±å失調çã«ãããcorollary discharge ã®æ¸¬å®å¤ã«ç±æ¥ãããæ¬è«æã®ã¿ã¤ãã«ã«ããBehavioral evidence (è¡åå¦çã¨ããã³ã¹)ã¯ä½æ°ãªã常å¥å¥ã«è¦ããããå®ã®ã¨ããã¯çµ±å失調çã®èªæé害ã説æãå¾ãå¯ä¸ã¨ããããç¥çµççå¦çãªäºè±¡ã®corollary dischargeãbehaviorã®ã¬ãã«ã«çµã³ã¤ããã¨ãããä¸çåã®è¡åå¦çã¨ããã³ã¹ãªã®ã§ããã
Corollary dischargeã®ç°å¸¸ãããã«åé èç½è³ªã®é«éåã®ç°å¸¸ã¨å¯æ¥ã«é¢é£ãããã¨ã示åããã¦ãããã¨ã¨ããããæ¬è«æã®ãã¼ã¿ã®å ã«ã¯ãçµ±å失調çã¨ããè³ã®ç æ°ã®å·¨å¤§ãªå§¿ãæ ãåºããã¦ããããã®å§¿ã¯ãã¾ã é§ã®ä¸ã®å·¨äººã®ããã«è¼ªé䏿çã ããè¨åºçç¶ããè³ã®è§£åççå¦ã¾ã§ã®é£çµé¨åãè¦ã£ã¦ããé§ããå·§å¦ãªå¿çå®é¨ã¨ããä¸é£ã®é¢¨ã§å¹ãé£ã°ããã®ãæ¬ç ç©¶ã§ããã
å®é¨å»å¦ã®é åã§ã¯ãã°ãã° from bench to bedside ã¨ãã表ç¾ãç®ã«ããããåºç¤çãªå®é¨ãã¼ã¿ãè¨åºæè¦ã«ç¹ããã¨ãæå³ãã表ç¾ã§ãããããã¾ã§è¨è¿°ã®ã¬ãã«ã§ããèªããã¦ããªãã£ãçµ±å失調çã®èªæé害ãè³ç§å¦ã®è¨èã§èªã£ãæ¬ç ç©¶ã¯ãã¾ãã«ç²¾ç¥å»å¦ã«ãããfrom bench to bedsideãå ·ç¾ãããã®ã¨è¨ãããã
(ææ¾å¤ªéã2016.2.23.)
ä½ä½æ§é »èçå群ã«ãããè³æ§é ã®ç¹æ®æ§ <èªå¾ç¥çµé害ã¨ç²¾ç¥çç¶ã®é¢é£æ§ãæ¢ã>
æ¢
ç° è¡ (æ
¶æç¾©å¡¾å¤§å¦æå¦é¨ææ)Umeda, S., Harrison, N. A., Gray, M. A., Mathias, C. J., & Critchley, H. D. (2015) Structural brain abnormalities in postural tachycardia syndrome: A VBM-DARTEL study. Frontiers in Neuroscience 9, 34.
William Jamesãæ åã«ããã身ä½ã®éè¦æ§ã訴ãã¦ããï¼120年以ä¸ã®æ³æãçµã¤ï¼ãã®éï¼æãã¤ãä¸å®ãã¯ããï¼ãã¾ãã¾ãªæ åãæ°åã«é¢ããç¥çµçç©å¦çã»ç¥çµå¿çå¦çãªç ç©¶ãçºå±ãï¼ãããã®èå¾ã«ããè³å ã¡ã«ããºã ã«é¢ããçè§£ãæ·±ããããï¼ç¹ã«è¿å¹´ã«ãªã£ã¦è¦ãã¦ãããã¨ã®ä¸ã¤ã¯ï¼æãã¤ãä¸å®ãªã©ã®ç²¾ç¥çç¶ã®èæ¯ã«ã¯ï¼èº«ä½æ©è½ã®ç¹æ®æ§ï¼ç¹ã«èªå¾ç¥çµæ©è½ã®ç°å¸¸ãå¼·ãé¢ä¸ãã¦ããã¨ããäºå®ã§ããï¼
æ¬è«æã¯ï¼èªå¾ç¥çµé害ã®ä¸ç¨®ã§ãããä½ä½æ§é »èçå群(postural tachycardia syndrome (PoTS))ã対象ã¨ããMRIã®æ§é ç»åç ç©¶ã§ããï¼PoTSã¯ï¼èµ·ç«æã®èããå¿æä¸æã«ãã£ã¦ç¹å¾´ã¥ããããèªå¾ç¥çµç æ ã§ããï¼èªå¾ç¥çµäº¢é²åã®é害ã¨ä½ç½®ã¥ããããï¼åå ã«é¢ãã¦ããã¾ãã¾ãªèª¬ãææ¡ããã¦ãããï¼å¿èèªä½ã®å®¹ç©ãå°ãããã¨ãéè¦ãªè¦å ã§ããã¨èãããã¦ããï¼é¢é£ããäºè±¡ã¨ãã¦ï¼å¤ãã®å®å®é£è¡å£«ã¯ï¼å°çã¸å¸°éå¾ã«PoTSçç¶ãåãããã¨ãç¥ããã¦ããï¼å®å®ç©ºéã§ã¯ï¼éåããªãããã«ï¼å¿èãå縮ãã¦ãã¾ããã¨ãèæ¯ã«ããï¼
MRIæ§é ç»åè§£æ(VBM-DARTEL)ã®çµæï¼å¥å¸¸ç¾¤ã¨æ¯ã¹PoTSã«ããã¦ï¼å¸¯ç¶ååé¨(anterior cingulate cortex)ããã³å³¶ç®è³ª(insular cortex)ã®å®¹ç©ãæ¸å°ãã¦ãããã¨ãæããã«ãªã£ãï¼ãã®2ã¤ã®é¨ä½ã¯ï¼è¿å¹´ï¼ã»ã¤ãªã¨ã³ã¹ãããã¯ã¼ã¯ã¨ãã¦ç¥ããï¼å èãçã®ç¶æ ï¼çã¿ã使¸©ï¼ä½æ¶²å¾ªç°ï¼ååºæè¦ãªã©ï¼èº«ä½ã®ãã¡ãªã¹ã¿ã·ã¹ããã®é¸è±ç¨åº¦ã®ã¢ãã¿ã¼(å å容æè¦)ï¼ããã³ããã«å¯¾ãã身ä½èª¿æ´æ©è½ã®é§åã«é¢ããã¨ãããé¨ä½ã§ããï¼æ¬ç ç©¶ã®çµæã¯ï¼PoTSã«ããã¦ï¼èº«ä½ã®ã¢ãã¿ã¼ããã³å¶å¾¡æ©è½ãä½ä¸ãã¦ãããã¨ã示åãããã®ã¨èããããï¼
ããã«ï¼ç²¾ç¥çç¶ã¨ã®é¢é£ã調ã¹ãããï¼æãã¤ããã³ä¸å®å¾åã¨ã®ç¸é¢ã調ã¹ãã¨ããï¼å³¶ç®è³ªã®å®¹ç©ãå°ããã»ã©ï¼æãã¤å¾åããã³ä¸å®å¾åãé«ããã¨ãæããã«ãªã£ãï¼ãããã®ææã¯ï¼æãã¤ãä¸å®ãªã©ã®çç¶ã®çèµ·ã«ï¼èº«ä½æ©è½ã®ç°å¸¸ãæ·±ãé¢ä¸ãããã¨ã示åãã¦ããï¼ç²¾ç¥çç¶ã®çèµ·ã¡ã«ããºã ãæ¢ãä¸ã§ï¼è³ã¨èº«ä½ã¨ã®ç¸äºä½ç¨ã¨ããè¦ç¹ããçµ±åçã«è§£æãããã¨ãèè¦ã§ããã¨èããããï¼
(æ¢ ç°è¡ã2016.1.20.)
解説ãã¯ããã¦äººã¯ãæ³£ãããæ²ããã®ã
ãæ²ããããæ³£ãã®ã§ã¯ãªããæ³£ãããæ²ããã®ã ã
19ä¸ç´ã®å¿çå¦è
ã¦ã£ãªã¢ã ã»ã¸ã§ã¤ã ãºã®ãã®ã¨ããããã®è¨èã¯ã人éã«ããã¦ãççå¦çåå¿(ãã¨ãã°ããæ³£ãã)ããå¿çå¦çæ
åä½é¨(ãã¨ãã°ããæ²ããã)ã®åå ã§ãããã¨ãæå³ãã¦ããã
人ã ã®èªç¶ãªå¸¸èçç´æã«åãããã®è¨èª¬ã¯æ£ããã®ããããæ£ããã¨ããããããã«ã¯å¦ä½ãªãã¡ã«ããºã ãããã®ãããã®å¿çå¦ç¾å¹´æ¥ã®åãããããè°è«ã大ããåé²ãããã®ããæ¢ ç°ææããã¤ã¦ã®çå¦å ã®ãã³ãã³å¤§å¦èªç¥ç¥çµç§å¦ç ç©¶æ / ãã³ãã³å¤§å¦ãç¥çµå¦ã»è³ç¥çµå¤ç§å¦ç é¢ èªå¾ç¥çµã¦ããããInstitute of Cognitive Neuroscience, University College London / Autonomic Unit, National Hospital for Neurology and Neurosurgery University College London ã§è¡ã£ãæ¬ç ç©¶ã§ããã対象ã¯èªå¾ç¥çµçç¶ã¨ç²¾ç¥çç¶(ä¸å®ç)ãåããç¾æ£ã®PoTS (postural tachycardia syndrome; ä½ä½æ§é »èçå群)ã主ããçµæã¯ãããããã»ã¤ãªã¨ã³ã¹ãããã¯ã¼ã¯Salience Networkãæ§æãã帯ç¶ååé¨ã¨å³¶ç®è³ªã®å®¹ç©æ¸å°ã§ããã
ã»ã¤ãªã¢ã³ã¹ãããã¯ã¼ã¯ã¨ã¯ããã®åã®éããSalient eventã«å¯¾ããçä½ã®ãããã°ããããåå¿ã«é¢ä¸ãããã¨ãæããã«ãªãã¤ã¤ããè³æ§é ã§ãããããã¦ãçµ±å失調çãæ°åé害ãããã«ã¯ããããç¥çµçæ§é害ã«ãããå¤ãã®ãããããã¯ãã¹ã¦ã®ãç²¾ç¥ç¾æ£ã§ãã®ãããã¯ã¼ã¯ã«ä½ããã®ç°å¸¸ãããã¨ããç¥è¦ãèç©ããã¤ã¤ãããå¿ã®ç ã¨å¼ã°ãã¦ããç²¾ç¥ç¾æ£ã«ãã®ãããªæè¦ãè¦åºããããã¨ããä¼çµ±çãªå¿ã¨è³ã®äºåæ³ã¸ã®å¼·åãã¤å ·ä½çãªå証ã§ããã¨ããç«å ´ãããããã身ä½çè²å½©ã®å¼·ãç¾æ£ã§ããPoTSã§ãã»ã¤ãªã¢ã³ã¹ãããã¯ã¼ã¯ã«æè¦ããããã¨ã示ããæ¬ç ç©¶ã¯ãå¿ãè³ã身ä½ã®é¢ä¿ã®ãããã«ã¯ãããã®å¢çã®ãè¦ç´ããè¿«ããã®ã§ããã¨è¨ããã
ããã¦æ¬ç ç©¶ã«ãããç¹è¨ãã¹ãç¹ã¯ããæ²ããããæ³£ãã®ããæ³£ãããæ²ããã®ããã¨ããåãã¨ã®æ·±ãé¢é£æ§ã§ããã
ãã®åããPoTSã«å¤æããã°ããä¸å®ã ããé »èã«ãªãã®ããé »èã ããä¸å®ã«ãªãã®ããã¨ãªãã
ç²¾å¯ã«è¨åºè¦³å¯ãè¡ãã°ããä¸å®ãã¨ãé »èãã®æéçåå¾é¢ä¿ã¾ã§ã¯æããã«ãããã¨ãã§ãããããããªãããæ²ãããã¨ãæ³£ããã«ã¤ãã¦ãåæ§ã§ããããããå æé¢ä¿ã¾ã§ã¯è¨¼æã§ããªãããã®ããã«ã¯è³å ã¡ã«ããºã ã®è§£æãå¿ é ã§ãããPoTSã®è³æ§é ã®ç¹æ®æ§ã示ããæ¬ç ç©¶ã¯ããã®è§£æã¸ã®æ©ãçå®ã«é²ãããã®ã§ãããåæã«ãããåççã§æå¹ãªæ²»çæ³ã®éçºã«ãç¹ããã§ããããç²¾å¯ãªè¨åºè¦³å¯ã¨ç»åè§£æãé§ä½¿ããæ¢ ç°ææã®æ¬è«æã«ã¯ããããäºæãããé³´åãããã
(ææ¾å¤ªéã2016.1.25.)
第39åãæ¥æ¬é«æ¬¡è³æ©è½é害å¦ä¼å¦è¡ç·ä¼2015å¹´12æ10æ¥ã11æ¥ ãã«ãµã¼ã«æ¸è°·ãã¡ã¼ã¹ã
ãã¼ããåé è
ä¼é·ãæ
å è¤ å
ä¸é
ä¼é·ä»£è¡ã䏿 å°
äºåå±é·ãè¹å±± éé
ããã«ãå è¤å
ä¸éææããããåé èãã¨ããç´çããã¼ãã«ããå¦ä¼ããä¸è¨ã®éãéå¬ãããæ¬å¦ä¼å²ä¸æå¤ã®ç´2400åã«ãåå ããã ãããäºæ³ãã¯ããã«è¶
ãã人æ°ã§ãã£ãããä¼å ´ãæçã¨ãªããåå è
ã®çæ§ã«ãä¸ä¾¿ãããããããã¨ããè©«ã³ç³ãä¸ãã¾ãã2æ¥éã«ãããç±å¿ãªè¨è«ã¯ãåé èã¨é«æ¬¡è³æ©è½é害å¦ã¸ã®é¢å¿ã®çã
ã®é«ã¾ãã宿ããããã®ã§ãã£ãã
å½ç 究室é¢é£ã®æ¼é¡ã¯æ¬¡ã®éã(ç 究室å¡ãçé æ¼è
ã§ãã£ããã®ã®ã¿ã示ã)ã
1æ¥ç®(2015å¹´12æ10æ¥ï¼
âã·ã³ãã¸ã¦ã 1: çºéé害ã¨ç¥çµå¿çå¦
çºéé害ã«ãããé¡èªç¥
å°è¥¿ æµ·é¦
èªéã¹ãã¯ãã©ã çã®å
è¦ç¹æ§
çå´ åä¸
âæè²è¬æ¼ 3
ã¦ãããæ§å¥å¿
ç°æ¸ è
âã¯ã¼ã¯ã·ã§ãã 1ï¼æ
å å¸ä¼ï¼æ¢
ç° è¡
W1-1
æ
åãçã¿åºããè³ã»å¿ã»èº«ä½ãã®ãã¤ããã¯ã¹ï¼è³ç»åç ç©¶ã¨ç¥çµå¿çå¦ç ç©¶ããã®çµ±åççè§£
æ¢
ç° è¡
âä¸è¬æ¼é¡
ã»æå³è¨æ¶é害ãé·å»¶ããå
¨çæ´»å²å¥å¿ã®ä¸ä¾
æ¯æ¨ æå® ä»
ã»æ³¨æé害ã®çµéâãã¬ã¼ã«ã¡ã¤ãã³ã°ãã¹ãã«ããæ¤è¨
稲æ ç¨ ä»
ã»è¨ç®è«çç²¾ç¥å»å¦ã«ããã¯ã¼ãã³ã°ã¡ã¢ãªé害ã¨åé åéã® NMDA å容ä½ãD1 å容使©è½ã®å¯¾å¿
æ²æ å®° ä»
ã»ç
çåéæ´»åã®åºç¾ã«æãããªå¥æ©ãã¿ãããå³åé èæå·ä¾
é«ç° æ¦äºº ä»
2æ¥ç®(2015å¹´12æ11æ¥ï¼
âã·ã³ãã¸ã¦ã 3ï¼åé å´é è夿§çã¨ç´ããããç
æ
å¸ä¼ï¼ä¸æ å°ãæ± ç° å¦
ã»åé å´é è夿§çã¨é¡ä¼¼ããç²¾ç¥ç¾æ£
䏿 å°
âã¯ã¼ã¯ã·ã§ãã2ï¼sense of agencyãã©ãã¤ã ã«ããæ°ããªãªãããªãã¼ã·ã§ã³æ¦ç¥âéå麻çºãã髿¬¡è³æ©è½é害ã¾ã§
å¸ä¼ï¼åç° è²´è¨
ã»èªå·±æèã®ç¥çµå¿çå¦ã®è©¦ã¿
åç° è²´è¨
âä¼é·è¬æ¼ï¼åé èã®è¨åºç¥çµå¿çå¦
å¸ä¼ï¼é¹¿å³¶ æ´é
åé èã®è¨åºç¥çµå¿çå¦
䏿 å°
âæè²è¬æ¼ 6
叿³ç¥çµå¿çå¦
ææ¾ 太é
âä¸è¬æ¼é¡
ã»å³åçã®åºç¯ãªè³æ¢å¡å¾ã«ã½ãããã©ãã¬ãã¢ã¨ãã¦ä½å
ã«åç©ãåºç¾ããã¨èããããä¸ä¾
ç§ç° æé¦ ä»
ã»æã¦ãããè¬ã§ä¸é¨ã®å¥å¿ãæ¹åããã¦ãããæ§å¥å¿ã®ä¸ä¾
å ç° ç« æ ä»
ã»é¡èãªè¦è¦æ§æéå®³ã¨æ¼¢å失æ¸ãåããè¥å¹´æ§ã¢ã«ããã¤ãã¼ç
çãã® 1 ä¾
山縣 æ ä»
ã»é¡èãªæ¼¢å失æ¸ãåããã¢ã«ããã¤ãã¼ç
çãã® 1 ä¾
å è¾¼ ä¿é ä»
ã»ç©å¿ã夿¥å診è
ã«å¯¾ãããã¬ãä¼è°ã·ã¹ãã ãç¨ããç¥çµå¿çæ¤æ»ã®å®ç¨æ§ã«é¢ããæ¤è¨
æ±å£ æ´å ä»
ã»è¨æ¶é害ãåããè³æå·è
ãèªå®å¥åº·å¢é²æ½è¨å©ç¨ããæç¾©ï¼ç¬¬ 2 å ±ï¼
å
å´ ç« ä»
ãªããå¦è¡ç·ä¼åæ¥ã®2015å¹´12æ9æ¥ã«ã¯ãå
æ¬æ¨ã®æ±äº¬ãããã¿ã¦ã³ãã¼ã«&ã«ã³ãã¡ã¬ã³ã¹ã«ããã¦ãå種å§å¡ä¼ã»å½¹å¡ä¼ãè¡ããã2004å¹´ä»¥æ¥æ¬å¦ä¼çäºé·ãåãããã鹿島æ´éææãéä»»ãããæ°ããªçäºé·ã¨ãã¦ä¸æå°ææãé¸ã°ããã
ããã¦ã¯ãªã¹ãã¹ã®ã¤ã«ããã¼ã·ã§ã³ãè¦ä¸ããä¼å ´ã§ãå½¹å¡æè¦ªä¼ããã³å è¤å
ä¸éå
çãå²ã¶ä¼ãè¡ãããã
(ææ¾å¤ªéã2015.12.24.)
å´é -é é ç®è³ªã®è縮ã«ããé²è¡æ§ã®è¶
ç®è³ªæ§æè¦å¤±èªããã³é²è¡æ§ã®è¦³å¿µå¤±è¡
è¹å±±éé(è¶³å©èµ¤ååç
é¢ãç¥çµç²¾ç¥ç§ãé¨é·)Progressive transcortical sensory aphasia and progressive ideational apraxia owing to temporoparietal cortical atrophy
Michitaka Funayama and Asuka Nakajima
BMC Neurology (2015) 15:231 DOI 10.1186/s12883-015-0490-2
ãèæ¯ã
åé å´é è夿§çã¯ãè¨åºçã«ä»¥ä¸ã®ï¼ã¤ã®ä¸ä½åé¡ããããããªãã¡ãè¡åé害ååé å´é åèªç¥ç, éæµæ¢æ§/å¤±ææ³åé²è¡æ§å¤±èª, æå³åé²è¡æ§å¤±èªã§ããã䏿¹ã§ãå¾é¨è³ã®ç®è³ªã«è縮ãèªãã夿§ç¾æ£ã®è¨åºçç¶ã¯ã¾ã ååã«è§£æããã¦ããªããç¾å¨ã¾ã§ã«ãå·¦ã·ã«ãã¦ã¹è£å¨å²ã®å´é -é é èã«è縮/æ©è½ä½ä¸ãèªããæµæ¢ã§ããã復å±ã®é害ãç®ç«ã¤å¤±èªãåããlogopenicåé²è¡æ§å¤±èªã両å´ã®å¾é -é é èãä¸å¿ã¨ããè縮/æ©è½ä½ä¸ãèªããè¦ç©ºéé害ã主çç¶ã¨ããå¾é¨ç®è³ªè縮çãé é èã®è縮/æ©è½ä½ä¸ãèªããé²è¡æ§ã®è¢ç¯éå失è¡ã主çç¶ã¨ããåçºæ§é²è¡æ§å¤±è¡ãæãããã¦ãããããããè¨åºçç¶ããã®ï¼ç¾¤ã«ãã¾ãå
¥ããªãæ£è
群ã¯ä»¥åããè¨åºç¾å ´ã§ã¯ææããã¦ããã
ãLogopenicåé²è¡æ§å¤±èªã¨å¾é¨ç®è³ªè縮çã®ä¸éã
æ¬ç ç©¶ã¯ãåï¼è
ãããªãã¡ãlogopenicåé²è¡æ§å¤±èªã¨å¾é¨ç®è³ªè縮çã®ä¸éã«å±ããçºçã65æ³ä»¥ä¸ã®2çä¾ã®è©³ç´°ãªè¨åºçç¶ãæããlogopenic åé²è¡æ§å¤±èªã¨å¾é¨ç®è³ªè縮çãã¹ãã¯ãã©ã ã§ããå¯è½æ§ã示ãããããããã®çä¾ã®ç
çæè¦ã示ããã¨ã¯ã§ããªãã£ãããç¥çµç
çç ç©¶ããã¯logopenicåé²è¡æ§å¤±èªã¨å¾é¨ç®è³ªè縮çã¯ã¢ã«ããã¤ãã¼ç
ã®çä¾ãå¤ãã¨å ±åããã¦ãããããªãã¡ãå¾é¨è³ã®ç®è³ªã«è縮ãèªããã¢ã«ããã¤ãã¼ç
ã¯ãlogopenicåé²è¡æ§å¤±èªã¨å¾é¨ç®è³ªè縮çããããã¿ã¤ãã¨ãã¦ããã®ä¸¡è
ã®è¨åºåãæã¤çä¾ãå°ãªããªãå¯è½æ§ã示åãããã
ãé²è¡æ§ã®è¦³å¿µå¤±è¡ããã³æ¦å¿µå¤±è¡ã
ã¾ããä»åã®ããããã®çä¾ã¯é²è¡æ§ã®è¦³å¿µå¤±è¡ãæ¦å¿µå¤±è¡ãèªãããããããã¯ä»¥åã«ã(Funayama M, Nakagawa Y, Yamaya Y, Yoshino F, Mimura M, Kato M. Progression of logopenic variant primary progressive aphasia to apraxia and semantic memory deficits. BMC Neurol. 2013;13:158. doi:10.1186/1471-2377-13-158.) ãlogopenicåé²è¡æ§å¤±èªã«ããã¦æ¯è¼ççºçæ©æãã失è¡ãä¼´ã£ã3çä¾ãå ±åãããä¸¡å ±åã®çä¾ã®å¤±è¡ã¯ãåçºæ§é²è¡æ§å¤±è¡ã«å
¸åçã«èªããããè¢ç¯éå失è¡ã¨ã¯ç°ãªããæå³æ§ã®é¯è¡çºãç®ç«ã¤ãã¨ãªã©ããè¡çºã¨æå³ã®ã¢ã¯ã»ã¹ãä¸ååã¨ãªãç
æ
ã示ãã¦ãããå¾é¨è³ã®ç®è³ªã«è縮ãèªããã¢ã«ããã¤ãã¼ç
ã§ã¯ããã®åã®å¤±è¡ãåºç¾ãããã¨ãå¤ãå¯è½æ§ã示åãããã
(è¹å±±ééã2015.11.12.)
解説ãåé¡ã¨ãã鿍
ãã¨ãã°ãè¹ã¯ä½è²ã?
ä¸è²ã誰ããããçããã§ãããã
ã ãè¹ã®è²ã®æ°ã¯ãå½ãæåã«ãã£ã¦ç°ãªããå
«è²ã¨ããå½ããããå
è²ã¨ããå½ããããäºè²ãåè²ããããã©ããæ£ããã®ã?ãã©ããæ£ããã¨ããã°æ£ããããæ£ãããªãã¨ããã°æ£ãããªãã
人éã®ç®ã«è¦ããæ³¢é·ã¯380nmãã750nmããã®ç¯å²ã®æ§ã
ãªæ³¢é·ãæ··ãã£ãå
ãç½è²å
ã§ãããç½è²å
ãããªãºã ã§åé¢ããã¨ãæ§ã
ãªè²ãè¦ãã¦ããããããè¹ã§ãããããªãã¡å
ã¨ã¯å
ã
ã¯åãç®ã®ãªãé£ç¶ããæ³¢é·ã¨ãã¦åå¨ããã®ã§ãã£ã¦ãããã人éã®è¦è¦ãããã«ã¯è²ã表ãè¨èã®æ°ã«ãã£ã¦ãæéã®è²æ°ã¨ãã¦èªèããã¦ããã«ãããªããè¹ã®è²ã®æ°ã¯ãç¥è¦ã¨è¨èã«ããå¶ç´ãåãã¦å®ãããã¦ããã®ã§ããã
ã§ã¯ãç²¾ç¥ç
ã¯ä½ç¨®é¡ã?
æ··æ²ã®ä¸ãããã¯ã¬ããªã³ã¯æ©çºæ§ç´åã¨èºãã¤ç
ãæ½åºããããã®2ã¤ã®ã«ãã´ãªã¼ã¸ã®åé¡ã鿍ã¨ãã¦ãç¾ä»£ç²¾ç¥å»å¦ã®çºéãå éããã¨è¨ã£ã¦ãéè¨ã§ã¯ãªãã
ã ãè¹ã¨ããèªç¶çã®ç¾è±¡ã¨åæ§ã«ãç¾æ£ã¨ããçç©å¦çç¾è±¡ããæ¬æ¥ã¯é£ç¶çãªãã®ã§ããããã¡ããé£ç¶ä½ã§ãã£ã¦ãããã®ä¸ã®ãã群ã«ä»ã®ãã®ã¨ä¸å®ä»¥ä¸ã®éããè¦åºãããã°ããã®ç¾¤ã¯ã«ãã´ãªã¼ã¨ãã¦å·®ãæ¯ããªãããããæ¬æ¥ãé£ç¶ä½ã§ãã以ä¸ãã©ã®ã«ãã´ãªã¼ã«ãåé¡ã§ããªããã®ãå¿
ãåºã¦æ¥ããã ããã¯ã¬ããªã³ã¯åé¡ä½ç³»ã次ã
ã«æ¹è¨ãããã ãæ¹è¨ãããé »ç¹ã«è¡ãããã«ã¯ãããªããã§ã¯ã©ããããã
第ä¸ã®æ¹æ³ã¯ãå°ã
ã®çç¾ã¯ç¡è¦ããæ¢åã®é
ç®ã®ä¸ã«å¼·å¼ã«åé¡ãã¦ãã¾ãã¨ãããã¨ã§ãããè¹ã¯ä¸è²ã§ããã¨åºå®ããä¸åçããªãå§¿å¢ãããã«ããããå®éã«è¹ãè¦ãã¨ããä¸è²ãè¦åãããã人ã¯ã¾ãããªãããããã§ãè¹ã¯ä¸è²ãªã®ã ã
第äºã®æ¹æ³ã¯ããåé¡ä¸è½ãã¨ããã«ãã´ãªã¼ãä½ããã¨ã§ãããNOS (Not Otherwise Specified) ã ãDSMã¯ãã®æ¹æ³ãæ¡ããã¨ã§ããããªãã±ã¼ã¹ãã©ããã«å¿
ãåé¡å¯è½ãªå½¢ãç¶æãã¦ããã
è¹ã¯ä¸è²å¼ã«æ¢åã®ä½ç³»ã墨å®ããããNOSå¼ã«ãã¿ç®±ãä½ã£ã¦ãã¾ãã¦ãããã¨ããããææã«ã¯å¿
è¦ã§ããç¾å®çã§ãããããç¥è¦ãèç©ããã¦ããã¨ãã¤ãã¯çç¾ãè¨çç¹ã«éããæ°ããªåé¡ä½ç³»ã«è±ç®ããããå¾ãªããªããè±ç®ããªãã¡é²æ©ã§ããã
ãã®èç©ãããç¥è¦ã¯ã©ã®ããã«ãã¦çã¾ãããã
è¹ã«ããã¦ã¯ãç¥è¦ã«ããå¶ç´ã¯çµ¶å¯¾çãªãã®ã§ããã裸ç¼ã§è¦ã¦ä½è²è¦ããããè¹ã®è²æ°ã¨ãããã®ã®æ¬è³ªãªã®ã§ãã£ã¦ãæ©å¨ã§åæããã°å¯è¦å
ç·ã¯ç¡éã«è¿ãè²ã®æ°ã«åé¢ã§ãããªã©ã¨è¨ã£ã¦ãæå³ã¯ãªãã
䏿¹ãè¨åºã¨ã¯ãéã«è£¸ç¼ã§ã¯è¦ããªããã®ã追究ããå¶ã¿ã§ããããã®ããã®æ¦å¨ã®ä¸ã¤ã¯ç»å診æãªã©ã®æ©å¨ã®é²æ©ã§ããããããã«è¨åºå®¶ã¨ãã¦ã®æ
§ç¼ãå ãã£ã¦åãã¦ã徿¥ã®åé¡ä½ç³»ãè¶
ããè¦ç¹ãçã¾ããã
æ¬è«æãè¹å±±é¨é·ã®ãå´é -é é ç®è³ªã®è縮ã«ããé²è¡æ§ã®è¶
ç®è³ªæ§æè¦å¤±èªããã³é²è¡æ§ã®è¦³å¿µå¤±è¡ãã¯ãããããä»äºã§ããã
å¾é¨è³ã®ç®è³ªã«è縮ãèªãã夿§ç¾æ£ã¯å¾æ¥ã(1) logopenicåé²è¡æ§å¤±èªã(2) å¾é¨ç®è³ªè縮çã(3) åçºæ§é²è¡æ§å¤±è¡ã®3ã¤ã«åé¡ããã¦ãããã(1)ã¨(2)ãã¹ãã¯ãã©ã ã§ããå¯è½æ§ã示ãããæ¬è«æãè¦ç´ããã°ãããªãã
ããã¯è¡¨é¢çã«ã¯åé¡å¦ã®é²æ©ã¸ã®è²¢ç®ã§ããããåé¡ã¯ææ®µã§ãã£ã¦ãç®çã§ã¯ãªããè¹ã®è²ã追究ããã°å
ã¨ããç©çç¾è±¡ã®æ¬è³ªã«æ¥è¿ã§ããã®ã¨åæ§ãè¨åºåã®åé¡ã追究ããã°ãç¾æ£ã®æ¬è³ªã«æ¥è¿ãããã¨ãã§ããããã®å
ã«ããã®ã¯ç¾æ£ã®éè¦ãªè¦ç´ ã§ããç¥çµç
çãéºä¼åã§ããã
ããã¦ç¥çµå¿çå¦ã§æ±ããã¨ã®å¤ãè³å¨è³ªç¾æ£ã§ã¯ãåé¡å¦ã«ããã¦ãã髿¬¡ã®ç¥çµçç¶ã¨ããã«å¯æ¥ã«é¢é£ããè³å±å¨é¨ä½ãè«ãããã¨ãã§ããã¨ãã大ããªç¹é·ããããæ¬è«æã§ã¯å¤±è¡ã強調ããã¦ãããããã¯ããã°ãè¹å±±é¨é·ã¨ããå
é§è
ã示ãã鿍ã§ããããã®éæ¨ã«çç®ãããã¨ã§ã誰ããç²¾å¯ãªè¨ºæã«åãã¦æ©ããã¨ãå¯è½ã«ãªãã
æ¬è«æãç²¾èªããã¨ã失è¡ä»¥å¤ã«ãå¤ãã®è¨åºç鿍ã示ããã¦ãããã¨ã«æ°ã¥ãããããã©ãã¾ã§ãç²¾å¯ãªè¨åºè¦³å¯ããçã¾ããè«æãªã®ã§ããããã®çµæãæ¬è«æèªä½ãã夿§ç¾æ£ã®æ¬è³ªã¨å
¨ä½åã¸ã®éæ¨ã¨ãªã£ã¦ããã
(ææ¾å¤ªéã2015.11.29.)
軽çã¢ã«ããã¤ãã¼ç
ã®è¨ºæè£å©ã«ã¯,æè¨æç»èª²é¡ãããæ¥æ¬èªçRapid Dementia Screening Testãæç¨ã§ãã
森山泰 (é§æ¨éç
é¢ç²¾ç¥ç§è¨ºçé¨é·)Yasushi Moriyama, Aihide Yoshino, Kaori Yamanaka, Motoichiro Kato, Taro Muramatsu, and Masaru Mimura
Japanese version of the Rapid Dementia Screening Test is effective for detecting patients with mild Alzheimerâs disease compared to the Clock Drawing Test
Psychogeriatrics. 2015 Jul 24. doi: 10.1111/psyg.12144.
æ¥æ¬èªç Rapid Dementia Screening Test(Japanese version of the Rapid Dementia Screening Test: RDST-J)ã¯Kalbeãã«ãã£ã¦éçºãããèªç¥çã¹ã¯ãªã¼ãã³ã°æ¤æ»ãé äºããæ¥æ¬èªã«ç¿»è¨³ãããã®ã§,ã¹ã¼ãã¼ãã¼ã±ãã課é¡ã¨æ°åå¤æèª²é¡ã®2é¡ãããªã.ã¹ã¼ãã¼ãã¼ã±ãã課é¡ã¯1åéã®å¶éæéå ã«ãã¹ã¼ãã¼ãã¼ã±ãããã³ã³ããã¨ã³ã¹ã¹ãã¢ã§è²·ãããã®ããã§ããã ããã£ã¦ãããè¨èªæµæ¢æ§èª²é¡ã§ãã. 䏿¹æ°åå¤æèª²é¡ã¯,ã¢ã©ãã¢æ°åãæ¼¢æ°åã«å¤æãã2é¡ï¼209âäºç¾ä¹,4054âååäºååï¼ã¨,æ¼¢æ°åãã¢ã©ãã¢æ°åã«å¤æãã2é¡ï¼å ç¾å «åä¸â681,äºåäºåä¸â2027ï¼ãããªã. æ¬æ¤æ»ã¯3ï½5åã§æ½è¡åã³æ¡ç¹ãå¯è½ã§ãã,ç´ã¨éç以å¤ã®ç¨å ·ãå¿ è¦ã¨ãã,被æ¤è ããã®åå ¥ããè¯ã. æ¬é¦ã§ã¯é äºã(2006)ããã®æ¥æ¬èªç(Japanese version of the Rapid Dementia Screening Test: RDST-J)ã使ãã¦ãã.
ä»åããããã¯RDST-Jãæè¨æç»èª²é¡ãã軽çèªç¥çã®è©ä¾¡ã«æç¨ã§ããè¨åºçå°è±¡ããã¡,ããã«ã¤ãã¦èª¿æ»ãã. 対象ã¯ã¢ã«ããã¤ãã¼ç (Alzheimerâs disease: AD) 250ä¾ã¨å¥å¸¸ç¾¤49ä¾ã§,AD群ã®MMSEã¯12-26ç¹,clinical dementia rating scale (CDR)ã¯3-0.5ã§ãã.æ£è 群ãCDRã®å¤ã§4群ã«åã,å¥å¸¸ç¾¤ãå«ããè¨5群ã«ãããæè¨æç»èª²é¡ã¨RDST-Jã®å¾ç¹åå¸ãçµ±è¨å¦çã«æ¤è¨ãã.
ãã®çµæ,èªç¥çã®éç度ã«å¿ãã¦RDST-J,æè¨æç»èª²é¡ã®æç¸¾ã¯ä½ä¸ãã¦ãã.ã¾ã軽çADç¾¤ã«æ³¨ç®ããã¨RDST-Jã¯å¥å¸¸ç¾¤ã¨CDR 0.5ã§ææå·®ãæããã,æè¨æç»èª²é¡ã¯ææå·®ãæããªãã£ã.ããã§RDST-Jã«ãããCDR 0.5ã®ã¹ã¯ãªã¼ãã³ã°æ¤æ»ã¨ãã¦ã®å¦¥å½æ§ã調ã¹ãã¨ãã,ã«ãããªãå¤ã7/8ã«è¨å®ããå ´åæåº¦57.1%,ç¹ç°åº¦81.0%ã§,8/9ã¨ããã¨æåº¦79.6%,ç¹ç°åº¦55.1% ã§ãã£ã.
ä»åã®æ¤è¨ããRDST-Jã¯æè¨æç»èª²é¡ã¨æ¯è¼ã,å¥å¸¸ç¾¤ã¨ CDR0.5 ã®éå¥è£å©ã«æç¨ã§ãããã¨ã示ããã.
(森山泰ã2015.10.3.)
解説ãèªç¥ççãã®ææ©æçºè¦
æ¥æ¬ç¤¾ä¼ã®æ¥éãªé«é½¢åã«å¾ããèªç¥çæ£è æ°ãæ¥å¢ãã¤ã¤ãããæããã¤ãå æ¥ã彿室ã®ä½æ¸¡å æ´å士ãä¸å¿ã¨ããç ç©¶çããèªç¥çã«ããæãå½ã®ç¤¾ä¼çè²»ç¨ã¯å¹´é14.5å åã«ã®ã¼ãã¨ãããã¼ã¿ãçºè¡¨ããããã®ã¾ã¾ããã¨ã2060å¹´ã«ã¯ãã®é¡ã¯24å åã«ãªãã¨æ¨è¨ãããã¨ãããããã®ã¾ã¾ããã¨ãæ¥æ¬ç¤¾ä¼ã¯å±ãªããããã®ã¾ã¾ãããªããããã«ã¯ãèªç¥ç対çãå éããªããã°ãªããªãããã®ããã«ã¯ã¾ããèªç¥çããã®çãã®äººã ããç°¡ä¾¿ãªæ¹æ³ã§çºè¦ããªããã°ãªããªããæ¯éå£ã¯è¨å¤§ã§ãã¿ã¼ã²ãããè¨å¤§ã§ãããããç¹ã«ç°¡ä¾¿ãªæ¹æ³ã§ãªããã°ãªããªãã
èªç¥çã®ã¹ã¯ãªã¼ãã³ã°æ¤æ»ã¨ãã¦åºãç¨ãããã¦ããã®ã¯MMSEã§ãããã ãããåºãç¨ãããã¦ãããã¨è¨ããã»ã©ã«ã¯ãå®éã®è¨åºå ´é¢ã§ã¯ãã¾ã使ããã¦ããªãã¨ãããã¼ã¿ããããMMSEã¯ãå¤å¿ãªæ¥å¸¸è¨åºã§ç¨ããã«ã¯ãã¾ã ã¾ã 簡便ãã«ããã¦ä¸ååãªæ¤æ»ãªã®ã§ããã
ããç°¡ä¾¿ãªæ¤æ»ã¨ãã¦ã¯æè¨æç»èª²é¡ãããç¥ããã¦ããããæ£®å±±åå£«ã®æ¬è«æã¯ããã®æè¨æç»èª²é¡ããããã«ç°¡ä¾¿ãªæ¤æ»ã§ã軽çã¢ã«ããã¤ãã¼ç ã®ã¹ã¯ãªã¼ãã³ã°ãå¯è½ã§ãããã¨ã示åãããã¼ã¿ãå示ãã¦ãããçµè«ãã²ã¨ãã¨ã§è¨ãã¨ããå¥å¸¸ç¾¤ã¨CDR 0.5ã®éå¥ã«ãRDST-Jãæç¨ãã¨ãããã¨ã§ãããCDR 0.5ã¨ã¯ããèªç¥ççããã§ãããæãå½ã«è¨å¤§ã«åå¨ãããã®ç¾¤ããç°¡ä¾¿ãªæ¤æ»ã§çºè¦ãããã¨ã®æç¾©ã¯é常ã«å¤§ãããæ¬è«æã«ã¯ããã«ãRDST-Jå¾ç¹ãèªç¥çã®éç度ã«å¿ãã¦ä½ä¸ãããã¨ã示ããã¦ãããCDR 0.5ããCDR 1ãããªãã¡ããèªç¥ççããããã軽度èªç¥çãã¸ã®ç§»è¡ã«ã¤ãã¦ã®ç ç©¶ã¯æ¬¡ã®èª²é¡ã§ãããããã«ãã®å ã¸ãèªç¥çã®ç ç©¶ã¯éããªãç¶ããæ£®å±±å士ã¯ãé§æ¨éç é¢ç²¾ç¥ç§è¨ºçé¨é·ã¨ãã第ä¸ç·ã§è¨åºã«æºããã¤ã¤ãç ç©¶è«æãä¼ããã¨ãªãçç£ãç¶ãã¦ããã
(ææ¾å¤ªéã2015.10.26.)
ã¢ã«ããã¤ãã¼ç
æ£è
ã«ããããããã¸ã«ããã¬ã©ã³ã¿ãã³ã¸ã®åãæ¿ãã®SPECTã«ããå¹æäºæ¸¬
岡çç´ (æ
¶æç¾©å¡¾å¤§å¦å»å¦ç ç©¶ç§å¤§å¦é¢å士課ç¨)Oka M, Nakaaki S, Negi A, Miyata J, Nakagawa A, Hirono N, Mimura M.
Predicting the neural effect of switching from donepezil to galantamine based on single-photon emission computed tomography findings in patients with Alzheimerâs disease
Psychogeriatrics.
Article first published online: 26 JUN 2015 | DOI: 10.1111/psyg.12132
æ¬é¦ã§åãã¦1999å¹´ã«ã¢ã«ããã¤ãã¼ç ã«é¢ãã¦æ¿èªãããã³ãªã³ã¨ã¹ãã©ã¼ã¼é»å®³è¬ã¯ãããã¸ã«ã§ãããã2011å¹´ã«ã¯ããã«2種é¡ã®ã³ãªã³ã¨ã¹ãã©ã¼ã¼é»å®³è¬ãèªå¯ããããããã¾ã§å¤æ°ã®è³ç»åç ç©¶ã¯ãã¢ã«ããã¤ãã¼ç æ£è ã®åé èã«ãããã³ãªã³ã¨ã¹ãã©ã¼ã¼é»å®³è¬ã®æ²»ç广ã«è¨åãã¦ãããåé èãé¢ä¸ããã¨è¨ããã¦ãããã¢ãã·ã¼ãéè¡æ©è½é害ã¯ã¢ã«ããã¤ãã¼ç æ£è åã³ãã®å®¶æã®çæ´»ã®è³ªãæªåããããããããªãããã¢ãã·ã¼ã¨éè¡æ©è½é害ã«å¯¾ããã³ãªã³ã¨ã¹ãã©ã¼ã¼é»å®³è¬ã®ç¥çµå¦ç广ã¯ã¾ã æããã«ãªã£ã¦ããªããããã§ãSPECTãç¨ãããã¼ã¹ã©ã¤ã³ã«ããã屿è³è¡æµéãç¨ãã¦ããããã¸ã«ããã¬ã©ã³ã¿ãã³ã¸ã®åãæ¿ãã«åå¿ããã¢ã«ããã¤ãã¼ç æ£è ã®ã¢ãã·ã¼ã¨éè¡æ©è½é害ã¸ã®å¹æäºæ¸¬ãæ¤è¨ããã
æ ¶æç¾©å¡¾å¤§å¦ç é¢ç²¾ç¥ç¥çµç§å¤æ¥ã«ããã¦ããããã¸ã«ã«ããæ²»çã«åå¿ã®ãªãã£ã(12ã¶æä»¥ä¸ãããºã¸ã«5mg/dayãæç¨ãã¦ãããMMSEã1å¹´éã§ã2ç¹ä»¥ä¸ä½ä¸ããï¼ã¢ã«ããã¤ãã¼ç æ£è ã«å¯¾ããã¬ã©ã³ã¿ãã³ã¸ã®åãæ¿ã24é±ååããªã¼ãã³ç ç©¶ããããªã£ãããã¼ã¹ã©ã¤ã³ã®æç¹ã§SPECTãæ½è¡ãããã¼ã¹ã©ã¤ã³ããã³ã¬ã©ã³ã¿ãã³åãæ¿ãå¾ã®12é±ã¨24é±ã®3æç¹ã§MMSEï¼Mini-Mental State Examinationï¼ãADAS-Jï¼the Japanese version of the Alzheimerâs Disease Assessment Scale-cognitive subscaleï¼FABï¼the Frontal Assessment Batteryï¼ãNPI-Qï¼the Neuropsychiatry Inventory Brief Questionnaire Formï¼ãDEXï¼the Dysexecutive Questionnaireï¼ãå«ãè¡ååã³èªç¥æ©è½æ¤æ»ãæ½è¡ããã
ã¢ã«ããã¤ãã¼ç æ£è ï¼78.6±5.6æ³ãæè²æ´ 12.5±3.0å¹´ï¼ã®27åï¼ç·11ï¼å¥³16ï¼ã®çµæãæ¤è¨ããã¨ãããã¬ã©ã³ã¿ãã³ã¸åãæ¿ãå¾ã«NPI-Qã«ãããã¢ãã·ã¼ãæææ§ãç°å¸¸è¡åã¨éè¡æ©è½ãè©ä¾¡ããDEXå¤ãææã«æ¹åãããããã¤ãã®åé èé åï¼èå¤å´åã³è ¹å¤å´åé åéãå帯ç¶åãç¼çª©é¨åé éï¼ã®è³è¡æµããã¼ã¹ã©ã¤ã³ã§ä½ãã»ã©ããããã¸ã«ããã¬ã©ã³ã¿ãã³ã¸ã®åãæ¿ããè¡ã£ãå¾ã«ãNPI-Qã«ãããã¢ãã·ã¼ï¼è² æ 度ï¼ã¨DEXå¤ãããæ¹åãããã¨ãSPECTã®æè¦ã¯äºæ¸¬ããã
ã¬ã©ã³ã¿ãã³ã«ã¯ãã¢ã»ãã«ã³ãªã³ã¨ã¹ãã©ã¼ã¼é»å®³ä½ç¨ã«å ãããã³ãã³æ§ã¢ã»ãã«ã³ãªã³å容ä½ã¸ã®åºæ¿ä½ç¨ãä½µãæã¤å¹æãããããã®ç ç©¶ã¯ããããã®å¹æãã¢ãã·ã¼ã¨éè¡æ©è½é害ã¨é¢é£ããåé èã«å½±é¿ãä¸ãããã¨ã示åãã¦ããã
(岡çç´ã2015.9.19.)
解説ãèªç¥çã®åççæ²»çæ¦ç¥ãç®æãã¦
ç æ°ã«ã¯çç¶ããããçç¶ã«ã¯åå ããããåå ãåãé¤ããã°çç¶ãæ¶ããç æ°ã¯æ²»ãããããã·ã³ãã«ãªæ²»çè«ã§ãããã ãç¾å®ã®ç æ°ã¯ãªããªãããã·ã³ãã«ã«ã¯ãããªãã
岡çç´å¤§å¦é¢çãå°éã¨ãã¦ããã¢ã«ããã¤ãã¼ç ããã·ã³ãã«ã«ãããªãç æ°ã®ä¸ã¤ã§ããã
ã¢ã«ããã¤ãã¼ç ã®çç¶ã¯ãèªç¥æ©è½ä½ä¸ã§ãããå ¨è¬çãªä½ä¸ã§ãããã ãèªç¥æ©è½ã¨ã¯å¤ç¨®å¤æ§ãªç¾ãæ¹ããããå ¨è¬çãªä½ä¸ã¨ããã®ã¯ãèªç¥çã®å®ç¾©ã¨ãã¦ã¯ããã§ããã¨ãããã¨ã§ãã£ã¦ãä½ä¸ã®ãããã£ã¼ã«ã¯å½ç¶ãªããä¸äººã²ã¨ãç°ãªããç æ°ã®ã¹ãã¼ã¸ã«ãã£ã¦ãç°ãªãã
ã¢ã«ããã¤ãã¼ç ã®åå è«ã®ä¸å¿ã¨ãªãã®ã¯ãã¢ããã¤ãã«ã¹ã±ã¼ãã§ãããã ãããããèªç¥æ©è½ä½ä¸ã¾ã§ã®ã¡ã«ããºã ã®å ¨å®¹ãè§£æããã¦ããããã§ã¯ãªããããã»ã¹ã®ã©ã®æ®µéãæ²»çã¿ã¼ã²ããã«ããã®ãæåãã䏿ã§ããã
ã¢ã«ããã¤ãã¼ç ã®è¬ã¯ãããè³å ã®ã¢ã»ãã«ã³ãªã³ã®æ¸å°ãæãããã³ãªã³ã¨ã¹ãã©ã¼ã¼é»å®³è¬ã§ãããç¾å¨æãå½ã«ã¯ãããã¸ã«(ã¢ãªã»ãã)ãã¬ã©ã³ã¿ãã³(ã¬ããã¼ã«)ããªãã¹ãã°ãã³(ã¤ã¯ã»ãã³ããã)ã®3種é¡ãããããã©ãããçç¶ã®ã¨ãã«ã©ã®è¬ãæå¹ãã¯ããã£ã¦ããªãã
ãã®ããã«ãã¢ã«ããã¤ãã¼ç ã«ã¤ãã¦ç¾ä»£ã®å»å¦ãæã£ã¦ããç¥è¦ã¯æççã§ãããæççã ããããããã®æçããããããã¦æçã®æ°ã¯ã©ãã©ãå¢å ãã¤ã¤ãããæçããã¼ã¹ã¨ãã¦çµã¿åããã¦ããã°ããã®å ã«ã¯ç æ°ã®è§£æã¨ããã广çãªæ²»çãããã¯ãã§ããã
岡大å¦é¢çã¯ãçç¶ã¨ãã¦ãã¢ãã·ã¼ã¨éè¡æ©è½é害ã«çç®ãããåå è«ã«ãããã客観çãªãã¼ã¿ã¨ãã¦ãè³è¡æµã測å®ãããè¬ã¨ãã¦ããããã¸ã«ã¨ã¬ã©ã³ã¿ãã³ãæ¯è¼ãããããã¦ç¤ºåã«å¯ãçµæãå¾ããã: ã¢ãã·ã¼ã¨éè¡æ©è½é害ã¯åé èã®è¡æµä½ä¸ã«é¢ä¿ãã¦ãããããããªãããããã®çç¶ã«ã¯ã¬ã©ã³ã¿ãã³ã®æ¹ãæå¹ãããããªããããã¯ãã³ãã³æ§ã¢ã»ãã«ã³ãªã³å容ä½åºæ¿ã«é¢ä¿ãã¦ãããããããªãã
ç¾æç¹ã§ã¯ãã©ããããããããªããã«ã¨ã©ã¾ããæ¬è«æã®ãã¼ã¿ã¯ã壮大ãªããºã«ã®1ãã¼ã¹ã«ãããªãã1ãã¼ã¹ã ããçå®ã«æªæ¥ã«ç¹ããè²´éãª1ãã¼ã¹ã§ããããã®ä»äºã¯å²¡å¤§å¦é¢çã®å¦ä½è«æã«ãªã£ãã
(ææ¾å¤ªéã2015.9.26.)
ä½é
¸ç´ è³çè
ã®å®æ
ãçæ´»æ¯æ´ãç¤¾ä¼æ¯æ´ã«ã¤ãã¦ã®å¤æ½è¨å
±åç ç©¶
å
å´ç« (æ±äº¬ç¦ç¥å¤§å¦ææãå¼ççç·åãªãããªãã¼ã·ã§ã³ã»ã³ã¿ã¼é¨é·)å¹³æ23ï½26年度ãç ç©¶å ±åæ¸ãå
¨246ãã¼ã¸ãï¼ç§å¦ç ç©¶è²»å©æäºæ¥No.23530748ãé売åãå
¨å½ã®é«æ¬¡è³æ©è½é害è
æ¯æ´æ ç¹æ©é¢ã«é
å¸ï¼
æ¬ååã¯ãç§å¦ç ç©¶è²»ãç¨ãã¦è¡ã£ããä½é ¸ç´ è³çã¨ãªãããªãã¼ã·ã§ã³ãã«é¢é£ããè¨åºç ç©¶ã¨åå¼·ã®ææã§ããå°å·ç©ããç 究代表è ã¨ãã¦ä¸åã«ã¾ã¨ãããã®ã§ããï¼åã®åæ ç ç©¶è ãªãã³ã«ç ç©¶ååè ã«ããã28ç·¨ã®æ¥æ¬èªã®è¨åºè«æï¼å å´ç« ã¯16ç·¨ãæ å½ï¼ã¨ããããã®ãã¾ã¨ãï¼æ¦ç¥ï¼ãããæãç«ã£ã¦ãã¾ãã
ç¥çµå¿çå¦ç ç©¶ä¼ã¯è¨åºæå®¤ãä¼ã主å¬ããè¨åºå»ãéã£ã¦ãããã¨ãç¹å¾´ã ã¨æãã¾ããä»ã§ããå®é¨ç ç©¶çãªçºè¡¨ãå¤ããªãã¾ãããã䏿åã¯ã鹿島æ´éå
çãããã¦å è¤å
ä¸éå
çã®ä¸ã極ãã¦æ¥å¸¸è¨åºçãªãã¼ãâãããã£ã¦ç ç©¶ä¼ãéå¶ããã¦ããææãããã¾ãããæ¬ç ç©¶ã¨ãã®ç ç©¶å ±åæ¸ã¯ãã®æµããåãç¶ãã§ãããã®ã§ãã
ã以ä¸ãå ±åæ¸ã®ã¾ã¨ãï¼æ¦ç¥ï¼ã転è¨ãããã¾ãã
â ãä½é ¸ç´ è³çè ã®ãªãããªãã¼ã·ã§ã³
ä½é
¸ç´ è³çï¼anoxic brain injuryï¼ã¨ã¯ãå¿èºç¾æ£ãªã©ã«ããå¿èºåæ¢ãå¼å¸ä¸å
¨ã溺水ãé«åº¦ã®è²§è¡ãä¸é
¸åçç´ ä¸æ¯ãªã©ã«ããã䏿¢ç¥çµç³»ã«ä¸éæ§ã«é
¸ç´ ãã°ã«ã³ã¼ã¹ã®ä¾çµ¦ãéçµ¶ãããã¨ã«ãã£ã¦è³ã«çããæ©è½é害ãç·ç§°ãããã®ã§ããããã®ç
æ
ã¯ãâ é
¸ç´ ãã®ãã®ãè³åèè¡ã«ä¾çµ¦ãããªãä½é
¸ç´ æ§ä½é
¸ç´ è¡çï¼hypoxic encephalopathyï¼â¡é
¸ç´ ã鿬ãããã¢ã°ããã³ã®æ¸å°ã«ããè²§è¡æ§ä½é
¸ç´ è¡çï¼anemic hypoxiaï¼â¢è³è¡æµãã®ãã®ãä½ä¸ããä½é
¸ç´ æ§èè¡æ§è³çï¼hypoxic ischemic encephalopathyï¼ã«åé¡ãããã
AEDï¼èªå対å¤å¼é¤åå¨ï¼ã®æ®åãæå½ææ¥å»çã®çºå±ã«ä¼´ããå¿èºåæ¢å¾ã®èççã¯åä¸ãã¦ãããããã¦æå½ã»èçããããã®ã®ãå¾éºçãæ®ãå ´åãå¤ãããã®çç¶ã¯ã麻çºã失調ãªã©ã®éåæ©è½é害ãããè¨æ¶é害ãä¸å¿ã¨ããèªç¥æ©è½é害ãçºåæ§ä½ä¸ã¾ã§å¤å½©ã§ãããå復ã¯ä»ã®è³å¨è³ªç¾æ£ã¨æ¯ã¹ã¦ç·©æ
¢ã§ãããå¤å·æ§è³æå·è
ã¨ã¯ç°ãªãçµéãã¨ãããã ãããªãããªãã¼ã·ã§ã³ç
é¢ã§è¨ºã¦ããæ£è
ã¯å¿èºåæ¢ä¾å
¨ä½ã®å
ã®ã»ãã®ä¸é¨ã®ä¾ã§ããã
å»å¦çãªãããªãã¼ã·ã§ã³ã«ããã¦ã¯ãå復æã®ç´æ¥çãªæ©è½å復è¨ç·´ã ãã§ã¯ãªãã代åçã»ç°å¢èª¿æ´çãªæ¹æ³ãç¨ãã¦ãæ£è
ã®ã§ããè½åãã²ãã ããã¨ã«ããçæ´»éå®³ãæ¹åãããã¨ã«éç¹ãããããé·æçãªè¦ç¹ã§ã®å¯¾å¿ãæã¾ãããå
¥é¢ãã夿¥ã夿¥ãã復è·ã¸ã®ç§»è¡æããå»çããä»è·ã»ç¦ç¥ãæ½è¨ããå¨å®
ã¸ç§»è¡ããçã®é©åãªææã«å»å¦çãªãããªãã¼ã·ã§ã³ã®æ¹æ³ãç¨ãã¦ä»å
¥ãããã¨ãã社ä¼åå ãä¿é²ãããèªæ®ºä¼å³ã«ããæººæ°´ãè¬ç©ä¸æ¯ãç¸é¦ãç·´çãªã©ã«ããä¸é
¸å䏿¯ã®å ´åã¯ãçºçåã®é©å¿ç¶æ
ãå®¶æç¶æ³ãªã©ç¤¾ä¼çèæ¯ãè¤éãªãã¨ãå¤ãããã®å ´åã«ç¤¾ä¼å¾©å¸°ãæ¯æ´ããããã«ã¯ãå¿çé¢ã®é
æ
®ãå®¶ææ¯æ´ã«å ãã¦ãç¦ç¥æ©é¢ãä¿å¥ã»ã³ã¿ã¼ãªã©ã¨ã®é·æçãªé£æºãå¿
è¦ã¨ãªãã
â ¡ãä½é ¸ç´ è³çè ã®çæ´»æ¯æ´ã»ç¤¾ä¼æ¯æ´
ä½é
¸ç´ è³çè
ã§ã¯ãå°±å´ç¾¤ã¨éå°±å´ç¾¤ã¨ãã«é«ãæãã¤æ°åã示ãã¦ãããæ°åç¶æ
ãå¥åº·é¢é£QOLã¯ãè¨æ¶é害ã®éç度ããçºçããã®æ¥æ°ã¨ã¯å¿
ãããé¢é£ãã¦ããªãã£ãã䏿¹ãè¨æ¶é害ãé度ã§ãæ°åãå®å®ãã¦ããå ´åããããããªãã¡ãã¨ãã¾ãç°å¢ãä»å
¥ã®æ¹æ³ã«ãããç¤¾ä¼æ´»åæ°´æºãç¶æããã¦ããå ´åãããã¤ãããæ··ä¹±ãã®å°ºåº¦ãä½ããå¥åº·åº¦èªå·±è©ä¾¡ããè¯å¥½ãã§ãã£ããã§ããè½åãã²ãã ããç¤¾ä¼æ´»åæ°´æºãç¶æãããããªä»å
¥ã工夫ãããã¨ãéè¦ã¨ãªããçºçããï¼å¹´ä»¥ä¸çµéãã¦ãããã§ããè½åããã²ãã ããã¨ã§ãæ¥å¸¸ç活活åãåä¸ããããã¨ãã§ããã社ä¼åå æ¯æ´ã®ããã«ã¯ãä½é
¸ç´ è³çè
ã«ããã¦ã¯å°ãªãã¨ã3å¹´éã¯ãªãããªãã¼ã·ã§ã³ãå¿
è¦ã§ããã
身ä½é害ï¼èº«ä½å¤±èª¿ãæ§é³é害ãå¥ä¸é害ï¼ã髿¬¡è³æ©è½é害ï¼è¨æ¶é害ï¼ãç²¾ç¥é害ãä½µåãã¦ããå ´åã«ã¯ãå¨å®
çæ´»ã§ã¯å¤æ¹é¢ã«ãããããã¸ã¡ã³ããå¿
è¦ã¨ãªãã主ä»è·è
ã®ä»è·è² æ
ã大ãããçºåæ§ãä½ä¸ãã¦ããå ´åã«ã¯ã訪åãªãããªãã¼ã·ã§ã³ãéæãµã¼ãã¹ã¸ã®å°å
¥ãã主ä»è·è
ã®è² æ
æãç·©åããããããã ã社ä¼åå 度ãåä¸ãããã¨ã§ãèªå®
ã§å®¶æã®å½¹å²ã責åã大ãããªãã主ä»è·è
ã§ããå®¶æã®è² æ
æã大ãããªãå ´åããããèªæ®ºæªéä¾ã§ã¯ããªãããªãã¼ã·ã§ã³æéä¸ã«æãããªæãã¤ã®åçã¯ãªãã¨ãã復è·å¾ã«æãã¤ãåçãããã
â ¢ããªãããªãã¼ã·ã§ã³ã®ç¾å ´ã«ãããICF
夿¥éé¢ä¸ã®ä½é
¸ç´ è³çè
ããICFãæ´»åã¨åå ã48é
ç®ã«ã¦è©ä¾¡ããã¨ãããï¼ï¼ï¼è¨æ¶é害ãçºåæ§ã®ä½ä¸ããADLä½ä¸ã社ä¼åå ã®å°ãªãã«é¢é£ãã¦ãããã¨ãï¼ï¼ï¼CASæ¥å¸¸çæ´»è¡åãããæ°ã¹ã³ã¢ãæµæ¢æ§ã§ææ¡ã§ããçºåæ§ã®ä½ä¸ã¯ãFAMéåãèªç¥ãICFã®ä¸é¨ã®ãæ´»åã¨åå ãã®ã³ã¼ãã¨ç¸é¢ãã¦ãããã¨ãï¼ï¼ï¼ICFã¯ä½é
¸ç´ è³çè
ã®çæ´»éå®³ãæ¯æ´ãã¹ãäºæãä¸é¨ææ¡ãã¦ãããã¨ãã示åãããã
å»çã¨ç¦ç¥ã®å
±éèªã¨ãã¦ãããã«å®¶æãå«ãã¦ICFãå©ç¨ããããã«ã¯ãICFã³ã¢ã»ãããå©ç¨ããæ¹æ³ããããè³æå·è
ç¨ã«èæ¡ãããè³å¤å·ã³ã¢ã»ããç°¡æçã®ãæ´»åã¨åå ãã®ããã¤ãã®é
ç®ã¨ãFAMèªç¥ãTBI-31ã Zaritã®å¤ã¨ã®éã«ç¸é¢ãã¿ããããå®¶æã§ã簡便ã«ä½¿ç¨ã§ããICFè³å¤å·ã³ã¢ã»ããç°¡æçï¼è³ªåç´çï¼ã¯ãå®¶æã®ææ¡ãããæ´»åãåå ãç¶æ³ãå»çè
ãç¦ç¥å¾äºè
ãçè§£ãããã¨ã«ãã²ãã¦ã¯å®¶ææ¯æ´ã«å©ç¨ã§ããã
â £ãä½é ¸ç´ è³çè ã®ç¤¾ä¼æ¯æ´é¢é£é å
çºåæ§ãä½ä¸ãå¤çããã®ä»å ¥ã«æçµ¶ãã¿ãããä½é ¸ç´ è³çè ã§ã¯ã社ä¼åå ã®åºããããªããã«ãããç¡çºã¨æå¦ã¨ãå¢å¼·ããå®¶æã®å¿èº«çè² æ ãããã«å¤§ãããªããä½é ¸ç´ è³çè ã«ç¹åããå½äºè ã®ä¼ã¯å°ãªãããããªä¸ã§ãç²¾ç¥ç§ãªãããªãã¼ã·ã§ã³ã®åºæ¬ååã®èãæ¹ããè³æå·å¾ã®é«æ¬¡è³æ©è½é害è ã®å ´åã«ãå½ã¦ã¯ãæ¯æ´ãã¦ãããã¨ãã§ãããä¸ã¤ã®é害åºåãåºå¥ãããã¨ãªãæ¯æ´ãã¦ããé害è èªç«æ¯æ´æ³ã2006å¹´ã«æ½è¡ããã2013å¹´4æãããç¾ç ãé害ã«ããæ¯æ´ã·ã¹ãã ã®éãããããªããã¦ããæ¹åã§ãé害è ç·åæ¯æ´æ³ã«å¤æ´ããããç²¾ç¥ç§ãªãããªãã¼ã·ã§ã³ã対象ã¨ããç¾æ£ã»é害ãã徿¥ããã®çµ±å失調çãã¢ã«ã³ã¼ã«ãèªç¥çã«å ãã¦ãçºéé害ã髿¬¡è³æ©è½é害ã¨åºãããã¿ãã¦ããã
â ¤ã髿¬¡è³æ©è½é害è ã®å»å¦çæ¯æ´é¢é£é å
ä½é ¸ç´ è³çè ã®çºåæ§ã®ä½ä¸ã注æé害ãè¨æ¶é害ã«å¯¾ãã¦ãå¤å·æ§è³æå·è ã®é«æ¬¡è³æ©è½é害ã«å¯¾ããè¬ç©çæ³ãä¸é¨åèã«ãªããé©åãªææã«å»å¦çãªãããªãã¼ã·ã§ã³ã§è¡ããã¦ããæ¹æ³ãç¨ãã¦åè©ä¾¡ãä»å ¥ãè¡ããã¨ããä½é ¸ç´ è³çè ã®çæ´»ã®è³ªãåä¸ãã社ä¼åå ãä¿é²ããã
ä»å¾ã®èª²é¡
社ä¼åå ã«è³ããªãå¨å® çæ´»è ãæ½è¨å ¥æè ãå°±å´ãã¦ãé©å¿é害ãèµ·ããè ã®é·æçäºå¾ã»æ¯æ´ãä»å¾ã®èª²é¡ã§ãããè¨æ¶é害ãç¹ã«é篤ãªè ã身ä½è½åã大ããæãªããã¦ããè ãå°å æçºçã®ä½é ¸ç´ è³çè ã¸ã®æ¯æ´ãä»å¾ã®èª²é¡ã§ããã
(å å´ç« ã2015.8.22)
解説ãä½é ¸ç´ è³çããã®å復
è³ã¸ã®é
¸ç´ ä¾çµ¦ã忢ããã¨ã人éã¯éããã«æ»äº¡ããã常èã§ããã
è³ã¸ã®é
¸ç´ ä¾çµ¦ãä¸å®æé忢ããã¨ãè³ã«ä¸å¯éçãªéå®³ãæ®ããå»å¦å¸¸èã§ããã
ã ãããããå
ã¯?ãã©ãããéå®³ãæ®ãã®ã?ãããã¯å復ããã®ã?ãã©ããªãªãããªãã¼ã·ã§ã³ãæå¹ãªã®ã?
海馬ã®ç¥çµç´°èãä½é
¸ç´ ç¶æ
ã«å¯¾ãã¦ç¹ã«èå¼±ã§ãããã¨ã¯ç¥çµçç©å¦çã«ã¯ããç¥ããã¦ããããããããè¨åºåã¾ã§ã«ã¯ããªãã®éããããããä½é
¸ç´ è³çã®å®éã®è¨åºä¾ã¯ãè¨æ¶é害以å¤ã«ãæ§ã
ãªé«æ¬¡è³æ©è½é害ãåããã®ã常ã ãçç¶ã®ææ¡ããæ²»çãèªç¥ãªãããªãã¼ã·ã§ã³ãããã¦ç¤¾ä¼çæ¯æ´ã®ããæ¹ã¾ã§ãä½é
¸ç´ è³çã®è¨åºã¯èª²é¡ãå±±ç©ãã¦ããã
ãããã©ãã¾ã§ãå®è·µçã«è¿½ç©¶ããã®ãå
å´ç« ææ(æ±äº¬ç¦ç¥å¤§å¦ç¤¾ä¼ç¦ç¥å¦é¨ãå¼ççç·åãªãããªãã¼ã·ã§ã³ã»ã³ã¿ã¼å°åæ¯æ´æ
å½é¨é·ãå
¼ãã)ã代表è
ã¨ããç ç©¶çã®æ¬å ±åæ¸ãä½é
¸ç´ è³çè
ã®å®æ
ãçæ´»æ¯æ´ãç¤¾ä¼æ¯æ´ã«ã¤ãã¦ã®å¤æ½è¨å
±åç ç©¶ãã§ããã
æå½å»çæè¡ã®é²æ©ã«ãã£ã¦ããã¤ã¦ã§ããã°çå½ã失ã£ã¦ããè³æå·ãããå¤ãã®äººã
ãçéã§ããããã«ãªã£ãããã®çµæãå¾éºçã¨ãã¦ã®é«æ¬¡æ©è½é害ãæãã人ã
ã®æ°ãæ¥å¢ãã¦ããã®ãã¾ãå³ç¶ããäºå®ã§ãããããã«ä¼´ããä½é
¸ç´ è³çã«éããã髿¬¡è³æ©è½é害ã®èªç¥ãªãããªãã¼ã·ã§ã³ã®éè¦ã¯æ¥ã
å¢å¤§ãã¦ããã
å
å´ç« ææã¯ãå¤å·æ§è³æå·ãä½é
¸ç´ è³çãªã©ã®æãå¤ãã®è¨åºä¾ã¨æ¥ãããªãããªãã¼ã·ã§ã³ãå®è·µãã¦ããå»å¸«ã®ä¸äººã§ãããæ¬å ±åæ¸ã¯å½¼ã®ä»äºãå½¢ã«ãªã£ãè²´éãªä¸åã§ãè¨åºä¸ç¤ºåã«å¯ã夿°ã®è¨è¿°ãå«ã¾ãã¦ããã
ãªãã髿¬¡è³æ©è½é害ã«ã¤ãã¦ã®åºç¤ç¥èãããæ²»çã»ãªãããªãã¼ã·ã§ã³ã»å°±å´æ¯æ´ã¾ã§ããå
å´ææãå®éã®ã±ã¼ã¹ãç´¹ä»ãã¤ã¤ã¾ã¨ããèæ¸ã¨ãã¦ã
髿¬¡è³æ©è½é害ãç²¾ç¥å»å¦ã»å¿çå¦ç対å¿ããã±ããããã¥ã¢ã«
(廿¯è¬åºçã2009å¹´)
ãããã
ä¸ã®ä¸ã®ããã±ããããã¥ã¢ã«ãããã±ããäºå
¸ãçã«ã¯ãä¸ä½ã©ããããã±ããã«å
¥ãããã ã¨è¨ããããªããµã¤ãºã®æ¬ãå¤ãããã髿¬¡è³æ©è½é害ãç²¾ç¥å»å¦ã»å¿çå¦ç対å¿ããã±ããããã¥ã¢ã«ãã¯ãæ°æ¸çã§æåéããã±ããã«æºå¸¯ã§ãããã³ãã£ãªåèã§ããã
(ææ¾å¤ªéã2015.8.26.)
ã1ãBálintçå群ã«ãããè¦ç©ºéã¯ã¼ãã³ã°ã¡ã¢ãªã¼ã®ä½ä¸
è¹å±±éé(è¶³å©èµ¤ååç
é¢ãç¥çµç²¾ç¥ç§ãé¨é·)
Funayama M, Nakagawa Y, Sunagawa K
Visuospatial working memory is severely impaired in Bálint syndrome patients
Cortex 2015: 255-264 (http:// dx.doi:10.1016/j.cortex.2015.05.023)
ã2ãBálintçå群ã«ãããé»å製åã®ãã¿ã³æä½
è¹å±±éé(è¶³å©èµ¤ååç
é¢ãç¥çµç²¾ç¥ç§ãé¨é·)
Sunagawa K, Nakagawa Y, Funayama M
Effectiveness of Use of Button-Operated Electronic Devices Among Persons With Bálint Syndrome.
Am J Occup Ther. 2015 Mar-Apr;69(2):6902290050p1-9. doi: 10.5014/ajot.2015.014522.
ã1ã Bálintçå群ã«ãããè¦ç©ºéã¯ã¼ãã³ã°ã¡ã¢ãªã¼ã®ä½ä¸
両å´é é èã®æå·ã®ããã«Bálintçå群ãçãã¦ããæ£è
ãã¾ã¯ãè¦è¦ãä¿ããã¦ããã«ãããããããé¨å±ã®ä¸ã§ãè¿·ã£ã¦ãã¾ã£ãããç©ä½ã«è¦ç·ãåããããªãã£ãããç©ä½ãã¤ãã¿æãããªã©ãèªåã¨å¨å²ããããã¯ãç©ä½å士ã®ä½ç½®é¢ä¿ã®ææ¡ãå°é£ã¨ãªãè¦ç©ºéé害ãçãããã¨ãç¥ããã¦ãã¾ããè¦ç©ºéé害ã®åå ã®ã²ã¨ã¤ã«ã¯ãè¦ç©ºéæ
å ±ãè³å
ã§ã¤ã¡ã¼ã¸åã§ããªãããããã¯ãã¤ã¡ã¼ã¸ãããã«æ¶ãã¦ãã¾ããã¨ãèãããã¦ãã¾ããããããªãããä»ã¾ã§ã¯ããã証æããè¨åºç ç©¶ã¯ããã¾ããã§ããã
çè
ãã¯Bálintçå群6åã«ãããè³å
ã§ã®è¦ç©ºéã¤ã¡ã¼ã¸ã®è½åãæ¤è¨ããããã«ãè¦ç©ºéã¤ã¡ã¼ã¸ã®ä¿åæéãã¤ã¡ã¼ã¸è½åãæ¸¬å®ãããã¨ãã§ããè¦ç©ºéã¯ã¼ãã³ã°ã¡ã¢ãªã¼ã®æ¤æ»ãè¡ãã¾ãããçµæã¯ã対ç
§ã¨ããå³é é èæå·ç¾¤ï¼15åï¼ã¨å¥å¸¸ç¾¤ï¼26åï¼ã¨æ¯è¼ãã¦Bálintçå群ã§ã¯è»½åº¦Bálintçå群4åãå«ãã¦è¦ç©ºéã¯ã¼ãã³ã°ã¡ã¢ãªã¼ã®æç¸¾ãä½ä¸ãã¦ãã¾ããããããã®çµæãããBálintçåç¾¤ã®æ¥å¸¸çæ´»ã®å°é£ãã¯ãè³å
ã®è¦ç©ºéã¤ã¡ã¼ã¸è½åãä½ä¸ãã¦ããããã§ããå¯è½æ§ãèãããã¾ããã
çè
ãã¯ããããã®çµæãè¸ã¾ãã¦ããããªãé é èã®æ©è½ã®è§£æã®ã¿ãªãããé é èæå·ã®æ£è
ãã¾ãã¡ã®æ¥å¸¸çæ´»åä½ã®ãªãããªã«å½¹ç«ã¦ã¦ããããã¨èãã¦ãã¾ãã
ã2ã Bálintçå群ã«ãããé»å製åã®ãã¿ã³æä½
ä¸è¨ã®Bálintçå群ã¯è¦ç©ºéé害ã®ããã«å¤ãã®æ¥å¸¸çæ´»ãå°é£ã¨ãªãã¾ãããã¨ãå®¶åºå
ã®å
¥æµ´ãæ´é¢ã¨ãã£ãADLã¬ãã«ã¯ä¿ããã¦ãã¦ããå¤ãã®æ£è
ãã¾ã§è¦ç©ºéé害ã®ããè¤éãªéå
·ã使ããã¨ãå°é£ã¨ãªã£ã¦ãã¾ããç¹ã«ãã½ã³ã³ãéè¡ã®ATMãæºå¸¯é»è©±ãªã©è¿å¹´å¿
é ã¨ãªã£ãé»åæ©å¨ã®ä½¿ç¨ã¯ããªãé£ãããªã£ã¦ãã¾ããããããBálintçå群ã§ã®é»åæ©å¨ã®ä½¿ç¨è½åã«é¢ããè¨åºç ç©¶ã¯æªã ã«è¡ããã¦ãã¾ããã§ããã
çè
ãã¯Bálintçå群(7å)ã®é»åæ©å¨æä½è½åãç ç©¶ããããã«ãã¹ãã¼ããã©ã³ãæ§å¼ã®æºå¸¯é»è©±ãé»åã®3種é¡ãç¨ãã¦æ°åã®å
¥åè½åï¼1æ¡ãã11ã±ã¿ï¼ãæ¤è¨ãã¾ãããçµæã¯ã対ç
§ã¨ããå¥å¿ç¾¤ï¼8åï¼ã¨å¥å¸¸ç¾¤ï¼8åï¼ã¨æ¯è¼ãã¦Bálintçå群ã§ã¯è»½åº¦Bálintçå群4ä¾ãå«ãã¦æ°åã®å
¥åã®æç¸¾ãä½ä¸ãã¦ãã¾ããããã ãè²ã¨é«ããå¨å²ã¨ç°ãªããã¿ã³ãæã¤é»åã§ã¯ãé度Bálintçå群ã§ãã£ã¦ãæ¡æ°ã®å°ãªãå ´åã¯æ°åã®å
¥åãå¯è½ã§ãããçè
ãã¯ããããã®çµæãBálintçå群ãå«ããé é èæå·ã®æ£è
ãã¾ã«å¯¾ããé»åæ©å¨ã®ãªãããªã«å¿ç¨ãã¦ããããã¨èãã¦ãã¾ãã
(è¹å±±ééã2015.7.12.)
解説ã䏿è°ãªç æ ã®è§£æããå®å¹ããèªç¥ãªãããªãã¼ã·ã§ã³ã¸
è¦ãã¦ããã®ã«è¦ãã¦ããªããããªã³ãBálintçå群ã¨ã¯ãããªç
æ
ã§ããã
æç§æ¸ãéãã°ãç²¾ç¥æ§æ³¨è¦éº»çº(è¦ç·ãéæã«ç§»åã§ããªã)ãè¦è¦æ§å¤±èª¿(è¦è¦åºæ¿ã«å¿ããå調éåãæªãç®ã®åã®å¯¾è±¡ãã¤ãããªã)ãç©ºéæ§æ³¨è¦é害(注è¦ãã¦ãã対象以å¤ã«æ³¨æãåã°ãªã)ã®3ã¤ãããªã³ãçå群ã®ç¹å¾´ã§ããã»ã»ã»ã¨è¨ããã¦ãããããã®ããã«å®ç¾©ã«ããã¨ããã£ã¦ãããã«ããããããããæ¤æ»ä¸ã¯è¦è¦ã¯ä¿ããã¦ããããå®çæ´»ã§ã¯è¦ãã¦ããªããã®ããã§ããããè¦è¦çã¤ã¡ã¼ã¸ãããã«è³ããæ¶ãã¦ãã¾ãããã ãã¨ããè¨åºçãªæåã®ã»ããããããããã§ãããã
é é èããå¾é èã®ããä¸å®é åã®æå·ã®éã«çºçãããã®ç¨ãªçå群ã¯ãããªã³ãã1909å¹´ã«è¨è¼ãã¦ä»¥æ¥ã䏿è°ãªçåã¨ãã¦æ³¨ç®ããã¦ããããã¡ã«ããºã ã¯ä¸æã®ã¾ã¾ã§ãã£ãããããªä¸ã§ãè¦è¦çã¯ã¼ãã³ã°ã¡ã¢ãªã¼ã®é害ã¯ãä¸ã¤ã®æåãªä»®èª¬ã¨ãªã£ã¦ãããã¯ã¼ãã³ã°ã¡ã¢ãªã¼ã¨ã¯ãããã°ãå¿ã®é»æ¿ãã§ãããæ å ±ã䏿çã«ä¿æããè³å ã®ãããã¡ã¼ã®ãããªæ©è½ãæãããã¨ãã°æ°åã峿ã«è¨æ¶ãã¦éå±ããã®ã¯ãã¯ã¼ãã³ã°ã¡ã¢ãªã¼ã®æ©è½ã§ããã
ããªã³ãçå群ã®è¦è¦çã¯ã¼ãã³ã°ã¡ã¢ãªã¼é害仮説ã¯ãè¨åºçç¶ããã¯é¦è¯ã§ãããã®ã®ããããããè¦ãã¦ããªããã¨è¡¨ç¾ãããã»ã©ã®è¦è¦æ©è½ã®é害ãããããªã³ãçå群ã§è¦è¦çã¯ã¼ãã³ã°ã¡ã¢ãªã¼ãæ¤è¨¼ããã®ã¯è³é£ã®æ¥ã§ããã
æ¬è«æã1ãBálintçå群ã«ãããè¦ç©ºéã¯ã¼ãã³ã°ã¡ã¢ãªã¼ã®ä½ä¸ã¯ãè¶³å©èµ¤ååç
é¢ç¥çµç²¾ç¥ç§ã®è¹å±±ééé¨é·ãããªã³ãçå群ã®ãã®æ´å²çé£é¡ã«æãã ä»äºã§ããããããå¯è½ã«ããã®ã¯ããã®ç¨ãªçå群ãè¤æ°ä¾çºè¦ããè¨åºå»ã¨ãã¦ã®æè
ã¨ãçç¶ã¬ãã«ã«åã£ãç¥çµå¿çå¦çæ¤æ»ã鏿ããç ç©¶è
ã¨ãã¦ã®æ
§ç¼ã§ãã£ãã
è¹å±±é¨é·ã«ããè«æã1ãã®ç´¹ä»æã¯
ãçè
ãã¯ããããã®çµæãè¸ã¾ãã¦ããããªãé é èã®æ©è½ã®è§£æã®ã¿ãªãããé é èæå·ã®æ£è
ãã¾ãã¡ã®æ¥å¸¸çæ´»åä½ã®ãªãããªã«å½¹ç«ã¦ã¦ããããã¨èãã¦ãã¾ããã
ã¨çµã°ãã¦ããã
ãã®ä¸æã¯ããæå³å®åçãªçµã³ã§ãããä¸ã®å¤ãã®è«æã¯ãã®ããã«ã次ã®ã¹ãããã¸ã®å¸æãèªãå½¢ã§çµã°ãã¦ãããããã¦ä¸ã®å¤ãã®è«æã®èè
ã¯ããã§æ©ã¿ãæ¢ãã¦ãããè«æã®çµã³ããã®ã¾ã¾ä»äºã®çµã³ã«ãªã£ã¦ãã¾ãã®ã常ã ã
è¹å±±é¨é·ã¯ããã§ã¯ãªãã£ãã叿ã®å®ç¾ã«åãã¦ç´ã¡ã«ä¸æ©è¸ã¿åºããããããæ¬è«æã2ãBálintçå群ã«ãããé»å製åã®ãã¿ã³æä½ã§ããã
æ¥éã«æ¥æ¬ç¤¾ä¼ã«æ®åããITæ©å¨ã¯ã髿¬¡è³æ©è½é害ã®äººã
ã«ã¨ã£ã¦ã¯è«¸åã®å£ã§ãããITæ©å¨ã¯ä¸æ¹ã§ã¯ãèªç¥è£
å
· cognitive orthosesããèªç¥ç¾©è¢cognitive prostheticsããªã©ã®ç¨èªã示ãããã«ãèªç¥ãªãããªãã¼ã·ã§ã³ã«æ´»ç¨ã§ããæåãªãã¼ã«ã§ããã(æ¬ãµã¤ã2015.5.25. ãèªç¥ãªãããªãã¼ã·ã§ã³å®è·µã¬ã¤ãã第7ç« å¤çã¨ã¤ã使ç¨ã®è¨ç·´ åç
§)ã仿¹ã§ã¯çæ´»ã®èªç«ãé»ãããªã¢ã¨ãªã£ã¦ããããã¨ãã°åç´ãªãã³ãã¼å
¥åãã§ããªããã°ãéè¡ã®ATMãæºå¸¯é»è©±ãªã©ã使ç¨ãããã¨ãã§ãããããã¨ç¾ä»£ç¤¾ä¼ã®çæ´»ã«ããã¦ã¯æ·±å»ãªé害ã¨ãªãããè¦ãã¦ããã®ã«è¦ãã¦ããªããããªã³ãçå群ã§ã¯ããã³ãã¼å
¥åã¯éè¦ãªèª²é¡ã§ããã
æ¬è«æã2ãã¯ããã®åé¡ã«çç®ããããªã³ãçå群ã®äººã
ã®æ¥å¸¸çæ´»æ¹åãç®æããä»äºã§ãããã¹ãããã¬ã©ã±ã¼ãé»åã¯ããã³ãã¼ã¨ããæå³ã§ã¯åãã§ãããã¿ã³ã®è¦è¦çå½¢ç¶ãå°ããã¤éã£ã¦ãããå¥å¸¸è
ã«ã¨ã£ã¦ã¯ãè¨ããã¦ã¿ãã°éã£ã¦ãããªã¨æããããç¨åº¦ã§ããããããªã³ãã®äººã
ã«ã¨ã£ã¦ã¯æä½ã®å¯å¦ã決å®çã«å·¦å³ããéãã«ãªãå¾ããæ¬è«æã2ãã¯ãããå®è¨¼çã«ç¤ºãããã®ã§ãITæ©å¨ã®ãªãããªãã¼ã·ã§ã³ã®è¨ç»ç«æ¡ã«éãã¦ã®éè¦ãªåºç¤ãã¼ã¿ã¨ãªããã®ã§ããã
è¹å±±é¨é·ã®æ¬è«æã1ãã2ãã¯ãããªã³ãçå群ã¨ããæ´å²çãªç æ ã«ã¤ãã¦ããã®ã¡ã«ããºã ã®è§£æã«ã¨ã©ã¾ãããåèã®è¨è¼ããç¾å¹´ãéããç¾ä»£ã®ITæ©å¨ã®ãªãããªãã¼ã·ã§ã³ã«è³ããé大ãªã¹ã±ã¼ã«ã®ä»äºã§ããããã®æ ¹åºã«ã¯é«æ¬¡è³æ©è½é害è ã®æ¥å¸¸çæ´»æ©è½ã®æ¹åã¨ããæçµç®æ¨ããããèªç¥ã®ããªã¢ããªã¼ã¯ãç¥çµå¿çå¦ã®ç®æãéè¦ãªã´ã¼ã«ã®ä¸ã¤ã§ããã
(ææ¾å¤ªéã2015.7.26.)
çµ±å失調çã®ã¯ã¼ãã³ã°ã¡ã¢ãªã®é害ã«é¢ããã³ã³ãã¥ã¼ãã¤ã·ã§ãã«ã¢ããã¼ã
æ²æå®°(æ
¶æç¾©å¡¾å¤§å¦å»å¦ç ç©¶ç§å¤§å¦é¢å士課ç¨)Okimura T, Tanaka S, Maeda T, Kato M, Mimura M
Simulation of the capacity and precision of working memory in the hypodopaminergic state: Relevance to schizophrenia.
Neuroscience, 295: 80-89, 2015.
çµ±å失調çã«ãããã¯ã¼ãã³ã°ã¡ã¢ãª(WM)é害ã®è³åºç¤ã¯ãåé åé(PFC)ã§ã®D1å容使©è½ã®ä½ä¸ã§ããã¨ããå®é¨çã¢ããã¼ãããã®ä»®èª¬ããããå®é¨çã¢ããã¼ãã¨ããã®ã¯ãããã¨åç©ã対象ã¨ããç¥çµå¿çå¦çã¢ããã¼ããç¥çµççå¦çã¢ããã¼ãã§ããããã®ä»®èª¬ããããã®ã¢ããã¼ãããæ¤è¨¼ãã詳細ãªç æ ã¡ã«ããºã ãè§£æããæ²»çæ¦ç¥ãéçºãããã¨ã¯ç¾å¨ã®ã¨ããå°é£ã§ããã使 ã§ããããï¼ãã®ä»®èª¬ã«é¢ããçæ³çãªç ç©¶ç®æ¨ãèãã¦ã¿ãã¨æããã«ãªããããªãã¡ãæªæ²»çã®çµ±åå¤±èª¿çæ£è ã«å¯¾ãã¦ãåç©å®é¨ã§ã®ãããªç¥çµççå¦çã¢ããã¼ãã«ããPFCã®D1å容使©è½ã¨WMé害ã®é¢é£æ§ã示ããè³ç¥çµåè·¯ã¬ãã«ã§ã®åçãªæ¸¬å®ã«ããWMéå®³ã®æ©åºã®è§£æã¨ããçæ³çãªç ç©¶ç®æ¨ã¯ç¾å¨ã®ã¨ããå°é£ã§ããã¨ãããã¨ã§ãããããããçµ±å失調çã«ãããWMé害ãããã®ç ã®é¡å¨çºçåå¾ãã人çã®çµããã¾ã§ç¶ããæ£è ã®äººçã®è² æ ã«ãªã£ã¦ãããã¨ãéã¿ãã°ãä½ããã®é²å±ãå¿ è¦ã¨ãããããã®1ã¤ã®é²å±ã¨ãã¦ãçè«çã¢ããã¼ãã§ããComputational psychiatry(è¨ç®è«çç²¾ç¥å»å¦)ã¨ãããã®ããè¿å¹´ãçç©å¦çãªå¦¥å½æ§ããã¡ããã¾ã§ã«çºå±ããçµ±å失調çã®ç æ ã¡ã«ããºã ã®çè«çæ çµã¿ã¸ã®ç¤ºåãä¸ãã¦ãã¦ããã
èããªãã¬ã¢ããã¼ãã§ããè¨ç®è«çç²¾ç¥å»å¦ã«ã¤ãã¦æ¦è¦ãè¿°ã¹ãå¿ è¦ããããããã®ã¢ããã¼ãã¯ãå®é¨ç©çå¦ã¨çè«ç©çå¦ã¨ã®ã¢ããã¸ã¼ã§ããã°ãå¾è ã§ãããããªãã¡ãç²¾ç¥ç¾æ£ã®ç ç©¶ã«ããã¦ãå®é¨çã¢ããã¼ãããå¾ãããè³ç¥çµåºç¤ãè¡åã»çç¶ã®ç¥è¦ãæ°çã¢ãã«ã§è¡¨ç¾ããæ°çã¢ãã«ããããããããæ¼ç¹¹ççµæãããå®é¨çã¢ããã¼ãã®ç ç©¶ã¸ã®äºæ¸¬ãä¸ããã¨ããå½¹å²ã§ãããã¡ãªããã¨ãã¦ã¯ãâ æ°çã¢ãã«ãå½¢æãããã°ãã¢ãã«ã«å¤åãå ãããã¨ã§ç°¡åã«é害ã¢ãã«ãå½¢æãããªãã¡ãæªæ²»çæ£è ã®ã¢ãã«ã使ã§ãããã¨ãâ¡ã¢ãã«ã®åçæ¯ãèããç°¡åã«è¡¨ç¾ã§ããã®ã§ã詳細ãªç æ ã¡ã«ããºã ã追åã§ãããã¨ãâ¢é害ã¢ãã«ã«å¯¾ããããã«æ°ççã«å¤åãå ãããã¨ã§é害ãå¥å¸¸åããããç°¡åã«æ¤è¨¼ã§ããã®ã§ãæ²»çæ¦ç¥ã®ä»®èª¬æ¤è¨¼ãä¾ãã°ãè¬ç©ã®æ©åºããã®æ²»ç广ã®äºæ¸¬ãããã¾ã§èããããªãã£ããããªæ²»çæ¦ç¥ã®ç¤ºåãå¯è½ã§ãããã¨ãæããããã
ãã®ã¡ãªãããå®é¨çã¢ããã¼ãã«æ°ããªè¦ç¹ãå ããçµ±å失調çã®WMéå®³ã®æ²»çã«å ãæããããããããã«ããããã«ã¯ãè¨ç®è«çç²¾ç¥å»å¦ãçµ±å失調çã®ç æ ã¡ã«ããºã ã®çè«çæ çµã¿ã¸ã®ç¤ºåãä¸ããã ãã§ã¯äºè¶³ãããå®é¨çã¢ããã¼ãã«ç´æ¥ãªã³ã¯ã§ããã»ã©ã®è©³ç´°ãªæåããã£ã¦è³åºç¤ã®ãã¤ããã¯ã¹ãçç¶ã®ç¹å¾´ãä¸ããªããã°ãªããããã®ä¸ã§æ²»çæ¦ç¥ã¸ã®ç¤ºåãå®é¨çã¢ããã¼ãã§åè¾¼ã¿å¯è½ã¨ãªããããã¾ã§ã詳細ã«è³åºç¤ã¨WMé害ã対å¿ä»ããè¨ç®è«çç²¾ç¥å»å¦çç ç©¶ã¯ãèè ã®ç¥ãéãã§ã¯åå¨ããªãã
æ¬ç ç©¶ã®æ¹æ³ã§ããããè³åºç¤ã¨ãã¦ãNMDAãAMPAãGABAAå容ä½ãNap, Caä¾åæ§Kã¤ãªã³ãã£ã³ãã«ããã£ãéä½ç´°èã¨æå¶æ§ä»å¨ãã¥ã¼ãã³ãæ°çã¢ãã«åããç¸äºä½ç¨ããã¤ããã«å ¨ã¦ã¤ãªããããããåå容ä½ãã¤ãªã³ãã£ãã«ã®æ©è½ã¯ãD1å容ä½ãä»ãããã¼ããã³èª¿ç¯ã«ãã墿¸ã§ããããã«ããããã®ç¥çµåè·¯ã¢ãã«ã«ããWMã®å®é¨ç³»ã¨ãã¦ãåå¨ä¸ã«10°æ¯é¢ãã36åã®ã¹ããããç¨æãã4ã¤ã®ã¹ãããã«åæã«100ããªç§éãã¥ã¼ãä¸ãããã¥ã¼ãæ¶ããå¾ã2000ããªç§éãä¸ãããã4ã¤ã®ã¹ãããã®ä½ç½®ãä¿æãã¦ããããã¨ããç³»ããã¦ãããã¼ããã³æ¿åº¦ãæ¯æ¸ç¶æ ããå¥å¸¸è ã¬ãã«ã飽åç¶æ ã¨7段éã«å¤ãã¦ãWMä¿æã®è½åãWM容é(4ã¤ã®ã¹ãããã®ãã¡ããã¤ä¿æã§ãã¦ããã)ã¨WM精度(ä¿æãããã¹ãããã®ä½ç½®ãã©ãã ãæ£ç¢ºã§ããã)ãã·ãã¥ã¬ã¼ã·ã§ã³ããã
çµæã¨ãã¦ãWM容éã¯ããã¼ããã³æ¿åº¦ãå¥å¸¸è ã®ã¬ãã«ã®ã¨ãã«æé«ã¨ãªããããããå°ãªãã¦ãå¤ãã¦ãä½ä¸ãããããã¯ãGoldman-Rakicãã示åããD1å容ä½ãä»ãããã¼ããã³èª¿ç¯ã¨WMæ©è½ã®inverted-Uç¹æ§ãå ·ä½çã«ã·ãã¥ã¬ã¼ã·ã§ã³ã§åç¾åãããã¨ãæå³ãããã¾ãçµ±å失調çã§ã¯WM容éãä½ä¸ãããã¨ã示ããã¦ããããããã¨ãä¸è´ããããããWM容éã¯ãã¼ããã³æ¿åº¦ãä½ä¸ãã¦ãå¢å ãã¦ãWM容éãä½ä¸ãããã¨ãä»ç²¾ç¥ç¾æ£ã§ãWM容éã®ä½ä¸ã¯èªãããã¨ãèããã¨ãWM容éä½ä¸ã ãã示ããã¨ã§ã¯çµ±å失調çã®ç¹å¾´ãæãããã¦ããªããããã§ãWM精度ã®çµæã®åçæ¯ãèããè¨ç®ããã¨ããã¼ããã³æ¿åº¦ãä½ä¸ãã¦ããã¨ãã«ã¯ãæéã¨ã¨ãã«ä¿æãããã¹ãããã®ä½ç½®ãã©ã³ãã ã«ç§»åããçµæã¨ãã¦WM精度ã¯ä½ä¸ããããã¼ããã³æ¿åº¦ãå¢å ãã¦ããã¨ãã«ã¯ãä¿æãããã¹ãããã®ä½ç½®ã¯å¥å¸¸è ã®ã¨ãã¨åãç¨åº¦ã®æ£ç¢ºãã§ãã£ã¦ç¶æããããçµ±å失調çã§ã®WM精度ã¯ä½ä¸ãã¦ãããå¥å¸¸è ã¨åããã¯ãå è¡ç ç©¶ã§ã¯ä¸è´ãã¦ããªããå®é¨ç³»ãæ¸¬å®æ¹æ³ã®åé¡ãããããè¬ç©ã®å½±é¿ããããä¾ãã°ãã¯ãã¶ãã³ã®å æããã¦ããæ£è ãå¤ãã£ãæ£è 群ã¨å¥å¸¸è 群ã®éã§WM精度ã®å·®ããªãã£ãã¨ããç ç©¶ãããããã®ç ç©¶ã«ã¤ãã¦ãæ¬ç ç©¶ããã®èå¯ã試ã¿ãã¨ãã¾ããæ¬ç ç©¶ãã示åãããçµ±å失調çã«ãããWM容éã¨ç²¾åº¦ã®ä¸¡æ¹ã®ä½ä¸ã®æ©åºã¯ãâ D1å容使©è½ã®ä½ä¸ã¯ãNMDAå容ä½ã®æ©è½ã®ä½ä¸ãããããã®ã§éä½ç´°èã®çºç«ãç¶æã§ããªããªãããã«WM容éãä½ä¸ããâ¡D1å容使©è½ã®ä½ä¸ã¯ãNMDAå容ä½ã®æ©è½ã®ä½ä¸ã¨æå¶æ§ä»å¨ãã¥ã¼ãã³ã®çºç«ã®ä½ä¸ããããããã¨ã§ã©ã³ãã ãªãã¤ãºã®å½±é¿ãå¢å ããããã«WM精度ãä½ä¸ãããã§ãããæ¬¡ã«ãã¯ãã¶ãã³ã«ã¯ãD1å容使©è½ä»¥å¤ã¸ã®è¬çå¦çç¹æ§ããããç´æ¥çã«NMDAå容使©è½ãå¢å ãããæå¶æ§ä»å¨ãã¥ã¼ãã³ã®è奮æ§ãé«ããã¨ããå ±åããããå¾ã£ã¦ãä¸è¨æ¬ç ç©¶ããã®ç¤ºåã¨ã¯ãã¶ãã³ã®è¬çå¦çç¹æ§ãåãããã¨ãã¯ãã¶ãã³ã®å ææ£è ã§ã¯ãWM容éãããWMç²¾åº¦ã®æ¹ãããè¯ãæ¹åãããçµæãWM精度ã®ã¿ãå¥å¸¸è ã¨åãã«ãªãã¨ããä¾ã«ãããç ç©¶ã®çµæãæ¼ç¹¹çã«èª¬æãããããã®ããã«ãç¥çµå¿çå¦ã¨ç²¾ç¥è¬çå¦ãå æ¬ãããã詳細ãªèå¯ããªããããã¨ã¯ãè¨ç®è«çç²¾ç¥å»å¦ã®ä¸ã¤ã®ã¡ãªããã§ãããã¾ããæ¬ç ç©¶ã§ã¯æ²»çæ¦ç¥ã«é¢ãã¦ã®ã·ãã¥ã¬ã¼ã·ã§ã³ãè¡ã£ããD1å容使©è½ã軽度ä½ä¸ã®ã¨ãã«NMDAå容ä½ã®æ©è½ã®ã¿ãé«ããã¨WMã®æ©è½ã¯ã容éã¨ç²¾åº¦ã¨ãã«æ¹åããããã®ãã¨ã¯ãNMDAå容ä½ã®æ©è½ãå¢å¼·ããè¬ç©ã®è¨åºæ²»é¨ã¸ã®ãµãã¼ããæç²¾ç¥ç è¬ã¨ã®ä½µç¨çæ³ã«ããWMéå®³ãæ¹åããã¨ããæ²»çæ¦ç¥ã示åãã¦ããã
æ¬ç ç©¶ã¯ãWMã®ä¿æã®å´é¢ããã¨ããã¦ããªããã¨ãã¾ãæ°çã¢ãã«ã¨ãã¦å¤æ°ããæå¶æ§ä»å¨ãã¥ã¼ãã³ã1ã¤ã«ãã¦ããç¹ãªã©ã®å¤ãã®éçãããããè¨ç®è«çç²¾ç¥å»å¦ã¨ããã¢ããã¼ããçµ±å失調çã®ç æ ã¡ã«ããºã ã¨æ²»çæ¦ç¥ã«ã¤ãã¦ã®çè«ç示åã«å¤§ããªå¯è½æ§ãç§ãã¦ãããã¨ã示ãããã¨èãããæ¬ç ç©¶ã§ã®æ°çã¢ãã«ãããã«å¤§è¦æ¨¡ãã¤ç²¾å·§ã«ããçµ±å失調çã®å»çã®ä¸å©ã«ãªãã°ã¨èããã
(æ²æå®°. 2015.6.15.)
解説ãè¨ç®è«çç²¾ç¥å»å¦ã§çµ±å失調çã®è¬ã«è¿«ã
çç©å¦çç²¾ç¥å»å¦ã¯ãåªãã¦å®è¨¼çã§ããã
è¨åºç²¾ç¥å»å¦ã¯ãåªãã¦å®åçã§ããã
è¨ç®è«çç²¾ç¥å»å¦ã¯ããã®ä¸¡è
ãæ©æ¸¡ãããæ°ããªæ¹æ³è«ã§ããã
ã¾ãã«å¾
æã®æ¹æ³è«ã¨è¨ãããããªããªããçç©å¦çç²¾ç¥å»å¦ã®ç¥è¦ãè¿å¹´ã¾ãã¾ãèç©ããã¦ããã®ã«ãããããããçç©å¦çãªãã¼ã¿ã¨è¨åºçãªçåã®éã®ã®ã£ãããä¾ç¶ã¨ãã¦åã¾ããªãããã ã
çµ±å失調çã«ä¾ãåãã°ããã¼ããã³ã»ãªãªã¼ãæå±ããã¦ããã®æ°åå¹´éã§ãçµ±å失調çã®è³ã¨ãã¼ããã³ã«ã¤ãã¦ã®è«æã¯è¨å¤§ã«åºçããã¦ããããçµ±å失調çã®è¨åºçç¶ã®å¤§é¨åã¯ããã¾ã 説æãããã«è³ã£ã¦ããªããçç©å¦çç²¾ç¥å»å¦ã®ç¥è¦ã¨è¨åºç²¾ç¥å»å¦ã®éã®éããã¯å¤§ãããããã¦æ·±ãã®ãç¾å®ãªã®ã§ããããã®ã®ã£ãããåããããã«ã¯ã徿¥ããã®ç²¾ç¥å»å¦ãç¥çµç§å¦ã§ã¯ä¸å¯è½ã§ãæ°ããªæ¹æ³è«ã大èã«åãå
¥ããªããã°ãªããªãã
ããã§å¤§ããªæå¾
ãæ¸ãããã¦ããã®ãè¨ç®è«çç²¾ç¥å»å¦ Computational Psychiatryã§ããã
è¨ç®è«çç²¾ç¥å»å¦ã¨ã¯è¨ç®è«çã¢ããã¼ããææ³ã¨ããç²¾ç¥å»å¦ã§ãããè¨ç®è«çã¢ããã¼ãã§ã¯ãè³ãå¤çã¨ããã«ç¸äºä½ç¨ãæ å ±ãå¦çãã¦ããã®ãã«çç®ãããããã°æ å ±å¦çæ©æ§ã¨ãã¦ã®è³ã»ç¥çµã·ã¹ãã ã®è¨ç®åçãæ¢æ±ããç ç©¶ææ³ã§ããã
æ±å¤§ã§æ°çå·¥å¦ãå¦ãã§ããå»å¦ã«è»¢ãç²¾ç¥ç§å»ã¨ãªã£ãæ²æå®°å¤§å¦é¢çã¯ãã³ã³ãã¥ã¼ã¿ã¼ãé§ä½¿ããçµ±å失調çã®è³å éç¨ã®ã·ãã¥ã¬ã¼ã·ã§ã³ãç¶ãã¦ãããããããã®ææç©ã®ä¸ã¤ã§ããæ¬è«æã®å§å·»ã¯ããããã âinverted Uâ ã«ã¤ãã¦ã®çè§£ã®æ·±åã§ãããInverted Uã¯ãGoldman-Rakicãã1995å¹´ã®natureèªè«æã§åãã¦ç¤ºåãããã®ã§ããã¯ã¼ãã³ã°ã¡ã¢ãªå®¹éã¯ããã¼ããã³æ¿åº¦ãå¥å¸¸è ã®ã¬ãã«ã®ã¨ãã«æé«ã¨ãªããããããå°ãªãã¦ãå¤ãã¦ãä½ä¸ãããã¨ããçµæããæ¨ªè»¸ããã¼ããã³æ¿åº¦ã縦軸ãã¯ã¼ãã³ã°ã¡ã¢ãªå®¹éã¨ããã°ã©ãã«è¦è¦åãããã®ã§ãããInverted Uã¯ããã¼ããã³ã¨ããç©è³ªã¨è¨åºçç¶ã®ããå®è¨¼çãªæ¥ç¹ãäºæãããæ¬æ°ã§åªãããã®ã§ãã£ãããçºè¡¨ããã¦ä»¥æ¥ç´20å¹´ãçµéãã¦ããçµ±å失調çã®çç¶ã¸ã®æ¥è¿ã¯é ã ã¨ãã¦é²ã¾ãªãç¶æ ã§ãã£ããæ²æé¢çã«ããæ¬è«æã¯ãã®ã®ã£ãããåããç»æçãªãã¼ã¿ã示ããç ç©¶ã§ããã
ã¯ã¼ãã³ã°ã¡ã¢ãªã«ã¤ãã¦å¾ãããæ¬ç ç©¶ã®çµæã¯ãããåççãªè¬ç©çæ³æ¦ç¥ã«ç¹ããå¾ããã¾ããè¨ç®è«çç²¾ç¥å»å¦ã¯ãçµ±å失調çã®ä»ã®çç¶ãèªç¥æ©è½ã®è§£æã«ãæ´»ç¨ã§ãããSense of Agency (èªå·±ä¸»ä½æ)ããã®éè¦ãªã¿ã¼ã²ããã®ä¸ã¤ã§ãæ²æé¢çã¯ç¾å¨ãSoAã¿ã¹ã¯(æ¬ãµã¤ã2014.3. åç°è¬å¸«ãçµ±å失調çã®èªæé害ã«ã¤ãã¦ã®å®è¨¼çç ç©¶ãåç §)ã¸ã®è¨ç®è«çã¢ããã¼ãã«ãç²¾åçã«å¾äºãã¦ããã
ãè¨ç®è«çç²¾ç¥å»å¦ããèããªãã¬è¨èããä¸è¬çãªè¨èã¨ãªãé ã«ã¯ãçµ±å失調çã®ç æ çè§£ãæ²»çæ¦ç¥ãé£èºçã«çºå±ããç²¾ç¥å»å¦ã®è¨åºã¯ç¾ä»£ã¨ã¯ç°æ¬¡å ã®é¢¨æ¯ã«ãªã£ã¦ãããããããªãã
(ææ¾å¤ªéã2015.6.22.)
èªç¥ãªãããªãã¼ã·ã§ã³å®è·µã¬ã¤ããå»å¦æ¸é¢ã2015å¹´6æ1æ¥çºå£²ç£è¨³ãææ¾å¤ªéã(æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§ åææ)
訳ã穴水幸å(å½éå»çç¦ç¥å¤§å¦ è¬å¸«)
ããå°å£è³ä¸(å½ç«ç ç©¶éçºæ³äººæ¥æ¬å»çç ç©¶éçºæ©æ§)
ããå°è¥¿æµ·é¦(æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§)
ããæè¤ææµ(æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§)
ããé«çåè¼(ç¬ç«è¡æ¿æ³äººæ¾å°ç·å»å¦ç·åç ç©¶æ)
ããéå´æå(æ±äº¬æ¦èµéç
é¢)
ããè¤æ°¸ç´ç¾(æ±äº¬é½ãªãããªãã¼ã·ã§ã³ç
é¢)
ããææ¾å¤ªé(æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§)
解説ãã¨ããã³ã¹ã«åºã¥ãèªç¥ãªãããªãã¼ã·ã§ã³
æ¬æ¸ã¯
McKay Moore Sohlberg, Lyn S. Turkstra
Optimizing Cognitive Rehabilitation --- Effective Instructional Methods
The Guilford Press 2011
ããå½ç 究室ã®ã¡ã³ãã¼ã訳åºãããã®ã§ããã
æ¬æ¸ã¯é¦é¡ã®éããã¾ãã«ãå®è·µã¬ã¤ããã§ããããã®ä¸åãããã°ãèªç¥ãªãããªãã¼ã·ã§ã³ãå®è·µã§ããããã®ããã«æè¨ãã¦ãå·®ãæ¯ããªãããããå®å°è¨åºããã®ã¾ã¾æ ãåºãããä¸åã§ãããè¨å ´ææº¢ããè¨åºã®å®ä¾ããããè¨ç·´ã®å®éãè¨é²ãããã¯ã¼ã¯ã·ã¼ããããããã®ã¯ã¼ã¯ã·ã¼ãã¯æ¬æ¸ã®ä»è¡¨ãã³ãã¼ãã¦ããããã¯ãã¼ã ãã¼ã¸ãããã¦ã³ãã¼ããã¦ãããã«ãå®å°ã§ä½¿ç¨å¯è½ã§ãããããã¦æ¬æ¸ã«ç´¹ä»ããã¦ãããªãããªãã¼ã·ã§ã³ã®ææ³ã«ã¯ãã¹ã¦æå¹æ§ã®ã¨ããã³ã¹ããããã¨ãã第â
é¨ã®åºç¤ç·¨ã«è¨å¤§ãªæç®ã¨ã¨ãã«ç¤ºããã¦ãããèªç¥ãªãããªãã¼ã·ã§ã³ã®è¨åºã»ç 究両æ¹ã«ãããç¾ä»£ã®ç¬¬ä¸äººè
ã§ããSohlbergã¨Turkstraãèããã¨ã§åãã¦å¯è½ã«ãªã£ãå®è·µã¬ã¤ãã§ããã(ãã¾ãã«å®è·µçãªãã翻訳ã«å°çª®ããé¨åããã£ããèè
ããè¨åºã§ç¨ãã¦ãã¦ãè¾æ¸ã«ã¯åºã¦ããªããã¼ã«ã«ãªç¥èªã®æå³ãã©ããã¦ãããããªãã£ããããã§Sohlbergå
çã«ç´æ¥åãåãããã¨ãããâ I am glad that our textbook will be useful to your peopleâã¨ãããè¨èã¨ã¨ãã«ãããã«ä¸å¯§ã«ãæç¤ºããã ãã解決ãããã¨ãã§ãã)
æ§æãç¾ãããèªã¿ããããã¨ãæ¬æ¸ã®å¤§ããªç¹é·ã¨ãªã£ã¦ãããå
¨ä½ãéãã¦ã®ãã¼ã¯ã¼ãã¯PIEã§ãããæ°ã
ã®è¨ç·´ææ³ãã
è¨ç»(P: Plan),
å®è¡(I: Implementation),
è©ä¾¡(E: Evaluation)
ã¨ããæ çµã¿ã§æ´çããã¦ããã
èªç¥ãªãããªãã¼ã·ã§ã³ã®å®è·µã¨ã¯ããã®PIEã®æµãã«ãã£ã¦ã次ã®åãã«çãã¦ãããã®ã§ããã¨ããã®ãèè
ãã®æãã§ãã:
WHO: æ£è
ã®ç¹æ§
WHAT: ã¿ã¼ã²ããã¿ã¹ã¯ (ä½ãæããã°çæ´»ãæ¹åããã®ãï¼)
WHERE: ã¿ã¼ã²ããç°å¢ (ã©ãã§ã¿ã¼ã²ããã¿ã¹ã¯ã使ãããã®ãï¼)
WHEN: ã¿ã¼ã²ããã¿ã¹ã¯å®è¡ã®ã¿ã¤ãã³ã°
WHY: ã´ã¼ã«ã®è¨å®
HOW: æ£è
åå¥è¨ç»ã®ãã¶ã¤ã³
ããã¦å ·ä½çãªè¨ç·´æ³ãã第⠡é¨ãå®è·µç·¨ãã«ç¤ºããã¦ãããããªãã¡äºå®ã¨æ¦å¿µ(5ç« )ã夿®µéã¹ãããã®è¨ç·´(6ç« )ãå¤çã¨ã¤ã使ç¨è¨ç·´(7ç« )ãã¡ã¿èªç¥çæ¹ç¥è¨ç·´(8ç« )ã社ä¼çæè½è¨ç·´(9ç« )ã§ãããè¿å¹´ãèªç¥ãªãããªãã¼ã·ã§ã³ã«æ¥éã«å°å ¥ããã¦ãã¦ãããITæ©å¨ãæ´»ç¨ããè¨ç·´ã«ã¤ãã¦ã®è¨è¼ãè±å¯ã§ããã
忏ã«ã¯ âEffective Instructional Methodâ ã¨å¯é¡ãã¤ãããã¦ãããã广çãªæç¤ºæ³ããèè
ãã®èªä¿¡ããããããå¯é¡ã ããã®èªä¿¡ã«ã¯åºç¤ã¨å®è·µã®ä¸¡æ¹ããã®è£ã¥ããããã
ã¾ãã«å®è·µã¬ã¤ãã§ããã
ãªãæ¬æ¸ã¯å»å¦æ¸é¢ãã¼ã ãã¼ã¸
http://www.igaku-shoin.co.jp/bookDetail.do?book=86156
ã«ãç´¹ä»ããã¦ããã
(ææ¾å¤ªéã2015.5.25.)
髿©è½èªéã¹ãã¯ãã©ã çå
ã«ãããèªç¥åã³çç¶ãããã£ã¼ã«ã®æ§å·®
çå´åä¸ï¼å¤§éªå¤§å¦é£åå°å
çºéå¦ç ç©¶ç§ã婿ãç¦äºå¤§å¦åã©ãã®ãããã®çºéç ç©¶ã»ã³ã¿ã¼ãç¹å½å©æï¼Kumazaki H, Muramatsu T, Kosaka H, Fujisawa T, Iwata K, Tomoda A, Tsuchiya K, Mimura M. Sex differences in cognitive and symptom profiles in children with high functioning autism spectrum disorders . Research in Autism Spectrum Disorders 13-14: 1-7, 2015.
ç²¾ç¥ç§å¤æ¥ã«ããã¦å¥³å
ã®é«æ©è½èªéã¹ãã¯ãã©ã çï¼Autism spectrum disorder: ASDï¼ãäºæ¬¡éå®³ãæ¥ããå診ã¨ãªãã±ã¼ã¹ããã°ãã°çµé¨ããã社ä¼ç¸äºæ§ã®é害ãä¸å ã¨ãªããæè²å¹´é½¢ã§ã¯ããããä¸ç»æ ¡ãéå¹´æã§ã¯è·å ´ä¸é©å¿ããæ´åãç¯ç½ªãªã©ã®æ§ã
ãªç¤¾ä¼çç ´ç¶»ããããæ·±å»ãªåé¡ã¨ãªã£ã¦ãããã±ã¼ã¹ã«ééãããã³ã«â使
ãã£ã¨æ©ãä»å
¥ã§ããªãã£ãã®ããå¥è¨ºã§ã¯ä½æ
å¼ã£ããããªãã£ãã®ãâã¨æãããæãããã¨ãããã女å
ã§é«æ©è½ã®ã±ã¼ã¹ã¯ç·å
ã®ã±ã¼ã¹ã¨æ¯ã¹å¹¼å°æã«ã¯çç¶ãè¦ãã¥ããã¨è¨ããã¦ããã女å
ã®é«æ©è½ASDãããã«æ©æçºè¦ãããã¯å«ç·ã®èª²é¡ã¨ãªã£ã¦ããã
æã
ã¯ASDã®æ§å·®ã«ã¤ãã¦å¯¾è±¡å¹´é½¢ãææ¥æåã®çãå¹´é½¢ç¯å²ã対象ã¨ãã¦æ§å·®ã調æ»ãããWISCãããã£ã¼ã«ã«ã¤ãã¦ã¯åé
ç®ã«ããã¦ææãªå·®ãèªããªãã£ãããCARS(Child Autistic Rating Scale)ãããã£ã¼ã«ã«ã¤ãã¦ã¯å¥³å
ã§ç·å
ããå
è¦ã»å³è¦ã»è§¦è¦(è¿æ¥æè¦)ã«ã¤ãã¦éç度ãéãã¨ã®çµæãåºããæè¦éæã¯ASDã®æ£è
ã«ã¨ã£ã¦å®çæ´»ã®ä¸ã§æ±ãå°é£æ§ã®æ¬è³ªã«è¿ãããã®ã³ã³ããã¼ã«ã¯ç¤¾ä¼æ§ã®ç²å¾ã対人é¢ä¿ã®å¦ç¿ã«éè¦ãªå½±é¿ãåã¼ããã¨ããASDã®æ ¸å¿é¨åã¨ã®é¢é£ãæ·±ãã¨ã®è¦æ¹ããããæè¦ã®åé¡ã¯ä½å¹´é½¢ã«ããã¦ãç¹å¾´çã§ãããç¾å¨ã¾ã§æè¦ã®æ§å·®ã«ã¤ãã¦ã®å ±åã¯ã»ã¨ãã©ãªããASDã«ããã¦å
è¦ç¹æ§ãå¼·ããã¨ãã³ãã¥ãã±ã¼ã·ã§ã³è½åãä¸é©å¿è¡çºã®äºå¾ã示åããã¨ã®å ±åããããã¨ãããå
è¦ã«çç®ããæç¾©ã¯å¤§ãããä»å¾å
è¦ãã¯ããã¨ããè¿æ¥æè¦ã«çç®ãããã¨ã§ã女æ§ã®ASDãã¨ãããäºå¾ã®æªã群ã¸ã®æ©æçºè¦ã»æ©æä»å
¥ã«ã¤ãªãããããããªãã¨èãã¦ããã
(çå´åä¸ã2015.4.19)
解説ãèªéã¹ãã¯ãã©ã çã®è¨ºæç²¾åº¦ãç ãæ¾ã¾ã
èªéã¹ãã¯ãã©ã çï¼ASDï¼ã¯ãç·å
ã®ã±ã¼ã¹ãã¯ããã«å¤ããã¨ã¯ããç¥ããã¦ãããããã説æãã仮説ã¨ãã¦ãBaron-Cohenã«ããæåãªextreme male brain theory ããããASDã®èªç¥æ©è½ã®ç¹å¾´ã¯ãã®ã¾ã¾ãç·ã®è³ãã®ç¹å¾´ã§ãããããã女å
ã®ASDãå°ãªãçç±ã ã¨ããã®ããã®ä»®èª¬ã§ããã
ãã®èª¬æã¯ç´å¾ãããããæ§å·®ã®çç©å¦ã«ãä¸è´ããåççãªçè«ã«æãããã ãããã¾ã§ã仮説ã«ãããªããã¨ã«ã¯æ³¨æãå¿
è¦ã§ãããç´å¾ãããã仮説ã¯ãç²¾å¯ãªæ¤è¨¼ããªãããåã«åãå
¥ãããã¦ãã¾ããã¨ããã°ãã°ããããã®çµæèª¤ã£ãéã«è¿·ãè¾¼ãå±éºãçã¾ããã®ã¯ãextreme male brain theoryãä¾å¤ã§ã¯ãªãã
ãã®å±éºã®ä¸ã¤ãã女å
ã®ASDãè¦è½ã¨ããããããªããã¨ã§ããã
çå´åä¸å©æã¯ãå
童精ç¥ç§ã®è±å¯ãªè¨åºçµé¨ã«åºã¥ãã夿°ã®å¥³å
ã®ASDã診æãããªãã¾ã¾ã«åããã¦ããã®ã§ã¯ãªããã¨ããå¼·ãå顿èãæã¡ãæ¬ç ç©¶ã«çæãããããã¦å¥³å
ASDã®è¿æ¥æè¦(å
è¦ã»å³è¦ã»è§¦è¦)ã®ç°å¸¸ã¯ç¸å¯¾çã«éãã¨ããã¯ãªã¢ãªçµæãå¾ãã
ASDã«ã¤ãã¦ã®éå»ã®ç ç©¶è«æã«ããã°ãIQã«ãã£ã¦ãã®æç
çã®æ§å·®ã¯ç°ãªãå¾åãèªãããã¦ãããIQãé«ãã¨ãç·å¥³æ¯ã¯ãã大ãããªãã®ã§ãã(IQãé«ã女å
ASDã¯ããå°ãªã)ãããã¯ãIQã®é«ã女å
ã¯ãèªãã®ASDå¾åãèªèãããããé è½ãããã¨ã§é©å¿ãã¦ãããASDã§ãããã¨ãè¦ãã«ãããªã£ã¦ããããã§ããã¨èãããã¦ãããããã¨ãèªç¥æ©è½ã«åºã¥ãè©ä¾¡ã¯å¥³å
ASDã®è¨ºæãæ··ä¹±ããããã¨ã«ãªããæ£ç¢ºãªè¨ºæã®ããã«ã¯ããçç©å¦çãªææ¨ãæ±ããããã
ãã®æå³ã§ããè¿æ¥æè¦(å
è¦ã»å³è¦ã»è§¦è¦)ã®æ¸¬å®ã女å
ASDã®è¨ºæã«å½¹ç«ã¤ã¨ããã°ãè¨åºçã«éå¸¸ã«ææç¾©ãªç¥è¦ã§ããã¨ãããã
次ã®ã¹ãããã¯ãã®çµæãããã«æ´ç·´ããå®è¨åºã®è¨ºæã«å½¹ç«ã¦ããã¨ã§ãããçå´å©æã¯ãå·¥å¦ç³»ã®å
±åç ç©¶è
ãæ°ãã«éçºããå
è¦æ¸¬å®æ©å¨ãç¨ãã¦ãæ©éãã®ä»äºã«çæãã¦ãããæ²»çã«é¢ãã¦ã¯ããããããç¨ããèªéã¹ãã¯ãã©ã çå
ã¸ã®ä»å
¥ã¨ããå
é§çãªåéã«ãåå
¥ãããªã©ãç¦äºã«æ ç¹ãç½®ãã¤ã¤ãå½å
å¤ãç²¾åçã«é£ã³åãç ç©¶ãç¶ãã¦ããã
(ææ¾å¤ªéã2015.4.22)
ä»äººã®ä¸å¹¸ã¯èã®å³
å è¤å
ä¸é (æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§ææ)Takahashi H, Kato M, Matsuura M, Mobbs D, Suhara T, Okubo Y.
When Your Gain Is My Pain and Your Pain Is My Gain: Neural Correlates of Envy and Schadenfreude.
Science. 2009; 323: 937-939.
解説 ãã®å ã¸
æ ¶æã®ç¥çµå¿çå¦ç 究室ãåµå§å½æããç´30å¹´éã«ãããç½å¼ããã¦ããå è¤å ä¸éææã®ä»£è¡¨ä½ã®ä¸ã¤ããScienceèªã«æ²è¼ããããã®è«æã§ãããã¿ã¤ãã«ã«ãããã¤ãèªã®Schadenfreudeã¨ããåèªã«ã¯ãè±èªã«ãæ¥æ¬èªã«ãé©åãªè¨³èªããªããããã¦è¨³ãã°ãæ¥ç¥ããã®æ¦ã³ãã¨ã§ããªããããæå³ããã¨ããã¯ãä»äººã®ä¸å¹¸ã¯èã®å³ãã§ããã人ã¯å¦¬ããä»äººã®ä¸å¹¸ãåã¶ã人éã®ææ ã®ä¸ã§æãéãã¨ããããããã«æãã éå¿çãªç ç©¶ããã®ãä»äººã®æåã妬ã¿ãä»äººã®å¤±æãåã¶ --- 妬ã¿ã¨ã·ã£ã¼ãã³ããã¤ãã®è³åºç¤ãã§ããã
å·§å¦ãªå¿ç課é¡ã¨fMRIãçµã¿åãããæ¬ç ç©¶ã®çµæã¯å¤§ããä¸ã¤ããã第ä¸ã«ã妬ã¿ã®ææ ã«ã¯åé¨å¸¯ç¶åãé¢é£ãã¦ãããã¨ã第äºã«ã妬ã¿ã®å¯¾è±¡ã®äººç©ã«ä¸å¹¸ãèµ·ããã¨ãç·æ¡ä½ãæ´»åãããã¨ãããããéè¦ãªãã¼ã¿ã§ããããåé¨å¸¯ç¶åãèè¤ãå¦çããé¨ä½ã§ãããç·æ¡ä½ãå ±é ¬ã«é¢é£ããé¨ä½ã§ãããã¨ã«éã¿ãã°ãããã¾ã§ã¯å¾æ¥ã®ç ç©¶ãåä¸å¹³é¢ä¸ã«æ¡å¤§ããçµæã§ããã¨ãè¨ãããã
æ¬ç ç©¶ã®å§å·»ã¯ããããã§ããã妬ã¿ã«é¢é£ããåé¨å¸¯ç¶åã®æ´»åãé«ã人ã»ã©ãä»äººã®ä¸å¹¸ã«å¯¾ãã¦ç·æ¡ä½ãå¼·ãåå¿ããããããæ¬ç ç©¶ã®ç¬¬ä¸ã®ãã¼ã¿ã§ããããä»äººã®ä¸å¹¸ã¯èã®å³ãã¨å¼·ãæãã人ã¨ãããã»ã©ã§ããªã人ã¯ã©ããéãã®ããããã«ã¤ãã¦ã®è³å ã¡ã«ããºã ã®ä¸ç«¯ãæããã«ãããã®çµæã¯ã人éã®ææ ã«ã¤ãã¦ã®è³ç§å¦ã«ãç«ä½çã«æ°ããªæ¬¡å ãæ¸ãå ããç»æçãªãã¼ã¿ã§ããã
èªåãããè¯ãçãããã¨ããæ°æã¡ã人éã®å ã ã¨ããã°ã妬ã¿ãã·ã£ã¼ãã³ããã¤ãã¯ããã«ä¼´ãå½±ã§ãããåä¸å¿ã®é²åã«ä¼´ãå½±ããã®å½±ã¯æ¥ç¥ããã®è¡çºãå½¢æããå½±ã伸ã³ãã°ç¯ç½ªã«ãã¤ãªãããé²åã¯äººéã®å¿ã«æ§ã ãªå½±ãä½ã£ã¦ãããæ»ææ§ãåãç¬å 欲ãçã ãããããå½±ã¯ãæã¨ãã¦äººéã®å ã®é¨åãçã£æã«è¦ãé ãã¦ãã¾ãããããã ããã¨ãã£ã¦ããããéå¾³è«ã§æãè¾¼ããã¨ãã¦ãæåããªããã¨ã¯ã人é¡ã®é·ãæ´å²ã証æãã¦ããã人éã®éãé¨åããç®ããããã¦ããéããæ¶æ» ããããã§ã¯ãªããå¦èªã®é²è¡æ©å¶ã¯ãã¤ãç ´ç¶»ããéå½ã«ããã
妬ã¿ãã·ã£ã¼ãã³ããã¤ãã«ä»£è¡¨ãããã人éã®é²åã«ä¼´ãéãé¨åãããããã¢ã³ã¹ã¿ã¼ã®ããã«æé·ãã人é¡ãç ´æ» ã«å°ããã¨ãé²ãããã«ã¯ãç´è¦ãã¦æ£ä½ãè¦æ¥µãããã¨ããå§ããªããã°ãªããªããã俺ãç©ãæ¸ãã¨ãããé²åã®æ¬ã ããããã¨ãå è¤ææãå£ã«ããè¨èã§ããã
ãããªãç ç©¶ãã¼ã¿ãããã大ããªåãã«çããããã®ã¹ãããã§ãããæ¬ç ç©¶ã§ã¯ããä»äººã®ä¸å¹¸ã¯èã®å³ãã®è³å ã¡ã«ããºã ã®ä¸ç«¯ãè§£æããããããã ãã§ã¯è峿¬ä½ã«ããè¦ãããã ããã®å ã«ã¯ã人é¡ã®å¹¸ç¦ã¸ã®éãéãã¦ãããéã¯é·ããã´ã¼ã«ã¯ã¯ããå½¼æ¹ã«æãããããã®éã¯ç¢ºãã«å ã«æº¢ãã¦ããã妬ã¿ãã·ã£ã¼ãã³ããã¤ãã®è³å ã¡ã«ããºã ã®è§£æã¯ããããã®ææ ã®ããåççãªè§£æ±ºã¸ã®ã¹ã¿ã¼ãã©ã¤ã³ã§ããããã¼ã¿ãçè§£ãããã¨ãããã¦æ¬¡ã®ã¹ãããã«çãããã¨ãããããåªããç ç©¶è«æã¸ã®æå¤§ã®æ¬æã§ããã
(ææ¾å¤ªéã2015.3.30.)
éç¾å®çãªæèã«ã¨ãããã¦å°±è·æ´»åã«å°é£ããããã¦ããé é¨å¤å·ã®1ä¾
å ç°ç« æï¼æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§ è¨åºå¿ç士ï¼ç¬¬24åèªç¥ãªãããªãã¼ã·ã§ã³ç ç©¶ä¼ã2014å¹´11æ1æ¥ãæ±äº¬
å ç°ç« æãå
æ¨é åãæ±å£æ´åãå°è¥¿æµ·é¦ã䏿å°
èªç¥æ©è½ãæ¯è¼çä¿ããã¦ããã社ä¼çè¡åé害ãåããæ£è ã«ã¯ããªãã¬ã¼ãã³ã°ãç¨ããå¿ççã¢ããã¼ããæå¹ã§ããã¨èããããçä¾ãå ±åããã
çä¾ã¯40æ³ä»£ç·æ§ãX-8å¹´ã«é 鍿æ²ããåé èåºè¡ãè³æ«å·ã¨å³ç¡¬èå¤è¡è
«ãèªãããä»é¢ã«ãã髿¬¡è³æ©è½ã®ãªãããªãã¼ã·ã§ã³ã¨çµé観å¯ãåãã¦ãããããã®å¾ãéé¢ã¯ä¸æãã¦ãããXå¹´ããå½é¢ã«å診ãèªç¥æ©è½æ¤æ»ã«ããã¦æãããªä½ä¸ã¯èªããªããã社ä¼çè¡åé害ãåãã¦ããã
åå·å¾ã䏿ã¯åå·åã®è·å ´ã«å¾©å¸°ãããã以åã®è·ç¨®ã«æ»ãã®ãé£ããã£ããåè·ããåã³ä¾é ¼ã®å£°ããããã¨ããéç¾å®çãªæèãç
èã®ä½ä¸ãªã©ããåå°±è·æ´»åã«å°é£ãçãã¦ããã
æ¬çä¾ã¯ç¥çµå¿çæ¤æ»ä¸ã§ã¯æç¸¾è¯å¥½ã§èªç¥æ©è½ã¯ä¿ããã¦ããã以åã«é«æ¬¡è³æ©è½ã®ãªãããªãåãã¦ãããç¾å¨ã¯å°±å´æ¯æ´æ½è¨ã®ããã°ã©ã ã«åå ä¸ã§ããããããã£ã¦èªç¥æ©è½ã®ãªãããªããããå¿ççå´é¢ããã®ã¢ããã¼ãã®å¿ è¦æ§ãèããèªå·±èªèã®å¤åã®ä¿é²ãç®æ¨ã«ãªãã¬ã¼ãã³ã°ãæ´ç¨ããå¿ççæ³ã宿½ããã
颿¥ãéããã«ã¤ããå½åã¯ãåç´ãªä½æ¥ã°ãããããã£ã¨é度ã®äººãåãããã®ãã¨å¦å®çãªè¦æ¹ã示ãã¦ãã就崿¯æ´æ½è¨ã®ããã°ã©ã ã¸ã®åå ã«ã¤ãã¦ãããªãºã ã¥ããã«ã¯ãªã£ã¦ãããã髿¬¡è³æ©è½éå®³ãæ±ãã¤ã¤åãã¦ãã人ã®è©±ãèãããããªã©æ°ããåãåãæ¹ãç²å¾ãããã®ç¹ãèªã話ãããã«ãªã£ããããã«ã颿¥è ã®åãããã«å¯¾ãã¦ãåè·ã¸ã®å¾©å¸°ã¯ãã©ã³ã¯ã®ããã«é£ãããããããªããã¨ã以åã®éç¾å®çãªçããããç¾å¨ã®ç¶æ³ã客観çã«çããå ´é¢ãè¦ãããããã«ãªã£ãããããã®ãã¨ãããªãã¬ã¼ãã³ã°ãæ´ç¨ããå¿ççæ³ã«ãããè·æ¥ã«é¢ããèªå·±èªèã®å¤åãä¿ããã¨ãã§ããã¨èããã
(å ç°ç« æã2015.2.23.)
解説 æãè¾¼ã¿ãæ£ã
ãã¼ã¯ã¼ãã¯ãªãã¬ã¼ãã³ã°ã§ããããªãã¬ã¼ãã³ã°ã¨ã¯ãæãè¾¼ã¿ãè§£ãã»ãããæ°ããè¦ç¹ãåãå
¥ããããã¨ããå¿ççæ³ã®ææ³ã§ããã
é常ã¯è³æå·è
ã対象ã«ç¨ãããã®ã§ã¯ãªããã®ææ³ããè³æå·è
ã®ä¸ã§ãç¹ã«èªç¥ãªãããªãã¼ã·ã§ã³ãå°é£ãªç¤¾ä¼çè¡åé害ã«é©ç¨ããã¨ããææ¢ãªçºæ³ãå®è¡ã«ç§»ããæ ¹æ°è¯ãç¶ãããã¨ã«ãã£ã¦ææãæããã®ããå ç°ç« æè¨åºå¿çå£«ã®æ¬å ±åã§ããã
ææ¢ã¨ãã£ã¦ããåã«å¥ãè¡ã£ãããã§ã¯æ±ºãã¦ãªãããã®çä¾å人ããé¡èãªç¤¾ä¼çè¡åé害ãæãã¦ããã«ãããããããé常ã®èªç¥æ©è½æ¤æ»ã®æç¸¾ã¯ä¿ããã¦ãããã¨ã«å ç°è¨åºå¿ç士ã¯çç®ãããªãã¬ã¼ãã³ã°ãæå¹ã§ãããã¨äºæ¸¬ããã®ã§ãããä¸è¦ããã¨å¤§èãªå½¼ã®æ²»çè¨ç»ã¯ãç·»å¯ãªç¥çµå¿çå¦çæ¤æ»ã®åæã«è£æã¡ããã¦ããã
è³æå·ããè³ã®æ©è½ã®ä¸é¨ã失ãããã®ã¯å·å³ãªäºå®ã§ããããã®ããæ²»çè
ã¯ã失ãããæ©è½ã¯åãæ»ããªãã¨ããæå主義ã«é¥ããã¡ã§ãããããããæ²»çè
ã®å´ã®æãè¾¼ã¿ããè³æå·è
ã¸ã®ç©æ¥µçãªãããããé»ãå¾åããããã¨ã¯å¦ããªããå ç°è¨åºå¿çå£«ã®æ¬ç ç©¶ã¯ããªãã¬ã¼ãã³ã°ãæ£è
ã®æ²»çã«å¿ç¨ãããã¨ã«ã¨ã©ã¾ãããä¸è¬çãªå¿ççæ³ã¯è³æå·è
ã«ã¯é©ç¨ã§ããªãã¨ããæ²»çè
ã®æãè¾¼ã¿ãæ£ããªãã¬ã¼ãã³ã°ã®å¿
è¦æ§ã示åãããã®ã¨è¨ãããããããªãã
(ææ¾å¤ªéã2015.2.26.)
ã¿ã¼ãã¼çå群ã«ãããç½è³ªç°å¸¸
山縣æ (æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§å©æ)Yamagata B, Barnea-Goraly N, Marzelli MJ, Park Y, Hong DS, Mimura M, Reiss AL. White Matter Aberrations in Prepubertal Estrogen-Naive Girls with Monosomic Turner Syndrome. Cereb Cortex 2012; 22:2761-2768.
ã¿ã¼ãã¼çå群ï¼Turner Syndrome; TSï¼ã¯ãæ£å¸¸å¥³æ§ã®æ§æè²ä½ãXXã®2æ¬ãªã®ã«å¯¾ããXæè²ä½ã1æ¬ãããªããã¨ã«ãã£ã¦çºçããä¸é£ã®çå群ã§ããï¼45XOï¼ãä½èº«é·ãå¿ç¾æ£ãäºæ¬¡æ§å¾´ã®æ¬ å¦ã¨ãã£ã身ä½çç¹å¾´ã¨è¦ç©ºéæ§æãéè¡æ©è½ã¾ã社ä¼èªç¥ãåå¹´é½¢ã®å¥å¸¸è
ã¨æ¯ã¹é害ããã¦ããã¨ããèªç¥ç¹æ§ãæãã¦ãããTSã対象ã¨ããè³ç»åç ç©¶ã¯ã女æ§ã«ããã¦ãXæè²ä½ã®ç°æ°æ§ãèªç¥ãè³ã®çºéã¸ã©ã®ããã«å½±é¿ããã®ããçè§£ããããã«éè¦ã§ãããéå»ã®MRIç ç©¶ããTSã«ãããè¦ç©ºéæ§æãè¨ç®è½åã®é害ãé é èã®ç°ç½è³ªã®ä½ç©æ¸å°ãåé âé é èã®æ©è½ä½ä¸ã¨é¢é£ãã¦ãããã¨ã示åããã¦ãããããã«è¿å¹´ãä½åè¨æ¶èª²é¡éè¡ä¸ã®åé èã¨é é èã®æ©è½ççµåãTSã«ããã¦é害ããã¦ãããã¨ãå ±åããã¦ããã䏿¹ã§ãDiffusion Tensor Imaging (DTI)ãç¨ãã¦TSã«ãããç½è³ªæ§é ç°å¸¸ã調ã¹ãç ç©¶ã¯éå»ã«2ç·¨ãããªãã (Molko et al., 2004; Holzapfel et al., 2006)ããããã¯ãmosaicã¨non-mosaic genotype(ã¢ã¶ã¤ã¯åã¨å®å
¨å)ãå«ãã heterogeneousãªsampleã§ãããã¾ãã¨ã¹ããã²ã³æ²»çã®ããèªç¥æ©è½ãè³ã®çºéã¸ã®å½±é¿ãèæ
®ããã¦ããªããããã§ãä»åãæã
ã¯ã¨ã¹ããã²ã³æ²»çãåãã¦ããªãææ¥æåã®non-mosaicãªTSã対象ã«ãã®ç½è³ªã®æ§é ç°å¸¸ã«ã¤ãã¦MRIãç¨ãã¦æ¤è¨ããã
3ã12æ³ã®TS群ï¼26åï¼ã¨å¥å¸¸å¯¾ç
§ç¾¤ï¼20åï¼ã対象ã«Tract-based spatial statistics (TBSS)ãAtlas-based ROI analysisãFiber-trackingã¨ãã£ã 3ã¤ã®ç°ãªã DTIè§£ææ¹æ³ã¨Voxel-based Morphometry (VBM)ãç¨ãã¦ç¾¤éã«ãããæ¡æ£ç°æ¹æ§(Fractional anisotropy; FA)ã¨ç½è³ªã®ä½ç©ã®éãã調æ»ããã
ãã®çµæãTSã¯è¦ç©ºéæ§æã表æ
èªç¥ãæè¦éåã社ä¼èªç¥ã«é¢ä¸ããè³é åã®ç½è³ªç¹ç¶ã«ããã¦å¥å¸¸å¯¾ç
§ç¾¤ã¨æ¯è¼ãã¦ææãªFAå¤ã®ä½ä¸ã示ãããç¹ã«å
¨ã¦ã®è§£ææ¹æ³ã«ããã¦ä¸è²«ãã¦å·¦ã®ä¸ç¸¦æããã³ç´¡éç¶åã«ããã¦TSã®FAå¤ãä½ä¸ãã¦ãããã¨ã示ãããã
ä»åã®æã
ã®çµæãããTSã®èªç¥ç¹æ§ã«é¢é£ããè³é åã«ããã¦ç½è³ªæ§é ç°å¸¸ã示ããããç¹ã«åé èã¨é é èãçµã¶ç½è³ªç¹ç¶ã§ããä¸ç¸¦æã«ããã¦å¾®ç´°ãªç½è³ªæ§é ç°å¸¸ãTSã«èªãããããã¨ã¯ç¾å¨ã¾ã§ã«éç©ããã¦ããè³ç»åç ç©¶ã®ç¥è¦ãããã«æ¯æãããã®ã¨ãªã£ããä»å¾ãTSã ãã§ãªãKlinefelterâs syndrome (47 XXY)ãXYY syndrome (47 XYY)ã¨ãã£ãæ§æè²ä½ã®ç°æ°æ§ãæããä»ã®éºä¼åç¾æ£ãå«ããè³ç»åç ç©¶ãé²ãã¦ãããã¨ã§ãæ§æè²ä½éºä¼åã¨è³ã®çºéãè¨åºçç¶ã®é¢ä¿ï¼Gene-Brain-Behaviorï¼ãç¥ãæ©ä¼ãããã«æã
ã«ä¸ãã¦ãããã¨æå¾
ãããã
(山縣æã2015.1.21.)
解説 éºä¼åããè³ã¸ãããã¦èªç¥æ©è½ã¸
人éåå¨ã®æ ¹æºã¨ãããã¹ãç©è³ªãéºä¼åãç¾ä»£ã®ç¥çµå¿çå¦ã§ã¯ã人éã®è¡åããããã¦èªç¥æ©è½ããéºä¼åã¾ã§é¡ã£ã¦ç ç©¶ãããã¨ãå¯è½ã«ãªã£ã¦ããã山縣æå士ã¯ãéºä¼åæ¤æ»ã»è³ç»åæ¤æ»ã»èªç¥æ©è½æ¤æ»ãé§ä½¿ãã¦ãã¿ã¼ãã¼çå群ã¨ããæããåºãç¥ããã¦ããç¾æ£ã«æ°ããªå
ããã¦ããã®æ¬è³ªã«è¿«ããã¼ã¿ãå¾ãã
ã¿ã¼ãã¼çå群ã¯ãæè²ä½ç°å¸¸ã®ä¸ã§ã¯é »åº¦ã®é«ããã®ã§ããããéºä¼åçã«ãè¨åºçã«ã決ãã¦åä¸ã§ãªããXæè²ä½ã1æ¬æ¬ ãã¦ãããå®å
¨å non-mosaicãã¨ãæ£å¸¸æè²ä½ãæã¤ç´°èã®æ··å¨ãèªãããã¢ã¶ã¤ã¯å mosaicãã§ã¯ãè¨åºåãããªãç°ãªãããããã£ã¦è³ã®æè¦ãç°ãªããã¨ãå½ç¶ã«æ¨å®ããããã¾ããæ²»çã¨ãã¦ç¨ããããã¨ã¹ããã²ã³ã¯ãèªç¥æ©è½ã«ãå½±é¿ãããã¿ã¼ãã¼çå群ã«ã¤ãã¦ã®éå»ã®ç ç©¶ã¯ãããããç¹ã«ã¤ãã¦ã®å³å¯ãã«æ¬ ããããä¿¡é ¼æ§ã«ã¯ããªãã®éçããã£ãã山縣å士ã¯ãå®å
¨å non-mosaicã§ããã¤ã¨ã¹ããã²ã³æ²»çãåãã¦ããªãã¿ã¼ãã¼çå群ã®ã¿ã«å¯¾è±¡ãå³é¸ãããã¨ã«ãã£ã¦ã徿¥ã®ç ç©¶ã大ããè¶
ããå°ç¹ã«å°éããã山縣å士ã®ãã¼ã¿ã¯ãéºä¼åããè¨åºåã«è³ãã¿ã¼ãã¼çå群ã®ã¡ã«ããºã ã®è§£æã¨æ°ããªæ²»çã®ã¿ã¼ã²ããã®éçºã«ç¹ãããã®ã§ããã®ã¿ãªãããGene-Brain-Behavior(éºä¼å-è³-è¡å)ã«ã¤ãã¦ã®äººé¡ã®ç¥èã®è²´éãª1ãã¼ã¸ãç¶´ããã®ã§ããã¨è¨ããã
æ¬ç ç©¶ã¯ã山縣å士ã2010å¹´ãã2012å¹´ã¾ã§çå¦ãã¦ããã¢ã¡ãªã«ã®ã¹ã¿ã³ãã©ã¼ã大å¦(Center for Interdisciplinary Brain Sciences Research, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine)ã§è¡ã£ãä»äºã§ãããç¾å¨å±±ç¸£å士ã¯ã対象ãçºéé害ã«åºããGene-Brain-Behavior(éºä¼å-è³-è¡å)ã®ã¢ããã¼ããç¶ç¶ãã¦ããã
(ææ¾å¤ªéã2015.1.24.)
æãã¤è¬ãã«ããªããªãã³ã«ããè³å
ãã«ã¨ããããªã³ãã©ã³ã¹ãã¼ã¿ã¼ã®å æç
é«éæ´æ (æ¾å°ç·å»å¦ç·åç ç©¶æ ååã¤ã¡ã¼ã¸ã³ã°ç ç©¶ã»ã³ã¿ã¼ãè¨åºç ç©¶æ¯æ´å®¤ã室é·ãååç¥çµã¤ã¡ã¼ã¸ã³ã°ç ç©¶ããã°ã©ã )Takano H, Arakawa R, Nogami T, Suzuki M, Nagashima T, Fujiwara H, Kimura Y, Kodaka F, Takahata K, Shimada H, Murakami Y, Tateno A, Yamada M, Ito H, Kawamura K, Zhang MR, Takahashi H, Kato M, Okubo Y, Suhara T.
Norepinephrine transporter occupancy by nortriptyline in patients with depression: a positron emission tomography study with (S,S)-[18F]FMeNER-Dâ.
Int J Neuropsychopharmacol 17(4):553-60, 2014.
Positron emission tomography (PET)ã¯ä¸ã¤ä¸ã¤ã®ç¥çµä¼éç³»ã«ç¹ç°çãªæ¾å°æ§ããã¼ããç¨ãã¦ããã®æ©è½ãè©ä¾¡ãã¦ãããã®ã§ãããè¨æ¸¬ã®ç²¾åº¦ã¯æ¾å°æ§ããã¼ãã®éçºã«å¤§ããä¾åããããã«ã¨ããããªã³ã¯ãã¼ããã³ãã»ãããã³ã¨ä¸¦ã¶ã¢ãã¢ãã³ã®å¾¡ä¸å®¶ã®ä¸ã¤ã§ããããã®è³å ãã©ã³ã¹ãã¼ã¿ã¼ã¯æãã¤è¬ã®ä¸»è¦ãªæ¨çã§ãããªãããé©åãªPETããã¼ãã®éçºã¯é ãã¦ãããæ¾å°ç·å»å¦ç·åç ç©¶æã§ã¯ä¸çã«å é§ãã¦F-18 FMeNER-D2ãç¨ããè³å ãã«ã¨ããããªã³ãã©ã³ã¹ãã¼ã¿ã¼ï¼NETï¼ã®äººã§ã®æ¸¬å®æ¹æ³ã確ç«ããè¨åºå¿ç¨ãé²ãã¦ãããæ¬ç ç©¶ã§ã¯NETã«é¸æçãªæãã¤è¬ãã«ããªããªãã³ãæç¨ä¸ã®ãã¤ç æ£è ã®æè¬éãè¡ä¸æ¿åº¦ã¨è³å NETå æçãæ¸¬å®ããããã«ããªããªãã³ã¯æå°æå¹è¡ä¸æ¿åº¦ãç¥ããã¦ãããæ¬ç ç©¶ã®ãã¼ã¿ãããã®æã®è³å NETå æçã¯ç´50ï¼ ã¨æ¨å®ããããããªãã¡ããã¤ç ã®æ²»çã«ããã¦ã¯50%以ä¸ã®è³å NETå æçãå¿ è¦ã§ãããã¨ã示åãããããã«ã¨ããããªã³ç¥çµä¼éã¯æ³¨æãææ¬²ãªã©ã®æ©è½ã«é¢ä¸ãã¦ããããã¤ç ã®ã¿ãªããä»ã®ç²¾ç¥ç¾æ£ã«ããã¦ãæ¤è¨ãæã¾ããããã®ããã«PETã§ã¯çãã人éã§é侵襲çã«è³å ã®çåå¦çãªæ©è½æ å ±ãå¾ããããããè³ç§å¦ç ç©¶ãç²¾ç¥ç¥çµç¾æ£ã®è¨åºç ç©¶ã«ããã¦ãããã¦æç¨ãªéå ·ã§ããã
(é«éæ´æã2014.12.1)
解説ãããæ´ç·´ãããæãã¤è¬æ²»çã¸
æãã¤è¬ã«ã¤ãã¦ã®ç¾ä»£ã®ç²¾ç¥å»å¦ãæã£ã¦ããç¥ã¯ã次ã®A, B, Cã«è¦ç´ãããã¨ãã§ãã:
A. æãã¤è¬ã¯ããã¤ç
ã«æå¹ã§ãããããã¯ãããã£ã¦ããã
B. æãã¤è¬ã¯ããªããã¤ç
ã«æå¹ãªã®ããããã¯ãããããã£ã¦ããªãã
C. æãã¤è¬ã¯ããã¤ç
ãæå¹ã«æ²»çããããã«ã¯ã©ã®ãããã®éã飲ãã°ããã®ããããã¯ã大ä½ã¯ããã£ã¦ããã
ããªãã¡ãããã®ãããã®éã®æãã¤è¬ã飲ãã°ããã¤ç
ã¯ãããªããããªããã®éãé©åãªã®ãããªããã¤ç
ããããªãã®ãã¯ãããããã£ã¦ããªããã®ãç¾ç¶ã§ããã
ããã«ã¯ãããªããã®éãé©åãªã®ããã¨ããªããã¤ç
ããããªãã®ããã¨ãããäºã¤ã®æªè§£æ±ºã®ãããã¦é大ãªåããããããã®åãã«å¯¾ããçããå¾ãããã°ããã¤ç
ã®ã¡ã«ããºã ã«ã¤ãã¦ã®çè§£ã¯å¤§ãã鲿©ãããã¤ç
ã®æ²»çæ³ã¯å¤§ããæ¹åããããã¤ç
ã®äººã
ã®å¤§ããªæ©æµã«ãªããã¨ã¯ééããªãã
ãæ¾å°ç·å»å¦ç·åç ç©¶æé«éæ´æå®¤é·ã®æ¬ç ç©¶ã¯ããã®åãã®è§£æ±ºã«å¤§ããè²¢ç®ãããã®ã§ãããæãã¤è¬ã«éãããè¬ã®é©éã¯ãæãåç´ã«ã¯é£²ãè¬ã®éãæ¬¡ã®æ®µéã¨ãã¦ã¯è¡ä¸æ¿åº¦ã®æ¸¬å®ã«ãã£ã¦æ±ºããã®ãä¸è¬çã ããæçµçã«ã¯äººä½å
ã®ãã®è¬ã®ã¿ã¼ã²ããã«ã©ãã ãæå¹ã«å°éãã¦ããããæ±ºãæã«ãªããæãã¤è¬ãã«ããªããªãã³(åååããªãã¬ã³)ã®ã¿ã¼ã²ããããã«ã¨ããããªã³ãã©ã³ã¹ãã¼ã¿ã¼(NET)ã§ãããã¨ã¯ãããªã以åããæããã«ããã¦ããããè¬ãããã«ã©ãã ãå°éãã¦ããããæ¸¬å®ããæ¹æ³ããªããé©éã¯è¡ä¸æ¿åº¦ã®ã¬ãã«ã§å¤å®ãã以å¤ã«ãªãç¶æ³ãç¶ãã¦ããããããæéããã®ããæ¬ç ç©¶ã®åé¡ã«ç¤ºããã¦ãã(S,S)-[18F]FMeNER-Dâã¨ããåå¦ç©è³ªã§ãããæ¾å°ç·å»å¦ç·åç ç©¶æã§éçºããããã®åå¦ç©è³ªã«ãã£ã¦ããã«ããªãããªã³ã«ããã¦ããªããã®éãé©åãªã®ãããæããã«ããæ¬ç ç©¶ã¯ãåºç¤ã¨è¨åºã®èåã«ããè¦äºãªçµå®ã¨è¨ããããããã¦ããªããã¤ç
ããããªãã®ããã¨ããåãã®è§£æã«ãç¹ãããã¨ã大ãã«æå¾
ãããã
é«é室é·ã¯ç¾å¨ãå½ç«ç²¾ç¥ã»ç¥çµå»çç ç©¶ã»ã³ã¿ã¼ç
é¢ã第ä¸ç²¾ç¥è¨ºçé¨ãå»é·ã¨ãã¦ç²¾ç¥ç§è¨åºãè¡ãã¨ã¨ãã«ãè³ç
æ
çµ±åã¤ã¡ã¼ã¸ã³ã°ã»ã³ã¿ã¼ãè¨åºè³ç»åç ç©¶é¨ã«æå±ãããã¥ã¼ãã¤ã¡ã¼ã¸ã³ã°ãé§ä½¿ãããããªãç ç©¶ãé²ãã¦ããã
(ææ¾å¤ªéã2014.12.18)
ãã¤ãã¢ã¼ãã³ã§ã®çå¦æè¨ ---ãã¼ã¡ã©ã³---
å è¤é(Klinik für Psychiatrie, Psychotherapie und Psychosomatik, Universitätsklinik Aachen)è¨åºç²¾ç¥å»å¦ 43(11) 1675-1677, 2014.
MEG(Magnetoencephalography)ã¨ã¯ãè³ã®ç¥çµæ´»åã«ä¼´ã£ã¦çããç£å ´å¤åãé èéª¨ã«æ¥ããã³ã¤ã«ã§æ¸¬å®ãããã®æ´»åæºã®æéçã»ç©ºéçå®ä½ãè¡ãè³æ©è½ç»åç ç©¶ã§ããã空éå®ä½ã®ã¢ãã«ã«ã¯æ§ã ãªæ¹æ³ãç¥ããã¦ããããåºæ¬çã«ã¯åã 人ã®è³ã«å³ãã座æ¨ç³»ãç¨ãããã¨ããã£ã±ãã§ãããããæ MEGææã«ãããæå¤§ã®åé¡ç¹ã¯æ¨æºè³ã«ãããæ´»åã¸ã®è§£éãæ¥µãã¦å°é£ãªé¨åã§ããã¨èãããããçµ±è¨å¦çãªå¦çãæ¥µãã¦ç ©éã¨ãããfMRIã¨æ¯è¼ãããå ´åã®ç©ºéåè§£è½ã®ä½ä¸ã«ç¹ãããããã®åé¡ã¯ãæ°ããªè§£ææ¹æ³ã®éçºã¨ä½µãã¦æ¯éã¨ã解決ãããªããã°ãªããªããè¿å¹´Matlabããã©ãããã©ã¼ã ã¨ãã¦åä½ããSPM(Statistical Parametric Mapping)ããå¾ãããMEGãã¼ã¿ã®çµ±è¨çè§£æãå¯è½ã¨ãã¤ã¤ãããèè ã¯Matlabã®ç¿çã¨ä½µãã¦ææ°ã®è§£æææããã¤ãã»ã¢ã¼ãã³ã«ã¦å¦ãã§ããã
ï¼å è¤éã2014.11.19ï¼
解説ãå å®ã®ãã¤ãçæ´»
æ
¶æã§å¦ä½åå¾å¾ããããªãèºé²ãç®æãã¦ãã¤ãã«é£ãã å è¤éå士ã®çå¦è¨ãããã¤ãã¢ã¼ãã³ã§ã®çå¦æè¨ ---ãã¼ã¡ã©ã³--- ãã§ããã
ãã¤ãèªã¨ããè¨èªã«ã¤ãã¦ã®å è¤å士èªèº«ã®å人å²ã¨è«è©ã¨ç¾ç¶ããå§ã¾ããã¢ã¼ãã³ã¨ããè¡ã¨å½¼ã®å¤åå
ã§ããã¢ã¼ãã³å·¥ç§å¤§å¦(ãã«ãã©ã¤ã³ã´ã§ã¹ããã¡ã¼ã¬ã³å·ç«ã®æè¡å°é大å¦)ã®ç´¹ä»ãããã¦å¦çæä»£ã®ã¨ããã®çµé¨ãçãããæµä½åå¦çè«ã¨è³æ©è½è§£æã«ãããçµ±è¨ã®ç¿çã«ã¤ãã¦ã®è«è¿°ãããã«ã¯ãã¤ãèªå¦ç¿ã¨Matlabå¦ç¿ã®æ·±ãé¢é£æ§ã¾ã§ãç°¡ã«ãã¦è¦ãå¾ãæµãããããªæç« ã«ãåèè«æããªããã®æ³¨ãã¤ãããããã¨ã§ãå¦è¡çãªæ·±ã¿ã確ä¿ãããçå ±ã¨ãªã£ã¦ãããé£ãè¨ãã°å è¤åå£«ãæ¿åã®åéã«ç²å¾ãããã¨æ¥æ¬ã®æã
ã«ä¼ãããã¦ãã伿ã®éã¨è³ªã¸ã®è¨åããªããã¨ã ããããã¾ã§è¿½åããã®ã¯ç¡ç²ã¨ãããã®ã§ããããä»ã«ä¾ãè¦ãªãåªãããã®çå¦è¨ã«ãããã«ããã§è§£èª¬ãã¤ããã®ã¯èè¶³ã¨æããããå¯é¡ã®è¬ãããããã¼ã¡ã©ã³ãã¨ããåèªã®è§£èªãå«ãããã²åæããèªã¿ãã ãããè¨åºç²¾ç¥å»å¦2014å¹´11æå·æ²è¼ããã¡ããæ¥æ¬èªã§æ¸ããã¦ããã
(ææ¾å¤ªéã2014.11.21.)
ããã£ããªçç¥æ§ã¨åé èç¼çª©é¢ã«ããããã¼ããã³D2å容ä½
森å£ç¿ï¼æ
¶æç¾©å¡¾å¤§å¦å»å¦ç ç©¶ç§å¤§å¦é¢å士課ç¨ï¼Dopamine D2 Receptors in the Orbitofrontal cortex and the Machiavellian intelligence
Moriguchi S, Yamada M, Mimura M, Suhara T
The 10th International Symposium on Functional NeuroReceptor Mapping of the Living Brain May 21 â 24, 2014, The Netherlands
ç¥çµå¿çå¦ç 究室æå±ã®å¤§å¦é¢å士課ç¨2å¹´ç®ã®æ£®å£ã§ãã
ç§ã¯ä¸»ã«PET (positron emission tomography)ãç¨ããç ç©¶ããã¦ãããç¾å¨ã¯å¿çè©ä¾¡ã¨PETãç¨ãã¦è³ã®ã©ã®é¨ä½ããã®å¿çã¨é¢é£ãã¦ãããã¨ãããã¨ã«ã¤ãã¦ç ç©¶ãã¦ããã¾ããå
容ã¯ã¨ããã¾ãã¨ããã£ããªçç¥æ§ã¨ãã¼ããã³æ©è½ã¨ã®é¢é£ã§ããããã£ããªçç¥æ§ã®æ¸¬å®ã¯ããã£ããªã®èæ¸ã§ãããå主è«ããããªã¼ãã¼ã¨ãªãè³è³ªãåããç¹å¾´ãæ½åºãããããã¨ã«å被é¨è
ã®ããã£ããªåº¦åããæ¸¬å®ãã¾ããããã¦ãã®ããã£ããªåº¦åãã¨å被é¨è
ã®ãã¼ããã³æ©è½ãPETã«ã¦æ¸¬å®ããã¨ããå
容ã§ãããã¡ãã«é¢ãã¾ãã¦ã¯ãã¾ã¨ã¾ã次第æ¹ãã¦ãå ±åããã¦é ããã°ã¨æã£ã¦ããã¾ãã
ä»åããã®ãããã£ããªçç¥æ§ã¨ãã¼ããã³æ©è½ããNeuro Receptor Mapping 2014ã¨ããå¦ä¼ã§çºè¡¨ãã¦ãã¾ããã
ããã§ã¯å¿çæ©è½ã¨PETç ç©¶ã§æåãªå
çã¨è©±ãããæ©ä¼ãããç·å¼µãã¾ãããæµ·å¤ã®å¦ä¼ã ã¨æ
è²»ãªã©ã§ãéã¯ãããã¾ãããä¸çã®ç ç©¶è
ã®æè¦ãèããã¨ããæå³ã§å½éå¦ä¼ã¸ã®åå ã¯ææç¾©ã ã¨æãã¾ãã大å¦é¢çã§ãã¨è¨åºãè¡ã£ã¦ããé ãããä¼ã¿ãåããããããå½éå¦ä¼ãªã©ã¸ã®åå ãæ¯è¼çãããããªãã¾ããã¾ããå¦ä¼ã§ã¯ãã®å¦ä¼èªä½ãåå¼·ã«ãªãã®ã§ãããå¦ä¼åã«ã»ããã¼ããã¬ã³ã¼ã¹ãªã©ãéå¬ãããäºãå¤ããåºæ¬çãªãã¨ãä½ç³»çã«å¦ã¶ãã¨ãã§ãã¾ããè¨åºã常å¤ã§ãã£ã¦ããé ã«ã¯ç
æ£ãé·æéãããäºãåºæ¥ããå¦ä¼ã®ä¸é¨ã«åå ããã®ã¿ã§ãã®ãããªã»ããã¼ã«åå ãããã¨ã¯ä¸ã
åºæ¥ã¾ããã§ããã
ãã¡ããè¨åºã¯å¤§åã§ãããã¢ã¤ãã¢ã®åºç¤ã«ãªãéè¦ãªãã®ã§ãããä¸åº¦å¤§å¦é¢ã§èªåã®è¨åºçµé¨ãæ´çããã¨ãããã¨ãè²´éãªçµé¨ã ã¨æãã¾ãã
ããèå³ããããã¾ãããæ¯éç¥çµå¿çå¦ç 究室ã§ä¸ç·ã«åå¼·ãã¾ãããã
(森å£ç¿ã2014.10.14.)
è§£èª¬ãæ§ã ãªç¥æ§ã®å½¢
é ãè¯ãã¨ã¯ã©ããããã¨ããç¥æ§çã¨ã¯ã©ããããã¨ããç¥è½ãé«ãã¨ã¯ã©ããããã¨ããããããç¥è½ã¨ã¯ä½ãã
ãç¥è½æ¤æ»ã§æ¸¬å®ããããã®ããããç¥è½ã§ããã
ç¡æå³ã¨è¨ããããªãçãã ããä¸é¢ã®ççã§ãããã¤ã¾ãã¯ä»ãç¥è½ãå®ç¾©ãããã¨ã¯åºæ¥ããç¥è½æ¤æ»ã¨ããã¦ããæ¤æ»ããããªã¼ã®æç¸¾ã§ããIQããä¸å¿ã¯ãç¥è½ãã¨å¼ã¶ã¨ããç´æäºãããã«ãããªãã
ã ããIQãä½ãã¦ãåªããè½åãæã£ã¦ãã人ã¯ããããããããéã«IQãé«ãã¦ãå®ç¤¾ä¼ã§ã®è½åãåªãã¦ããªã人ã¯ããããããã人éã®è½åã¯ãç¥è½æ¤æ»ã§ã¯æ¸¬å®ã§ããªãæ§ã
ãªèªç¥æ©è½ããæãç«ã£ã¦ããã®ã ã
ãã®ä¸ã¤ãããã£ããªçç¥æ§ã§ããã
ãããã£ããªãã¨ã¯ããå主è«ãã®èè
ã§ããããã³ãã»ããã£ããª(1469-1527)ã«ç±æ¥ããããããã£ããªçç¥æ§ãã¯ãè¿å¹´ã®ãã¼ã½ããªãã£ç ç©¶ã§æ³¨ç®ãéãã¦ããæ¦å¿µã§ã主ã¨ãã¦äººãæä½ããããã§å¿
è¦ãªç¥æ§ãæãããã®æä½ã¨ã¯ãããããééå¾³çãªãã®ãå«ãã人ãé¨ããåªã³ããªã©ã®ãã¯ããã¯ãé§ä½¿ãã¦ã§ãã人ãæä½ããèªãã®ç®çãéæãããã¨ãããããããè½åã«é·ãã¦ãã人ããããã£ããªçç¥æ§ãåªãã¦ãããã¨å¼ã°ããã
ééå¾³çãªãã®ãå«ãã¨ãããã¨ã¯ãããã£ããªçã¨ã¯æªãæ§æ ¼ã§ããã¨ããè§£éãã§ãããã¨ã«ãªããã ãããæã¾ãã£åä¸ã«ã¯ã°ãããã®ã¯ä»ãæãåãã§ããããå主ã¨ã¾ã§ã¯ãããªãã¦ããéå£ã®ãªã¼ãã¼ã«ã¯å¤ããå°ãªããããã£ããªçãªå¾åããããããã£ããªçç¥æ§ããªããã°ããªã¼ãã¼ã¨ãã¦ã®é©æ§ã¯ä¸ååã¨ãããã¨ã«ãªãããå¹³å人ã®ãéå¾³ãã¯ããªã¼ãã¼ã¨ããç«å ´ã®äººã«ãã®ã¾ã¾ã¯é©ç¨ã§ããªãã®ã§ããã
森å£ç¿å¤§å¦é¢çã¯ãPETãç¨ãã¦ãããã£ããªçç¥æ§ã¨è³å
ãã¼ããã³æ´»åã®é¢é£ã追究ãããªã©ã³ãã§éå¬ãããå½éå¦ä¼ã§çºè¡¨ãããã¨ã«ãã£ã¦ãä¸çã®ç ç©¶è
ã¨äº¤æµããæ©ä¼ãå¾ããå¦ä¼çºè¡¨ã¯ç»å±±ã§ããã°ä¸è
¹ã§ããããã®ç ç©¶çµæã®å½éçãªä¸æµèªã¸ã®è«æçºè¡¨ãå¾
ãããã¨ããã§ããã
(ææ¾å¤ªéã2014.10.21)
åé åéæå·å¾ã®å±æè¨æ¶é害
æ¢
ç°è¡ (æ
¶æç¾©å¡¾å¤§å¦æå¦é¨ææ)Umeda, S., Kurosaki, Y., Terasawa, Y., Kato, M., & Miyahara, Y.(2011)ãDeficits in prospective memory following damage to the prefrontal cortex. Neuropsychologia, 49, 2178-2184.
æªæ¥ã«å®è¡ãã¹ãäºå®ãç´æãªã©ã®è¨æ¶ã¯ï¼å±æè¨æ¶(prospective memory)ã¨å¼ã°ããï¼å±æè¨æ¶ã®é害ã¯ï¼å¥å¿çï¼èªç¥çããã³åé èæå·ã«ããã¦é¡èã§ããï¼è¨æ¶é害ã®é篤度ãèªç¥çã®é²è¡ç¨åº¦ã®ææ¡ã«ããã¦ãéè¦ãªæå³ãæã£ã¦ããï¼
å±æè¨æ¶ã®æ³èµ·ã«ã¯ï¼2ã¤ã®ã¿ã¤ãã®å¦çè¦ç´ ãå«ã¾ããï¼
ã²ã¨ã¤ã¯ãä½ãè¡ãã¹ãè¡çºããããã¨ãããã¨ã®æ³èµ·(å卿³èµ·)ã§ããï¼æ³èµ·ã®èªçºæ§ãã¿ã¤ãã³ã°ãå¿
è¦ã¨ãããè¦ç´ ã§ããï¼
ããã²ã¨ã¤ã¯ï¼ãå
·ä½çã«ä½ãè¡ãããã¨ãããã¨ã®æ³èµ·(å
容æ³èµ·)ã§ããï¼æå¸³ãªã©ã®è¨æ¶è£å©ã«ä¾åãããã¨ã®ã§ããè¦ç´ ã§ããï¼
ããã¾ã§ã®ç ç©¶ããï¼å
容æ³èµ·ã®ç¥çµåºç¤ã«ã¤ãã¦ã¯ï¼æµ·é¦¬ãã¯ããã¨ããããããåè·¯å
ã®è³é¨ä½ã®é¢ä¸ãææããã¦ããï¼ä¸æ¹ï¼å卿³èµ·ã®ç¥çµåºç¤ã«ã¤ãã¦ã¯ï¼åé èã®é¢ä¸ãææããã¦ãã®ã®ï¼è©³ç´°ãªé¨ä½ã«ã¤ãã¦ã¯æããã«ããã¦ããªãï¼
ããã§ï¼74ä¾ã®è³æå·ä¾ã対象ã¨ãã¦ï¼çªå·æèª²é¡ã¨å¼ã°ãã課é¡ãç¨ãã¦ï¼è³å
ã®ãããã®é¨ä½ã®æå·ãå卿³èµ·ã®ããã©ã¼ãã³ã¹ä½ä¸ãçã¿åºãã¦ãããã¨ããç¹ã«ã¤ãã¦æ¤è¨ããï¼
ãã®çµæï¼å卿³èµ·ã®ããã©ã¼ãã³ã¹ã«å½±é¿ãä¸ããé¨ä½ã¨ãã¦ï¼1) å³åé åéèå¤å´é¨ï¼2) å³åé åéè ¹å å´é¨ï¼3) å·¦åé åéèå å´é¨ï¼ã®é ã«æ·±ãé¢ä¸ãèªããããï¼ãããã®é¨ä½ã¯ããããããã¼ããã³ã®10éã«ä½ç½®ãã¦ããï¼åé åéã®å 端é¨å¨è¾ºãï¼èªçºçãªæå³ã®æ³èµ·ãå¯è½ã«ããå¦çãæ ã£ã¦ãããã®ã¨èå¯ãããï¼
(æ¢ ç°è¡ã2014.9.3.)
è§£èª¬ãæªæ¥ã®è¨æ¶
岡æ¬å¤ªéã®ãææ¥ã®ç¥è©±ãã¯ãæ¸è°·é§
ãäºã®é ç·ã¨JRã®é£çµ¡éè·¯ã«ãã巨大ãªå£ç»ã§ããã常ã«äººã
ã§æº¢ããå ´æã«è¨ç½®ããããã®ä½åã«ã¯ãåçã®ç¸è£ããç¬éã大èãªè²å½©ã¨æ§å³ã§æããã¦ããã人é¡ã®æ²åãã¹ãã¬ã¼ãã«æããè¸è¡ä½åã¨ãã¦ã¯ããã«ã½ã®ãã²ã«ãã«ããæåã ãããã®äºã¤ã®ä½åã®éã ã£ãéãã¯ããã®ã¿ã¤ãã«ã«ããããææ¥ã®ç¥è©±ãã¨ããã¦é説çãªã¿ã¤ãã«ãã¤ãã岡æ¬å¤ªéã¯ãæ²åãæ²åã¨ãã¦ã ãæããã®ã§ã¯ãªããæªæ¥ã«åãã£ã¦çãä¸ãã人éã®èªãããã®ä½åã«ãããã¨ãããã
ãç¥è©±ãã¨ããè¨èã«ã¯é ãéå»ã®ãã®ã¨ããã¤ã¡ã¼ã¸ãããããããã«ç¥è©±ã¨ã¯ããããããä½ãããæç¹ã«ããã¦ã¯ç¾ä»£ã§ãããããããä½ãããç¥è©±ã¯æªæ¥ã®ç¥è©±ãææ¥ã®ç¥è©±ã ã
æ¢
ç°è¡ææ(æ
¶æç¾©å¡¾å¤§å¦æå¦é¨å¿çå¦å°æ»)ã®è«æã®ã¿ã¤ãã«ã«ãããå±æè¨æ¶ãã¨ã¯ãæªæ¥ã«ã¤ãã¦ã®è¨æ¶ã§ããã
ãè¨æ¶ãã¨ã¯ããæãåºãããã¨ã«ãã£ã¦ç®ã«è¦ãããã®ã¨ãªãããæãåºãã対象ã¯éå»ã®ãã®ã«éãã¨èããã¡ã§ãããã人éã«ã¯æªæ¥ã®è¨æ¶ããããäºå®ãæãåºããã¨ãã¾ããã£ã¦äºå®ãã¦ãããã¨ããé©åãªã¿ã¤ãã³ã°ã§æãåºãå®è¡ãããã¨ããã®ããã®è¨æ¶ãå±æè¨æ¶ã§ããã社ä¼ã§çæ´»ãã¦ããããã§ãäºå®ãæ£ç¢ºã«ããªããã¨ã大åãªãã¨ã¯è¨ãããã¾ã§ããªãæããã§ãäºå®ãè³æå·è
ã®ç¤¾ä¼å¾©å¸°ã«ããã¦ã¯ãéå»ã®è¨æ¶ããããããæªæ¥ã®è¨æ¶ãããªãã¡å±æè¨æ¶ã®é害ãããªã¢ã«ãªããã¨ã¯ããææããã¦ããã
ãå±æè¨æ¶ã¯ãå°éçã«ã¿ãã¨ããªãè¤éãªæ§é ãæã¡ãé常ã«å¤ãã®è¦å ããããã£ã¦ããèªç¥æ©è½ã§ãããããå卿³èµ·ã(äºå®ããã£ãã¨ããäºã«ã¤ãã¦ã®æ³èµ·)ã¨ãå
容æ³èµ·ã(ãã®äºå®ãå
·ä½çã«ä½ã§ãã£ããã¨ããäºã«ã¤ãã¦ã®æ³èµ·)ã¨ããäºã¤ã®éç¨ã«åç¯ããã¨ããçºæ³ããå±æè¨æ¶ã®ç ç©¶ãå éããã(æ¢
ç°è¡ãå°è°·æ´¥åæ: å±æè¨æ¶ã®çè«çèå¯. å¿çå¦ç ç©¶ã69: 317-333, 1998)
æ¬è«æããåé åéæå·å¾ã®å±æè¨æ¶é害ãã¯ãå±æè¨æ¶ã®äºã¤ã®è¦ç´ ã®ãã¡ã®ä¸ã¤ã§ããå卿³èµ·ã«åé åéã®å
端é¨å¨è¾ºãå¼·ããããã£ã¦ãããã¨ããå·§å¦ãªç¥çµå¿çå¦çæ¤æ»ã¨ãã¥ã¼ãã¤ã¡ã¼ã¸ã³ã°ã®çµã¿åããã«ãã£ã¦ç¤ºããç ç©¶ã§ããã
è³å
ã®é¢é£é¨ä½ãæç¢ºã«ç¤ºããããã¨ã§ãå±æè¨æ¶ã®çè«çç ç©¶ãããã«ã¯èªç¥ãªãããªãã¼ã·ã§ã³ã®æ¹ç¥ã¯ãããã«å¤§ããçºå±ããã§ãããã
ä¸è¬ã«ãéå»ã®åºæ¥äºãããæãåºããªã人ã¯ãè¨æ¶åã®æªã人ãã¨å¼ã°ããããç´æãªã©ããã£ã½ããã¦ãã¾ã人ã¯ãä¿¡é ¼ã§ããªã人ãã¨å¼ã°ãããèªç¥æ©è½ã®é害ã¨ãã観ç¹ããã¯ãéå»ã«ã¤ãã¦ã®è¨æ¶éå®³ãæªæ¥ã«ã¤ãã¦ã®è¨æ¶é害ãå·®ç°åãããã¨ã¯åºæ¥ãªãã¯ãã ããå±æè¨æ¶é害ã¯ããã®ããã«ä¸å½ã¨ããããè©ä¾¡ãåããã¡ã§ãããåæ§ã®ãã¨ã¯ãå¤ãã®èªç¥æ©è½é害ã«ãå ±éããäºæ ã§ãããç¥çµå¿çå¦çç ç©¶ã®é²æ©ã«ãã£ã¦ã人éã®èªç¥æ©è½ã®å®åãæããã«ãªã£ã¦ããã«ã¤ãã¦ãé害è ã¸ã®åè¦ãè§£æ¶ãã¦ãããã¨ãæå¾ ãããã
æ¸è°·é§ ã®éè¸ã®ä¸ã«ãã³ãããææ¥ã®ç¥è©±ãã®ããã«ãå»å¦ç ç©¶ããã¹ã¦ã®äººã«éããããã®ã«ãªã£ã¦åãã¦ããã®ç価ãçºæ®ãããã¨è¨ãã¹ãã§ãããã
(ææ¾å¤ªéã2014.9.24.)
çµ±å失調çã®ãé大ãªèªæãã®Sense of Agency ã¿ã¹ã¯ã«ããè©ä¾¡
æ¯æ¨æå® (æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨å¤§å¦é¢å士課ç¨)The âExaggerated Selfâ in Schizophrenia evaluated using the Sense of Agency task (Keio method, trial-by-trial ver.)
Koreki A, Maeda T, Fukushima H, Okimura T, Takahata K, Umeda S, Iwashita S, Kato M, Mimura M
ASSC (Association for the Scientific Study of Consciousness) 17
San Diego, CA; July 12-15, 2013.
çµ±å失調çã§ã¯sense of agency(SoA)ã®ç°å¸¸ããããã¨ã¯å½æå®¤ã®ç ç©¶ãå«ãã¦ä»ã¾ã§ã«ç¤ºããã¦ãããSoAã®æç«æ©åºã¨ãã¦ããäºæ¸¬ãã¨å®éã®æè¦ãã£ã¼ãããã¯ãä¸è´ãããã©ããã¨ããForward modelï¼ä¸è´ããã°èªåããã£ãã¨æããï¼ãæå±ããã¦ããããçµ±å失調çã§ã¯ãäºæ¸¬ãã®ç°å¸¸ãããã¨å
è¡ç ç©¶ã§ææããã¦ãããããããã®ãäºæ¸¬ãã®ç°å¸¸ãã©ã®ãããªãã®ããã¾ããã®ç°å¸¸ãSoAã«ã©ã®ããã«é¢ãã£ã¦ãããã¯æããã§ã¯ãªãã£ãã
ä»åã®ç ç©¶ã§ã¯ãæ
¶æç¬èªã®SoA課é¡ãæ¹å¤ãã¦è¡ããã¨ã§ãçµ±åå¤±èª¿çæ£è
ã®ãäºæ¸¬ãããé
ãã¦ãããå¯è½æ§ã示ããã¨ãã§ãããããã«ãã®ãäºæ¸¬ãã®é
ããå®é¨ä¸ã§ã®éå°ãªSoAã«ç¹ããå¯è½æ§ã示ãããããã®éå°ãªSoAã¯çµ±å失調çã®é¢ä¿å¦æ³ã説æããããããã䏿¹ã§å¹»è´ãããããä½é¨ã¯èª¬æã§ããªãããäºæ¸¬ããé
ããåãForward modelã«åºã¥ãã°æè¦ãã£ã¼ãããã¯ã¨ä¸è´ããªããªãSoAãä½ä¸ããã¨èãããããããå¹»è´ãããããä½é¨ã«ç¹ããã¨ãèããããããä»å¾ã¯ãããªãæ¤è¨¼ãå¿
è¦ã§ããã
(æ¯æ¨æå®ã2014.8.1.)
解説ãçµ±å失調çã®èªæé害ã客観åãã
ã¿ã¤ãã«ã®ãé大ãªèªæãã¨ã¯ãçµ±å失調çã®è¨åºçç¶ã¨ãã¦è¦ããããã䏿±ã§æ¦äºãèµ·ããã®ã¯èªåãââãããããã ããªã©ãèªåãå¤çã«å½±é¿ãåã¼ãã¦ããã¨ããå½¢ã§ä½é¨ãããèªæé害ãæããçµ±å失調çã§ã¯ä»æ¹ãããããä½é¨ãå¹»è´ã«ããå½ä»¤ã®ããã«ãå¤çããèªåã«å½±é¿ãåãã§ããã¨ããä½é¨ãããã°ãé大ãªèªæãã«å¯¾ãã¦ãå¼±åããèªæãã¨ãããèªæé害ãããããããçç¶ã¯èªæã®å¢çã®ç°å¸¸ã¨ããå
±éç¹ã¯ãã£ã¦ããç¾è±¡ã¨ãã¦ã¯æ£åå¯¾ã®æ§è³ªãæã£ã¦ããããã®ãããªèªæé害ã¯ãçµ±å失調çã®çç¶ã®ä¸æ ¸ã¨ãã¦ããµã¤ã¨ã³ã¹ã®æã®å±ããªãé£åä¸ã®é£åã¨ãã¦ã®å°ä½ãä¿ã¡ç¶ãã¦æ¥ã¦ããã
æ¯æ¨æå®å¤§å¦é¢çã¯ãã®èªæé害ã«åãè¾¼ãã ç ç©¶ããµã³ã¸ã¨ã´ã®ASSC (Association for the Scientific Study of Consciousness)ã§ãã¹ã¿ã¼çºè¡¨ããStudent Poster Awardãç²å¾ããã
ASSCã¯ãç²¾ç¥å»å¦ã®ã¿ãªãããç¥çµç§å¦ãèªç¥ç§å¦ãå¿çå¦ãå²å¦ãªã©ãæ§ã
ãªåéã®å°éå®¶ãåéããããæèãã«é¢ããå¦ä¼ã§ãããä»åã®åè³ã¯ãçµ±å失調çã®çç¶ã¸ã®å¦éçãªæ³¨ç®ã¨ãã観ç¹ãããã大ããªæç¾©ãæãããã®ã§ããã
ãã®ç ç©¶ã§ç¨ãããããã¼ã«ã¯ãå½ç 究室ã®åç°è²´è¨è¬å¸«ãä¸å¿ã¨ãªã£ã¦éçºããSense of Agency Task (SoAã¿ã¹ã¯)(æ¬ãµã¤ãã2014.3 åç°è¬å¸«ãçµ±å失調çã®èªæé害ã«ã¤ãã¦ã®å®è¨¼çç ç©¶ãåç
§)ã§ãããæ¯æ¨é¢çã¯åç°è¬å¸«ã®åæ³ãæ¹å¤ããä¸è©¦è¡ãã¨ã«æéãã¤ã¢ã¹ã調æ´ããã¨ããå·§ã¿ãªææ³ãç¨ããçµ±å失調çã«ããããé大ãªèªæããã©ã®ããã«å½¢æããããã«ã¤ãã¦è¡åå®é¨çã«ç¤ºããã¨ã«æåããã
æ¯æ¨é¢çã¯ãè¡åå®é¨ã«ã¨ã©ã¾ããããã¥ã¼ãã¤ã¡ã¼ã¸ã³ã°ãé§ä½¿ãã¦ã®çµ±å失調çã®ç¥çµåºç¤ã®è§£æãç ç©¶ãã¼ãã¨ãã¦ãããç¾å¨ãæ
¶æã®é¢é£ç
é¢ã§ããé§æ¨éç
é¢(æ±äº¬é½å
«çåå¸)ã«ä½µè¨ããã¦ããç²¾ç¥å»å¦ã»è¡åç§å¦ç ç©¶æã«ã¦ãSoAã¿ã¹ã¯ãç¨ããæ©è½çMRI(fMRI)ç ç©¶ãDTI (Diffuse Tensor Imaging)ç ç©¶ãé²è¡ä¸ã§ããããããªãçºå±ã¨ææãæå¾
ãããã
(ææ¾å¤ªéã2014.8.24.)
éãã¤ãæ¤æ»ãç¨ããã軽度ã¢ã«ããã¤ãã¼ç
ã«ãããé é èæ©è½ä½ä¸ã«ããè¦ç©ºéæ©è½éå®³ã®æ¤åºã«ã¤ãã¦
ç°æ¸è(æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§è¬å¸«)Tabuchi H, Konishi M, Saito N, Kato M, Mimura M.
Reverse Fox test for detecting visuospatial dysfunction corresponding to parietal hypoperfusion in mild Alzheimerâs disease.
Am J Alzheimers Dis Other Demen. 29 (2) :177-182, 2014.
ã¢ã«ããã¤ãã¼ç
ã§ã¯ç·©å¾ã«é²è¡ããè¨éåé害ãããç¥ããã¦ããããè¦ç©ºéèªç¥æ©è½ã®ä½ä¸ãç
åæããèªããããï¼è¨æ¶é害ã«å
è¡ãã¦çããã¨ã®ä¸»å¼µãããï¼ãä»åæã
ã¯ã模å£ã«ããæ°ããæææ§ææ¤æ»ï¼éãã¤ãæ¤æ»ï¼ã«ãã軽度ã¢ã«ããã¤ãã¼ç
æ£è
ã®è¦ç©ºéèªç¥æ©è½ãè©ä¾¡ãã診æã«ãããæç¨æ§ãæ¤è¨ããã
éãã¤ãæ¤æ»ã¯ç´1åç¨åº¦ã®ç°¡ä¾¿ãªæ¤æ»ã§ãããã¾ãæ¤æ»è
ã¯ä¸¡æã§ããããã親æå
ã䏿å
ã»è¬æå
ã¨ãã£ã¤ãã人差ãæã¨å°æãã¾ã£ããã«ä¼¸ã°ãããããã影絵ã§ä½¿ãããããã¤ããã®å½¢ã示ããããã«æ¤æ»è
ã¯çæ¹ã®æãã²ããã峿ã®äººå·®ãæã¨å·¦æã®å°æãå·¦æã®äººå·®ãæã¨å³æã®å°æããã£ã¤ãã¦ããéãã¤ããã®å½¢ãä½ãã被é¨è
ã«æ¨¡å£ããããæç¤ºããã
æ
¶æç¾©å¡¾å¤§å¦ç
é¢ã¡ã¢ãªã¼ã¯ãªããã¯ã«éé¢ãã¦ãã65ã89æ³ã®è»½åº¦ã¢ã«ããã¤ãã¼ç
æ£è
47åï¼Clinical Dementia Rating 0.5ãªããï¼ãå¹³åå¹´é½¢77.9 + 5.2æ³ï¼ãèªç¥æ©è½æ£å¸¸ã®å¯¾ç
§ç¾¤18åï¼å¹³åå¹´é½¢75.1 + 5.2æ³ï¼ã対象ã¨ãããã¢ã«ããã¤ãã¼ç¾¤ã§ã¯éãã¤ãæ¤æ»ã®æåçã¯31.9%ã対ç
§ç¾¤ã§ã¯94.4%ã§ãã£ããã¾ãã¢ã«ããã¤ãã¼ç¾¤ã«ããã¦ãéãã¤ã失æç¾¤15åï¼å¹³åå¹´é½¢78.7 + 5.1æ³ï¼ã¯æå群32åï¼å¹³åå¹´é½¢77.6 + 5.2æ³ï¼ã¨æ¯ã¹ã¦è¨æ¶ã»éè¡æ©è½ãªã©ã«é¢ããæ¤æ»çµæã«å·®ãã¿ãããªãã£ãããè³è¡æµæ¤æ»ã«ããã¦å¾é¨å¸¯ç¶åã»æ¥åé¨ãå«ãé é èé åããã³å´é èé åã§ã®è¡æµä½ä¸ãèªããã
è¿å¹´ãã¢ã«ããã¤ãã¼ç
ã«é¢ãã診æåºæºãååä¸ç´ã¶ãã«æ¹è¨ããã髿¶²æ¤æ»ãã¢ããã¤ãã¤ã¡ã¼ã¸ã³ã°ãªã©ã®ç»åæ¤æ»ãæ¨å¥¨ããã¦ãããããããããã®æ¤æ»ã宿½ã§ããæ½è¨ã¯éããã¦ãããé常ã®è¨ºçç¾å ´ã§ã®è¨ºæã§ã¯ãè¨åºçç¶ãç¥çµå¿çå¦çæ¤æ»çµæãªã©ãéè¦ã¨ãªããç¹å¾´çãªçç¶ã簡便ãã¤å¹æçã«æãããã¨ãã§ããæ¤æ»ã¯ãç¹ã«å¤æ¥è¨ºçãªã©ã§ã¯æç¨ãªè¨ºæè£å©ãã¼ã«ã¨ãªãã¨èããããã
ï¼ç°æ¸èã2014.7.2ï¼
解説ãããããµã¤ããããã¥ã¼ãã¤ã¡ã¼ã¸ã³ã°ã¸
両æã§ããããããã¤ãããä½ãã誰ã§ãç¥ã£ã¦ãã影絵ã®ãã¤ãã§ãããããã¦ä¸æ¹ã®ãã¤ããã²ãã£ã¦å転ãããäºã¤ã®ãã¤ããéã«ã¤ãªããããã ãã§ãããããããéãã¤ãæ¤æ»ãã ãåæã®ã¢ã«ããã¤ãã¼ç
ã診æããããã®ãæããããæ¤æ»ã§ããããã¼ãã¯ã¨ãã£ã¦ããããä¼çµ±çã¨ãã£ã¦ããããã·ã³ãã«ã¨ãã£ã¦ããããã簡便ã¨ãã£ã¦ããããæ½è¡ã«ã¯ä½ããããªããæãããã°ã§ãããçæéã§ã§ããã誰ã§ãã§ãããããã¦ä¿¡é ¼åº¦ã¯é«ããã ãã¡ã«ããºã ã¯ä¸æã ã£ãã
ç°æ¸è¬å¸«ã¯ãã®ä¼çµ±çãªæ¤æ»ã®ã¡ã«ããºã ããç¾ããè«æã«ä»ä¸ãã¦çºè¡¨ãããè«æã®å³ã¯äºã¤ã®ã¿ãéãã¤ãæ¤æ»ã®åçã¨ãSPECTã®ç»åã§ããããã®äºã¤ã®å³ã®é¢ä¿ãã¹ãã¬ã¼ãã«ç¤ºãããæå¿«ãªã¡ãã»ã¼ã¸ãä¼ããè«æã§ããã
ããããµã¤ãã®ãã¼ãã¯ããéè£
åã®ãã¤ãã¯ã¾ã§ãé§ä½¿ããã®ããç¾ä»£ã®ç²¾ç¥ç§è¨ºæã§ããã両è
ã®çµåã診æã«ã¯ä¸å¯æ¬ ã§ãããè³ã®æ©è½ç»åã¯ããèªä½ã§ã¯åãªãçµ±è¨çµæã®æç»ã«ããããç²¾å¯ãªè¨åºçç¶ã®åæã¨çµåããæã¯ããã¦å½ãå¹ãè¾¼ã¾ãããéã«ãä¼çµ±çãªããããµã¤ãã®æ¤æ»ããè³å
ã¡ã«ããºã ã¨ã®é¢é£æ§ã示ãããæã¯ããã¦ç§å¦æ§ãç²å¾ãããéãã¤ãæ¤æ»ã¨ãããã¼ãã¯ã¨SPECTã¨ãããã¤ãã¯ã綺éºã«çµåããããã®ä»äºã¯ãç°æ¸è¬å¸«ã®å¦ä½è«æã¨ãªã£ãã
ãã£ã¼ã«ãã¨ãªã£ãã¡ã¢ãªã¼ã¯ãªããã¯ã¯ã2008å¹´ãç¥çµå
ç§ã¨ç²¾ç¥ç¥çµç§ã¨ã®å
±åéå¶ã§æ
¶æç¾©å¡¾å¤§å¦ç
é¢ã«éè¨ãããå®å
¨äºç´å¶ã®ã¯ãªããã¯ã§ãããå診ã¯ãåæèªç¥çããããã¯çºçåã®èªç¥çã主ã§ãããã対象è
ã®æ©æè¨ºæã»æ©æä»å
¥ã«å¤§ããè²¢ç®ããã¨ã¨ãã«ãè¿æªæ¥ã®é«é½¢å社ä¼ã«åãã¦ã®è²´éãªç ç©¶ãã¼ã¿ã次ã
ã«çã¾ãã¦ããã
ãªããã¡ã¢ãªã¼ã¯ãªããã¯ã®è§£èª¬æ¸ã¨ãã¦
ãã¡ã¢ãªã¼ã¯ãªããã¯è¨ºçããã¥ã¢ã«
鹿島æ´é/é´æ¨åå® (ç£ä¿®), ç°æ¸è/伿±å¤§ä» (ç·¨é) åæ±å (2011å¹´çºå)ã
ãããã
(ææ¾å¤ªéã2014.7.21.)
æ¥å¸¸çæ´»ä¸ã®è¡åé害ã¨å¥å¿ãåä½µããåºç¯ãªåé èæ«å·ã®1ä¾
â è¿½å ±åãåå·å¾24å¹´ â
çªè¡è£åã(å¹³å·ç
é¢ãè¨èªè´è¦å£«)第23åèªç¥ãªãããªãã¼ã·ã§ã³ç ç©¶ä¼ã2013å¹´10æ5æ¥ãæ±äº¬
çªè¡è£åã平巿·³ä¸ã浪岡æ¿ç¾ãæ£®å±±æ³°ãæ¢
ç°è¡ãå è¤å
ä¸é
ãçä¾ã50æ³ä»£ãç·æ§ãX-22å¹´ãï¼éãã転è½ãè³æ«å·åå·ãéé è¡è
«é¤å»è¡å®æ½ãããã以å¾ãå¥å¿ã乱費ãåéãã¢ã«ã³ã¼ã«ä¹±ç¨ãæ´è¨ãçä»ããã§ããªããªã©ã®è¡åç°å¸¸ãããX-14å¹´ãçæ´»ã®ç ´ç¶»ã¨ã¢ã«ã³ã¼ã«ã®åé¡ã§Kç
é¢ ã«å
¥é¢ããå
¥éé¢ãç¹°ãè¿ããªããæ²»çãXå¹´å½é¢å診ããã¢ã«ã³ã¼ã«æ²»çã¨èªç¥ãªãããªãã¼ã·ã§ã³éå§ãå½åç¥çæ©è½ã¯æ¯è¼çä¿ããã¦ããããååæ§è¨æ¶ï¼è¿æè¨æ¶ãæéçåºåãå±æè¨æ¶ãªã©ï¼ã®åé¡ãåã³è¨èªæ§ã¯ã¼ãã³ã°ã¡ã¢ãªã¼å®¹éã®ä½ä¸ã注æé害ï¼åé
æ§ã»è»¢æãè»¢å°æ§ã®åé¡ï¼ãéè¡æ©è½é害ãåé èçç¶ï¼åºå·å¾åãæè»æ§ä½ä¸ãè¢«åºæ¿æ§äº¢é²ã夿åä½ä¸ãåé¡è§£æ±ºè½åä½ä¸ãè±æå¶çãç
èä½ä¸ãªã©ï¼ãé¡èãªæ¥å¸¸çæ´»ä¸ã®è¡åé害ãã¿ããã¦ãããMRI T2強調ç»åã§ã両å´åé èåºç¯å²ã«æ¸¡ãä½å¸åã軽度ã®è縮ãè³å®¤æ¡å¤§ãèªããã
å°åé¢é£æ©é¢ã¨é£æºããªãããç´2å¹´ã«æ¸¡ãè¨æ¶è¨ç·´ï¼åºç¤è¨ç·´ãã¢ã©ã¼ã è¨ç·´ãå¤çè£å©ææ®µæ´»ç¨ï¼ã注æåè¨ç·´ãåé¡è§£æ±ºè¨ç·´ãéè¡æ©è½è¨ç·´ãçæ´»é¢ã®æ¯æ´ããã°ã©ã ï¼éé管çè¨ç·´ãåé¡è¡åã«å¯¾ããã¢ããã¼ãä»ï¼ã宿½ãçµéä¸âæ°ã¥ãâãå¢å ããå
ããªããã社ä¼çæ´»ã«ãããã¹ãã«ãè¡åå¤å®¹ãå³ãã¦ãããç¥çµå¿çå¦çæ¤æ»ä¸14å¹´åã®è©ä¾¡ã«æ¯ããç¥çæ©è½ãè¨æ¶ã¯å¤§ããªæ¹åã¯ã¿ãããªãã£ãããæ³¨æãåé èæ©è½ãéè¡æ©è½ã§è¥å¹²å¤åãå¾ãããè¡åé¢ã«ãå¤åãã¿ããããããXï¼2å¹´ããªãããªãçµäºããã
æ°ã¥ãã«é¢ãã¦ã¯ãåé èæ©è½ã®æ¹åãèªå·±èªèåãæ¥å¸¸æ´»åã®æ¹åã«å¯ä¸ãã¦ãããã¨ãèãããããã¾ããè¡åã®å¤å®¹ãå³ãããã¨ãããæ
¢æ§æã§ãä»å
¥ããæå³ããã£ãã¨èããã
(çªè¡è£åã2014.6. 20)
解説ã24å¹´éã®ãã©ãã¼ã¢ãã
è¶
æ
¢æ§æã«ãããè³æå·è
ã®èªç¥æ©è½ãèªç¥ãªãããªãã¼ã·ã§ã³ã®å¹æã«ã¤ãã¦ã®ãã¼ã¿ã¯æç®ä¸ã«ãã»ã¨ãã©åå¨ããªããä¸ã¤ã®ã±ã¼ã¹ã20年以ä¸ã«ããã£ã¦ãã©ãã¼ã¢ãããããã¨ã¯ç¾å®çã«ã¯é常ã«å°é£ãªã®ã§ãããããããã®ã±ã¼ã¹ã§ã¯ãåé èæå·ã®çç¶ã¨ãã¦ã®è±æå¶ãä¹±è²»ãæ´è¨ãã¢ã«ã³ã¼ã«åé¡ã¨ãã¦é¡å¨åãã¦ãããèªç¥ãªãããªãã¼ã·ã§ã³ã®ããã°ã©ã ã«ã®ãããã¨èªä½ã«å¤§å¤ãªè¦å´ãè¦æ±ãããæ²»çè
ã®æ¶èã«ãããã©ãã¼ä¸æã®å±æ©ã常ã«åå¨ããã
çªè¡è£åè¨èªè´è¦å£«ã¯ããã®ãããªæ°ã
ã®æªæ¡ä»¶ãä¹ãè¶ãã¦ç±å¿ã«ã±ã¼ã¹ã«æ¥ããè¶
æ
¢æ§æã«ããã¦ãèªç¥ãªãããªãã¼ã·ã§ã³ãä¸å®ã®æå¹æ§ãæã¤ãã¨ã示ãããããã«ç¥çµå¿çå¦çæ¤æ»æç¸¾ã14å¹´åã¨æ¯è¼ããæ¹åããæ©è½ã¨æ¹åããªãæ©è½ãå³»å¥ãã¦æ¥å¸¸çæ´»æ©è½ã¨ã®é¢ä¿ãè«ããã
ãã®ã±ã¼ã¹ã®14å¹´åã®ãã¼ã¿ã¯ãé§æ¨éç
é¢ã®æ£®å±±æ³°å士ã1999å¹´ã®ç¥çµå¿çå¦ä¼ã§çºè¡¨ãããã®ã§ãããæ£®å±±å士ãå½ç 究室ã®ã¡ã³ãã¼ã§ãããæ
¶æç¥çµå¿çå¦ç 究室ã®å±¤ã®åãã¨ååä½å¶ããã£ã¦å¾ãããè²´éãªãã¼ã¿ã§ããã¨ããããã
æ§ã
ãªè³æå·ã«ãã£ã¦é害ãããèªç¥æ©è½ãå復ãããã¨ãã試ã¿ãèªç¥ãªãããªãã¼ã·ã§ã³ã§ãããå®å¹æããèªç¥ãªãããªãã¼ã·ã§ã³ã®ããã«ã¯ãç²¾å¯ãªç¥çµå¿çå¦çè©ä¾¡ã«ãã£ã¦ããã®å¯¾è±¡è
ã«ããã¦å¤±ããã¦ããæ©è½ã¨æ®åãã¦ããæ©è½ãæ£ç¢ºã«ææ¡ãããã¨ãå¿
è¦æ¡ä»¶ã§ãç¾å¨ã§ã¯èªç¥ãªãããªãã¼ã·ã§ã³ã¯è¨åºã«ç´çµããå¿ç¨ç¥çµå¿çå¦ã®ä¸åéã¨ãªã£ã¦ããã
çªè¡è¨èªè´è¦å£«ããã®ç ç©¶ãçºè¡¨ããèªç¥ãªãããªãã¼ã·ã§ã³ç ç©¶ä¼http://reha.cognition.jp/ã¯ãä¸è¬æ¼é¡ã®çºè¡¨æéã20åã¨ä»ã®å¦ä¼ã«æ¯ãã¦2å以ä¸ã«é·ããèªç¥ãªãããªãã¼ã·ã§ã³ã®å®è·µã«ã¤ãã¦åºãæ·±ãè°è«ãå¯è½ãªè¨å®ã«ãªã£ã¦ããã
1995å¹´ã彿æ
¶æç¥çµå¿çå¦ç ç©¶ä¼ã主宰ãã¦ãã鹿島æ´é客塿æ(ç¾)ãä¸å¿ã«è¨ç«ããããã¾ãã«è¨åºå®¶ã»å®è·µå®¶ã®ããã®ç ç©¶ä¼ã§ãããä¼å¡ã®å
訳ã¯å»å¸«ã25%ãã³ã¡ãã£ã«ã«ã75%ã§ãç¾å¨äºåå±ã¯å½æå®¤å
ã«ç½®ããã¦ããã
次åããªãã¡ç¬¬24åèªç¥ãªãããªãã¼ã·ã§ã³ç ç©¶ä¼ã¯2014å¹´11æ1æ¥ãæ±äº¬ã®ç 究社è±èªã»ã³ã¿ã¼å¤§ä¼è°å®¤ã§éå¬ãããã
(ææ¾å¤ªéã2014.6.21)
logopenicåé²è¡æ§å¤±èªãã失è¡ããã³æå³è¨æ¶é害ã¸ã®å±é
è¹å±±éé(è¶³å©èµ¤ååç
é¢ãç¥çµç²¾ç¥ç§ãé¨é·)Funayama M, Nakagawa Y, Yamaya Y, Yoshino F, Mimura M, Kato M.
Progression of logopenic variant primary progressive aphasia to apraxia and semantic memory deficits.
BMC Neurol 13: 158, 2013.
è¿å¹´ãè³ç»åã®çºå±ãç¸æ¬¡ãæ°ããç
çæè¦ã®çºè¦ã«ãã£ã¦å¤æ§ç¾æ£ã«ä¼´ãé²è¡æ§å¤±èªã¯æ³¨ç®ãéãã¦ãããé²è¡æ§å¤±èªã¯ãéæµæ¢æ§/å¤±ææ³åé²è¡æ§å¤±èªãæå³åé²è¡æ§å¤±èªãlogopenicåé²è¡æ§å¤±èªã®3é¡åã«åé¡ã§ãããç
åæã«ã¯å¤±èªã䏿 ¸çç¶ã§ãããã夿§ç¾æ£ã§ããããå¾ã
ã«å¤±èªä»¥å¤ã®çç¶ãåããããã«ãªããéæµæ¢æ§/å¤±ææ³åã¯çµéã¨ã¨ãã«ã¢ãã·ã¼ã対人é¢ä¿ã®åé¡ãè±æå¶ã常åè¡çºãå
±æã®ä¹ãããèªå·±æ´å¯ã®ä¹ãããªã©ããæå³åã¯æå³è¨æ¶é害ãå
±æã®ä¹ãããèå³ã®çå°åããã³ç¹å®ã®äºæã¸ã®æ²¡é ãªã©ã¨ã両è
ã¨ã主ã«ç¤¾ä¼è¡åé¢ã§ã®åé¡ãåºç¾ãã¦ããã䏿¹ã§ãè¿å¹´æ¦å¿µåãããlogopenicåã®é·æäºå¾ã«ã¤ãã¦ã¯ãä»ã¾ã§ã«å ±åã¯ã»ã¨ãã©ãªããã¦ããªãã£ãã
ä»åããããã¯ãçºçãã8年以ä¸çµéããlogopenicåé²è¡æ§å¤±èªã®3ä¾ï¼ç·æ§2ä¾ã女æ§1ä¾ï¼ãå ±åããã3ä¾ã¨ã50代çºçã§ãããSPECTã§ã¯å·¦å´ãä¸å¿ã¨ããå´é -é é èæ¥åé¨ãä¸å¿ã«ç¸å¯¾çè¡æµéã®ä½ä¸ãèªããã3ä¾ã¨ãåæã«logopenicåé²è¡æ§å¤±èªãåããæ°å¹´å¾ãã観念éå失è¡ãããã«æ¦å¿µå¤±è¡ãåºç¾ããçºçå¾5~9å¹´å¾ã«ã¯å®¶æã親æãèªç¥ã§ããªã人ç©èªç¥ã®é害ãç°é£çãåºç¾ãããã¨ãã½ã¼ãè¨æ¶é害ã¯3~4å¹´ã»ã©çµéãã¦ããåºç¾ããããæ¬3çä¾ã®ä¸æ ¸çç¶ã§ã¯ãªãã£ãããã®çµéã¯ã失èªãã失è¡ãããã«æå³è¨æ¶é害ã«è³ã£ãã¨ã¾ã¨ãããã¨ãã§ããã
è¿å¹´ã®ç¥çµç
çç ç©¶ããã¯ãlogopenicåé²è¡æ§å¤±èªã®ç´2/3ãã¢ã«ããã¤ãã¼ç
ã§ãããã¨ã夿ãã¦ãããããããã®çä¾ã¯ãæããè¨ããã¦ãã失èªã»å¤±è¡ã»å¤±èªãä¼´ããããçµéãæ©ãè¥å¹´çºçã®ã¢ã«ããã¤ãã¼ç
ã§ãã£ãå¯è½æ§ãé«ããæ¬ç ç©¶ããæ¨å¯ããã¨ãlogopenicåé²è¡æ§å¤±èªã®ä¸é¨ã¯ããã®ã¿ã¤ãã®ã¢ã«ããã¤ãã¼ç
ã§ããå¯è½æ§ãé«ãã
(è¹å±±ééã2014.5.8.)
解説ãç²¾ç¥ç¾æ£è§£æã®çé«
Logopenicåé²è¡æ§å¤±èªãèãæ
£ããªãç
åã ãã¾ã âlogopenicâããã´ã»ãããã¯ãlogo-ã¯ãè¨èããpenicã¯ãä¸è¶³ãã表ãã®ãªã·ã¢èªã§ããããé²è¡æ§å¤±èªãã¨ã¯ãä½å¹´ãããã¦å¾ã
ã«çç¶ãé²ãã§è¡ã失èªçã§ããã失èªçã¨ããã°è³è¡ç®¡é害ã«ãããã®ãå
¸åçã ããè³è¡ç®¡é害ã«ãããã®ã§ãªãããã¨ãã£ã¦è³çãè³è
«çãªã©ã§ããªããå¾ã
ã«è¨èã失ããã¦ããçµéãåãã±ã¼ã¹ããããæåã®å ±åã¯1892å¹´ã®ãã㯠Pick ã«ãããã®ã ãã20ä¸ç´å¾åã«ãªã£ã¦ããããçä¾ãç¶ã
ã¨å ±åãããããã«ãªã£ãããããé²è¡æ§å¤±èªã§ãããåå ã¯ä¸æã ã䏿ã®åå ã«ãããè³ã®ããé¨ä½ããè縮ãå§ã¾ãã®ã ãå§ã¾ãã¯ãè¨èªã«ããããé¨ä½ã®ããä¸é¨ãããããã¦å¾ã
ã«è¨èªä¸æ¢ãä¾µããããã«ã¯è³å
¨ä½ã«è縮ãåã¶ãã¨ãããã
Logopenicåé²è¡æ§å¤±èªã¯ã第ä¸ã®é²è¡æ§å¤±èªã¨å¼ã°ããæ°ããæ¦å¿µã§ãããè¨èªçç¶ã¨ãã¦ã¯ãç¹ã«å¾©å±ã®é害ãç®ç«ã¤ã®ãç¹å¾´ã ãå ãã¦é«åº¦ã«å°éçãªè¨èªçç¶åæã«ãããä¸ã¤ã®ç¾æ£åä½ã¨ãã¦ã¾ã¨ããããã21ä¸ç´ã«å
¥ã£ã¦ããã®ãã¨ã ãã ãçµéã¯ä¸æã§ãã£ããå¾ã
ã«é²è¡ããã¨ããããã©ã®ãããã®é度ã§é²è¡ããã®ããè¨èªä»¥å¤ã®çç¶ã¯ã©ã®ããã«æ¨ç§»ããã®ããæçµåã¯ã©ããªãã®ããæ¢åã®å¤æ§ç¾æ£ã®ä¸ã«åé¡ã§ããã®ãããããã¯ãã¹ã¦ä¸æã§ãã£ãããlogopenicåé²è¡æ§å¤±èªãã失è¡ããã³æå³è¨æ¶é害ã¸ã®å±éãã¨é¡ãããè¹å±±è«æã¯ã8å¹´éã¨ããé·æã«ããã£ã¦3çä¾ãç¶¿å¯ã«è¦³å¯ãããã®åãã«å¯¾ããçããæç¤ºãããã®ã§ããã
é·æçµéã®ç ç©¶ããªãå¿
è¦ãªã®ãããã¡ããä¸ã¤ã«ã¯ãæ£è
ããæ¬äººãå®¶æã®ããã§ãããããã¦ããä¸ã¤ã¯ãç¾æ£ã®æ¬è³ªã®æ´å¯ã®ããã§ãããçç¶ã¨ã¯ãç¹ã¨ç·ã§ãããç¹ã¨ã¯æ¨ªæé¢ãããªãã¡ããã䏿æãåãåã£ãæã«ãããã«è¦ãããçç¶ãç·ã¨ã¯ç¸¦æé¢ãããªãã¡é·æçµéã ãæä½ç診æåºæºã叿²ãã¦ããç¾ä»£ã®ç²¾ç¥å»å¦ã§ã¯ãç¹ã ããéå°ã«éè¦ããã¦ããããã¡ããç¹ãéè¦ã§ãããç¹ã®ææ¡ã ãã§ãã容æãªãã¨ã§ã¯ãªãã失èªçã®è¨èªçç¶åæã¨åçã®é«åº¦ãªè¨ºææè¡ããã©ããªç²¾ç¥ç¾æ£ã®æ¨ªæé¢ã®çç¶ã®ææ¡ã«ããã¦ãæ±ããããããããå¦ä½ã«ç²¾å¯ã«åæãã¦ããç¹ã ããè¦ã¦ããã®ã§ã¯éçã¯æããã ãç¹ã¨ç·ãæã£ã¦åãã¦ãç¾æ£ã®æ¬è³ªã«æ¥è¿ãããã¨ãã§ãããè³å¨è³ªç¾æ£ã®çåãç²¾å¯ã«åæããã¨ãããç¥çµå¿çå¦ã§ç¶¿ã
ã¨ç¶æ¿ããã¦ããæ¹æ³è«ã¯ãç²¾ç¥å»å¦ã®æ¬æ¥ã®è¨ºæå¦ãã®ãã®ã§ããã
è¹å±±é¨é·ã¯ãlogopenicåé²è¡æ§å¤±èªçã®çç¶ãç²¾å¯ã«åæããããã«ã¯é·æçµéãæããã«ãããã¨ã«ããããã®ç¾æ£ã®åå è«ã¨ãã¦ã®ã¢ã«ããã¤ãã¼ç
ã¨ã®ç¹ããã示ããããlogopenicåé²è¡æ§å¤±èªçã®å°ãªãã¨ãä¸é¨ã¯ãè¥å¹´åã¢ã«ããã¤ãã¼ç
ã§ããã
çµè«ã¨ãã¦ç¤ºåããã¦ããã®ã¯ãããã¾ã§ãæ·¡ã
ã¨ããäºå®ã ãã ãããã示ããè¹å±±è«æã¯ãç²¾ç¥ç¾æ£ã®çã®è§£ææ¹æ³ã¯ããããã¹ãã ã¨ããã¢ãã«ãè¦äºã«å®è·µãã¦ã¿ããä»äºã§ããã
(2014.5.27. ææ¾å¤ªé)
è³æå·å¾ã«ã¿ãããè¸è¡çè½åã®éè±ã«é¢ããç ç©¶
é«çåè¼ (æ¾å°ç·å»å¦ç·åç ç©¶æ å士ç ç©¶å¡)Takahata K, Saito F, Muramatsu T, Yamada M, Shirahase J, Tabuchi H, Suhara T, Mimura M, Kato M.
Emergence of realism: Enhanced visual artistry and high accuracy of visual numerosity representation after left prefrontal damage.
Neuropsychologia 57: 38-49, 2014.
ç²¾ç¥å»å¦ã«ããã¦ã¯ãç¾æ£ã«ããèªç¥æ©è½ã®ä½ä¸ãç°å¸¸ãªã©ã主ã«é害ã¨ãã¦ã®å´é¢ã強調ããã¦ãã¾ããããã¯ãå»å¦ã¨ãã¦å½ç¶ã®ãã¨ã§ããã䏿¹ã§ãè³æå·ãåé å´é è夿§ç(FTLD)ãçºçããå¾ã«ãç¹å®ã®è½åãåä¸ããä¾ãç¨ãªããåå¨ãããã¨ããç¥çµå¿çå¦ã®åéã§å¤ãããå ±åããã¦ãã¾ããããã®ãããªãç²¾ç¥ç¥çµç¾æ£ã«ãã£ã¦å¼ãèµ·ãããããé説çã¨ãè¨ããç¾è±¡ã¯ãç²å¾æ§ãµã´ã¡ã³çå群ãã¨å¼ã°ãã¦ãããåªä½åçã®åé èã®å±å¨ç
å¤ã«ãã£ã¦çãããã¨ãå¤ããçµµç»ãé å½¢ãªã©ã®è¦ç©ºéèªç¥ã«é¢é£ããè¸è¡çæè½ã§éè±ããä¾ãå¤ããã¨ãç¥ããã¦ãã¾ããè¿å¹´ãç²å¾æ§ãµã´ã¡ã³çå群ã«é¢ããå ±åããå½å
å¤ã§ç¸æ¬¡ãããã«ãªãã¾ããããè³å±å¨æ©è½ã®é害ã«ããè¸è¡çæè½ãåä¸ããæ©æ§ã¯é·ãã䏿ã®ã¾ã¾ã§ãããç¹ã«ãè¸è¡çæè½ã®ä¸ã§ãåå®è½åãåä¸ããçä¾ãå¤ãã¨ããç¹ã¯ãç²å¾æ§ãµã´ã¡ã³çå群ã«ã¾ã¤ããè¬ã¨ããã¦ãã¾ããã
æ¬ç ç©¶ã¯ãå è¤å
ä¸éå
çã®ãæå°ã®ä¸ã大å¦é¢æä»£ã«è¡ããããã®ã§ãå·¦åé åéã®æå·å¾ã«çµµç»è½åã亢é²ããçä¾ã«ããã¦ãµã´ã¡ã³æ§ã®æ©è½äº¢é²ã®èæ¯æ©æ§ãæ¢ã£ãç ç©¶ã§ãã以åãããæã
ã¯ãåªä½åçã®åé èãæå·ãããã¨ã«ãããåé¨ä½ãæå¶ãã¦ããéåªä½åçã®å¾é¨è³ã®æ©è½ãè§£æ¾ããããã¨ã«ãã£ã¦åå®è½åã亢é²ãããã®ã§ã¯ãªããã¨èãã¦ããã¾ãããä»åã幸ãã«ãæ£è
ããã«ãååãã¦é ãããã¨ã«ãªããç¥çµå¿çæ¤æ»ãèªç¥å¿ç課é¡ãè³è¡æµã·ã³ããå°éå®¶ã«ããçµµç»æè½ã®è©ä¾¡ãªã©ã®è¤æ°ã®ææ³ãçµã¿åããããã¨ã«ãã£ã¦ä»®èª¬ã®æ¤è¨¼ãè¡ãã¾ããã詳ããçµæã«ã¤ãã¦ã¯ãè«æãåç
§ãã¦é ããã°ã¨æãã¾ãããæ£è
ããã«ããã¦åé èæ©è½ã®ä½ä¸ã«ãé¢ãããåå®çãªæç»æè¡ãé«ã¾ã£ã¦ãããã¨ãå¥å¸¸å¯¾ç
§ç¾¤ãããæ£ç¢ºãªæ°éå¼å¥è½ã示ãããã¨ãéåªä½åçã®é é èã®è¡æµã亢é²ãã¦ãããã¨ãªã©ã確èªãããæã
ã®ä»®èª¬ãæ¯æããããã¨ã示ããã¾ããã
æ¬ç ç©¶ã®ææã¯ãç²å¾æ§ãµã´ã¡ã³çå群ã®ç
æ
è§£æã«ã¤ãªããã ãã§ãªããè³æå·ãèªç¥çæ£è
ããã®ãªãããªãã¼ã·ã§ã³ã«ãå½¹ç«ã¦ãããã®ã§ã¯ãªããã¨èãã¦ãã¾ããä»å¾ãçä¾ãç©ã¿éãã¦ãããªãæ¤è¨ãå ãã¦ããããã¨èãã¦ãã¾ãã
(é«çåè¼ã2014.4.9.)
解説 è¦éããæè½
è³ãæå·ãããã°ãè³ã®æ©è½ã¯æãããã¨æãã§ãããã
å¤ãã®å ´åã¯ãã®éãã§ãããã¨ããããç¨ã§ã¯ããããè³æå·ã«ãã£ã¦éã«ç¹å®ã®è³æ©è½ãæ´»æ§åãããã¨ããããç ã£ã¦ããæè½ãéè±ããã¨ãã£ã¦ãããããããç²å¾æ§ãµã´ã¡ã³çå群ã¨å¼ã°ããç¾è±¡ã§ããã
ãµã´ã¡ã³çå群ã¨ã¯ãä¸ç¨®ã®å¤©æã§ããã19ä¸ç´ã«ãå
天çãªç¥è½ä½ä¸ãæã¡ãªããç¹å®ã®é å(ãã¨ãã°è¨æ¶å)ã«çªåºããè½åãæã£ã¦ããè¤æ°ã®ã±ã¼ã¹ããidiot-savant(ç½ç´ã®å¤©æ)ãã¨åã¥ãããã¦çºè¡¨ãããã®ãæåã§ãããæåãªãµã´ã¡ã³ã¨ãã¦ãæ ç»ãã¬ã¤ã³ãã³ãã®ã¢ãã«ã¨ãªã£ããã ã»ãã¼ã¯ãæãããã¨ãã§ãããå½¼ã¯æ·±å»ãªä¸æ¢ç¥çµç³»ã®ç°å¸¸ãåå¨ããã«ãããããããéå»ã«èªãã ç´9,000åã®æ¸ç©ã®å
å®¹ãæ£ç¢ºã«æè¨ãã¦ããã¨ããé©ç°çãªè¨æ¶åãå
·ãããµã´ã¡ã³ã¨ãã¦ç¥ããã¦ããã
ãµã´ã¡ã³èªä½ãç¨ãªç¾æ£ã§ããããç²å¾æ§ãµã´ã¡ã³çå群ã¯ããã«ç¨ã§ãããç²å¾æ§ãµã´ã¡ã³ã¨ã¯ãæäººã«ãªã£ã¦ããä½ããã®è³æå·ã被ã£ãçµæãä½ããã®åªããæ©è½ãç¾ãããã±ã¼ã¹ãæãããªããã®ãããªç¾è±¡ãèµ·ãããã¯è¬ã§ãã£ããããã¾ã§Lancetãªã©ã«ããããããªçä¾å ±åããããããããããç²å¾æ§ãµã´ã¡ã³çå群ã¨ããã±ã¼ã¹ãåå¨ãããã¨ããè¨è¿°ã®ã¬ãã«ãè¶
ãããã®ã§ã¯ãªãã£ãã
é«çå士ã2014å¹´ã«Neuropsychologiaã«çºè¡¨ãããã®è«æã¯ãç²å¾æ§ãµã´ã¡ã³ã®è¬ã«æãã ãã®ã§ãããæç¤ºããã¦ããã®ã¯ãè³æå·ã®ä¸ä¾ã«ã¤ãã¦ã®è©³ç´°ãªæ¤è¨ã§ããã®ç·æ§ã¯è³è¡ç®¡é害ã§å·¦åé èã«æå·ãè² ã£ãå¾ãè¦äºãªçµµãæããããã«ãªã£ããããã§ã
ã»è³è¡æµã®æ¸¬å®
ã»åé èæ©è½ãè¦è¦çæ°éèªç¥èª²é¡çã®ç¥çµå¿çå¦çæ¤æ»
ã»è³æå·åã«æããçµµã¨è³æå·å¾ã«æããçµµã®è³ªã®æ¯è¼(æ±äº¬è大ã®27人ã®å°éå®¶ã«å®éçè©ä¾¡ãä¾é ¼ãçµæã¯ããå宿§ããè²å½©ãã®é
ç®ããè³æå·å¾ã«æ¹å)
ãªã©ãè¡ã£ãçµæãå³åé èãæ¥åé¨ãé é éæºã®è¡æµå¢å ããæç»è½åçã«é¢é£ãããã¨ã証æããããé·å¹´ã«ãããè¬ã§ãã£ãç²å¾æ§ãµã´ã¡ã³ã®è³åºç¤ã®è§£æã«æããå
ãå·®ããã®ã§ããã
ãã®é«çå士ã®è«æã¯ã
The human species is the sole animal that can draw a picture.
(人é¡ã¯ãçµµãæãå¯ä¸ã®åç©ã§ãã)
ã¨ãã䏿ããå§ã¾ã£ã¦ããã
人éã ããæã¤ãçµµãæãã¨ããæ©è½ãé«åº¦ã«è¤éåãã人éã®è³ãå¯è½ã«ããæ©è½ã¯ãã»ãã«ãæ°éããªãããããã®è³ã®å¥¥åºã«ãã£ãæ©è½ããå·¦åé èã®æå·ã«ãã£ã¦éè±ããã¨ããã®ãããã®é«çè«æã®ä¸»æ¨ã§ããã
é²åã®éç¨ã§éãã«ç ãã«ã¤ããã¿ã¤ã ã«ãã»ã«ã®ããã«è¦éãå¾
ã£ã¦ããæè½ãããããã人éã®è³ã«ã¯ã¾ã ã¾ã ããã«éããªãã
(ææ¾å¤ªéã2014.4.23.)
çµ±å失調çã®èªæé害ã«ã¤ãã¦ã®å®è¨¼çç ç©¶
åç°è²´è¨(æ
¶æç¾©å¡¾å¤§å¦å»å¦é¨ç²¾ç¥ç¥çµç§è¬å¸«)Maeda T, Takahata K, Muramatsu M, Okimura T, Koreki A, Iwashita S, Mimura M, Kato M.
Reduced sense of agency in chronic residual schizophrenia with predominant negative symptoms.
Psychiatry Research, 209(3): 386-392,2013
çµ±å失調çã«ããã¦ãèªæé害ã¯ä¸æ ¸çãªçç¶ã¨èãããã¦ãããè¿å¹´ãèªç¥ç§å¦ã«ããã¦èªå·±æèãç ç©¶ãããã©ãã¤ã ã¨ãã¦ãsense of agency (SoA)ãçºå±ãã¦ãã¦ããããã®å´é¢ãããçµ±å失調çã®èªæé害ã«ã¤ãã¦ãæ¤è¨ããã¦ãã¦ãããæã ããçµ±å失調çã«ãããSoAã«ã¤ãã¦å®è¨¼çã«è©ä¾¡ããããã«ç¬èªã®ã¿ã¹ã¯ãèæ¡ãç ç©¶ããããã¦ãããæ¬è«æã§ã¯ãæ ¢æ§æã§é°æ§çç¶ã忝ã®çµ±å失調çã«ããã¦ãSoAãä½ä¸ãã¦ãããã¨ã示ãããã®ã§ãããè¨åºçã«ã¯ã¨ããã«ãããã®ã®ãé°æ§çç¶ãå¼·ãæ£è ã«ããã¦ãèªæéå®³ãæ½å¨ãã¦ãããã¨ããå®é¨çã«ã¯ç¤ºãããç¹ã§éè¦ã§ãããæ ¢æ§æã§é½æ§çç¶ã忝ã®çµ±å失調çã«ããã¦ãSoAç°å¸¸ãã¿ããããã®ã®ï¼Maeda et al., 2012ï¼ãç°å¸¸ãã¿ã¼ã³ã¯é°æ§çç¶ç¾¤ã¨ã¯ç°ãªã£ã¦ããã以ä¸ãããSoAç°å¸¸ã¯ãçµ±å失調çã®trait & state markerã¨ãã¦ã®æç¾©ãããããããããä»å¾ãæ¥æ§æãããã«ã¯åé§ç¶æ ï¼schizotypal personality disorderãå«ãï¼ã«ã¤ãã¦æ¤è¨¼ãã¦ããããã
(åç°è²´è¨, 2014.3.12.)
解説 çµ±å失調çã®è¬ãè§£ã: ç²¾ç¥ç çå¦ã¨è³ç§å¦ã®åºä¼ã
å¹»è´ã妿³ãæèé害ãã»ã»ã»çµ±å失調çã®çç¶ã¨ãã¦æãããããã®ã¯æ°å¤ããããããããã®åºåºã«ããã¨ããããã®ãèªæé害ã§ããã徿¥ãè¨è¿°çãªç²¾ç¥ç
çå¦ã®é åã ãã«æ£²æ¯ãã¦ãããã®èªæé害ããµã¤ã¨ã³ã¹ã®å¯¾è±¡ã¨ããçµ±å失調çã®æ¬è³ªã«è¿«ãã®ãåç°è²´è¨è¬å¸«ã®ãã¼ãã§ããã®ããã«å½¼ãä¸å¿ã¨ãªã£ã¦éçºãããã¼ã«ãSense of Agency Task (SoAã¿ã¹ã¯)ã§ããã
Sense of Agencyã¨ã¯æ¥æ¬èªã§ã¯èªå·±ä¸»ä½æã¨å¼ã°ãã¦ãããå¥å¸¸è
ã«ã¨ã£ã¦ã¯èªåã®æèãè¡åã®ä¸»ä½(agency)ãèªå·±ã§ããã¨èªèãããã®ã¯å½ç¶ãããã»ã©å½ç¶ã§ããããçµ±å失調çã§ã¯ãã®èªèãå´©ããããããã«ã¯å¤çã®ç¾è±¡ã®ä¸»ä½ãèªå·±ã§ããã¨èªèããããããããããSense of Agencyã®ç°å¸¸ã§ããã
ãã¨ãã°ãçµ±å失調çã®çç¶ã§ããããããä½é¨ã¯ãèªå·±ã®è¡åãä»è
ã«ã³ã³ããã¼ã«ãããã¨æãããããã®ã§ãã¾ãã«Sense of Agencyã®ç°å¸¸ã§ãããã¾ããçµ±å失調çã®æã代表çãªçç¶ã¨ããããå¹»è´ããå
ã
ã¯èªãã®è³å
ã«çºçãããã®ã§ããã¯ãã®æèã声ããä»è
ã®ãã®ã¨ãã¦æãããããã®ã¨ã¨ãããã°ããã¯ãSense of Agencyã®ç°å¸¸ã§ããã¨ãããã
åç°è¬å¸«ãä¸å¿ã¨ãªã£ã¦éçºããSoAã¿ã¹ã¯ã¯ãããããµã¤ãã§ç°¡ä¾¿ã«è¡ããæ¤æ»ã§ããã½ã³ã³ã®ãã£ã¹ãã¬ã¤ä¸ã®å
ç¹ã®åãããèªåèªèº«ã®ãã¼æä½ã«ãããå¦ãã®ä¸»è¦³ç夿ãåããã¨ã«ãã£ã¦ãSense of Agencyãã¿ããã®ã§ããããã®ã¿ã¹ã¯ã®ããã¥ã¼ã¯2012å¹´ã®è«æ:
Maeda T, Kato M, Muramatsu T, Iwashita S, Mimura M, Kashima H.
Aberrant sense of agency in patients with schizophrenia: forward and backward over-attribution of temporal causality during intentional action.
Psychiatry Res. 2012 Jun 30;198(1):1-6.
ã§ããã
æ¬è«æ Reduced sense of agency in chronic residual schizophrenia with predominant negative symptoms. ã¯ããã«ç¶ã第äºå¼¾ã«ä½ç½®ã¥ãããããã®ã§ãçµ±å失調çã«ãããSoAæ¸å¼±ãå®è¨¼çã«ç¤ºããä¸çåã®è«æã§ããã
䏿¹ã§ãSoAã¿ã¹ã¯æ½è¡æã®è³å
æ´»åãfunctional MRIã§ç¤ºããè«æã
Fukushima H, Goto Y, Maeda T, Kato M, Umeda S.
Neural substrates for judgment of self-agency in ambiguous situations.
PLoS One. 2013 Aug 19;8(8):e72267.
ã2013å¹´ã«åè¡ãã¦ããã
SoAã¿ã¹ã¯ãç¨ãããããä¸é£ã®ç ç©¶ã¯ãèªæé害ã¨ãããçµ±å失調çã®ä¸æ ¸ã¨ããããçç¶ãããã徿¥ã¯ãµã¤ã¨ã³ã¹ã®å¯¾è±¡ã«ãªãã«ããã£ãçç¶ããå®è¨¼çç ç©¶ã®å°ç¨ã«æããã¨ããç¹ã²ã¨ã¤ãã¨ã£ã¦ã¿ã¦ããé常ã«å¤§ããªæç¾©ãæãããã®ã§ãããè¿ãå°æ¥ã«ã¯ãçµ±å失調çã®åé§ç¶æ
ã®æ£ç¢ºãªè©ä¾¡ã¸ã®å¿ç¨ãæå¾
ãããã
ãªããçµ±å失調çã®èªæé害ã®ç¾å¨ãåç°è¬å¸«ã解説ãããã®ã¨ãã¦ã
æ¥æ¬çµ±å失調çå¦ä¼ç£ä¿®ãçµ±å失調çã
第24ç« çµ±å失調çã®èªæé害ã®èªç¥ç§å¦
ãããã(2013.6 çºå)
(ææ¾å¤ªé, 2014.3.30.)